
<html lang="en"     class="pb-page"  data-request-id="bf9924c1-7bf3-40ff-a05b-f49b314c5dd6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b01456;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology" /></meta><meta name="dc.Creator" content="Chiara  Borsari" /></meta><meta name="dc.Creator" content="Darci J.  Trader" /></meta><meta name="dc.Creator" content="Annalisa  Tait" /></meta><meta name="dc.Creator" content="Maria P.  Costi" /></meta><meta name="dc.Description" content="After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugat..." /></meta><meta name="Description" content="After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugat..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 5, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01456" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2020 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01456" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01456" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01456" /></link>
        
    
    

<title>Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01456" /></meta><meta property="og:title" content="Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0021.jpeg" /></meta><meta property="og:description" content="After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugates, bifunctional compounds, multitargeting molecules, chimeras, hybrids, engineered compounds. However, these engineered constructs share a general structure: a first component that targets a specific cell and a second component that exerts the pharmacological activity. A stable or cleavable linker connects the two modules of a chimera. Herein, we discuss the recent advances in the rapidly expanding field of chimeric molecules leveraging chemical biology concepts. This Perspective is focused on bifunctional compounds in which one component is a lead compound or a drug. In detail, we discuss chemical features of chimeric molecules and their use for targeted delivery and for target engagement studies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01456"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01456">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01456&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01456&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01456&amp;href=/doi/10.1021/acs.jmedchem.9b01456" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1908-1928</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01318" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b01512" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Chiara Borsari</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chiara Borsari</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chiara++Borsari">Chiara Borsari</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4688-8362" title="Orcid link">http://orcid.org/0000-0002-4688-8362</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Darci J. Trader</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Darci J. Trader</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 610 Purdue Mall, West Lafayette, Indiana 47907, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Darci+J.++Trader">Darci J. Trader</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0607-1243" title="Orcid link">http://orcid.org/0000-0002-0607-1243</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Annalisa Tait</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Annalisa Tait</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41125 Modena, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Annalisa++Tait">Annalisa Tait</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Maria P. Costi</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria P. Costi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 103, 41125 Modena, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#711c1003181001101e1d105f121e02051831041f181c1e03145f1805"><span class="__cf_email__" data-cfemail="f09d9182999180919f9c91de939f838499b0859e999d9f8295de9984">[emailÂ protected]</span></a>. Phone: +390592058579.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria+P.++Costi">Maria P. Costi</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0443-5402" title="Orcid link">http://orcid.org/0000-0002-0443-5402</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01456&amp;href=/doi/10.1021%2Facs.jmedchem.9b01456" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1908â1928</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 5, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 September 2019</li><li><span class="item_label"><b>Published</b> online</span>5 February 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01456" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01456</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="https://acsopenscience.org/open-access/licensing-options/"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by"><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_cc-1612971093887.svg" alt="CC: Creative Commons" /></img><span><strong>CC: </strong>Creative Commons</span></a><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_by-1612971093257.svg" alt="BY: Credit must be given to the creator" /></img><span><strong>BY: </strong>Credit must be given to the creator</span></a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01456"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5649</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01456" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Chiara&quot;,&quot;last_name&quot;:&quot;Borsari&quot;},{&quot;first_name&quot;:&quot;Darci&quot;,&quot;last_name&quot;:&quot;J. Trader&quot;},{&quot;first_name&quot;:&quot;Annalisa&quot;,&quot;last_name&quot;:&quot;Tait&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;P. Costi&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;1908-1928&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01456&quot;},&quot;abstract&quot;:&quot;After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugates, bifunctional compounds, multitargeting molecules, chimeras, hybrids, engineered compounds. However, these engineered constructs share a general structure: a first component that targets a specific cell and a second component that exerts the pharmacological activity. A stable or cleavable linker connects the two modules of a chimera. Herein, we discuss the recent advances in the rapidly expanding field of chimeric molecules leveraging chemical biology concepts. This Perspective is focused on bifunctional compounds in which one component is a lead compound or a drug. In detail, we discuss chemical features of chimeric molecules and their use for targeted delivery and for target engagement studies.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01456&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01456" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01456&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01456" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01456&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01456" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01456&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01456&amp;href=/doi/10.1021/acs.jmedchem.9b01456" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01456" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01456" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01456%26sid%3Dliteratum%253Aachs%26pmid%3D32023055%26genre%3Darticle%26aulast%3DBorsari%26date%3D2020%26atitle%3DDesigning%2BChimeric%2BMolecules%2Bfor%2BDrug%2BDiscovery%2Bby%2BLeveraging%2BChemical%2BBiology%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D5%26spage%3D1908%26epage%3D1928%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291909" title="Immunology">Immunology</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290975" title="Biopolymers">Biopolymers</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/jmcmar.2020.63.issue-5/20200312/jmcmar.2020.63.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">After the first seed concept introduced in the 18th century, different disciplines have attributed different names to dual-functional molecules depending on their application, including bioconjugates, bifunctional compounds, multitargeting molecules, chimeras, hybrids, engineered compounds. However, these engineered constructs share a general structure: a first component that targets a specific cell and a second component that exerts the pharmacological activity. A stable or cleavable linker connects the two modules of a chimera. Herein, we discuss the recent advances in the rapidly expanding field of chimeric molecules leveraging chemical biology concepts. This Perspective is focused on bifunctional compounds in which one component is a lead compound or a drug. In detail, we discuss chemical features of chimeric molecules and their use for targeted delivery and for target engagement studies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/63/5"><issue-title>Women in Medicinal Chemistry</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A chimeric molecule is an engineered construct in which two or more components are linked to form a novel biological agent. Chimeric molecules can be considered as variants of an idea proposed by Paul Ehrlich in the late 1800s. This concept describes a bifunctional molecule in which one component targets the molecule to a specific cell and the second component exerts a pharmacological activity.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Different disciplines have attributed multiple names to dual-functional molecules (chimeras, hybrids, bioconjugates, bifunctional compounds, multitargeting molecules, engineered compounds) depending on the field of application, but the general structure is conserved.</div><div class="NLM_p">Recently, the knowledge in cellular and molecular biology widely increased. The chemical biology field allowed the application of the chemistry knowledge to deliver specific biomolecules on the cell membrane and into the cells. The concepts of chemical biology were translated into drug discovery of chimeric molecules (or chimeras).<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> These entities display (i) a targeting moiety and (ii) an effector molecule within the same chemical construct, and their individual function could be largely modulated with appropriate conjugation chemistry strategies where a linker is the bridging element (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref1 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref3">(1,3)</a> Recently, the exploitation of these systems for drug delivery implementation, particularly into cancer cells, has been reviewed.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overview of chimeric compounds with a diversity of structures: (a) examples of chimeras discussed in the Perspective, where linker moiety is highlighted in blue; (b) general structures of chimeric compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This Perspective discusses the recent advances in the rapidly expanding field of chimeric molecules in which one component is a lead compound or a drug. In detail we discuss chemical features of chimeric molecules, targeted delivery, and the exploitation of chimeric molecules for target engagement studies.</div><div class="NLM_p"><a class="ref internalNav" href="#sec2" aria-label="Section 2">Section 2</a> is focused on linker chemistry. To develop small molecules that engage a specific cell type or protein target, a small molecule needs to be linked with another moiety that allows selective target recognition. The linker plays a pivotal role in the development of chimeric compounds and allows bridging of two pharmacophores within one molecule. The type and the length of the linker are essential parameters for the design and biological activity of chimeras, leading to a rapid expansion of the linker chemistry field.</div><div class="NLM_p"><a class="ref internalNav" href="#sec3" aria-label="Section 3">Section 3</a> deals with drug delivery based on receptor-mediated endocytosis (RME). Cell membrane permeation represents the major bottleneck in achieving the sufficient drug concentration for therapeutic effect. Drug delivery systems exploiting receptor-mediated endocytosis have been proposed as a promising tool to overcome tissue barriers and have given an important contribution to medical practice, especially in the area of cancer and central nervous system (CNS) disorders. Three classes of ligands have been used to target receptors at the cell membrane and are herein discussed: (i) cell-penetrating peptides (CPPs), (ii) tumor homing peptides, and (iii) monoclonal antibodies.</div><div class="NLM_p last"><a class="ref internalNav" href="#sec4" aria-label="Section 4">Section 4</a> covers the recent advancements in chimeric molecules engineered to demonstrate how a drug engages its own target intracellularly. Herein, we discuss the crucial integration of chemical biology knowledge, drug discovery strategies, and medicinal chemistry to foster structureâmechanism of action studies and subsequent structural modifications.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Linker Features in the Modular Approach to Chimeric Compounds</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26144" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26144" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  Linker Chemistry</h3><div class="NLM_p">Physically connecting two chemical moieties or a small molecule with a protein occurs through a moiety called linker. A wide variety of linkers have been developed that consider if the target of the small molecule is intra- or extracellular and what type of cell or tissue the small molecule needs to target. If the desired target is intracellular, typically the linker includes a moiety that can be cleaved once the chimera is inside the cell. Linkers also play an important role in activity-based protein profiling experiments.</div><div class="NLM_p">A commonly used linker type is hydrazone, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a. The hydrazone moiety can typically be easily installed because of its compatibility with peptide synthesis.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The hydrazone moiety is stable at physiological pH and cleaves at an acidic pH, but additional conditions that do not require acids have been developed.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> While the hydrazone moiety has been widely used in diversity-oriented synthesis<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and as an additional handle in peptide synthesis,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> more recently it has been exploited as a reversible linker for proteomics experiments.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Several different types have been developed, including an acyl hydrazone from the Kohn laboratory.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Their study highlights a more efficient capture and release of the targeted protein pool as compared to standard protocols due to the mild conditions for the hydrazone release. Captured proteins do not have to be exposed to SDS or 8 M guanidine to release them for mass spectrometry experiments. The Dawson group developed a bisaryl hydrazone linker also highlighting the mild conditions that can be exploited to release captured proteins from a hydrazone-linked molecule.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Examples of linkers and cleavage conditions: (a) hydrazone; (b) disulfide linker; (c) traditional click chemistry reaction used to easily link moieties together. The inverse DielsâAlder reaction has been used to link molecules to a solid surface for screening or for the release of a cytotoxic moiety. Linkers are highlighted in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The disulfide moiety is also commonly investigated in chemical biology (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). It has been highly utilized to cyclize peptides. The cyclization of peptides has been shown to increase their resistance to proteases and, in some cases, stabilizes the structure to boost its ability to bind to the targeted protein.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> More recent trends have promoted the concept of peptide stapling rather than disulfide bonds because of the reversibility of the disulfide bond.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Nonetheless, disulfides in peptide therapeutics are still common, with the most well-known therapeutic peptide that incorporates disulfide bonds being insulin.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Disulfide linkers have also been exploited in recombinant fusion proteins<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and for the synthesis of peptide libraries.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a></div><div class="NLM_p">Since the disulfide linker bond can be reversed under physiological conditions, it has been integrated into drug delivery approaches and in prodrug scaffolds. Cells have a high level of free âSH moieties in their cytosol. Once the disulfide-linked drug enters the cytosol, the disulfide can be reduced, releasing the drug moiety.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The disulfide linker has been extensively used in the conjugation of small molecules to antibodies. Anticancer drugs, including doxorubicin (<b>1</b>), methotrexate, and mitomycin C, have been linked to antibodies and, after internalization, the disulfide linker is cleaved and the cytotoxic agent released.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> This method increases the uptake of the cytotoxic drug by cancer cells and not by the healthy ones. A linker containing a free thiol is conjugated to the small molecule of interest at a location that does not affect its activity. This entire moiety is then bound to an antibody through generation of a disulfide bond between the free thiol linked to the small molecule and a cysteine residue on the antibody.</div><div class="NLM_p">Other linkers used in chemical biology can be generated through the reaction commonly referred to as click chemistry (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c). The term click chemistry, coined by Karl Barry Sharpless, refers to a variety of reactions that are considered simple and regiospecific and provide high yields.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> However, click chemistry has become traditionally referred to as the Huisgen 1,3-dipolar cycloaddition of azides and terminal alkynes. The most basic click reaction, with cooper as a catalyst, produces a 1,4-subsituted triazole. This reaction has been used to (i) link natural products to tags aiding in identification and detection,<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> (ii) introduce a biotin moiety on proteins of interest for enrichment for mass spectrometry experiments,<a onclick="showRef(event, 'ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26">(23â26)</a> and (iii) synthesize a variety of small molecule libraries on solid-phase or polymer-like structures.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27â30)</a> A click reaction generating a releasable linker is the inverse-electron-demand DielsâAlder between a conjugated trans-cyclooctene and a tetrazine moiety. This type of cleavage linker has been demonstrated to effectively release <b>1</b> or other ligands conjugated to an antibody.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> The Garner laboratory has also employed this type of click reaction to develop different platforms for the screening of small molecule binders to RNA.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a></div><div class="NLM_p last">The linkers described here are just a few of those that have been developed to help answer a variety of chemical biology questions and for therapeutic application. In the remaining subsections, we will describe more specific examples of how linkers are critical for the success of drug discovery programs and for the study of essential cellular processes.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.2.  PROTAC Linker Considerations</h3><div class="NLM_p">Proteolysis targeting chimeras or PROTACs represent a new method to target proteins of interest and degrade them to elicit a therapeutic response. This method exploits a chimeric molecule. A small molecule binder to an E3 ligase is linked to another small molecule that binds with the protein of interest. The targeted protein is then ubiquitinated after coming into close contact with the E3 ligase and degraded by the proteasome. One of the most critical decisions in designing a PROTAC is the length of the linker required to connect the small molecule binding to the protein of interest and the desired E3 ligase. PROTACs have been developed to degrade a variety of target proteins including ALK,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> the estrogen receptor,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> MDM2,<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> tau,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> BET protein, and CDK9 protein. For these two last ones, the chimeric compounds JQ-1 and CDK9 are reported in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. Well-established PROTACs are commercially available. After selection of which E3 ligase to target, typically either cereblon (CRBN) or von HippelâLindau (VHL), an appropriate linker between the E3 ligase binding moiety and the molecule binding the protein to be degraded needs to be installed.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of the well-known, potent PROTACs including JQ1 and a CDK9 inhibitor, presenting the best linker length. Linkers are highlighted in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An interesting study by the Kim group highlights how critical the linker length is in order to generate a potent degrader. They created an estrogen receptor (ER)-Î±-targeting PROTAC and installed a variety of linkers with different lengths. These linkers were composed of polyethylene glycol units, ranging in length from 11 to 16 atoms. Their results showed that while the 12- and 16-atom linkers had similar binding affinities to the ER, the 16-atom linker was significantly more potent in degrading the ER.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p last">The importance of the linker length for a PROTAC was also demonstrated by the KrÃ¶nke group.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> They designed a homo-PROTAC for the degradation of the E3 ligase CRBN. If CRBN cannot ligate its cellular substrates, ubiquitinated proteins can increase, leading to cell death. They connected two thalidomide moieties with PEG linkers of various lengths and determined their abilities to degrade CRBN. In this case, the optimized linker was a short 8 atoms length PEG. These studies, along with many others, highlight that new PROTACs must be tested with a variety of different length linkers.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Linker dynamics, such as thermodynamics, linker flexibility, and decreasing steric clash, have been studied, and all of these parameters should be considered when designing a new PROTAC.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.3.  Linkers for the Discovery and Isolation of Natural Products</h3><div class="NLM_p">Natural products represent a novel pool of potential antibiotic and anticancer molecules. Traditional purification techniques are biased toward discovering natural products that have been already identified. As described in the click chemistry section, it is a method to target alkyne-containing natural products, but these are a very small pool of natural products. The biggest challenge in discovering therapeutically relevant natural products is finding small molecules that have not been previously identified. Traditional extraction methods of a crude natural product lysate followed by LC/MS analysis is biased toward discovering the most abundant molecules in the lysate. Linkers that can isolate natural products based on their functional group composition have been developed. This technique produces different pools of natural products, helping to unmask those that are too low in abundance to be detected in the crude lysate. The Carlson group has developed a family of reversible linkers to isolate hydroxyl-, phenol-, and carboxylic acid-containing natural products.<a onclick="showRef(event, 'ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47 ref48">(45â48)</a> These linkers contain different siloxy moieties that can selectively capture or release different molecules containing the aforementioned functional groups (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The capture of hydroxyl-containing natural products occurs by the formation of a silyl ether bond. This links the natural product to the resin. Molecules not bound to the resin are rinsed away using a variety of solvents. The molecules linked to the resin can be released by exposing the resin to a fluoride source, such as TBAF or HF. This creates two pools of molecules, those that contain a hydroxyl moiety and those not bearing this functional group. These unique pools of molecules can be concentrated and analyzed by LC/MS or fractionated for activity-based assays.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Linkers for the physical capture of natural products. Resins utilize a linker (colored in blue) with a silicon atom to capture (a) hydroxyl- or (b) carboxylic acid-containing molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Linkers for the isolation of natural products containing other functional groups have also been developed. There are several examples of linkers to capture thiol containing natural products through either a disulfide bond formation or a 1,4-nucleophilic addition.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> Linkers to natural products containing less prevalent functional groups, including epoxides and Î²-lactams, have also been described.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.4.  Linking Covalent Inhibitors to Fluorophores</h3><div class="NLM_p">Monitoring and visualizing essential cell processes are critical for drug development. The monitoring of enzymes critical to cell survival is an important chemical biology technique. To accomplish this, a number of covalent inhibitors have been linked to fluorophores through a variety of linkers aiming to visualize the desired cellular process. These probes can be used in confocal microscopy and/or flow cytometry to evaluate the effect of potential small molecule therapeutics. One example is the development of a fluorescent derivative of Taxol (<b>2</b>) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a). This cytotoxic drug was discovered â¼50 years ago and has been used to treat a variety of cancer types. <b>2</b> targets cells that are rapidly dividing by interacting with microtubules and initiating mitotic arrest. However, it is currently unclear the mechanism by which <b>2</b> elicits its toxic effect and why some patients do not respond to the treatment.<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53,54)</a> To visualize the subcellular localization of <b>2</b>, the Peterson group synthesized a probe that links this microtubule-stabilizing drug to Pacific Blue.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> They tested three different linker lengths between <b>2</b> and the Pacific Blue moiety, and their results indicated that having a glycine linker, rather than a Î²-alanine or GABA linker, led to the best binding affinity to the tubulin heterodimer. Their probe was highly specific for tubulin binding, and they proposed that it can be used as a new tool for studying how <b>2</b> affects the proliferation rate of cancer cells.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Two probes to observe (a) tubulin dynamics and (b) proteasome activity with the linker portion colored in blue. A variety of linker lengths between the small molecule binder/inhibitor and the fluorophore were evaluated to ensure that the fluorophore did not interfere with the binding to the protein of interest.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Fluorescent probes with a variety of linker types have also been developed to monitor the activity of the proteasome. The proteasome is a large protein complex in cells, responsible for proteins degradation. If unwanted proteins accumulate in cells, this can lead to endoplasmic reticulum stress and eventually apoptosis.<a onclick="showRef(event, 'ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58">(56â58)</a> Fluorescent probes have been developed to study the activity of the proteasome in cells.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> One of the major considerations when developing a proteasome activity probe is the linker length between the fluorophore and the active-site binding moiety. The fluorophore must be far enough from the binding site moiety to prevent any steric hindrance but not too bulky that it cannot enter the catalytic channel of the proteasome. The Overkleeft group has developed a number of fluorescent probes to monitor the activity of the proteasome. They have applied an activity probe that consists of the BODIPY fluorophore linked to epoxomicin, a covalent inhibitor of the proteasome (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> This probe, along with others with different linker lengths, can be used to evaluate proteasome activity and determine the composition of the different types of active sites that assemble to form the full proteasome.<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62,63)</a> In addition, a variety of probes with different types of linkers have been developed to monitor the activity of the immunoproteasome.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The immunoproteasome rather than the standard proteasome is produced when cells encounter an inflammatory signal.</div><div class="NLM_p last">The recent advancements in linker chemistry suggest that in the future linkers will allow making steps forward in the design of chimeras. Moreover, the linker will play a pivotal role in the delivery and release of therapeutic agents, as well as in the investigation of biological pathways.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">3.  Chimeric Compounds and Receptor-Mediated Endocytosis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10740" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10740" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.1.  Receptor-Mediated Endocytosis for Drug Delivery</h3><div class="NLM_p">Lack of optimal pharmacokinetic profile is one of the main reasons why compounds fail during preclinical and clinical studies. Barrier permeability is an obstacle in achieving the therapeutic effect. Drug delivery opportunities are currently rising, and researchers are focusing their work on overcoming tissue barriers. Receptor-mediated endocytosis (RME, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) has been extensively studied as a method for boosting the transport of bioactive cargo across membranes, including the bloodâbrain barrier (BBB).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Schematic strategy of the selective delivery of biological cargos into cells exploiting receptor-mediated endocytosis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ligands binding to surface receptors can induce cellular uptake of therapeutics, including monoclonal antibodies, peptides, nucleic acids, small-molecule drugs, and nanoparticles. Herein, we discuss the recent advancements in the use of ligands for selectively binding to cell surface receptors. Three classes of ligands are discussed: (i) cell-penetrating peptides (CPPs), (ii) tumor homing peptides (THPs), and (iii) monoclonal antibodies. The highest ligand selectivity is displayed for antibodies, and this led to the FDA approval of five antibodyâdrug conjugates (ADCs): Mylotarg (<b>3</b>),<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a> Besponsa (<b>4</b>),<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Adcetris (<b>5</b>),<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a> Kadcyla (<b>6</b>),<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> and Polivy (<b>7</b>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div><div class="NLM_p last">However, huge advancements have been shown also in the field of THPs. THPs are short peptides that have an inherent property to recognize tumor cells. Tumor necrosis factor Î± (hTNFÎ±) was conjugated with a tumor homing peptide (NGR),<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> and phase I and phase II clinical trials of NGR-hTNFÎ± as a single agent and in combination with <b>1</b> are ongoing. In addition, THPs have a possible application in diagnostic imaging to help target radiopharmaceutical agents.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> THPs represent a step forward in cancer diagnosis and treatment.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">3.2.  Cell-Penetrating Peptides</h3><div class="NLM_p">CPPs are considered the least selective ligands for RME and are believed to translocate across cell membranes via a receptor-independent mechanism.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Very recently, disclosures in cell-surface receptors responsible for cellular uptake of CPPs paved the way for the optimization and exploitation of CPPs as ligands.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><div class="NLM_p">CPPs are cationic and/or amphipathic peptides of typically 8â30 amino acids and have been widely used to induce cellular uptake of bioactive cargoes.<a onclick="showRef(event, 'ref78 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref78 ref79 ref80">(78â80)</a> CPPs can be either covalently or noncovalently be coupled with a cargo. Identification of key amino acids to induce cellular uptake has been a pivotal parameter for the development of efficient ligands. The isolation of the active transporting peptide sequence within the HIV-TAT (TAT48â57: GRKKRRQRRR) represented a breakthrough for CPPs development. This sequence is called TAT peptide or TAT.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Due to their high efficiency in internalization, arginine-rich CPPs such as oligoarginine and TAT facilitate the intracellular delivery of a wide range of cargoes, including peptides, antibodies, nucleic acids, nanoparticles, and small molecule drugs.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Different studies have reported the pivotal role of arginine as a basic amino acid in CPPs, since it interacts with the guanidinium and phosphate groups at the cellular membrane. Indeed, the surface of cancer cells is known to be more negative with respect to that of normal cells. The negative charge generated on cancer cells is related to the different sugar metabolism pathways from normal cells due to the higher amount of lactic acid production.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Positively charged CPPs bind through electrostatic interactions to the outside of cancer cells and promote RME.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> However, the widespread use of CPPs is hampered by the lack of specific selectivity. TAT has been shown to strongly enhance the intracellular delivery of <b>1</b>. Due to the nonspecific cell penetrating features of TAT, CPPs have been coupled to nanocarriers. Recently, Yang et al. developed acid-sensitive micelles as delivery method for TAT protection. The luteinizing hormone modified poly(ethylene glycol)-poly(<span class="smallcaps smallerCapital">l</span>-histidine)-<b>1</b> (LHRH-PEG-PHIS-<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>a) micelles were employed to deliver <b>1</b>-TAT (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>b). This strategy represents a step forward in the safer use of cytotoxic agents since the micelles dissociate in response to the tumor extracellular pH. Afterward, <b>1</b>-TAT can cross the cell membrane of tumor cells and elicit a cytotoxic effect.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) LHRH-PEG-PHIS-<b>1</b>. (b) <b>1</b>-TAT conjugate. (c) Cleavable probe of octa-arginine peptide. Linker is colored in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2018, an anionic cell-penetrating tetrapeptide, Glu-Thr-Trp-Trp (ETWW), with excellent potential for cell penetration, has been reported. The tetrapeptide has been coupled to liposomes to efficiently deliver <b>1</b> to the nucleus of cancer cells.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Very recently, Dominguez-Berrocal et al. developed a chimeric trifunctional peptide composed of a CPP, a nuclear localization sequence, and a peptide blocking the interaction of the primary downstream effectors of the Hippo signaling pathway (TEAD and YAP). The novel peptide delivered the cargo specifically to the nucleus and showed an apoptotic effect in tumor cell lines. The antitumor efficacy in a breast cancer xenograft model is encouraging for the development of nuclear anticancer drugs.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></div><div class="NLM_p">In addition to cancer treatment, nanoparticle-forming CPPs have been investigated in gene therapy approaches. However, CPP-mediated plasmid DNA (pDNA) delivery has been inefficient mostly because CPPs condense pDNA into nanoparticles that easily disintegrate, without delivering the therapeutic amount of pDNA into cells. In addition, CPPs and their cargo could be trapped into endocytic vesicles, preventing the pDNA from reaching the nucleus. These limitations can be overcome with the addition of a hydrophobic stearic acid residue since hydrophobic interactions are essential to form and stabilize the CPP/pDNA nanoparticles. Veiman et al. proposed pepFect14 (stearyl-AGYLLGKLLOOLAAAALOOLL, PF14, where O is ornithine) as a suitable non-natural peptide to form stable nanoparticles with pDNA. These nanoparticles could lead to an efficient gene delivery allowing the optimal transfection of genetic material into cells.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> The uptake of PF14 and other CPP/oligonucleotide (siRNA or pDNA) complexes is mediated by scavenger receptors (SCARA).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> These receptors bind promiscuously all negatively charged macromolecules and mediate their uptake.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div><div class="NLM_p">Another noteworthy application of CPPs is the delivery of neuroprotective peptides to the central nervous system for the treatment of neurological disorders. Arginine-rich CPPs show promising results in the delivery of neuroprotective peptides, especially to aid in treating cerebral ischemia and stroke. Several groups have shown that TAT and other arginine-rich cell penetrating peptides have intrinsic neuroprotective properties.<a onclick="showRef(event, 'ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref91 ref92">(91,92)</a> Meloni et al. suggested that the neuroprotection might be related to carrier peptide endocytosis: neuronal cell surface structures such as ion channels and transporters are internalized during endocytosis, decreasing the calcium influx associated with excitotoxicity.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> In addition, endocytosis causes internalization of cell surface receptors leading to a decrease in receptor-mediated neurodamaging signaling pathways.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div><div class="NLM_p">Endocytosis has a crucial role in the cellular uptake of CPPs. Macropinocytosis<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> and other classes of endocytosis such as clathrin-mediated<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> and caveolae-mediated endocytosis<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> are involved. Moreover, direct penetration of CPPs through plasma membranes has been described.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Originally it was believed that CPPs translocated across cell membranes via a receptor-independent mechanism, leading to a not-cell-type-specific uptake.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Very recently, Kawaguchi et al. identified syndecan-4 as a cell-surface receptor responsible for cellular uptake of octa-arginine (R8) peptide via clathrin-mediated endocytosis. A cleavable probe of the R8 peptide (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>c) was used to identify syndecan-4 as an endogenous membrane-associated receptor.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Even though this cell-surface receptor is ubiquitously expressed, it is overexpressed in breast and testicular cancer cells<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99,100)</a> and in kidney cells of patients with IgA nephropathy.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><div class="NLM_p last">Rodriguez Plaza et al. proposed that CPPs work as cationic antibacterial peptides (CAPs) in the presence of bacterial cells. While CPPs enter eukaryotic cells without apparent toxicity, CAPs are able to make pores in the membrane and kill bacteria. Iztli peptide 1 (IP-1), showing both CPP and CAP activities, was utilized to explain this different behavior. IP-1, a hunterâkiller peptide against <i>Saccharomyces cerevisiae</i>, makes pores only in the presence of high electric potential value at the membrane, which have been found in bacteria and mitochondria.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Therefore, CPPs are able to switch from penetrating mammalian cells with any apparent toxicity to killing bacterial cells in the presence of large membrane potential.<a onclick="showRef(event, 'ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref102 ref103">(102,103)</a></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">3.3.  Tumor Homing Peptides</h3><div class="NLM_p">As described in <a class="ref internalNav" href="#sec3_2" aria-label="section 3.2">section 3.2</a>, the majority of CPPs lack specificity leading to reduced therapeutic efficiency and side effects. To overcome the limitations of CPPs, more specific peptides, namely, tumor homing peptides (THPs), have been developed.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> THPs are short peptides constituted by a few amino acids (3â15) and are considered a type of CPP. They have the intrinsic property to recognize oncological-specific proteins and molecular markers overexpressed on tumor cells or tumor vasculature.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> After binding to cell surface receptors, tumor homing peptides induce RME. Classical vascular-homing peptides are peptides containing the NGR motif, which binds to aminopeptidase N (CD13) or the RGD motif, which binds to Î±<sub>Î½</sub> integrins.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Aminopeptidase N is overexpressed by endothelial cells of tumor vasculature and has been demonstrated to be involved in angiogenesis and cancer progression. Likewise, Î±<sub>Î½</sub> integrins are overexpressed in blood vessels in the tumor and represent a potential target to deliver cytokines to tumor vasculature. <b>1</b> was the first anticancer drug to be coupled to a NGR peptide. Later, phase I and phase II clinical trials of NGR-hTNFÎ± as a single antitumor agent and in combination with <b>1</b> have been performed for a variety of cancers, including ovarian, colorectal, and small cell lung cancer (SCLC).<a onclick="showRef(event, 'ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref107 ref108">(107,108)</a> Tumor necrosis factor Î± (TNFÎ±) has demonstrated powerful antitumor activity but also severe toxicity. Conjugation of hTNFÎ± with the tumor homing peptide NGR (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) improved safety and efficacy of TNF. Moreover, a synergism between NGR-hTNFÎ± and chemotherapy was observed, since NGR-hTNFÎ± has been shown to increase the intratumoral chemotherapy penetration.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Very recently, phase II clinical results have been disclosed and NGR-hTNF plus <b>1</b> demonstrated promising activity in patients with relapsed SCLC.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> A phase III clinical trial was performed in patients with malignant pleural mesothelioma to assess the efficacy and safety of NGR-hTNF plus best investigator choice [NCT01098266]. Despite the positive results in phase II evaluation, the phase III clinical trial did not meet its end point; no significant differences in overall survival were observed between treated groups. However, further investigation is needed due to the poor prognosis of patients after first-line treatment.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structure of a monomer NGR-hTNF [<a href="https://www.molmed.com/node/33" class="extLink">https://www.molmed.com/node/33</a>].</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the TNF protein, the TNF gene has been employed for cancer gene therapy and has been reported to promote antitumor responses both in animal models and in patients. The plasmid DNA encoding CNGRCG-TNF and ACDCRGDCFCG-TNF (pNGR-TNF and pRGD-TNF, respectively) displayed growth inhibition of subcutaneous murine B16F1 melanomas and RMA-T lymphomas after intramuscular injection.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> RGD-TNFÎ± was also evaluated for its ability to enhance the antitumor effect of chemotherapy; however NGR-hTNFÎ± was mostly chosen for clinical trials. RGD has been preferentially exploited for diagnostic applications and many RGD-based radiopharmaceutical agents have been assessed for cancer imaging.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Bispecific NGR peptides (GNGRAHA), targeting both CD13 and Î±vÎ²3 integrin in the endothelium of solid tumors, have been developed. In 2018, Seidi et al. combined the NGR peptide, GNGRAHA, with a truncated form of coagulase (tCoa) generating a bifunctional protein (tCoa-NGR) with novel anticancer properties. This strategy allowed selective targeting of the tumor neovasculature and inducing of selective thrombosis in tumor-feeding vessels. In tumor models, tCoa-NGR led to a significant reduction of tumor growth after systemic administration.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Therefore, tCoa-NGR represents a promising anticancer strategy to induce tumor infarction and reduce systemic side effects.</div><div class="NLM_p">Besides TNF, tumor homing peptides could facilitate distribution of other cytokines into tumor cells and enhance their therapeutic effect. In 2017, it has been shown that RGD enhances the antitumor effect of IL-24. Melanoma differentiation-associated gene-7/interleukin-24 gene (MDA-7/IL-24) is a unique tumor suppressor gene, which promotes selective apoptosis of cancer cells. RGD-coupled IL-24 construct induced apoptosis in hepatocellular carcinoma-related cell line.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> The results highlight the benefit of cytokine targeting by THPs to cancer cells. Coupling RGD to the N-terminus of IL-24 led to a stronger interaction with the receptors. On the contrary, adding RGD to the C-terminus of IL-24 disrupted native interactions and reduced the apoptosis induction properties.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Very recently, Bina et al. confirmed these results with <i>in silico</i> targeting of RGD/NGR-modified IL-24 to tumor cells.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><div class="NLM_p">THPs have shown potential to be versatile platforms of polymers for nonviral gene delivery.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> pDNA complexes of recombinant proteins with poly(<span class="smallcaps smallerCapital">l</span>-lysine) and THP showed significant improvement of target specificity to cancer cells by additions of F3 and CGKRK THPs. F3 peptides are high affinity ligands for nucleolin, which is expressed on the surface of cancer angiogenic endothelial cells, and selectively bind MDA-MB-435 cells.<a onclick="showRef(event, 'ref116 ref117'); return false;" href="javascript:void(0);" class="ref ref116 ref117">(116,117)</a> CGKRK peptides were described to bind to heparin sulfate in cancer vessels.<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(118,119)</a></div><div class="NLM_p last">THPâgold nanoconjugates actively targeted MCF-7 cells in comparison to nontumor 3T3-L1 fibroblast cells.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> THPs specific for MCF-7 cells were selected from a phage display library, synthesized, and conjugated to spherical gold nanoparticles by a heterobifunctional cross-linker with an ethylene oxide spacer. This work proved the possibility of developing nanomaterials that can rely on tumor targeting potential irrespective of a specific knowledge of the target cell biology.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.4.  Monoclonal Antibodies</h3><div class="NLM_p">Over the past decade, monoclonal antibodies (mAbs) have significantly improved the clinical outcomes for cancer patients since they specifically bind tumor-associated target antigens and eventually deliver cytotoxic agents to tumor cells in a targeted manner while sparing normal cells.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> mAbs are conjugated to small-molecule chemotherapeutics, and the resulting antibodyâdrug conjugate (ADC) is parentally administered (intravenous or subcutaneous). After binding to their target antigens, ADCs are internalized through RME.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> The development of a procedure to produce mAbs has increased the enthusiasm of scientists for the development of precise targeted cancer therapy. Humanized and fully human antibodies have the advantage of being retained longer in circulation than their murine equivalents and led to a dramatic increase in the use of antibody-based drugs against cancer.<a onclick="showRef(event, 'ref123 ref124'); return false;" href="javascript:void(0);" class="ref ref123 ref124">(123,124)</a> However, many challenges have to be overcome for the development of optimized and functional antibodyâdrug conjugates with possible application as therapeutic agents.</div><div class="NLM_p">One of the major challenges in the development of ADCs is to incorporate a linker able to preserve the ADC stability in systemic circulation for an extended period and to release the payload at the targeted site. Conjugation site and linker choice are key parameters in the pharmacokinetic properties of ADCs. The site of attachment to an antibody can also be engineered in different ways to incorporate a linker and subsequently a bioactive molecule.</div><div class="NLM_p">Considering the five ADCs approved so far by FDA, gemtuzumab ozogamicin (<b>3</b>) and inotuzumab ozogamicin (<b>4</b>) have an acid-sensitive hydrazone linker (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), brentuximab vedotin (<b>5</b>) and polatuzumab vedotin (<b>7</b>) have a lysosomal protease-sensitive peptide linker (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>a), and trastuzumab emtansine (<b>6</b>) exploits a noncleavable SMCC (<i>N</i>-succinimidyl-4-(maleimidomethyl)cyclohexane-1-carboxylate) linker (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>b).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structure of <b>3</b> and <b>4</b>. Linker is colored in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Chemical structure of <b>5</b> and <b>7</b>. (b) Chemical structure of <b>6</b>. Linkers are colored in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>3</b> uses side chain reactive lysines of a humanized anti-CD33 mAb to attach calicheamicin, a highly cytotoxic agent that induces double-strand DNA cleavage, by a bifunctional acid sensitive hydrazone linker (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). After being launched in 2000 as therapeutic agent for relapsed acute myelogenous leukemia, this ADC was withdrawn from the market due to the limited benefit over conventional anticancer treatment and the serious hepatotoxicity.<a onclick="showRef(event, 'ref125 ref126'); return false;" href="javascript:void(0);" class="ref ref125 ref126">(125,126)</a> This withdrawal increased the concern on the stability of the hydrazone linker. In addition, the ADC heterogeneous nature of the drug conjugate concurred to premature release of the conjugated payload, leading to a significant toxicity compared to traditional chemotherapy. Subsequent trials using a lower dose led, in September 2017, to the FDA approval of <b>3</b> for newly diagnosed and relapsed/refractory acute myeloid leukemia.<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a></div><div class="NLM_p">Compound <b>4</b> is another antibodyâdrug conjugate of calicheamicin.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> It is formed by a CD22-directed monoclonal antibody covalently bonded to <i>N</i>-acetyl-Î³-calicheamicin (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). <b>4</b> received FDA approval in 2017 to treat relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a><b>4</b> has shown excellent activity in the clinic, and ongoing trials are evaluating its value as frontline treatment.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> A phase III clinical trials is assessing the benefits of treating newly diagnosed B-cell acute lymphoblastic leukemia with <b>4</b> in combination with chemotherapy [NCT03150693].</div><div class="NLM_p">In 2011, compound <b>5</b> received approval for Hodgkinâs lymphoma (HL) and anaplastic large-cell lymphoma (ALCL).<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a><b>5</b> utilizes side chain cysteines to conjugate monomethyl auristatin E (MMAE), a potent antimitotic agent, with the anti-CD30 mAb (cAC10) through an enzymatically cleavable dipeptide (valineâcitrulline) linker (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>a).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> A selective reduction of the disulfide bonds in the four interchain provides up to eight reactive sulfhydryl groups that facilitate drug conjugation (drug to antibody ratios are from 0 to 8).<a onclick="showRef(event, 'ref130 ref131'); return false;" href="javascript:void(0);" class="ref ref130 ref131">(130,131)</a> Exploiting this method to link the drug, rather than using lysine conjugation, results in ADCs that could be easily purified and pharmacokinetically characterized. Besides its application in the treatment of different types of lymphomas, the safety and antitumor activity of <b>5</b> have been demonstrated also in patients with CD30-expressing solid tumors in a phase II clinical trial.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></div><div class="NLM_p">In 2019, compound <b>7</b>, a second ADC of MMAE whose mAb targets CD79b (B-cell antigen receptor complex-associated protein Î² chain), was granted accelerated FDA approval for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in combination with bendamustine plus rituximab (BR).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> A multicenter phase Ib/II clinical trial including a cohort of 80 patients with relapsed or refractory DLBCL [NCT02257567] granted drug approval. At the end of the therapy, the complete response rate was 40% with <b>7</b> plus BR, compared with 18% with BR alone.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></div><div class="NLM_p">Compound <b>6</b> uses a noncleavable SMCC linker to cross-link the warhead cytotoxic agent emtansine (DM1), a microtubule inhibitor, to lysine residues of anti-HER2 mAb, trastuzumab (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>b). Lysine-MCC-DM1 complex, an intercellular metabolite, turned out to be as active as the parent drug, after trastuzumab degradation by lysosomes. It is clinically employed in patients with HER2-positive metastatic breast cancer.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> The approval of <b>6</b> for the treatment of breast cancer highlighted the capability of ADCs to target solid malignancies in addition to hematologic tumors. With the recent approval of <b>7</b>, there has been a boost in research investigating the use of ADCs in cancer treatment. ADCs are likely to become a pivotal part of future targeted cancer therapy.</div><div class="NLM_p">Although a huge effort has been made to produce ADCs for oncology, they are also an attractive platform to deliver noncytotoxic bioactive cargos in a cell-specific way aiming to reduce potential side effects related to off-target interactions. For example, an antibodyâdrug conjugate that selectively recognizes immune cells through the CD11a antigen has been conjugated to a derivative of a highly potent phosphodiesterase 4 (PDE4) inhibitor (GSK256066) (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>a). This strategy could limit neurological side and gastrointestinal toxicity that have hampered a broad application of PDE4 inhibitors.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> To obtain a site-specific conjugation to the anti-human CD11a antibody, the unnatural residue <i>p</i>-acetylphenylalanine (pAcF) was linked to the heavy chain of efalizumab (site A122). To enable conjugation of GSK256066, a linker containing a tetraethylene glycol spacer with a terminal aminooxy group was reacted under slightly acidic conditions with the pAcF ketone, resulting in stable covalent conjugates. Conjugation was performed with drug/antibody ratio of 2 (1 bioactive molecule linked to each heavy chain). Recent studies have supported the feasibility to develop mAbs-PDE4 inhibitor conjugates as promising therapeutics for treating ulcerative colitis due to the specific delivery of immune suppressants to immune compartment.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> In addition, autoimmune diseases represent a potential field for ADCs application and significant advancements have been done in the past decade. Wang et al. proposed the use of dasatinib (<b>8</b>), a Bcr-Ab1 tyrosine kinase inhibitor, for immune suppression and developed an immunosuppressive ADC (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>b) which targets CXCR4 and delivers <b>8</b> to human T lymphocytes. Modeling and structureâactivity relationship studies highlighted that the hydroxyl moiety of <b>8</b> is not required to observed pharmacological activity.<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89,90)</a> Therefore, it was modified for conjugation to the antibody with a noncleavable linker by reaction with <i>p</i>-nitrophenyl chloroformate and carbamylation with a tetrapolyethylene glycol (PEG) linker displaying an aminooxy group. The resulting <b>8</b>âantibody conjugate inhibits T cell receptor (TCR)-mediated T cell activation and cytokine expression with nanomolar EC<sub>50</sub> and shows minimal effects on cell viability. This strategy could lead to an improved efficacy and safety of kinase inhibitors and to their exploitation in nononcological diseases.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> A phase II clinical trial is currently ongoing to determine the benefit of <b>5</b> in the treatment of systemic sclerosis, a multisystem autoimmune disease [NCT03198689].</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (a) Anti-inflammatory human Î±CD11a antibody conjugated to a PDE4 inhibitor. (b<sub>1</sub>, b<sub>2</sub>) HLCX, immunosuppressive humanized antibody that binds selectively to CXCR4, conjugated to <b>8</b> with a noncleavable linker (b<sub>1</sub>) and a disulfide-cleavable linker (b<sub>2</sub>). Linkers are colored in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These results highlight that, besides cancer, ADCs have potential application in a wide range of inflammatory and autoimmune disorders. Naked therapeutic antibodies have launched a novel era of both autoimmune disease and cancer treatment, but ADCs represent the next-generation antibody therapies and will represent a breakthrough in the treatment of these illnesses.</div><div class="NLM_p last">The ability of monoclonal antibodies to selectively bind tumor-associated target antigens and release cytotoxic agents to the tumors in a targeted manner has dramatically improved the clinical practice. Further advancements in this field will lead to the success of precise targeted cancer therapy. RME is also exploited by CPPs and THPs, but they have a poor selectivity compared to antibodies. However, nanocarriers are attractive tools to be coupled to CPPs and THPs and improve their safety and selectivity. In addition, the use of nanocarrier is boosting the antibody-based delivery of biological cargos into cancer cells. In the future, these systems are expected to become essential therapeutics for the treatment of malignancies and central nervous system disorders. Moreover, THPs are essential components of radiopharmaceutical agents and will represent a step forward in cancer diagnosis.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">4.  Chimeric Compounds and Target Engagement</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67116" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67116" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">4.1.  Target Engagement</h3><div class="NLM_p">One of the main failures in translating preclinical results into a positive clinical outcome is the lack of pharmacokinetic and pharmacodynamic validation of drugâtarget interactions <i>in vivo</i> with serious impact on efficiency and costs of the drug discovery process. The mechanism that small molecules adopt to engage their targets inside living cells is a crucial step in medicinal chemistry and chemical biology, since it requires the availability of appropriate assays and inhibitors/ligands. The molecular recognition event in living cells between drugs and targets is defined as âtarget engagementâ, and the associated technologies represent a rapidly evolving field of research.<a onclick="showRef(event, 'ref137 ref138 ref139 ref140'); return false;" href="javascript:void(0);" class="ref ref137 ref138 ref139 ref140">(137â140)</a></div><div class="NLM_p">This technology allows target validation in living systems: in cells, tissues, and animal models. It confirms compounds cellular entry and target binding and can suggest optimized drug delivery to enable compounds to be more effective, specific, bioavailable, and less toxic.<a onclick="showRef(event, 'ref2 ref141 ref142'); return false;" href="javascript:void(0);" class="ref ref2 ref141 ref142">(2,141,142)</a><i>In vitro</i> studies could foresee the optimization of human performance characteristics.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> To perform these studies, selected leads and drugs should be conjugated with appropriate tags to obtain chimeric compounds with a diversity of structures (see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref2 ref141 ref142'); return false;" href="javascript:void(0);" class="ref ref2 ref141 ref142">(2,141,142)</a></div><div class="NLM_p">To perform a target engagement study, it is essential to (i) know the target localization into the cell, (ii) design an assay for cellular setting, (iii) ensure the detection of the observable changes on cellular surface or intracellularly, depending on targets location, and (iv) ensure the escape of off-targets and background noise of the cellular matrices.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> While quantification of compound binding to purified proteins or surface receptors (in particular to GPCR) is well established,<a onclick="showRef(event, 'ref145 ref146'); return false;" href="javascript:void(0);" class="ref ref145 ref146">(145,146)</a> the interaction of compounds with intracellular targets is difficult to quantify.</div><div class="NLM_p">Regarding the fluorimetric detection, a fluorescent probe has to be covalently conjugated with the inhibitor (see <a class="ref internalNav" href="#sec2_4" aria-label="section 2.4">section 2.4</a>)<a onclick="showRef(event, 'ref2 ref141 ref142'); return false;" href="javascript:void(0);" class="ref ref2 ref141 ref142">(2,141,142)</a> and should show sufficient solubility (slightly different from the values required for a drug) and a logÂ <i>P</i> of around 3, necessary for a suitable drug or inhibitor tagging. Lipophilicity may influence the amount of compound able to enter the cell and consequently available for binding. In addition, the fluorescent tag module should not mask the compound affinity for the target (see <a class="ref internalNav" href="#sec2" aria-label="section 2">section 2</a>). Target engagement assays might be invasive since they drive the intracellular environment away from equilibrium conditions.<a onclick="showRef(event, 'ref147 ref148 ref149'); return false;" href="javascript:void(0);" class="ref ref147 ref148 ref149">(147â149)</a> Orthogonal assays are usually needed to validate the results.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Aktinson and co-workers studied the interaction of selective autophagy receptors with two conserved hydrophobic pockets (called W-site and L-site) of mATG8 (autophagy receptors to autophagy related 8) proteins through a linear residue, namely, the LC3-interacting region (LIR). Fourteen LIR-containing peptides were designed and synthesized, and their affinity for mATG8 was investigated using a competitive time-resolved FRET (TR-FRET). The assay used a GST-tagged mATG8 protein and a terbium labeled anti-GST antibody to measure the equilibrium dissociation constant, <i>K</i><sub>d</sub>, by TR-FRET. The results were confirmed by additional structural information using nuclear magnetic resonance (NMR) spectroscopy. This work points out the importance of having two assays that exploit different experimental readouts to validate the results.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></div><div class="NLM_p">A similar approach was reported to discover inhibitors of the signal-regulatory protein (SIRP)Î±-CD47 interaction with a high-throughput screening approach.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> CD47 is an immune checkpoint that downregulates the functionality of both innate and adaptive anticancer immune response through its SIRPÎ± receptor. A series of small molecule ligands that selectively target SIRPÎ± interactions with CD47 was discovered. The assay was performed using a specific LANCE TR-FRET assay and a â¼90â¯000-compound library. In parallel, an AlphaScreen based on similar TR-FRET technology was adopted for validation purposes. SIRPÎ± was biotin tagged, and an antibody with the energy donor reagent was the tagged chimeric biomolecule exploited in the assays.</div><div class="NLM_p last">In the following subsections, target engagement technologies and examples of the use of tagged compounds are described.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">4.2.  Strategies Based on Small Molecule and Target Protein Modification</h3><div class="NLM_p">The proximity between a bioactive small molecule and its targeted protein can be studied using spectroscopic methods such as fluorescence or bioluminescence resonance energy transfer measurements (FRET and BRET, respectively). FRET and BRET occur only when the donor and acceptor are in close proximity (2â6 nm) and are unique methods to inspect intermolecular protein interactions and proteinâligand interactions in cells.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><div class="NLM_p">In FRET (fluorescence resonance energy transfer or FÃ¶rster resonance energy transfer) studies, a donor fluorophore upon excitation transfers energy to a nearby acceptor fluorophore. When a suitable acceptor is present, the donor emission is quenched and emission of light occurs at a longer wavelength (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). The essential criteria to observe FRET are (i) suitable distance, (ii) appropriate donor/acceptor orientation, and (iii) large overlap of the donor emission spectrum and the acceptor absorption spectrum. FRET can be quantified determining the change in donor fluorescence lifetime through fluorescence lifetime imaging microscopy (FLIM) based on FRET readout.<a onclick="showRef(event, 'ref153 ref154 ref155'); return false;" href="javascript:void(0);" class="ref ref153 ref154 ref155">(153â155)</a> FRET-FLIM monitors target engagement in living cells and provides details on the temporal and spatial distribution of the ligandâprotein complex.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Description of FRET experiments for target engagement with no interaction (left) and interaction (right): FP, fluorescent protein; green dot line = donor excitation spectrum; green line = donor emission spectrum; violet dot line = acceptor excitation spectrum; violet line = acceptor emission spectrum.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In some cases, a fluorescent protein (FP) is fused in cells to the target protein, and a FRET signal is generated when fluorophores are in close proximity (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>, left). In a different protocol, the target protein can be ectopically expressed in the same cells and modified in a specific residue in order to bind a suitable fluorescent donor (or acceptor) (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>, right).<a onclick="showRef(event, 'ref156 ref157'); return false;" href="javascript:void(0);" class="ref ref156 ref157">(156,157)</a> The target protein could be properly engineered to allow binding detection, for example, with a tetracysteine tag.<a onclick="showRef(event, 'ref156 ref157'); return false;" href="javascript:void(0);" class="ref ref156 ref157">(156,157)</a> Cells expressing the target protein coupled to a FP are treated with the a small molecule labeled with a fluorescent dye; subsequently the lifetime distribution of the donor fluorophore into a cell is determined. The donor fluorescence lifetime reveals the interaction sites into a cell as well as the areas with a reduced donor lifetime.</div><div class="NLM_p">FRET based technology has been exploited, for example, for the recognition of phosphodiesterase<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> and thymidylate synthase (TS) by tagged inhibitors. TS is an obligate homodimeric enzyme, and a tetracysteine (TC4) tag is introduced at the N-terminus. The fluorescein diarsenical probe FlAsH, added to the HEK-293 cell lysate containing the ectopically expressed protein, is coordinated by the tetracysteine behaving as a fluorescence donor. The tagged substrate is an octapeptide (LR) and is conjugated with the fluorescence acceptor probe Hylite-405 (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>). Titration of hTS-tetracys-Flash (acceptor) with LR-hilyte 405 (donor) in lysates of cells transfected with hTS-tetracys shows an increase in FRET signal.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. FRET experiment with TS dimer. The N-terminus is modified by inserting the sequence CCGPCC-tetracysteine (TC). Probe excitation at the proper wavelength causes the energy transfer and FRET signal increases upon binding of the LR-hilyte-405 ligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">TR-FRET has been applied to the assessment of Brutonâs tyrosine kinase (BTK) occupancy in the clinical trials of tirabrutinib (<b>9</b>). Compound <b>9</b> (GS-4059/ONO-4059) is a second-generation, irreversible BTK inhibitor explored for the treatment of lymphoid malignancies. The inhibitor was conjugated with biotin through a carbamideâPEG mixed linker, and free and total BTK levels were measured using TR-FRET.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">4.3.  BRET Experiments</h3><div class="NLM_p">BRET (bioluminescence resonance energy transfer) is a mechanism describing the energy transfer between a donor (luciferase) and an acceptor (fluorescent) molecule. The spectral separation between donor and acceptor excitation required in FRET (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) is not required in BRET since the production of light originates from a chemical reaction catalyzed by the donor enzyme (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>, right). Since BRET does not require the use of excitation illumination, it has advantages over FRET. BRET is therefore more applicable to the analysis of photoresponsive cells or cells that are easily damaged by excitation light. BRET has been exploited to detect proteinâprotein interactions in real time in living cells.<a onclick="showRef(event, 'ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref159 ref160">(159,160)</a> In target engagement studies, cells express the target protein fused to a luciferase, while a ligand with a fluorophore tag behaves as an acceptor (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>). Different BRET techniques are known and differ for the combination of the donor/acceptor/substrate used.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Distance, orientation, and spectral overlap are the major parameters that influence both BRET and FRET. However, external excitation of the donor is not required in BRET; therefore phenomena related to simultaneous donor/acceptor excitation, fluorescence of the background, and photobleaching are not occurring. A microplate luminescence/fluorescence reader is one of the major components of the BRET imagining microscopy system, and the acceptor fluorescence is detected as readout. BRET allows determination of the affinity of a small molecule for the target protein and the study of the intracellular residence time of inhibitors using kinetic measurements. This method was exploited to prove the isoenzyme-specific engagement of histone deacetylase inhibitors<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> and ligand engagement of G-protein-coupled receptors (Î²<sub>2</sub>-adrenergic and adenosine receptors).<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Robers et al. exploited a Nanoluc small luciferase protein (19 kDa) as a BRET donor instead of luciferase (Luc), since it showed a higher fluorescence yield, a narrow spectrum, and a stable luminescence. As a BRET acceptor, the non-chloro-TOM dye (NCT), showing membrane permeability and significant spectral resolution, was employed. To explore the interaction of intracellular engagement of HDAC inhibitors, the hydroxamate-based inhibitor (SAHA) was conjugated with NCT and was used as displacement substrate (tracer displacement by unlabeled compounds).<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Description of BRET experiments for target engagement with no interaction (left) and interaction (right): Luc, luciferase; green line = donor emission spectrum; violet dot line = acceptor excitation spectrum; violet line = acceptor emission spectrum.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The same authors reported the quantitative aspects relevant to fully characterize the engagement. Inside living cells, a NanoLuc-tagged intracellular protein of interest achieves a dynamic equilibrium with a cell-permeable fluorescent dye (tracer). After binding of an unlabeled small molecule, complex disruption leads to a loss of BRET signal that is detected in a microplate format (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>). NanoBRET tracers are often produced starting from a drug or a tool compound and allow a quantitative measurement of the apparent affinity and a real-time assessment of the residence time.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a></div><div class="NLM_p">The BRET method was also adopted for the identification of antimicrobial hits targeting the proteinâprotein interaction between the initiation factor Ï and the Î²â²-subunit of bacterial RNA polymerase.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The study combined an <i>in silico</i> screening with an <i>in vivo</i> bioluminescence resonance energy transfer in yeast cells, showing the large applicability of this technology. One hit was identified and optimized using medicinal chemistry approaches.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a></div><div class="NLM_p">The description of the quantitative, real-time measurements of intracellular target engagement using energy transfer is reported, and NanoBRET tracers with optimized cell permeability have been developed and fully characterized (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>a). Two main classes have been identified that represent robust chemical tools for the assay. Linkers between the dye and the reacting group such as succinimide (NanoBRET 590 SE) or reactive esters (nanoBRET 618 TFP) can influence tracer properties, including affinity and cell permeability.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. (a) Chemical structure of NanoBRET ester activated dyes; (b) example of linker building blocks. Dyes directly bound to the building block are known; however sometimes a linker (colored in blue) between the head tag and the fluorescent probe is necessary.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">4.4.  A Chemical Proteomic Approach for Covalently Binding Ligands</h3><div class="NLM_p">Affinity-based chemical proteomics (ABCP) is a method to study proteins or ligandâtarget interactions, based on protein isolation by an affinity reagent that can be coupled to a reporter system for detection. Affinity-based chemical proteomic has been used in target engagement studies of small-molecule drugs that covalently react with their targeted protein.<a onclick="showRef(event, 'ref164 ref165'); return false;" href="javascript:void(0);" class="ref ref164 ref165">(164,165)</a> The compounds have a chimeric nature since a reactive functionality such as an alkyne (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>a) or azide group is introduced in a suitable position of the scaffold. After addition to the cell, the ligand reacts with the protein target bearing a reactive group exposed and regioselectively placed. Both wild type and mutant proteins can be exploited for the study. When the functional tag (or affinity tag) is added to the cell, it binds to the covalent ligand through a click chemistry reaction (alkyne with azide, <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>b). âClick chemistryâ<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> is exploited to attach <i>in situ</i> a functional tag, such as biotin. The functional tag allows affinity purification of the covalently bound protein of interest using, for example, streptavidin beads (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>c), and protein identification is performed using tryptic digestion and nanoliquid chromatographyâtandem MS analysis (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>d). The functional tag presents a reactive head for the ligand and an affinity tag for the resin to allow affinity chromatography.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Example of ABCP process for covalently binding ligands. (a) Different targets available in the cells for binding the covalent ligand (orange) with the alkyne reactive functionality. (b) Covalent ligand binds the target and forms a covalent or noncovalent complex. The reactive group is exposed outside the binding site. (c) The functional tag (green) is added. It reacts with the reacting group of the covalent ligand (alkyne) with a click chemistry reaction, thus forming a covalent complex with the target. The green tag has a high affinity for the resin that should sequester the chimeraâtarget complex from the sample matrix. (d) The affinity resin is added. The complex, once detached from the resin, is analyzed through mass spectrometry and the biomolecular target identified.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This method can be applied also to probes that bind proteins in a reversible fashion by the addition of a photoreactive group for UV detection of probeâprotein interactions in cells (see photoaffinity labeling).<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> ABCP allows also off-targets detection in cells.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a></div><div class="NLM_p">Wong et al. investigated the specificity for a series of ATP-competitive bivalent kinase inhibitors targeting ABL1.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> They proved the affinity and selectivity of bivalent inhibitors against Abl protein kinase with respect to other off-targets using dual functional chemical proteomics probes. A bivalent inhibitor A-2 showed high affinity together with improved selectivity over the parental ATP-competitive inhibitor.</div><div class="NLM_p">Another example of the pivotal role of chemical proteomic in chemical biology is the use of activity-based protein profiling (ABPP) to study proteins in their native environment.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> By exploitation of click chemistry, an affinity-based probe for the human adenosine A<sub>2A</sub> receptor (hA<sub>2A</sub>R) was developed to investigate the structural biology of the G-protein-coupled receptor (GPCR). Yang et al. developed compound <b>10</b> (LUF7445), a clickable affinity-based probe, with an electrophilic reactive group, as a covalent antagonist of hA<sub>2A</sub>R. LUF7445 was discovered through chemical modification of compound ZM241385 introducing a fluorosulfonyl group, and different linker lengths have been investigated. On the most potent ligand, an alkyne-click handle was introduced leading to the synthesis of probe <b>13</b> (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>). The binding of the ligand to the receptor was washout-resistant. This probe allowed assessment of the presence of hA<sub>2A</sub>R in complex biological samples. The identification of the affinity probe for a GPCR is a promising tool to monitor the endogenous GPCR expression related to human diseases.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Chemical structures of the hA<sub>2A</sub>R antagonists investigated by Yang et al. The selective hA<sub>2A</sub>R antagonist (ZM241385) guided the design of the covalent antagonist <b>10</b>. The authors assessed the importance of the linker length (colored in blue) between the scaffold and the head on affinity and synthesized the optimized compounds <b>11</b> and <b>12</b>. Starting from compound <b>12</b>, the affinity-based probe <b>13</b> with an alkyne ligation-group and a fluorosulfonyl electrophilic was synthesized.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">4.5.  Photoaffinity Labeling</h3><div class="NLM_p">Photoaffinity labeling (PAL) is a well-known technique used to study specific protein function or inhibition.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Photo-cross-linkers are conjugated with drugs or substrates that can bind to the target protein (protein of interest). Typically, photo-cross-linkers are (i) benzophenone (BP), (ii) aryl azide (AA), and (iii) diazirine (DA) (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>). Upon photoirradiation, the photo-cross-linking functional group generates highly reactive species that react with adjacent molecules, leading to a direct covalent modification.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. (a) Most relevant photoaffinity compounds used to tag protein ligands aiming to study target engagement, protein functions, and their photoreaction: benzofenone, aryl azide, and diazirine (trifluoromethylphenyl diazirine, trifluoromethylethyl diazirine). (b) General structures of scaffolds for photoaffinity tagging.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">PAL can capture partners through noncovalent interactions and explore the ligand accessible protein space in a selective mode. Photo-cross-linking agents have turned out to be essential tools to study difficult targets such as proteinâprotein interactions. Despite the high significance and extensive application, only few photo-cross-linkers are currently available. In the 1970s, BP has been introduced as a photo-cross-linker and is the most used in PAL due to the good selectivity and affinity toward methionine. Upon irradiation by 350â365 nm wavelengths, BP is converted into an active diradical. It reacts with protein functional groups exploiting an abstractionârecombination reaction mechanism. Aryl azides cross-link through nitrene, a reactive species, that is generated by loss of N<sub>2</sub> upon photoirradiation with 254 and 400 nm wavelengths. Nitrene reacts with nearby CâH and heteroatomâH bonds, creating a novel covalent product. AAs are known to be chemically stable and to have superior photophysical properties than the corresponding acyl and alkyl analogs. Trifluoromethyl phenyl DAs and alkyl DAs can both produce carbene as reactive species losing N<sub>2</sub> upon photoirradiation at 350 nm. They can form covalent adducts as phenyl diazirine (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>a).<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> Novel functionalized scaffold to be included in the chimeric compounds can be designed starting from different precursor reagents. In <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>b the colored fragments are included in the final chemical photoaffinity reagent.</div><div class="NLM_p">A typical methodology for target deconvolution in drug discovery is applied to living cells or protein complexes, including cell lysates, that are incubated with the compound. The derivatized compound has a photoaffinity linker and a reacting agent (drug, inhibitor, or ligand), and the compoundâprotein binding is fixed by UV irradiation.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Affinity tag is used to isolate proteins covalently bound to the compound, which are then analyzed exploiting MS-based proteomics for proteins identification (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>). T. Tomohiro identified pyruvate carboxylase and C-terminal biotin carboxyl carrier protein as biotin-binding protein from HeLa cells using a PAL-based enrichment with an isotope-coded fluorescent and photocleavable tag followed by MS.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Relatively small functional groups for click chemistry have been recently introduced aimed at improving the photo-cross-linking yield and at gaining sensitivity of MS-based proteomics. This method could be applied also when the affinity between the target protein and the small molecule is weak.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Efficient PAL method for protein identification using a bead-based multivalent probe.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Kaori Sakurai group used PAL to detect the binding protein of benzenesulfonamide.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> They produced trifunctional probes bearing a lysine scaffold and containing a benzenesulfonamide moiety as protein-binding ligand. The photoactivatable group was BP, and biotin was selected as reporter group, allowing the detection of the proteinâcovalent adducts (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>).</div><div class="NLM_p">Other engineered chimeric structures have been adopted for tagging experiments. For example, a chimeric molecule to identify the target of oleanolic acid was prepared<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>a), and a photoactivated Î³-secretase inhibitor in which the tag covalently label presenilin 1 was developed<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>b). Presenilin 1 belongs to the Î³ secretase complex and plays an important role in the generation of amyloid Î² (AÎ²) from the amyloid precursor protein, and it is associated with the onset of Alzheimer disease. The novel photoaffinity labeled palmitoyl derivative (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>c) is directed to the peroxisomal Î²-oxidation enzyme, a primary enzyme for fatty acid degradation.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. (a) Chimeric molecule designed to identify the target of oleanolic acid; (b) photoactivated-Î³-secretase inhibitor in which the tag covalently label presenilin 1; (c) photoaffinity labeled palmytoil derivative directed to the peroxisomal Î²-oxidation enzyme. Shown in green are the photoreactive groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently a high number of PAL applications have been published, underlining the increasing importance of this method in drug discovery.</div><div class="NLM_p last">Other technologies are under development within the engagement technology field such as the carbene footprinting technology.<a onclick="showRef(event, 'ref179 ref180'); return false;" href="javascript:void(0);" class="ref ref179 ref180">(179,180)</a> An example is given by the differential protein footprinting approach that adopted an efficient photoactivated probe and used it in mass spectrometry to map the binding cleft of lysozyme, as well as between UPS5, a deubiquitinating enzyme, and a diubiquitin substrate.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">5.  Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70570" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70570" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The development of new technologies and chemical biology strategies has largely stimulated medicinal chemistsâ creativity to design molecules that could meet the challenges that a drug encounters from the delivery to the patient up to target binding.</div><div class="NLM_p last">This ambitious task was initially addressed using simple structures with chemicophysical properties suitable for cell membrane penetration. However, chemistry exploration and modular approaches led to the design of engineered constructs called chimeric molecules. Chimeras have been exploited in a wide range of applications, such as drug targeting and release, drug tracking and monitoring when tagged with fluorescent probes, target engagement, and mechanism of action clarification. Recently, engineered systems in which both compounds/drugs and proteins are chemically modified to give more specific and less invasive assays have been developed. Crucial is the role of the linking fragment connecting the functional head with the tag. Starting from a disulfide and an ester, the first linkers were based on the early concept of prodrugs, in which a cleavable bond could easily release the bioactive compound. Application of this linker chemistry was promising; however, the use of these systems was hampered by the risk of low specificity. Improved engineered compounds were developed, and linkers were recognized as an essential tool for structureâactivity relationship studies of chimeric compounds and for providing the requested reactivity to conjugate the head and the tag. From a linear structure, such as PEG and alkyl chains with reactive groups at the two edges, a âthree-dimensionalâ decoration of the chain is taking place to address the biological requirements, as observed in some ADCs. Irrespective of application field, chimeric molecules and linkers are conceptually related and can be exploited also in fields different from those mentioned in the present Perspective, including biosensors, biomarkers, and molecular machine. Chimeras are being developed by teamwork of medicinal chemists and chemical biologists and represent formidable tools for targeted therapies and personalized medicine.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01456/suppl_file/jm9b01456_liveslides.mp4">jm9b01456_liveslides.mp4 (5.72 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01456" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40066" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40066" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria P. Costi</span> - <span class="hlFld-Affiliation affiliation">Department
of Life Sciences, University of Modena and
Reggio Emilia, Via Campi 103, 41125 Modena, Italy</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0443-5402" title="Orcid link">http://orcid.org/0000-0002-0443-5402</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6e030f1c070f1e0f01020f400d011d1a072e1b000703011c0b40071a"><span class="__cf_email__" data-cfemail="026f63706b6372636d6e632c616d71766b42776c6b6f6d70672c6b76">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiara Borsari</span> - <span class="hlFld-Affiliation affiliation">Department
of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4688-8362" title="Orcid link">http://orcid.org/0000-0002-4688-8362</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darci J. Trader</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 610 Purdue Mall, West Lafayette, Indiana 47907, United
States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0607-1243" title="Orcid link">http://orcid.org/0000-0002-0607-1243</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annalisa Tait</span> - <span class="hlFld-Affiliation affiliation">Department
of Life Sciences, University of Modena and
Reggio Emilia, Via Campi 103, 41125 Modena, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38702" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38702" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Chiara Borsari</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=BIO-d7e1633-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Chiara Borsari</b> is a medicinal chemist, working as postdoctoral fellow at the University of Basel in the group of Prof. M. Wymann. Her research is focused on the design and synthesis of small-molecule anticancer agents. Her main goal is the development of irreversible inhibitors as a novel strategy in targeted cancer therapy. She got her Ph.D. at the University of Modena and Reggio Emilia. During her Ph.D., she has joined the NHRF in Athens and the State University of New York at Albany. She is also keen on communicating science to the public: she created a short movie âLife in Colourâ, explaining the advancements in cancer research, and she is part of the European Federation for Medicinal Chemistry Communication Team.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Darci J. Trader</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=BIO-d7e1638-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Darci J. Trader</b> received a Ph.D. in Chemistry under the direction of Prof. Erin E. Carlson at Indiana University in 2013. Her postdoctoral studies were at The Scripps Research Institute in the laboratory of Prof. Thomas Kodadek. She began her independent career at Purdue University in 2016. Her lab, which is in the Department of Medicinal Chemistry and Molecular Pharmacology, is focused on developing methods and probes to monitor or perturb both ubiquitin-dependent and -independent proteasome activity.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Annalisa Tait</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=BIO-d7e1643-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Annalisa Tait</b> is an Associate Professor at the Department of Life Sciences of the University of Modena and Reggio Emilia. She has a broad experience in medicinal chemistry, and she is currently teaching Medicinal Chemistry/Drug Analysis in Pharmacy and Biotechnology degree courses, as well as in the Hospital Pharmacy School of Specialization. She was Director of the Doctorate School in Science and Technologies for Health Products. Her research is mainly focused on synthesis, structural characterization, and evaluation of heterocyclic derivatives as antiviral, phosphodiesterase inhibitors and ligands of Î±, 5-HT1A, NOP, and Ï receptors.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Maria P. Costi</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=BIO-d7e1648-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Maria P. Costi</b> obtained her Ph.D. in Medicinal Chemistry at the University of Modena and Reggio Emilia and was a Visiting Scientist at the University of California, San Francisco. She is Professor of Medicinal Chemistry at the Department of Life Sciences, leading the integrated laboratory of drug discovery and biotechnology. She published approximately 150 papers in international journals, deposited 20 patents, and serves as an editorial board member of different journals. Her research focus is on targeting the folate metabolism in different organisms for the discovery of anticancer, anti-infective drugs by combining medicinal chemistry and chemical biology tools. A second field of her research is the discovery of novel drugs for neglected tropical diseases. She coordinated many European and national projects.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank G. Ponterini for advice and discussions. This work was supported by the Foundation for Cancer Research in Italy by Grant AIRC IG16977 (to M.P.C.).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">RME</td><td class="NLM_def"><p class="first last">receptor mediated endocytosis</p></td></tr><tr><td class="NLM_term">ADC</td><td class="NLM_def"><p class="first last">antibodyâdrug conjugate</p></td></tr><tr><td class="NLM_term">CPP</td><td class="NLM_def"><p class="first last">cell-penetrating peptide</p></td></tr><tr><td class="NLM_term">THP</td><td class="NLM_def"><p class="first last">tumor homing peptide</p></td></tr><tr><td class="NLM_term">mAbs</td><td class="NLM_def"><p class="first last">monoclonal antibodies</p></td></tr><tr><td class="NLM_term">SDSâPAGE</td><td class="NLM_def"><p class="first last">sodium dodecyl sulfateâpolyacrylamide gel electrophoresis</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">PROTAC</td><td class="NLM_def"><p class="first last">proteolysis targeting chimera</p></td></tr><tr><td class="NLM_term">CRBN</td><td class="NLM_def"><p class="first last">cereblon</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetra-<i>n</i>-butylammonium fluoride</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved FÃ¶rster resonance energy transfer</p></td></tr><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">FLIM</td><td class="NLM_def"><p class="first last">fluorescence lifetime imaging microscopy</p></td></tr><tr><td class="NLM_term">BET protein</td><td class="NLM_def"><p class="first last">bromodomain and extraterminal domain protein family</p></td></tr><tr><td class="NLM_term">CDK9</td><td class="NLM_def"><p class="first last">cyclin dependent kinase 9.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 180 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, F. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weil, T.</span></span> <span> </span><span class="NLM_article-title">Functional protein nanostructures: a chemical toolbox</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">9069</span>â <span class="NLM_lpage">9105</span>, <span class="refDoi">Â DOI: 10.1039/C8CS00590G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC8CS00590G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30452046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aqt7%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=9069-9105&author=S.+L.+Kuanauthor=F.+R.+G.+Bergaminiauthor=T.+Weil&title=Functional+protein+nanostructures%3A+a+chemical+toolbox&doi=10.1039%2FC8CS00590G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Functional protein nanostructures: a chemical toolbox</span></div><div class="casAuthors">Kuan, Seah Ling; Bergamini, Fernando R. G.; Weil, Tanja</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9069-9105</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Nature has evolved an optimal synthetic factory in the form of translational and posttranslational processes by which millions of proteins with defined primary sequences and 3D structures can be built.  Nature's toolkit gives rise to protein building blocks, which dictates their spatial arrangement to form functional protein nanostructures that serve a myriad of functions in cells, ranging from biocatalysis, formation of structural networks, and regulation of biochem. processes, to sensing.  With the advent of chem. tools for site-selective protein modifications and recombinant engineering, there is a rapid development to develop and apply synthetic methods for creating structurally defined, functional protein nanostructures for a broad range of applications in the fields of catalysis, materials and biomedical sciences.  In this review, design principles and structural features for achieving and characterizing functional protein nanostructures by synthetic approaches are summarized.  The synthetic customization of protein building blocks, the design and introduction of recognition units and linkers and subsequent assembly into structurally defined protein architectures are discussed herein.  Key examples of these supramol. protein nanostructures, their unique functions and resultant impact for biomedical applications are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEJPACRafpH7Vg90H21EOLACvtfcHk0liPZw4M5j5d1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aqt7%252FI&md5=01035c8507ab259bfcb90e9148e116a0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1039%2FC8CS00590G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CS00590G%26sid%3Dliteratum%253Aachs%26aulast%3DKuan%26aufirst%3DS.%2BL.%26aulast%3DBergamini%26aufirst%3DF.%2BR.%2BG.%26aulast%3DWeil%26aufirst%3DT.%26atitle%3DFunctional%2520protein%2520nanostructures%253A%2520a%2520chemical%2520toolbox%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2018%26volume%3D47%26spage%3D9069%26epage%3D9105%26doi%3D10.1039%2FC8CS00590G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Corson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberle, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Design and applications of bifunctional small molecules: why two heads are better than one</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">677</span>â <span class="NLM_lpage">692</span>, <span class="refDoi">Â DOI: 10.1021/cb8001792</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb8001792" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yiurzF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=677-692&author=T.+W.+Corsonauthor=N.+Aberleauthor=C.+M.+Crews&title=Design+and+applications+of+bifunctional+small+molecules%3A+why+two+heads+are+better+than+one&doi=10.1021%2Fcb8001792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than One</span></div><div class="casAuthors">Corson, Timothy W.; Aberle, Nicholas; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">677-692</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Induction of protein-protein interactions is a daunting challenge, but recent studies show promise for small mols. that specifically bring two or more protein mols. together for enhanced or novel biol. effect.  The first such bifunctional mols. were the rapamycin- and FK506-based "chem. inducers of dimerization", but the field has since expanded with new mols. and new applications in chem. genetics and cell biol.  Examples include coumermycin-mediated gyrase B dimerization, proteolysis targeting chimeric mols. (PROTACs), drug hybrids, and strategies for exploiting multivalency in toxin binding and antibody recruitment.  This Review discusses these and other advances in the design and use of bifunctional small mols. and potential strategies for future systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-ZyBtc3QT9rVg90H21EOLACvtfcHk0liPZw4M5j5d1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yiurzF&md5=2edac15286d3a739dd66214a332a545b</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1021%2Fcb8001792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb8001792%26sid%3Dliteratum%253Aachs%26aulast%3DCorson%26aufirst%3DT.%2BW.%26aulast%3DAberle%26aufirst%3DN.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DDesign%2520and%2520applications%2520of%2520bifunctional%2520small%2520molecules%253A%2520why%2520two%2520heads%2520are%2520better%2520than%2520one%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2008%26volume%3D3%26spage%3D677%26epage%3D692%26doi%3D10.1021%2Fcb8001792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lautenslager, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, L. L.</span></span> <span> </span><span class="NLM_article-title">Chimeric molecules constructed with endogenous substances</span>. <i>Adv. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">233</span>â <span class="NLM_lpage">262</span>, <span class="refDoi">Â DOI: 10.1016/S1569-2558(08)60387-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2FS1569-2558%2808%2960387-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADyaK28XmtlaqsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1994&pages=233-262&author=G.+T.+Lautenslagerauthor=L.+L.+Simpson&title=Chimeric+molecules+constructed+with+endogenous+substances&doi=10.1016%2FS1569-2558%2808%2960387-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Chimeric molecules constructed with endogenous substances</span></div><div class="casAuthors">Lautenslager, Gregory T.; Simpson, Lance L.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Molecular and Cell Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Homing Mechanisms and Cellular Targeting</span>),
    <span class="NLM_cas:pages">233-262</span>CODEN:
                <span class="NLM_cas:coden">AMCBEZ</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">JAI Press</span>)
        </div><div class="casAbstract">A review, with 86 refs.  The authors provide here representative examples of the kinds of data that are emerging from the field of chimeric drug research.  Topics discussed include: prepn. of chimeric mols., demonstration of target delivery in vivo and in vitro, potentially therapeutic chimeric mols., chimeric mols. as tools in cell biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYo6EI8Z40w7Vg90H21EOLACvtfcHk0lgPZe-IYQW1oQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtlaqsLY%253D&md5=7d9f1cd52dde17677f9d7defb1b84882</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2FS1569-2558%2808%2960387-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1569-2558%252808%252960387-2%26sid%3Dliteratum%253Aachs%26aulast%3DLautenslager%26aufirst%3DG.%2BT.%26aulast%3DSimpson%26aufirst%3DL.%2BL.%26atitle%3DChimeric%2520molecules%2520constructed%2520with%2520endogenous%2520substances%26jtitle%3DAdv.%2520Mol.%2520Cell%2520Biol.%26date%3D1994%26volume%3D9%26spage%3D233%26epage%3D262%26doi%3D10.1016%2FS1569-2558%2808%2960387-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maniaci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Bifunctional chemical probes inducing protein-protein interactions</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">145</span>â <span class="NLM_lpage">156</span>, <span class="refDoi">Â DOI: 10.1016/j.cbpa.2019.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.cbpa.2019.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=31419624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyltbjF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2019&pages=145-156&author=C.+Maniaciauthor=A.+Ciulli&title=Bifunctional+chemical+probes+inducing+protein-protein+interactions&doi=10.1016%2Fj.cbpa.2019.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional chemical probes inducing protein-protein interactions</span></div><div class="casAuthors">Maniaci, Chiara; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-156</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Inducing biomol. interactions with synthetic mols. to impact biol. function is a concept of enormous appeal.  Recent years have seen a resurgence of interest in designing bispecific mols. that serve as bridging agents to bring proteins together.  Pioneering structural and biophys. investigation of ternary complexes formed by mono-functional and bifunctional ligands highlights that proximity-induced stabilization or de novo formation of protein-protein interactions is a common feature of their mol. recognition.  In this review, we illustrate these concepts and advances with representative case studies, and highlight progress over the past three years, with particular focus on recruitment to E3 ubiquitin ligases by 'mol. glues' and chimeric dimerizers (PROTACs) for targeted protein degrdn.  This approach promises to significantly expand the range of tractable targets for chem. biol. and therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobXJM1PThHPbVg90H21EOLACvtfcHk0lgPZe-IYQW1oQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyltbjF&md5=4302bb010003177f4f5e5c3d4a401dc9</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2019.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2019.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DManiaci%26aufirst%3DC.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DBifunctional%2520chemical%2520probes%2520inducing%2520protein-protein%2520interactions%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D52%26spage%3D145%26epage%3D156%26doi%3D10.1016%2Fj.cbpa.2019.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gilad, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuchinsky, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-David, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minnes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gancz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senderowitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luboshits, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firer, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellerman, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent molecular chimera (CM358) to treat human metastatic melanoma</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">602</span>â <span class="NLM_lpage">615</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2017.06.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.ejmech.2017.06.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28710962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKrs7%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=602-615&author=Y.+Giladauthor=H.+Tuchinskyauthor=G.+Ben-Davidauthor=R.+Minnesauthor=A.+Ganczauthor=H.+Senderowitzauthor=G.+Luboshitsauthor=M.+A.+Firerauthor=G.+Gellerman&title=Discovery+of+potent+molecular+chimera+%28CM358%29+to+treat+human+metastatic+melanoma&doi=10.1016%2Fj.ejmech.2017.06.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent molecular chimera (CM358) to treat human metastatic melanoma</span></div><div class="casAuthors">Gilad, Y.; Tuchinsky, H.; Ben-David, G.; Minnes, R.; Gancz, A.; Senderowitz, H.; Luboshits, G.; Firer, M. A.; Gellerman, G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">602-615</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The resistance of cancer cells to chemotherapeutic agents, whether through intrinsic mechanisms or developed resistance, motivates the search for new chemotherapeutic strategies.  In the present report, the authors demonstrate a facile synthetic strategy towards the discovery of new anti-cancer substances.  This strategy is based on simple covalent coupling between known anti-cancer drugs, which results in novel 'chimeric' small mols.  One of these novel compds., CM358, is the product of an amide bond formation between the known Topoisomerase II (Topo II) inhibitor amonafide (AM) and the known DNA mustard alkylator chlorambucil (CLB).  It demonstrates significant enhanced cytotoxicity over an equimolar mixt. of AM and CLB in various cancer cell lines and in a xenograft model of human metastatic melanoma.  Topo II inhibition as well as in silico docking studies suggest that CM358 is a stronger Topo II binder than AM.  This may be attributed, at least partially, to the placement of the CLB moiety in a favorable orientation with respect to DNA crosslinking with nearby guanines.  In a human metastatic melanoma (WM 266-4) xenograft model, this compd. was profoundly superior to a mixt. of AM and CLB in redn. of tumor growth, maintenance of body wt. and extension of overall survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqEtOV5jXdSrVg90H21EOLACvtfcHk0lgPZe-IYQW1oQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKrs7%252FM&md5=c734f4cf1302f1b5bfc7c07de256b2c6</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.06.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.06.066%26sid%3Dliteratum%253Aachs%26aulast%3DGilad%26aufirst%3DY.%26aulast%3DTuchinsky%26aufirst%3DH.%26aulast%3DBen-David%26aufirst%3DG.%26aulast%3DMinnes%26aufirst%3DR.%26aulast%3DGancz%26aufirst%3DA.%26aulast%3DSenderowitz%26aufirst%3DH.%26aulast%3DLuboshits%26aufirst%3DG.%26aulast%3DFirer%26aufirst%3DM.%2BA.%26aulast%3DGellerman%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520potent%2520molecular%2520chimera%2520%2528CM358%2529%2520to%2520treat%2520human%2520metastatic%2520melanoma%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D602%26epage%3D615%26doi%3D10.1016%2Fj.ejmech.2017.06.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tashima, T.</span></span> <span> </span><span class="NLM_article-title">Effective cancer therapy based on selective drug delivery into cells across their membrane using receptor-mediated endocytosis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3015</span>â <span class="NLM_lpage">3024</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2018.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.bmcl.2018.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30031619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlGht7jJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3015-3024&author=T.+Tashima&title=Effective+cancer+therapy+based+on+selective+drug+delivery+into+cells+across+their+membrane+using+receptor-mediated+endocytosis&doi=10.1016%2Fj.bmcl.2018.07.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Effective cancer therapy based on selective drug delivery into cells across their membrane using receptor-mediated endocytosis</span></div><div class="casAuthors">Tashima, Toshihiko</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3015-3024</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cancer is one of the major causes of death globally.  The current treatment options are insufficient, leading to unmet medical needs in cancer treatment.  Off-target side effects, multidrug resistance, selective distribution to cancerous tissues, and cell membrane permeation of anti-cancer agents are crit. problems to overcome.  There is a method to solve these problems by using receptor-mediated endocytosis (RME).  It is well known that proteins such as integrin, HER2, EGFR, or other cancer biomarkers are specifically overexpressed on the surface of target cancer cells.  By taking advantage of such specific receptors, payloads can be transported into cells through endocytosis using a conjugate composed of the corresponding ligands connected to the payloads by an appropriate linker.  After RME, the payloads released by endosomal escape into the cytoplasm can exhibit the cytotoxic activity against cancer cells.  Cell-penetrating peptides (CPPs), tumor-homing peptides (THPs), and monoclonal antibodies (mAbs) are utilized as ligands in this system.  Antibody drug conjugates (ADCs) based on RME have already been used to cure cancer.  In addn. to the canonical conjugate method, nanocarriers for spontaneous accumulation in cancer tissue due to enhanced permeability and retention (EPR) effect are extensively used.  In this review, I introduce the possibilities and advantages of drug design and development based on RME for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGochutAByX4_bVg90H21EOLACvtfcHk0lgPZk3YjzMaMQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlGht7jJ&md5=14af0e12d630a91dc941f8dc9431b893</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DTashima%26aufirst%3DT.%26atitle%3DEffective%2520cancer%2520therapy%2520based%2520on%2520selective%2520drug%2520delivery%2520into%2520cells%2520across%2520their%2520membrane%2520using%2520receptor-mediated%2520endocytosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3015%26epage%3D3024%26doi%3D10.1016%2Fj.bmcl.2018.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazny, R.</span></span> <span> </span><span class="NLM_article-title">Hydrazone linker units</span>. In  <i>Linker Strategies in Solid-Phase Organic Synthesis</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, P. J. H.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons, Ltd.</span>: <span class="NLM_publisher-loc">Chichester, U.K.</span>, <span class="NLM_year">2009</span>; pp  <span class="NLM_fpage">303</span>â <span class="NLM_lpage">315</span>, <span class="refDoi">Â DOI: 10.1002/9780470749043.ch10</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2F9780470749043.ch10" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=303-315&author=R.+Laznyauthor=P.+J.+H.+Scott&title=Linker+Strategies+in+Solid-Phase+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2F9780470749043.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470749043.ch10%26sid%3Dliteratum%253Aachs%26aulast%3DLazny%26aufirst%3DR.%26atitle%3DHydrazone%2520linker%2520units%26btitle%3DLinker%2520Strategies%2520in%2520Solid-Phase%2520Organic%2520Synthesis%26aulast%3DScott%26aufirst%3DP.%2BJ.%2BH.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26date%3D2009%26spage%3D303%26epage%3D315%26doi%3D10.1002%2F9780470749043.ch10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enders, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, R.</span></span> <span> </span><span class="NLM_article-title">Recovery of carbonyl compounds from <i>N,N</i>-dialkylhydrazones</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">157</span>â <span class="NLM_lpage">169</span>, <span class="refDoi">Â DOI: 10.1021/ar990062y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar990062y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotlyisg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=157-169&issue=3&author=D.+Endersauthor=L.+Wortmannauthor=R.+Peters&title=Recovery+of+carbonyl+compounds+from+N%2CN-dialkylhydrazones&doi=10.1021%2Far990062y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recovery of Carbonyl Compounds from N,N-Dialkylhydrazones</span></div><div class="casAuthors">Enders, Dieter; Wortmann, Lars; Peters, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-169</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deprotonation of enantiomerically pure hydrazones and subsequent trapping with suitable electrophiles generates new stereogenic centers with excellent stereoselectivity.  To liberate the original carbonyl functionality in the final products, it is necessary to cleave the hydrazone moiety.  In recent years, many reagents have been developed to regenerate carbonyl compds. from the corresponding dialkylhydrazones which are compatible with a wide range of functionalities.  This has allowed the use of hydrazones in the total synthesis of complex natural products.  This Account is meant to be an overview of methods which are classified as oxidative, hydrolytic, and reductive cleavage procedures; 67 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWS8reJIc5UbVg90H21EOLACvtfcHk0lgPZk3YjzMaMQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotlyisg%253D%253D&md5=ce11524b0ba2d6fd0c98f19a145944d1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Far990062y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far990062y%26sid%3Dliteratum%253Aachs%26aulast%3DEnders%26aufirst%3DD.%26aulast%3DWortmann%26aufirst%3DL.%26aulast%3DPeters%26aufirst%3DR.%26atitle%3DRecovery%2520of%2520carbonyl%2520compounds%2520from%2520N%252CN-dialkylhydrazones%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2000%26volume%3D33%26issue%3D3%26spage%3D157%26epage%3D169%26doi%3D10.1021%2Far990062y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclaire, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vial, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wietor, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, J. K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, S.</span></span> <span> </span><span class="NLM_article-title">Dynamic combinatorial chemistry</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3652</span>â <span class="NLM_lpage">3711</span>, <span class="refDoi">Â DOI: 10.1021/cr020452p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr020452p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVKhsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2006&pages=3652-3711&issue=9&author=P.+T.+Corbettauthor=J.+Leclaireauthor=L.+Vialauthor=K.+R.+Westauthor=J.-L.+Wietorauthor=J.+K.+M.+Sandersauthor=S.+Otto&title=Dynamic+combinatorial+chemistry&doi=10.1021%2Fcr020452p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic Combinatorial Chemistry</span></div><div class="casAuthors">Corbett, Peter T.; Leclaire, Julien; Vial, Laurent; West, Kevin R.; Wietor, Jean-Luc; Sanders, Jeremy K. M.; Otto, Sijbren</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3652-3711</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review comprehensively discusses all the major aspects of the dynamic combinatorial chem. which is the combinatorial chem. under thermodn. control.  The brief history of its development is followed by the discussion of the various reversible reactions, including the exchange reactions (acyl, imine, acetal or disulfide exchange), Diels-Alder reactions, metathesis, or metal-ligand coordination, with the emphasis on the conditions and functional group tolerance.  The exptl. issues of the synthesis of dynamic combinatorial libraries are also discussed.  This is followed by the section on the application of this approach for the synthesis of various receptors, ligands for biomols., and dynamic combinatorial studies on folding of peptides, nucleotides and synthetic polymers.  The review is concluded by the theor. studies of the dynamic combinatorial chem. and discussion of the related approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-I-tfzACnLVg90H21EOLACvtfcHk0lgPZk3YjzMaMQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVKhsbo%253D&md5=6cc165c2f6d788f43a24493350143f0f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fcr020452p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr020452p%26sid%3Dliteratum%253Aachs%26aulast%3DCorbett%26aufirst%3DP.%2BT.%26aulast%3DLeclaire%26aufirst%3DJ.%26aulast%3DVial%26aufirst%3DL.%26aulast%3DWest%26aufirst%3DK.%2BR.%26aulast%3DWietor%26aufirst%3DJ.-L.%26aulast%3DSanders%26aufirst%3DJ.%2BK.%2BM.%26aulast%3DOtto%26aufirst%3DS.%26atitle%3DDynamic%2520combinatorial%2520chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2006%26volume%3D106%26issue%3D9%26spage%3D3652%26epage%3D3711%26doi%3D10.1021%2Fcr020452p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dyniewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LipiÅski, P. F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeÅniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BochyÅska-CzyÅ¼, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muchowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">TourwÃ©, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misicka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowski, A. W.</span></span> <span> </span><span class="NLM_article-title">Hydrazone linker as a useful tool for preparing chimeric peptide/nonpeptide bifunctional compounds</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">73</span>â <span class="NLM_lpage">77</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.6b00381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKgtrfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=73-77&issue=1&author=J.+Dyniewiczauthor=P.+F.+J.+Lipi%C5%84skiauthor=P.+Kossonauthor=A.+Le%C5%9Bniakauthor=M.+Bochy%C5%84ska-Czy%C5%BCauthor=A.+Muchowskaauthor=D.+Tourw%C3%A9author=S.+Balletauthor=A.+Misickaauthor=A.+W.+Lipkowski&title=Hydrazone+linker+as+a+useful+tool+for+preparing+chimeric+peptide%2Fnonpeptide+bifunctional+compounds&doi=10.1021%2Facsmedchemlett.6b00381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrazone linker as a useful tool for preparing chimeric peptide/nonpeptide bifunctional compounds</span></div><div class="casAuthors">Dyniewicz, Jolanta; Lipinski, Piotr F. J.; Kosson, Piotr; Lesniak, Anna; Bochynska-Czyz, Marta; Muchowska, Adriana; Tourwe, Dirk; Ballet, Steven; Misicka, Aleksandra; Lipkowski, Andrzej W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-77</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The area of multitarget compds., joining two pharmacophores within one mol., is a vivid field of research in medicinal chem.  Not only pharmacophoric elements are essential for the design and activity of such compds., but the type and length of linkers used to connect them are also crucial.  In the present contribution, we describe compd. (I) (as TFA salt) in which a typical opioid peptide sequence is combined with a fragment characteristic for neurokinin-1 receptor (NK1R) antagonists through a hydrazone bridge.  The compd. has a high affinity for Î¼- and Î´-opioid receptors (IC50= 12.7 and 74.0 nM, resp.) and a weak affinity for the NK1R.  Mol. modeling and structural considerations explain the obsd. activities.  In in vivo test, intrathecal and i.v. administrations of I exhibited a strong analgesic effect, which indicates potential BBB penetration.  This letter brings an exemplary application of the hydrazone linker for fast, facile, and successful prepn. of chimeric compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcYsdWkRkoCbVg90H21EOLACvtfcHk0limIq4iLvr4Nw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKgtrfI&md5=18b4e0c673d79a861b38446b4354c59b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00381%26sid%3Dliteratum%253Aachs%26aulast%3DDyniewicz%26aufirst%3DJ.%26aulast%3DLipi%25C5%2584ski%26aufirst%3DP.%2BF.%2BJ.%26aulast%3DKosson%26aufirst%3DP.%26aulast%3DLe%25C5%259Bniak%26aufirst%3DA.%26aulast%3DBochy%25C5%2584ska-Czy%25C5%25BC%26aufirst%3DM.%26aulast%3DMuchowska%26aufirst%3DA.%26aulast%3DTourw%25C3%25A9%26aufirst%3DD.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DMisicka%26aufirst%3DA.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26atitle%3DHydrazone%2520linker%2520as%2520a%2520useful%2520tool%2520for%2520preparing%2520chimeric%2520peptide%252Fnonpeptide%2520bifunctional%2520compounds%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D73%26epage%3D77%26doi%3D10.1021%2Facsmedchemlett.6b00381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FonoviÄ, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelst, S. H. L.</span></span> <span> </span><span class="NLM_article-title">Cleavable linkers in chemical proteomics applications</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1491</i></span>,  <span class="NLM_fpage">185</span>â <span class="NLM_lpage">203</span>, <span class="refDoi">Â DOI: 10.1007/978-1-4939-6439-0_14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-4939-6439-0_14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27778290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCkt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1491&publication_year=2017&pages=185-203&author=Y.+Yangauthor=M.+Fonovi%C4%87author=S.+H.+L.+Verhelst&title=Cleavable+linkers+in+chemical+proteomics+applications&doi=10.1007%2F978-1-4939-6439-0_14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cleavable linkers in chemical proteomics applications</span></div><div class="casAuthors">Yang, Yinliang; Fonovic, Marko; Verhelst, Steven H. L.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1491</span>
        (<span class="NLM_cas:issue">Activity-Based Proteomics</span>),
    <span class="NLM_cas:pages">185-203</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The discovery of the protein targets of small mol. probes is a crucial aspect of activity-based protein profiling and chem. biol.  Mass spectrometry is the primary method for target identification, and in the last decade, cleavable linkers have become a popular strategy to facilitate protein enrichment and identification.  In this chapter, we provide an overview of cleavable linkers used in chem. proteomics approaches, discuss their different chemistries, and describe how they aid in protein identification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE55qAFBd5ZrVg90H21EOLACvtfcHk0limIq4iLvr4Nw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCkt7k%253D&md5=6dee0fec091866f2a29bc333a6da635a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-6439-0_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-6439-0_14%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DFonovi%25C4%2587%26aufirst%3DM.%26aulast%3DVerhelst%26aufirst%3DS.%2BH.%2BL.%26atitle%3DCleavable%2520linkers%2520in%2520chemical%2520proteomics%2520applications%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2017%26volume%3D1491%26spage%3D185%26epage%3D203%26doi%3D10.1007%2F978-1-4939-6439-0_14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, H.</span></span> <span> </span><span class="NLM_article-title">Useful tools for biomolecule isolation, detection, and identification: acylhydrazone-based cleavable linkers</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">763</span>â <span class="NLM_lpage">772</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2009.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.chembiol.2009.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=19635413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVCjsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=763-772&issue=7&author=K.+D.+Parkauthor=R.+Liuauthor=H.+Kohn&title=Useful+tools+for+biomolecule+isolation%2C+detection%2C+and+identification%3A+acylhydrazone-based+cleavable+linkers&doi=10.1016%2Fj.chembiol.2009.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Useful Tools for Biomolecule Isolation, Detection, and Identification: Acylhydrazone-Based Cleavable Linkers</span></div><div class="casAuthors">Park, Ki Duk; Liu, Rihe; Kohn, Harold</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">763-772</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Proteomic searches using affinity-based chromatog. (e.g., biotin-[strept]avidin) have been severely hampered by low protein recovery yields, protein destruction and denaturation, and the release of background proteins from the support.  These limitations confound protein identification.  A new acylhydrazone-based cleavable linker was developed to permit the efficient isolation of proteins with a traceable tag allowing detection and identification under mild conditions.  The utility of the acylhydrazone linker was validated in a proteomic search wherein aldehyde dehydrogenase-1 was selectively captured and isolated from the mouse sol. liver proteome without interfering background proteins.  The use of acylhydrazone linkers is expected to be generalized, allowing for the selective release of tagged mols. from noncovalent and covalently tagged supports.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ewRLvYfaFbVg90H21EOLACvtfcHk0limIq4iLvr4Nw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVCjsb4%253D&md5=5a876b2ace7fc36fd058457f70875bf8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.%2BD.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DKohn%26aufirst%3DH.%26atitle%3DUseful%2520tools%2520for%2520biomolecule%2520isolation%252C%2520detection%252C%2520and%2520identification%253A%2520acylhydrazone-based%2520cleavable%2520linkers%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26issue%3D7%26spage%3D763%26epage%3D772%26doi%3D10.1016%2Fj.chembiol.2009.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dirksen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegneswaran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, P. E.</span></span> <span> </span><span class="NLM_article-title">Bisaryl hydrazones as exchangeable biocompatible linkers</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2023</span>â <span class="NLM_lpage">2027</span>, <span class="refDoi">Â DOI: 10.1002/anie.200906756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.200906756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFSnsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=2023-2027&issue=11&author=A.+Dirksenauthor=S.+Yegneswaranauthor=P.+E.+Dawson&title=Bisaryl+hydrazones+as+exchangeable+biocompatible+linkers&doi=10.1002%2Fanie.200906756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Bisaryl Hydrazones as Exchangeable Biocompatible Linkers</span></div><div class="casAuthors">Dirksen, Anouk; Yegneswaran, Subramanian; Dawson, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2023-2027, S2023/1-S2023/32</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Stable, yet exchangeable, bisaryl hydrazones undergo rapid exchange (cleavage) under mild conditions by catalytic transimination.  This highly efficient hydrazone exchange is useful for the affinity purifn. of biotinylated proteins on (strept)avidin beads.  The authors studied the biotinylation agent CLB354 which is com. available.  The reversibility and stability of CLB354 were first validated in soln. at pH 6.0 to facilitate both reequilibration kinetics and protein stability.  The CLB354 hydrazone was fully stable overnight; however, upon treatment with 100 mM aniline, approx. 25% of the hydrazone was hydrolyzed rapidly, and a new equil. was attained.  Further, the hydrazone can be cleaved by transimination with any aminooxy compd.  Thus, CLB354-modified serum albumin can be refunctionalized by exchanging the CLB354 biotin tag with a new label or affinity tag, e.g., by using aminooxyacetyl-Alexa Fluor 488 or aminooxyacetyl-modified FLAG peptide and 100 mM aniline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOj6SRJFrSQbVg90H21EOLACvtfcHk0lgd82Xvq-8jEg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFSnsb4%253D&md5=f9789e287885d2150b3847e65a6febd9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fanie.200906756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200906756%26sid%3Dliteratum%253Aachs%26aulast%3DDirksen%26aufirst%3DA.%26aulast%3DYegneswaran%26aufirst%3DS.%26aulast%3DDawson%26aufirst%3DP.%2BE.%26atitle%3DBisaryl%2520hydrazones%2520as%2520exchangeable%2520biocompatible%2520linkers%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26issue%3D11%26spage%3D2023%26epage%3D2027%26doi%3D10.1002%2Fanie.200906756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">GÃ³ngora-BenÃ­tez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulla-Puche, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albericio, F.</span></span> <span> </span><span class="NLM_article-title">Multifaceted roles of disulfide bonds. Peptides as therapeutics</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">901</span>â <span class="NLM_lpage">926</span>, <span class="refDoi">Â DOI: 10.1021/cr400031z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400031z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7nJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=901-926&issue=2&author=M.+G%C3%B3ngora-Ben%C3%ADtezauthor=J.+Tulla-Pucheauthor=F.+Albericio&title=Multifaceted+roles+of+disulfide+bonds.+Peptides+as+therapeutics&doi=10.1021%2Fcr400031z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Multifaceted Roles of Disulfide Bonds. Peptides as Therapeutics</span></div><div class="casAuthors">Gongora-Benitez, Miriam; Tulla-Puche, Judit; Albericio, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">901-926</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present review, we have focused our attention on disulfide bonds as constrained elements and their further implications in the development of peptide-based therapeutics.  Thus, the versatile roles of the disulfide bonds formed between Cys residues in therapeutic peptides have been covered.  First, the biol. relevance of these covalent linkages in the oxidative folding process and the contribution of these structural elements to the 3D conformational stability of polypeptides have been discussed.  In addn., the capacity of these linkages to modulate the pharmacodynamic and pharmacokinetic properties of the peptide has been fully disclosed.  Overall, peptide cyclization through the incorporation of disulfide bridges not only may allow the improvement of diverse pharmacol. features, but may also provide valuable information about biol. processes and that is relevant for the further design of peptide analogs and peptidomimetics.  Here we have referred to several studies in which the insertion of a disulfide bond has endowed peptides enhanced pharmacol. properties, including bioactivity, selectivity and resistance to proteases. ,many other studies have demonstrated that these constrained elements are potentially capable of stabilizing secondary structure elements involved in widespread mol. surface recognition processes.  Moreover, disulfide bonds are being applied as reversible covalent bonds for the construction of peptide conjugates that comprise a drug delivery carrier for enhancing cell permeability.  In this regard, the early development of bioactive peptides linked to drug delivery systems is gaining relevance, and this tendency has been progressively implemented in many pharmaceutical companies.  In particular, CPPs may allow a large no. of peptide drugs to enter the market, and they are expected to contribute to accelerating the research performed in both the industrial sector and in the academic world.  The next generation of CPPs is expected to combine both targeting and internalization advantages.  On the other hand, of special interest are small disulfide-rich peptides,which have also been discussed as valuable therapeutic agents.  In general, these privileged mols. show extraordinary chem. and biol. stability and, given their highly constrained architecture, many of them and analogs thereof are currently undergoing preclin. studies or are in clin. trials.  Together with the increasing significance of these constrained peptides as drugs themselves, some of these rigid structures have been used as scaffolds for peptide engineering.  Thus, by taking advantages of the privileged pharmacokinetic properties of some of these extremely rigid architectures, this novel approach is emerging as an extremely valuable tool for peptide drug discovery.  Furthermore, of relevance, owing to their special topol. and cyclic backbone, some small cyclicdisulfide-rich peptides have the capacity to cross the cell membrane.  These peptides constitute a new family of CPPs that are referred to as cyclic cell-penetrating peptides(CCPPs).  These mols. ofer several advantages over linear CPPs, including greater stability and bioavailability, and therefore, they are promising mols. for drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBYp3zST79N7Vg90H21EOLACvtfcHk0lgd82Xvq-8jEg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7nJ&md5=903478ec86d15479bf1987d142cccf58</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcr400031z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400031z%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B3ngora-Ben%25C3%25ADtez%26aufirst%3DM.%26aulast%3DTulla-Puche%26aufirst%3DJ.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DMultifaceted%2520roles%2520of%2520disulfide%2520bonds.%2520Peptides%2520as%2520therapeutics%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26issue%3D2%26spage%3D901%26epage%3D926%26doi%3D10.1021%2Fcr400031z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kourra, C. M. B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, N.</span></span> <span> </span><span class="NLM_article-title">Converting disulfide bridges in native peptides to stable methylene thioacetals</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">7007</span>â <span class="NLM_lpage">7012</span>, <span class="refDoi">Â DOI: 10.1039/C6SC02285E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC6SC02285E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28451136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Crt7bO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=7007-7012&issue=12&author=C.+M.+B.+K.+Kourraauthor=N.+Cramer&title=Converting+disulfide+bridges+in+native+peptides+to+stable+methylene+thioacetals&doi=10.1039%2FC6SC02285E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Converting disulfide bridges in native peptides to stable methylene thioacetals</span></div><div class="casAuthors">Kourra, C. M. B. K.; Cramer, N.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7007-7012</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Disulfide bridges play a crucial role in defining and rigidifying the three-dimensional structure of peptides.  However, disulfides are inherently unstable in reducing environments.  Consequently, the development of strategies aiming to circumvent these deficiencies - ideally with little structural disturbance - are highly sought after.  Herein, we report a simple protocol converting the disulfide bond of peptides into highly stable methylene thioacetal.  The transformation occurs under mild, biocompatible conditions, enabling the conversion of unprotected native peptides into analogs with enhanced stability.  The developed protocol is applicable to a range of peptides and selective in the presence of a multitude of potentially reactive functional groups.  The thioacetal modification annihilates the reductive lability and increases the serum, pH and temp. stability of the important peptide hormone oxytocin.  Moreover, it is shown that the biol. activities for oxytocin are retained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNUJLTzqWREbVg90H21EOLACvtfcHk0lgd82Xvq-8jEg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Crt7bO&md5=a91a7082858d171b9f5c3e07e30f7c61</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1039%2FC6SC02285E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC02285E%26sid%3Dliteratum%253Aachs%26aulast%3DKourra%26aufirst%3DC.%2BM.%2BB.%2BK.%26aulast%3DCramer%26aufirst%3DN.%26atitle%3DConverting%2520disulfide%2520bridges%2520in%2520native%2520peptides%2520to%2520stable%2520methylene%2520thioacetals%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26issue%3D12%26spage%3D7007%26epage%3D7012%26doi%3D10.1039%2FC6SC02285E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinther, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huus, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steensgaard, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SÃ¸rensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kjeldsen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubalek, F.</span></span> <span> </span><span class="NLM_article-title">Additional disulfide bonds in insulin: prediction, recombinant expression, receptor binding affinity, and stability</span>. <i>Protein Sci. Publ. Protein Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">779</span>â <span class="NLM_lpage">788</span>, <span class="refDoi">Â DOI: 10.1002/pro.2649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fpro.2649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25627966" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=779-788&issue=5&author=T.+N.+Vintherauthor=I.+Petterssonauthor=K.+Huusauthor=M.+Schleinauthor=D.+B.+Steensgaardauthor=A.+S%C3%B8rensenauthor=K.+J.+Jensenauthor=T.+Kjeldsenauthor=F.+Hubalek&title=Additional+disulfide+bonds+in+insulin%3A+prediction%2C+recombinant+expression%2C+receptor+binding+affinity%2C+and+stability&doi=10.1002%2Fpro.2649"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fpro.2649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.2649%26sid%3Dliteratum%253Aachs%26aulast%3DVinther%26aufirst%3DT.%2BN.%26aulast%3DPettersson%26aufirst%3DI.%26aulast%3DHuus%26aufirst%3DK.%26aulast%3DSchlein%26aufirst%3DM.%26aulast%3DSteensgaard%26aufirst%3DD.%2BB.%26aulast%3DS%25C3%25B8rensen%26aufirst%3DA.%26aulast%3DJensen%26aufirst%3DK.%2BJ.%26aulast%3DKjeldsen%26aufirst%3DT.%26aulast%3DHubalek%26aufirst%3DF.%26atitle%3DAdditional%2520disulfide%2520bonds%2520in%2520insulin%253A%2520prediction%252C%2520recombinant%2520expression%252C%2520receptor%2520binding%2520affinity%252C%2520and%2520stability%26jtitle%3DProtein%2520Sci.%2520Publ.%2520Protein%2520Soc.%26date%3D2015%26volume%3D24%26issue%3D5%26spage%3D779%26epage%3D788%26doi%3D10.1002%2Fpro.2649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaro, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.-C.</span></span> <span> </span><span class="NLM_article-title">Design of an in vivo cleavable disulfide linker in recombinant fusion proteins</span>. <i>BioTechniques</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">513</span>â <span class="NLM_lpage">518</span>, <span class="refDoi">Â DOI: 10.2144/000113450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.2144%2F000113450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=20615204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1ynu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=513-518&issue=1&author=X.+Chenauthor=Y.+Baiauthor=J.+L.+Zaroauthor=W.-C.+Shen&title=Design+of+an+in+vivo+cleavable+disulfide+linker+in+recombinant+fusion+proteins&doi=10.2144%2F000113450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Design of an in vivo cleavable disulfide linker in recombinant fusion proteins</span></div><div class="casAuthors">Chen, Xiaoying; Bai, Yun; Zaro, Jannica L.; Shen, Wei-Chiang</div><div class="citationInfo"><span class="NLM_cas:title">BioTechniques</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">513-518</span>CODEN:
                <span class="NLM_cas:coden">BTNQDO</span>;
        ISSN:<span class="NLM_cas:issn">0736-6205</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">In order to achieve optimal biol. activity and desired pharmacokinetic profiles, a dithiocyclopeptide linker was designed for in vivo release of protein domains from a recombinant fusion protein.  This novel in vivo cleavable disulfide linker, based on a dithiocyclopeptide contg. a thrombin-sensitive sequence and an intramol. disulfide bond, was inserted between transferrin and granulocyte colony-stimulating factor (G-CSF) recombinant fusion protein domains.  After expression of the fusion protein, G-C-T, from HEK293 cells, thrombin treatment in vitro generated a fusion protein linked via a reversible disulfide bond that was quickly cleaved in vivo, sepg. the protein domains.  After release from the fusion protein, free G-CSF exhibited an improved biol. activity in a cell proliferation assay.  Although reversible disulfide bonds are commonly used in protein chem. conjugation methods, to our knowledge this report is the first example of the construction of a recombinant fusion protein with a disulfide linkage for the release of the functional domain.  This linker design can be adapted to diverse recombinant fusion proteins in which in vivo sepn. of protein domains is required to achieve an improved therapeutic effect and a desirable pharmacokinetic profile and biodistribution of the functional domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJe1VaOAvimLVg90H21EOLACvtfcHk0lh5P89nVtAm6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1ynu7o%253D&md5=1bdf286914280510536ef1bc415198d3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2144%2F000113450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2144%252F000113450%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DZaro%26aufirst%3DJ.%2BL.%26aulast%3DShen%26aufirst%3DW.-C.%26atitle%3DDesign%2520of%2520an%2520in%2520vivo%2520cleavable%2520disulfide%2520linker%2520in%2520recombinant%2520fusion%2520proteins%26jtitle%3DBioTechniques%26date%3D2010%26volume%3D49%26issue%3D1%26spage%3D513%26epage%3D518%26doi%3D10.2144%2F000113450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Sanfrutos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutting, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinis, C.</span></span> <span> </span><span class="NLM_article-title">Structurally diverse cyclisation linkers impose different backbone conformations in bicyclic peptides</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1032</span>â <span class="NLM_lpage">1038</span>, <span class="refDoi">Â DOI: 10.1002/cbic.201200049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fcbic.201200049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22492661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Kltb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1032-1038&issue=7&author=S.+Chenauthor=J.+Morales-Sanfrutosauthor=A.+Angeliniauthor=B.+Cuttingauthor=C.+Heinis&title=Structurally+diverse+cyclisation+linkers+impose+different+backbone+conformations+in+bicyclic+peptides&doi=10.1002%2Fcbic.201200049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structurally Diverse Cyclisation Linkers Impose Different Backbone Conformations in Bicyclic Peptides</span></div><div class="casAuthors">Chen, Shiyu; Morales-Sanfrutos, Julia; Angelini, Alessandro; Cutting, Brian; Heinis, Christian</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1032-1038</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Combinatorial libraries of structurally diverse peptide macrocycles offer a rich source for the development of high-affinity ligands to targets of interest.  In this work we have developed linkers for the generation of genetically encoded bicyclic peptides and tested whether the peptides cyclised by them have significant variations in their backbone conformations.  Two new cyclisation reagents, each contg. three thiol-reactive groups, efficiently and selectively cyclised linear peptides contg. three cysteine moieties.  When the mesitylene linker of the bicyclic peptide PK15, a potent inhibitor of plasma kallikrein (Ki=2 nM), was replaced by the new linkers, its inhibitory activity dropped by a factor of more than 1000, suggesting that the linkers impose different conformations on the peptide.  Indeed, structural anal. by soln.-state NMR revealed different NOE constraints in the three bicyclic peptides, indicating that these relatively small linkers at the centers of bicyclic peptide structures significantly influence the conformations of the peptides.  These results demonstrate the prominent structural role of linkers in peptide macrocycles and suggest that application of different cyclisation linkers in a combinatorial fashion could be an attractive means to generate topol. diverse macrocycle libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphdCp8KV5HeLVg90H21EOLACvtfcHk0lh5P89nVtAm6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Kltb4%253D&md5=ddb3f7e338a22ea1a1e3ced71624781d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201200049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201200049%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DMorales-Sanfrutos%26aufirst%3DJ.%26aulast%3DAngelini%26aufirst%3DA.%26aulast%3DCutting%26aufirst%3DB.%26aulast%3DHeinis%26aufirst%3DC.%26atitle%3DStructurally%2520diverse%2520cyclisation%2520linkers%2520impose%2520different%2520backbone%2520conformations%2520in%2520bicyclic%2520peptides%26jtitle%3DChemBioChem%26date%3D2012%26volume%3D13%26issue%3D7%26spage%3D1032%26epage%3D1038%26doi%3D10.1002%2Fcbic.201200049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tegge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bautsch, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of cyclic peptides and peptide libraries on a new disulfide linker</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">693</span>â <span class="NLM_lpage">699</span>, <span class="refDoi">Â DOI: 10.1002/psc.879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fpsc.879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=17668890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1aju7vN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=693-699&issue=10&author=W.+Teggeauthor=W.+Bautschauthor=R.+Frank&title=Synthesis+of+cyclic+peptides+and+peptide+libraries+on+a+new+disulfide+linker&doi=10.1002%2Fpsc.879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of cyclic peptides and peptide libraries on a new disulfide linker</span></div><div class="casAuthors">Tegge, Werner; Bautsch, Wilfried; Frank, Ronald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">693-699</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A new cysteine-based disulfide linker I for Fmoc solid-phase peptide synthesis was developed, and it allowed the on-resin assembly and side chain deprotection of cyclic peptides.  Cyclic peptides of the structure [cyclo(a-a-x-x-a-a-c); a = D-Ala, c = D-Cys, x = D-amino acid] composed of D-amino acids were assembled and the synthesis and cleavage conditions studied.  The best cyclization results were obtained with PyBOP/HOAt/diisopropylethyl amine.  Racemization rates of the cysteine in the analyzed model sequences were between 5.2 and 12.3%.  Cleavage of the disulfide bond was best carried out with DTT in 50% 2-propanol/100 mM ammonium bicarbonate.  The cleaved peptides can be used directly in biol. assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0YzKe6x4FyrVg90H21EOLACvtfcHk0liknuYnXDMbng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1aju7vN&md5=4a29ed9136b622bae76366c2aac7625a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fpsc.879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.879%26sid%3Dliteratum%253Aachs%26aulast%3DTegge%26aufirst%3DW.%26aulast%3DBautsch%26aufirst%3DW.%26aulast%3DFrank%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520cyclic%2520peptides%2520and%2520peptide%2520libraries%2520on%2520a%2520new%2520disulfide%2520linker%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2007%26volume%3D13%26issue%3D10%26spage%3D693%26epage%3D699%26doi%3D10.1002%2Fpsc.879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ArnÃ©r, E. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span></span> <span> </span><span class="NLM_article-title">Physiological functions of thioredoxin and thioredoxin reductase: thioredoxin and thioredoxin reductase</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>267</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6102</span>â <span class="NLM_lpage">6109</span>, <span class="refDoi">Â DOI: 10.1046/j.1432-1327.2000.01701.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1046%2Fj.1432-1327.2000.01701.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11012661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVygsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=6102-6109&issue=20&author=E.+S.+J.+Arn%C3%A9rauthor=A.+Holmgren&title=Physiological+functions+of+thioredoxin+and+thioredoxin+reductase%3A+thioredoxin+and+thioredoxin+reductase&doi=10.1046%2Fj.1432-1327.2000.01701.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological functions of thioredoxin and thioredoxin reductase</span></div><div class="casAuthors">Arner, Elias S. J.; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6102-6109</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 85 refs.  The thioredoxin system (thioredoxin, thioredoxin reductase, and NADPH) is ubiquitous from archea to man.  Thioredoxins, with a dithiol/disulfide active site (CGPC) are the major cellular protein disulfide reductases; they therefore also serve as electron donors for enzymes such as ribonucleotide reductases, thioredoxin peroxidases (peroxiredoxins), and methionine sulfoxide reductases.  Glutaredoxins catalyze glutathione-disulfide oxido-redns. overlapping the functions of thioredoxins and using electrons from NADPH via glutathione reductase.  Thioredoxin isoforms are present in most organisms and mitochondria have a sep. thioredoxin system.  Plants have chloroplast thioredoxins, which via ferredoxin-thioredoxin reductase regulates photosynthetic enzymes by light.  Thioredoxins are crit. for redox regulation of protein function and signaling via thiol redox control.  A growing no. of transcription factors including NF-ÎºB or the Ref-1-dependent AP1 require thioredoxin redn. for DNA binding.  The cytosolic mammalian thioredoxin, lack of which is embryonically lethal, has numerous functions in defense against oxidative stress, control of growth and apoptosis, but is also secreted and has co-cytokine and chemokine activities.  Thioredoxin reductase is a specific dimeric 70-kDa flavoprotein in bacteria, fungi, and plants with a redox active site disulfide/dithiol.  In contrast, thioredoxin reductases of higher eukaryotes are larger (112-130 kDa), Se-dependent dimeric flavoproteins with a broad substrate specificity that also reduce non-disulfide substrates such as hydroperoxides, vitamin C, or selenite.  All mammalian thioredoxin reductase isoenzymes are homologous to glutathione reductase and contain a conserved C-terminal elongation with a cysteine-selenocysteine sequence forming a redox-active selenenylsulfide/selenolthiol active site and are inhibited by Au-thioglucose (aurothioglucose) and other clin. used drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpFnizkYrcdLVg90H21EOLACvtfcHk0liknuYnXDMbng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVygsLw%253D&md5=d9813ca6b77dd9cae997e6f78a8c2272</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01701.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01701.x%26sid%3Dliteratum%253Aachs%26aulast%3DArn%25C3%25A9r%26aufirst%3DE.%2BS.%2BJ.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DPhysiological%2520functions%2520of%2520thioredoxin%2520and%2520thioredoxin%2520reductase%253A%2520thioredoxin%2520and%2520thioredoxin%2520reductase%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26issue%3D20%26spage%3D6102%26epage%3D6109%26doi%3D10.1046%2Fj.1432-1327.2000.01701.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garnett, M. C.</span></span> <span> </span><span class="NLM_article-title">Targeted drug conjugates: principles and progress</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">171</span>â <span class="NLM_lpage">216</span>, <span class="refDoi">Â DOI: 10.1016/S0169-409X(01)00227-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2FS0169-409X%2801%2900227-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11731026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1ahsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=171-216&issue=2&author=M.+C.+Garnett&title=Targeted+drug+conjugates%3A+principles+and+progress&doi=10.1016%2FS0169-409X%2801%2900227-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted drug conjugates: principles and progress</span></div><div class="casAuthors">Garnett, Martin C.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-216</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Reports of targeting drugs using antibodies have appeared in the literature since 1958, but exciting clin. results in this field have only been reported in the last few years.  Progress in this field has occurred largely through an understanding how drug-immunoconjugates work.  The objective of this review is to draw together the fundamental principles on which this field of work is based, to examine the evidence supporting those principles, and the effectiveness and selectivity of targeted drug conjugates.  The activity of many drug-immunoconjugates can now largely be accounted for by the underlying principles.  Excellent development work, both with conventional anti-cancer agents and very potent drugs have led to a no. of interesting clin. trials.  In the best Phase I and II trials, good evidence of effectiveness have been reported, which suggest that drug-immunoconjugates may now be heralding a new era for chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzGpSvXcXgr7Vg90H21EOLACvtfcHk0liknuYnXDMbng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1ahsbY%253D&md5=31e7f00b7fd6e839cc09b783132697fa</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2801%2900227-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252801%252900227-7%26sid%3Dliteratum%253Aachs%26aulast%3DGarnett%26aufirst%3DM.%2BC.%26atitle%3DTargeted%2520drug%2520conjugates%253A%2520principles%2520and%2520progress%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D53%26issue%3D2%26spage%3D171%26epage%3D216%26doi%3D10.1016%2FS0169-409X%2801%2900227-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hein, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span> <span> </span><span class="NLM_article-title">Click chemistry, a powerful tool for pharmaceutical sciences</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2216</span>â <span class="NLM_lpage">2230</span>, <span class="refDoi">Â DOI: 10.1007/s11095-008-9616-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs11095-008-9616-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=18509602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOru7%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=2216-2230&issue=10&author=C.+D.+Heinauthor=X.-M.+Liuauthor=D.+Wang&title=Click+chemistry%2C+a+powerful+tool+for+pharmaceutical+sciences&doi=10.1007%2Fs11095-008-9616-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry, a powerful tool for pharmaceutical sciences</span></div><div class="casAuthors">Hein, Christopher D.; Liu, Xin-Ming; Wang, Dong</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2216-2230</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Click chem. refers to a group of reactions that are fast, simple to use, easy to purify, versatile, regiospecific, and give high product yields.  While there are a no. of reactions that fulfill the criteria, the Huisgen 1,3-dipolar cycloaddn. of azides and terminal alkynes has emerged as the frontrunner.  It has found applications in a wide variety of research areas, including materials sciences, polymer chem., and pharmaceutical sciences.  In this manuscript, important aspects of the Huisgen cycloaddn. will be reviewed, along with some of its many pharmaceutical applications.  Bioconjugation, nanoparticle surface modification, and pharmaceutical-related polymer chem. will all be covered.  Limitations of the reaction will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtfV89MGuuCrVg90H21EOLACvtfcHk0liknuYnXDMbng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOru7%252FI&md5=7e0c89178299b2eb8a5b0099ac661a34</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs11095-008-9616-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-008-9616-1%26sid%3Dliteratum%253Aachs%26aulast%3DHein%26aufirst%3DC.%2BD.%26aulast%3DLiu%26aufirst%3DX.-M.%26aulast%3DWang%26aufirst%3DD.%26atitle%3DClick%2520chemistry%252C%2520a%2520powerful%2520tool%2520for%2520pharmaceutical%2520sciences%26jtitle%3DPharm.%2520Res.%26date%3D2008%26volume%3D25%26issue%3D10%26spage%3D2216%26epage%3D2230%26doi%3D10.1007%2Fs11095-008-9616-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hems, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagstaff, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saalbach, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, R. A.</span></span> <span> </span><span class="NLM_article-title">CuAAC click chemistry for the enhanced detection of novel alkyne-based natural product toxins</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">86</span>),  <span class="NLM_fpage">12234</span>â <span class="NLM_lpage">12237</span>, <span class="refDoi">Â DOI: 10.1039/C8CC05113E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC8CC05113E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30311608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFWktLfK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2018&pages=12234-12237&issue=86&author=E.+S.+Hemsauthor=B.+A.+Wagstaffauthor=G.+Saalbachauthor=R.+A.+Field&title=CuAAC+click+chemistry+for+the+enhanced+detection+of+novel+alkyne-based+natural+product+toxins&doi=10.1039%2FC8CC05113E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">CuAAC click chemistry for the enhanced detection of novel alkyne-based natural product toxins</span></div><div class="casAuthors">Hems, Edward S.; Wagstaff, Ben A.; Saalbach, Gerhard; Field, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">86</span>),
    <span class="NLM_cas:pages">12234-12237</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In the context of discovering and quantifying terminal alkyne-based natural products, here the authors report the combination of CuAAC click chem. with LC-MS for the detection of polyether toxins (prymnesins) assocd. with harmful algal blooms.  The added-value of the CuAAC-based approach is evident from the authors' ability to detect novel prymnesin-like compds. in algal species with previously uncharacterized toxins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWd-cevavKZLVg90H21EOLACvtfcHk0lgYCx-U4JcX1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFWktLfK&md5=d2d25d8284f45e8c631845b1c28f4e13</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2FC8CC05113E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CC05113E%26sid%3Dliteratum%253Aachs%26aulast%3DHems%26aufirst%3DE.%2BS.%26aulast%3DWagstaff%26aufirst%3DB.%2BA.%26aulast%3DSaalbach%26aufirst%3DG.%26aulast%3DField%26aufirst%3DR.%2BA.%26atitle%3DCuAAC%2520click%2520chemistry%2520for%2520the%2520enhanced%2520detection%2520of%2520novel%2520alkyne-based%2520natural%2520product%2520toxins%26jtitle%3DChem.%2520Commun.%26date%3D2018%26volume%3D54%26issue%3D86%26spage%3D12234%26epage%3D12237%26doi%3D10.1039%2FC8CC05113E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span> <span> </span><span class="NLM_article-title">Chemical assay-guided natural product isolation <i>via</i> solid-supported chemodosimetric fluorescent probe</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2806</span>â <span class="NLM_lpage">2811</span>, <span class="refDoi">Â DOI: 10.1039/C5SC00360A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC5SC00360A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28706669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWqtr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=2806-2811&issue=5&author=H.+Jeonauthor=C.+Limauthor=J.+M.+Leeauthor=S.+Kim&title=Chemical+assay-guided+natural+product+isolation+via+solid-supported+chemodosimetric+fluorescent+probe&doi=10.1039%2FC5SC00360A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical assay-guided natural product isolation via solid-supported chemodosimetric fluorescent probe</span></div><div class="casAuthors">Jeon, Hongjun; Lim, Chaemin; Lee, Ji Min; Kim, Sanghee</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2806-2811</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">As a new model of chem. assay-guided natural product isolation, an effective chemodosimetric assay system was devised.  Our chem. assay system features a fluorogenic chemodosimeter immobilized on a solid support, which offers advantages in identifying the desired compds. in complex natural product mixts.  To isolate only compds. with the target functional groups, the click chem. concept was adopted.  The model system presented here was developed for natural products with a terminal alkyne.  Using our newly designed alkyne sensing beads with the aforementioned features, we have readily identified, quantified, and isolated compds. with a terminal alkyne group from plant exts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofs5p9BeLMpbVg90H21EOLACvtfcHk0lgYCx-U4JcX1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWqtr0%253D&md5=da31fcf576ffbfc28c7ad57d84cd4c97</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC5SC00360A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC00360A%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DS.%26atitle%3DChemical%2520assay-guided%2520natural%2520product%2520isolation%2520via%2520solid-supported%2520chemodosimetric%2520fluorescent%2520probe%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3D2806%26epage%3D2811%26doi%3D10.1039%2FC5SC00360A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mfuh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amako, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, C. M.</span></span> <span> </span><span class="NLM_article-title">Small molecule interactome mapping by photoaffinity labeling reveals binding site hotspots for the NSAIDs</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4259</span>â <span class="NLM_lpage">4268</span>, <span class="refDoi">Â DOI: 10.1021/jacs.7b11639</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b11639" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksFemu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=4259-4268&issue=12&author=J.+Gaoauthor=A.+Mfuhauthor=Y.+Amakoauthor=C.+M.+Woo&title=Small+molecule+interactome+mapping+by+photoaffinity+labeling+reveals+binding+site+hotspots+for+the+NSAIDs&doi=10.1021%2Fjacs.7b11639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Interactome Mapping by Photoaffinity Labeling Reveals Binding Site Hotspots for the NSAIDs</span></div><div class="casAuthors">Gao, Jinxu; Mfuh, Adelphe; Amako, Yuka; Woo, Christina M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4259-4268</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Many therapeutics elicit cell-type specific polypharmacol. that is executed by a network of mol. recognition events between a small mol. and the whole proteome.  However, measurement of the structures that underpin the mol. assocns. between the proteome and even common therapeutics, such as the nonsteroidal anti-inflammatory drugs (NSAIDs), is limited by the inability to map the small mol. interactome.  To address this gap, the authors developed a platform termed small mol. interactome mapping by photoaffinity labeling (SIM-PAL) and applied it to the in cellulo direct characterization of specific NSAID binding sites.  SIM-PAL uses photochem. conjugation of NSAID derivs. in the whole proteome and enrichment and isotope-recoding of the conjugated peptides for targeted mass spectrometry-based assignment.  Using SIM-PAL, the authors identified the NSAID interactome consisting of over 1000 significantly enriched proteins and directly characterized nearly 200 conjugated peptides representing direct binding sites of the photo-NSAIDs with proteins from Jurkat and K562 cells.  The enriched proteins were often identified as parts of complexes, including known targets of NSAID activity (e.g., NF-ÎºB) and novel interactions (e.g., AP-2, proteasome).  The conjugated peptides revealed direct NSAID binding sites from the cell surface to the nucleus and a specific binding site hotspot for the three photo-NSAIDs on histones H2A and H2B.  NSAID binding stabilized COX-2 and histone H2A by cellular thermal shift assay.  Since small mol. stabilization of protein complexes is a gain of function regulatory mechanism, it is conceivable that NSAIDs affect biol. processes through these broader proteomic interactions.  SIM-PAL enabled characterization of NSAID binding site hotspots and is amenable to map global binding sites for virtually any mol. of interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRBw8rIiOnebVg90H21EOLACvtfcHk0lhcvbFf4hYEWw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksFemu7Y%253D&md5=76e1aaaf371bdee85352c048938fd556</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b11639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b11639%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DMfuh%26aufirst%3DA.%26aulast%3DAmako%26aufirst%3DY.%26aulast%3DWoo%26aufirst%3DC.%2BM.%26atitle%3DSmall%2520molecule%2520interactome%2520mapping%2520by%2520photoaffinity%2520labeling%2520reveals%2520binding%2520site%2520hotspots%2520for%2520the%2520NSAIDs%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D12%26spage%3D4259%26epage%3D4268%26doi%3D10.1021%2Fjacs.7b11639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agnew, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweredoski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwieniec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshaies, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, J. L.</span></span> <span> </span><span class="NLM_article-title">Designer reagents for mass spectrometry-based proteomics: clickable cross-linkers for elucidation of protein structures and interactions</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2662</span>â <span class="NLM_lpage">2669</span>, <span class="refDoi">Â DOI: 10.1021/ac202637n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac202637n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFSiurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=2662-2669&issue=6&author=C.+H.+Sohnauthor=H.+D.+Agnewauthor=J.+E.+Leeauthor=M.+J.+Sweredoskiauthor=R.+L.+J.+Grahamauthor=G.+T.+Smithauthor=S.+Hessauthor=G.+Czerwieniecauthor=J.+A.+Looauthor=J.+R.+Heathauthor=R.+J.+Deshaiesauthor=J.+L.+Beauchamp&title=Designer+reagents+for+mass+spectrometry-based+proteomics%3A+clickable+cross-linkers+for+elucidation+of+protein+structures+and+interactions&doi=10.1021%2Fac202637n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Designer Reagents for Mass Spectrometry-Based Proteomics: Clickable Cross-Linkers for Elucidation of Protein Structures and Interactions</span></div><div class="casAuthors">Sohn, Chang Ho; Agnew, Heather D.; Lee, J. Eugene; Sweredoski, Michael J.; Graham, Robert L. J.; Smith, Geoffrey T.; Hess, Sonja; Czerwieniec, Gregg; Loo, Joseph A.; Heath, James R.; Deshaies, Raymond J.; Beauchamp, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2662-2669</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors present novel homobifunctional amine-reactive clickable cross-linkers (CXLs) for investigation of three-dimensional protein structures and protein-protein interactions (PPIs).  CXLs afford consolidated advantages not previously available in a simple cross-linker, including (1) their small size and cationic nature at physiol. pH, resulting in good water soly. and cell-permeability, (2) an alkyne group for bio-orthogonal conjugation to affinity tags via the click reaction for enrichment of cross-linked peptides, (3) a nucleophilic displacement reaction involving the 1,2,3-triazole ring formed in the click reaction, yielding a lock-mass reporter ion for only clicked peptides, and (4) higher charge states of cross-linked peptides in the gas-phase for augmented electron transfer dissocn. (ETD) yields.  Ubiquitin, a lysine-abundant protein, is used as a model system to demonstrate structural studies using CXLs.  To validate the sensitivity of the authors' approach, biotin-azide labeling and subsequent enrichment of cross-linked peptides are performed for cross-linked ubiquitin digests mixed with yeast cell lysates.  Cross-linked peptides are detected and identified by collision induced dissocn. (CID) and ETD with linear quadrupole ion trap (LTQ)-Fourier transform ion cyclotron resonance (FTICR) and LTQ-Orbitrap mass spectrometers.  The application of CXLs to more complex systems (e.g., in vivo crosslinking) is illustrated by Western blot detection of Cul1 complexes including known binders, Cand1 and Skp2, in HEK 293 cells, confirming good water soly. and cell-permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhUvKb5u9bdbVg90H21EOLACvtfcHk0lhcvbFf4hYEWw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFSiurc%253D&md5=9db7fedc435cc06c74be7dca907c3a14</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fac202637n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac202637n%26sid%3Dliteratum%253Aachs%26aulast%3DSohn%26aufirst%3DC.%2BH.%26aulast%3DAgnew%26aufirst%3DH.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DSweredoski%26aufirst%3DM.%2BJ.%26aulast%3DGraham%26aufirst%3DR.%2BL.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BT.%26aulast%3DHess%26aufirst%3DS.%26aulast%3DCzerwieniec%26aufirst%3DG.%26aulast%3DLoo%26aufirst%3DJ.%2BA.%26aulast%3DHeath%26aufirst%3DJ.%2BR.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26aulast%3DBeauchamp%26aufirst%3DJ.%2BL.%26atitle%3DDesigner%2520reagents%2520for%2520mass%2520spectrometry-based%2520proteomics%253A%2520clickable%2520cross-linkers%2520for%2520elucidation%2520of%2520protein%2520structures%2520and%2520interactions%26jtitle%3DAnal.%2520Chem.%26date%3D2012%26volume%3D84%26issue%3D6%26spage%3D2662%26epage%3D2669%26doi%3D10.1021%2Fac202637n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiapparelli, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClatchy, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cline, H. T.</span></span> <span> </span><span class="NLM_article-title">Direct detection of biotinylated proteins by mass spectrometry</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3966</span>â <span class="NLM_lpage">3978</span>, <span class="refDoi">Â DOI: 10.1021/pr5002862</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr5002862" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlalu7fP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=3966-3978&issue=9&author=L.+M.+Schiapparelliauthor=D.+B.+McClatchyauthor=H.-H.+Liuauthor=P.+Sharmaauthor=J.+R.+Yatesauthor=H.+T.+Cline&title=Direct+detection+of+biotinylated+proteins+by+mass+spectrometry&doi=10.1021%2Fpr5002862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Detection of Biotinylated Proteins by Mass Spectrometry</span></div><div class="casAuthors">Schiapparelli, Lucio Matias; McClatchy, Daniel B.; Liu, Han-Hsuan; Sharma, Pranav; Yates, John R.; Cline, Hollis T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3966-3978</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mass spectrometric strategies to identify protein subpopulations involved in specific biol. functions rely on covalently tagging biotin to proteins using various chem. modification methods.  The biotin tag is primarily used for enrichment of the targeted subpopulation for subsequent mass spectrometry (MS) anal.  A limitation of these strategies is that MS anal. does not easily discriminate unlabeled contaminants from the labeled protein subpopulation under study.  To solve this problem, the authors developed a flexible method that only relies on direct MS detection of biotin-tagged proteins called "Direct Detection of Biotin-contg. Tags" (DiDBiT).  Compared with conventional targeted proteomic strategies, DiDBiT improves direct detection of biotinylated proteins â¼200 fold.  DiDBiT is applicable to several protein labeling protocols in cell culture and in vivo using cell permeable NHS-biotin and incorporation of the noncanonical amino acid, azidohomoalanine (AHA), into newly synthesized proteins, followed by click chem. tagging with biotin.  DiDBiT improves the direct detection of biotin-tagged newly synthesized peptides >20-fold compared to conventional methods.  With the increased sensitivity afforded by DiDBiT, the authors demonstrate the MS detection of newly synthesized proteins labeled in vivo in the rodent nervous system with unprecedented temporal resoln. as short as 3 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9UP2KaZC2YrVg90H21EOLACvtfcHk0lidr4geOgNDQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlalu7fP&md5=453780d5e1b813625d87f8317725c9e1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fpr5002862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr5002862%26sid%3Dliteratum%253Aachs%26aulast%3DSchiapparelli%26aufirst%3DL.%2BM.%26aulast%3DMcClatchy%26aufirst%3DD.%2BB.%26aulast%3DLiu%26aufirst%3DH.-H.%26aulast%3DSharma%26aufirst%3DP.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26aulast%3DCline%26aufirst%3DH.%2BT.%26atitle%3DDirect%2520detection%2520of%2520biotinylated%2520proteins%2520by%2520mass%2520spectrometry%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2014%26volume%3D13%26issue%3D9%26spage%3D3966%26epage%3D3978%26doi%3D10.1021%2Fpr5002862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span> <span> </span><span class="NLM_article-title">Chemical proteomics approaches for identifying the cellular targets of natural products</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">681</span>â <span class="NLM_lpage">708</span>, <span class="refDoi">Â DOI: 10.1039/C6NP00001K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC6NP00001K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27098809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsF2gsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=681-708&issue=5&author=M.+H.+Wrightauthor=S.+A.+Sieber&title=Chemical+proteomics+approaches+for+identifying+the+cellular+targets+of+natural+products&doi=10.1039%2FC6NP00001K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical proteomics approaches for identifying the cellular targets of natural products</span></div><div class="casAuthors">Wright, M. H.; Sieber, S. A.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">681-708</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Covering: 2010 up to 2016: Deconvoluting the mode of action of natural products and drugs remains one of the biggest challenges in chem. and biol. today.  Chem. proteomics is a growing area of chem. biol. that seeks to design small mol. probes to understand protein function.  In the context of natural products, chem. proteomics can be used to identify the protein binding partners or targets of small mols. in live cells.  Here, the authors highlight recent examples of chem. probes based on natural products and their application for target identification.  The review focuses on probes that can be covalently linked to their target proteins (either via intrinsic chem. reactivity or via the introduction of photocrosslinkers), and can be applied "in situ" - in living systems rather than cell lysates.  The authors also focus here on strategies that employ a click reaction, the copper-catalyzed azide-alkyne cycloaddn. reaction (CuAAC), to allow minimal functionalization of natural product scaffolds with an alkyne or azide tag.  The authors also discuss 'competitive mode' approaches that screen for natural products that compete with a well-characterized chem. probe for binding to a particular set of protein targets.  Fueled by advances in mass spectrometry instrumentation and bioinformatics, many modern strategies are now embracing quant. proteomics to help define the true interacting partners of probes, and the authors highlight the opportunities this rapidly evolving technol. provides in chem. proteomics.  Finally, some of the limitations and challenges of chem. proteomics approaches are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkznMeYsfcMLVg90H21EOLACvtfcHk0lidr4geOgNDQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsF2gsbc%253D&md5=0732834925092e013d9545f46ce4fd2f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC6NP00001K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6NP00001K%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%2BH.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26atitle%3DChemical%2520proteomics%2520approaches%2520for%2520identifying%2520the%2520cellular%2520targets%2520of%2520natural%2520products%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2016%26volume%3D33%26issue%3D5%26spage%3D681%26epage%3D708%26doi%3D10.1039%2FC6NP00001K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vahermo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutikainen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yli-Kauhaluoma, J.</span></span> <span> </span><span class="NLM_article-title">Solid-phase synthesis of 1,2,3-triazoles via 1,3-dipolar cycloaddition</span>. <i>J. Comb. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">826</span>â <span class="NLM_lpage">833</span>, <span class="refDoi">Â DOI: 10.1021/cc030110c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc030110c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1aqtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=826-833&issue=6&author=K.+Harjuauthor=M.+Vahermoauthor=I.+Mutikainenauthor=J.+Yli-Kauhaluoma&title=Solid-phase+synthesis+of+1%2C2%2C3-triazoles+via+1%2C3-dipolar+cycloaddition&doi=10.1021%2Fcc030110c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-Phase Synthesis of 1,2,3-Triazoles via 1,3-Dipolar Cycloaddition</span></div><div class="casAuthors">Harju, Kirsi; Vahermo, Mikko; Mutikainen, Ilpo; Yli-Kauhaluoma, Jari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">826-833</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The solid-phase synthesis of 1,2,3-triazoles via 1,3-dipolar cycloaddn. of polymer-bound azides to various alkynes is reported.  Polymer-bound azides were synthesized from polymer-bound halides and sodium azide and reacted with alkynes to produce polymer-bound 1,2,3-triazoles.  Cleavage of the triazoles was performed with trifluoroacetic acid.  A traceless synthesis of 1,2,3-triazoles was developed using 2-methoxy-substituted resin (polymer-bound 4-hydroxy-2-methoxybenzyl alc.).  In addn., a synthesis of 4-hydroxybenzyl-substituted 1,2,3-triazoles from the bromo-Wang resin (4-(bromomethyl)phenoxymethyl polystyrene) was achieved.  Crystal structure of some of these compds. were also reported in details.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxFbM111d_-rVg90H21EOLACvtfcHk0lidr4geOgNDQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1aqtrY%253D&md5=9038258f59e7fc8a0d180ccc01b76eb6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fcc030110c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc030110c%26sid%3Dliteratum%253Aachs%26aulast%3DHarju%26aufirst%3DK.%26aulast%3DVahermo%26aufirst%3DM.%26aulast%3DMutikainen%26aufirst%3DI.%26aulast%3DYli-Kauhaluoma%26aufirst%3DJ.%26atitle%3DSolid-phase%2520synthesis%2520of%25201%252C2%252C3-triazoles%2520via%25201%252C3-dipolar%2520cycloaddition%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2003%26volume%3D5%26issue%3D6%26spage%3D826%26epage%3D833%26doi%3D10.1021%2Fcc030110c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blass, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulkner, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunn, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natchus, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portlock, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tullis, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, R.</span></span> <span> </span><span class="NLM_article-title">Solid-phase synthesis of functionalized 1,2,3-triazoles</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">4059</span>â <span class="NLM_lpage">4061</span>, <span class="refDoi">Â DOI: 10.1016/S0040-4039(02)00742-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2FS0040-4039%2802%2900742-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjsl2iurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=4059-4061&issue=22&author=B.+E.+Blassauthor=K.+R.+Coburnauthor=A.+L.+Faulknerauthor=C.+L.+Hunnauthor=M.+G.+Natchusauthor=M.+S.+Parkerauthor=D.+E.+Portlockauthor=J.+S.+Tullisauthor=R.+Wood&title=Solid-phase+synthesis+of+functionalized+1%2C2%2C3-triazoles&doi=10.1016%2FS0040-4039%2802%2900742-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-phase synthesis of functionalized 1,2,3-triazoles</span></div><div class="casAuthors">Blass, Benjamin E.; Coburn, Keith R.; Faulkner, Amy L.; Hunn, Cheryl L.; Natchus, Michael G.; Parker, M. Sharon; Portlock, David E.; Tullis, Joshua S.; Wood, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4059-4061</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Functionalized 1,2,3-triazoles are prepd. by 2 + 3 cycloaddn. of resin bound Î±-azido esters with substituted alkynes.  The reaction is regioselective when the electron-deficient alkyne Me propiolate is used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6SbfVVfh2_bVg90H21EOLACvtfcHk0lidr4geOgNDQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjsl2iurs%253D&md5=33205d48ac04c22beb32664a0dfc4c31</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2802%2900742-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252802%252900742-6%26sid%3Dliteratum%253Aachs%26aulast%3DBlass%26aufirst%3DB.%2BE.%26aulast%3DCoburn%26aufirst%3DK.%2BR.%26aulast%3DFaulkner%26aufirst%3DA.%2BL.%26aulast%3DHunn%26aufirst%3DC.%2BL.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DParker%26aufirst%3DM.%2BS.%26aulast%3DPortlock%26aufirst%3DD.%2BE.%26aulast%3DTullis%26aufirst%3DJ.%2BS.%26aulast%3DWood%26aufirst%3DR.%26atitle%3DSolid-phase%2520synthesis%2520of%2520functionalized%25201%252C2%252C3-triazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26issue%3D22%26spage%3D4059%26epage%3D4061%26doi%3D10.1016%2FS0040-4039%2802%2900742-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angelo, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, P. S.</span></span> <span> </span><span class="NLM_article-title">Solution- and solid-phase synthesis of triazole oligomers that display protein-like functionality</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7963</span>â <span class="NLM_lpage">7967</span>, <span class="refDoi">Â DOI: 10.1021/jo701292h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo701292h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGmurzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=7963-7967&issue=21&author=N.+G.+Angeloauthor=P.+S.+Arora&title=Solution-+and+solid-phase+synthesis+of+triazole+oligomers+that+display+protein-like+functionality&doi=10.1021%2Fjo701292h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Solution- and solid-phase synthesis of triazole oligomers that display protein-like functionality</span></div><div class="casAuthors">Angelo, Nicholas G.; Arora, Paramjit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7963-7967</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We recently developed a new class of oligomers that contain Î±-amino acid residues linked by 1,2,3-triazole groups (Angelo, N. G. at al., 2005).  Synthesis of these oligomers involves an iterative sequence consisting of diazotransfer and Huisgen 1,3-dipolar cycloaddn. steps.  In this contribution, we describe an efficient one-pot, two-step sequence for the prepn. of triazoles from the corresponding amino acid-derived amines and alkynes in soln.  The one-pot sequence affords the desired products in significantly higher yields than our original method.  We also outline a highly effective protocol for the synthesis of these triazole-based biomimetic oligomers on the solid phase.  We find that amino acid derivs. and iterative formation of triazole rings require nontraditional reaction conditions for high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdq71A6hgSsLVg90H21EOLACvtfcHk0ljImWZOn1bhPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGmurzO&md5=67e5dbe97b10b50228cfd0967cd6ce0f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo701292h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo701292h%26sid%3Dliteratum%253Aachs%26aulast%3DAngelo%26aufirst%3DN.%2BG.%26aulast%3DArora%26aufirst%3DP.%2BS.%26atitle%3DSolution-%2520and%2520solid-phase%2520synthesis%2520of%2520triazole%2520oligomers%2520that%2520display%2520protein-like%2520functionality%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26issue%3D21%26spage%3D7963%26epage%3D7967%26doi%3D10.1021%2Fjo701292h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galibert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piller, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piller, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aucagne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmas, A. F.</span></span> <span> </span><span class="NLM_article-title">Combining triazole ligation and enzymatic glycosylation on solid phase simplifies the synthesis of very long glycoprotein analogues</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3617</span>â <span class="NLM_lpage">3623</span>, <span class="refDoi">Â DOI: 10.1039/C5SC00773A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC5SC00773A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30155000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsVCgt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=3617-3623&issue=6&author=M.+Galibertauthor=V.+Pillerauthor=F.+Pillerauthor=V.+Aucagneauthor=A.+F.+Delmas&title=Combining+triazole+ligation+and+enzymatic+glycosylation+on+solid+phase+simplifies+the+synthesis+of+very+long+glycoprotein+analogues&doi=10.1039%2FC5SC00773A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Combining triazole ligation and enzymatic glycosylation on solid phase simplifies the synthesis of very long glycoprotein analogues</span></div><div class="casAuthors">Galibert, Mathieu; Piller, Veronique; Piller, Friedrich; Aucagne, Vincent; Delmas, Agnes F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3617-3623</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The solid-phase chem. assembly of a protein through iterative chemoselective ligation of unprotected peptide segments can be followed with chem. and/or enzymic transformations of the resulting immobilized protein, the latter steps thus benefitting from the advantages provided by the solid support.  We demonstrate here the usefulness of this strategy for the chemo-enzymic synthesis of glycoprotein analogs.  A linker was specifically designed for application to the synthesis of O-glycoproteins: this new linker is readily cleaved under mild aq. conditions compatible with very sensitive glycosidic bonds, but is remarkably stable under a wide range of chem. and biochem. conditions.  It was utilized for solid-supported N-to-C peptidomimetic triazole ligation followed by enzymic glycosylation, ultimately leading to a very large MUC1-derived glycoprotein contg. 160 amino acid residues, 24 Î±-GalNAc moieties linked to Ser and Thr, and 3 triazoles as peptide bond mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoThcaaBgGp-bVg90H21EOLACvtfcHk0ljImWZOn1bhPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsVCgt7Y%253D&md5=2a70b397de1e8d632c9f74e02fb7f5d1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2FC5SC00773A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC00773A%26sid%3Dliteratum%253Aachs%26aulast%3DGalibert%26aufirst%3DM.%26aulast%3DPiller%26aufirst%3DV.%26aulast%3DPiller%26aufirst%3DF.%26aulast%3DAucagne%26aufirst%3DV.%26aulast%3DDelmas%26aufirst%3DA.%2BF.%26atitle%3DCombining%2520triazole%2520ligation%2520and%2520enzymatic%2520glycosylation%2520on%2520solid%2520phase%2520simplifies%2520the%2520synthesis%2520of%2520very%2520long%2520glycoprotein%2520analogues%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26issue%3D6%26spage%3D3617%26epage%3D3623%26doi%3D10.1039%2FC5SC00773A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Duijnhoven, S. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ten Hoeve, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijn, L. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeben, F. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Versteegen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robillard, M. S.</span></span> <span> </span><span class="NLM_article-title">Triggered drug release from an antibodyâdrug conjugate using fast âclick-to-releaseâ chemistry in mice</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1697</span>â <span class="NLM_lpage">1706</span>, <span class="refDoi">Â DOI: 10.1021/acs.bioconjchem.6b00231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.6b00231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslOqs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1697-1706&issue=7&author=R.+Rossinauthor=S.+M.+J.+van+Duijnhovenauthor=W.+ten+Hoeveauthor=H.+M.+Janssenauthor=L.+H.+J.+Kleijnauthor=F.+J.+M.+Hoebenauthor=R.+M.+Versteegenauthor=M.+S.+Robillard&title=Triggered+drug+release+from+an+antibody%E2%80%93drug+conjugate+using+fast+%E2%80%9Cclick-to-release%E2%80%9D+chemistry+in+mice&doi=10.1021%2Facs.bioconjchem.6b00231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Triggered Drug Release from an Antibody-Drug Conjugate Using Fast "Click-to-Release" Chemistry in Mice</span></div><div class="casAuthors">Rossin, Raffaella; van Duijnhoven, Sander M. J.; ten Hoeve, Wolter; Janssen, Henk M.; Hoeben, Freek J. M.; Versteegen, Ron M.; Robillard, Marc S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1697-1706</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of a bioorthogonal reaction for the selective cleavage of tumor-bound antibody-drug conjugates (ADCs) would represent a powerful new tool for ADC therapy, as it would not rely on the currently used intracellular biol. activation mechanisms, thereby expanding the scope to noninternalizing cancer targets.  Here we report that the recently developed inverse-electron-demand Diels-Alder pyridazine elimination reaction can provoke rapid and self-immolative release of doxorubicin from an ADC in vitro and in tumor-bearing mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_mlmSXQbE_rVg90H21EOLACvtfcHk0ljImWZOn1bhPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslOqs7c%253D&md5=9f3a1807dac9f4e032f951c2b7ea253d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.6b00231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.6b00231%26sid%3Dliteratum%253Aachs%26aulast%3DRossin%26aufirst%3DR.%26aulast%3Dvan%2BDuijnhoven%26aufirst%3DS.%2BM.%2BJ.%26aulast%3Dten%2BHoeve%26aufirst%3DW.%26aulast%3DJanssen%26aufirst%3DH.%2BM.%26aulast%3DKleijn%26aufirst%3DL.%2BH.%2BJ.%26aulast%3DHoeben%26aufirst%3DF.%2BJ.%2BM.%26aulast%3DVersteegen%26aufirst%3DR.%2BM.%26aulast%3DRobillard%26aufirst%3DM.%2BS.%26atitle%3DTriggered%2520drug%2520release%2520from%2520an%2520antibody%25E2%2580%2593drug%2520conjugate%2520using%2520fast%2520%25E2%2580%259Cclick-to-release%25E2%2580%259D%2520chemistry%2520in%2520mice%26jtitle%3DBioconjugate%2520Chem.%26date%3D2016%26volume%3D27%26issue%3D7%26spage%3D1697%26epage%3D1706%26doi%3D10.1021%2Facs.bioconjchem.6b00231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Versteegen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">tenHoeve, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robillard, M. S.</span></span> <span> </span><span class="NLM_article-title">Click to release: instantaneous doxorubicin elimination upon tetrazine ligation</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">52</span>),  <span class="NLM_fpage">14112</span>â <span class="NLM_lpage">14116</span>, <span class="refDoi">Â DOI: 10.1002/anie.201305969</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.201305969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVClsb%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=14112-14116&issue=52&author=R.+M.+Versteegenauthor=R.+Rossinauthor=W.+tenHoeveauthor=H.+M.+Janssenauthor=M.+S.+Robillard&title=Click+to+release%3A+instantaneous+doxorubicin+elimination+upon+tetrazine+ligation&doi=10.1002%2Fanie.201305969"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Click to Release: Instantaneous Doxorubicin Elimination upon Tetrazine Ligation</span></div><div class="casAuthors">Versteegen, Ron M.; Rossin, Raffaella; ten Hoeve, Wolter; Janssen, Henk M.; Robillard, Marc S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">14112-14116</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have developed a new bioorthogonal elimination reaction that enables instantaneous, self-immolative, and traceless release of doxorubicin from trans-cyclooctene following tetrazine ligation.  In this proof-of-principle study, the inverse-electron-demand Diels-Alder (inv-DA) pyridazine elimination reached 79 % yield within minutes under ambient conditions at micromolar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3HeqXm0w1MrVg90H21EOLACvtfcHk0lh5a86Ke5Vm6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVClsb%252FM&md5=c926aeb4b257768962ca1b3d6285a0aa</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fanie.201305969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201305969%26sid%3Dliteratum%253Aachs%26aulast%3DVersteegen%26aufirst%3DR.%2BM.%26aulast%3DRossin%26aufirst%3DR.%26aulast%3DtenHoeve%26aufirst%3DW.%26aulast%3DJanssen%26aufirst%3DH.%2BM.%26aulast%3DRobillard%26aufirst%3DM.%2BS.%26atitle%3DClick%2520to%2520release%253A%2520instantaneous%2520doxorubicin%2520elimination%2520upon%2520tetrazine%2520ligation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26issue%3D52%26spage%3D14112%26epage%3D14116%26doi%3D10.1002%2Fanie.201305969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, A. L.</span></span> <span> </span><span class="NLM_article-title">Click chemistry-mediated complementation assay for RNAâprotein interactions</span>. <i>ACS Comb. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">522</span>â <span class="NLM_lpage">527</span>, <span class="refDoi">Â DOI: 10.1021/acscombsci.9b00071</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscombsci.9b00071" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVyku7bM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=522-527&issue=7&author=E.+J.+Shermanauthor=D.+A.+Lorenzauthor=A.+L.+Garner&title=Click+chemistry-mediated+complementation+assay+for+RNA%E2%80%93protein+interactions&doi=10.1021%2Facscombsci.9b00071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Click Chemistry-Mediated Complementation Assay for RNA-Protein Interactions</span></div><div class="casAuthors">Sherman, Emily J.; Lorenz, Daniel A.; Garner, Amanda L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Combinatorial Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">522-527</span>CODEN:
                <span class="NLM_cas:coden">ACSCCC</span>;
        ISSN:<span class="NLM_cas:issn">2156-8944</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Click chem.-based assays are a growing class of biochem. assay for facilitating the discovery of modulators of important biol. processes.  To date, most have relied on the use of immobilized biomols., which increases the cost of the assay and decreases throughput because of the necessary washing steps.  To overcome these challenges, we have developed a click chem.-mediated complementation assay that retains many of the advantages of the previous technol., including catalytic signal amplification for assay robustness and applicability to full-length biomols., but that can be performed in a homogeneous format.  As demonstration of this methodol., we have developed a new high-throughput screening method for RNA-protein interactions using the interaction of Lin28 with the pre-microRNA, prelet-7, as a model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJQ1dvOtKrn7Vg90H21EOLACvtfcHk0lh5a86Ke5Vm6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVyku7bM&md5=5d6cc0f309b80fbd3dd99ee2540485ee</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facscombsci.9b00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscombsci.9b00071%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DE.%2BJ.%26aulast%3DLorenz%26aufirst%3DD.%2BA.%26aulast%3DGarner%26aufirst%3DA.%2BL.%26atitle%3DClick%2520chemistry-mediated%2520complementation%2520assay%2520for%2520RNA%25E2%2580%2593protein%2520interactions%26jtitle%3DACS%2520Comb.%2520Sci.%26date%3D2019%26volume%3D21%26issue%3D7%26spage%3D522%26epage%3D527%26doi%3D10.1021%2Facscombsci.9b00071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, A. L.</span></span> <span> </span><span class="NLM_article-title">A click chemistry-based microRNA maturation assay optimized for high-throughput screening</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">53</span>),  <span class="NLM_fpage">8267</span>â <span class="NLM_lpage">8270</span>, <span class="refDoi">Â DOI: 10.1039/C6CC02894B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC6CC02894B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27284591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVyku7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=8267-8270&issue=53&author=D.+A.+Lorenzauthor=A.+L.+Garner&title=A+click+chemistry-based+microRNA+maturation+assay+optimized+for+high-throughput+screening&doi=10.1039%2FC6CC02894B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A click chemistry-based microRNA maturation assay optimized for high-throughput screening</span></div><div class="casAuthors">Lorenz, Daniel A.; Garner, Amanda L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">8267-8270</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Catalytic enzyme-linked click-chem. assays (cat-ELCCA) are an emerging class of biochem. assay.  Herein we report on expanding the toolkit of cat-ELCCA to include the kinetically superior inverse-electron demand Diels-Alder (IEDDA) reaction.  The result is a technol. with improved sensitivity and reproducibility, enabling automated high-throughput screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSCdT1hlZPvLVg90H21EOLACvtfcHk0lh5a86Ke5Vm6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVyku7k%253D&md5=53bf017ea3d054a4b31486358929f3c8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2FC6CC02894B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CC02894B%26sid%3Dliteratum%253Aachs%26aulast%3DLorenz%26aufirst%3DD.%2BA.%26aulast%3DGarner%26aufirst%3DA.%2BL.%26atitle%3DA%2520click%2520chemistry-based%2520microRNA%2520maturation%2520assay%2520optimized%2520for%2520high-throughput%2520screening%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26issue%3D53%26spage%3D8267%26epage%3D8270%26doi%3D10.1039%2FC6CC02894B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Proteolysis targeting chimeras (PROTACs) of anaplastic lymphoma kinase (ALK)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">304</span>â <span class="NLM_lpage">314</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2018.03.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.ejmech.2018.03.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29627725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1ejs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2018&pages=304-314&author=C.+Zhangauthor=X.-R.+Hanauthor=X.+Yangauthor=B.+Jiangauthor=J.+Liuauthor=Y.+Xiongauthor=J.+Jin&title=Proteolysis+targeting+chimeras+%28PROTACs%29+of+anaplastic+lymphoma+kinase+%28ALK%29&doi=10.1016%2Fj.ejmech.2018.03.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK)</span></div><div class="casAuthors">Zhang, Chengwei; Han, Xiao-Ran; Yang, Xiaobao; Jiang, Biao; Liu, Jing; Xiong, Yue; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">304-314</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) activation has been assocd. with many types of human cancer.  Significant efforts have been devoted to the development of ALK inhibitors to antagonize the kinase activity of ALK.  Four ALK inhibitors have been approved by the FDA to date for treating patients with ALK-pos. nonsmall cell lung cancers (NSCLC).  However, drug resistance has been obsd. in the majority of patients treated with these inhibitors.  New therapeutic strategies (e.g., compds. with novel mechanisms of action) are needed to overcome the drug resistance issue.  The emerging PROTAC (Proteolysis Targeting Chimera) technol. has been successfully applied to selective degrdn. of multiple protein targets, but not ALK.  Since ALK protein levels are not important for viability in mammals, ALK PROTACs could lead to novel therapeutics with minimal toxicity.  Here the authors report the design, synthesis and biol. evaluation of novel PROTACs (degraders) of ALK.  MS4077 (I) and MS4078 (II) potently decreased cellular levels of oncogenic active ALK fusion proteins in a concn.- and time-dependent manner in SU-DHL-1 lymphoma and NCI-H2228 lung cancer cells.  The ALK protein degrdn. induced by compds. I and II was cereblon and proteasome dependent.  In addn., compds. I and II potently inhibited proliferation of SU-DHL-1 cells.  Furthermore, compd. II displayed good plasma exposure in a mouse pharmacokinetic study, thus is suitable for in vivo efficacy studies.  The authors also developed MS4748 and MS4740 , very close analogs of I and II resp., which are incapable to degrade the ALK fusion proteins, as neg. controls.  All 4 compds. are valuable chem. tools for investigating effects of ALK pharmacol. degrdn.  The study paved the way for developing the next generation of ALK PROTACs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPGM3aAZZ6h7Vg90H21EOLACvtfcHk0lhZXbCBywBnSA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1ejs7Y%253D&md5=804324b95034f38b46e45f89e18e55be</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.071%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DX.-R.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DProteolysis%2520targeting%2520chimeras%2520%2528PROTACs%2529%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D151%26spage%3D304%26epage%3D314%26doi%3D10.1016%2Fj.ejmech.2018.03.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillen, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flessa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toy, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braqi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandarlapaty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span> <span> </span><span class="NLM_article-title">new class of selective estrogen receptor degraders (SERDs): expanding the toolbox of PROTAC degrons</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">803</span>â <span class="NLM_lpage">808</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.8b00106</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00106" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1KnsrjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=803-808&issue=8&author=L.+Wangauthor=V.+S.+Guillenauthor=N.+Sharmaauthor=K.+Flessaauthor=J.+Minauthor=K.+E.+Carlsonauthor=W.+Toyauthor=S.+Braqiauthor=B.+S.+Katzenellenbogenauthor=J.+A.+Katzenellenbogenauthor=S.+Chandarlapatyauthor=A.+Sharma&title=new+class+of+selective+estrogen+receptor+degraders+%28SERDs%29%3A+expanding+the+toolbox+of+PROTAC+degrons&doi=10.1021%2Facsmedchemlett.8b00106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New Class of Selective Estrogen Receptor Degraders (SERDs): Expanding the Toolbox of PROTAC Degrons</span></div><div class="casAuthors">Wang, Lucia; Guillen, Valeria S.; Sharma, Naina; Flessa, Kevin; Min, Jian; Carlson, Kathryn E.; Toy, Weiyi; Braqi, Sara; Katzenellenbogen, Benita S.; Katzenellenbogen, John A.; Chandarlapaty, Sarat; Sharma, Abhishek</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">803-808</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An effective endocrine therapy for breast cancer is to selectively and effectively degrade the estrogen receptor (ER).  Up until now, there have been largely only two mol. scaffolds capable of doing this.  In this study, the authors have developed new classes of scaffolds that possess selective estrogen receptor degrader (SERD) and ER antagonistic properties.  These novel SERDs potently inhibit MCF-7 breast cancer cell proliferation and the expression of ER target genes, and their efficacy is comparable to Fulvestrant.  Unlike Fulvestrant, the modular protein-targeted chimera (PROTAC)-type design of these novel SERDs should allow easy diversification into a library of analogs to further fine-tune their pharmacokinetic properties including oral availability.  This work also expands the pool of currently available PROTAC-type scaffolds that could be beneficial for targeted degrdn. of various other therapeutically important proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUcvpKaxYxg7Vg90H21EOLACvtfcHk0lhZXbCBywBnSA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1KnsrjM&md5=b432fad9bae5cb37e79c34c985475845</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00106%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGuillen%26aufirst%3DV.%2BS.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DFlessa%26aufirst%3DK.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DToy%26aufirst%3DW.%26aulast%3DBraqi%26aufirst%3DS.%26aulast%3DKatzenellenbogen%26aufirst%3DB.%2BS.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26aulast%3DChandarlapaty%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%26atitle%3Dnew%2520class%2520of%2520selective%2520estrogen%2520receptor%2520degraders%2520%2528SERDs%2529%253A%2520expanding%2520the%2520toolbox%2520of%2520PROTAC%2520degrons%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26issue%3D8%26spage%3D803%26epage%3D808%26doi%3D10.1021%2Facsmedchemlett.8b00106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hines, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lartigue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">MDM2-recruiting PROTAC offers superior, synergistic antiproliferative activity via simultaneous degradation of BRD4 and stabilization of p53</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">251</span>â <span class="NLM_lpage">262</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-18-2918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1158%2F0008-5472.CAN-18-2918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30385614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotFGnsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=251-262&issue=1&author=J.+Hinesauthor=S.+Lartigueauthor=H.+Dongauthor=Y.+Qianauthor=C.+M.+Crews&title=MDM2-recruiting+PROTAC+offers+superior%2C+synergistic+antiproliferative+activity+via+simultaneous+degradation+of+BRD4+and+stabilization+of+p53&doi=10.1158%2F0008-5472.CAN-18-2918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">MDM2-recruiting PROTAC offers superior, synergistic antiproliferative activity via simultaneous degradation of BRD4 and stabilization of p53</span></div><div class="casAuthors">Hines, John; Lartigue, Schan; Dong, Hanqing; Qian, Yimin; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">251-262</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Although the no. of proteins effectively targeted for posttranslational degrdn. by PROTAC has grown steadily, the no. of E3 ligases successfully exploited to accomplish this has been limited to the few for which small-mol. ligands have been discovered.  Although the E3 ligase MDM2 is bound by the nutlin class of small-mol. ligands, there are few nutlin-based PROTAC.  Because a nutlin-based PROTAC should both knockdown its target protein and upregulate the tumor suppressor p53, we examd. the ability of such a PROTAC to decrease cancer cell viability.  A nutlin-based, BRD4-degrading PROTAC, A1874, was able to degrade its target protein by 98% with nanomolar potency.  Given the complementary ability of A1874 to stabilize p53, we discovered that the nutlin-based PROTAC was more effective in inhibiting proliferation of many cancer cell lines with wild-type p53 than was a corresponding VHL-utilizing PROTAC with similar potency and efficacy to degrade BRD4.  This is the first report of a PROTAC in which the E3 ligase ligand and targeting warhead combine to exert a synergistic antiproliferative effect.  Our study highlights the untapped potential that may be unlocked by expanding the repertoire of E3 ligases that can be recruited by PROTAC.  Significance: These findings present the first BRD4-targeting MDM2-based PROTAC that possesses potent, distinct, and synergistic biol. activities assocd. with both ends of this heterobifunctional mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4UdOVtfCjPLVg90H21EOLACvtfcHk0lhZXbCBywBnSA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotFGnsr0%253D&md5=e5dbf80505bb32c232bce66b0445a1a9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-18-2918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-18-2918%26sid%3Dliteratum%253Aachs%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DLartigue%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DMDM2-recruiting%2520PROTAC%2520offers%2520superior%252C%2520synergistic%2520antiproliferative%2520activity%2520via%2520simultaneous%2520degradation%2520of%2520BRD4%2520and%2520stabilization%2520of%2520p53%26jtitle%3DCancer%2520Res.%26date%3D2019%26volume%3D79%26issue%3D1%26spage%3D251%26epage%3D262%26doi%3D10.1158%2F0008-5472.CAN-18-2918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wurz, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span> <span> </span><span class="NLM_article-title">Targeted degradation of MDM2 as a new approach to improve the efficacy of MDM2-p53 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">445</span>â <span class="NLM_lpage">447</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01945</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01945" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKqsbfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=445-447&issue=2&author=R.+P.+Wurzauthor=V.+J.+Cee&title=Targeted+degradation+of+MDM2+as+a+new+approach+to+improve+the+efficacy+of+MDM2-p53+inhibitors&doi=10.1021%2Facs.jmedchem.8b01945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Degradation of MDM2 as a New Approach to Improve the Efficacy of MDM2-p53 Inhibitors</span></div><div class="casAuthors">Wurz, Ryan P.; Cee, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">445-447</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  MDM2 is a key oncogenic protein that serves as a neg. regulator of the tumor suppressor p53.  While a no. of inhibitors of the MDM2-p53 interaction have progressed to clin. testing as treatments for a variety of hematol. and solid tumor cancers, the results thus far have been mixed, with perhaps the strongest responses obsd. in relapsed/refractory acute myeloid leukemia (AML).  In an effort to improve the efficacy for this class of compds., researchers have turned to targeted degrdn. of MDM2.  IMiD-based MDM2 PROTAC 8, which potently reduces MDM2 protein levels through targeted degrdn., exhibits enhanced efficacy in the RS4;11 xenograft model relative to a nondegrading MDM2-p53 inhibitor MI-1061.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJX1faKXhdSbVg90H21EOLACvtfcHk0lgWQvLNtuP2OQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKqsbfI&md5=bcfd2c618a1fb00d4fc4885fdb4fc3c6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01945%26sid%3Dliteratum%253Aachs%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26atitle%3DTargeted%2520degradation%2520of%2520MDM2%2520as%2520a%2520new%2520approach%2520to%2520improve%2520the%2520efficacy%2520of%2520MDM2-p53%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D2%26spage%3D445%26epage%3D447%26doi%3D10.1021%2Facs.jmedchem.8b01945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silva, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donovan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucente, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickerson, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggarty, S. J.</span></span> <span> </span><span class="NLM_article-title">Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e45457</span> <span class="refDoi">Â DOI: 10.7554/eLife.45457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.7554%2FeLife.45457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30907729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVegtb%252FK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=M.+C.+Silvaauthor=F.+M.+Fergusonauthor=Q.+Caiauthor=K.+A.+Donovanauthor=G.+Nandiauthor=D.+Patnaikauthor=T.+Zhangauthor=H.-T.+Huangauthor=D.+E.+Lucenteauthor=B.+C.+Dickersonauthor=T.+J.+Mitchisonauthor=E.+S.+Fischerauthor=N.+S.+Grayauthor=S.+J.+Haggarty&title=Targeted+degradation+of+aberrant+tau+in+frontotemporal+dementia+patient-derived+neuronal+cell+models&doi=10.7554%2FeLife.45457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models</span></div><div class="casAuthors">Silva, M. Catarina; Ferguson, Fleur M.; Cai, Quan; Donovan, Katherine A.; Nandi, Ghata; Patnaik, Debasis; Zhang, Tinghu; Huang, Hai-Tsang; Lucente, Diane E.; Dickerson, Bradford C.; Mitchison, Timothy J.; Fischer, Eric S.; Gray, Nathanael S.; Haggarty, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45457</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Tauopathies are neurodegenerative diseases characterized by aberrant forms of tau protein accumulation leading to neuronal death in focal brain areas.  Positron emission tomog. (PET) tracers that bind to pathol. tau are used in diagnosis, but there are no current therapies to eliminate these tau species.  We employed targeted protein degrdn. technol. to convert a tau PET-probe into a functional degrader of pathogenic tau.  The hetero-bifunctional mol. QC-01-175 was designed to engage both tau and Cereblon (CRBN), a substrate-receptor for the E3-ubiquitin ligase CRL4CRBN, to trigger tau ubiquitination and proteasomal degrdn.  QC-01-175 effected clearance of tau in frontotemporal dementia (FTD) patient-derived neuronal cell models, with minimal effect on tau from neurons of healthy controls, indicating specificity for disease-relevant forms.  QC-01-175 also rescued stress vulnerability in FTD neurons, phenocopying CRISPR-mediated MAPT-knockout.  This work demonstrates that aberrant tau in FTD patient-derived neurons is amenable to targeted degrdn., representing an important advance for therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2f2OKye5kv7Vg90H21EOLACvtfcHk0lgWQvLNtuP2OQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVegtb%252FK&md5=63ea1b63444b4ec41839300ce90c6dea</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.7554%2FeLife.45457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.45457%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DM.%2BC.%26aulast%3DFerguson%26aufirst%3DF.%2BM.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DDonovan%26aufirst%3DK.%2BA.%26aulast%3DNandi%26aufirst%3DG.%26aulast%3DPatnaik%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DH.-T.%26aulast%3DLucente%26aufirst%3DD.%2BE.%26aulast%3DDickerson%26aufirst%3DB.%2BC.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26aulast%3DFischer%26aufirst%3DE.%2BS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26atitle%3DTargeted%2520degradation%2520of%2520aberrant%2520tau%2520in%2520frontotemporal%2520dementia%2520patient-derived%2520neuronal%2520cell%2520models%26jtitle%3DeLife%26date%3D2019%26volume%3D8%26doi%3D10.7554%2FeLife.45457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cyrus, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehenkel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-B.</span></span> <span> </span><span class="NLM_article-title">Impact of linker length on the activity of PROTACs</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">359</span>â <span class="NLM_lpage">364</span>, <span class="refDoi">Â DOI: 10.1039/C0MB00074D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC0MB00074D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=20922213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslGhsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=359-364&issue=2&author=K.+Cyrusauthor=M.+Wehenkelauthor=E.-Y.+Choiauthor=H.-J.+Hanauthor=H.+Leeauthor=H.+Swansonauthor=K.-B.+Kim&title=Impact+of+linker+length+on+the+activity+of+PROTACs&doi=10.1039%2FC0MB00074D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of linker length on the activity of PROTACs</span></div><div class="casAuthors">Cyrus, Kedra; Wehenkel, Marie; Choi, Eun-Young; Han, Hyeong-Jun; Lee, Hyosung; Swanson, Hollie; Kim, Kyung-Bo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">359-364</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Conventional genetic approaches have provided a powerful tool in the study of proteins.  However, these techniques often preclude selective manipulation of temporal and spatial protein functions, which is crucial for the investigation of dynamic cellular processes.  To overcome these limitations, a small mol.-based novel technol. termed "PROteolysis TArgeting ChimeraS (PROTACs)" has been developed, targeting proteins for degrdn. at the post-translational level.  Despite the promising potential of PROTACs to serve as mol. probes of complex signaling pathways, their design has not been generalized for broad application.  Here, we present the first generalized approach for PROTAC design by fine-tuning the distance between the two participating partner proteins, the E3 ubiquitin ligase and the target protein.  As such, we took a chem. approach to create estrogen receptor (ER)-Î± targeting PROTACs with varying linker lengths and the loss of the ER in cultured cells was monitored via western blot and fluorometric analyses.  We found a significant effect of chain length on PROTAC efficacy, and, in this case, the optimum distance between the E3 recognition motif and the ligand was a 16 atom chain length.  The information gathered from this expt. may offer a generalizable PROTAC design strategy to further the expansion of the PROTAC toolbox, opening new possibilities for the broad application of the PROTAC strategy in the study of multiple signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP7hxQSvFw57Vg90H21EOLACvtfcHk0lgWQvLNtuP2OQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslGhsw%253D%253D&md5=56dc56cb3a73d17bc8903c4962d7648c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1039%2FC0MB00074D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0MB00074D%26sid%3Dliteratum%253Aachs%26aulast%3DCyrus%26aufirst%3DK.%26aulast%3DWehenkel%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DE.-Y.%26aulast%3DHan%26aufirst%3DH.-J.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DSwanson%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.-B.%26atitle%3DImpact%2520of%2520linker%2520length%2520on%2520the%2520activity%2520of%2520PROTACs%26jtitle%3DMol.%2520BioSyst.%26date%3D2011%26volume%3D7%26issue%3D2%26spage%3D359%26epage%3D364%26doi%3D10.1039%2FC0MB00074D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinebach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udeshi, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehm, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KÃ¶pff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¼tschow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KrÃ¶nke, J.</span></span> <span> </span><span class="NLM_article-title">Homo-PROTACs for the chemical knockdown of cereblon</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2771</span>â <span class="NLM_lpage">2782</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.8b00693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.8b00693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFejsLrO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2771-2782&issue=9&author=C.+Steinebachauthor=S.+Lindnerauthor=N.+D.+Udeshiauthor=D.+C.+Maniauthor=H.+Kehmauthor=S.+K%C3%B6pffauthor=S.+A.+Carrauthor=M.+G%C3%BCtschowauthor=J.+Kr%C3%B6nke&title=Homo-PROTACs+for+the+chemical+knockdown+of+cereblon&doi=10.1021%2Facschembio.8b00693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Homo-PROTACs for the Chemical Knockdown of Cereblon</span></div><div class="casAuthors">Steinebach, Christian; Lindner, Stefanie; Udeshi, Namrata D.; Mani, Deepak C.; Kehm, Hannes; Koepff, Simon; Carr, Steven A.; Guetschow, Michael; Kroenke, Jan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2771-2782</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The immunomodulatory drugs (IMiDs) thalidomide, lenalidomide, and pomalidomide, all approved for the treatment of multiple myeloma, induce targeted ubiquitination and degrdn. of Ikaros (IKZF1) and Aiolos (IKZF3) via the cereblon (CRBN) E3 ubiquitin ligase.  IMiD-based proteolysis-targeting chimeras (PROTACs) can efficiently recruit CRBN to a protein of interest, leading to its ubiquitination and proteasomal degrdn.  By linking two pomalidomide mols., we designed homobifunctional, so-called homo-PROTACs and investigated their ability to induce self-directed ubiquitination and degrdn.  The homodimerized compd. I was characterized as a highly potent and efficient CRBN degrader with only minimal effects on IKZF1 and IKZF3.  The cellular selectivity of I for CRBN degrdn. was confirmed at the proteome level by quant. mass spectrometry.  Inactivation by compd. I did not affect proliferation of different cell lines, prevented pomalidomide-induced degrdn. of IKZF1 and IKZF3, and antagonized the effects of pomalidomide on multiple myeloma cells.  Homobifunctional CRBN degraders will be useful tools for future biomedical investigations of CRBN-related signaling and may help to further elucidate the mol. mechanism of thalidomide analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosUoD-BkTUibVg90H21EOLACvtfcHk0lhVYntezgTY8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFejsLrO&md5=71bf2d53ad23c2b873f754de5144883c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facschembio.8b00693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.8b00693%26sid%3Dliteratum%253Aachs%26aulast%3DSteinebach%26aufirst%3DC.%26aulast%3DLindner%26aufirst%3DS.%26aulast%3DUdeshi%26aufirst%3DN.%2BD.%26aulast%3DMani%26aufirst%3DD.%2BC.%26aulast%3DKehm%26aufirst%3DH.%26aulast%3DK%25C3%25B6pff%26aufirst%3DS.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DKr%25C3%25B6nke%26aufirst%3DJ.%26atitle%3DHomo-PROTACs%2520for%2520the%2520chemical%2520knockdown%2520of%2520cereblon%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26issue%3D9%26spage%3D2771%26epage%3D2782%26doi%3D10.1021%2Facschembio.8b00693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toure, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellerschmied, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salami, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaime-Figueroa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Modular PROTAC design for the degradation of oncogenic BCR-ABL</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">807</span>â <span class="NLM_lpage">810</span>, <span class="refDoi">Â DOI: 10.1002/anie.201507634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.201507634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOlt7rN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=807-810&issue=2&author=A.+C.+Laiauthor=M.+Toureauthor=D.+Hellerschmiedauthor=J.+Salamiauthor=S.+Jaime-Figueroaauthor=E.+Koauthor=J.+Hinesauthor=C.+M.+Crews&title=Modular+PROTAC+design+for+the+degradation+of+oncogenic+BCR-ABL&doi=10.1002%2Fanie.201507634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL</span></div><div class="casAuthors">Lai, Ashton C.; Toure, Momar; Hellerschmied, Doris; Salami, Jemilat; Jaime-Figueroa, Saul; Ko, Eunhwa; Hines, John; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">807-810</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Proteolysis Targeting Chimera (PROTAC) technol. is a rapidly emerging alternative therapeutic strategy with the potential to address many of the challenges currently faced in modern drug development programs.  PROTAC technol. employs small mols. that recruit target proteins for ubiquitination and removal by the proteasome.  The synthesis of PROTAC compds. that mediate the degrdn. of c-ABL and BCR-ABL by recruiting either Cereblon or Von Hippel Lindau E3 ligases is reported.  During the course of their development, the authors discovered that the capacity of a PROTAC to induce degrdn. involves more than just target binding: the identity of the inhibitor warhead and the recruited E3 ligase largely det. the degrdn. profiles of the compds.; thus, as a starting point for PROTAC development, both the target ligand and the recruited E3 ligase should be varied to rapidly generate a PROTAC with the desired degrdn. profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdcSTHt5WfILVg90H21EOLACvtfcHk0lhVYntezgTY8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOlt7rN&md5=58a5d78f32bc8a21fd1a6e0c38b8979c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507634%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DA.%2BC.%26aulast%3DToure%26aufirst%3DM.%26aulast%3DHellerschmied%26aufirst%3DD.%26aulast%3DSalami%26aufirst%3DJ.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DModular%2520PROTAC%2520design%2520for%2520the%2520degradation%2520of%2520oncogenic%2520BCR-ABL%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D2%26spage%3D807%26epage%3D810%26doi%3D10.1002%2Fanie.201507634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zorba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Irrizary, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabaniuk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuff, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niosi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luthra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M. F.</span></span> <span> </span><span class="NLM_article-title">Delineating the role of cooperativity in the design of potent PROTACs for BTK</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span> (<span class="NLM_issue">31</span>),  <span class="NLM_fpage">E7285</span>â <span class="NLM_lpage">E7292</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1803662115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1073%2Fpnas.1803662115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30012605" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E7285-E7292&issue=31&author=A.+Zorbaauthor=C.+Nguyenauthor=Y.+Xuauthor=J.+Starrauthor=K.+Borzilleriauthor=J.+Smithauthor=H.+Zhuauthor=K.+A.+Farleyauthor=W.+Dingauthor=J.+Schiemerauthor=X.+Fengauthor=J.+S.+Changauthor=D.+P.+Uccelloauthor=J.+A.+Youngauthor=C.+N.+Garcia-Irrizaryauthor=L.+Czabaniukauthor=B.+Schuffauthor=R.+Oliverauthor=J.+Montgomeryauthor=M.+M.+Haywardauthor=J.+Coeauthor=J.+Chenauthor=M.+Niosiauthor=S.+Luthraauthor=J.+C.+Shahauthor=A.+El-Kattanauthor=X.+Qiuauthor=G.+M.+Westauthor=M.+C.+Noeauthor=V.+Shanmugasundaramauthor=A.+M.+Gilbertauthor=M.+F.+Brownauthor=M.+F.+Calabrese&title=Delineating+the+role+of+cooperativity+in+the+design+of+potent+PROTACs+for+BTK&doi=10.1073%2Fpnas.1803662115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1803662115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1803662115%26sid%3Dliteratum%253Aachs%26aulast%3DZorba%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DStarr%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DFarley%26aufirst%3DK.%2BA.%26aulast%3DDing%26aufirst%3DW.%26aulast%3DSchiemer%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DJ.%2BS.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DYoung%26aufirst%3DJ.%2BA.%26aulast%3DGarcia-Irrizary%26aufirst%3DC.%2BN.%26aulast%3DCzabaniuk%26aufirst%3DL.%26aulast%3DSchuff%26aufirst%3DB.%26aulast%3DOliver%26aufirst%3DR.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DNiosi%26aufirst%3DM.%26aulast%3DLuthra%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DJ.%2BC.%26aulast%3DEl-Kattan%26aufirst%3DA.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DWest%26aufirst%3DG.%2BM.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCalabrese%26aufirst%3DM.%2BF.%26atitle%3DDelineating%2520the%2520role%2520of%2520cooperativity%2520in%2520the%2520design%2520of%2520potent%2520PROTACs%2520for%2520BTK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26issue%3D31%26spage%3DE7285%26epage%3DE7292%26doi%3D10.1073%2Fpnas.1803662115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HaliloÇ§lu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussinov, R.</span></span> <span> </span><span class="NLM_article-title">Dynamic allostery: linkers are not merely flexible</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">907</span>â <span class="NLM_lpage">917</span>, <span class="refDoi">Â DOI: 10.1016/j.str.2011.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.str.2011.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=21742258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslWhs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=907-917&issue=7&author=B.+Maauthor=C.-J.+Tsaiauthor=T.+Halilo%C7%A7luauthor=R.+Nussinov&title=Dynamic+allostery%3A+linkers+are+not+merely+flexible&doi=10.1016%2Fj.str.2011.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic Allostery: Linkers Are Not Merely Flexible</span></div><div class="casAuthors">Ma, Buyong; Tsai, Chung-Jung; Haliloglu, Tuerkan; Nussinov, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">907-917</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Most proteins consist of multiple domains.  How do linkers efficiently transfer information between sites that are on different domains to activate the protein.  Mere flexibility only implies that the conformations would be sampled.  For fast timescales between triggering events and cellular response, which often involves large conformational change, flexibility on its own may not constitute a good soln.  We posit that successive conformational states along major allosteric propagation pathways are pre-encoded in linker sequences where each state is encoded by the previous one.  The barriers between these states that are hierarchically populated are lower, achieving faster timescales even for large conformational changes.  We further propose that evolution has optimized the linker sequences and lengths for efficiency, which explains why mutations in linkers may affect protein function and review the literature in this light.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowoC_Noh0o87Vg90H21EOLACvtfcHk0lifIqKlVUXqzw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslWhs7c%253D&md5=06fde055f3fbee945de9acefb36eff96</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2011.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2011.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DB.%26aulast%3DTsai%26aufirst%3DC.-J.%26aulast%3DHalilo%25C7%25A7lu%26aufirst%3DT.%26aulast%3DNussinov%26aufirst%3DR.%26atitle%3DDynamic%2520allostery%253A%2520linkers%2520are%2520not%2520merely%2520flexible%26jtitle%3DStructure%26date%3D2011%26volume%3D19%26issue%3D7%26spage%3D907%26epage%3D917%26doi%3D10.1016%2Fj.str.2011.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Odendaal, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trader, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. E.</span></span> <span> </span><span class="NLM_article-title">Chemoselective enrichment for natural products discovery</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">760</span>â <span class="NLM_lpage">764</span>, <span class="refDoi">Â DOI: 10.1039/c0sc00620c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2Fc0sc00620c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=24926410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFGlu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=760-764&issue=4&author=A.+Y.+Odendaalauthor=D.+J.+Traderauthor=E.+E.+Carlson&title=Chemoselective+enrichment+for+natural+products+discovery&doi=10.1039%2Fc0sc00620c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective enrichment for natural products discovery</span></div><div class="casAuthors">Odendaal, Antoinette Y.; Trader, Darci J.; Carlson, Erin E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">760-764</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Natural products account for a significant proportion of modern day therapeutic agents.  However, the discovery of novel compds. is hindered by the isolation process, which often relies upon extn. and chromatog. sepn. techniques.  These methods, which are dependent upon the physicochem. properties of the compds., have a limited ability to both purify and conc. the minor components of a biol. ext.  We have devised an isolation strategy based upon an orthogonal chem. feature, namely, functional group compn.  Development of a functional group-targeted method is expected to achieve exceptional resoln. given the large no. of distinct moieties present in natural product exts.  Here, the authors describe the generation of controllably reversible covalent enrichment tags for the chemoselective isolation of alc.-contg. natural products from complex mixts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiRYVde2bZIrVg90H21EOLACvtfcHk0lifIqKlVUXqzw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFGlu74%253D&md5=1f82d819b8146ac319307f981ca95029</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fc0sc00620c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0sc00620c%26sid%3Dliteratum%253Aachs%26aulast%3DOdendaal%26aufirst%3DA.%2BY.%26aulast%3DTrader%26aufirst%3DD.%2BJ.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26atitle%3DChemoselective%2520enrichment%2520for%2520natural%2520products%2520discovery%26jtitle%3DChem.%2520Sci.%26date%3D2011%26volume%3D2%26issue%3D4%26spage%3D760%26epage%3D764%26doi%3D10.1039%2Fc0sc00620c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trader, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. E.</span></span> <span> </span><span class="NLM_article-title">Siloxyl ether functionalized resins for chemoselective enrichment of carboxylic acids</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">5652</span>â <span class="NLM_lpage">5655</span>, <span class="refDoi">Â DOI: 10.1021/ol202376m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol202376m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Clsb3F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=5652-5655&issue=20&author=D.+J.+Traderauthor=E.+E.+Carlson&title=Siloxyl+ether+functionalized+resins+for+chemoselective+enrichment+of+carboxylic+acids&doi=10.1021%2Fol202376m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Siloxyl Ether Functionalized Resins for Chemoselective Enrichment of Carboxylic Acids</span></div><div class="casAuthors">Trader, Darci J.; Carlson, Erin E.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5652-5655</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although the carboxylic acid moiety is prevalent in many biol. produced mols., including natural products and proteins, methods to chemoselectively target this functional group have remained elusive.  Generally, strategies that utilize carboxylate nucleophilicity also promote reactions with other nucleophiles such as amines and hydroxyls.  A reagent was sought to facilitate the selective isolation of carboxylic acid contg. compds. from complex mixts.  Here, the development of siloxyl ether functionalized solid supports is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQD8dn1Sp1vbVg90H21EOLACvtfcHk0lifIqKlVUXqzw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Clsb3F&md5=2b39fdf1ea6087efd95bf5a7832342bf</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fol202376m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol202376m%26sid%3Dliteratum%253Aachs%26aulast%3DTrader%26aufirst%3DD.%2BJ.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26atitle%3DSiloxyl%2520ether%2520functionalized%2520resins%2520for%2520chemoselective%2520enrichment%2520of%2520carboxylic%2520acids%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26issue%3D20%26spage%3D5652%26epage%3D5655%26doi%3D10.1021%2Fol202376m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trader, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. E.</span></span> <span> </span><span class="NLM_article-title">Taming of a superbase for selective phenol desilylation and natural product isolation</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">7349</span>â <span class="NLM_lpage">7355</span>, <span class="refDoi">Â DOI: 10.1021/jo4010298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo4010298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslCju7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=7349-7355&issue=14&author=D.+J.+Traderauthor=E.+E.+Carlson&title=Taming+of+a+superbase+for+selective+phenol+desilylation+and+natural+product+isolation&doi=10.1021%2Fjo4010298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Taming of a Superbase for Selective Phenol Desilylation and Natural Product Isolation</span></div><div class="casAuthors">Trader, Darci J.; Carlson, Erin E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7349-7355</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydroxyl moieties are highly prevalent in natural products.  We previously reported a chemoselective strategy for enrichment of hydroxyl-functionalized mols. by formation of a silyl ether bond to a resin.  To generate smaller pools of mols. for anal., we developed cleavage conditions to promote stepwise release of phenolic silyl ethers followed by aliph. silyl ethers with a "tamed" version of the superbase 1,1,3,3-tetramethylguanidine.  We demonstrate this as a general strategy for selective deprotection of phenolic silyl ethers under neutral conditions at room temp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW_Cpc_bn3VbVg90H21EOLACvtfcHk0lgskNmwPBlr1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslCju7k%253D&md5=9b803667733f0ad8be6cf0370513346f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo4010298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo4010298%26sid%3Dliteratum%253Aachs%26aulast%3DTrader%26aufirst%3DD.%2BJ.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26atitle%3DTaming%2520of%2520a%2520superbase%2520for%2520selective%2520phenol%2520desilylation%2520and%2520natural%2520product%2520isolation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2013%26volume%3D78%26issue%3D14%26spage%3D7349%26epage%3D7355%26doi%3D10.1021%2Fjo4010298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trader, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. E.</span></span> <span> </span><span class="NLM_article-title">Toward the development of solid-supported reagents for separation of alcohol-containing compounds by steric environment</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">27â28</span>),  <span class="NLM_fpage">4191</span>â <span class="NLM_lpage">4196</span>, <span class="refDoi">Â DOI: 10.1016/j.tet.2014.03.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.tet.2014.03.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1WlsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=4191-4196&issue=27%E2%80%9328&author=D.+J.+Traderauthor=E.+E.+Carlson&title=Toward+the+development+of+solid-supported+reagents+for+separation+of+alcohol-containing+compounds+by+steric+environment&doi=10.1016%2Fj.tet.2014.03.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Toward the development of solid-supported reagents for separation of alcohol-containing compounds by steric environment</span></div><div class="casAuthors">Trader, Darci J.; Carlson, Erin E.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">27-28</span>),
    <span class="NLM_cas:pages">4191-4196</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The affinity of silicon for oxygen has long been exploited to preferentially react hydroxyl moieties in the presence of others.  Here, the authors explore the ability of a variety of dialkylsiloxane-functionalized resins to selectively capture and subsequently, release alc.-contg. compds. based on the steric environment about the silicon and hydroxyl moiety.  The devised reagents will be applicable to the sepn. of compd. mixts., esp. for the selective enrichment of low abundant mols. such as bioactive natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUDWRH8S6lMLVg90H21EOLACvtfcHk0lgskNmwPBlr1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1WlsLk%253D&md5=81ff67283413b5656369d2000a2870b1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2014.03.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2014.03.040%26sid%3Dliteratum%253Aachs%26aulast%3DTrader%26aufirst%3DD.%2BJ.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26atitle%3DToward%2520the%2520development%2520of%2520solid-supported%2520reagents%2520for%2520separation%2520of%2520alcohol-containing%2520compounds%2520by%2520steric%2520environment%26jtitle%3DTetrahedron%26date%3D2014%26volume%3D70%26issue%3D27%25E2%2580%259328%26spage%3D4191%26epage%3D4196%26doi%3D10.1016%2Fj.tet.2014.03.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Capehart, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. E.</span></span> <span> </span><span class="NLM_article-title">Mass spectrometry-based assay for the rapid detection of thiol-containing natural products</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">90</span>),  <span class="NLM_fpage">13229</span>â <span class="NLM_lpage">13232</span>, <span class="refDoi">Â DOI: 10.1039/C6CC07111B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC6CC07111B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27722280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SisLzK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=13229-13232&issue=90&author=S.+L.+Capehartauthor=E.+E.+Carlson&title=Mass+spectrometry-based+assay+for+the+rapid+detection+of+thiol-containing+natural+products&doi=10.1039%2FC6CC07111B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Mass spectrometry-based assay for the rapid detection of thiol-containing natural products</span></div><div class="casAuthors">Capehart, Stacy L.; Carlson, Erin E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">90</span>),
    <span class="NLM_cas:pages">13229-13232</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Natural products are privileged scaffolds due to their high propensity to possess bioactivity.  To expedite discovery of thiol-contg. compds., we devised a selective solid-supported reagent for their immobilization, followed by cleavage of a photocleavable linker to yield stable natural product conjugates for direct detection by mass spectrometry.  Importantly, the natural products can also be tracelessly released to yield the native structures for chem. and biol. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2V-WLNy0IQLVg90H21EOLACvtfcHk0lgskNmwPBlr1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SisLzK&md5=735fd48eb84f27aeadd726e0fd04969d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1039%2FC6CC07111B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CC07111B%26sid%3Dliteratum%253Aachs%26aulast%3DCapehart%26aufirst%3DS.%2BL.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26atitle%3DMass%2520spectrometry-based%2520assay%2520for%2520the%2520rapid%2520detection%2520of%2520thiol-containing%2520natural%2520products%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26issue%3D90%26spage%3D13229%26epage%3D13232%26doi%3D10.1039%2FC6CC07111B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tietz, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokolowski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melby, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroghazi, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, D. A.</span></span> <span> </span><span class="NLM_article-title">Nucleophilic 1,4-additions for natural product discovery</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2014</span>â <span class="NLM_lpage">2022</span>, <span class="refDoi">Â DOI: 10.1021/cb500324n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500324n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVWmsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2014-2022&issue=9&author=C.+L.+Coxauthor=J.+I.+Tietzauthor=K.+Sokolowskiauthor=J.+O.+Melbyauthor=J.+R.+Doroghaziauthor=D.+A.+Mitchell&title=Nucleophilic+1%2C4-additions+for+natural+product+discovery&doi=10.1021%2Fcb500324n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleophilic 1,4-Additions for Natural Product Discovery</span></div><div class="casAuthors">Cox, Courtney L.; Tietz, Jonathan I.; Sokolowski, Karol; Melby, Joel O.; Doroghazi, James R.; Mitchell, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2014-2022</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Natural products remain an important source of drug candidates, but the difficulties inherent to traditional isolation, coupled with unacceptably high rates of compd. rediscovery, limit the pace of natural product detection.  Here we describe a reactivity-based screening method to rapidly identify exported bacterial metabolites that contain dehydrated amino acids (i.e., carbonyl- or imine-activated alkenes), a common motif in several classes of natural products.  Our strategy entails the use of a com. available thiol, dithiothreitol, for the covalent labeling of activated alkenes by nucleophilic 1,4-addn.  Modification is easily discerned by comparing mass spectra of reacted and unreacted cell surface exts.  When combined with bioinformatic anal. of putative natural product gene clusters, targeted screening and isolation can be performed on a prioritized list of strains.  Moreover, known compds. are easily dereplicated, effectively eliminating superfluous isolation and characterization.  As a proof of principle, this labeling method was used to identify known natural products belonging to the thiopeptide, lanthipeptide, and linaridin classes.  Further, upon screening a panel of only 23 actinomycetes, we discovered and characterized a novel thiopeptide antibiotic, cyclothiazomycin C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6dV1rGigxarVg90H21EOLACvtfcHk0lg5iqXO_koIAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVWmsr8%253D&md5=913792736c31c9515f1dd7f4e1df07bf</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fcb500324n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500324n%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BL.%26aulast%3DTietz%26aufirst%3DJ.%2BI.%26aulast%3DSokolowski%26aufirst%3DK.%26aulast%3DMelby%26aufirst%3DJ.%2BO.%26aulast%3DDoroghazi%26aufirst%3DJ.%2BR.%26aulast%3DMitchell%26aufirst%3DD.%2BA.%26atitle%3DNucleophilic%25201%252C4-additions%2520for%2520natural%2520product%2520discovery%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26issue%3D9%26spage%3D2014%26epage%3D2022%26doi%3D10.1021%2Fcb500324n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro-FalcÃ³n, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, C. C.</span></span> <span> </span><span class="NLM_article-title">Thiol probes to detect electrophilic natural products based on their mechanism of action</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2328</span>â <span class="NLM_lpage">2336</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.5b00924</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00924" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2mt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2328-2336&issue=8&author=G.+Castro-Falc%C3%B3nauthor=D.+Hahnauthor=D.+Reimerauthor=C.+C.+Hughes&title=Thiol+probes+to+detect+electrophilic+natural+products+based+on+their+mechanism+of+action&doi=10.1021%2Facschembio.5b00924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Thiol Probes To Detect Electrophilic Natural Products Based on Their Mechanism of Action</span></div><div class="casAuthors">Castro-Falcon, Gabriel; Hahn, Dongyup; Reimer, Daniela; Hughes, Chambers C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2328-2336</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New methods are urgently needed to find novel natural products as structural leads for the development of new drugs against emerging diseases such as cancer and multiresistant bacterial infections.  Here we introduce a reactivity-guided drug discovery approach for electrophilic natural products, a therapeutically relevant class of natural products that covalently modify their cellular targets, in crude exts.  Using carefully designed halogenated arom. reagents, the process furnishes derivs. that are UV-active and highly conspicuous via mass spectrometry by virtue of an isotopically unique bromine or chlorine tag.  In addn. to the identification of high-value metabolites, the process facilitates the difficult task of structure elucidation by providing derivs. that are primed for X-ray crystallog. anal.  We show that a cysteine probe efficiently and chemoselectively labels enone-, Î²-lactam-, and Î²-lactone-based electrophilic natural products (parthenolide, andrographolide, wortmannin, penicillin G, salinosporamide), while a thiophenol probe preferentially labels epoxide-based electrophilic natural products (triptolide, epoxomicin, eponemycin, cyclomarin, salinamide).  Using the optimized method, we were able to detect and isolate the epoxide-bearing natural product tirandalydigin from Salinispora and thereby link an orphan gene cluster to its gene product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_VJhjyqvV2LVg90H21EOLACvtfcHk0lg5iqXO_koIAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2mt7k%253D&md5=106b4dc36df6e75d3ef52ae3c8314d5e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00924%26sid%3Dliteratum%253Aachs%26aulast%3DCastro-Falc%25C3%25B3n%26aufirst%3DG.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DReimer%26aufirst%3DD.%26aulast%3DHughes%26aufirst%3DC.%2BC.%26atitle%3DThiol%2520probes%2520to%2520detect%2520electrophilic%2520natural%2520products%2520based%2520on%2520their%2520mechanism%2520of%2520action%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26issue%3D8%26spage%3D2328%26epage%3D2336%26doi%3D10.1021%2Facschembio.5b00924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudolf, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandl, F. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span> <span> </span><span class="NLM_article-title">Subclass-specific labeling of protein-reactive natural products with customized nucleophilic probes</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3701</span>â <span class="NLM_lpage">3707</span>, <span class="refDoi">Â DOI: 10.1002/chem.201405009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fchem.201405009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25605563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWit70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=3701-3707&issue=9&author=G.+C.+Rudolfauthor=M.+F.+Kochauthor=F.+A.+M.+Mandlauthor=S.+A.+Sieber&title=Subclass-specific+labeling+of+protein-reactive+natural+products+with+customized+nucleophilic+probes&doi=10.1002%2Fchem.201405009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Subclass-Specific Labeling of Protein-Reactive Natural Products with Customized Nucleophilic Probes</span></div><div class="casAuthors">Rudolf, Georg C.; Koch, Maximilian F.; Mandl, Franziska A. M.; Sieber, Stephan A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3701-3707</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Natural products represent a rich source of bioactive compds. that constitute a large fraction of approved drugs.  Among those are mols. with electrophilic scaffolds, such as Michael acceptors, Î²-lactams, and epoxides that irreversibly inhibit essential enzymes based on their catalytic mechanism.  In the search for novel bioactive mols., current methods are challenged by the frequent rediscovery of known chem. entities.  Herein small nucleophilic probes that attack electrophilic natural products and enhance their detection by HPLC-UV and HPLC-MS are introduced.  A screen of diverse probe designs revealed one compd. with a desired selectivity for epoxide- and maleimide-based antibiotics.  Correspondingly, the natural products showdomycin and phosphomycin could be selectively targeted in exts. of their natural producing organism, in which the probe-modified mols. exhibited superior retention and MS detection relative to their unmodified counterparts.  This method may thus help to discover small, electrophilic mols. that might otherwise easily elude detection in complex samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM01h3ok-8ErVg90H21EOLACvtfcHk0lg5iqXO_koIAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWit70%253D&md5=ea664fb3ba17ec1a4b60c396e2e10fa3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fchem.201405009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201405009%26sid%3Dliteratum%253Aachs%26aulast%3DRudolf%26aufirst%3DG.%2BC.%26aulast%3DKoch%26aufirst%3DM.%2BF.%26aulast%3DMandl%26aufirst%3DF.%2BA.%2BM.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26atitle%3DSubclass-specific%2520labeling%2520of%2520protein-reactive%2520natural%2520products%2520with%2520customized%2520nucleophilic%2520probes%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26issue%3D9%26spage%3D3701%26epage%3D3707%26doi%3D10.1002%2Fchem.201405009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rohena, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mooberry, S. L.</span></span> <span> </span><span class="NLM_article-title">Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">335</span>â <span class="NLM_lpage">355</span>, <span class="refDoi">Â DOI: 10.1039/C3NP70092E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC3NP70092E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=24481420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVagsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=335-355&issue=3&author=C.+C.+Rohenaauthor=S.+L.+Mooberry&title=Recent+progress+with+microtubule+stabilizers%3A+new+compounds%2C+binding+modes+and+cellular+activities&doi=10.1039%2FC3NP70092E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities</span></div><div class="casAuthors">Rohena, Cristina C.; Mooberry, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">335-355</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: late 2008 to August 2013Nature has yielded numerous classes of chem. distinct microtubule stabilizers.  Several of these, including paclitaxel (Taxol) and docetaxel (Taxotere), are important drugs used in the treatment of cancer.  New microtubule stabilizers and novel formulations of these agents continue to provide advances in cancer therapy.  In this review we cover recent progress in the chem. and biol. of these diverse microtubule stabilizers focusing on the wide range of organisms that produce these compds., their mechanisms of inhibiting microtubule-dependent processes, mechanisms of drug resistance, and their interactions with tubulin including their distinct binding sites and modes.  A new potential role for microtubule stabilizers in neurodegenerative diseases is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGbuNICZ6-bLVg90H21EOLACvtfcHk0lg5iqXO_koIAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVagsro%253D&md5=50febeef8c139e67374a92250e7e2a7a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1039%2FC3NP70092E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3NP70092E%26sid%3Dliteratum%253Aachs%26aulast%3DRohena%26aufirst%3DC.%2BC.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DRecent%2520progress%2520with%2520microtubule%2520stabilizers%253A%2520new%2520compounds%252C%2520binding%2520modes%2520and%2520cellular%2520activities%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2014%26volume%3D31%26issue%3D3%26spage%3D335%26epage%3D355%26doi%3D10.1039%2FC3NP70092E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komlodi-Pasztor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sackett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkerson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, T.</span></span> <span> </span><span class="NLM_article-title">Mitosis is not a key target of microtubule agents in patient tumors</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">244</span>â <span class="NLM_lpage">250</span>, <span class="refDoi">Â DOI: 10.1038/nrclinonc.2010.228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnrclinonc.2010.228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=21283127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFKlsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=244-250&issue=4&author=E.+Komlodi-Pasztorauthor=D.+Sackettauthor=J.+Wilkersonauthor=T.+Fojo&title=Mitosis+is+not+a+key+target+of+microtubule+agents+in+patient+tumors&doi=10.1038%2Fnrclinonc.2010.228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Mitosis is not a key target of microtubule agents in patient tumors</span></div><div class="casAuthors">Komlodi-Pasztor, Edina; Sackett, Dan; Wilkerson, Julia; Fojo, Tito</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">244-250</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Perspective, the clin. disappointment of mitosis-specific agents is explained in the context of the mechanism of action of microtubule-targeting agents.  The authors propose a new paradigm for the anticancer activity of microtubule-targeting agents and suggest that mitosis-specific inhibitors will not result in significant clin. impact.  Mitosis-specific agents have, to date, not been clin. successful.  By contrast, microtubule-targeting agents (MTAs) have a long record of success, usually attributed to the induction of mitotic arrest.  Indeed, it was this success that led to the search for mitosis-specific inhibitors.  We believe the clin. disappointment of mitosis-specific inhibitors stands as evidence that MTAs have been successful not only by interfering with mitosis but, more importantly, by disrupting essential interphase cellular mechanisms.  In this Perspective we will review literature that supports a paradigm shift in how we think about one of our most widely used classes of chemotherapeutics-MTAs.  We believe that the steady presence and const. physiol. role of microtubules are responsible for the overall success of MTAs.  While mitosis-specific inhibitors are effective on only a small fraction of the tumor mass (dividing cells), MTAs target tubulin, a protein that has crucial roles in both mitotic and non-mitotic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYOmCILGEs2LVg90H21EOLACvtfcHk0ljhPpssph1dgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFKlsLY%253D&md5=2a72541e9b990534b74e88c18265e4c8</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2010.228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2010.228%26sid%3Dliteratum%253Aachs%26aulast%3DKomlodi-Pasztor%26aufirst%3DE.%26aulast%3DSackett%26aufirst%3DD.%26aulast%3DWilkerson%26aufirst%3DJ.%26aulast%3DFojo%26aufirst%3DT.%26atitle%3DMitosis%2520is%2520not%2520a%2520key%2520target%2520of%2520microtubule%2520agents%2520in%2520patient%2520tumors%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D8%26issue%3D4%26spage%3D244%26epage%3D250%26doi%3D10.1038%2Fnrclinonc.2010.228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, B. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a fluorescent analogue of paclitaxel that selectively binds microtubules and sensitively detects efflux by P-glycoprotein</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">6927</span>â <span class="NLM_lpage">6931</span>, <span class="refDoi">Â DOI: 10.1002/anie.201703298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.201703298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsVait7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=6927-6931&issue=24&author=M.+M.+Leeauthor=Z.+Gaoauthor=B.+R.+Peterson&title=Synthesis+of+a+fluorescent+analogue+of+paclitaxel+that+selectively+binds+microtubules+and+sensitively+detects+efflux+by+P-glycoprotein&doi=10.1002%2Fanie.201703298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a Fluorescent Analogue of Paclitaxel that Selectively Binds Microtubules and Sensitively Detects Efflux by P-Glycoprotein</span></div><div class="casAuthors">Lee, Molly M.; Gao, Zhe; Peterson, Blake R.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6927-6931</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The anticancer drug paclitaxel (Taxol) exhibits paradoxical and poorly understood effects against slow-growing tumors.  To investigate its biol. activity, fluorophores such as Oregon Green have been linked to this drug.  However, this modification increases its polarity by approx. 1000-fold and reduces the toxicity of Taxol towards cancer cell lines by over 200-fold.  To construct more drug-like fluorescent probes suitable for imaging by confocal microscopy and anal. by flow cytometry, we synthesized derivs. of Taxol linked to the drug-like fluorophore Pacific Blue (PB).  We found that PB-Gly-Taxol bound the target protein Î²-tubulin with both high affinity in vitro and high specificity in living cells, exhibited substantial cytotoxicity towards HeLa cells, and was a highly sensitive substrate of the multidrug resistance transporter P-glycoprotein (P-gp).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1uJC2tWeaq7Vg90H21EOLACvtfcHk0ljhPpssph1dgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsVait7s%253D&md5=df79696b677a7d539b11e9dd25cad86b</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fanie.201703298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201703298%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BM.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DPeterson%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%2520of%2520a%2520fluorescent%2520analogue%2520of%2520paclitaxel%2520that%2520selectively%2520binds%2520microtubules%2520and%2520sensitively%2520detects%2520efflux%2520by%2520P-glycoprotein%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26issue%3D24%26spage%3D6927%26epage%3D6931%26doi%3D10.1002%2Fanie.201703298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obeng, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boise, L. H.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>107</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4907</span>â <span class="NLM_lpage">4916</span>, <span class="refDoi">Â DOI: 10.1182/blood-2005-08-3531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1182%2Fblood-2005-08-3531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=16507771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFCgtL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=4907-4916&issue=12&author=E.+A.+Obengauthor=L.+M.+Carlsonauthor=D.+M.+Gutmanauthor=W.+J.+Harringtonauthor=K.+P.+Leeauthor=L.+H.+Boise&title=Proteasome+inhibitors+induce+a+terminal+unfolded+protein+response+in+multiple+myeloma+cells&doi=10.1182%2Fblood-2005-08-3531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells</span></div><div class="casAuthors">Obeng, Esther A.; Carlson, Louise M.; Gutman, Delia M.; Harrington, William J., Jr.; Lee, Kelvin P.; Boise, Lawrence H.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4907-4916</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Multiple myeloma (MM) is an incurable plasma cell malignancy.  The 26S proteasome inhibitor, bortezomib, selectively induces apoptosis in MM cells; however, the nature of its selectivity remains unknown.  Here we demonstrate that 5 different MM cell lines display similar patterns of sensitivity to 3 proteasome inhibitors (PIs) but respond differently to specific NF-ÎºB inhibition.  We further show that PIs initiate the unfolded protein response (UPR), a signaling pathway activated by the accumulation of misfolded proteins within the endoplasmic reticulum (ER).  Consistent with reports that prosurvival/physiol. UPR components are required for B-cell differentiation into antibody-secreting cells, we found that MM cells inherently expressed the ER chaperones GRP78/Bip and GRP94/gp96.  However, bortezomib rapidly induced components of the proapoptotic/terminal UPR, including PERK, the ER stress-specific eIF-2Î± kinase; ATF4, an ER stress-induced transcription factor; and its proapoptotic target, CHOP/GADD153.  Consistent with our hypothesis that PIs induce the accumulation of misfolded ER-processed proteins, we found that the amt. of Ig subunits retained within MM cells correlated with their sensitivity to PIs.  These findings suggest that MM cells have a lower threshold for PI-induced UPR induction and ER stress-induced apoptosis because they constitutively express ER stress survival factors to function as secretory cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9ai4oVJk_fbVg90H21EOLACvtfcHk0ljhPpssph1dgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFCgtL8%253D&md5=b5567cce878c528c30a55fc8079b19b4</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-08-3531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-08-3531%26sid%3Dliteratum%253Aachs%26aulast%3DObeng%26aufirst%3DE.%2BA.%26aulast%3DCarlson%26aufirst%3DL.%2BM.%26aulast%3DGutman%26aufirst%3DD.%2BM.%26aulast%3DHarrington%26aufirst%3DW.%2BJ.%26aulast%3DLee%26aufirst%3DK.%2BP.%26aulast%3DBoise%26aufirst%3DL.%2BH.%26atitle%3DProteasome%2520inhibitors%2520induce%2520a%2520terminal%2520unfolded%2520protein%2520response%2520in%2520multiple%2520myeloma%2520cells%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26issue%3D12%26spage%3D4907%26epage%3D4916%26doi%3D10.1182%2Fblood-2005-08-3531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, D. J.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibitors in cancer therapy: lessons from the first decade</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1649</span>â <span class="NLM_lpage">1657</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-07-2218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1158%2F1078-0432.CCR-07-2218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=18347166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlejt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1649-1657&issue=6&author=R.+Z.+Orlowskiauthor=D.+J.+Kuhn&title=Proteasome+inhibitors+in+cancer+therapy%3A+lessons+from+the+first+decade&doi=10.1158%2F1078-0432.CCR-07-2218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors in cancer therapy: lessons from the first decade</span></div><div class="casAuthors">Orlowski, Robert Z.; Kuhn, Deborah J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1649-1657</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The ubiquitin-proteasome pathway is involved in intracellular protein turnover, and its function is crucial to cellular homeostasis.  First synthesized as probes of proteolytic processes, proteasome inhibitors began to be thought of as potential drug candidates when they were found to induce programmed cell death preferentially in transformed cells.  They made their first leap into the clinic to be tested as therapeutic agents 10 years ago, and since then, great strides have been made in defining their mechanisms of action, their clin. efficacy and toxicity, and some of their limitations in the form of resistance pathways.  Validation of the ubiquitin-proteasome pathway as a target for cancer therapy has come in the form of approvals of the first such inhibitor, bortezomib, for relapsed/refractory multiple myeloma and mantle cell lymphoma, for which this agent has become a std. of care.  Lessons learned from this first-in-class agent are now being applied to the development of a new generation of proteasome inhibitors that hold the promise of efficacy in bortezomib-resistant disease and possibly in a broader spectrum of diseases.  This saga provides a salient example of the promise of translational medicine and a paradigm by which other agents may be successfully brought from the bench to the bedside.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCNIRIVHoPx7Vg90H21EOLACvtfcHk0ljnZK2Z5W25zQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlejt74%253D&md5=f1639611d273422351658c10b4d8e9ad</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-2218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-2218%26sid%3Dliteratum%253Aachs%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DKuhn%26aufirst%3DD.%2BJ.%26atitle%3DProteasome%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520lessons%2520from%2520the%2520first%2520decade%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26issue%3D6%26spage%3D1649%26epage%3D1657%26doi%3D10.1158%2F1078-0432.CCR-07-2218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oerlemans, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assaraf, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Zantwijk, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkers, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheffer, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debipersad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vojtekova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Heijden, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ylstra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspers, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkmans, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheper, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, G.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of bortezomib resistance: proteasome subunit 5 (PSMB5) gene mutation and overexpression of PSMB5 protein</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2489</span>â <span class="NLM_lpage">2499</span>, <span class="refDoi">Â DOI: 10.1182/blood-2007-08-104950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1182%2Fblood-2007-08-104950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=18565852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCru7zO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=2489-2499&issue=6&author=R.+Oerlemansauthor=N.+E.+Frankeauthor=Y.+G.+Assarafauthor=J.+Cloosauthor=I.+van+Zantwijkauthor=C.+R.+Berkersauthor=G.+L.+Schefferauthor=K.+Debipersadauthor=K.+Vojtekovaauthor=C.+Lemosauthor=J.+W.+van+der+Heijdenauthor=B.+Ylstraauthor=G.+J.+Petersauthor=G.+L.+Kaspersauthor=B.+A.+Dijkmansauthor=R.+J.+Scheperauthor=G.+Jansen&title=Molecular+basis+of+bortezomib+resistance%3A+proteasome+subunit+5+%28PSMB5%29+gene+mutation+and+overexpression+of+PSMB5+protein&doi=10.1182%2Fblood-2007-08-104950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of bortezomib resistance: proteasome subunit Î²5 (PSMB5) gene mutation and overexpression of PSMB5 protein</span></div><div class="casAuthors">Oerlemans, Ruud; Franke, Niels E.; Assaraf, Yehuda G.; Cloos, Jacqueline; van Zantwijk, Ina; Berkers, Celia R.; Scheffer, George L.; Debipersad, Kabir; Vojtekova, Katharina; Lemos, Clara; van der Heijden, Joost W.; Ylstra, Bauke; Peters, Godefridus J.; Kaspers, Gertjan L.; Dijkmans, Ben A. C.; Scheper, Rik J.; Jansen, Gerrit</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2489-2499</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The proteasome inhibitor bortezomib is a novel anticancer drug that has shown promise in the treatment of refractory multiple myeloma.  However, its clin. efficacy has been hampered by the emergence of drug-resistance phenomena, the mol. basis of which remains elusive.  Toward this end, we here developed high levels (45- to 129-fold) of acquired resistance to bortezomib in human myelomonocytic THP1 cells by exposure to stepwise increasing (2.5-200 nM) concns. of bortezomib.  Study of the mol. mechanism of bortezomib resistance in these cells revealed (1) an Ala49Thr mutation residing in a highly conserved bortezomib-binding pocket in the proteasome Î²5-subunit (PSMB5) protein, (2) a dramatic overexpression (up to 60-fold) of PSMB5 protein but not of other proteasome subunits including PSMB6, PSMB7, and PSMA7, (3) high levels of cross-resistance to Î²5 subunit-targeted cytotoxic peptides 4A6, MG132, MG262, and ALLN, but not to a broad spectrum of chemotherapeutic drugs, (4) no marked changes in chymotrypsin-like proteasome activity, and (5) restoration of bortezomib sensitivity in bortezomib-resistant cells by siRNA-mediated silencing of PSMB5 gene expression.  Collectively, these findings establish a novel mechanism of bortezomib resistance assocd. with the selective overexpression of a mutant PSMB5 protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtSyGb53RI9rVg90H21EOLACvtfcHk0ljnZK2Z5W25zQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCru7zO&md5=48981ee986f506ff7c36107cfd606d43</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-08-104950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-08-104950%26sid%3Dliteratum%253Aachs%26aulast%3DOerlemans%26aufirst%3DR.%26aulast%3DFranke%26aufirst%3DN.%2BE.%26aulast%3DAssaraf%26aufirst%3DY.%2BG.%26aulast%3DCloos%26aufirst%3DJ.%26aulast%3Dvan%2BZantwijk%26aufirst%3DI.%26aulast%3DBerkers%26aufirst%3DC.%2BR.%26aulast%3DScheffer%26aufirst%3DG.%2BL.%26aulast%3DDebipersad%26aufirst%3DK.%26aulast%3DVojtekova%26aufirst%3DK.%26aulast%3DLemos%26aufirst%3DC.%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DJ.%2BW.%26aulast%3DYlstra%26aufirst%3DB.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26aulast%3DKaspers%26aufirst%3DG.%2BL.%26aulast%3DDijkmans%26aufirst%3DB.%2BA.%26aulast%3DScheper%26aufirst%3DR.%2BJ.%26aulast%3DJansen%26aufirst%3DG.%26atitle%3DMolecular%2520basis%2520of%2520bortezomib%2520resistance%253A%2520proteasome%2520subunit%25205%2520%2528PSMB5%2529%2520gene%2520mutation%2520and%2520overexpression%2520of%2520PSMB5%2520protein%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26issue%3D6%26spage%3D2489%26epage%3D2499%26doi%3D10.1182%2Fblood-2007-08-104950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmony, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span> <span> </span><span class="NLM_article-title">Activity-based imaging probes of the proteasome</span>. <i>Cell Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">101</span>, <span class="refDoi">Â DOI: 10.1007/s12013-013-9626-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs12013-013-9626-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23700161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGlt7vL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=91-101&issue=1&author=K.+C.+Carmonyauthor=K.+B.+Kim&title=Activity-based+imaging+probes+of+the+proteasome&doi=10.1007%2Fs12013-013-9626-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-Based Imaging Probes of the Proteasome</span></div><div class="casAuthors">Carmony, Kimberly Cornish; Kim, Kyung Bo</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-101</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Over the years, the proteasome has been extensively investigated due to its crucial roles in many important signaling pathways and its implications in diseases.  Two proteasome inhibitors-bortezomib and carfilzomib-have received FDA approval for the treatment of multiple myeloma, thereby validating the proteasome as a chemotherapeutic target.  As a result, further research efforts have been focused on dissecting the complex biol. of the proteasome to gain the insight required for developing next-generation proteasome inhibitors.  It is clear that chem. probes have made significant contributions to these efforts, mostly by functioning as inhibitors that selectively block the catalytic activity of proteasomes.  Analogs of these inhibitors are now providing addnl. tools for visualization of catalytically active proteasome subunits, several of which allow real-time monitoring of proteasome activity in living cells as well as in in vivo settings.  These imaging probes will provide powerful tools for assessing the efficacy of proteasome inhibitors in clin. settings.  In this review, we will focus on the recent efforts towards developing imaging probes of proteasomes, including the latest developments in immunoproteasome-selective imaging probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomIIGjZYtqkbVg90H21EOLACvtfcHk0ljnZK2Z5W25zQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGlt7vL&md5=ab86e23696ee5f95d51d391abace9038</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs12013-013-9626-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12013-013-9626-4%26sid%3Dliteratum%253Aachs%26aulast%3DCarmony%26aufirst%3DK.%2BC.%26aulast%3DKim%26aufirst%3DK.%2BB.%26atitle%3DActivity-based%2520imaging%2520probes%2520of%2520the%2520proteasome%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2013%26volume%3D67%26issue%3D1%26spage%3D91%26epage%3D101%26doi%3D10.1007%2Fs12013-013-9626-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Jong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuurman, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodenko, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovaa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkers, C. R.</span></span> <span> </span><span class="NLM_article-title">Fluorescence-based proteasome activity profiling</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>803</i></span>,  <span class="NLM_fpage">183</span>â <span class="NLM_lpage">204</span>, <span class="refDoi">Â DOI: 10.1007/978-1-61779-364-6_13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-61779-364-6_13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22065226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlersLnO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=803&publication_year=2012&pages=183-204&author=A.+de%0AJongauthor=K.+G.+Schuurmanauthor=B.+Rodenkoauthor=H.+Ovaaauthor=C.+R.+Berkers&title=Fluorescence-based+proteasome+activity+profiling&doi=10.1007%2F978-1-61779-364-6_13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence-based proteasome activity profiling</span></div><div class="casAuthors">de Jong, Annemieke; Schuurman, Karianne G.; Rodenko, Boris; Ovaa, Huib; Berkers, Celia R.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">803</span>
        (<span class="NLM_cas:issue">Chemical Proteomics</span>),
    <span class="NLM_cas:pages">183-204</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">With the proteasome emerging as a therapeutic target for cancer treatment, accurate tools for monitoring proteasome (inhibitor) activity are in demand.  In this chapter, we describe the synthesis and use of a fluorescent proteasome activity probe that allows for accurate profiling of proteasomal activity in cell lysates, intact cells, and murine and human patient-derived material, with high sensitivity using SDS-PAGE.  The probe allows for direct scanning of the gel for fluorescent emission of the distinct proteasomal subunits and circumvents the use of Western blot anal.  Due to its suitable biochem. and biophys. properties, the fluorescent probe can also be used for confocal laser scanning microscopy and flow cytometry-based expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGKphTXhYIbVg90H21EOLACvtfcHk0lijJTYOSn2gdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlersLnO&md5=3c45141e01daf097484509bb1b3efa21</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-364-6_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-61779-364-6_13%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJong%26aufirst%3DA.%26aulast%3DSchuurman%26aufirst%3DK.%2BG.%26aulast%3DRodenko%26aufirst%3DB.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DBerkers%26aufirst%3DC.%2BR.%26atitle%3DFluorescence-based%2520proteasome%2520activity%2520profiling%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2012%26volume%3D803%26spage%3D183%26epage%3D204%26doi%3D10.1007%2F978-1-61779-364-6_13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geurink, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Elst, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Ru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veelen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Dulk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ossendorp, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit Î²5t</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">795</span>â <span class="NLM_lpage">801</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2010.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.chembiol.2010.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=20797608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2iu7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=795-801&issue=8&author=B.+I.+Floreaauthor=M.+Verdoesauthor=N.+Liauthor=W.+A.+van+der+Lindenauthor=P.+P.+Geurinkauthor=H.+van+den+Elstauthor=T.+Hofmannauthor=A.+de+Ruauthor=P.+A.+van+Veelenauthor=K.+Tanakaauthor=K.+Sasakiauthor=S.+Murataauthor=H.+den+Dulkauthor=J.+Brouwerauthor=F.+A.+Ossendorpauthor=A.+F.+Kisselevauthor=H.+S.+Overkleeft&title=Activity-based+profiling+reveals+reactivity+of+the+murine+thymoproteasome-specific+subunit+%CE%B25t&doi=10.1016%2Fj.chembiol.2010.05.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit Î²5t</span></div><div class="casAuthors">Florea, Bogdan I.; Verdoes, Martijn; Li, Nan; van der Linden, Wouter A.; Geurink, Paul P.; van den Elst, Hans; Hofmann, Tanja; de Ru, Arnoud; van Veelen, Peter A.; Tanaka, Keiji; Sasaki, Katsuhiro; Murata, Shigeo; den Dulk, Hans; Brouwer, Jaap; Ossendorp, Ferry A.; Kisselev, Alexei F.; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">795-801</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Epithelial cells of the thymus cortex express a unique proteasome particle involved in pos. T cell selection.  This thymoproteasome contains the recently discovered Î²5t subunit that has an uncharted activity, if any.  We synthesized fluorescent epoxomicin probes that were used in a chem. proteomics approach, entailing activity-based profiling, affinity purifn., and LC-MS identification, to demonstrate that the Î²5t subunit is catalytically active in the murine thymus.  A panel of established proteasome inhibitors showed that the broad-spectrum inhibitor epoxomicin blocks the Î²5t activity and that the subunit-specific antagonists bortezomib and NC005 do not inhibit Î²5t.  We show that Î²5t has a substrate preference distinct from Î²5/Î²5i that might explain how the thymoproteasome generates the MHC class I peptide repertoire needed for pos. T cell selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvUV4I2cVH_LVg90H21EOLACvtfcHk0lijJTYOSn2gdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2iu7nK&md5=7a7c58efdb059452ad0b6579e5677bfa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3DGeurink%26aufirst%3DP.%2BP.%26aulast%3Dvan%2Bden%2BElst%26aufirst%3DH.%26aulast%3DHofmann%26aufirst%3DT.%26aulast%3Dde%2BRu%26aufirst%3DA.%26aulast%3Dvan%2BVeelen%26aufirst%3DP.%2BA.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DMurata%26aufirst%3DS.%26aulast%3Dden%2BDulk%26aufirst%3DH.%26aulast%3DBrouwer%26aufirst%3DJ.%26aulast%3DOssendorp%26aufirst%3DF.%2BA.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DActivity-based%2520profiling%2520reveals%2520reactivity%2520of%2520the%2520murine%2520thymoproteasome-specific%2520subunit%2520%25CE%25B25t%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26issue%3D8%26spage%3D795%26epage%3D801%26doi%3D10.1016%2Fj.chembiol.2010.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ovaa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Swieten, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeuwenburgh, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiebiger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den
Nieuwendijk, A. M. C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galardy, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploegh, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">Chemistry in living cells: detection of active proteasomes by a two-step labeling strategy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">31</span>),  <span class="NLM_fpage">3626</span>â <span class="NLM_lpage">3629</span>, <span class="refDoi">Â DOI: 10.1002/anie.200351314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.200351314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFWksbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=3626-3629&issue=31&author=H.+Ovaaauthor=P.+F.+van+Swietenauthor=B.+M.+Kesslerauthor=M.+A.+Leeuwenburghauthor=E.+Fiebigerauthor=A.+M.+C.+H.+van+den%0ANieuwendijkauthor=P.+J.+Galardyauthor=G.+A.+van+der+Marelauthor=H.+L.+Ploeghauthor=H.+S.+Overkleeft&title=Chemistry+in+living+cells%3A+detection+of+active+proteasomes+by+a+two-step+labeling+strategy&doi=10.1002%2Fanie.200351314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry in living cells: Detection of active proteasomes by a two-step labeling strategy</span></div><div class="casAuthors">Ovaa, Huib; van Swieten, Paul F.; Kessler, Benedikt M.; Leeuwenburgh, Michiel A.; Fiebiger, Edda; van den Nieuwendijk, Adrianus M. C. H.; Galardy, Paul J.; van der Marel, Gijsbert A.; Ploegh, Hidde L.; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3626-3629</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors describe new functional proteomics strategy that allows two step labeling for the catalytically active subunits of the proteasome in living cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOOcjHX7i-a7Vg90H21EOLACvtfcHk0liq0PsjYxSQbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFWksbg%253D&md5=a439beadb0efa7c681108cb3ce8a50c1</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351314%26sid%3Dliteratum%253Aachs%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3Dvan%2BSwieten%26aufirst%3DP.%2BF.%26aulast%3DKessler%26aufirst%3DB.%2BM.%26aulast%3DLeeuwenburgh%26aufirst%3DM.%2BA.%26aulast%3DFiebiger%26aufirst%3DE.%26aulast%3Dvan%2Bden%2BNieuwendijk%26aufirst%3DA.%2BM.%2BC.%2BH.%26aulast%3DGalardy%26aufirst%3DP.%2BJ.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DPloegh%26aufirst%3DH.%2BL.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DChemistry%2520in%2520living%2520cells%253A%2520detection%2520of%2520active%2520proteasomes%2520by%2520a%2520two-step%2520labeling%2520strategy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26issue%3D31%26spage%3D3626%26epage%3D3629%26doi%3D10.1002%2Fanie.200351314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillaert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sae-Heng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risseeuw, M. D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippov, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">Acetylene functionalized BODIPY dyes and their application in the synthesis of activity based proteasome probes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">6169</span>â <span class="NLM_lpage">6171</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2007.09.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.bmcl.2007.09.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=17888658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt7%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6169-6171&issue=22&author=M.+Verdoesauthor=U.+Hillaertauthor=B.+I.+Floreaauthor=M.+Sae-Hengauthor=M.+D.+P.+Risseeuwauthor=D.+V.+Filippovauthor=G.+A.+van+der+Marelauthor=H.+S.+Overkleeft&title=Acetylene+functionalized+BODIPY+dyes+and+their+application+in+the+synthesis+of+activity+based+proteasome+probes&doi=10.1016%2Fj.bmcl.2007.09.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylene functionalized BODIPY dyes and their application in the synthesis of activity based proteasome probes</span></div><div class="casAuthors">Verdoes, Martijn; Hillaert, Ulrik; Florea, Bogdan I.; Sae-Heng, Myra; Risseeuw, Martijn D. P.; Filippov, Dmitri V.; Van der Marel, Gijsbert A.; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6169-6171</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The synthesis of three acetylene functionalized BODIPY dyes is described.  These dyes are used to fluorescently modify an azido functionalized epoxomicin analog employing the Huisgen 1,3-dipolar cycloaddn., resulting in a panel of fluorescent epoxomicin derived proteasome probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjRloqekg7s7Vg90H21EOLACvtfcHk0liq0PsjYxSQbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt7%252FL&md5=cd747cd1e5d341f9a077eb1b661d8d55</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.025%26sid%3Dliteratum%253Aachs%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DHillaert%26aufirst%3DU.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DSae-Heng%26aufirst%3DM.%26aulast%3DRisseeuw%26aufirst%3DM.%2BD.%2BP.%26aulast%3DFilippov%26aufirst%3DD.%2BV.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DAcetylene%2520functionalized%2520BODIPY%2520dyes%2520and%2520their%2520application%2520in%2520the%2520synthesis%2520of%2520activity%2520based%2520proteasome%2520probes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D22%26spage%3D6169%26epage%3D6171%26doi%3D10.1016%2Fj.bmcl.2007.09.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">A set of activity-based probes to visualize human (immuno)proteasome activities</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4199</span>â <span class="NLM_lpage">4203</span>, <span class="refDoi">Â DOI: 10.1002/anie.201509092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.201509092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCntLbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=4199-4203&issue=13&author=G.+de%0ABruinauthor=B.+T.+Xinauthor=M.+Krausauthor=M.+van+der%0ASteltauthor=G.+A.+van+der+Marelauthor=A.+F.+Kisselevauthor=C.+Driessenauthor=B.+I.+Floreaauthor=H.+S.+Overkleeft&title=A+set+of+activity-based+probes+to+visualize+human+%28immuno%29proteasome+activities&doi=10.1002%2Fanie.201509092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A set of activity-based probes to visualize human (immuno)proteasome activities</span></div><div class="casAuthors">de Bruin, Gerjan; Xin, Bo Tao; Kraus, Marianne; van der Stelt, Mario; van der Marel, Gijsbert A.; Kisselev, Alexei F.; Driessen, Christoph; Florea, Bogdan I.; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4199-4203</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Proteasomes are therapeutic targets for various cancers and autoimmune diseases.  Constitutively expressed proteasomes have three active sites, Î²1c, Î²2c, and Î²5c.  Lymphoid tissues also express the immunoproteasome subunits Î²1i, Î²2i, and Î²5i.  Rapid and simultaneous measurement of the activity of these catalytic subunits would assist in the discovery of new inhibitors, improve anal. of proteasome inhibitors in clin. trials, and simplify anal. of subunit expression.  In this work, we present a cocktail of activity-based probes that enables simultaneous gel-based detection of all six catalytic human proteasome subunits.  We used this cocktail to develop specific inhibitors for Î²1c, Î²2c, Î²5c, and Î²2i, to compare the active-site specificity of clin. proteasome inhibitors, and to demonstrate that many hematol. malignancies predominantly express immunoproteasomes.  Furthermore, we show that selective and complete inhibition of Î²5i and Î²1i is cytotoxic to primary cells from acute lymphocytic leukemia (ALL) patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrebn-jSmyOmLVg90H21EOLACvtfcHk0liq0PsjYxSQbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCntLbJ&md5=b04c6ea92827f327395fc313444e5126</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fanie.201509092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201509092%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBruin%26aufirst%3DG.%26aulast%3DXin%26aufirst%3DB.%2BT.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DDriessen%26aufirst%3DC.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DA%2520set%2520of%2520activity-based%2520probes%2520to%2520visualize%2520human%2520%2528immuno%2529proteasome%2520activities%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D13%26spage%3D4199%26epage%3D4203%26doi%3D10.1002%2Fanie.201509092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jen, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Valle, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aydanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norsworthy, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przepiorka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdur, R.</span></span> <span> </span><span class="NLM_article-title">FDA approval: gemtuzumab ozogamicin for the treatment of adults with newly diagnosed CD33-positive acute myeloid leukemia</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3242</span>â <span class="NLM_lpage">3246</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-17-3179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1158%2F1078-0432.CCR-17-3179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29476018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlantb%252FO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=3242-3246&author=E.+Y.+Jenauthor=C.+W.+Koauthor=J.+E.+Leeauthor=P.+L.+Del+Valleauthor=A.+Aydanianauthor=C.+Jewellauthor=K.+J.+Norsworthyauthor=D.+Przepiorkaauthor=L.+Nieauthor=J.+Liuauthor=C.+M.+Shethauthor=M.+Shapiroauthor=A.+T.+Farrellauthor=R.+Pazdur&title=FDA+approval%3A+gemtuzumab+ozogamicin+for+the+treatment+of+adults+with+newly+diagnosed+CD33-positive+acute+myeloid+leukemia&doi=10.1158%2F1078-0432.CCR-17-3179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia</span></div><div class="casAuthors">Jen, Emily Y.; Ko, Chia-Wen; Lee, Jee Eun; Del Valle, Pedro L.; Aydanian, Antonina; Jewell, Charles; Norsworthy, Kelly J.; Przepiorka, Donna; Nie, Lei; Liu, Jiang; Sheth, Christopher M.; Shapiro, Marjorie; Farrell, Ann T.; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3242-3246</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">On Sept. 1, 2017, the FDA granted approval for gemtuzumab ozogamicin (Mylotarg; Pfizer Inc.) in combination with daunorubicin and cytarabine and as a monotherapy for the treatment of adult patients with newly diagnosed CD33-pos. acute myeloid leukemia (AML).  Gemtuzumab ozogamicin is a CD33-targeted antibody-drug conjugate joined to calicheamicin.  Approval of gemtuzumab ozogamicin combination treatment was based on a randomized trial of 271 patients with newly diagnosed AML treated with daunorubicin and cytarabine with or without 3 mg/m2 fractionated gemtuzumab ozogamicin, which resulted in an event-free survival (EFS) of 13.6 mo for gemtuzumab ozogamicin + daunorubicin and cytarabine and 8.8 mo for daunorubicin and cytarabine alone [HR = 0.68 (95% confidence interval (CI), 0.51-0.91)].  Hemorrhage, prolonged thrombocytopenia, and veno-occlusive disease were serious toxicities that were more common in patients treated with gemtuzumab ozogamicin + daunorubicin and cytarabine.  Approval of gemtuzumab ozogamicin monotherapy was based on a randomized trial of 237 patients with newly diagnosed AML treated without curative intent.  Median overall survival (OS) was 4.9 mo with gemtuzumab ozogamicin vs. 3.6 mo on best supportive care [HR = 0.69 (95% CI, 0.53-0.90)].  Adverse events were similar on both arms.  Postapproval, several studies are required including evaluation of fractionated gemtuzumab ozogamicin pharmacokinetics, safety of combination gemtuzumab ozogamicin in the pediatric population, immunogenicity, and the effects of gemtuzumab ozogamicin on platelet function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Pd2W8O-Rs7Vg90H21EOLACvtfcHk0lgnaXTNd05FBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlantb%252FO&md5=00a69bf2b71711a4567d30035ef9797d</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-17-3179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-17-3179%26sid%3Dliteratum%253Aachs%26aulast%3DJen%26aufirst%3DE.%2BY.%26aulast%3DKo%26aufirst%3DC.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DDel%2BValle%26aufirst%3DP.%2BL.%26aulast%3DAydanian%26aufirst%3DA.%26aulast%3DJewell%26aufirst%3DC.%26aulast%3DNorsworthy%26aufirst%3DK.%2BJ.%26aulast%3DPrzepiorka%26aufirst%3DD.%26aulast%3DNie%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSheth%26aufirst%3DC.%2BM.%26aulast%3DShapiro%26aufirst%3DM.%26aulast%3DFarrell%26aufirst%3DA.%2BT.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DFDA%2520approval%253A%2520gemtuzumab%2520ozogamicin%2520for%2520the%2520treatment%2520of%2520adults%2520with%2520newly%2520diagnosed%2520CD33-positive%2520acute%2520myeloid%2520leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2018%26volume%3D24%26spage%3D3242%26epage%3D3246%26doi%3D10.1158%2F1078-0432.CCR-17-3179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norsworthy, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przepiorka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdur, R.</span></span> <span> </span><span class="NLM_article-title">FDA approval summary: mylotarg for treatment of patients with relapsed or refractory CD33-positive acute myeloid leukemia</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1103</span>â <span class="NLM_lpage">1108</span>, <span class="refDoi">Â DOI: 10.1634/theoncologist.2017-0604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1634%2Ftheoncologist.2017-0604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29650683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1yntr3O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=1103-1108&author=K.+J.+Norsworthyauthor=C.+W.+Koauthor=J.+E.+Leeauthor=J.+Liuauthor=C.+S.+Johnauthor=D.+Przepiorkaauthor=A.+T.+Farrellauthor=R.+Pazdur&title=FDA+approval+summary%3A+mylotarg+for+treatment+of+patients+with+relapsed+or+refractory+CD33-positive+acute+myeloid+leukemia&doi=10.1634%2Ftheoncologist.2017-0604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia</span></div><div class="casAuthors">Norsworthy, Kelly J.; Ko, Chia-Wen; Lee, Jee Eun; Liu, Jiang; John, Christy S.; Przepiorka, Donna; Farrell, Ann T.; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1103-1108</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1549-490X</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">GO is a CD33-directed antibody drug conjugate linked to the cytotoxic antibiotic calicheamicin.  It originally received accelerated approval for treatment of older patients with relapsed CD33-pos. AML in 2000, but it was withdrawn from the market in 2010 when the confirmatory trial failed to demonstrate clin. benefit among safety concerns, such as a higher rate of induction fatalities on the GO combination arm compared with chemotherapy alone.  In addn., GO was assocd. with hepatic veno-occlusive disease (VOD), which has substantial morbidity and mortality.  Pharmacokinetic analyses suggested a lower max. concn. of GO would result in less VOD without affecting target satn. or efficacy.  A meta-anal. across dose schedules of GO in patients with R/R AML showed that a lower-dose "fractionated" schedule of 3 mg/m2 days 1, 4, and 7 was assocd. with less early mortality, hemorrhage, and VOD, without an apparent decrease in complete remission (CR) rate.  MyloFrance 1 was a single-arm study evaluating response rates in patients with relapsed CD33-pos. AML treated with the lower-dose fractionated GO regimen.  The CR rate was 26% (95% confidence interval 16%-40%).  Common adverse reactions were fever, infections, nausea, vomiting, constipation, bleeding, increased liver enzymes, and mucositis.  There were no cases of VOD.  These results supported the approval of GO as monotherapy for R/R CD33-pos. AML using the lower-dose fractionated regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ5hq8ChgdU7Vg90H21EOLACvtfcHk0lgnaXTNd05FBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1yntr3O&md5=9b54edbd41525fca590ee14bfa2434ce</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2017-0604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2017-0604%26sid%3Dliteratum%253Aachs%26aulast%3DNorsworthy%26aufirst%3DK.%2BJ.%26aulast%3DKo%26aufirst%3DC.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJohn%26aufirst%3DC.%2BS.%26aulast%3DPrzepiorka%26aufirst%3DD.%26aulast%3DFarrell%26aufirst%3DA.%2BT.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DFDA%2520approval%2520summary%253A%2520mylotarg%2520for%2520treatment%2520of%2520patients%2520with%2520relapsed%2520or%2520refractory%2520CD33-positive%2520acute%2520myeloid%2520leukemia%26jtitle%3DOncologist%26date%3D2018%26volume%3D23%26spage%3D1103%26epage%3D1108%26doi%3D10.1634%2Ftheoncologist.2017-0604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, Y. N.</span></span> <span> </span><span class="NLM_article-title">Inotuzumab ozogamicin: first global approval</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1603</span>â <span class="NLM_lpage">1610</span>, <span class="refDoi">Â DOI: 10.1007/s40265-017-0802-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs40265-017-0802-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28819740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlGktL3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=1603-1610&author=Y.+N.+Lamb&title=Inotuzumab+ozogamicin%3A+first+global+approval&doi=10.1007%2Fs40265-017-0802-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Inotuzumab Ozogamicin: First Global Approval</span></div><div class="casAuthors">Lamb, Yvette N.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1603-1610</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">I.v. inotuzumab ozogamicin (Besponsa; Pfizer) is an anti-CD22 monoclonal antibody-calicheamicin conjugate that binds to CD22-expressing tumor cells.  Upon binding, the complex is internalized and the cytotoxic calicheamicin deriv. is released inside the cell, inducing double-strand DNA breakage and subsequent cell death.  In June 2017, the EMA granted inotuzumab ozogamicin approval as monotherapy for the treatment of adults with relapsed or refractory CD22-pos. B-cell precursor acute lymphoblastic leukemia (ALL).  The use of inotuzumab ozogamicin in adult patients with Philadelphia chromosome-pos., relapsed or refractory CD22-pos. B-cell precursor ALL is restricted to those who have failed treatment with at least one tyrosine kinase inhibitor.  Inotuzumab ozogamicin was granted priority review for the treatment of relapsed or refractory B-cell precursor ALL by the US FDA in Feb. 2017.  In the USA, a phase III trial evaluating inotuzumab ozogamicin in combination with frontline chemotherapy in adults with newly diagnosed B-cell ALL has recently been initiated and inotuzumab ozogamicin is under phase II evaluation in childhood CD22-pos. B-cell ALL.  Inotuzumab ozogamicin combination therapies are also being evaluated in the phase I/II or II setting in ALL and chronic myeloid leukemia and in the phase I setting in Burkitt's lymphoma.  This article summarizes the milestones in the development of inotuzumab ozogamicin leading to this first approval for ALL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSHnoFMpPaqbVg90H21EOLACvtfcHk0lgnaXTNd05FBQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlGktL3P&md5=76c6dbf41181e769901bbc313aabdb20</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1007%2Fs40265-017-0802-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-017-0802-5%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DY.%2BN.%26atitle%3DInotuzumab%2520ozogamicin%253A%2520first%2520global%2520approval%26jtitle%3DDrugs%26date%3D2017%26volume%3D77%26spage%3D1603%26epage%3D1610%26doi%3D10.1007%2Fs40265-017-0802-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donato, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FernÃ¡ndez-Zarzoso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hueso, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la
Rubia, J.</span></span> <span> </span><span class="NLM_article-title">Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: an evidence-based review</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">4583</span>â <span class="NLM_lpage">4590</span>, <span class="refDoi">Â DOI: 10.2147/OTT.S141053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.2147%2FOTT.S141053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30122950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BB3c7ps1ajuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=4583-4590&author=E.+M.+Donatoauthor=M.+Fern%C3%A1ndez-Zarzosoauthor=J.+A.+Huesoauthor=J.+de+la%0ARubia&title=Brentuximab+vedotin+in+Hodgkin+lymphoma+and+anaplastic+large-cell+lymphoma%3A+an+evidence-based+review&doi=10.2147%2FOTT.S141053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: an evidence-based review</span></div><div class="casAuthors">Donato Eva M; Fernandez-Zarzoso Miguel; Hueso Jose Antonio; de la Rubia Javier; de la Rubia Javier</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4583-4590</span>
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    </div><div class="casAbstract">Hodgkin lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) account for ~10% and 2%-3% of all cases of lymphoid neoplasms, respectively.  Up to 30% of patients with HL are refractory or relapse after first-line therapy, and elderly patients with HL represent a subgroup of patients with suboptimal responses to the currently available treatments.  Five-year overall survival for ALCL patients is 50%-80% with conventional chemotherapy.  Therefore, new therapeutic approaches are needed for these groups of patients.  Brentuximab vedotin is a chimeric IgG1 anti-CD30 antibody-drug conjugate that has all the features that are necessary to make a substantive difference with the standard therapies in patients with HL and ALCL: a novel mechanism of action, single-agent activity, non-cross-resistance, and safety both in the relapsed-refractory and in the front-line setting.  This review provides an update of the results of the most relevant clinical trials including brentuximab vedotin for patients with HL and ALCL conducted to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOH2aP9Lst_yEJCPKhJPuqfW6udTcc2ebQwxCpnxVdAbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7ps1ajuw%253D%253D&md5=08cf83d2027f2c9e7b7dc132a4551818</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.2147%2FOTT.S141053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S141053%26sid%3Dliteratum%253Aachs%26aulast%3DDonato%26aufirst%3DE.%2BM.%26aulast%3DFern%25C3%25A1ndez-Zarzoso%26aufirst%3DM.%26aulast%3DHueso%26aufirst%3DJ.%2BA.%26aulast%3Dde%2Bla%2BRubia%26aufirst%3DJ.%26atitle%3DBrentuximab%2520vedotin%2520in%2520Hodgkin%2520lymphoma%2520and%2520anaplastic%2520large-cell%2520lymphoma%253A%2520an%2520evidence-based%2520review%26jtitle%3DOncoTargets%2520Ther.%26date%3D2018%26volume%3D11%26spage%3D4583%26epage%3D4590%26doi%3D10.2147%2FOTT.S141053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasamon, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Claro, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenthal, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdur, R.</span></span> <span> </span><span class="NLM_article-title">FDA approval summary: brentuximab vedotin in first-line treatment of peripheral T-cell lymphoma</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">e180</span>â <span class="NLM_lpage">e187</span>, <span class="refDoi">Â DOI: 10.1634/theoncologist.2019-0098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1634%2Ftheoncologist.2019-0098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30914464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFKhs7fF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=e180-e187&author=N.+C.+Richardsonauthor=Y.+L.+Kasamonauthor=H.+Chenauthor=R.+A.+de+Claroauthor=J.+Yeauthor=G.+M.+Blumenthalauthor=A.+T.+Farrellauthor=R.+Pazdur&title=FDA+approval+summary%3A+brentuximab+vedotin+in+first-line+treatment+of+peripheral+T-cell+lymphoma&doi=10.1634%2Ftheoncologist.2019-0098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma</span></div><div class="casAuthors">Richardson, Nicholas C.; Kasamon, Yvette L.; Chen, Haiyan; de Claro, R. Angelo; Ye, Jingjing; Blumenthal, Gideon M.; Farrell, Ann T.; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e180-e187</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1549-490X</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">Approval was based on ECHELON-2, a randomized, double-blind, actively controlled trial that compared BV+CHP with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in 452 patients with newly diagnosed, CD30-expressing PTCL.  Efficacy was based on independent review facility-assessed progression-free survival (PFS).  The median PFS was 48.2 mo with BV+CHP vs. 20.8 mo with CHOP, resulting in a hazard ratio (HR) of 0.71 (95% confidence interval).  The trial also demonstrated improvement in overall survival (HR 0.66; 95% CI: 0.46-0.95), complete response rate (68% vs. 56%), and overall response rate (83% vs. 72%) with BV+CHP.  The most common adverse reactions (incidence â¥20%) obsd. â¥2% more with BV+CHP were nausea, diarrhea, fatigue or asthenia, mucositis, pyrexia, vomiting, and anemia.  Peripheral neuropathy rates were similar (52% with BV+CHP, 55% with CHOP).  Through the Real-Time Oncol. Review pilot program, which allows FDA early access to key data, FDA granted this approval less than 2 wk after official submission of the application.  Implications for Practice : This is the first U.S. Food and Drug Administration approval for treatment of patients with newly diagnosed peripheral T-cell lymphomas (PTCL).  Improvement in progression-free and overall survival over cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy, which has been the std. of care for decades, is unprecedented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEhAAcx2pjcbVg90H21EOLACvtfcHk0ljOAdjAWsNG1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFKhs7fF&md5=1508f5760132350665aaa03a10ed0623</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2019-0098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2019-0098%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DN.%2BC.%26aulast%3DKasamon%26aufirst%3DY.%2BL.%26aulast%3DChen%26aufirst%3DH.%26aulast%3Dde%2BClaro%26aufirst%3DR.%2BA.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DBlumenthal%26aufirst%3DG.%2BM.%26aulast%3DFarrell%26aufirst%3DA.%2BT.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DFDA%2520approval%2520summary%253A%2520brentuximab%2520vedotin%2520in%2520first-line%2520treatment%2520of%2520peripheral%2520T-cell%2520lymphoma%26jtitle%3DOncologist%26date%3D2019%26volume%3D24%26spage%3De180%26epage%3De187%26doi%3D10.1634%2Ftheoncologist.2019-0098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von
Minckwitz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mano, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loibl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamounas, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Untch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolmark, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastogi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneeweiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redondo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacot, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conlin, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arce-Salinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wapnir, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackisch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiGiovanna, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasching, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crown, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">WÃ¼lfing, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rota Caremoli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesarowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smitt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douthwaite, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singel, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, C. E.,  Jr.</span></span> <span> </span><span class="NLM_article-title">KATHERINE Investigators. Trastuzumab emtansine for residual invasive HER2-positive breast cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>380</i></span>,  <span class="NLM_fpage">617</span>â <span class="NLM_lpage">628</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa1814017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1056%2FNEJMoa1814017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30516102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvVSjsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2019&pages=617-628&author=G.+von%0AMinckwitzauthor=C.+S.+Huangauthor=M.+S.+Manoauthor=S.+Loiblauthor=E.+P.+Mamounasauthor=M.+Untchauthor=N.+Wolmarkauthor=P.+Rastogiauthor=A.+Schneeweissauthor=A.+Redondoauthor=H.+H.+Fischerauthor=W.+Jacotauthor=A.+K.+Conlinauthor=C.+Arce-Salinasauthor=I.+L.+Wapnirauthor=C.+Jackischauthor=M.+P.+DiGiovannaauthor=P.+A.+Faschingauthor=J.+P.+Crownauthor=P.+W%C3%BClfingauthor=Z.+Shaoauthor=E.+Rota+Caremoliauthor=H.+Wuauthor=L.+H.+Lamauthor=D.+Tesarowskiauthor=M.+Smittauthor=H.+Douthwaiteauthor=S.+M.+Singelauthor=C.+E.+Geyer&title=KATHERINE+Investigators.+Trastuzumab+emtansine+for+residual+invasive+HER2-positive+breast+cancer&doi=10.1056%2FNEJMoa1814017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Trastuzumab emtansine for residual invasive HER2-positive breast cancer</span></div><div class="casAuthors">von Minckwitz, G.; Huang, C.-S.; Mano, M. S.; Loibl, S.; Mamounas, E. P.; Untch, M.; Wolmark, N.; Rastogi, P.; Schneeweiss, A.; Redondo, A.; Fischer, H. H.; Jacot, W.; Conlin, A. K.; Arce-Salinas, C.; Wapnir, I. L.; Jackisch, C.; DiGiovanna, M. P.; Fasching, P. A.; Crown, J. P.; Wuelfing, P.; Shao, Z.; Caremoli, E. Rota; Wu, H.; Lam, L. H.; Tesarowski, D.; Smitt, M.; Douthwaite, H.; Singel, S. M.; Geyer, C. E., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">617-628</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background Patients who have residual invasive breast cancer after receiving neoadjuvant chemotherapy plus human epidermal growth factor receptor 2 (HER2)-targeted therapy have a worse prognosis than those who have no residual cancer.  Trastuzumab emtansine (T-DM1), an antibody-drug conjugate of trastuzumab and the cytotoxic agent emtansine (DM1), a maytansine deriv. and microtubule inhibitor, provides benefit in patients with metastatic breast cancer that was previously treated with chemotherapy plus HER2-targeted therapy.  Methods We conducted a phase 3, open-label trial involving patients with HER2-pos. early breast cancer who were found to have residual invasive disease in the breast or axilla at surgery after receiving neoadjuvant therapy contg. a taxane (with or without anthracycline) and trastuzumab.  Patients were randomly assigned to receive adjuvant T-DM1 or trastuzumab for 14 cycles.  The primary end point was invasive disease-free survival (defined as freedom from ipsilateral invasive breast tumor recurrence, ipsilateral locoregional invasive breast cancer recurrence, contralateral invasive breast cancer, distant recurrence, or death from any cause).  Results At the interim anal., among 1486 randomly assigned patients (743 in the T-DM1 group and 743 in the trastuzumab group), invasive disease or death had occurred in 91 patients in the T-DM1 group (12.2%) and 165 patients in the trastuzumab group (22.2%).  The estd. percentage of patients who were free of invasive disease at 3 years was 88.3% in the T-DM1 group and 77.0% in the trastuzumab group.  Invasive disease-free survival was significantly higher in the T-DM1 group than in the trastuzumab group (hazard ratio for invasive disease or death, 0.50; 95% confidence interval, 0.39 to 0.64; P<0.001).  Distant recurrence as the first invasive-disease event occurred in 10.5% of patients in the T-DM1 group and 15.9% of those in the trastuzumab group.  The safety data were consistent with the known safety profile of T-DM1, with more adverse events assocd. with T-DM1 than with trastuzumab alone.  Conclusions Among patients with HER2-pos. early breast cancer who had residual invasive disease after completion of neoadjuvant therapy, the risk of recurrence of invasive breast cancer or death was 50% lower with adjuvant T-DM1 than with trastuzumab alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_AnDXLpkvDLVg90H21EOLACvtfcHk0ljOAdjAWsNG1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvVSjsrc%253D&md5=cf91a52e85e92514122bace6236f69fb</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1814017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1814017%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BMinckwitz%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DC.%2BS.%26aulast%3DMano%26aufirst%3DM.%2BS.%26aulast%3DLoibl%26aufirst%3DS.%26aulast%3DMamounas%26aufirst%3DE.%2BP.%26aulast%3DUntch%26aufirst%3DM.%26aulast%3DWolmark%26aufirst%3DN.%26aulast%3DRastogi%26aufirst%3DP.%26aulast%3DSchneeweiss%26aufirst%3DA.%26aulast%3DRedondo%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DH.%2BH.%26aulast%3DJacot%26aufirst%3DW.%26aulast%3DConlin%26aufirst%3DA.%2BK.%26aulast%3DArce-Salinas%26aufirst%3DC.%26aulast%3DWapnir%26aufirst%3DI.%2BL.%26aulast%3DJackisch%26aufirst%3DC.%26aulast%3DDiGiovanna%26aufirst%3DM.%2BP.%26aulast%3DFasching%26aufirst%3DP.%2BA.%26aulast%3DCrown%26aufirst%3DJ.%2BP.%26aulast%3DW%25C3%25BClfing%26aufirst%3DP.%26aulast%3DShao%26aufirst%3DZ.%26aulast%3DRota%2BCaremoli%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DL.%2BH.%26aulast%3DTesarowski%26aufirst%3DD.%26aulast%3DSmitt%26aufirst%3DM.%26aulast%3DDouthwaite%26aufirst%3DH.%26aulast%3DSingel%26aufirst%3DS.%2BM.%26aulast%3DGeyer%26aufirst%3DC.%2BE.%26atitle%3DKATHERINE%2520Investigators.%2520Trastuzumab%2520emtansine%2520for%2520residual%2520invasive%2520HER2-positive%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2019%26volume%3D380%26spage%3D617%26epage%3D628%26doi%3D10.1056%2FNEJMoa1814017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krop, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welslau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baselga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiÃ©ras, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guardino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwell, K.</span></span> <span> </span><span class="NLM_article-title">EMILIA Study Group. Trastuzumab emtansine for HER2-positive advanced breast cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">1783</span>â <span class="NLM_lpage">1791</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa1209124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1056%2FNEJMoa1209124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23020162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt73M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=1783-1791&author=S.+Vermaauthor=D.+Milesauthor=L.+Gianniauthor=I.+E.+Kropauthor=M.+Welslauauthor=J.+Baselgaauthor=M.+Pegramauthor=D.+Y.+Ohauthor=V.+Di%C3%A9rasauthor=E.+Guardinoauthor=L.+Fangauthor=M.+W.+Luauthor=S.+Olsenauthor=K.+Blackwell&title=EMILIA+Study+Group.+Trastuzumab+emtansine+for+HER2-positive+advanced+breast+cancer&doi=10.1056%2FNEJMoa1209124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Trastuzumab emtansine for HER2-positive advanced breast cancer</span></div><div class="casAuthors">Verma, Sunil; Miles, David; Gianni, Luca; Krop, Ian E.; Welslau, Manfred; Baselga, Jose; Pegram, Mark; Oh, Do-Youn; Dieras, Veronique; Guardino, Ellie; Fang, Liang; Lu, Michael W.; Olsen, Steven; Blackwell, Kim</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1783-1791</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate incorporating the human epidermal growth factor receptor 2 (HER2)-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.  The antibody and the cytotoxic agent are conjugated by means of a stable linker.  METHODS: We randomly assigned patients with HER2-pos. advanced breast cancer, who had previously been treated with trastuzumab and a taxane, to T-DM1 or lapatinib plus capecitabine.  The primary end points were progression-free survival (as assessed by independent review), overall survival, and safety.  Secondary end points included progression-free survival (investigator-assessed), the objective response rate, and the time to symptom progression.  Two interim analyses of overall survival were conducted.  RESULTS: Among 991 randomly assigned patients, median progression-free survival as assessed by independent review was 9.6 mo with T-DM1 vs. 6.4 mo with lapatinib plus capecitabine (hazard ratio for progression or death from any cause, 0.65; 95% confidence interval [CI], 0.55 to 0.77; P<0.001), and median overall survival at the second interim anal. crossed the stopping boundary for efficacy (30.9 mo vs. 25.1 mo; hazard ratio for death from any cause, 0.68; 95% CI, 0.55 to 0.85; P<0.001).  The objective response rate was higher with T-DM1 (43.6%, vs. 30.8% with lapatinib plus capecitabine; P<0.001); results for all addnl. secondary end points favored T-DM1.  Rates of grade 3 or above were higher with lapatinib plus capecitabine than with T-DM1 (57% vs. 41%).  The incidences of thrombocytopenia and increased serum aminotransferase levels were higher with T-DM1, whereas the incidences of diarrhea, nausea, vomiting, and palmar-plantar erythrodysesthesia were higher with lapatinib plus capecitabine.  CONCLUSIONS: T-DM1 significantly prolonged progression-free and overall survival with less toxicity than lapatinib plus capecitabine in patients with HER2-pos. advanced breast cancer previously treated with trastuzumab and a taxane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGRhxRQ7JSJrVg90H21EOLACvtfcHk0lgi3Y5ZjeIfaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt73M&md5=3be5bac27a81b530442dc8a6b4a1f82e</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1209124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1209124%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DS.%26aulast%3DMiles%26aufirst%3DD.%26aulast%3DGianni%26aufirst%3DL.%26aulast%3DKrop%26aufirst%3DI.%2BE.%26aulast%3DWelslau%26aufirst%3DM.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DPegram%26aufirst%3DM.%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DDi%25C3%25A9ras%26aufirst%3DV.%26aulast%3DGuardino%26aufirst%3DE.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DS.%26aulast%3DBlackwell%26aufirst%3DK.%26atitle%3DEMILIA%2520Study%2520Group.%2520Trastuzumab%2520emtansine%2520for%2520HER2-positive%2520advanced%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26spage%3D1783%26epage%3D1791%26doi%3D10.1056%2FNEJMoa1209124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deeks, E. D.</span></span> <span> </span><span class="NLM_article-title">Polatuzumab vedotin: first global approval</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1467</span>â <span class="NLM_lpage">1475</span>, <span class="refDoi">Â DOI: 10.1007/s40265-019-01175-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs40265-019-01175-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=31352604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BB3MvitVSmsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=1467-1475&issue=13&author=E.+D.+Deeks&title=Polatuzumab+vedotin%3A+first+global+approval&doi=10.1007%2Fs40265-019-01175-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Polatuzumab Vedotin: First Global Approval</span></div><div class="casAuthors">Deeks Emma D</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1467-1475</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Polatuzumab vedotin (polatuzumab vedotin-piiq; PolivyÂ®) is an antibody-drug conjugate comprising a monoclonal antibody against CD79b (a B cell receptor component) covalently conjugated to the anti-mitotic cytotoxic agent monomethyl auristatin (MMAE) via a cleavable linker.  After binding to CD79b on the B-cell surface, polatuzumab vedotin is internalized and the linker is cleaved, releasing MMAE into the cell, where it inhibits division and induces apoptosis.  Polatuzumab vedotin is being developed by Genentech (a subsidiary of Roche) for the treatment of haematological malignancies.  In June 2019, the US FDA granted accelerated approval to polatuzumab vedotin, in combination with bendamustine plus rituximab, for the treatment of adults with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who have received at least two prior therapies.  Use of the compound in combination with bendamustine plus rituximab is also under regulatory review for relapsed/refractory DLBCL in the EU and is in ongoing phase 1b/2 development in this setting or relapsed/refractory follicular lymphoma (FL) in several countries.  Various other polatuzumab vedotin combination therapy regimens are also in phase 1b/2 development for relapsed/refractory non-Hodgkin lymphoma (NHL) [including DLBCL and FL] or in phase 2 or 3 development for previously untreated DLBCL, while polatuzumab vedotin monotherapy has been in phase 1 development for relapsed/refractory B-cell NHL in Japan.  This article summarizes the milestones in the development of polatuzumab vedotin leading to this first approval for its use in combination with bendamustine plus rituximab for relapsed/refractory DLBCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWjRJKq7mXFhjv2lLSLOxFfW6udTcc2eZz7KSlh3G6bLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvitVSmsA%253D%253D&md5=2aed4fe7658078144e9a1169ecf60e37</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1007%2Fs40265-019-01175-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-019-01175-0%26sid%3Dliteratum%253Aachs%26aulast%3DDeeks%26aufirst%3DE.%2BD.%26atitle%3DPolatuzumab%2520vedotin%253A%2520first%2520global%2520approval%26jtitle%3DDrugs%26date%3D2019%26volume%3D79%26issue%3D13%26spage%3D1467%26epage%3D1475%26doi%3D10.1007%2Fs40265-019-01175-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sacchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curnis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corti, A.</span></span> <span> </span><span class="NLM_article-title">Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">7150</span>â <span class="NLM_lpage">7155</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-04-1445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1158%2F0008-5472.CAN-04-1445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=15466213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFaltro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7150-7155&author=A.+Sacchiauthor=A.+Gasparriauthor=F.+Curnisauthor=M.+Belloneauthor=A.+Corti&title=Crucial+role+for+interferon+gamma+in+the+synergism+between+tumor+vasculature-targeted+tumor+necrosis+factor+alpha+%28NGR-TNF%29+and+doxorubicin&doi=10.1158%2F0008-5472.CAN-04-1445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Crucial role for interferon Î³ in the synergism between tumor vasculature-targeted tumor necrosis factor Î± (NGR,TNF) and doxorubicin</span></div><div class="casAuthors">Sacchi, Angelina; Gasparri, Anna; Curnis, Flavio; Bellone, Matteo; Corti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7150-7155</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">NGR-TNF is a deriv. of TNF-Î±, consisting of TNF fused to CNGRCG, a tumor vasculature-targeting peptide.  Previous studies showed that NGR-TNF can exert synergistic antitumor effects with doxorubicin and with other chemotherapeutic drugs in murine models.  In this study, the authors have investigated the role of endogenous IFN-Î³ on the antitumor activity of NGR-TNF in combination with doxorubicin.  The study was carried out using murine B16F1 melanoma and TS/A mammary adenocarcinoma implanted s.c. in (a) immunocompetent mice, (b) athymic nude mice, and (c) IFN-Î³-knockout mice.  Synergism between NGR-TNF and doxorubicin was obsd. in immunocompetent mice but not in nude or IFN-Î³-knockout mice.  Preadministration of a neutralizing anti-IFN-Î³ antibody to immunocompetent mice inhibited the NGR-TNF/doxorubicin synergism, whereas administration of IFN-Î³ to nude and to IFN-Î³-knockout mice restored the synergistic activity.  The synergism in nude mice was restored also by transfecting tumor cells with the IFN-Î³ cDNA.  Administration of NGR-TNF in combination with IFN-Î³ to nude mice, but not of NGR-TNF alone, doubled the penetration of doxorubicin in TS/A tumors.  These findings point to a crucial role for locally produced IFN-Î³ in tumor vascular targeting with NGR-TNF and doxorubicin.  Finally, addn. of IFN-Î³ to the treatment of immunocompetent mice with NGR-TNF/doxorubicin induced only modest improvement in response, suggesting that exogenous IFN-Î³ can improve the therapeutic activity of these drugs only in case of suboptimal prodn. of endogenous IFN-Î³.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC_DWQbtJ-erVg90H21EOLACvtfcHk0liHG4aLOFHTEQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFaltro%253D&md5=64a30f33d0c908bfeecbe05149ab5976</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1445%26sid%3Dliteratum%253Aachs%26aulast%3DSacchi%26aufirst%3DA.%26aulast%3DGasparri%26aufirst%3DA.%26aulast%3DCurnis%26aufirst%3DF.%26aulast%3DBellone%26aufirst%3DM.%26aulast%3DCorti%26aufirst%3DA.%26atitle%3DCrucial%2520role%2520for%2520interferon%2520gamma%2520in%2520the%2520synergism%2520between%2520tumor%2520vasculature-targeted%2520tumor%2520necrosis%2520factor%2520alpha%2520%2528NGR-TNF%2529%2520and%2520doxorubicin%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7150%26epage%3D7155%26doi%3D10.1158%2F0008-5472.CAN-04-1445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregorc, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelletto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genova, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambiase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoro, A.</span></span> <span> </span><span class="NLM_article-title">NGR-hTNF and doxorubicin as second-line treatment of patients with small cell lung cancer</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1133</span>â <span class="NLM_lpage">e112</span>, <span class="refDoi">Â DOI: 10.1634/theoncologist.2018-0292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1634%2Ftheoncologist.2018-0292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30076277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1yntr3L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=1133-e112&author=V.+Gregorcauthor=R.+Cavinaauthor=S.+Novelloauthor=F.+Grossiauthor=C.+Lazzariauthor=E.+Capellettoauthor=C.+Genovaauthor=G.+Saliniauthor=A.+Lambiaseauthor=A.+Santoro&title=NGR-hTNF+and+doxorubicin+as+second-line+treatment+of+patients+with+small+cell+lung+cancer&doi=10.1634%2Ftheoncologist.2018-0292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">NGR-hTNF and Doxorubicin as Second-Line Treatment of Patients with Small Cell Lung Cancer</span></div><div class="casAuthors">Gregorc, Vanesa; Cavina, Raffaele; Novello, Sivia; Grossi, Francesco; Lazzari, Chiara; Capelletto, Enrica; Genova, Carlo; Salini, Giulia; Lambiase, Antonio; Santoro, Armando</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1133-e112</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1549-490X</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">Lessons Learned : NGR-hTNF was safely combined with doxorubicin, showing a promising antitumor activity in unselected patients with relapsed small cell lung cancer.  Similar antitumor activity was obsd. in platinum-sensitive and platinum-resistant patient cohorts.  Relapsed small cell lung cancer (SCLC) patients have limited treatment options and poor outcomes.  NGR-hTNF is a vascular-targeting agent, which increases intratumoral chemotherapy penetration and T-lymphocyte infiltration.  The primary endpoint of this single-arm phase II trial was progression-free survival (PFS), and safety, response rate, and survival were secondary endpoints.  The most common grade 3-4 toxicities were neutropenia (53%) and anemia (21%).  Median PFS was 3.2 mo for all patients, 2.7 mo for platinum-resistant patients, and 4.1 mo for platinum-sensitive patients.  Seven patients had partial responses (25%), including four (25%) with platinum-resistant and three (25%) with platinum-sensitive relapse.  Mean changes from baseline in tumor burden (after two, four, and six cycles) did not differ between platinum-resistant (-9%, -29%, and -32%) and platinum-sensitive (-11%, -20%, and -43%) cohorts.  Overall survival was assocd. only with baseline lymphocyte counts, with median survival times of 13.1 and 5.2 mo for lymphocyte counts above or below the median, resp.  NGR-hTNF plus doxorubicin showed manageable toxicity and promising activity in patients with relapsed SCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4JWmw-WDN-7Vg90H21EOLACvtfcHk0ljVpSU7Sgmalw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1yntr3L&md5=27b5dc0eef3e76ba871f0572063b6443</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2018-0292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2018-0292%26sid%3Dliteratum%253Aachs%26aulast%3DGregorc%26aufirst%3DV.%26aulast%3DCavina%26aufirst%3DR.%26aulast%3DNovello%26aufirst%3DS.%26aulast%3DGrossi%26aufirst%3DF.%26aulast%3DLazzari%26aufirst%3DC.%26aulast%3DCapelletto%26aufirst%3DE.%26aulast%3DGenova%26aufirst%3DC.%26aulast%3DSalini%26aufirst%3DG.%26aulast%3DLambiase%26aufirst%3DA.%26aulast%3DSantoro%26aufirst%3DA.%26atitle%3DNGR-hTNF%2520and%2520doxorubicin%2520as%2520second-line%2520treatment%2520of%2520patients%2520with%2520small%2520cell%2520lung%2520cancer%26jtitle%3DOncologist%26date%3D2018%26volume%3D23%26spage%3D1133%26epage%3De112%26doi%3D10.1634%2Ftheoncologist.2018-0292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Clinical application of radiolabeled RGD peptides for PET imaging of integrin Î±vÎ²3</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">78</span>â <span class="NLM_lpage">92</span>, <span class="refDoi">Â DOI: 10.7150/thno.13242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.7150%2Fthno.13242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=26722375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XntF2nt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=78-92&author=H.+Chenauthor=G.+Niuauthor=H.+Wuauthor=X.+Chen&title=Clinical+application+of+radiolabeled+RGD+peptides+for+PET+imaging+of+integrin+%CE%B1v%CE%B23&doi=10.7150%2Fthno.13242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical application of radiolabeled RGD peptides for PET imaging of integrin Î±vÎ²3</span></div><div class="casAuthors">Chen, Haojun; Niu, Gang; Wu, Hua; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-92</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Mol. imaging for non-invasive assessment of angiogenesisis is of great interest for clinicians because of the wide-spread application of anti-angiogenic cancer therapeutics.  Besides, many other interventions that involve the change of blood vessel/tumor microenvironment would also benefit from such imaging strategies.  Of the imaging techniques that target angiogenesis, radiolabeled Arg-Gly-Asp (RGD) peptides have been a major focus because of their high affinity and selectivity for integrin Î±vÎ²3--one of the most extensively examd. target of angiogenesis.  Since the level of integrin Î±vÎ²3 expression has been established as a surrogate marker of angiogenic activity, imaging Î±vÎ²3 expression can potentially be used as an early indicator of effectiveness of antiangiogenic therapy at the mol. level.  In this review, we summarize RGD-based PET tracers that have already been used in clin. trials and intercompared them in terms of radiosynthesis, dosimetry, pharmacokinetics and clin. applications.  A perspective of their future use in the clinic is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMF5yFaBW4RLVg90H21EOLACvtfcHk0ljVpSU7Sgmalw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntF2nt7c%253D&md5=7124509bee7f3bb9b90a3a8d0ae0f82c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.7150%2Fthno.13242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.13242%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DNiu%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DClinical%2520application%2520of%2520radiolabeled%2520RGD%2520peptides%2520for%2520PET%2520imaging%2520of%2520integrin%2520%25CE%25B1v%25CE%25B23%26jtitle%3DTheranostics%26date%3D2016%26volume%3D6%26spage%3D78%26epage%3D92%26doi%3D10.7150%2Fthno.13242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sehnert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhardt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DÃ¼bel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. E.</span></span> <span> </span><span class="NLM_article-title">The âsneaking-ligandâ approach: cell-type specific inhibition of the classical NF-ÎºB pathway</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1280</i></span>,  <span class="NLM_fpage">559</span>â <span class="NLM_lpage">578</span>, <span class="refDoi">Â DOI: 10.1007/978-1-4939-2422-6_33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-4939-2422-6_33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25736772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1yqsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1280&publication_year=2015&pages=559-578&author=B.+Sehnertauthor=H.+Burkhardtauthor=S.+D%C3%BCbelauthor=R.+E.+Voll&title=The+%E2%80%9Csneaking-ligand%E2%80%9D+approach%3A+cell-type+specific+inhibition+of+the+classical+NF-%CE%BAB+pathway&doi=10.1007%2F978-1-4939-2422-6_33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The "Sneaking-Ligand" Approach: Cell-Type Specific Inhibition of the Classical NF-ÎºB Pathway</span></div><div class="casAuthors">Sehnert, Bettina; Burkhardt, Harald; Duebel, Stefan; Voll, Reinhard E.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1280</span>
        (<span class="NLM_cas:issue">NF-kappa B</span>),
    <span class="NLM_cas:pages">559-578</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The intracellular delivery of mols. across the plasma membrane represents a major obstacle.  The conjugation of cell-permeable peptides (CPPs) to proteins promotes the uptake and internalization.  However, uptake of CPPs is receptor independent and not cell-type specific.  Recently, we established the "sneaking-ligand" approach which is based on multimodular recombinant fusion proteins that consist of three modules connected with serine-glycine linkers.  Module one is responsible for receptor-mediated endocytosis; module two supports translocation into the cytoplasm so that the effector module three can interact with its binding partner in the cytoplasm.  For NF-ÎºB inhibition, we described an NF-ÎºB inhibitor that targets selectively the activated endothelium via an oligopeptide motif.  Upon E-selectin-mediated endocytosis, the Pseudomonas exotoxin A domain II (ETAII) translocates the NEMO-binding peptide to the cytoplasm interfering with IÎºB kinase complex assembly.  Inflammatory autoimmune diseases are triggered, but also resolved by a variety of cell types.  Therefore, the inhibition of NF-ÎºB should be restricted to those cells that are crucially involved in the pathogenesis of inflammatory diseases.  A general blockade of NF-ÎºB may result in severe immunosuppression and possibly in organ dysfunction or damage.  The "sneaking-ligand" approach could minimize the risks of therapeutic interventions and identify disease-relevant cell types.  Here we describe the recombinant expression and purifn. of the E-selectin-specific "sneaking-ligand construct" (SLC1) and its ability to inhibit cytokine-induced NF-ÎºB activation in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIYbdxKarRm7Vg90H21EOLACvtfcHk0ljVpSU7Sgmalw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1yqsb8%253D&md5=875051a6f3aee09a809a6848860b217d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-2422-6_33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-2422-6_33%26sid%3Dliteratum%253Aachs%26aulast%3DSehnert%26aufirst%3DB.%26aulast%3DBurkhardt%26aufirst%3DH.%26aulast%3DD%25C3%25BCbel%26aufirst%3DS.%26aulast%3DVoll%26aufirst%3DR.%2BE.%26atitle%3DThe%2520%25E2%2580%259Csneaking-ligand%25E2%2580%259D%2520approach%253A%2520cell-type%2520specific%2520inhibition%2520of%2520the%2520classical%2520NF-%25CE%25BAB%2520pathway%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2015%26volume%3D1280%26spage%3D559%26epage%3D578%26doi%3D10.1007%2F978-1-4939-2422-6_33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakase, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futaki, S.</span></span> <span> </span><span class="NLM_article-title">Syndecan-4 is a receptor for clathrin-mediated endocytosis of arginine-rich cell-penetrating peptides</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1119</span>â <span class="NLM_lpage">1130</span>, <span class="refDoi">Â DOI: 10.1021/acs.bioconjchem.6b00082</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.6b00082" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVOqtLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1119-1130&author=Y.+Kawaguchiauthor=T.+Takeuchiauthor=K.+Kuwataauthor=J.+Chibaauthor=Y.+Hatanakaauthor=I.+Nakaseauthor=S.+Futaki&title=Syndecan-4+is+a+receptor+for+clathrin-mediated+endocytosis+of+arginine-rich+cell-penetrating+peptides&doi=10.1021%2Facs.bioconjchem.6b00082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Syndecan-4 Is a Receptor for Clathrin-Mediated Endocytosis of Arginine-Rich Cell-Penetrating Peptides</span></div><div class="casAuthors">Kawaguchi, Yoshimasa; Takeuchi, Toshihide; Kuwata, Keiko; Chiba, Junya; Hatanaka, Yasumaru; Nakase, Ikuhiko; Futaki, Shiroh</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1119-1130</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arginine-rich cell-penetrating peptides (CPPs) such as Tat and oligoarginine peptides have been widely used as carriers for intracellular delivery of bioactive mols.  Despite accumulating evidence for involvement of endocytosis in the cellular uptake of arginine-rich CPPs, the primary cell-surface receptors for these peptide carriers that would initiate endocytic processes leading to intracellular delivery of bioactive cargoes have remained poorly understood.  Our previous attempt to identify membrane receptors for octa-arginine (R8) peptide, one of the representative arginine-rich CPPs, using the photo-crosslinking probe bearing a photoreactive diazirine was not successful due to considerable amts. of cellular proteins nonspecifically bound to the affinity beads.  To address this issue, here we developed a photo-crosslinking probe in which a cleavable linker of a diazobenzene moiety was employed to allow selective elution of cross-linked proteins by reducing agent-mediated cleavage.  We demonstrated that introduction of the diazobenzene moiety into the photoaffinity probe enables efficient purifn. of cross-linked proteins with significant redn. of nonspecific binding proteins, leading to successful identification of 17 membrane-assocd. proteins that would interact with R8 peptide.  RNAi-mediated knockdown expts. in combination with the pharmacol. inhibitors revealed that, among the proteins identified, syndecan-4, one of the heparan sulfate proteoglycans, is an endogenous membrane-assocd. receptor for the cellular uptake of R8 peptide via clathrin-mediated endocytosis.  This syndecan-4-dependent pathway was also involved in the intracellular delivery of bioactive proteins mediated by R8 peptide.  These results reveal that syndecan-4 is a primary cell-surface target for R8 peptide that allows intracellular delivery of bioactive cargo mols. via clathrin-mediated endocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0PfX3BhtTMbVg90H21EOLACvtfcHk0liiIbx2zKbI4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVOqtLc%253D&md5=88e30a7cc5c1b295e1ec4f60f14d2777</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.6b00082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.6b00082%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DKuwata%26aufirst%3DK.%26aulast%3DChiba%26aufirst%3DJ.%26aulast%3DHatanaka%26aufirst%3DY.%26aulast%3DNakase%26aufirst%3DI.%26aulast%3DFutaki%26aufirst%3DS.%26atitle%3DSyndecan-4%2520is%2520a%2520receptor%2520for%2520clathrin-mediated%2520endocytosis%2520of%2520arginine-rich%2520cell-penetrating%2520peptides%26jtitle%3DBioconjugate%2520Chem.%26date%3D2016%26volume%3D27%26spage%3D1119%26epage%3D1130%26doi%3D10.1021%2Facs.bioconjchem.6b00082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milletti, F.</span></span> <span> </span><span class="NLM_article-title">Cell-penetrating peptides: classes, origin, and current landscape</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">850</span>â <span class="NLM_lpage">860</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2012.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.drudis.2012.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22465171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xltl2qsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=850-860&author=F.+Milletti&title=Cell-penetrating+peptides%3A+classes%2C+origin%2C+and+current+landscape&doi=10.1016%2Fj.drudis.2012.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-penetrating peptides: classes, origin, and current landscape</span></div><div class="casAuthors">Milletti, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">850-860</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  With more than ten new FDA approvals since 2001, peptides are emerging as an important therapeutic alternative to small mols.  However, unlike small mols., peptides on the market today are limited to extracellular targets.  By contrast, cell-penetrating peptides (CPPs) can target intracellular proteins and also carry other cargoes (e.g. other peptides, small mols. or proteins) into the cell, thus offering great potential as future therapeutics.  In this review I present a classification scheme for CPPs based on their phys.-chem. properties and origin, and I provide a general framework for understanding and discovering new CPPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokvlaYLzhGQrVg90H21EOLACvtfcHk0liiIbx2zKbI4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xltl2qsrc%253D&md5=b3a88bd00e9aa633937eedb488d24552</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26atitle%3DCell-penetrating%2520peptides%253A%2520classes%252C%2520origin%252C%2520and%2520current%2520landscape%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D850%26epage%3D860%26doi%3D10.1016%2Fj.drudis.2012.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pooga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">Classes of cell-penetrating peptides</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1324</i></span>,  <span class="NLM_fpage">3</span>â <span class="NLM_lpage">28</span>, <span class="refDoi">Â DOI: 10.1007/978-1-4939-2806-4_1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-4939-2806-4_1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=26202259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FlvVamsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1324&publication_year=2015&pages=3-28&author=M.+Poogaauthor=U.+Langel&title=Classes+of+cell-penetrating+peptides&doi=10.1007%2F978-1-4939-2806-4_1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Classes of Cell-Penetrating Peptides</span></div><div class="casAuthors">Pooga Margus; Langel Ulo</div><div class="citationInfo"><span class="NLM_cas:title">Methods in molecular biology (Clifton, N.J.)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1324</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3-28</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During the three decades of cell-penetrating peptides era the superfamily of CPPs has rapidly expanded, and the quest for new sequences continues.  CPPs have been well recognized by scientific community and they have been used for transduction of a wide variety of molecules and particles into cultured cells and in vivo.  In parallel with application of CPPs for delivering of active payloads, the mechanisms that such peptides take advantage of for gaining access to cells' insides have been in the focus of intense studies.  Although the common denominator "cell penetration" unites all CPPs, the interaction partners on the cell surface, evoked cellular responses and even the uptake mechanisms might greatly vary between different peptide types.  Here we present some possibilities for classification of CPPs based on their type of origin, physical-chemical properties, and the extent of modifications and design efforts.  We also briefly analyze the internalization mechanisms with regard to their classification into groups based on physical-chemical characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTODotqZ4D8gYJKJbLTgsvCfW6udTcc2ebPJzc3PDZy5rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FlvVamsQ%253D%253D&md5=04bf0a57fe57eae76555477a73ebc580</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-2806-4_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-2806-4_1%26sid%3Dliteratum%253Aachs%26aulast%3DPooga%26aufirst%3DM.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DClasses%2520of%2520cell-penetrating%2520peptides%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2015%26volume%3D1324%26spage%3D3%26epage%3D28%26doi%3D10.1007%2F978-1-4939-2806-4_1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LÃ¶nn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, S. F.</span></span> <span> </span><span class="NLM_article-title">Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell</span>. <i>Expert Opin. Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1627</span>â <span class="NLM_lpage">1636</span>, <span class="refDoi">Â DOI: 10.1517/17425247.2015.1046431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1517%2F17425247.2015.1046431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25994800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC2MfmtVOktA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=1627-1636&author=P.+L%C3%B6nnauthor=S.+F.+Dowdy&title=Cationic+PTD%2FCPP-mediated+macromolecular+delivery%3A+charging+into+the+cell&doi=10.1517%2F17425247.2015.1046431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell</span></div><div class="casAuthors">Lonn Peter; Dowdy Steven F; Lonn Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on drug delivery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1627-36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Macromolecular therapeutics, including enzymes, transcription factors, siRNAs, peptides and large synthetic molecules, can potentially be used to treat human diseases by targeting intracellular molecular pathways and modulating biological responses.  However, large macromolecules have no ability to enter cells and require delivery vehicles.  Protein transduction domains (PTDs), also known as cell-penetrating peptides (CPPs), are a diverse class of peptides that can deliver macromolecules into cells.  AREAS COVERED:  In this review, we cover the uptake and usage of arginine-rich PTDs/CPPs (TAT-PTD, Penetratin/Antp and 8R).  We review the endocytosis-mediated uptake of these peptides and highlight three important steps: i) cell association; ii) internalization and iii) endosomal escape.  We also discuss the array of different cargos that have been delivered by cationic PTDs/CPPs as well as cellular processes and biological responses that have been modulated.  EXPERT OPINION:  PTDs/CPPs have shown great potential to deliver otherwise undeliverable macromolecular therapeutics into cells for experimentation in cell culture and in animal disease models in vivo.  Moreover, over 25 clinical trials have been performed predominantly using the TAT-PTD.  However, more work is still needed.  Endosomal escape and target-cell specificity remain two of the major future challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHkdvjMpsQUAqdek-gHSrIfW6udTcc2eaQvLbnu__0Hrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfmtVOktA%253D%253D&md5=23f45daeb40a68d82b7b33aebe41c097</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1517%2F17425247.2015.1046431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2015.1046431%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6nn%26aufirst%3DP.%26aulast%3DDowdy%26aufirst%3DS.%2BF.%26atitle%3DCationic%2520PTD%252FCPP-mediated%2520macromolecular%2520delivery%253A%2520charging%2520into%2520the%2520cell%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2015%26volume%3D12%26spage%3D1627%26epage%3D1636%26doi%3D10.1517%2F17425247.2015.1046431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker-Hapak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, S. F.</span></span> <span> </span><span class="NLM_article-title">TAT-mediated protein transduction into mammalian cells</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">247</span>â <span class="NLM_lpage">256</span>, <span class="refDoi">Â DOI: 10.1006/meth.2001.1186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1006%2Fmeth.2001.1186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11403574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkt1Kjsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=247-256&author=M.+Becker-Hapakauthor=S.+S.+McAllisterauthor=S.+F.+Dowdy&title=TAT-mediated+protein+transduction+into+mammalian+cells&doi=10.1006%2Fmeth.2001.1186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">TAT-mediated protein transduction into mammalian cells</span></div><div class="casAuthors">Becker-Hapak, Michelle; McAllister, Sandra S.; Dowdy, Steven F.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-256</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Manipulation of mammalian cells has been achieved by the transfection of expression vectors, microinjection, or diffusion of peptidyl mimetics.  While these approaches have been somewhat successful, the classic manipulation methods are not easily regulated and can be laborious.  One approach to circumvent these problems is the use of HIV TAT-mediated protein transduction.  Although this technol. was originally described in 1988, few improvements were reported in the subsequent 10 yr.  In the last few years, significant steps have been taken to advance this technol. into a broadly applicable method that allows for the rapid introduction of full-length proteins into primary and transformed cells.  The technol. requires the synthesis of a fusion protein, linking the TAT transduction domain to the mol. of interest using a bacterial expression vector, followed by the purifn. of this fusion protein under either sol. or denaturing conditions.  The purified fusion protein can be directly added to mammalian cell culture or injected in vivo into mice.  Protein transduction occurs in a concn.-dependent manner, achieving max. intracellular concns. in less than 5 min, with nearly equal intracellular concns. between all cells in the transduced population.  Full-length TAT fusion proteins have been used to address a no. of biol. questions, relating to cell cycle progression, apoptosis, and cellular architecture.  Described here are the fundamental requirements for the creation, isolation, and utilization of TAT-fusion proteins to affect mammalian cells.  A detailed protocol for prodn. and transduction of TAT-Cdc42 into primary cells is given to illustrate the technique.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobW7K39xtvULVg90H21EOLACvtfcHk0li4E25CC7e4hA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkt1Kjsrk%253D&md5=8cf037588673b4d2930326b1a5f49954</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1006%2Fmeth.2001.1186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmeth.2001.1186%26sid%3Dliteratum%253Aachs%26aulast%3DBecker-Hapak%26aufirst%3DM.%26aulast%3DMcAllister%26aufirst%3DS.%2BS.%26aulast%3DDowdy%26aufirst%3DS.%2BF.%26atitle%3DTAT-mediated%2520protein%2520transduction%2520into%2520mammalian%2520cells%26jtitle%3DMethods%26date%3D2001%26volume%3D24%26spage%3D247%26epage%3D256%26doi%3D10.1006%2Fmeth.2001.1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadhwani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¼rck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berditsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schober, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, A. S.</span></span> <span> </span><span class="NLM_article-title">Lactam-stapled cell-penetrating peptides: cell uptake and membrane binding properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8071</span>â <span class="NLM_lpage">8082</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00813</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00813" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFWjt7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8071-8082&author=M.+J.+Kleinauthor=S.+Schmidtauthor=P.+Wadhwaniauthor=J.+B%C3%BCrckauthor=J.+Reichertauthor=S.+Afoninauthor=M.+Berditschauthor=T.+Schoberauthor=R.+Brockauthor=M.+Kansyauthor=A.+S.+Ulrich&title=Lactam-stapled+cell-penetrating+peptides%3A+cell+uptake+and+membrane+binding+properties&doi=10.1021%2Facs.jmedchem.7b00813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties</span></div><div class="casAuthors">Klein, Marco J.; Schmidt, Samuel; Wadhwani, Parvesh; Buerck, Jochen; Reichert, Johannes; Afonin, Sergii; Berditsch, Marina; Schober, Tim; Brock, Roland; Kansy, Manfred; Ulrich, Anne S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8071-8082</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stapling of side chains to stabilize an Î±-helical structure has been generally assocd. with an increased uptake of CPPs.  Here, we compare four amphiphilic stapled peptides with their linear counterparts in terms of their membrane binding and conformational features in order to correlate these with uptake efficiency and toxicol. effects.  The impact of lactam stapling was found to vary strongly with regard to the different aspects of peptide-membrane interactions.  Nearly all stapled peptides caused less membrane perturbation (vesicle leakage, hemolysis, bacterial lysis) than their linear counterparts.  In one case (MAP-1) where stapling enhanced Î±-helicity in aq. and lipid environments, leakage was eliminated while cell uptake in HEK293 and HeLa cells remained high, which improved the overall characteristics.  The other systems (DRIM, WWSP, KFGF) did not improve, however.  The data suggest that cell uptake of amphipathic CPPs correlates with their adopted Î±-helix content in membranes rather than their helicity in soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxrP7UiuD6-LVg90H21EOLACvtfcHk0li4E25CC7e4hA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFWjt7jK&md5=9cd212ed0548dd17f54e0def8b20bd39</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00813%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DM.%2BJ.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DWadhwani%26aufirst%3DP.%26aulast%3DB%25C3%25BCrck%26aufirst%3DJ.%26aulast%3DReichert%26aufirst%3DJ.%26aulast%3DAfonin%26aufirst%3DS.%26aulast%3DBerditsch%26aufirst%3DM.%26aulast%3DSchober%26aufirst%3DT.%26aulast%3DBrock%26aufirst%3DR.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DUlrich%26aufirst%3DA.%2BS.%26atitle%3DLactam-stapled%2520cell-penetrating%2520peptides%253A%2520cell%2520uptake%2520and%2520membrane%2520binding%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8071%26epage%3D8082%26doi%3D10.1021%2Facs.jmedchem.7b00813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathman, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothbard, J. B.</span></span> <span> </span><span class="NLM_article-title">Polyarginine enters cells more efficiently than other polycationic homopolymers</span>. <i>J. Pept. Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">318</span>â <span class="NLM_lpage">325</span>, <span class="refDoi">Â DOI: 10.1034/j.1399-3011.2000.00723.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1034%2Fj.1399-3011.2000.00723.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11095185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVGltbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2000&pages=318-325&author=D.+J.+Mitchellauthor=D.+T.+Kimauthor=L.+Steinmanauthor=C.+G.+Fathmanauthor=J.+B.+Rothbard&title=Polyarginine+enters+cells+more+efficiently+than+other+polycationic+homopolymers&doi=10.1034%2Fj.1399-3011.2000.00723.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Polyarginine enters cells more efficiently than other polycationic homopolymers</span></div><div class="casAuthors">Mitchell, D. J.; Kim, D. T.; Steinman, L.; Fathman, C. G.; Rothbard, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">318-325</span>CODEN:
                <span class="NLM_cas:coden">JPERFA</span>;
        ISSN:<span class="NLM_cas:issn">1397-002X</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">Homopolymers or peptides contg. a high percentage of cationic amino acids have been shown to have a unique ability to cross the plasma membrane of cells, and consequently have been used to facilitate the uptake of a variety of biopolymers and small mols.  To investigate whether the polycationic character of these mols., or some other structural feature, was the mol. basis for the effect, the ability of a variety of homopolymers to enter cells was assayed by confocal microscopy and flow cytometry.  Polymers of L- or D-arginine contg. six or more amino acids entered cells far more effectively than polymers of equal length composed of lysine, ornithine and histidine.  Peptides of fewer than six amino acids were ineffective.  The length of the arginine side-chain could be varied without significant loss of activity.  These data combined with the inability of polymers of citrulline to enter cells demonstrated that the guanidine headgroup of arginine was the crit. structural component responsible for the biol. activity.  Cellular uptake could be inhibited by pre-incubation of the cells with sodium azide, but not by low temp. (3Â°C), indicating that the process was energy dependent, but did not involve endocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDvbyXtDgX0rVg90H21EOLACvtfcHk0lg5De_67SbRNw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVGltbY%253D&md5=f17351640273d66473f3a2f5e70e2f09</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1034%2Fj.1399-3011.2000.00723.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1399-3011.2000.00723.x%26sid%3Dliteratum%253Aachs%26aulast%3DMitchell%26aufirst%3DD.%2BJ.%26aulast%3DKim%26aufirst%3DD.%2BT.%26aulast%3DSteinman%26aufirst%3DL.%26aulast%3DFathman%26aufirst%3DC.%2BG.%26aulast%3DRothbard%26aufirst%3DJ.%2BB.%26atitle%3DPolyarginine%2520enters%2520cells%2520more%2520efficiently%2520than%2520other%2520polycationic%2520homopolymers%26jtitle%3DJ.%2520Pept.%2520Res.%26date%3D2000%26volume%3D56%26spage%3D318%26epage%3D325%26doi%3D10.1034%2Fj.1399-3011.2000.00723.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalafatovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giralt, E.</span></span> <span> </span><span class="NLM_article-title">Cell-penetrating peptides: design strategies beyond primary structure and amphipathicity</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1929</span>, <span class="refDoi">Â DOI: 10.3390/molecules22111929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.3390%2Fmolecules22111929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVGjtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1929&issue=11&author=D.+Kalafatovicauthor=E.+Giralt&title=Cell-penetrating+peptides%3A+design+strategies+beyond+primary+structure+and+amphipathicity&doi=10.3390%2Fmolecules22111929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-penetrating peptides: design strategies beyond primary structure and amphipathicity</span></div><div class="casAuthors">Kalafatovic, Daniela; Giralt, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1929/1-1929/38</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Efficient intracellular drug delivery and target specificity are often hampered by the presence of biol. barriers.  Thus, compds. that efficiently cross cell membranes are the key to improving the therapeutic value and on-target specificity of non-permeable drugs.  The discovery of cell-penetrating peptides (CPPs) and the early design approaches through mimicking the natural penetration domains used by viruses have led to greater efficiency of intracellular delivery.  Following these nature-inspired examples, a no. of rationally designed CPPs has been developed.  In this review, a variety of CPP designs will be described, including linear and flexible, pos. charged and often amphipathic CPPs, and more rigid versions comprising cyclic, stapled, or dimeric and/or multivalent, self-assembled peptides or peptido-mimetics.  The application of distinct design strategies to known physico-chem. properties of CPPs offers the opportunity to improve their penetration efficiency and/or internalization kinetics.  This led to increased design complexity of new CPPs that does not always result in greater CPP activity.  Therefore, the transition of CPPs to a clin. setting remains a challenge also due to the concomitant involvement of various internalization routes and heterogeneity of cells used in the in vitro studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXVMiu0WvRi7Vg90H21EOLACvtfcHk0lg5De_67SbRNw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVGjtrY%253D&md5=cde796080669da1abb1bd06fd1ed57a5</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22111929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22111929%26sid%3Dliteratum%253Aachs%26aulast%3DKalafatovic%26aufirst%3DD.%26aulast%3DGiralt%26aufirst%3DE.%26atitle%3DCell-penetrating%2520peptides%253A%2520design%2520strategies%2520beyond%2520primary%2520structure%2520and%2520amphipathicity%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26issue%3D11%26spage%3D1929%26doi%3D10.3390%2Fmolecules22111929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Multifunctional pH-sensitive micelles for tumor-specific uptake and cellular delivery</span>. <i>Polym. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1373</span>â <span class="NLM_lpage">1382</span>, <span class="refDoi">Â DOI: 10.1039/C4PY01403K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC4PY01403K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSitr7N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1373-1382&author=T.+Yangauthor=F.+Liauthor=H.+Zhangauthor=L.+Fanauthor=Y.+Qiaoauthor=G.+Tanauthor=H.+Zhangauthor=H.+Wu&title=Multifunctional+pH-sensitive+micelles+for+tumor-specific+uptake+and+cellular+delivery&doi=10.1039%2FC4PY01403K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional pH-sensitive micelles for tumor-specific uptake and cellular delivery</span></div><div class="casAuthors">Yang, Tiehong; Li, Fei; Zhang, Haitao; Fan, Li; Qiao, Youbei; Tan, Guangguo; Zhang, Haifei; Wu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Polymer Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1373-1382</span>CODEN:
                <span class="NLM_cas:coden">PCOHC2</span>;
        ISSN:<span class="NLM_cas:issn">1759-9962</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The distinct ability of cell-penetrating peptides (CPPs) has led to the development of novel drug delivery methods in human cells for therapeutic purposes.  The lack of specific selectivity is a main obstacle to the widespread use of CPPs.  A novel delivery method based on acid-sensitive micelles used for the introduction and protection of TAT was developed.  Doxorubicin-TAT conjugate (Dox-TAT) was loaded in the LH-releasing hormone modified poly (ethylene glycol)-poly (L-histidine)-doxorubicin (LHRH-PEG-PHIS-Dox) micelle.  Dox was chem. conjugated to the polymer backbone not only to improve the stability of micelles, but also to increase the drug loading efficiency of the micelle.  These micelles could dissoc. the responding tumor extracellular pHe and release Dox-TAT to pass directly through the cell membrane to the cytosol of the multidrug resistant cancer cells.  The undissociated micelles could also be actively internalized into the cells by receptor-mediated endocytosis, resulting in high cytotoxicity.  LHRH-PEG-PHIS-Dox/Dox-TAT showed the highest antitumor effects among the 4 treatment groups in vitro and vivo and showed no remarkable effect on the body wt. compared to the control.  This skillfully designed system combined the double functions of targeted delivery and TAT-mediated efficient entry, which could increase the antitumor activity, even in drug resistant tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopRWvv29el1rVg90H21EOLACvtfcHk0lg5De_67SbRNw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSitr7N&md5=d91fafa26fb6aadc18237183d3cea230</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1039%2FC4PY01403K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4PY01403K%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DMultifunctional%2520pH-sensitive%2520micelles%2520for%2520tumor-specific%2520uptake%2520and%2520cellular%2520delivery%26jtitle%3DPolym.%2520Chem.%26date%3D2015%26volume%3D6%26spage%3D1373%26epage%3D1382%26doi%3D10.1039%2FC4PY01403K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhunia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohapatra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span> <span> </span><span class="NLM_article-title">Spatial position regulates power of tryptophan: discovery of a major-groove-specific nuclear-localizing, cell-penetrating tetrapeptide</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">1697</span>â <span class="NLM_lpage">1714</span>, <span class="refDoi">Â DOI: 10.1021/jacs.7b10254</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b10254" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVCms73M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=1697-1714&author=D.+Bhuniaauthor=P.+Mondalauthor=G.+Dasauthor=A.+Sahaauthor=P.+Senguptaauthor=J.+Janaauthor=S.+Mohapatraauthor=S.+Chatterjeeauthor=S.+Ghosh&title=Spatial+position+regulates+power+of+tryptophan%3A+discovery+of+a+major-groove-specific+nuclear-localizing%2C+cell-penetrating+tetrapeptide&doi=10.1021%2Fjacs.7b10254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Spatial Position Regulates Power of Tryptophan: Discovery of a Major-Groove-Specific Nuclear-Localizing, Cell-Penetrating Tetrapeptide</span></div><div class="casAuthors">Bhunia, Debmalya; Mondal, Prasenjit; Das, Gaurav; Saha, Abhijit; Sengupta, Pallabi; Jana, Jagannath; Mohapatra, Saswat; Chatterjee, Subhrangsu; Ghosh, Surajit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1697-1714</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Identification of key amino acids is required for development of efficient cell-penetrating peptides (CPPs) and has tremendous implications in medicine.  Extensive research work has enlightened us about the importance of two amino acids, arginine and tryptophan, in cell penetration.  Here, we present a top-down approach to show how spatial positions of two tryptophan regulate the cellular entry and nuclear localization.  This enables us to develop short, non-toxic tetrapeptides with excellent potential for cell penetration and nuclear localization.  Among them, Glu-Thr-Trp-Trp (ETWW) emerges as the most promising.  Results suggest that it enters into cancer cells following an endocytic pathway and binds at the major groove of nuclear DNA, where successive tryptophan plays major role.  We subsequently show that it is not a P-glycoprotein substrate and is non-toxic to PC12-derived neurons, suggesting its excellent potential as a CPP.  Furthermore, its potential as a CPP is validated in multi-cellular 3D cell culture (spheroid) and in in vivo mice model.  This study provides major fundamental insights about the positional importance of tryptophan and opens new avenues toward the development of next-generation CPPs and major-groove-specific anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNpbOr7U6DZrVg90H21EOLACvtfcHk0lgUbixlWgaa1g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVCms73M&md5=6bf318f4ce47228b74c9325820424673</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b10254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b10254%26sid%3Dliteratum%253Aachs%26aulast%3DBhunia%26aufirst%3DD.%26aulast%3DMondal%26aufirst%3DP.%26aulast%3DDas%26aufirst%3DG.%26aulast%3DSaha%26aufirst%3DA.%26aulast%3DSengupta%26aufirst%3DP.%26aulast%3DJana%26aufirst%3DJ.%26aulast%3DMohapatra%26aufirst%3DS.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DS.%26atitle%3DSpatial%2520position%2520regulates%2520power%2520of%2520tryptophan%253A%2520discovery%2520of%2520a%2520major-groove-specific%2520nuclear-localizing%252C%2520cell-penetrating%2520tetrapeptide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26spage%3D1697%26epage%3D1714%26doi%3D10.1021%2Fjacs.7b10254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez-Berrocal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebel-Binay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebollo, A.</span></span> <span> </span><span class="NLM_article-title">New therapeutic approach for targeting Hippo signaling pathway</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">4771</span>, <span class="refDoi">Â DOI: 10.1038/s41598-019-41404-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fs41598-019-41404-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30886324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BB3cbls1aisg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=4771&issue=1&author=L.+Dominguez-Berrocalauthor=E.+Cirriauthor=X.+Zhangauthor=L.+Andriniauthor=G.+H.+Marinauthor=S.+Lebel-Binayauthor=A.+Rebollo&title=New+therapeutic+approach+for+targeting+Hippo+signaling+pathway&doi=10.1038%2Fs41598-019-41404-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">New Therapeutic Approach for Targeting Hippo Signalling Pathway</span></div><div class="casAuthors">Dominguez-Berrocal Leticia; Cirri Erica; Lebel-Binay Sophie; Zhang Xiguang; Rebollo Angelita; Andrini Laura; Marin Gustavo H</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4771</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nuclear localization signals are short amino acid sequences that target proteins for nuclear import.  In this manuscript, we have generated a chimeric tri-functional peptide composed of a cell penetrating peptide (CPP), a nuclear localization sequence and an interfering peptide blocking the interaction between TEAD and YAP, two transcription factors involved in the Hippo signalling pathway, whose deregulation is related to several types of cancer.  We have validated the cell penetration and nuclear localization by flow cytometry and fluorescence microscopy and shown that the new generated peptide displays an apoptotic effect in tumor cell lines thanks to the specific nuclear delivery of the cargo, which targets a protein/protein interaction in the nucleus.  In addition, the peptide has an anti-tumoral effect in vivo in xenograft models of breast cancer.  The chimeric peptide designed in the current study shows encouraging prospects for developing nuclear anti- neoplastic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0QQqyEO8ni6__Jf7-eMvJfW6udTcc2eYXTbGhqoHtJLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbls1aisg%253D%253D&md5=e5e3fe64f71051dcfa5607a2426f65fb</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-41404-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-41404-w%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez-Berrocal%26aufirst%3DL.%26aulast%3DCirri%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAndrini%26aufirst%3DL.%26aulast%3DMarin%26aufirst%3DG.%2BH.%26aulast%3DLebel-Binay%26aufirst%3DS.%26aulast%3DRebollo%26aufirst%3DA.%26atitle%3DNew%2520therapeutic%2520approach%2520for%2520targeting%2520Hippo%2520signaling%2520pathway%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D4771%26doi%3D10.1038%2Fs41598-019-41404-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Veiman, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mager, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurrikoff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arukuusk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhorutsenko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pooga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, Ã.</span></span> <span> </span><span class="NLM_article-title">PepFect14 peptide vector for efficient gene delivery in cell cultures</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">199</span>â <span class="NLM_lpage">210</span>, <span class="refDoi">Â DOI: 10.1021/mp3003557</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp3003557" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslemu7bP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=199-210&author=K.+L.+Veimanauthor=I.+Magerauthor=K.+Ezzatauthor=H.+Margusauthor=T.+Lehtoauthor=K.+Langelauthor=K.+Kurrikoffauthor=P.+Arukuuskauthor=J.+Suhorutsenkoauthor=K.+Padariauthor=M.+Poogaauthor=T.+Lehtoauthor=%C3%9C.+Langel&title=PepFect14+peptide+vector+for+efficient+gene+delivery+in+cell+cultures&doi=10.1021%2Fmp3003557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88aR"><div class="casContent"><span class="casTitleNuber">88a</span><div class="casTitle"><span class="NLM_cas:atitle">PepFect14 Peptide Vector for Efficient Gene Delivery in Cell Cultures</span></div><div class="casAuthors">Veiman, Kadi-Liis; Mager, Imre; Ezzat, Kariem; Margus, Helerin; Lehto, Tonis; Langel, Kent; Kurrikoff, Kaido; Arukuusk, Piret; Suhorutsenko, Julia; Padari, Kart; Pooga, Margus; Lehto, Taavi; Langel, Ulo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-210</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The successful applicability of gene therapy approaches will heavily rely on the development of efficient and safe nonviral gene delivery vectors, for example, cell-penetrating peptides (CPPs).  CPPs can condense oligonucleotides and plasmid DNA (pDNA) into nanoparticles, thus allowing the transfection of genetic material into cells.  However, despite few promising attempts, CPP-mediated pDNA delivery has been relatively inefficient due to the unfavorable nanoparticle characteristics or the nanoparticle entrapment to endocytic compartments.  In many cases, both of these drawbacks could be alleviated by modifying CPPs with a stearic acid residue, as demonstrated in the delivery of both the pDNA and the short oligonucleotides.  In this study, PepFect14 (PF14) peptide, previously used for the transport of shorter oligonucleotides, is demonstrated to be suited also for the delivery of pDNA.  It is shown that PF14 forms stable nanoparticles with pDNA with a neg. surface charge and size of around 130-170 nm.  These nanoparticles facilitate efficient gene delivery and expression in a variety of regular adherent cell lines and also in difficult-to-transfect primary cells.  Uptake studies indicate that PF14/pDNA nanoparticles are utilizing class A scavenger receptors (SCARA) and caveolae-mediated endocytosis as the main route for cellular internalization.  Conclusively, PF14 is an efficient nonviral vector for gene delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVJFF3VBLZIrVg90H21EOLACvtfcHk0lgUbixlWgaa1g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslemu7bP&md5=76ca152e87152d037613e228df76d4ba</span></div><a href="/servlet/linkout?suffix=cit88a&amp;dbid=16384&amp;doi=10.1021%2Fmp3003557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp3003557%26sid%3Dliteratum%253Aachs%26aulast%3DVeiman%26aufirst%3DK.%2BL.%26aulast%3DMager%26aufirst%3DI.%26aulast%3DEzzat%26aufirst%3DK.%26aulast%3DMargus%26aufirst%3DH.%26aulast%3DLehto%26aufirst%3DT.%26aulast%3DLangel%26aufirst%3DK.%26aulast%3DKurrikoff%26aufirst%3DK.%26aulast%3DArukuusk%26aufirst%3DP.%26aulast%3DSuhorutsenko%26aufirst%3DJ.%26aulast%3DPadari%26aufirst%3DK.%26aulast%3DPooga%26aufirst%3DM.%26aulast%3DLehto%26aufirst%3DT.%26aulast%3DLangel%26aufirst%3D%25C3%259C.%26atitle%3DPepFect14%2520peptide%2520vector%2520for%2520efficient%2520gene%2520delivery%2520in%2520cell%2520cultures%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D199%26epage%3D210%26doi%3D10.1021%2Fmp3003557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit88b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Andaloussi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaghloul, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magdy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guterstam, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sillard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arzumanov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gait, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HÃ¤llbrink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, Ã.</span></span> <span> </span><span class="NLM_article-title">PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5284</span>â <span class="NLM_lpage">5298</span>, <span class="refDoi">Â DOI: 10.1093/nar/gkr072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1093%2Fnar%2Fgkr072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=21345932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslOgtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=5284-5298&issue=12&author=K.+Ezzatauthor=S.+El+Andaloussiauthor=E.+M.+Zaghloulauthor=T.+Lehtoauthor=S.+Lindbergauthor=P.+M.+Morenoauthor=J.+R.+Violaauthor=T.+Magdyauthor=R.+Abdoauthor=P.+Guterstamauthor=R.+Sillardauthor=S.+M.+Hammondauthor=M.+J.+Woodauthor=A.+A.+Arzumanovauthor=M.+J.+Gaitauthor=C.+I.+Smithauthor=M.+H%C3%A4llbrinkauthor=%C3%9C.+Langel&title=PepFect+14%2C+a+novel+cell-penetrating+peptide+for+oligonucleotide+delivery+in+solution+and+as+solid+formulation&doi=10.1093%2Fnar%2Fgkr072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88bR"><div class="casContent"><span class="casTitleNuber">88b</span><div class="casTitle"><span class="NLM_cas:atitle">PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation</span></div><div class="casAuthors">Ezzat, Kariem; El Andaloussi, Samir; Zaghloul, Eman M.; Lehto, Taavi; Lindberg, Staffan; Moreno, Pedro M. D.; Viola, Joana R.; Magdy, Tarek; Abdo, Rania; Guterstam, Peter; Sillard, Rannar; Hammond, Suzan M.; Wood, Matthew J. A.; Arzumanov, Andrey A.; Gait, Michael J.; Smith, C. I. Edvard; Haellbrink, Mattias; Langel, Uelo</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5284-5298</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Numerous human genetic diseases are caused by mutations that give rise to aberrant alternative splicing.  Recently, several of these debilitating disorders have been shown to be amenable for splice-correcting oligonucleotides (SCOs) that modify splicing patterns and restore the phenotype in exptl. models.  However, translational approaches are required to transform SCOs into usable drug products.  In this study, we present a new cell-penetrating peptide, PepFect14 (PF14), which efficiently delivers SCOs to different cell models including HeLa pLuc705 and mdx mouse myotubes; a cell culture model of Duchenne's muscular dystrophy (DMD).  Non-covalent PF14-SCO nanocomplexes induce splice-correction at rates higher than the com. available lipid-based vector Lipofectamine 2000 (LF2000) and remain active in the presence of serum.  Furthermore, we demonstrate the feasibility of incorporating this delivery system into solid formulations that could be suitable for several therapeutic applications.  Solid dispersion technique is utilized and the formed solid formulations are as active as the freshly prepd. nanocomplexes in soln. even when stored at an elevated temps. for several weeks.  In contrast, LF2000 drastically loses activity after being subjected to same procedure.  This shows that using PF14 is a very promising translational approach for the delivery of SCOs in different pharmaceutical forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoamzA5Sq7uFrVg90H21EOLACvtfcHk0lhgZfeqFn5fMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslOgtbw%253D&md5=64e66305efb772c25386977d53802340</span></div><a href="/servlet/linkout?suffix=cit88b&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkr072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkr072%26sid%3Dliteratum%253Aachs%26aulast%3DEzzat%26aufirst%3DK.%26aulast%3DEl%2BAndaloussi%26aufirst%3DS.%26aulast%3DZaghloul%26aufirst%3DE.%2BM.%26aulast%3DLehto%26aufirst%3DT.%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DMoreno%26aufirst%3DP.%2BM.%26aulast%3DViola%26aufirst%3DJ.%2BR.%26aulast%3DMagdy%26aufirst%3DT.%26aulast%3DAbdo%26aufirst%3DR.%26aulast%3DGuterstam%26aufirst%3DP.%26aulast%3DSillard%26aufirst%3DR.%26aulast%3DHammond%26aufirst%3DS.%2BM.%26aulast%3DWood%26aufirst%3DM.%2BJ.%26aulast%3DArzumanov%26aufirst%3DA.%2BA.%26aulast%3DGait%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BI.%26aulast%3DH%25C3%25A4llbrink%26aufirst%3DM.%26aulast%3DLangel%26aufirst%3D%25C3%259C.%26atitle%3DPepFect%252014%252C%2520a%2520novel%2520cell-penetrating%2520peptide%2520for%2520oligonucleotide%2520delivery%2520in%2520solution%2520and%2520as%2520solid%2520formulation%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26issue%3D12%26spage%3D5284%26epage%3D5298%26doi%3D10.1093%2Fnar%2Fgkr072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmfors, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudoran, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juks, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Andaloussi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pooga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1172</span>â <span class="NLM_lpage">1180</span>, <span class="refDoi">Â DOI: 10.1096/fj.11-191536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1096%2Ffj.11-191536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22138034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt12ntLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1172-1180&author=K.+Ezzatauthor=H.+Helmforsauthor=O.+Tudoranauthor=C.+Juksauthor=S.+Lindbergauthor=K.+Padariauthor=S.+El-Andaloussiauthor=M.+Poogaauthor=U.+Langel&title=Scavenger+receptor-mediated+uptake+of+cell-penetrating+peptide+nanocomplexes+with+oligonucleotides&doi=10.1096%2Ffj.11-191536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89aR"><div class="casContent"><span class="casTitleNuber">89a</span><div class="casTitle"><span class="NLM_cas:atitle">Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides</span></div><div class="casAuthors">Ezzat, Kariem; Helmfors, Henrik; Tudoran, Oana; Juks, Carmen; Lindberg, Staffan; Padari, Kaert; El-Andaloussi, Samir; Pooga, Margus; Langel, Ulo</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1172-1180, 10.1096/fj.11-191536</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Cell-penetrating peptides (CPPs) are short cationic peptides that penetrate cells by interacting with the neg. charged plasma membrane; however, the detailed uptake mechanism is not clear.  In contrary to the conventional mode of action of CPPs, we show here that a CPP, PepFect14 (PF14), forms neg. charged nanocomplexes with oligonucleotides and their uptake is mediated by class-A scavenger receptors (SCARAs).  Specific inhibitory ligands of SCARAs, such as fucoidin, polyinosinic acid, and dextran sulfate, totally inhibit the activity of PF14-oligonucleotide nanocomplexes in the HeLa pLuc705 splice-correction cell model, while nonspecific, chem. related mols. do not.  Furthermore, RNA interference (RNAi) knockdown of SCARA subtypes (SCARA3 and SCARA5) that are expressed in this cell line led to a significant redn. of the activity to <50%.  In line with this, immunostaining shows prevalent colocalization of the nanocomplexes with the receptors, and electron microscopy images show no binding or internalization of the nanocomplexes in the presence of the inhibitory ligands.  Interestingly, naked oligonucleotides also colocalize with SCARAs when used at high concns.  These results demonstrate the involvement of SCARA3 and SCARA5 in the uptake of PF14-oligonucleotide nanocomplexes and suggest for the first time that some CPP-based systems function through scavenger receptors, which could yield novel possibilities to understand and improve the transfection by CPPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8-lZu5xJLF7Vg90H21EOLACvtfcHk0lhgZfeqFn5fMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt12ntLg%253D&md5=552bb91ce3e35694a212893d5d12ea34</span></div><a href="/servlet/linkout?suffix=cit89a&amp;dbid=16384&amp;doi=10.1096%2Ffj.11-191536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.11-191536%26sid%3Dliteratum%253Aachs%26aulast%3DEzzat%26aufirst%3DK.%26aulast%3DHelmfors%26aufirst%3DH.%26aulast%3DTudoran%26aufirst%3DO.%26aulast%3DJuks%26aufirst%3DC.%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DPadari%26aufirst%3DK.%26aulast%3DEl-Andaloussi%26aufirst%3DS.%26aulast%3DPooga%26aufirst%3DM.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DScavenger%2520receptor-mediated%2520uptake%2520of%2520cell-penetrating%2520peptide%2520nanocomplexes%2520with%2520oligonucleotides%26jtitle%3DFASEB%2520J.%26date%3D2012%26volume%3D26%26spage%3D1172%26epage%3D1180%26doi%3D10.1096%2Ffj.11-191536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit89b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MuÃ±oz-AlarcÃ³n, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmfors, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosqueira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyllborg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudoran, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>441</i></span>,  <span class="NLM_fpage">242</span>â <span class="NLM_lpage">247</span>, <span class="refDoi">Â DOI: 10.1016/j.ijpharm.2012.11.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.ijpharm.2012.11.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23200958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVWju7zO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2013&pages=242-247&author=S.+Lindbergauthor=A.+Mu%C3%B1oz-Alarc%C3%B3nauthor=H.+Helmforsauthor=D.+Mosqueiraauthor=D.+Gyllborgauthor=O.+Tudoranauthor=U.+Langel&title=PepFect15%2C+a+novel+endosomolytic+cell-penetrating+peptide+for+oligonucleotide+delivery+via+scavenger+receptors&doi=10.1016%2Fj.ijpharm.2012.11.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89bR"><div class="casContent"><span class="casTitleNuber">89b</span><div class="casTitle"><span class="NLM_cas:atitle">PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors</span></div><div class="casAuthors">Lindberg, Staffan; Munoz-Alarcon, Andres; Helmfors, Henrik; Mosqueira, Diogo; Gyllborg, Daniel; Tudoran, Oana; Langel, Ulo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">441</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">242-247</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Gene-regulatory biomols. such as splice-correcting oligonucleotides and anti-microRNA oligonucleotides are important tools in the struggle to understand and treat genetic disorders caused by defective gene expression or aberrant splicing.  However, oligonucleotides generally suffer from low bioavailability, hence requiring efficient and non-toxic delivery vectors to reach their targets.  Cell-penetrating peptides constitute a promising category of carrier mols. for intracellular delivery of bioactive cargo.  In this study we present a novel cell-penetrating peptide, PepFect15, comprising the previously reported PepFect14 peptide modified with endosomolytic trifluoromethylquinoline moieties to facilitate endosomal escape.  Pepfect15 efficiently delivers both splice-correcting oligonucleotides and anti-microRNA oligonucleotides into cells through a non-covalent complexation strategy.  To our knowledge this is the first work that describes peptide-mediated anti-microRNA delivery.  The peptide and its cargo form stable, neg. charged nanoparticles that are taken up by cells largely through scavenger receptor type A mediated endocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdGDuD_mlcKLVg90H21EOLACvtfcHk0lhgZfeqFn5fMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVWju7zO&md5=e6a081f1ee6e2d46c0f15027c8c62cf1</span></div><a href="/servlet/linkout?suffix=cit89b&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2012.11.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2012.11.037%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DMu%25C3%25B1oz-Alarc%25C3%25B3n%26aufirst%3DA.%26aulast%3DHelmfors%26aufirst%3DH.%26aulast%3DMosqueira%26aufirst%3DD.%26aulast%3DGyllborg%26aufirst%3DD.%26aulast%3DTudoran%26aufirst%3DO.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DPepFect15%252C%2520a%2520novel%2520endosomolytic%2520cell-penetrating%2520peptide%2520for%2520oligonucleotide%2520delivery%2520via%2520scavenger%2520receptors%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2013%26volume%3D441%26spage%3D242%26epage%3D247%26doi%3D10.1016%2Fj.ijpharm.2012.11.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmfors, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Alarcon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srimanee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">A convergent uptake route for peptide- and polymer-based nucleotide delivery systems</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>206</i></span>,  <span class="NLM_fpage">58</span>â <span class="NLM_lpage">66</span>, <span class="refDoi">Â DOI: 10.1016/j.jconrel.2015.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.jconrel.2015.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25769688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVahu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2015&pages=58-66&author=S.+Lindbergauthor=J.+Regbergauthor=J.+Erikssonauthor=H.+Helmforsauthor=A.+Munoz-Alarconauthor=A.+Srimaneeauthor=R.+A.+Figueroaauthor=E.+Hallbergauthor=K.+Ezzatauthor=U.+Langel&title=A+convergent+uptake+route+for+peptide-+and+polymer-based+nucleotide+delivery+systems&doi=10.1016%2Fj.jconrel.2015.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">A convergent uptake route for peptide- and polymer-based nucleotide delivery systems</span></div><div class="casAuthors">Lindberg, Staffan; Regberg, Jakob; Eriksson, Jonas; Helmfors, Henrik; Munoz-Alarcon, Andres; Srimanee, Artita; Figueroa, Ricardo A.; Hallberg, Einar; Ezzat, Kariem; Langel, Ulo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">58-66</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cell-penetrating peptides (CPPs) have been used as vehicles to deliver various cargos into cells and are promising as tools to deliver therapeutic biomols. such as oligonucleotides both in vitro and in vivo.  CPPs are pos. charged and it is believed that CPPs deliver their cargo in a receptor-independent manner by interacting with the neg. charged plasma membrane and thereby inducing endocytosis.  In this study we examine the mechanism of uptake of several different, well known, CPPs that form complexes with oligonucleotides.  We show that these CPP:oligonucleotide complexes are neg. charged in transfection-media and their uptake is mediated by class A scavenger receptors (SCARA).  These receptors are known to promiscuously bind to, and mediate uptake of poly-anionic macromols.  Uptake of CPP:oligonucleotide complexes was abolished using pharmacol. SCARA inhibitors as well as siRNA-mediated knockdown of SCARA.  Addnl., uptake of CPP:oligonucleotide was significantly increased by transiently overexpressing SCARA.  Furthermore, SCARA inhibitors also blocked internalization of cationic polymer:oligonucleotide complexes.  Our results demonstrate that the previous held belief that CPPs act receptor independently does not hold true for CPP:oligonucleotide complexes, as scavenger receptor class A (SCARA) mediates the uptake of all the examd. CPP:oligonucleotide complexes in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI3Fl4rEfn7rVg90H21EOLACvtfcHk0lhl8Owejcr2RQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVahu7o%253D&md5=1c1a1e52b01f8a47087b18518e5e7654</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2015.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2015.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DRegberg%26aufirst%3DJ.%26aulast%3DEriksson%26aufirst%3DJ.%26aulast%3DHelmfors%26aufirst%3DH.%26aulast%3DMunoz-Alarcon%26aufirst%3DA.%26aulast%3DSrimanee%26aufirst%3DA.%26aulast%3DFigueroa%26aufirst%3DR.%2BA.%26aulast%3DHallberg%26aufirst%3DE.%26aulast%3DEzzat%26aufirst%3DK.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DA%2520convergent%2520uptake%2520route%2520for%2520peptide-%2520and%2520polymer-based%2520nucleotide%2520delivery%2520systems%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2015%26volume%3D206%26spage%3D58%26epage%3D66%26doi%3D10.1016%2Fj.jconrel.2015.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Craig, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuckey, N. W.</span></span> <span> </span><span class="NLM_article-title">Attenuation of neuronal death by peptide inhibitors of AP-1 activation in acute and delayed in vitro ischaemia (oxygen/glucose deprivation) models</span>. <i>Int. J. Pept. Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">6</span>, <span class="refDoi">Â DOI: 10.1007/s10989-010-9234-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs10989-010-9234-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKltbzE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1-6&author=A.+J.+Craigauthor=B.+P.+Meloniauthor=P.+M.+Wattauthor=N.+W.+Knuckey&title=Attenuation+of+neuronal+death+by+peptide+inhibitors+of+AP-1+activation+in+acute+and+delayed+in+vitro+ischaemia+%28oxygen%2Fglucose+deprivation%29+models&doi=10.1007%2Fs10989-010-9234-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of Neuronal Death by Peptide Inhibitors of AP-1 Activation in Acute and Delayed In Vitro Ischaemia (Oxygen/Glucose Deprivation) Models</span></div><div class="casAuthors">Craig, Amanda J.; Meloni, Bruno P.; Watt, Paul; Knuckey, Neville W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Peptide Research and Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">IJPRFC</span>;
        ISSN:<span class="NLM_cas:issn">1573-3149</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Using acute and delayed in vitro ischemia models we evaluated the neuroprotective efficacy of five peptides (PYC19D-TAT, PYC35D-TAT, PYC36D-TAT, PYC38D-TAT, PYC41D-TAT) previously demonstrated to down-regulate AP-1 activation (e.g. c-Jun/c-Fos activation), and inhibit neuronal death in vitro following glutamate and kainic acid excitotoxicity.  The JNK inhibitor peptide (JNKI-1D-TAT) and the TAT cell-penetrating-carrier peptide (D-TAT) were used as controls.  In the acute model, all five AP-1 inhibitory peptides, JNKI-1D-TAT, and D-TAT provided neuroprotection by increasing neuronal viability from â5 to 23-53%.  In the delayed model, three of the five AP-1 inhibitory peptides (PYC35D-TAT, PYC36D-TAT, PYC38D-TAT) and JNKI-1D-TAT provided neuroprotection by increasing neuronal viability from â10 to 35-80%.  This study not only highlights a group of peptides with therapeutic potential, but also the need to assess putative therapeutics in multiple in vitro models to achieve a comprehensive representation of their neuroprotective capacity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXA0B2gepsjrVg90H21EOLACvtfcHk0lhl8Owejcr2RQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKltbzE&md5=b311025351457862bdd1f74a3336ff58</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1007%2Fs10989-010-9234-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10989-010-9234-8%26sid%3Dliteratum%253Aachs%26aulast%3DCraig%26aufirst%3DA.%2BJ.%26aulast%3DMeloni%26aufirst%3DB.%2BP.%26aulast%3DWatt%26aufirst%3DP.%2BM.%26aulast%3DKnuckey%26aufirst%3DN.%2BW.%26atitle%3DAttenuation%2520of%2520neuronal%2520death%2520by%2520peptide%2520inhibitors%2520of%2520AP-1%2520activation%2520in%2520acute%2520and%2520delayed%2520in%2520vitro%2520ischaemia%2520%2528oxygen%252Fglucose%2520deprivation%2529%2520models%26jtitle%3DInt.%2520J.%2520Pept.%2520Res.%2520Ther.%26date%3D2011%26volume%3D17%26spage%3D1%26epage%3D6%26doi%3D10.1007%2Fs10989-010-9234-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaslin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puyal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. G.</span></span> <span> </span><span class="NLM_article-title">Excitotoxicity-induced endocytosis confers drug targeting in cerebral ischemia</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">337</span>â <span class="NLM_lpage">347</span>, <span class="refDoi">Â DOI: 10.1002/ana.21584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fana.21584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=19334077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BD1M3lvVCjtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=337-347&author=A.+Vaslinauthor=J.+Puyalauthor=P.+G.+Clarke&title=Excitotoxicity-induced+endocytosis+confers+drug+targeting+in+cerebral+ischemia&doi=10.1002%2Fana.21584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Excitotoxicity-induced endocytosis confers drug targeting in cerebral ischemia</span></div><div class="casAuthors">Vaslin Anne; Puyal Julien; Clarke Peter G H</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">337-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Targeting neuroprotectants specifically to the cells that need them is a major goal in biomedical research.  Many peptidic protectants contain an active sequence linked to a carrier such as the transactivator of transcription (TAT) transduction sequence, and here we test the hypothesis that TAT-linked peptides are selectively endocytosed into neurons stressed by excitotoxicity and focal cerebral ischemia.  METHODS:  In vivo experiments involved intracerebroventricular injection of TAT peptides or conventional tracers (peroxidase, fluorescein isothiocyanate-dextran) in young rats exposed to occlusion of the middle cerebral artery at postnatal day 12.  Cellular mechanisms of uptake were analyzed in dissociated cortical neuronal cultures.  RESULTS:  In both models, all tracers were taken up selectively into stressed neurons by endocytosis.  In the in vivo model, this was neuron specific and limited to the ischemic area, where the neurons displayed enhanced immunolabeling for early endosomal antigen-1 and clathrin.  The highly efficient uptake of TAT peptides occurred by the same selective mechanism as for conventional tracers.  All tracers were targeted to the nucleus and cytoplasm of neurons that appeared viable, although ultimately destined to die.  In dissociated cortical neuronal cultures, an excitotoxic dose of N-methyl-D-aspartate induced a similar endocytosis.  It was 100 times more efficient with TAT peptides than with dextran, because the former bound to heparan sulfate proteoglycans at the cell surface, but it depended on dynamin and clathrin in both cases.  INTERPRETATION:  Excitotoxicity-induced endocytosis is the main entry route for protective TAT peptides and targets selectively the neurons that need to be protected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBbvFEgSBPZbqxQ2mb9Pu8fW6udTcc2eYtlqJFgS4b_bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3lvVCjtQ%253D%253D&md5=2e3666075098f275fcd6d2c35f42ba80</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2Fana.21584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21584%26sid%3Dliteratum%253Aachs%26aulast%3DVaslin%26aufirst%3DA.%26aulast%3DPuyal%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DP.%2BG.%26atitle%3DExcitotoxicity-induced%2520endocytosis%2520confers%2520drug%2520targeting%2520in%2520cerebral%2520ischemia%26jtitle%3DAnn.%2520Neurol.%26date%3D2009%26volume%3D65%26spage%3D337%26epage%3D347%26doi%3D10.1002%2Fana.21584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookes, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuckey, N. W.</span></span> <span> </span><span class="NLM_article-title">Poly-arginine and arginine-rich peptides are neuroprotective in stroke models</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">993</span>â <span class="NLM_lpage">1004</span>, <span class="refDoi">Â DOI: 10.1038/jcbfm.2015.11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fjcbfm.2015.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25669902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVyjt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=993-1004&author=B.+P.+Meloniauthor=L.+M.+Brookesauthor=V.+W.+Clarkauthor=J.+L.+Crossauthor=A.+B.+Edwardsauthor=R.+S.+Andertonauthor=R.+M.+Hopkinsauthor=K.+Hoffmannauthor=N.+W.+Knuckey&title=Poly-arginine+and+arginine-rich+peptides+are+neuroprotective+in+stroke+models&doi=10.1038%2Fjcbfm.2015.11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Poly-arginine and arginine-rich peptides are neuroprotective in stroke models</span></div><div class="casAuthors">Meloni, Bruno P.; Brookes, Laura M.; Clark, Vince W.; Cross, Jane L.; Edwards, Adam B.; Anderton, Ryan S.; Hopkins, Richard M.; Hoffmann, Katrin; Knuckey, Neville W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">993-1004</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Using cortical neuron18al cultures and glutamic acid excitotoxicity and oxygen-glucose deprivation (OGD) stroke models, we demonstrated that poly-arginine and arginine-rich cell-penetrating peptides (CPPs), are highly neuroprotective, with efficacy increasing with increasing arginine content, have the capacity to reduce glutamic acid-induced neuronal calcium influx and require heparan sulfate preotoglycan-mediated endocytosis to induce a neuroprotective effect.  Furthermore, neuroprotection could be induced with immediate peptide treatment or treatment up to 2 to 4 h before glutamic acid excitotoxicity or OGD, and with poly-arginine-9 (R9) when administered i.v. after stroke onset in a rat model.  In contrast, the JNKI-1 peptide when fused to the (non-arginine) kFGF CPP, which does not rely on endocytosis for uptake, was not neuroprotective in the glutamic acid model; the kFGF peptide was also ineffective.  Similarly, pos. charged poly-lysine-10 (K10) and R9 fused to the neg. charged poly-glutamic acid-9 (E9) peptide (R9/E9) displayed minimal neuroprotection after excitotoxicity.  These results indicate that peptide pos. charge and arginine residues are crit. for neuroprotection, and have led us to hypothesize that peptide-induced endocytic internalization of ion channels is a potential mechanism of action.  The findings also question the mode of action of different neuroprotective peptides fused to arginine-rich CPPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVDmEy49zKrVg90H21EOLACvtfcHk0lhCSUaDdY4wRA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVyjt7g%253D&md5=bc6817a13ec5b3982e609ec93bcc924c</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2015.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2015.11%26sid%3Dliteratum%253Aachs%26aulast%3DMeloni%26aufirst%3DB.%2BP.%26aulast%3DBrookes%26aufirst%3DL.%2BM.%26aulast%3DClark%26aufirst%3DV.%2BW.%26aulast%3DCross%26aufirst%3DJ.%2BL.%26aulast%3DEdwards%26aufirst%3DA.%2BB.%26aulast%3DAnderton%26aufirst%3DR.%2BS.%26aulast%3DHopkins%26aufirst%3DR.%2BM.%26aulast%3DHoffmann%26aufirst%3DK.%26aulast%3DKnuckey%26aufirst%3DN.%2BW.%26atitle%3DPoly-arginine%2520and%2520arginine-rich%2520peptides%2520are%2520neuroprotective%2520in%2520stroke%2520models%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2015%26volume%3D35%26spage%3D993%26epage%3D1004%26doi%3D10.1038%2Fjcbfm.2015.11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cregg, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePaul, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyck, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madalena, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimi-Abdolrezaee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, J.</span></span> <span> </span><span class="NLM_article-title">Modulation of the proteoglycan receptor PTPÏ promotes recovery after spinal cord injury</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>518</i></span>,  <span class="NLM_fpage">404</span>â <span class="NLM_lpage">408</span>, <span class="refDoi">Â DOI: 10.1038/nature13974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnature13974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25470046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFamsrfM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=518&publication_year=2015&pages=404-408&author=B.+T.+Langauthor=J.+M.+Creggauthor=M.+A.+DePaulauthor=A.+P.+Tranauthor=K.+Xuauthor=S.+M.+Dyckauthor=K.+M.+Madalenaauthor=B.+P.+Brownauthor=Y.+L.+Wengauthor=S.+Liauthor=S.+Karimi-Abdolrezaeeauthor=S.+A.+Buschauthor=Y.+Shenauthor=J.+Silver&title=Modulation+of+the+proteoglycan+receptor+PTP%CF%83+promotes+recovery+after+spinal+cord+injury&doi=10.1038%2Fnature13974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the proteoglycan receptor PTPÏ promotes recovery after spinal cord injury</span></div><div class="casAuthors">Lang, Bradley T.; Cregg, Jared M.; DePaul, Marc A.; Tran, Amanda P.; Xu, Kui; Dyck, Scott M.; Madalena, Kathryn M.; Brown, Benjamin P.; Weng, Yi-Lan; Li, Shuxin; Karimi-Abdolrezaee, Soheila; Busch, Sarah A.; Shen, Yingjie; Silver, Jerry</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">518</span>
        (<span class="NLM_cas:issue">7539</span>),
    <span class="NLM_cas:pages">404-408</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Contusive spinal cord injury leads to a variety of disabilities owing to limited neuronal regeneration and functional plasticity.  It is well established that an upregulation of glial-derived chondroitin sulfate proteoglycans (CSPGs) within the glial scar and perineuronal net creates a barrier to axonal regrowth and sprouting.  Protein tyrosine phosphatase Ï (PTPÏ), along with its sister phosphatase leukocyte common antigen-related (LAR) and the nogo receptors 1 and 3 (NgR), have recently been identified as receptors for the inhibitory glycosylated side chains of CSPGs.  Here we find in rats that PTPÏ has a crit. role in converting growth cones into a dystrophic state by tightly stabilizing them within CSPG-rich substrates.  We generated a membrane-permeable peptide mimetic of the PTPÏ wedge domain that binds to PTPÏ and relieves CSPG-mediated inhibition.  Systemic delivery of this peptide over weeks restored substantial serotonergic innervation to the spinal cord below the level of injury and facilitated functional recovery of both locomotor and urinary systems.  Our results add a new layer of understanding to the crit. role of PTPÏ in mediating the growth-inhibited state of neurons due to CSPGs within the injured adult spinal cord.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRJw9YvZignrVg90H21EOLACvtfcHk0lhCSUaDdY4wRA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFamsrfM&md5=b1576e037194831e9d65889f31b85808</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fnature13974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13974%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DB.%2BT.%26aulast%3DCregg%26aufirst%3DJ.%2BM.%26aulast%3DDePaul%26aufirst%3DM.%2BA.%26aulast%3DTran%26aufirst%3DA.%2BP.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DDyck%26aufirst%3DS.%2BM.%26aulast%3DMadalena%26aufirst%3DK.%2BM.%26aulast%3DBrown%26aufirst%3DB.%2BP.%26aulast%3DWeng%26aufirst%3DY.%2BL.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DKarimi-Abdolrezaee%26aufirst%3DS.%26aulast%3DBusch%26aufirst%3DS.%2BA.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSilver%26aufirst%3DJ.%26atitle%3DModulation%2520of%2520the%2520proteoglycan%2520receptor%2520PTP%25CF%2583%2520promotes%2520recovery%2520after%2520spinal%2520cord%2520injury%26jtitle%3DNature%26date%3D2015%26volume%3D518%26spage%3D404%26epage%3D408%26doi%3D10.1038%2Fnature13974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wadia, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stan, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, S. F.</span></span> <span> </span><span class="NLM_article-title">Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">310</span>â <span class="NLM_lpage">315</span>, <span class="refDoi">Â DOI: 10.1038/nm996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnm996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=14770178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Wnurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=310-315&author=J.+S.+Wadiaauthor=R.+V.+Stanauthor=S.+F.+Dowdy&title=Transducible+TAT-HA+fusogenic+peptide+enhances+escape+of+TAT-fusion+proteins+after+lipid+raft+macropinocytosis&doi=10.1038%2Fnm996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis</span></div><div class="casAuthors">Wadia, Jehangir S.; Stan, Radu V.; Dowdy, Steven F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">310-315</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The TAT protein transduction domain (PTD) has been used to deliver a wide variety of biol. active cargo for the treatment of multiple preclin. disease models, including cancer and stroke.  However, the mechanism of transduction remains unknown.  Because of the TAT PTD's strong cell-surface binding, early assumptions regarding cellular uptake suggested a direct penetration mechanism across the lipid bilayer by a temp.- and energy-independent process.  Here we show, using a transducible TAT-Cre recombinase reporter assay on live cells, that after an initial ionic cell-surface interaction, TAT-fusion proteins are rapidly internalized by lipid raft-dependent macropinocytosis.  Transduction was independent of interleukin-2 receptor/raft-, caveolar- and clathrin-mediated endocytosis and phagocytosis.  Using this information, we developed a transducible, pH-sensitive, fusogenic dTAT-HA2 peptide that markedly enhanced TAT-Cre escape from macropinosomes.  Taken together, these observations provide a scientific basis for the development of new, biol. active, transducible therapeutic mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaAe03bmoBfLVg90H21EOLACvtfcHk0ljuDIidye0bgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Wnurg%253D&md5=e0ec3c1addca9481feb438cf564045cc</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1038%2Fnm996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm996%26sid%3Dliteratum%253Aachs%26aulast%3DWadia%26aufirst%3DJ.%2BS.%26aulast%3DStan%26aufirst%3DR.%2BV.%26aulast%3DDowdy%26aufirst%3DS.%2BF.%26atitle%3DTransducible%2520TAT-HA%2520fusogenic%2520peptide%2520enhances%2520escape%2520of%2520TAT-fusion%2520proteins%2520after%2520lipid%2520raft%2520macropinocytosis%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D310%26epage%3D315%26doi%3D10.1038%2Fnm996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richard, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melikov, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prevot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebleu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernomordik, L. V.</span></span> <span> </span><span class="NLM_article-title">Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">15300</span>â <span class="NLM_lpage">15306</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M401604200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1074%2Fjbc.M401604200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=15687490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFSltL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=15300-15306&author=J.+P.+Richardauthor=K.+Melikovauthor=H.+Brooksauthor=P.+Prevotauthor=B.+Lebleuauthor=L.+V.+Chernomordik&title=Cellular+uptake+of+unconjugated+TAT+peptide+involves+clathrin-dependent+endocytosis+and+heparan+sulfate+receptors&doi=10.1074%2Fjbc.M401604200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors</span></div><div class="casAuthors">Richard, Jean Philippe; Melikov, Kamran; Brooks, Hilary; Prevot, Paul; Lebleu, Bernard; Chernomordik, Leonid V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">15300-15306</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Delivery of macromols. mediated by protein transduction domains (PTDs) attracts a lot of interest due to its therapeutic and biotechnol. potential.  A major reevaluation of the mechanism of PTD-mediated internalization and the role of endocytosis in this mechanism has been recently initiated.  Here, we demonstrated that the entry of TAT peptide (one of the most widely used PTDs) into different primary cells is ATP and temp.-dependent, indicating the involvement of endocytosis.  Specific inhibitors of clathrin-dependent endocytosis partially inhibited TAT peptide uptake, implicating this pathway in TAT peptide entry.  In contrast, the caveolin-dependent pathway is not essential for the uptake of unconjugated TAT peptide as evidenced by the efficient internalization of TAT in the presence of the known inhibitors of raft/caveolin-dependent pathway and for cells lacking or deficient in caveolin-1 expression.  Whereas a significant part of TAT peptide uptake involved heparan sulfate receptors, efficient internalization of peptide was obsd. even in their absence, indicating the involvement of other receptors.  Our results suggested that unconjugated peptide might follow endocytic pathways different from those utilized by TAT peptide conjugated to different proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0jQflp6Sa2LVg90H21EOLACvtfcHk0ljuDIidye0bgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFSltL4%253D&md5=1d8de5308857569b689db4f3383f2572</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M401604200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M401604200%26sid%3Dliteratum%253Aachs%26aulast%3DRichard%26aufirst%3DJ.%2BP.%26aulast%3DMelikov%26aufirst%3DK.%26aulast%3DBrooks%26aufirst%3DH.%26aulast%3DPrevot%26aufirst%3DP.%26aulast%3DLebleu%26aufirst%3DB.%26aulast%3DChernomordik%26aufirst%3DL.%2BV.%26atitle%3DCellular%2520uptake%2520of%2520unconjugated%2520TAT%2520peptide%2520involves%2520clathrin-dependent%2520endocytosis%2520and%2520heparan%2520sulfate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D15300%26epage%3D15306%26doi%3D10.1074%2Fjbc.M401604200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcangeli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fittipaldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltram, F.</span></span> <span> </span><span class="NLM_article-title">Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time</span>. <i>Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">284</span>â <span class="NLM_lpage">294</span>, <span class="refDoi">Â DOI: 10.1016/S1525-0016(03)00122-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2FS1525-0016%2803%2900122-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=12907151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFOktr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=284-294&author=A.+Ferrariauthor=V.+Pellegriniauthor=C.+Arcangeliauthor=A.+Fittipaldiauthor=M.+Giaccaauthor=F.+Beltram&title=Caveolae-mediated+internalization+of+extracellular+HIV-1+tat+fusion+proteins+visualized+in+real+time&doi=10.1016%2FS1525-0016%2803%2900122-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Caveolae-Mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time</span></div><div class="casAuthors">Ferrari, Aldo; Pellegrini, Vittorio; Arcangeli, Caterina; Fittipaldi, Antonio; Giacca, Mauro; Beltram, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">284-294</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The Tat protein from HIV-1, when fused with heterologous proteins or peptides, can traverse cell membranes.  This ability has generated great interest due to potential therapeutic applications.  However, the relevant cellular pathway and its dynamics have not been elucidated yet.  Here we unravel the intracellular fate of exogenously added Tat fused with green fluorescent protein (GFP) in live HeLa and CHO cells, from the early interaction with the plasma membrane up to the long-term accumulation in the perinuclear region.  We demonstrate that the internalization process of full-length Tat and of heterologous proteins fused to the transduction domain of Tat exploits a caveolar-mediated pathway and is inhibited at 4Â°.  Remarkably, a slow linear movement toward the nucleus of individual GFP-tagged Tat-filled caveolae with an av. velocity of 3 Î¼m/h was obsd.  No fluorescence was obsd. in the nucleus, possibly suggesting that Tat fusion protein unfolding is required for nuclear translocation.  In addn., early sensitivity to cytochalasin-D treatment indicates the essential role of the actin cytoskeleton in the displacement of Tat vesicles toward the nucleus.  Our results imply that HIV-1 Tat mediates the internalization of protein cargos in a slow and temp.-dependent manner by exploiting the caveolar pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC_IT5g1y8KbVg90H21EOLACvtfcHk0ljuDIidye0bgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFOktr8%253D&md5=e5f60c42ccba353cf96503a2a453d3a7</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2FS1525-0016%2803%2900122-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1525-0016%252803%252900122-9%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DA.%26aulast%3DPellegrini%26aufirst%3DV.%26aulast%3DArcangeli%26aufirst%3DC.%26aulast%3DFittipaldi%26aufirst%3DA.%26aulast%3DGiacca%26aufirst%3DM.%26aulast%3DBeltram%26aufirst%3DF.%26atitle%3DCaveolae-mediated%2520internalization%2520of%2520extracellular%2520HIV-1%2520tat%2520fusion%2520proteins%2520visualized%2520in%2520real%2520time%26jtitle%3DMol.%2520Ther.%26date%3D2003%26volume%3D8%26spage%3D284%26epage%3D294%26doi%3D10.1016%2FS1525-0016%2803%2900122-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kosuge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakase, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futaki, S.</span></span> <span> </span><span class="NLM_article-title">Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">656</span>â <span class="NLM_lpage">664</span>, <span class="refDoi">Â DOI: 10.1021/bc700289w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc700289w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVGgu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=656-664&author=M.+Kosugeauthor=T.+Takeuchiauthor=I.+Nakaseauthor=A.+T.+Jonesauthor=S.+Futaki&title=Cellular+internalization+and+distribution+of+arginine-rich+peptides+as+a+function+of+extracellular+peptide+concentration%2C+serum%2C+and+plasma+membrane+associated+proteoglycans&doi=10.1021%2Fbc700289w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Internalization and Distribution of Arginine-Rich Peptides as a Function of Extracellular Peptide Concentration, Serum, and Plasma Membrane Associated Proteoglycans</span></div><div class="casAuthors">Kosuge, Michie; Takeuchi, Toshihide; Nakase, Ikuhiko; Jones, Arwyn Tomos; Futaki, Shiroh</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">656-664</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The exact mechanisms by which Arg-rich cell-penetrating peptides enter cells are still the subject of debate.  Here, we have analyzed in detail the effects of serum and extracellular concn. on the internalization of oligoarginines (Rn; n = 4, 8, 12, 16).  The presence of serum in the incubation medium had a major influence on the uptake of R12 and R16 peptides but did not affect the uptake of R4 and R8 significantly.  Incubation of cells at 37 Â°C with R12 and R16 peptides in serum-contg. medium showed that the majority of labeling was confined to punctate endocytic structures.  Performing the same expts. in serum-free media led to a dramatic increase in cytosolic labeling, and similarly diffuse R12 and R16 labeling was obsd. in cells treated with peptides at 4 Â°C.  This suggests, in both cases, that the peptides were entering via a nonendocytic mechanism.  Further studies on R12 peptide suggest that the initiation of nonendocytic uptake and cytosolic labeling is also dependent on serum concn. and extracellular peptide concn.  At relatively low concns., the peptide labels endocytic structures, but upon raising the peptide concn., the fraction labeling the cytosol increases dramatically and this accompanies a nonlinear increase in total cellular fluorescence.  Membrane-assocd. proteoglycans also contribute to increasing the peptide concn. at the cell surface by enhancing their recruitment via electrostatic interactions.  These results demonstrate that uptake mechanisms of these compds. are highly dependent on both the presence of serum and the effective extracellular peptide concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE7X585THn2rVg90H21EOLACvtfcHk0ljuDIidye0bgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVGgu78%253D&md5=437124544cad7ac13a1300f39e8f3218</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fbc700289w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc700289w%26sid%3Dliteratum%253Aachs%26aulast%3DKosuge%26aufirst%3DM.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DNakase%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DA.%2BT.%26aulast%3DFutaki%26aufirst%3DS.%26atitle%3DCellular%2520internalization%2520and%2520distribution%2520of%2520arginine-rich%2520peptides%2520as%2520a%2520function%2520of%2520extracellular%2520peptide%2520concentration%252C%2520serum%252C%2520and%2520plasma%2520membrane%2520associated%2520proteoglycans%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D656%26epage%3D664%26doi%3D10.1021%2Fbc700289w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labropoulou, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skandalis, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravazoula, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perimenis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karamanos, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalofonos, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theocharis, A. D.</span></span> <span> </span><span class="NLM_article-title">Expression of syndecan-4 and correlation with metastatic potential in testicular germ cell tumours</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">214864</span>, <span class="refDoi">Â DOI: 10.1155/2013/214864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1155%2F2013%2F214864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23844358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC3sjpvFehsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=214864&author=V.+T.+Labropoulouauthor=S.+S.+Skandalisauthor=P.+Ravazoulaauthor=P.+Perimenisauthor=N.+K.+Karamanosauthor=H.+P.+Kalofonosauthor=A.+D.+Theocharis&title=Expression+of+syndecan-4+and+correlation+with+metastatic+potential+in+testicular+germ+cell+tumours&doi=10.1155%2F2013%2F214864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of syndecan-4 and correlation with metastatic potential in testicular germ cell tumours</span></div><div class="casAuthors">Labropoulou Vassiliki T; Skandalis Spyros S; Ravazoula Panagiota; Perimenis Petros; Karamanos Nikos K; Kalofonos Haralabos P; Theocharis Achilleas D</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">214864</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although syndecan-4 is implicated in cancer progression, there is no information for its role in testicular germ cell tumours (TGCTs).  Thus, we examined the expression of syndecan-4 in patients with TGCTs and its correlation with the clinicopathological findings.  Immunohistochemical staining in 71 tissue specimens and mRNA analysis revealed significant overexpression of syndecan-4 in TGCTs.  In seminomas, high percentage of tumour cells exhibited membranous and/or cytoplasmic staining for syndecan-4 in all cases.  Stromal staining for syndecan-4 was found in seminomas and it was associated with nodal metastasis (P = 0.04), vascular/lymphatic invasion (P = 0.01), and disease stage (P = 0.04).  Reduced tumour cell associated staining for syndecan-4 was observed in nonseminomatous germ cell tumours (NSGCTs) compared to seminomas.  This loss of syndecan-4 was associated with nodal metastasis (P = 0.01), vascular/lymphatic invasion (P = 0.01), and disease stage (P = 0.01).  Stromal staining for syndecan-4 in NSGCTs did not correlate with any of the clinicopathological variables.  The stromal expression of syndecan-4 in TGCTs was correlated with microvessel density (P = 0.03).  Our results indicate that syndecan-4 is differentially expressed in seminomas and NSGCTs and might be a useful marker.  Stromal staining in seminomas and reduced levels of syndecan-4 in tumour cells in NSGCTs are related to metastatic potential, whereas stromal staining in TGCTs is associated with neovascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4lnANo20pTlVwdslNBF-tfW6udTcc2eaMWAPwwd0ZR7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjpvFehsA%253D%253D&md5=8b2b678a183cf03b40145f4c340612aa</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1155%2F2013%2F214864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F214864%26sid%3Dliteratum%253Aachs%26aulast%3DLabropoulou%26aufirst%3DV.%2BT.%26aulast%3DSkandalis%26aufirst%3DS.%2BS.%26aulast%3DRavazoula%26aufirst%3DP.%26aulast%3DPerimenis%26aufirst%3DP.%26aulast%3DKaramanos%26aufirst%3DN.%2BK.%26aulast%3DKalofonos%26aufirst%3DH.%2BP.%26aulast%3DTheocharis%26aufirst%3DA.%2BD.%26atitle%3DExpression%2520of%2520syndecan-4%2520and%2520correlation%2520with%2520metastatic%2520potential%2520in%2520testicular%2520germ%2520cell%2520tumours%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2013%26volume%3D2013%26spage%3D214864%26doi%3D10.1155%2F2013%2F214864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baba, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swartz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Buren, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eickhoff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolberg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedl, A.</span></span> <span> </span><span class="NLM_article-title">Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">98</span>, <span class="refDoi">Â DOI: 10.1007/s10549-005-9135-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs10549-005-9135-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=16636895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVaqsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=91-98&author=F.+Babaauthor=K.+Swartzauthor=R.+van+Burenauthor=J.+Eickhoffauthor=Y.+Zhangauthor=W.+Wolbergauthor=A.+Friedl&title=Syndecan-1+and+syndecan-4+are+overexpressed+in+an+estrogen+receptor-negative%2C+highly+proliferative+breast+carcinoma+subtype&doi=10.1007%2Fs10549-005-9135-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype</span></div><div class="casAuthors">Baba, Fuesun; Swartz, Kathryn; Buren, Regina; Eickhoff, Jens; Zhang, Yong; Wolberg, William; Friedl, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Members of the syndecan and glypican families of cell surface heparan sulfate proteoglycans (HSPGs) are modulators of growth factor signaling and cell adhesion.  Both loss and gain in expression of syndecans and glypicans has been assocd. with malignant progression.  The goal of this project was to investigate a possible relationship between expression of cell surface HSPGs (syndecan-1, syndecan-4 and glypican-1) and established prognostic factors or clin. outcome in breast carcinomas.  Tissue arrays contg. 207 human breast carcinoma samples in duplicate were immuno-labeled with antibodies to syndecan-1, syndecan-4, glypican-1, Ki67, E-cadherin, estrogen receptor (ER) and progesterone receptor (PR).  Clin. follow-up information was available for up to 18.6 years (median follow-up 6.2 years).  Syndecan-1 and syndecan-4 expression in carcinoma cells ranged from complete loss to high expression, but glypican-1 was detected only in a small subset of breast carcinomas.  Expression of all three HSPGs was significantly assocd. with the Ki67 proliferation index (syndecan-1: p=0.0025; syndecan-4: p<0.0001; glypican-1 p=0.01).  Syndecan-1 and syndecan-4 expression correlated with ER negativity, grade, and size of the primary tumors.  Syndecan-1 expression (but not syndecan-4 nor glypican-1) predicted patient outcome (DFS: p=0.0054; OS: p=0.0086).  However, multivariate anal. failed to identify syndecan-1 as an independent prognostic marker, which was due to its significant assocn. with established prognostic factors.  The strong assocn. between cell surface HSPGs and the Ki67 proliferation marker would support a biol. role in carcinoma growth regulation.  Furthermore, the close correlation between syndecan expression and neg. ER status raises the possibility of hormonal regulation or more likely an assocn. with an aggressive, ER-neg. carcinoma phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-sbDg04DpCbVg90H21EOLACvtfcHk0liY4LcUgd8djQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVaqsb0%253D&md5=0360ceb3457f64ec8db596ec5f18c81e</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1007%2Fs10549-005-9135-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-005-9135-2%26sid%3Dliteratum%253Aachs%26aulast%3DBaba%26aufirst%3DF.%26aulast%3DSwartz%26aufirst%3DK.%26aulast%3Dvan%2BBuren%26aufirst%3DR.%26aulast%3DEickhoff%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWolberg%26aufirst%3DW.%26aulast%3DFriedl%26aufirst%3DA.%26atitle%3DSyndecan-1%2520and%2520syndecan-4%2520are%2520overexpressed%2520in%2520an%2520estrogen%2520receptor-negative%252C%2520highly%2520proliferative%2520breast%2520carcinoma%2520subtype%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2006%26volume%3D98%26spage%3D91%26epage%3D98%26doi%3D10.1007%2Fs10549-005-9135-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couchman, J. R.</span></span> <span> </span><span class="NLM_article-title">Syndecan-4 up-regulation in proliferative renal disease is related to microfilament organization</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1631</span>â <span class="NLM_lpage">1633</span>, <span class="refDoi">Â DOI: 10.1096/fj.00-0794fje</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1096%2Ffj.00-0794fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11427509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFaktLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=1631-1633&author=S.+Yungauthor=A.+Woodsauthor=T.+M.+Chanauthor=M.+Daviesauthor=J.+D.+Williamsauthor=J.+R.+Couchman&title=Syndecan-4+up-regulation+in+proliferative+renal+disease+is+related+to+microfilament+organization&doi=10.1096%2Ffj.00-0794fje"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Syndecan-4 up-regulation in proliferative renal disease is related to microfilament organization</span></div><div class="casAuthors">Yung, Susan; Woods, Anne; Chan, Tak Mao; Davies, Malcolm; Williams, John D.; Couchman, John R.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1631-1633, 10.1096/fj.00-0794fje</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Syndecan-4 is a transmembrane heparan sulfate proteoglycan (HSPG) expressed widely in mammalian cells.  It has been implicated in growth-factor binding, cell-extracellular matrix adhesion, and tissue damage responses.  Although several HSPGs are present within kidney mesangium and glomerular basement membranes, no data are available on the synthesis of syndecan-4 by mesangial cells or its expression in human renal disease.  We examd. renal biopsy specimens from normal controls, nonproliferative disease (thin-membrane disease), and progressive proliferative disease (IgA nephropathy).  By using RT-PCR and immunohistochem. staining, we identified an increase in both gene expression (IgA nephropathy vs. thin membrane disease, P = 0.0004) and synthesis of syndecan-4 in progressive proliferative disease.  Syndecan-4 increased within both mesangium and tubulo-interstitium, as did Î±-actinin, a microfilament cytoskeletal component.  Syndecan-4 was a focal adhesion component in human mesangial cells, colocalizing with vinculin and Î±-actinin, and was. present in the cortical, submembraneous myosin sheath as seen for Î±-actinin.  Both syndecan-4 and Î±-actinin were retained selectively in detergent-resistant cytoskeleton-matrix prepns., emphasizing their close assocn. in cell-matrix adhesion.  Syndecan-4 may be important in the adhesion, migration, and proliferation of HMC, and its up-regulation could indicate proliferative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZWlp1tS35VrVg90H21EOLACvtfcHk0liY4LcUgd8djQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFaktLc%253D&md5=ebd4f8a2e4e5c14f674cfff5e6bcf72e</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1096%2Ffj.00-0794fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.00-0794fje%26sid%3Dliteratum%253Aachs%26aulast%3DYung%26aufirst%3DS.%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DT.%2BM.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DCouchman%26aufirst%3DJ.%2BR.%26atitle%3DSyndecan-4%2520up-regulation%2520in%2520proliferative%2520renal%2520disease%2520is%2520related%2520to%2520microfilament%2520organization%26jtitle%3DFASEB%2520J.%26date%3D2001%26volume%3D15%26spage%3D1631%26epage%3D1633%26doi%3D10.1096%2Ffj.00-0794fje" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez Plaza, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Nava, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diener, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, M. T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, I. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantoja, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volkmer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klipp, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rio, G.</span></span> <span> </span><span class="NLM_article-title">Cell penetrating peptides and cationic antibacterial peptides: two sides of the same coin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">14448</span>â <span class="NLM_lpage">14457</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M113.515023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1074%2Fjbc.M113.515023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=24706763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1artbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=14448-14457&author=J.+G.+Rodriguez+Plazaauthor=R.+Morales-Navaauthor=C.+Dienerauthor=G.+Schreiberauthor=Z.+D.+Gonzalezauthor=M.+T.+L.+Ortizauthor=I.+O.+Blakeauthor=O.+Pantojaauthor=R.+Volkmerauthor=E.+Klippauthor=A.+Herrmannauthor=G.+Del+Rio&title=Cell+penetrating+peptides+and+cationic+antibacterial+peptides%3A+two+sides+of+the+same+coin&doi=10.1074%2Fjbc.M113.515023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Cell Penetrating Peptides and Cationic Antibacterial Peptides</span></div><div class="casAuthors">Rodriguez Plaza, Jonathan G.; Morales-Nava, Rosmarbel; Diener, Christian; Schreiber, Gabriele; Gonzalez, Zyanya D.; Ortiz, Maria Teresa Lara; Blake, Ivan Ortega; Pantoja, Omar; Volkmer, Rudolf; Klipp, Edda; Herrmann, Andreas; Del Rio, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">14448-14457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cell penetrating peptides (CPP) and cationic antibacterial peptides (CAP) have similar physicochem. properties and yet it is not understood how such similar peptides display different activities.  To address this question, we used Iztli peptide 1 (IP-1) because it has both CPP and CAP activities.  Combining exptl. and computational modeling of the internalization of IP-1, we show it is not internalized by receptor-mediated endocytosis, yet it permeates into many different cell types, including fungi and human cells.  We also show that IP-1 makes pores in the presence of high elec. potential at the membrane, such as those found in bacteria and mitochondria.  These results provide the basis to understand the functional redundancy of CPPs and CAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvXU3959As-bVg90H21EOLACvtfcHk0lhNwJikML-s1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1artbc%253D&md5=9e84d680274a096b1ae254e23d354de9</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.515023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.515023%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%2BPlaza%26aufirst%3DJ.%2BG.%26aulast%3DMorales-Nava%26aufirst%3DR.%26aulast%3DDiener%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DG.%26aulast%3DGonzalez%26aufirst%3DZ.%2BD.%26aulast%3DOrtiz%26aufirst%3DM.%2BT.%2BL.%26aulast%3DBlake%26aufirst%3DI.%2BO.%26aulast%3DPantoja%26aufirst%3DO.%26aulast%3DVolkmer%26aufirst%3DR.%26aulast%3DKlipp%26aufirst%3DE.%26aulast%3DHerrmann%26aufirst%3DA.%26aulast%3DDel%2BRio%26aufirst%3DG.%26atitle%3DCell%2520penetrating%2520peptides%2520and%2520cationic%2520antibacterial%2520peptides%253A%2520two%2520sides%2520of%2520the%2520same%2520coin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D14448%26epage%3D14457%26doi%3D10.1074%2Fjbc.M113.515023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, G.</span></span> <span> </span><span class="NLM_article-title">Selectivity for and destruction of Salmonella typhimurium via a membrane damage mechanism of a cell penetrating peptide ppTG20 analogue</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">337</span>â <span class="NLM_lpage">343</span>, <span class="refDoi">Â DOI: 10.1016/j.ijantimicag.2012.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.ijantimicag.2012.05.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22819152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVymsLbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=337-343&author=L.+Liauthor=Y.+Shiauthor=G.+Suauthor=G.+Le&title=Selectivity+for+and+destruction+of+Salmonella+typhimurium+via+a+membrane+damage+mechanism+of+a+cell+penetrating+peptide+ppTG20+analogue&doi=10.1016%2Fj.ijantimicag.2012.05.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity for and destruction of Salmonella typhimurium via a membrane damage mechanism of a cell-penetrating peptide ppTG20 analog</span></div><div class="casAuthors">Li, LiRong; Shi, YongHui; Su, GuanFang; Le, GuoWei</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-343</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">P7, an analog of the cell-penetrating peptide (CPP) ppTG20, was derived by replacing Phe and Trp with Arg based on the structure-activity relationships of CPPs and antimicrobial peptides (AMPs).  P7 showed antimicrobial activity against Salmonella typhimurium at 4 Î¼M and possessed broad antimicrobial activity greater than its parent peptide.  P7 displayed good selectivity, with low hemolysis below its min. inhibitory concn. range, but displayed cytotoxic activity against the HT29 and MDA-MB231 mammalian cell lines.  Studies of calcein leakage from egg yolk L-Î±-phosphatidylcholine/egg yolk L-Î±-phosphatidyl-DL-glycerol (EYPC/EYPG) (bacterial membrane mimic) and EYPC/cholesterol (eukaryotic membrane mimic) vesicles also demonstrated that P7 exhibited high selectivity and caused pore formation in the bacterial membrane.  CD expts. suggested that the conformation of P7 underwent transitions from a random coil in sodium phosphate buffer to an Î±-helical conformation in bacterial model membranes.  P7 induced influx of the membrane fluorescent probe 1-N-phenylnaphthylamine (NPN) and the nucleic acid fluorescent probe SYTOX Green by increasing live S. typhimurium cell outer membrane and plasma membrane permeability, resp.  P7 also induced ion channel formation in the cell plasma membrane causing leakage of potassium ions.  Flow cytometric anal. demonstrated that S. typhimurium cell membrane integrity was destroyed following incubation with P7.  These results indicated that P7 exhibited good bacterial selectivity and exerted its antibacterial activity by a membrane damage mechanism.  Furthermore, these results suggested that CPPs may represent a source of templates for AMP design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP6YHjUBhdPrVg90H21EOLACvtfcHk0lhNwJikML-s1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVymsLbJ&md5=39420120bb4d50ddd1882a35a6e73a6f</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2012.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2012.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DG.%26aulast%3DLe%26aufirst%3DG.%26atitle%3DSelectivity%2520for%2520and%2520destruction%2520of%2520Salmonella%2520typhimurium%2520via%2520a%2520membrane%2520damage%2520mechanism%2520of%2520a%2520cell%2520penetrating%2520peptide%2520ppTG20%2520analogue%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2012%26volume%3D40%26spage%3D337%26epage%3D343%26doi%3D10.1016%2Fj.ijantimicag.2012.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gautam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group">Open Source Drug Discovery Consortium</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghava, G. P. S.</span></span> <span> </span><span class="NLM_article-title">Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2367</span>â <span class="NLM_lpage">2391</span>, <span class="refDoi">Â DOI: 10.2174/0929867321666140217122100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.2174%2F0929867321666140217122100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=24533809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1Wgu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=2367-2391&author=A.+Gautamauthor=P.+Kapoorauthor=K.+Chaudharyauthor=R.+Kumarauthor=Open+Source+Drug+Discovery+Consortiumauthor=G.+P.+S.+Raghava&title=Tumor+homing+peptides+as+molecular+probes+for+cancer+therapeutics%2C+diagnostics+and+theranostics&doi=10.2174%2F0929867321666140217122100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Homing Peptides as Molecular Probes for Cancer Therapeutics, Diagnostics and Theranostics</span></div><div class="casAuthors">Gautam, A.; Kapoor, P.; Chaudhary, K.; Kumar, R.; Raghava, G. P. S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2367-2391</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer is one of the leading causes of mortality worldwide, with more than 10 million new cases each year.  Despite the presence of several anticancer agents, cancer treatment is still not very effective.  Main reasons behind this high mortality rate are the lack of screening tests for early diagnosis, and non-availability of tumor specific drug delivery system.  Most of the current anticancer drugs are unable to differentiate between cancerous and normal cells, leading to systemic toxicity, and adverse side effects.  In order to tackle this problem, a considerable progress has been made over the years to identify peptides, which specifically bind to the tumor cells, and tumor vasculature (tumor homing peptides).  With the advances in phage display technol., and combinatorial libraries like one-bead one-compd. library, several hundreds of tumor homing peptides, and their derivs., which have potential to detect tumor in vivo, and deliver anticancer agents specifically to the tumor site, have been discovered.  Currently, many tumor homing peptide-based therapies for cancer treatment and diagnosis are being tested in various phases of clin. trials.  In this review, we have discussed the progress made so far in the identification of tumor homing peptides, and their applications in cancer therapeutics, diagnosis, and theranostics.  In addn., a brief discussion on tumor homing peptide resource, and in silico designing of tumor homing peptides has also been provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZnw78DFn6PLVg90H21EOLACvtfcHk0lhf94YljTHxdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpt1Wgu7o%253D&md5=0708beeac08584ead97e1ac9666621e8</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.2174%2F0929867321666140217122100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666140217122100%26sid%3Dliteratum%253Aachs%26aulast%3DGautam%26aufirst%3DA.%26aulast%3DKapoor%26aufirst%3DP.%26aulast%3DChaudhary%26aufirst%3DK.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3D%26aulast%3DRaghava%26aufirst%3DG.%2BP.%2BS.%26atitle%3DTumor%2520homing%2520peptides%2520as%2520molecular%2520probes%2520for%2520cancer%2520therapeutics%252C%2520diagnostics%2520and%2520theranostics%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D2367%26epage%3D2391%26doi%3D10.2174%2F0929867321666140217122100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, G. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. M.</span></span> <span> </span><span class="NLM_article-title">Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1783</span>â <span class="NLM_lpage">1791</span>, <span class="refDoi">Â DOI: 10.1016/j.biopha.2016.10.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.biopha.2016.10.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27899251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGjtr7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2016&pages=1783-1791&author=L.+Q.+Fanauthor=G.+X.+Duauthor=P.+F.+Liauthor=M.+W.+Liauthor=Y.+Sunauthor=L.+M.+Zhao&title=Improved+breast+cancer+cell-specific+intracellular+drug+delivery+and+therapeutic+efficacy+by+coupling+decoration+with+cell+penetrating+peptide+and+SP90+peptide&doi=10.1016%2Fj.biopha.2016.10.102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide</span></div><div class="casAuthors">Fan, Li-Qiang; Du, Guo-Xiu; Li, Peng-Fei; Li, Ming-Wei; Sun, Yao; Zhao, Li-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1783-1791</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Lack of satisfactory specificity towards tumor cells and poor intracellular delivery efficacy are the major drawbacks with conventional cancer chemotherapy.  Conjugated anticancer drugs to targeting moieties e.g. to peptides with the ability to recognize cancer cells and to cell penetrating peptide can improve these characteristics, resp.  Combining a tumor homing peptide with an appropriate cell-penetrating peptide can enhance the tumor-selective internalization efficacy of the carrying cargo mols.  In the present study, the breast cancer homing ability of SP90 peptide and the synergistic effect of SP90 with a cell-penetrating peptide(C peptide) were evaluated.  SP90 and chimeric peptide SP90-C specifically targeted cargo mol. into breast cancer cells, esp. triple neg. MDA-MB-231 cell, in a dose- and time-dependent manner, but not normal breast cells and other cancer cells, while C peptide alone had no cell-selectivity.  SP90-C increased the intracellular delivery efficiency by 12-fold or 10-fold compared to SP90 or C peptide alone, resp.  SP90 and SP90-C conjugation increased the anti-proliferative and apoptosis-inducing activity of HIV-1 Vpr, a potential novel anticancer protein drug, to breast cancer cell but not normal breast cell by arresting cells in G2/M phase.  With excellent breast cancer cell-selective penetrating efficacy, SP90-C appears as a promising candidate vector for targeted anti-cancer drug delivery.  SP90-VPR-C is a potential novel breast cancer-targeted anticancer agent for its high anti-tumor activity and low toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq24qwlXCMTZbVg90H21EOLACvtfcHk0lhf94YljTHxdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGjtr7J&md5=a8705ffd636328de359610245c9be9d0</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2016.10.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2016.10.102%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DL.%2BQ.%26aulast%3DDu%26aufirst%3DG.%2BX.%26aulast%3DLi%26aufirst%3DP.%2BF.%26aulast%3DLi%26aufirst%3DM.%2BW.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DL.%2BM.%26atitle%3DImproved%2520breast%2520cancer%2520cell-specific%2520intracellular%2520drug%2520delivery%2520and%2520therapeutic%2520efficacy%2520by%2520coupling%2520decoration%2520with%2520cell%2520penetrating%2520peptide%2520and%2520SP90%2520peptide%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2016%26volume%3D84%26spage%3D1783%26epage%3D1791%26doi%3D10.1016%2Fj.biopha.2016.10.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Q.</span></span> <span> </span><span class="NLM_article-title">Vascular-homing peptides for cancer therapy</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">187</span>â <span class="NLM_lpage">195</span>, <span class="refDoi">Â DOI: 10.1016/j.biopha.2017.05.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.biopha.2017.05.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28544932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotlWmu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2017&pages=187-195&author=L.+Luauthor=H.+Qiauthor=J.+Zhuauthor=W.+X.+Sunauthor=B.+Zhangauthor=C.+Y.+Tangauthor=Q.+Cheng&title=Vascular-homing+peptides+for+cancer+therapy&doi=10.1016%2Fj.biopha.2017.05.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular-homing peptides for cancer therapy</span></div><div class="casAuthors">Lu, Lan; Qi, Huan; Zhu, Jie; Sun, Wen Xia; Zhang, Bin; Tang, Chun Yan; Cheng, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">187-195</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In the past 30 years, a variety of phage libraries have been extensively utilized to identify and develop tumor homing peptides (THPs).  THPs specifically bind to tumor cells or elements of the tumor microenvironment while no or low affinity to normal cells.  In this regard, the efficacy of therapeutic agents in cancer therapy can be enhanced by targeting strategies based on coupling with THPs that recognize receptors expressed by tumor cells or tumor vasculature.  Esp., vascular-homing peptides, targeting tumor vasculature, have their receptors expressed on or around the blood vessel including pro-angiogenic factors, metalloproteinase, integrins, fibrin-fibronectin complexes, etc.  This review briefly summarizes recent studies on identification and therapeutic applications of vascular-homing peptides targeting common angiogenic markers or with unknown vascular targets in some certain types of cancers.  These newly discovered vascular-homing peptides are promising candidates which could provide novel strategies for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk1emmqQIRebVg90H21EOLACvtfcHk0lhf94YljTHxdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotlWmu7Y%253D&md5=b631bcb2a5a38a173ac8da55466e3559</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.05.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.05.054%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DW.%2BX.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DC.%2BY.%26aulast%3DCheng%26aufirst%3DQ.%26atitle%3DVascular-homing%2520peptides%2520for%2520cancer%2520therapy%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D92%26spage%3D187%26epage%3D195%26doi%3D10.1016%2Fj.biopha.2017.05.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregorc, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennicelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Punt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citterio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmer-Bonte, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caligaris Cappio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambiase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordignon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Herpen, C. M.</span></span> <span> </span><span class="NLM_article-title">Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">219</span>â <span class="NLM_lpage">224</span>, <span class="refDoi">Â DOI: 10.1038/sj.bjc.6605162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fsj.bjc.6605162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=19568235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1MXoslOmur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2009&pages=219-224&author=V.+Gregorcauthor=A.+Santoroauthor=E.+Bennicelliauthor=C.+J.+Puntauthor=G.+Citterioauthor=J.+N.+Timmer-Bonteauthor=F.+Caligaris+Cappioauthor=A.+Lambiaseauthor=C.+Bordignonauthor=C.+M.+van+Herpen&title=Phase+Ib+study+of+NGR-hTNF%2C+a+selective+vascular+targeting+agent%2C+administered+at+low+doses+in+combination+with+doxorubicin+to+patients+with+advanced+solid+tumours&doi=10.1038%2Fsj.bjc.6605162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumors</span></div><div class="casAuthors">Gregorc, V.; Santoro, A.; Bennicelli, E.; Punt, C. J. A.; Citterio, G.; Timmer-Bonte, J. N. H.; Caligaris Cappio, F.; Lambiase, A.; Bordignon, C.; van Herpen, C. M. L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-224</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Asparagine-glycine-arginine-human tumor necrosis factor (NGR-hTNF) is a vascular targeting agent exploiting a tumor-homing peptide (NGR) that selectively binds to aminopeptidase N/CD13, overexpressed on tumor blood vessels.  Significant preclin. synergy was shown between low doses of NGR-TNF and doxorubicin.  The primary aim of this phase I trial was to verify the safety of low-dose NGR-hTNF combined with doxorubicin in treating refractory/resistant solid tumors.  Secondary objectives included pharmacokinetics (PKs), pharmacodynamics, and clin. activity.  In all 15 patients received NGR-hTNF (0.2-0.4-0.8-1.6 Î¼g/m-2) and doxorubicin (60-75 mg/m-2), both given i.v. every 3 wk.  No dose-limiting toxicity occurred and the combination was well tolerated.  Around two cases of neutropenic fevers, lasting 2 days, and two cases of cardiac ejection-fraction drops, one asymptomatic and the other symptomatic, were registered.  Only 11% of the adverse events were related to NGR-hTNF and were short-lasting and mild-to-moderate in severity.  There was no apparent PK interaction and the shedding of sol. TNF-receptors did not increase to 0.8 Î¼g/m-2.  One partial response (7%), at dose level 0.8 Î¼g/m-2, and 10 stable diseases (66%), lasting for a median duration of 5.6 mo, were obsd.  NGR-hTNF plus doxorubicin was administered safely and showed promising activity in patients pre-treated with anthracyclines.  The dose level of 0.8 Î¼g/m-2 NGR-hTNF plus doxorubicin 75 mg/m-2 was selected for phase II development.  British Journal of Cancer (2009) 101, 219-224; doi:10.1038/sj.bjc.6605162 www.bjcancer.com Published online 30 June 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmvMk75_JYVLVg90H21EOLACvtfcHk0liWKwl5ou-hug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXoslOmur0%253D&md5=12ade314d9e9d352fa27250cfc56fdee</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605162%26sid%3Dliteratum%253Aachs%26aulast%3DGregorc%26aufirst%3DV.%26aulast%3DSantoro%26aufirst%3DA.%26aulast%3DBennicelli%26aufirst%3DE.%26aulast%3DPunt%26aufirst%3DC.%2BJ.%26aulast%3DCitterio%26aufirst%3DG.%26aulast%3DTimmer-Bonte%26aufirst%3DJ.%2BN.%26aulast%3DCaligaris%2BCappio%26aufirst%3DF.%26aulast%3DLambiase%26aufirst%3DA.%26aulast%3DBordignon%26aufirst%3DC.%26aulast%3Dvan%2BHerpen%26aufirst%3DC.%2BM.%26atitle%3DPhase%2520Ib%2520study%2520of%2520NGR-hTNF%252C%2520a%2520selective%2520vascular%2520targeting%2520agent%252C%2520administered%2520at%2520low%2520doses%2520in%2520combination%2520with%2520doxorubicin%2520to%2520patients%2520with%2520advanced%2520solid%2520tumours%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2009%26volume%3D101%26spage%3D219%26epage%3D224%26doi%3D10.1038%2Fsj.bjc.6605162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorusso, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scambia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amadio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">di Legge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietragalla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vincenzo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masciullo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Stefano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangili, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citterio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambiase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordignon, C.</span></span> <span> </span><span class="NLM_article-title">Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">37</span>â <span class="NLM_lpage">42</span>, <span class="refDoi">Â DOI: 10.1038/bjc.2012.233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fbjc.2012.233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22644293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xptl2itrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=37-42&author=D.+Lorussoauthor=G.+Scambiaauthor=G.+Amadioauthor=A.+di+Leggeauthor=A.+Pietragallaauthor=R.+De+Vincenzoauthor=V.+Masciulloauthor=M.+Di+Stefanoauthor=G.+Mangiliauthor=G.+Citterioauthor=M.+Mantoriauthor=A.+Lambiaseauthor=C.+Bordignon&title=Phase+II+study+of+NGR-hTNF+in+combination+with+doxorubicin+in+relapsed+ovarian+cancer+patients&doi=10.1038%2Fbjc.2012.233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients</span></div><div class="casAuthors">Lorusso, D.; Scambia, G.; Amadio, G.; di Legge, A.; Pietragalla, A.; De Vincenzo, R.; Masciullo, V.; Di Stefano, M.; Mangili, G.; Citterio, G.; Mantori, M.; Lambiase, A.; Bordignon, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-42</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: The NGR-hTNF (asparagine-glycine-arginine-human tumor necrosis factor) is able to promote antitumor immune responses and to improve the intratumoral doxorubicin uptake by selectively damaging tumor blood vessels.  Methods: Patients progressing after â¥1 platinum/taxane-based regimen received NGR-hTNF 0.8 Î¼g m-2 and doxorubicin 60 mg m-2 every 3 wk.  Primary endpoint was a Response Evaluation Criteria in Solid Tumors-defined response rate with a target of more than 6 out of 37 responding patients.  Results: A total of 37 patients with platinum-free interval lower than 6 mo (PFI<6; n=25), or between 6 and 12 mo (PFI=6-12; n=12) were enrolled.  Median baseline peripheral blood lymphocyte count (PBLC) was 1.6 per mL (interquartile range, 1.2-2.1).  In all, 18 patients (49%) received more than 6 cycles.  Febrile neutropenia was registered in one patient (3%).  Among 35 assessable patients, 8 (23%; 95% CI 12-39%) had partial response (2 with PFI<6; 6 with PFI=6-12) and 15 (43%) had stable disease (10 with PFI<6; 5 with PFI=6-12).  Median progression-free survival (PFS) was 5.0 mo for all patients, 3.8 mo for patients with PFI<6, and 7.8 mo for patients with PFI=6-12.  Median overall survival (OS) was 17.0 mo.  Patients with baseline PBLC higher than the first quartile had improved PFS (P=0.01) and OS (P=0.001).  Conclusion: Tolerability and activity of this combination warrant further randomized testing in patients with PFI<6.  The role of PBLC as a blood-based biomarker deserves further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoONjEpS26OS7Vg90H21EOLACvtfcHk0liWKwl5ou-hug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xptl2itrw%253D&md5=6bd86917b1f896d085371ca682a9a040</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2012.233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2012.233%26sid%3Dliteratum%253Aachs%26aulast%3DLorusso%26aufirst%3DD.%26aulast%3DScambia%26aufirst%3DG.%26aulast%3DAmadio%26aufirst%3DG.%26aulast%3Ddi%2BLegge%26aufirst%3DA.%26aulast%3DPietragalla%26aufirst%3DA.%26aulast%3DDe%2BVincenzo%26aufirst%3DR.%26aulast%3DMasciullo%26aufirst%3DV.%26aulast%3DDi%2BStefano%26aufirst%3DM.%26aulast%3DMangili%26aufirst%3DG.%26aulast%3DCitterio%26aufirst%3DG.%26aulast%3DMantori%26aufirst%3DM.%26aulast%3DLambiase%26aufirst%3DA.%26aulast%3DBordignon%26aufirst%3DC.%26atitle%3DPhase%2520II%2520study%2520of%2520NGR-hTNF%2520in%2520combination%2520with%2520doxorubicin%2520in%2520relapsed%2520ovarian%2520cancer%2520patients%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2012%26volume%3D107%26spage%3D37%26epage%3D42%26doi%3D10.1038%2Fbjc.2012.233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregorc, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaafar, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favaretto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jassem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polychronis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidoli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiseo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bearz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greillier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontana, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambiase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâBrien, M.</span></span> <span> </span><span class="NLM_article-title">NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">799</span>â <span class="NLM_lpage">811</span>, <span class="refDoi">Â DOI: 10.1016/S1470-2045(18)30193-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2FS1470-2045%2818%2930193-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29753703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptlejsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=799-811&author=V.+Gregorcauthor=R.+M.+Gaafarauthor=A.+Favarettoauthor=F.+Grossiauthor=J.+Jassemauthor=A.+Polychronisauthor=P.+Bidoliauthor=M.+Tiseoauthor=R.+Shahauthor=P.+Taylorauthor=S.+Novelloauthor=A.+Muzioauthor=A.+Bearzauthor=L.+Greillierauthor=F.+Fontanaauthor=G.+Saliniauthor=A.+Lambiaseauthor=M.+O%E2%80%99Brien&title=NGR-hTNF+in+combination+with+best+investigator+choice+in+previously+treated+malignant+pleural+mesothelioma+%28NGR015%29%3A+a+randomised%2C+double-blind%2C+placebo-controlled+phase+3+trial&doi=10.1016%2FS1470-2045%2818%2930193-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial</span></div><div class="casAuthors">Gregorc, Vanesa; Gaafar, Rabab M.; Favaretto, Adolfo; Grossi, Francesco; Jassem, Jacek; Polychronis, Andreas; Bidoli, Paolo; Tiseo, Marcello; Shah, Riyaz; Taylor, Paul; Novello, Silvia; Muzio, Alberto; Bearz, Alessandra; Greillier, Laurent; Fontana, Floriana; Salini, Giulia; Lambiase, Antonio; O'Brien, Mary</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">799-811</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Malignant pleural mesothelioma is an aggressive cancer with highly vascularised tumors.  It has poor prognosis and few treatment options after failure of first-line chemotherapy.  NGR-hTNF is a vascular-targeting drug that increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumor microenvironment.  In this trial, we aimed to investigate the efficacy and safety of NGR-hTNF in patients with malignant pleural mesothelioma who had progressed during or after a first-line treatment.  NGR015 was a randomised, double-blind, placebo-controlled phase 3 trial done in 41 centers in 12 countries.  Eligible participants had malignant pleural mesothelioma of any histol. subtype (epithelial, sarcomatoid, or mixed), were aged 18 years or older, and had an Eastern Cooperative Oncol. Group performance status of 0-2 and radiol. documented progressive disease after one pemetrexed-based chemotherapy regimen.  Participants were randomly assigned to receive weekly NGR-hTNF 0Â·8 Î¼g/m2 i.v. plus best investigator choice (n=200), or placebo plus best investigator choice (n=200).  Best investigator choice was decided before random assignment and could be single-agent gemcitabine (1000-1250 mg/m2 i.v.), vinorelbine (25 mg/m2 i.v. or 60 mg/m2 orally), doxorubicin (60-75 mg/m2 i.v.), or best supportive care only.  Patients were randomised (1:1) with a block size of four after stratification for performance status and best investigator choice.  The primary study endpoint was overall survival in the intention-to-treat population.  The trial is closed to new participants and is registered with ClinicalTrials.gov (NCT01098266).  Between Apr. 12, 2010 and Jan 21, 2013, we enrolled 400 eligible participants. 381 (95%) of 400 patients were selected to receive chemotherapy before all participants were randomly assigned to receive NGF-hTNF plus best investigator choice (n=200) or placebo plus best investigator choice (n=200).  At the cutoff date (Apr. 29, 2014), the median follow-up was 18Â·7 mo (IQR 15Â·1-24Â·4), and overall survival did not differ between the two treatment groups (median 8Â·5 mo [95% CI 7Â·2-9Â·9] in the NGR-hTNF group vs 8Â·0 mo [6Â·6-8Â·9] in the placebo group; hazard ratio 0Â·94, 95% CI 0Â·75-1Â·18; p=0Â·58).  Grade 3 or worse study-emergent adverse events occurred in 136 (70%) of patients receiving NGR-hTNF vs. 118 (61%) of patients receiving placebo, with the most common being neutropenia (35 [18%] of 193 patients vs 36 [19%] of 193 patients), pain (11 [6%] vs 16 [8%]), dyspnoea (nine [5%] vs seven [4%]), and chills (nine [5%] vs none). 50 (26%) patients in the NGR-hTNF group had a serious adverse event, compared with 47 (24%) in the placebo group.  Treatment-related serious adverse events occurred in 17 (9%) patients in the NGR-hTNF group and 20 patients (10%) in the placebo group.  There were 12 deaths in the NGR-hTNF group and 13 deaths in the placebo group, but none were treatment related.  The study did not meet its primary endpoint.  The hypothesis-generating findings from the subgroup analyses deserve a confirmatory randomised trial because patients who rapidly progress after first-line treatment have a poor prognosis.MolMed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMlaVH76-vRLVg90H21EOLACvtfcHk0liWKwl5ou-hug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptlejsL8%253D&md5=e4eb787a369c92e712b827322f623b43</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2818%2930193-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252818%252930193-1%26sid%3Dliteratum%253Aachs%26aulast%3DGregorc%26aufirst%3DV.%26aulast%3DGaafar%26aufirst%3DR.%2BM.%26aulast%3DFavaretto%26aufirst%3DA.%26aulast%3DGrossi%26aufirst%3DF.%26aulast%3DJassem%26aufirst%3DJ.%26aulast%3DPolychronis%26aufirst%3DA.%26aulast%3DBidoli%26aufirst%3DP.%26aulast%3DTiseo%26aufirst%3DM.%26aulast%3DShah%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DNovello%26aufirst%3DS.%26aulast%3DMuzio%26aufirst%3DA.%26aulast%3DBearz%26aufirst%3DA.%26aulast%3DGreillier%26aufirst%3DL.%26aulast%3DFontana%26aufirst%3DF.%26aulast%3DSalini%26aufirst%3DG.%26aulast%3DLambiase%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%26atitle%3DNGR-hTNF%2520in%2520combination%2520with%2520best%2520investigator%2520choice%2520in%2520previously%2520treated%2520malignant%2520pleural%2520mesothelioma%2520%2528NGR015%2529%253A%2520a%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520phase%25203%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2018%26volume%3D19%26spage%3D799%26epage%3D811%26doi%3D10.1016%2FS1470-2045%2818%2930193-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zarovni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corti, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor alpha coupled to NGR and RGD tumor-homing peptides</span>. <i>Hum. Gene Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">373</span>â <span class="NLM_lpage">382</span>, <span class="refDoi">Â DOI: 10.1089/104303404322959524</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1089%2F104303404322959524" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=15053862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisF2ksb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=373-382&author=N.+Zarovniauthor=L.+Monacoauthor=A.+Corti&title=Inhibition+of+tumor+growth+by+intramuscular+injection+of+cDNA+encoding+tumor+necrosis+factor+alpha+coupled+to+NGR+and+RGD+tumor-homing+peptides&doi=10.1089%2F104303404322959524"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor Î± coupled to NGR and RGD tumor-homing peptides</span></div><div class="casAuthors">Zarovni, Natasa; Monaco, Lucia; Corti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Human Gene Therapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">373-382</span>CODEN:
                <span class="NLM_cas:coden">HGTHE3</span>;
        ISSN:<span class="NLM_cas:issn">1043-0342</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">The antitumor properties of tumor necrosis factor Î± (TNF) and its efficacy in selective destruction of tumor-assocd. vessels are well known.  Besides the TNF protein, the TNF gene has been used for gene therapy of cancer and shown to induce antitumor responses both in animal models and in patients.  We show here that the therapeutic properties of the TNF gene are improved by fusing the TNF sequence with those of peptides able to target tumor vessels, such as CNGRCG or ACDCRGDCFCG.  I.m. administration of plasmid DNA encoding CNGRCG-TNF and ACDCRGDCFCG-TNF (pNGR-TNF and pRGD-TNF, resp.), but not plasmids encoding TNF (pTNF) or empty vector (pMock), inhibited the growth of s.c. murine B16F1 melanomas and RMA-T lymphomas implanted at sites distant from the site of plasmid injection.  The combination of pNGR-TNF or pRGD-TNF with doxorubicin or melphalan induced stronger effects than single agents.  These treatments induced antitumor effects without activating toxic or neg. feedback mechanisms.  In addn., pRGD-TNF increased the uptake of an antibody directed to a tumor-assocd. antigen.  These results suggest that the therapeutic properties of NGR-TNF and RGD-TNF cDNAs are greater than those of TNF cDNA and provide the rationale for developing new gene therapy approaches based on vascular targeting with TNF coupled to tumor-homing peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7XOSfbgn9DrVg90H21EOLACvtfcHk0lj1OwANDeyPDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisF2ksb4%253D&md5=ab5d29e64a8d4f33bd570677c2cf3854</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1089%2F104303404322959524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F104303404322959524%26sid%3Dliteratum%253Aachs%26aulast%3DZarovni%26aufirst%3DN.%26aulast%3DMonaco%26aufirst%3DL.%26aulast%3DCorti%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520tumor%2520growth%2520by%2520intramuscular%2520injection%2520of%2520cDNA%2520encoding%2520tumor%2520necrosis%2520factor%2520alpha%2520coupled%2520to%2520NGR%2520and%2520RGD%2520tumor-homing%2520peptides%26jtitle%3DHum.%2520Gene%2520Ther.%26date%3D2004%26volume%3D15%26spage%3D373%26epage%3D382%26doi%3D10.1089%2F104303404322959524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seidi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahanban-Esfahlan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monhemi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zare, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minofar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daei Farshchi Adli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farajzadeh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behzadi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesgari Abbasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubauer, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriggl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarghami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javaheri, T.</span></span> <span> </span><span class="NLM_article-title">NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">3967</span>â <span class="NLM_lpage">3980</span>, <span class="refDoi">Â DOI: 10.1038/s41388-018-0213-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fs41388-018-0213-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29662195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXns1Ortb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=3967-3980&author=K.+Seidiauthor=R.+Jahanban-Esfahlanauthor=H.+Monhemiauthor=P.+Zareauthor=B.+Minofarauthor=A.+Daei+Farshchi+Adliauthor=D.+Farajzadehauthor=R.+Behzadiauthor=M.+Mesgari+Abbasiauthor=H.+A.+Neubauerauthor=R.+Morigglauthor=N.+Zarghamiauthor=T.+Javaheri&title=NGR+%28Asn-Gly-Arg%29-targeted+delivery+of+coagulase+to+tumor+vasculature+arrests+cancer+cell+growth&doi=10.1038%2Fs41388-018-0213-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth</span></div><div class="casAuthors">Seidi, Khaled; Jahanban-Esfahlan, Rana; Monhemi, Hassan; Zare, Peyman; Minofar, Babak; Daei Farshchi Adli, Amir; Farajzadeh, Davoud; Behzadi, Ramezan; Mesgari Abbasi, Mehran; Neubauer, Heidi A.; Moriggl, Richard; Zarghami, Nosratollah; Javaheri, Tahereh</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">3967-3980</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Induction of selective thrombosis and infarction in tumor-feeding vessels represents an attractive strategy to combat cancer.  Here we took advantage of the unique coagulation properties of staphylocoagulase and genetically engineered it to generate a new fusion protein with novel anti-cancer properties.  This novel bi-functional protein consists of truncated coagulase (tCoa) and an NGR (GNGRAHA) motif that recognizes CD13 and Î±vÎ²3 integrin receptors, targeting it to tumor endothelial cells.  Herein, we report that tCoa coupled by its C-terminus to an NGR sequence retained its normal binding activity with prothrombin and avÎ²3 integrins, as confirmed in silico and in vitro.  Moreover, in vivo biodistribution studies demonstrated selective accumulation of FITC-labeled tCoa-NGR fusion proteins at the site of s.c. implanted PC3 tumor xenografts in nude mice.  Notably, systemic administration of tCoa-NGR to mice bearing 4T1 mouse mammary xenografts or PC3 human prostate tumors resulted in a significant redn. in tumor growth.  These anti-tumor effects were accompanied by massive thrombotic occlusion of small and large tumor vessels, tumor infarction and tumor cell death.  From these findings, we propose tCoa-NGR mediated tumor infarction as a novel and promising anti-cancer strategy targeting both CD13 and integrin Î±vÎ²3 pos. tumor neovasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8xflAWfaBbrVg90H21EOLACvtfcHk0lj1OwANDeyPDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXns1Ortb8%253D&md5=8299f8a01f2f50e5a7b6a08b4a8d424d</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1038%2Fs41388-018-0213-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41388-018-0213-4%26sid%3Dliteratum%253Aachs%26aulast%3DSeidi%26aufirst%3DK.%26aulast%3DJahanban-Esfahlan%26aufirst%3DR.%26aulast%3DMonhemi%26aufirst%3DH.%26aulast%3DZare%26aufirst%3DP.%26aulast%3DMinofar%26aufirst%3DB.%26aulast%3DDaei%2BFarshchi%2BAdli%26aufirst%3DA.%26aulast%3DFarajzadeh%26aufirst%3DD.%26aulast%3DBehzadi%26aufirst%3DR.%26aulast%3DMesgari%2BAbbasi%26aufirst%3DM.%26aulast%3DNeubauer%26aufirst%3DH.%2BA.%26aulast%3DMoriggl%26aufirst%3DR.%26aulast%3DZarghami%26aufirst%3DN.%26aulast%3DJavaheri%26aufirst%3DT.%26atitle%3DNGR%2520%2528Asn-Gly-Arg%2529-targeted%2520delivery%2520of%2520coagulase%2520to%2520tumor%2520vasculature%2520arrests%2520cancer%2520cell%2520growth%26jtitle%3DOncogene%26date%3D2018%26volume%3D37%26spage%3D3967%26epage%3D3980%26doi%3D10.1038%2Fs41388-018-0213-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosseini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseini, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashempour, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattahi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghizadeh, M.</span></span> <span> </span><span class="NLM_article-title">Effect of RGD coupled MDA-7/IL-24 on apoptosis induction in a hepatocellular carcinoma cell line</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">495</span>â <span class="NLM_lpage">501</span>, <span class="refDoi">Â DOI: 10.3892/mmr.2016.6009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.3892%2Fmmr.2016.6009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27959433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptVymt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=495-501&author=E.+Hosseiniauthor=S.+Y.+Hosseiniauthor=T.+Hashempourauthor=M.+R.+Fattahiauthor=M.+Sadeghizadeh&title=Effect+of+RGD+coupled+MDA-7%2FIL-24+on+apoptosis+induction+in+a+hepatocellular+carcinoma+cell+line&doi=10.3892%2Fmmr.2016.6009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of RGD coupled MDA-7/IL-24 on apoptosis induction in a hepatocellular carcinoma cell line</span></div><div class="casAuthors">Hosseini, Ebrahim; Hosseini, Seyed Younes; Hashempour, Tayebeh; Fattahi, Mohammad Reza; Sadeghizadeh, Majid</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">495-501</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The melanoma differentiation assocd. gene 7 (MDA 7) gene, also termed interleukin 24 (IL 24), is a tumor suppressor gene that induces apoptosis in a broad scope of malignant neoplastic cells.  The apoptosis induction capacity of the MDA 7/IL 24 gene is partially assocd. with adhering to cognate receptors.  The current study aimed to enhance the antitumor effect of IL 24.  The intrinsic signal sequence of IL 24 replaced with a fused artificial signal (secrecon) RGD4C sequence and its impact was evaluated in HepG2 cells.  The modified SP.RGD.IL 24 and native IL 24 cDNA sequences were cloned into the pcDNA3.1 expression vector.  Subsequently, the expression level, secretion efficacy and targeting propensity of the modified SP.RGD.IL 24 product compared with normal IL 24 by were detd. by enzyme linked immunosorbent assay.  The constructs were then transfected into HepG2 and LX 2 cells as tumor and normal hepatic cell lines, resp.  The expression level of the pro apoptotic DNA damage inducible transcript 3 (Gadd153) and BCL2 assocd. X apoptosis regulator (Bax) genes in the different groups were compared by reverse transcription quant. polymerase chain reaction.  Addnl., the rate of apoptosis induction of modified and intact IL 24 sequences was compared by flow cytometry anal. of cells following their propidium iodide/annexin V staining.  SP.RGD IL 24 protein was expressed and secreted in a similar manner to native IL 24, however, the modified SP.RGD.IL 24 adhered to tumor cells more efficiently than IL 24 (P<0.05).  SP.RGD.IL 24 significantly induced upregulation of Gadd153 and Bax in HepG2 cells compared with native IL 24 (P<0.05).  However, neither had a significant impact on the expression level of pro apoptotic genes in LX 2 cells.  Flow cytometry anal. also indicated that modified SP.RGD.IL 24 induced apoptosis more than native IL 24 in HepG2 cells (P<0.05).  In conclusion, the novel generated RGD coupled IL 24 construct exhibited sufficient anticancer activity compared with the native IL 24.  The results of the current study provide novel insights for the future of cytokine targeting and indicates its potential capacity as a valuable candidate for gene therapy methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFk5dU-cAWjrVg90H21EOLACvtfcHk0lj1OwANDeyPDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptVymt7Y%253D&md5=ea330c953d3c5f0473996e0420b72054</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2016.6009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2016.6009%26sid%3Dliteratum%253Aachs%26aulast%3DHosseini%26aufirst%3DE.%26aulast%3DHosseini%26aufirst%3DS.%2BY.%26aulast%3DHashempour%26aufirst%3DT.%26aulast%3DFattahi%26aufirst%3DM.%2BR.%26aulast%3DSadeghizadeh%26aufirst%3DM.%26atitle%3DEffect%2520of%2520RGD%2520coupled%2520MDA-7%252FIL-24%2520on%2520apoptosis%2520induction%2520in%2520a%2520hepatocellular%2520carcinoma%2520cell%2520line%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2017%26volume%3D15%26spage%3D495%26epage%3D501%26doi%3D10.3892%2Fmmr.2016.6009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. N.</span></span> <span> </span><span class="NLM_article-title">Potent antitumor effect elicited by RGD-mda-7, an mda-7/IL-24 mutant, via targeting the integrin receptor of tumor cells</span>. <i>Cancer Biother.Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">647</span>â <span class="NLM_lpage">655</span>, <span class="refDoi">Â DOI: 10.1089/cbr.2011.0984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1089%2Fcbr.2011.0984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=21902545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWrsbrI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=647-655&author=B.+F.+Zhangauthor=J.+J.+Liuauthor=D.+S.+Peiauthor=Z.+X.+Yangauthor=J.+H.+Diauthor=F.+F.+Chenauthor=H.+Z.+Liauthor=W.+Xuauthor=Y.+P.+Wuauthor=J.+N.+Zheng&title=Potent+antitumor+effect+elicited+by+RGD-mda-7%2C+an+mda-7%2FIL-24+mutant%2C+via+targeting+the+integrin+receptor+of+tumor+cells&doi=10.1089%2Fcbr.2011.0984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Antitumor Effect Elicited by RGD-mda-7, an mda-7/IL-24 Mutant, via Targeting the Integrin Receptor of Tumor Cells</span></div><div class="casAuthors">Zhang, Bao-Fu; Liu, Jun-Jie; Pei, Dong-Sheng; Yang, Zhi-Xia; Di, Jie-Hui; Chen, Fei-Fei; Li, Hui-Zhong; Xu, Wei; Wu, Yong-Ping; Zheng, Jun-Nian</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">647-655</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">The melanoma differentiation-assocd. gene-7/interleukin-24 gene (mda-7/IL-24) is a novel tumor-suppressor/cytokine gene that exhibits potent tumor-suppressive activity without damaging normal cells.  To enhance the antitumor effect, an mda-7/IL-24 mutant, RGD-mda-7, which includes the cell adhesive sequence 164Arg-165Gly-166Asp (RGD motif), was constructed and evaluated for bioactivity.  RGD peptide binds to integrins Î±VÎ²3 and Î±VÎ²5, which are selectively expressed in tumor neovasculature and in the surface of some tumor cells.  The wtmda-7/IL-24 and RGD-mda-7 were expressed in Escherichia coli and then purified and renatured.  The immunostimulatory activity of RGD-mda-7 was assayed by stimulating peripheral blood mononuclear cells.  The results suggested that the abilities of RGD-mda-7 to induce IL-6, TNF-Î±, and IFN-Î³ prodn. were higher than wtmda-7/IL-24.  Tumor targeting of RGD-mda-7 was assayed using cell adhesion expts.  The antitumor effect of the purified RGD-mda-7 on cell proliferation in vitro was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake, cell apoptosis by staining with fluorescent probes of FITC-annexin V and DAPI, and caspase-3 expression and activity.  The in vitro results showed that RGD-mda-7 inhibited the proliferation of multiple tumor cell lines (Hela, ACHN, HepG2, and A549).  Staining with fluorescent probes of FITC-annexin V and DAPI indicated that RGD-mda-7 could induce apoptosis more effectively in four tumor cell lines than wtmda-7/IL-24, but has no effect on normal cell line NHLF.  Western blotting showed that treatment of tumor cells with RGD-mda-7 could activate apoptotic pathway by cleavage of caspase-3 as same as wtmda-7/IL-24.  Further, RGD-mda-7 group showed a higher cleaved level of caspase-3, but not in NHLF cells.  These results demonstrate that RGD-MDA-7 possesses more potent antitumor effects than wtmda-7/IL-24 and therefore merits further investigation in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3JNaAmoTztLVg90H21EOLACvtfcHk0lgEtxVClk7i2A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWrsbrI&md5=d2756e2822bced4bbf5eddcc831d1cfd</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2011.0984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2011.0984%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%2BF.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DPei%26aufirst%3DD.%2BS.%26aulast%3DYang%26aufirst%3DZ.%2BX.%26aulast%3DDi%26aufirst%3DJ.%2BH.%26aulast%3DChen%26aufirst%3DF.%2BF.%26aulast%3DLi%26aufirst%3DH.%2BZ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%2BP.%26aulast%3DZheng%26aufirst%3DJ.%2BN.%26atitle%3DPotent%2520antitumor%2520effect%2520elicited%2520by%2520RGD-mda-7%252C%2520an%2520mda-7%252FIL-24%2520mutant%252C%2520via%2520targeting%2520the%2520integrin%2520receptor%2520of%2520tumor%2520cells%26jtitle%3DCancer%2520Biother.Radiopharm.%26date%3D2011%26volume%3D26%26spage%3D647%26epage%3D655%26doi%3D10.1089%2Fcbr.2011.0984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseini, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenavar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortazavi, M.</span></span> <span> </span><span class="NLM_article-title">The effect of RGD/NGR peptide modification of melanoma differentiation-associated gene-7/interleukin-24 on its receptor attachment, an in silico analysis</span>. <i>Cancer Biother.Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">205</span>â <span class="NLM_lpage">214</span>, <span class="refDoi">Â DOI: 10.1089/cbr.2017.2195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1089%2Fcbr.2017.2195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28792792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKjtLrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=205-214&author=S.+Binaauthor=S.+Y.+Hosseiniauthor=F.+Shenavarauthor=E.+Hosseiniauthor=M.+Mortazavi&title=The+effect+of+RGD%2FNGR+peptide+modification+of+melanoma+differentiation-associated+gene-7%2Finterleukin-24+on+its+receptor+attachment%2C+an+in+silico+analysis&doi=10.1089%2Fcbr.2017.2195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">The Effect of RGD/NGR Peptide Modification of Melanoma Differentiation-Associated Gene-7/Interleukin-24 on Its Receptor Attachment, an In Silico Analysis</span></div><div class="casAuthors">Bina, Samaneh; Hosseini, Seyed Younes; Shenavar, Fatemeh; Hosseini, Ebrahim; Mortazavi, Mojtaba</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">205-214</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Melanoma differentiation-assocd. gene-7 (mda-7/interleukin [IL]-24), a unique tumor suppressor gene, induces selective apoptosis in tumor cells.  Secreted IL-24 binds to heterodimeric receptor complexes of IL-20R1/IL-20R2, IL-22R1/IL-20R2, or sigma-1 receptor (Sig1R) that consequently enhances apoptosis.  However, this mechanism is not well understood and most likely involves different pathways.  Targeting of cytokine by tumor homing peptides (THPs) to the tumor cell surface mol.-like integrin shows to be beneficial in gene immunotherapy approaches.  In this study, the in silico targeting of RGD/NGR-modified IL-24 to tumor cells was conducted.  In this regard, the sequences of six new synthetic IL-24s that have been modified by RGD (Arg-Gly-Asp) or NGR (CRNGRGPDC) were aligned and their structures were modeled through homol. modeling to evaluate their attachment potential to cognate receptor complexes such as IL-20R1/IL-20R2, IL-22R1/IL-20R2, or Sig1R.  The results of homol. modeling showed that modification of IL-24 with RGD motif in N-terminal and middle of this protein exhibited stronger interaction with cognate receptors.  These results also demonstrated that modified IL-24 with RGD motif in the C-terminal has lost native activity.  However, the interaction of THP-modified IL-24 with Sig1R would not be affected to that extent, interestingly.  Conclusively, in silico anal. showed that modification of IL-24 with THPs needs a more detailed study as these modifications may disrupt native interaction with receptors and reduce apoptosis induction property.  This structural anal. gives us a better understanding of mda-7/IL-24 interaction with cognate receptors and helps a more rational design for further cytokine modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVoSjS1yD987Vg90H21EOLACvtfcHk0lgEtxVClk7i2A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKjtLrM&md5=fda11918ca6ee51f24a2c8cfee50faab</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2017.2195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2017.2195%26sid%3Dliteratum%253Aachs%26aulast%3DBina%26aufirst%3DS.%26aulast%3DHosseini%26aufirst%3DS.%2BY.%26aulast%3DShenavar%26aufirst%3DF.%26aulast%3DHosseini%26aufirst%3DE.%26aulast%3DMortazavi%26aufirst%3DM.%26atitle%3DThe%2520effect%2520of%2520RGD%252FNGR%2520peptide%2520modification%2520of%2520melanoma%2520differentiation-associated%2520gene-7%252Finterleukin-24%2520on%2520its%2520receptor%2520attachment%252C%2520an%2520in%2520silico%2520analysis%26jtitle%3DCancer%2520Biother.Radiopharm.%26date%3D2017%26volume%3D32%26spage%3D205%26epage%3D214%26doi%3D10.1089%2Fcbr.2017.2195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Numata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reagan, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblatt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, D. L.</span></span> <span> </span><span class="NLM_article-title">Spider silk-based gene carriers for tumor cell-specific delivery</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1605</span>â <span class="NLM_lpage">1610</span>, <span class="refDoi">Â DOI: 10.1021/bc200170u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc200170u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1yhsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1605-1610&author=K.+Numataauthor=M.+R.+Reaganauthor=R.+H.+Goldsteinauthor=M.+Rosenblattauthor=D.+L.+Kaplan&title=Spider+silk-based+gene+carriers+for+tumor+cell-specific+delivery&doi=10.1021%2Fbc200170u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Spider Silk-Based Gene Carriers for Tumor Cell-Specific Delivery</span></div><div class="casAuthors">Numata, Keiji; Reagan, Michaela R.; Goldstein, Robert H.; Rosenblatt, Michael; Kaplan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1605-1610</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The present study demonstrates pDNA complexes of recombinant silk proteins contg. poly(L-lysine) and tumor-homing peptides (THPs), which are globular and approx. 150-250 nm in diam., show significant enhancement of target specificity to tumor cells by addns. of F3 and CGKRK THPs.  We report herein the prepn. and study of novel nanoscale silk-based ionic complexes contg. pDNA able to home specifically to tumor cells.  Particular focus was on how the THP, F3 (KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK), and CGKRK, enhanced transfection specificity to tumor cells.  Genetically engineered silk proteins contg. both poly(L-lysine) domains to interact with pDNA and the THP to bind to specific tumor cells for target-specific pDNA delivery were prepd. using Escherichia coli, followed by in vitro and in vivo transfection expts. into MDA-MB-435 melanoma cells and highly metastatic human breast tumor MDA-MB-231 cells.  Non-tumorigenic MCF-10A breast epithelial cells were used as a control cell line for in vitro tumor-specific delivery studies.  These results demonstrate that combination of the bioengineered silk delivery systems and THP can serve as a versatile and useful new platform for nonviral gene delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5KI76DmrK-LVg90H21EOLACvtfcHk0lgEtxVClk7i2A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1yhsbg%253D&md5=84da58032d1c002b3dcbaebaea340ee8</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fbc200170u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200170u%26sid%3Dliteratum%253Aachs%26aulast%3DNumata%26aufirst%3DK.%26aulast%3DReagan%26aufirst%3DM.%2BR.%26aulast%3DGoldstein%26aufirst%3DR.%2BH.%26aulast%3DRosenblatt%26aufirst%3DM.%26aulast%3DKaplan%26aufirst%3DD.%2BL.%26atitle%3DSpider%2520silk-based%2520gene%2520carriers%2520for%2520tumor%2520cell-specific%2520delivery%26jtitle%3DBioconjugate%2520Chem.%26date%3D2011%26volume%3D22%26spage%3D1605%26epage%3D1610%26doi%3D10.1021%2Fbc200170u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foo, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karageorgiou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitchel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, D. L.</span></span> <span> </span><span class="NLM_article-title">RGD-functionalized bioengineered spider dragline silk biomaterial</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3139</span>â <span class="NLM_lpage">3145</span>, <span class="refDoi">Â DOI: 10.1021/bm0607877</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bm0607877" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWkurbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=3139-3145&author=E.+Biniauthor=C.+W.+Fooauthor=J.+Huangauthor=V.+Karageorgiouauthor=B.+Kitchelauthor=D.+L.+Kaplan&title=RGD-functionalized+bioengineered+spider+dragline+silk+biomaterial&doi=10.1021%2Fbm0607877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">RGD-Functionalized Bioengineered Spider Dragline Silk Biomaterial</span></div><div class="casAuthors">Bini, Elisabetta; Foo, Cheryl Wong Po; Huang, Jia; Karageorgiou, Vassilis; Kitchel, Brandon; Kaplan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3139-3145</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spider silk fibers have remarkable mech. properties that suggest the component proteins could be useful biopolymers for fabricating biomaterial scaffolds for tissue formation.  Two bioengineered protein variants from the consensus sequence of the major component of dragline silk from Nephila clavipes were cloned and expressed to include RGD cell-binding domains.  The engineered silks were characterized by CD and FTIR and showed structural transitions from random coil to insol. Î²-sheet upon treatment with methanol.  The recombinant proteins were processed into films and fibers and successfully used as biomaterial matrixes to culture human bone marrow stromal cells induced to differentiate into bone-like tissue upon addn. of osteogenic stimulants.  The recombinant spider silk and the recombinant spider silk with RGD encoded into the protein both supported enhanced the differentiation of human bone marrow derived mesenchymal stem cells (hMSCs) to osteogenic outcomes when compared to tissue culture plastic.  The recombinant spider silk protein without the RGD displayed enhanced bone related outcomes, measured by calcium deposition, when compared to the same protein with RGD.  Based on comparisons to our prior studies with silkworm silks and RGD modifications, the current results illustrate the potential to bioengineer spider silk proteins into new biomaterial matrixes, while also highlighting the importance of subtle differences in silk sources and modes of presentation of RGD to cells in terms of tissue-specific outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvK5XgFzps6LVg90H21EOLACvtfcHk0ljdqW5B2m8Gfw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWkurbJ&md5=8477bf8542dd6539fa980764bc9b3acf</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Fbm0607877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbm0607877%26sid%3Dliteratum%253Aachs%26aulast%3DBini%26aufirst%3DE.%26aulast%3DFoo%26aufirst%3DC.%2BW.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DKarageorgiou%26aufirst%3DV.%26aulast%3DKitchel%26aufirst%3DB.%26aulast%3DKaplan%26aufirst%3DD.%2BL.%26atitle%3DRGD-functionalized%2520bioengineered%2520spider%2520dragline%2520silk%2520biomaterial%26jtitle%3DBiomacromolecules%26date%3D2006%26volume%3D7%26spage%3D3139%26epage%3D3145%26doi%3D10.1021%2Fbm0607877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valluzzi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernaglia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, D. L.</span></span> <span> </span><span class="NLM_article-title">Cloning, expression, and assembly of sericin-like protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">46117</span>â <span class="NLM_lpage">46123</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M307792200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1074%2Fjbc.M307792200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=12963711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosl2iurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=46117-46123&author=J.+Huangauthor=R.+Valluzziauthor=E.+Biniauthor=B.+Vernagliaauthor=D.+L.+Kaplan&title=Cloning%2C+expression%2C+and+assembly+of+sericin-like+protein&doi=10.1074%2Fjbc.M307792200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, Expression, and Assembly of Sericin-like Protein</span></div><div class="casAuthors">Huang, Jia; Valluzzi, Regina; Bini, Elisabetta; Vernaglia, Brian; Kaplan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">46117-46123</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Recombinant sericin proteins of different mol. masses (17.4, 31.9, and 46.5 kDa), based on the 38-amino acid repetitive motif of native sericin, were cloned, expressed, and purified.  The recombinant sericin self-assembled during dialysis (starting concn. of 2.5 mg/mL) forming twisted fibers.  CD and Fourier transform IR spectroscopy studies demonstrated protein conformational transitions occurred from random coil to Î²-sheets during the dialysis.  Congo red-stained recombinant sericin fibrils exhibited apple-green birefringence, indicating long-range order in the array of Î²-sheets.  Biosynthetic sericin has a high content of polar amino acids (e.g. >40 mol % serine), leading to a Î²-sheet conformation formed by hydrogen bonding via polar zipper interactions.  Anal. of recombinant sericin sequence using Mandel-Gutfreund's definition of polar and non-polar amino acids showed that the hydrophobicity pattern resembles the most frequent pattern of amyloidogenic proteins, polar amino acid aggregates (PPPPP).  Many Î²-proteins and peptides are designed to study amyloidogenesis using a polar/non-polar alternating pattern (PNPNPN).  Sericin-like proteins or peptides provide an alternative model in terms of hydrophobicity pattern with which to explore questions related to Î²-sheet formation and amyloidogenesis.  The glue-like property of sericin is attributed to the hydrogen bonding between serine residues of sericin with serine residues in the fibroin structural components of silk fiber.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJY5taYG6ayrVg90H21EOLACvtfcHk0ljdqW5B2m8Gfw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosl2iurs%253D&md5=67d0129e750dc8a3bbe83c43538791b3</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307792200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307792200%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DValluzzi%26aufirst%3DR.%26aulast%3DBini%26aufirst%3DE.%26aulast%3DVernaglia%26aufirst%3DB.%26aulast%3DKaplan%26aufirst%3DD.%2BL.%26atitle%3DCloning%252C%2520expression%252C%2520and%2520assembly%2520of%2520sericin-like%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D46117%26epage%3D46123%26doi%3D10.1074%2Fjbc.M307792200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiGirolamo, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, D. L.</span></span> <span> </span><span class="NLM_article-title">Construction, cloning, and expression of synthetic genes encoding spider dragline silk</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">10879</span>â <span class="NLM_lpage">10885</span>, <span class="refDoi">Â DOI: 10.1021/bi00034a022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00034a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADyaK2MXnsVymu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=10879-10885&author=J.+T.+Princeauthor=K.+P.+McGrathauthor=C.+M.+DiGirolamoauthor=D.+L.+Kaplan&title=Construction%2C+cloning%2C+and+expression+of+synthetic+genes+encoding+spider+dragline+silk&doi=10.1021%2Fbi00034a022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Construction, Cloning, and Expression of Synthetic Genes Encoding Spider Dragline Silk</span></div><div class="casAuthors">Prince, John T.; McGrath, Kevin P.; DiGirolamo, Carla M.; Kaplan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">10879-85</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Synthetic genes encoding recombinant spider silk proteins have been constructed, cloned, and expressed.  Protein sequences were derived from Nephila clavipes dragline silk proteins and reverse-translated to the corresponding DNA sequences.  Codon selection was chosen to maximize expression levels in Escherichia coli.  DNA "monomer" sequences were multimerized to encode high mol. wt. synthetic spider silks using a "head-to-tail" construction strategy.  Multimers were cloned into a prokaryotic expression vector and the encoded silk proteins were expressed in E. coli upon induction with IPTG.1.  Four multimers, ranging in size from 14.7 to 41.3 kDa, were chosen for detailed anal.  These proteins were isolated by immobilized metal affinity chromatog. and purified using reverse-phase HPLC.  The compn. and identity of the purified proteins were confirmed by amino acid compn. anal., N-terminal sequencing, laser desorption mass spectroscopy, and Western anal. using antibodies reactive to native spider dragline silk.  CD measurements indicate that the synthetic spider silks have substantial Î²-sheet structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzJnLQNu110bVg90H21EOLACvtfcHk0ljdqW5B2m8Gfw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsVymu74%253D&md5=9af2b96394613f96dd80b085af242a67</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fbi00034a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00034a022%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DJ.%2BT.%26aulast%3DMcGrath%26aufirst%3DK.%2BP.%26aulast%3DDiGirolamo%26aufirst%3DC.%2BM.%26aulast%3DKaplan%26aufirst%3DD.%2BL.%26atitle%3DConstruction%252C%2520cloning%252C%2520and%2520expression%2520of%2520synthetic%2520genes%2520encoding%2520spider%2520dragline%2520silk%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D10879%26epage%3D10885%26doi%3D10.1021%2Fbi00034a022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeler, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W. J.</span></span> <span> </span><span class="NLM_article-title">The regulation of type 7 adenylyl cyclase by its C1b region and <i>Escherichia coli</i> peptidylprolyl isomerase, SlyD</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">8500</span>â <span class="NLM_lpage">8506</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M010361200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1074%2Fjbc.M010361200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11113152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFKgtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=8500-8506&author=S.+Z.+Yanauthor=J.+A.+Beelerauthor=Y.+B.+Chenauthor=R.+K.+Sheltonauthor=W.+J.+Tang&title=The+regulation+of+type+7+adenylyl+cyclase+by+its+C1b+region+and+Escherichia+coli+peptidylprolyl+isomerase%2C+SlyD&doi=10.1074%2Fjbc.M010361200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">The regulation of type 7 adenylyl cyclase by its C1b region and Escherichia coli peptidylprolyl isomerase, SlyD</span></div><div class="casAuthors">Yan, Shui-Zhong; Beeler, Jeff A.; Chen, Yibang; Shelton, Robyn K.; Tang, Wei-Jen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">8500-8506</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mammalian membrane-bound adenylyl cyclase consists of two highly conserved cytoplasmic domains (C1a and C2a) sepd. by a less conserved connecting region, C1b, and one of two transmembrane domains, M2.  The C1a and C2a domains form a catalytic core that can be stimulated by forskolin and the stimulatory G protein subunit Î± (GÎ±s).  In this study, we analyzed the regulation of type 7 adenylyl cyclase (AC7) by C1b.  The C1a, C1b, and C2a domains of AC7 were purified sep.  Escherichia coli SlyD protein, a cis-trans peptidylprolyl isomerase (PPIase), copurifies with AC7 C1b (7C1b).  SlyD protein can inhibit the GÎ±s- and/or forskolin-activated activity of both sol. and membrane-bound AC7.  Mutant forms of SlyD with reduced PPIase activity are less potent in the inhibition of AC7 activity.  Interestingly, different isoforms of mammalian membrane-bound adenylyl cyclase can be either inhibited or stimulated by SlyD protein, raising the possibility that mammalian PPIase may regulate enzymic activity of mammalian adenylyl cyclase.  Purified 7C1b-SlyD complex has a greater inhibitory effect on AC7 activity than SlyD alone.  This inhibition by 7C1b is abolished in a 7C1b mutant in which a conserved glutamic acid (amino acid residue 582) is changed to alanine.  Inhibition of adenylyl cyclase activity by 7C1b is further confirmed by using 7C1b purified from an E. coli slyD-deficient strain.  This inhibitory activity of AC7 is also obsd. with the 28-mer peptides derived from a region of C1b conserved in AC7 and AC2 but is not obsd. with a peptide derived from the corresponding region of AC6.  This inhibitory activity exhibited by the C1b domain may result from the interaction of 7C1b with 7C1a and 7C2a and may serve to hold AC7 in the basal nonstimulated state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph9J9YcVgkp7Vg90H21EOLACvtfcHk0liuZoxsAGx6JA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFKgtLs%253D&md5=27290875d988e901e5df4bb39d6d32dd</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M010361200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M010361200%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BZ.%26aulast%3DBeeler%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DY.%2BB.%26aulast%3DShelton%26aufirst%3DR.%2BK.%26aulast%3DTang%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520regulation%2520of%2520type%25207%2520adenylyl%2520cyclase%2520by%2520its%2520C1b%2520region%2520and%2520Escherichia%2520coli%2520peptidylprolyl%2520isomerase%252C%2520SlyD%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D8500%26epage%3D8506%26doi%3D10.1074%2Fjbc.M010361200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galbiati, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civitarese, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allevi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avvakumova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosperi, D.</span></span> <span> </span><span class="NLM_article-title">âBlindâ targeting in action: from phage display to breast cancer cell targeting with peptide-gold nanoconjugates</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">155</span>â <span class="NLM_lpage">162</span>, <span class="refDoi">Â DOI: 10.1016/j.phrs.2016.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.phrs.2016.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27293049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2gtLbO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=155-162&author=E.+Galbiatiauthor=L.+Gambiniauthor=V.+Civitareseauthor=M.+Belliniauthor=D.+Ambrosiniauthor=R.+Alleviauthor=S.+Avvakumovaauthor=S.+Romeoauthor=D.+Prosperi&title=%E2%80%9CBlind%E2%80%9D+targeting+in+action%3A+from+phage+display+to+breast+cancer+cell+targeting+with+peptide-gold+nanoconjugates&doi=10.1016%2Fj.phrs.2016.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">"Blind" targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates</span></div><div class="casAuthors">Galbiati, Elisabetta; Gambini, Luca; Civitarese, Viola; Bellini, Michela; Ambrosini, Dario; Allevi, Raffaele; Avvakumova, Svetlana; Romeo, Sergio; Prosperi, Davide</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">155-162</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tumor homing peptides (THPs) specific for a representative breast cancer cell line (MCF-7) were carefully selected basing on a phage-displayed peptide library freely available on the web, namely the "TumorHoPe: A Database of Tumor Homing Peptides".  The selected THPs were synthesized and evaluated in terms of their affinity toward MCF-7 cells.  Out of 5 tested THPs, 3 best-performing peptide sequences and 1 scrambled sequence were sep. conjugated to spherical gold nanoparticles yielding stable nanoconjugates.  THP nanoconjugates were examd. for their ability to actively target MCF-7 cells in comparison to noncancerous 3T3-L1 fibroblast cells.  These THP-gold nanoconjugates exhibited good selectivity and binding affinity by flow cytometry, and low cytotoxicity as assayed by cell death expts.  The uptake of targeted nanoconjugates by the breast cancer cells was confirmed by transmission electron microscopy anal.  This work demonstrates that it is possible to exploit the conjugation of short peptides selected from phage-displayed libraries to develop nanomaterials reliably endowed with tumor targeting potential irresp. of a specific knowledge of the target cell biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz990-b0NgJbVg90H21EOLACvtfcHk0liuZoxsAGx6JA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2gtLbO&md5=2270ce0006b9fb97e5b3fc15769c508c</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2016.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2016.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DGalbiati%26aufirst%3DE.%26aulast%3DGambini%26aufirst%3DL.%26aulast%3DCivitarese%26aufirst%3DV.%26aulast%3DBellini%26aufirst%3DM.%26aulast%3DAmbrosini%26aufirst%3DD.%26aulast%3DAllevi%26aufirst%3DR.%26aulast%3DAvvakumova%26aufirst%3DS.%26aulast%3DRomeo%26aufirst%3DS.%26aulast%3DProsperi%26aufirst%3DD.%26atitle%3D%25E2%2580%259CBlind%25E2%2580%259D%2520targeting%2520in%2520action%253A%2520from%2520phage%2520display%2520to%2520breast%2520cancer%2520cell%2520targeting%2520with%2520peptide-gold%2520nanoconjugates%26jtitle%3DPharmacol.%2520Res.%26date%3D2016%26volume%3D111%26spage%3D155%26epage%3D162%26doi%3D10.1016%2Fj.phrs.2016.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S.</span></span> <span> </span><span class="NLM_article-title">Antibody-drug conjugates as novel anti-cancer chemotherapeutics</span>. <i>Biosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>, <span class="NLM_elocation-id">e00225</span> <span class="refDoi">Â DOI: 10.1042/BSR20150089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1042%2FBSR20150089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=26182432" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&author=C.+Petersauthor=S.+Brown&title=Antibody-drug+conjugates+as+novel+anti-cancer+chemotherapeutics&doi=10.1042%2FBSR20150089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1042%2FBSR20150089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBSR20150089%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DS.%26atitle%3DAntibody-drug%2520conjugates%2520as%2520novel%2520anti-cancer%2520chemotherapeutics%26jtitle%3DBiosci.%2520Rep.%26date%3D2015%26volume%3D35%26doi%3D10.1042%2FBSR20150089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, C. K.</span></span> <span> </span><span class="NLM_article-title">Therapeutic drug monitoring of monoclonal antibodies: applicability based on their pharmacokinetic properties</span>. <i>Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">14</span>â <span class="NLM_lpage">18</span>, <span class="refDoi">Â DOI: 10.1016/j.dmpk.2018.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.dmpk.2018.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30606646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFSmsbfO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2019&pages=14-18&author=C.+K.+Imamura&title=Therapeutic+drug+monitoring+of+monoclonal+antibodies%3A+applicability+based+on+their+pharmacokinetic+properties&doi=10.1016%2Fj.dmpk.2018.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic drug monitoring of monoclonal antibodies: Applicability based on their pharmacokinetic properties</span></div><div class="casAuthors">Imamura, Chiyo K.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-18</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Monoclonal antibodies (mAbs) have dramatically improved clin. outcomes for inflammatory and malignant diseases.  The elimination route of mAbs is cellular uptake by nonspecific pinocytosis or receptor-mediated endocytosis followed by proteolytic degrdn. which is protected by neonatal Fc-receptor or mediated by antigenic target.  There is a wide-interindividual variability in mAbs exposure due to target burden and other factors affecting unique their pharmacokinetics.  It has been reported that higher exposures are correlated with better clin. outcomes of various therapeutic mAbs.  On the other hand, flat exposure-efficacy relationships of anti-PD-1 antibodies nivolmab and pembrolizumab mean ensuring abs. max. efficacy in each patient by the approved dose regardless of their large interpatient variability in pharmacokinetics.  Administration of mAbs can induce prodn. of anti-drug antibodies (ADAs), which impact on their pharmacokinetics and pharmacodynamics.  In therapeutic drug monitoring (TDM) of mAbs, when total (free, sol. target bound and ADAs bound) mAbs concn. is measured, ADAs content (concn./titer) should be also monitored because mAbs exists in inactive complex with ADAs.  Along with detn. of appropriated therapeutic windows taking into account ADAs content, treatment algorithms for TDM-guided clin. decision-making must be developed and prospectively shown to be superior to traditional clin. care for each mAb in each indication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfQ0LoTNuGGbVg90H21EOLACvtfcHk0liuZoxsAGx6JA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFSmsbfO&md5=15e3cc37e07716639286fb3c9ac2fbcd</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.dmpk.2018.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dmpk.2018.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DImamura%26aufirst%3DC.%2BK.%26atitle%3DTherapeutic%2520drug%2520monitoring%2520of%2520monoclonal%2520antibodies%253A%2520applicability%2520based%2520on%2520their%2520pharmacokinetic%2520properties%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2019%26volume%3D34%26spage%3D14%26epage%3D18%26doi%3D10.1016%2Fj.dmpk.2018.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Antibody engineering for pursuing a healthier future</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">495</span>, <span class="refDoi">Â DOI: 10.3389/fmicb.2017.00495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.3389%2Ffmicb.2017.00495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28400756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC1cvmvFGjuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=495&author=A.+F.+Saeedauthor=R.+Wangauthor=S.+Lingauthor=S.+Wang&title=Antibody+engineering+for+pursuing+a+healthier+future&doi=10.3389%2Ffmicb.2017.00495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody Engineering for Pursuing a Healthier Future</span></div><div class="casAuthors">Saeed Abdullah F U H; Wang Rongzhi; Ling Sumei; Wang Shihua</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">495</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Since the development of antibody-production techniques, a number of immunoglobulins have been developed on a large scale using conventional methods.  Hybridoma technology opened a new horizon in the production of antibodies against target antigens of infectious pathogens, malignant diseases including autoimmune disorders, and numerous potent toxins.  However, these clinical humanized or chimeric murine antibodies have several limitations and complexities.  Therefore, to overcome these difficulties, recent advances in genetic engineering techniques and phage display technique have allowed the production of highly specific recombinant antibodies.  These engineered antibodies have been constructed in the hunt for novel therapeutic drugs equipped with enhanced immunoprotective abilities, such as engaging immune effector functions, effective development of fusion proteins, efficient tumor and tissue penetration, and high-affinity antibodies directed against conserved targets.  Advanced antibody engineering techniques have extensive applications in the fields of immunology, biotechnology, diagnostics, and therapeutic medicines.  However, there is limited knowledge regarding dynamic antibody development approaches.  Therefore, this review extends beyond our understanding of conventional polyclonal and monoclonal antibodies.  Furthermore, recent advances in antibody engineering techniques together with antibody fragments, display technologies, immunomodulation, and broad applications of antibodies are discussed to enhance innovative antibody production in pursuit of a healthier future for humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQW4iF9XXfGFtHxxy173TfNfW6udTcc2ebPVjrEfWz8xLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvmvFGjuw%253D%253D&md5=671371258655d9b244e8878b0fb0c509</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2017.00495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2017.00495%26sid%3Dliteratum%253Aachs%26aulast%3DSaeed%26aufirst%3DA.%2BF.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLing%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DAntibody%2520engineering%2520for%2520pursuing%2520a%2520healthier%2520future%26jtitle%3DFront.%2520Microbiol.%26date%3D2017%26volume%3D8%26spage%3D495%26doi%3D10.3389%2Ffmicb.2017.00495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhimolea, E.</span></span> <span> </span><span class="NLM_article-title">The future of antibodies as cancer drugs</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">954</span>â <span class="NLM_lpage">963</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2012.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.drudis.2012.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22561895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVWhtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=954-963&author=J.+M.+Reichertauthor=E.+Dhimolea&title=The+future+of+antibodies+as+cancer+drugs&doi=10.1016%2Fj.drudis.2012.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">The future of antibodies as cancer drugs</span></div><div class="casAuthors">Reichert, Janice M.; Dhimolea, Eugen</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">17-18</span>),
    <span class="NLM_cas:pages">954-963</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Targeted therapeutics such as monoclonal antibodies (mAbs) have proven successful as cancer drugs.  To profile products that could be marketed in the future, we examd. the current com. clin. pipeline of mAb candidates for cancer.  Our anal. revealed trends toward development of a variety of noncanonical mAbs, including antibody-drug conjugates (ADCs), bispecific antibodies, engineered antibodies and antibody fragments and/or domains.  We found substantial diversity in the antibody sequence source, isotype, carbohydrate residues, targets and mechanisms of action (MOA).  Although well-validated targets, such as epidermal growth factor receptor (EGFR) and CD20, continue to provide opportunities for companies, we found notable trends toward targeting less-well-validated antigens and exploration of innovative MOA such as the generation of anticancer immune responses or recruitment of cytotoxic T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9CNrebCmHvLVg90H21EOLACvtfcHk0ljCgMeV6vDfCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVWhtLs%253D&md5=76a93479c0bcb8d2773134cdb21f465b</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DReichert%26aufirst%3DJ.%2BM.%26aulast%3DDhimolea%26aufirst%3DE.%26atitle%3DThe%2520future%2520of%2520antibodies%2520as%2520cancer%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D954%26epage%3D963%26doi%3D10.1016%2Fj.drudis.2012.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerbing, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimondi, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aplenc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamis, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonzo, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meshinchi, S.</span></span> <span> </span><span class="NLM_article-title">CD33 expression and its association with gemtuzumab ozogamicin response: results from the randomized phase III Childrenâs Oncology Group Trial AAML0531</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">747</span>â <span class="NLM_lpage">755</span>, <span class="refDoi">Â DOI: 10.1200/JCO.2015.62.6846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1200%2FJCO.2015.62.6846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=26786921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Ciu7vJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=747-755&author=J.+A.+Pollardauthor=M.+Lokenauthor=R.+B.+Gerbingauthor=S.+C.+Raimondiauthor=B.+A.+Hirschauthor=R.+Aplencauthor=I.+D.+Bernsteinauthor=A.+S.+Gamisauthor=T.+A.+Alonzoauthor=S.+Meshinchi&title=CD33+expression+and+its+association+with+gemtuzumab+ozogamicin+response%3A+results+from+the+randomized+phase+III+Children%E2%80%99s+Oncology+Group+Trial+AAML0531&doi=10.1200%2FJCO.2015.62.6846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">CD33 expression and its association with gemtuzumab ozogamicin response: results from the randomized phase III children's oncology group trial AAML0531</span></div><div class="casAuthors">Pollard, Jessica A.; Loken, Michael; Gerbing, Robert B.; Raimondi, Susana C.; Hirsch, Betsy A.; Aplenc, Richard; Bernstein, Irwin D.; Gamis, Alan S.; Alonzo, Todd A.; Meshinchi, Soheil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">747-755</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: CD33 is variably expressed on acute myeloid leukemia (AML) blasts and is targeted by gemtuzumab ozogamicin (GO).  GO has shown benefit in both adult and pediatric AML trials, yet limited data exist about whether GO response correlates with CD33 expression level.  Patients and Methods: CD33 expression levels were prospectively quantified by multidimensional flow cytometry in 825 patients enrolled in Children's Oncol. Group AAML0531 and correlated with response to GO.  Results: Patients with low CD33 expression (lowest quartile of expression [Q1]) had no benefit with the addn. of GO to conventional chemotherapy (relapse risk [RR]: GO 36% v No-GO 34%, P =.731; event-free survival [EFS]: GO 53% v No-GO 58%,P =.456).  However, patients with higher CD33 expression (Q2 to Q4) had significantly reduced RR (GO 32% v No-GO 49%, P <.001) and improved EFS (GO 53% v No-GO 41%, P =.005).  This differential effect was obsd. in all risk groups.  Specifically, low-risk (LR), intermediate-risk (IR), and high-risk (HR) patients with low CD33 expression had similar outcomes regardless of GO exposure, whereas the addn. of GO to conventional chemotherapy resulted in a significant decrease in RR and disease-free survival (DFS) for patients with higher CD33 expression (LR RR, GO 13% v No-GO 35%, P =.001; LR DFS, GO 79% v No-GO 59%, P =.007; IR RR, GO 44% v No-GO 57%, P =.044; IR DFS, GO 51% v No-GO 40%, P =.078; HR RR, GO 40% v No-GO 73%, P =.016; HR DFS, GO 47% v No-GO 28%, P =.135).  Conclusion: We demonstrate that GO lacks clin. benefit in patients with low CD33 expression but significantly reduces RR and improves EFS in patients with high CD33 expression, which suggests a role for CD33-targeted therapeutics in subsets of pediatric AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh3RhS-uyQSbVg90H21EOLACvtfcHk0ljCgMeV6vDfCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Ciu7vJ&md5=49165c37020863b29b547bb83bca7eef</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1200%2FJCO.2015.62.6846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2015.62.6846%26sid%3Dliteratum%253Aachs%26aulast%3DPollard%26aufirst%3DJ.%2BA.%26aulast%3DLoken%26aufirst%3DM.%26aulast%3DGerbing%26aufirst%3DR.%2BB.%26aulast%3DRaimondi%26aufirst%3DS.%2BC.%26aulast%3DHirsch%26aufirst%3DB.%2BA.%26aulast%3DAplenc%26aufirst%3DR.%26aulast%3DBernstein%26aufirst%3DI.%2BD.%26aulast%3DGamis%26aufirst%3DA.%2BS.%26aulast%3DAlonzo%26aufirst%3DT.%2BA.%26aulast%3DMeshinchi%26aufirst%3DS.%26atitle%3DCD33%2520expression%2520and%2520its%2520association%2520with%2520gemtuzumab%2520ozogamicin%2520response%253A%2520results%2520from%2520the%2520randomized%2520phase%2520III%2520Children%25E2%2580%2599s%2520Oncology%2520Group%2520Trial%2520AAML0531%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D34%26spage%3D747%26epage%3D755%26doi%3D10.1200%2FJCO.2015.62.6846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sievers, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadtmauer, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LÃ¶wenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dombret, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theobald, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eten, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loken, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dongen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appelbaum, F. R.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3244</span>â <span class="NLM_lpage">3254</span>, <span class="refDoi">Â DOI: 10.1200/JCO.2001.19.13.3244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1200%2FJCO.2001.19.13.3244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11432892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlShtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=3244-3254&issue=13&author=E.+L.+Sieversauthor=R.+A.+Larsonauthor=E.+A.+Stadtmauerauthor=E.+Esteyauthor=B.+L%C3%B6wenbergauthor=H.+Dombretauthor=C.+Karanesauthor=M.+Theobaldauthor=J.+M.+Bennettauthor=M.+L.+Shermanauthor=M.+S.+Bergerauthor=C.+B.+Etenauthor=M.+R.+Lokenauthor=J.+J.+van+Dongenauthor=I.+D.+Bernsteinauthor=F.+R.+Appelbaum&title=Efficacy+and+safety+of+gemtuzumab+ozogamicin+in+patients+with+CD33-positive+acute+myeloid+leukemia+in+first+relapse&doi=10.1200%2FJCO.2001.19.13.3244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse</span></div><div class="casAuthors">Sievers, Eric L.; Larson, Richard A.; Stadtmauer, Edward A.; Estey, Elihu; Lowenberg, Bob; Dombret, Herve; Karanes, Chatchada; Theobald, Matthias; Bennett, John M.; Sherman, Matthew L.; Berger, Mark S.; Elen, Catharine B.; Loken, Michael R.; Van Dongen, Jacques J. M.; Bernstein, Irwin D.; Appelbaum, Frederick R.; Boogaerts, M.; Erba, H.; Huijgens, P.; Spielberger, R.; Tarantolo, S.; Castaigne, S.; Mignot, A.; Gramatski, M.; Harousseau, J.-L.; Mineur, P.; Roy, D.; Tallman, M.; Voliotis, D.; Ehninger, G.; Goldstone, A.; Juliusson, G.; List, A.; Aglietta, M.; Burnett, A.; Cambier, N.; Cassileth, P.; Fernandez, M.-N.; Fiere, D.; Gobbi, M.; Heil, G.; Hess, U.; Horst, A.; Karp, J.; Minden, M.; Paul, C.; Rai, K.; Schenkein, D.; Schuster, M.; Sierra, J.; Stenke, L.; Wahlin, A.; Wernli, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3244-3254</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose: Three open-label, multicenter trials were conducted to evaluate the efficacy and safety of single-agent Mylotarg (gemtuzumab ozogamicin; CMA-676; Wyeth Labs., Philadelphia, PA), an antibody-targeted chemotherapy agent, in patients with CD33-pos. acute myeloid leukemia (AML) in untreated first relapse.  Patients and Methods: The study population comprised 142 patients with AML in first relapse with no history of an antecedent hematol. disorder and a median age of 61 yr.  All patients received Mylotarg as a 2-h i.v. infusion, at a dose of 9 mg/m2, at 2-wk intervals for two doses.  Patients were evaluated for remission, survival, and treatment-emergent adverse events.  Results: Thirty percent of patients treated with Mylotarg obtained remission as characterized by 5% or less blasts in the marrow, recovery of neutrophils to at least 1,500/Î¼L, and RBC and platelet transfusion independence.  Although patients treated with Mylotarg had relatively high incidences of myelosuppression, grade 3 or 4 hyperbilirubinemia (23%), and elevated hepatic transaminase levels (17%), the incidences of grade 3 or 4 mucositis (4%) and infections (28%) were relatively low.  There was a low incidence of severe nausea and vomiting (11%) and no treatment-related cardiotoxicity, cerebellar toxicity, or alopecia.  Many patients received Mylotarg on an outpatient basis (38% and 41% of patients for the first and second doses, resp.).  Among the 142 patients, the median total duration of hospitalization was 24 days; 16% of patients required 7 days of hospitalization or less.  Conclusion: Administration of the antibody-targeted chemotherapy agent Mylotarg to patients with CD33-pos. AML in first relapse induces complete remissions with what appears to be a favorable safety profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1QUS965AwaLVg90H21EOLACvtfcHk0lhpRDk3dopDPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlShtbw%253D&md5=2edabaf5f61f4d4e63853851f6a8dd00</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1200%2FJCO.2001.19.13.3244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2001.19.13.3244%26sid%3Dliteratum%253Aachs%26aulast%3DSievers%26aufirst%3DE.%2BL.%26aulast%3DLarson%26aufirst%3DR.%2BA.%26aulast%3DStadtmauer%26aufirst%3DE.%2BA.%26aulast%3DEstey%26aufirst%3DE.%26aulast%3DL%25C3%25B6wenberg%26aufirst%3DB.%26aulast%3DDombret%26aufirst%3DH.%26aulast%3DKaranes%26aufirst%3DC.%26aulast%3DTheobald%26aufirst%3DM.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DSherman%26aufirst%3DM.%2BL.%26aulast%3DBerger%26aufirst%3DM.%2BS.%26aulast%3DEten%26aufirst%3DC.%2BB.%26aulast%3DLoken%26aufirst%3DM.%2BR.%26aulast%3Dvan%2BDongen%26aufirst%3DJ.%2BJ.%26aulast%3DBernstein%26aufirst%3DI.%2BD.%26aulast%3DAppelbaum%26aufirst%3DF.%2BR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520gemtuzumab%2520ozogamicin%2520in%2520patients%2520with%2520CD33-positive%2520acute%2520myeloid%2520leukemia%2520in%2520first%2520relapse%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2001%26volume%3D19%26issue%3D13%26spage%3D3244%26epage%3D3254%26doi%3D10.1200%2FJCO.2001.19.13.3244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ricart, A. D.</span></span> <span> </span><span class="NLM_article-title">Antibody-drug conjugates of calicheamicin derivative: gemtuzumab ozogamicin and inotuzumab ozogamicin</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6417</span>â <span class="NLM_lpage">6427</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-11-0486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1158%2F1078-0432.CCR-11-0486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22003069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSksrzF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6417-6427&author=A.+D.+Ricart&title=Antibody-drug+conjugates+of+calicheamicin+derivative%3A+gemtuzumab+ozogamicin+and+inotuzumab+ozogamicin&doi=10.1158%2F1078-0432.CCR-11-0486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin</span></div><div class="casAuthors">Ricart, Alejandro D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6417-6427</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Antibody-drug conjugates (ADC) are an attractive approach for the treatment of acute myeloid leukemia and non-Hodgkin lymphomas, which in most cases, are inherently sensitive to cytotoxic agents.  CD33 and CD22 are specific markers of myeloid leukemias and B-cell malignancies, resp.  These endocytic receptors are ideal for an ADC strategy because they can effectively carry the cytotoxic payload into the cell.  Gemtuzumab ozogamicin (GO, Mylotarg) and inotuzumab ozogamicin consist of a deriv. of calicheamicin (a potent DNA-binding cytotoxic antibiotic) linked to a humanized monoclonal IgG4 antibody directed against CD33 or CD22, resp.  Both of these ADCs have a target-mediated pharmacokinetic disposition.  GO was the first drug to prove the ADC concept in the clinic, specifically in phase II studies that included substantial proportions of older patients with relapsed acute myeloid leukemia.  In contrast, in phase III studies, it has thus far failed to show clin. benefit in first-line treatment in combination with std. chemotherapy.  Inotuzumab ozogamicin has shown remarkable clin. activity in relapsed/refractory B-cell non-Hodgkin lymphoma, and it has started phase III evaluation.  The safety profile of these ADCs includes reversible myelosuppression (esp. neutropenia and thrombocytopenia), elevated hepatic transaminases, and hyperbilirubinemia.  There have been postmarketing reports of hepatotoxicity, esp. veno-occlusive disease, assocd. with GO.  The incidence is â¼2%, but patients who undergo hematopoietic stem cell transplantation have an increased risk.  As we steadily move toward the goal of personalized medicine, these kinds of agents will provide a unique opportunity to treat selected patient subpopulations based on the expression of their specific tumor targets.  Clin Cancer Res; 17(20); 6417-27.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXhh65029iwbVg90H21EOLACvtfcHk0lhpRDk3dopDPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSksrzF&md5=103b40cfe49632a86367414e0e97c011</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-0486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-0486%26sid%3Dliteratum%253Aachs%26aulast%3DRicart%26aufirst%3DA.%2BD.%26atitle%3DAntibody-drug%2520conjugates%2520of%2520calicheamicin%2520derivative%253A%2520gemtuzumab%2520ozogamicin%2520and%2520inotuzumab%2520ozogamicin%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D6417%26epage%3D6427%26doi%3D10.1158%2F1078-0432.CCR-11-0486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadeau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeidan, A. M.</span></span> <span> </span><span class="NLM_article-title">Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia</span>. <i>J. Blood Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">67</span>â <span class="NLM_lpage">74</span>, <span class="refDoi">Â DOI: 10.2147/JBM.S136575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.2147%2FJBM.S136575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29713210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVKlsbvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=67-74&author=N.+Uyauthor=M.+Nadeauauthor=M.+Stahlauthor=A.+M.+Zeidan&title=Inotuzumab+ozogamicin+in+the+treatment+of+relapsed%2Frefractory+acute+B+cell+lymphoblastic+leukemia&doi=10.2147%2FJBM.S136575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia</span></div><div class="casAuthors">Uy, Natalie; Nadeau, Michelle; Stahl, Maximilian; Zeidan, Amer M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Blood Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">67-74</span>CODEN:
                <span class="NLM_cas:coden">JBMOB7</span>;
        ISSN:<span class="NLM_cas:issn">1179-2736</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">The improvement in outcomes of adult patients with acute lymphoblastic leukemia (ALL) has been modest, with the exception of Philadelphia chromosome-pos. disease, despite advances in supportive care and stem cell transplantation.  The recent approvals of novel agents, including the bispecific T-cell engager blinatumomab, the antibody-drug conjugate inotuzumab ozogamicin, and chimeric antigen receptor T-cell products are changing the management of B-ALL, which traditionally relied on chemotherapy-based approaches.  Inotuzumab ozogamicin is a humanized CD22 monoclonal antibody linked to the cytotoxic agent calicheamicin.  CD22 is expressed on leukemic blasts in >90% of ALL patients, and inotuzumab ozogamicin has shown excellent clin. activity even among heavily pretreated relapsed/refractory (R/R) B-ALL patients and elderly B-ALL patients.  Clin. trials have shown superior survival with the drug over chemotherapy-based approaches in the first- or second-line salvage therapy for relapsed B-ALL as monotherapy.  Currently, new trials are evaluating inotuzumab ozogamicin in the frontline setting in combination-based approaches.  In this review, we summarize the preclin. and clin. data of inotuzumab ozogamicin in R/R B-ALL and foresee the future use of this drug in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXQ-gzUimZrbVg90H21EOLACvtfcHk0lg2VISLNvhnPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVKlsbvE&md5=d2a0bf30dbbbbc5a21d2bccb4bd7890f</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.2147%2FJBM.S136575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FJBM.S136575%26sid%3Dliteratum%253Aachs%26aulast%3DUy%26aufirst%3DN.%26aulast%3DNadeau%26aufirst%3DM.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DZeidan%26aufirst%3DA.%2BM.%26atitle%3DInotuzumab%2520ozogamicin%2520in%2520the%2520treatment%2520of%2520relapsed%252Frefractory%2520acute%2520B%2520cell%2520lymphoblastic%2520leukemia%26jtitle%3DJ.%2520Blood%2520Med.%26date%3D2018%26volume%3D9%26spage%3D67%26epage%3D74%26doi%3D10.2147%2FJBM.S136575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doronina, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toki, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torgov, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendelsohn, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerveny, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chace, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBlanc, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gearing, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovee, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegall, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francisco, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senter, P. D.</span></span> <span> </span><span class="NLM_article-title">Development of potent monoclonal antibody auristatin conjugates for cancer therapy</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">778</span>â <span class="NLM_lpage">784</span>, <span class="refDoi">Â DOI: 10.1038/nbt832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnbt832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=12778055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFertLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=778-784&author=S.+O.+Doroninaauthor=B.+E.+Tokiauthor=M.+Y.+Torgovauthor=B.+A.+Mendelsohnauthor=C.+G.+Cervenyauthor=D.+F.+Chaceauthor=R.+L.+DeBlancauthor=R.+P.+Gearingauthor=T.+D.+Boveeauthor=C.+B.+Siegallauthor=J.+A.+Franciscoauthor=A.+F.+Wahlauthor=D.+L.+Meyerauthor=P.+D.+Senter&title=Development+of+potent+monoclonal+antibody+auristatin+conjugates+for+cancer+therapy&doi=10.1038%2Fnbt832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Development of potent monoclonal antibody auristatin conjugates for cancer therapy</span></div><div class="casAuthors">Doronina, Svetlana O.; Toki, Brian E.; Torgov, Michael Y.; Mendelsohn, Brian A.; Cerveny, Charles G.; Chace, Dana F.; DeBlanc, Ron L.; Gearing, R. Patrick; Bovee, Tim D.; Siegall, Clay B.; Francisco, Joseph A.; Wahl, Alan F.; Meyer, Damon L.; Senter, Peter D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">778-784</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We describe the in vitro and in vivo properties of monoclonal antibody (mAb)-drug conjugates consisting of the potent synthetic dolastatin 10 analogs auristatin E (AE) and monomethylauristatin E (MMAE), linked to the chimeric mAbs cBR96 (specific to Lewis Y on carcinomas) and cAC10 (specific to CD30 on hematol. malignancies).  The linkers used for conjugate formation included an acid-labile hydrazone and protease-sensitive dipeptides, leading to uniformly substituted conjugates that efficiently released active drug in the lysosomes of antigen-pos. (Ag+) tumor cells.  The peptide-linked mAb-valine-citrulline-MMAE and mAb-phenylalanine-lysine-MMAE conjugates were much more stable in buffers and plasma than the conjugates of mAb and the hydrazone of 5-benzoylvaleric acid-AE ester (AEVB).  As a result, the mAb-Val-Cit-MMAE conjugates exhibited greater in vitro specificity and lower in vivo toxicity than corresponding hydrazone conjugates.  In vivo studies demonstrated that the peptide-linked conjugates induced regressions and cures of established tumor xenografts with therapeutic indexes as high as 60-fold.  These conjugates illustrate the importance of linker technol., drug potency and conjugation methodol. in developing safe and efficacious mAb-drug conjugates for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro97SFKtdQ7rVg90H21EOLACvtfcHk0lg2VISLNvhnPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFertLc%253D&md5=d77716ec93de5ac7473c18a597339086</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1038%2Fnbt832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt832%26sid%3Dliteratum%253Aachs%26aulast%3DDoronina%26aufirst%3DS.%2BO.%26aulast%3DToki%26aufirst%3DB.%2BE.%26aulast%3DTorgov%26aufirst%3DM.%2BY.%26aulast%3DMendelsohn%26aufirst%3DB.%2BA.%26aulast%3DCerveny%26aufirst%3DC.%2BG.%26aulast%3DChace%26aufirst%3DD.%2BF.%26aulast%3DDeBlanc%26aufirst%3DR.%2BL.%26aulast%3DGearing%26aufirst%3DR.%2BP.%26aulast%3DBovee%26aufirst%3DT.%2BD.%26aulast%3DSiegall%26aufirst%3DC.%2BB.%26aulast%3DFrancisco%26aufirst%3DJ.%2BA.%26aulast%3DWahl%26aufirst%3DA.%2BF.%26aulast%3DMeyer%26aufirst%3DD.%2BL.%26aulast%3DSenter%26aufirst%3DP.%2BD.%26atitle%3DDevelopment%2520of%2520potent%2520monoclonal%2520antibody%2520auristatin%2520conjugates%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Biotechnol.%26date%3D2003%26volume%3D21%26spage%3D778%26epage%3D784%26doi%3D10.1038%2Fnbt832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamblett, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senter, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chace, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerveny, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissler, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopcha, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabinski, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francisco, J. A.</span></span> <span> </span><span class="NLM_article-title">Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">7063</span>â <span class="NLM_lpage">7070</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-04-0789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1158%2F1078-0432.CCR-04-0789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=15501986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslGlu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=7063-7070&author=K.+J.+Hamblettauthor=P.+D.+Senterauthor=D.+F.+Chaceauthor=M.+M.+Sunauthor=J.+Lenoxauthor=C.+G.+Cervenyauthor=K.+M.+Kisslerauthor=S.+X.+Bernhardtauthor=A.+K.+Kopchaauthor=R.+F.+Zabinskiauthor=D.+L.+Meyerauthor=J.+A.+Francisco&title=Effects+of+drug+loading+on+the+antitumor+activity+of+a+monoclonal+antibody+drug+conjugate&doi=10.1158%2F1078-0432.CCR-04-0789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate</span></div><div class="casAuthors">Hamblett, Kevin J.; Senter, Peter D.; Chace, Dana F.; Sun, Michael M. C.; Lenox, Joel; Cerveny, Charles G.; Kissler, Kim M.; Bernhardt, Starr X.; Kopcha, Anastasia K.; Zabinski, Roger F.; Meyer, Damon L.; Francisco, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7063-7070</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">An antibody-drug conjugate consisting of monomethyl auristatin E (MMAE) conjugated to the anti-CD30 monoclonal antibody (mAb) cAC10, with eight drug moieties per mAb, was previously shown to have potent cytotoxic activity against CD30+ malignant cells.  To det. the effect of drug loading on antibody-drug conjugate therapeutic potential, we assessed cAC10 antibody-drug conjugates contg. different drug-mAb ratios in vitro and in vivo.  Coupling MMAE to the cysteines that comprise the interchain disulfides of cAC10 created an antibody-drug conjugate population, which was purified using hydrophobic interaction chromatog. to yield antibody-drug conjugates with two, four, and eight drugs per antibody (E2, E4, and E8, resp.).  Antibody-drug conjugate potency was tested in vitro against CD30+ lines followed by in vivo xenograft models.  The max.-tolerated dose and pharmacokinetic profiles of the antibody-drug conjugates were investigated in mice.  Although antibody-drug conjugate potency in vitro was directly dependent on drug loading (IC50 values E8<E4<E2), the in vivo antitumor activity of E4 was comparable with E8 at equal mAb doses, although the E4 contained half the amt. of MMAE per mAb.  E2 was also an active antitumor agent but required higher doses.  The max.-tolerated dose of E2 in mice was at least double that of E4, which in turn was twice that of E8.  MMAE loading affected plasma clearance, as E8 cleared 3-fold faster than E4 and 5-fold faster than E2.  By decreasing drug loading per antibody, the therapeutic index was increased demonstrating that drug loading is a key design parameter for antibody-drug conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCAEfk7W0KNbVg90H21EOLACvtfcHk0lg2VISLNvhnPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslGlu78%253D&md5=2d2dd7a498d1181a57dcd3ab8b931e65</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-0789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-0789%26sid%3Dliteratum%253Aachs%26aulast%3DHamblett%26aufirst%3DK.%2BJ.%26aulast%3DSenter%26aufirst%3DP.%2BD.%26aulast%3DChace%26aufirst%3DD.%2BF.%26aulast%3DSun%26aufirst%3DM.%2BM.%26aulast%3DLenox%26aufirst%3DJ.%26aulast%3DCerveny%26aufirst%3DC.%2BG.%26aulast%3DKissler%26aufirst%3DK.%2BM.%26aulast%3DBernhardt%26aufirst%3DS.%2BX.%26aulast%3DKopcha%26aufirst%3DA.%2BK.%26aulast%3DZabinski%26aufirst%3DR.%2BF.%26aulast%3DMeyer%26aufirst%3DD.%2BL.%26aulast%3DFrancisco%26aufirst%3DJ.%2BA.%26atitle%3DEffects%2520of%2520drug%2520loading%2520on%2520the%2520antitumor%2520activity%2520of%2520a%2520monoclonal%2520antibody%2520drug%2520conjugate%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D7063%26epage%3D7070%26doi%3D10.1158%2F1078-0432.CCR-04-0789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tankersley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundblad, J. L.</span></span> <span> </span><span class="NLM_article-title">A new preparation of modified immune serum globulin (human) suitable for intravenous administration. I. Standardization of the reduction and alkylation reaction</span>. <i>Vox Sang.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">373</span>â <span class="NLM_lpage">382</span>, <span class="refDoi">Â DOI: 10.1111/j.1423-0410.1981.tb00725.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1111%2Fj.1423-0410.1981.tb00725.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=7293114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADyaL3MXlsFKnsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1981&pages=373-382&author=D.+D.+Schroederauthor=D.+L.+Tankersleyauthor=J.+L.+Lundblad&title=A+new+preparation+of+modified+immune+serum+globulin+%28human%29+suitable+for+intravenous+administration.+I.+Standardization+of+the+reduction+and+alkylation+reaction&doi=10.1111%2Fj.1423-0410.1981.tb00725.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">A new preparation of modified immune serum globulin (human) suitable for intravenous administration.  I.  Standardization of the reduction and alkylation reaction</span></div><div class="casAuthors">Schroeder, Duane D.; Tankersley, Donald L.; Lundblad, John L.</div><div class="citationInfo"><span class="NLM_cas:title">Vox Sanguinis</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">373-82</span>CODEN:
                <span class="NLM_cas:coden">VOSAAD</span>;
        ISSN:<span class="NLM_cas:issn">0042-9007</span>.
    </div><div class="casAbstract">Immune serum globulin (ISG) prepd. by Cohn cold alc. fractionation of pooled human plasma was reduced with dithiothreitol (DTT)  [3483-12-3] and alkylated with iodoacetamide  [144-48-9] and other alkylating agents.  There are a few labile interheavy chain disulfide bonds in ISG which react under mild, nondissociating conditions.  The extent of disulfide cleavage is controlled primarily by the ratio of DTT to ISG until 4-5 disulfide bonds have been reduced.  Detailed studies were reported on the variables of ISG concn., DTT to ISG ratio, pH, and time, leading to a chem. modified ISG that has a controlled and limited no. of reduced and alkylated disulfide bonds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOh3_8MIJz_7Vg90H21EOLACvtfcHk0lj45ykExxzC7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXlsFKnsL4%253D&md5=ec50baf4cc3d54ec3671fc927b8732e5</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1111%2Fj.1423-0410.1981.tb00725.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1423-0410.1981.tb00725.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DD.%2BD.%26aulast%3DTankersley%26aufirst%3DD.%2BL.%26aulast%3DLundblad%26aufirst%3DJ.%2BL.%26atitle%3DA%2520new%2520preparation%2520of%2520modified%2520immune%2520serum%2520globulin%2520%2528human%2529%2520suitable%2520for%2520intravenous%2520administration.%2520I.%2520Standardization%2520of%2520the%2520reduction%2520and%2520alkylation%2520reaction%26jtitle%3DVox%2520Sang.%26date%3D1981%26volume%3D40%26spage%3D373%26epage%3D382%26doi%3D10.1111%2Fj.1423-0410.1981.tb00725.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheler, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einhorn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowlati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiting, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalal, S. I.</span></span> <span> </span><span class="NLM_article-title">A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">738</span>â <span class="NLM_lpage">747</span>, <span class="refDoi">Â DOI: 10.1007/s10637-019-00768-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs10637-019-00768-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30993587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFersLbL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=738-747&author=J.+P.+Sharmanauthor=J.+J.+Whelerauthor=L.+Einhornauthor=A.+Dowlatiauthor=G.+I.+Shapiroauthor=J.+Hiltonauthor=J.+M.+Burkeauthor=T.+Siddiqiauthor=N.+Whitingauthor=S.+I.+Jalal&title=A+phase+2%2C+open-label+study+of+brentuximab+vedotin+in+patients+with+CD30-expressing+solid+tumors&doi=10.1007%2Fs10637-019-00768-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors</span></div><div class="casAuthors">Sharman, Jeffrey P.; Wheler, Jennifer J.; Einhorn, Lawrence; Dowlati, Afshin; Shapiro, Geoffrey I.; Hilton, John; Burke, John M.; Siddiqi, Tanya; Whiting, Nancy; Jalal, Shadia I.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">738-747</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Brentuximab vedotin (BV) is an anti-CD30 antibody-drug conjugate used in the treatment of several types of lymphomas.  Expression of the target antigen has also been reported on a variety of malignant tumors of nonlymphoid origin.  This phase 2, open-label study evaluated the safety and antitumor activity of BV in patients with CD30-expressing nonlymphomatous malignancies.  Methods: Patients were dosed with 1.8 or 2.4 mg/kg BV once every three weeks.  Antitumor activity was assessed at Cycles 2, 4, and every 4 cycles thereafter.  Patients with stable disease or better were eligible to continue treatment until disease progression, unacceptable toxicity, or study closure.  Results: Of the 2693 patients screened, 3.8% had solid tumors with CD30 expression and 63 eligible patients with solid tumors enrolled in this study.  The most common CD30 pos. solid tumors were testicular cancer and mesothelioma.  Both subtypes had more than one patient with an objective response.  The median duration of BV exposure was 6.1 wk.  The disease control rate, defined as achieving stable disease or better at any point during the study, was 55%.  The objective response rate was 11%, with a median duration of response of 2.92 mo.  The most common adverse events reported were fatigue (57%), nausea (33%), and decreased appetite (32%).  Conclusion: The safety profile of BV in patients with solid tumors was similar to the known safety profile of BV.  In solid tumors, BV had modest activity as a single agent, which was similar to other second-line treatments already available to patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq27DoX7tPvgLVg90H21EOLACvtfcHk0lj45ykExxzC7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFersLbL&md5=e416b5ef07c0ac20471a7f93bf0ed7b3</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1007%2Fs10637-019-00768-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-019-00768-6%26sid%3Dliteratum%253Aachs%26aulast%3DSharman%26aufirst%3DJ.%2BP.%26aulast%3DWheler%26aufirst%3DJ.%2BJ.%26aulast%3DEinhorn%26aufirst%3DL.%26aulast%3DDowlati%26aufirst%3DA.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DHilton%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DJ.%2BM.%26aulast%3DSiddiqi%26aufirst%3DT.%26aulast%3DWhiting%26aufirst%3DN.%26aulast%3DJalal%26aufirst%3DS.%2BI.%26atitle%3DA%2520phase%25202%252C%2520open-label%2520study%2520of%2520brentuximab%2520vedotin%2520in%2520patients%2520with%2520CD30-expressing%2520solid%2520tumors%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2019%26volume%3D37%26spage%3D738%26epage%3D747%26doi%3D10.1007%2Fs10637-019-00768-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sehn, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamdar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMillan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flowers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ãzcan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">TrnÄnÃ½, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salles, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matasar, M. J.</span></span> <span> </span><span class="NLM_article-title">Randomized phase 2 trial of polatuzumab vedotin (pola) with bendamustine and rituximab (BR) in relapsed/refractory (r/r) FL and DLBCL</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">7507</span>, <span class="refDoi">Â DOI: 10.1200/JCO.2018.36.15_suppl.7507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1200%2FJCO.2018.36.15_suppl.7507" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2018&pages=7507&issue=15&author=L.+H.+Sehnauthor=M.+Kamdarauthor=A.+F.+Herreraauthor=A.+McMillanauthor=C.+Flowersauthor=W.+S.+Kimauthor=T.+M.+Kimauthor=M.+%C3%96zcanauthor=J.+Demeterauthor=M.+Hertzbergauthor=M.+Trn%C4%9Bn%C3%BDauthor=G.+A.+Sallesauthor=A.+Daviesauthor=J.+H.+Hirataauthor=J.+Chengauthor=G.+Kuauthor=M.+J.+Matasar&title=Randomized+phase+2+trial+of+polatuzumab+vedotin+%28pola%29+with+bendamustine+and+rituximab+%28BR%29+in+relapsed%2Frefractory+%28r%2Fr%29+FL+and+DLBCL&doi=10.1200%2FJCO.2018.36.15_suppl.7507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1200%2FJCO.2018.36.15_suppl.7507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2018.36.15_suppl.7507%26sid%3Dliteratum%253Aachs%26aulast%3DSehn%26aufirst%3DL.%2BH.%26aulast%3DKamdar%26aufirst%3DM.%26aulast%3DHerrera%26aufirst%3DA.%2BF.%26aulast%3DMcMillan%26aufirst%3DA.%26aulast%3DFlowers%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DW.%2BS.%26aulast%3DKim%26aufirst%3DT.%2BM.%26aulast%3D%25C3%2596zcan%26aufirst%3DM.%26aulast%3DDemeter%26aufirst%3DJ.%26aulast%3DHertzberg%26aufirst%3DM.%26aulast%3DTrn%25C4%259Bn%25C3%25BD%26aufirst%3DM.%26aulast%3DSalles%26aufirst%3DG.%2BA.%26aulast%3DDavies%26aufirst%3DA.%26aulast%3DHirata%26aufirst%3DJ.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DKu%26aufirst%3DG.%26aulast%3DMatasar%26aufirst%3DM.%2BJ.%26atitle%3DRandomized%2520phase%25202%2520trial%2520of%2520polatuzumab%2520vedotin%2520%2528pola%2529%2520with%2520bendamustine%2520and%2520rituximab%2520%2528BR%2529%2520in%2520relapsed%252Frefractory%2520%2528r%252Fr%2529%2520FL%2520and%2520DLBCL%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2018%26volume%3D36%26issue%3D15%26spage%3D7507%26doi%3D10.1200%2FJCO.2018.36.15_suppl.7507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weglarz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampton, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollong, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazane, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. S.</span></span> <span> </span><span class="NLM_article-title">Targeted delivery of an anti-inflammatory PDE4 inhibitor to immune cells via an antibody-drug conjugate</span>. <i>Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2078</span>â <span class="NLM_lpage">2089</span>, <span class="refDoi">Â DOI: 10.1038/mt.2016.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fmt.2016.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27731313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKgtL7I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2078-2089&author=S.+Yuauthor=A.+D.+Pearsonauthor=R.+K.+Limauthor=D.+T.+Rodgersauthor=S.+Liauthor=H.+B.+Parkerauthor=M.+Weglarzauthor=E.+N.+Hamptonauthor=M.+J.+Bollongauthor=J.+Shenauthor=C.+Zambaldoauthor=D.+Wangauthor=A.+K.+Woodsauthor=T.+M.+Wrightauthor=P.+G.+Schultzauthor=S.+A.+Kazaneauthor=T.+S.+Youngauthor=M.+S.+Tremblay&title=Targeted+delivery+of+an+anti-inflammatory+PDE4+inhibitor+to+immune+cells+via+an+antibody-drug+conjugate&doi=10.1038%2Fmt.2016.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-drug Conjugate</span></div><div class="casAuthors">Yu, Shan; Pearson, Aaron D.; Lim, Reyna K. V.; Rodgers, David T.; Li, Sijia; Parker, Holly B.; Weglarz, Meredith; Hampton, Eric N.; Bollong, Michael J.; Shen, Jiayin; Zambaldo, Claudio; Wang, Danling; Woods, Ashley K.; Wright, Timothy M.; Schultz, Peter G.; Kazane, Stephanie A.; Young, Travis S.; Tremblay, Matthew S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2078-2089</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphodiesterase 4 (PDE4) inhibitors are approved for the treatment of some moderate to severe inflammatory conditions.  However, dose-limiting side effects in the central nervous system and gastrointestinal tract, including nausea, emesis, headache, and diarrhea, have impeded the broader therapeutic application of PDE4 inhibitors.  We sought to exploit the wealth of validation surrounding PDE4 inhibition by improving the therapeutic index through generation of an antibody-drug conjugate (ADC) that selectively targets immune cells through the CD11a antigen.  The resulting ADC consisted of a human Î±CD11a antibody (based on efalizumab clone hu1124) conjugated to an analog of the highly potent PDE4 inhibitor GSK256066.  Both the human Î±CD11a ADC and a mouse surrogate Î±CD11a ADC (based on the M17 clone) rapidly internalized into immune cells and suppressed lipopolysaccharide (LPS)-induced TNFÎ± secretion in primary human monocytes and mouse peritoneal cells, resp.  In a carrageenan-induced air pouch inflammation mouse model, treatment with the ADC significantly reduced inflammatory cytokine prodn. in the air pouch exudate.  Overall, these results provide compelling evidence for the feasibility of delivering drugs with anti-inflammatory activity selectively to the immune compartment via CD11a and the development of tissue-targeted PDE4 inhibitors as a promising therapeutic modality for treating inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTURNcWDw-37Vg90H21EOLACvtfcHk0ljmAqvGyOUi3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKgtL7I&md5=82964396c796f6cfda7cf938e55bcc72</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1038%2Fmt.2016.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmt.2016.175%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DS.%26aulast%3DPearson%26aufirst%3DA.%2BD.%26aulast%3DLim%26aufirst%3DR.%2BK.%26aulast%3DRodgers%26aufirst%3DD.%2BT.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DH.%2BB.%26aulast%3DWeglarz%26aufirst%3DM.%26aulast%3DHampton%26aufirst%3DE.%2BN.%26aulast%3DBollong%26aufirst%3DM.%2BJ.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DZambaldo%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWoods%26aufirst%3DA.%2BK.%26aulast%3DWright%26aufirst%3DT.%2BM.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DKazane%26aufirst%3DS.%2BA.%26aulast%3DYoung%26aufirst%3DT.%2BS.%26aulast%3DTremblay%26aufirst%3DM.%2BS.%26atitle%3DTargeted%2520delivery%2520of%2520an%2520anti-inflammatory%2520PDE4%2520inhibitor%2520to%2520immune%2520cells%2520via%2520an%2520antibody-drug%2520conjugate%26jtitle%3DMol.%2520Ther.%26date%3D2016%26volume%3D24%26spage%3D2078%26epage%3D2089%26doi%3D10.1038%2Fmt.2016.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weglarz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zumbaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazane, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M.</span></span> <span> </span><span class="NLM_article-title">P-262 A PDE4 inhibitor-antibody conjugate for treating ulcerative colitis</span>. <i>Inflammatory Bowel Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">262</span>, <span class="refDoi">Â DOI: 10.1097/01.MIB.0000512805.98510.c0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1097%2F01.MIB.0000512805.98510.c0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=262&issue=1&author=S.+Yuauthor=A.+Pearsonauthor=R.+Limauthor=D.+Rodgersauthor=S.+Liauthor=H.+Parkerauthor=M.+Weglarzauthor=E.+Hamptonauthor=M.+Bollongauthor=J.+Shenauthor=C.+Zumbaldoauthor=D.+Wangauthor=A.+Woodsauthor=T.+Wrightauthor=P.+Schultzauthor=S.+Kazaneauthor=T.+Youngauthor=M.+Tremblay&title=P-262+A+PDE4+inhibitor-antibody+conjugate+for+treating+ulcerative+colitis&doi=10.1097%2F01.MIB.0000512805.98510.c0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1097%2F01.MIB.0000512805.98510.c0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.MIB.0000512805.98510.c0%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DS.%26aulast%3DPearson%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DR.%26aulast%3DRodgers%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DH.%26aulast%3DWeglarz%26aufirst%3DM.%26aulast%3DHampton%26aufirst%3DE.%26aulast%3DBollong%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DZumbaldo%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DT.%26aulast%3DSchultz%26aufirst%3DP.%26aulast%3DKazane%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DTremblay%26aufirst%3DM.%26atitle%3DP-262%2520A%2520PDE4%2520inhibitor-antibody%2520conjugate%2520for%2520treating%2520ulcerative%2520colitis%26jtitle%3DInflammatory%2520Bowel%2520Dis.%26date%3D2017%26volume%3D23%26issue%3D1%26spage%3D262%26doi%3D10.1097%2F01.MIB.0000512805.98510.c0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazane, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span> <span> </span><span class="NLM_article-title">An immunosuppressive antibody-drug conjugate</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">3229</span>â <span class="NLM_lpage">3232</span>, <span class="refDoi">Â DOI: 10.1021/jacs.5b00620</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b00620" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtV2ms78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=3229-3232&author=R.+E.+Wangauthor=T.+Liuauthor=Y.+Wangauthor=Y.+Caoauthor=J.+Duauthor=X.+Luoauthor=V.+Deshmukhauthor=C.+H.+Kimauthor=B.+R.+Lawsonauthor=M.+S.+Tremblayauthor=T.+S.+Youngauthor=S.+A.+Kazaneauthor=F.+Wangauthor=P.+G.+Schultz&title=An+immunosuppressive+antibody-drug+conjugate&doi=10.1021%2Fjacs.5b00620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">An Immunosuppressive Antibody-dasatinib conjugate and its Lck inhibitory activity</span></div><div class="casAuthors">Wang, Rongsheng E.; Liu, Tao; Wang, Ying; Cao, Yu; Du, Jintang; Luo, Xiaozhou; Deshmukh, Vishal; Kim, Chan Hyuk; Lawson, Brian R.; Tremblay, Matthew S.; Young, Travis S.; Kazane, Stephanie A.; Wang, Feng; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3229-3232</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors have developed a novel antibody-drug conjugate (ADC) that can selectively deliver the Lck inhibitor dasatinib to human T lymphocytes.  This ADC is based on a humanized antibody that selectively binds with high affinity to CXCR4, an antigen that is selectively expressed on hematopoietic cells.  The resulting dasatinib-antibody conjugate suppresses T-cell-receptor (TCR)-mediated T-cell activation and cytokine expression with low nM EC50 and has minimal effects on cell viability.  This ADC may lead to a new class of selective immunosuppressive drugs with improved safety and extend the ADC strategy to the targeted delivery of kinase inhibitors for indications beyond oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5o7sm-GjByLVg90H21EOLACvtfcHk0ljmAqvGyOUi3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtV2ms78%253D&md5=13c29dbff95aee1e20e256351beb4dcb</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b00620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b00620%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%2BE.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DDeshmukh%26aufirst%3DV.%26aulast%3DKim%26aufirst%3DC.%2BH.%26aulast%3DLawson%26aufirst%3DB.%2BR.%26aulast%3DTremblay%26aufirst%3DM.%2BS.%26aulast%3DYoung%26aufirst%3DT.%2BS.%26aulast%3DKazane%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DAn%2520immunosuppressive%2520antibody-drug%2520conjugate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D3229%26epage%3D3232%26doi%3D10.1021%2Fjacs.5b00620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span> <i>Chemical Biology: From Small Molecules to Systems
Biology and Drug
Design</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, L. S.</span>, <span class="NLM_string-name">Kapoor, T.</span>, <span class="NLM_string-name">Wess, G.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2007</span>; Vol.  <span class="NLM_volume">1-3</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2F9783527619375" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=L.+S.+Schreiber&author=T.+Kapoor&author=G.+Wess&title=Chemical+Biology%3A+From+Small+Molecules+to+Systems%0ABiology+and+Drug%0ADesign"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1002%2F9783527619375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527619375%26sid%3Dliteratum%253Aachs%26btitle%3DChemical%2520Biology%253A%2520From%2520Small%2520Molecules%2520to%2520Systems%250ABiology%2520and%2520Drug%250ADesign%26aulast%3DSchreiber%26aufirst%3DL.%2BS.%26pub%3DWiley-VCH%26date%3D2007%26volume%3D1-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span> <span> </span><span class="NLM_article-title">Applications of chemogenomic library screening in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">285</span>â <span class="NLM_lpage">296</span>, <span class="refDoi">Â DOI: 10.1038/nrd.2016.244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnrd.2016.244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28104905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ort7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=285-296&issue=4&author=L.+H.+Jonesauthor=M.+E.+Bunnage&title=Applications+of+chemogenomic+library+screening+in+drug+discovery&doi=10.1038%2Fnrd.2016.244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of chemogenomic library screening in drug discovery</span></div><div class="casAuthors">Jones, Lyn H.; Bunnage, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">285-296</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The allure of phenotypic screening, combined with the industry preference for target-based approaches, has prompted the development of innovative chem. biol. technologies that facilitate the identification of new therapeutic targets for accelerated drug discovery.  A chemogenomic library is a collection of selective small-mol. pharmacol. agents, and a hit from such a set in a phenotypic screen suggests that the annotated target or targets of that pharmacol. agent may be involved in perturbing the observable phenotype.  In this Review, we describe opportunities for chemogenomic screening to considerably expedite the conversion of phenotypic screening projects into target-based drug discovery approaches.  Other applications are explored, including drug repositioning, predictive toxicol. and the discovery of novel pharmacol. modalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruetMviqci8rVg90H21EOLACvtfcHk0lhMUddYIRw9AA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ort7c%253D&md5=a51a882947528be18392170cfa48c554</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.244%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26atitle%3DApplications%2520of%2520chemogenomic%2520library%2520screening%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26issue%3D4%26spage%3D285%26epage%3D296%26doi%3D10.1038%2Fnrd.2016.244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hermansonn, G. T.</span></span> <i>Bioconjugate Techniques</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA, U.S.</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=G.+T.+Hermansonn&title=Bioconjugate+Techniques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHermansonn%26aufirst%3DG.%2BT.%26btitle%3DBioconjugate%2520Techniques%26pub%3DAcademic%2520Press%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span> <span> </span><span class="NLM_article-title">Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">13449</span>â <span class="NLM_lpage">13458</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M117.787267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1074%2Fjbc.M117.787267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28634233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlWhurzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=13449-13458&author=D.+Chenauthor=A.+Janssonauthor=D.+Simauthor=A.+Larssonauthor=P.+Nordlund&title=Structural+analyses+of+human+thymidylate+synthase+reveal+a+site+that+may+control+conformational+switching+between+active+and+inactive+states&doi=10.1074%2Fjbc.M117.787267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states</span></div><div class="casAuthors">Chen, Dan; Jansson, Anna; Sim, Daniel; Larsson, Andreas; Nordlund, Par</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">13449-13458</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is the sole enzyme responsible for de novo biosynthesis of thymidylate (TMP) and is essential for cell proliferation and survival.  Inhibition of human TS (hTS) has been extensively investigated for cancer chemotherapy, but several aspects of its activity and regulation are still uncertain.  In this study, we performed comprehensive structural and biophys. studies of hTS using crystallog. and thermal shift assay and provided the first detailed structural information on the conformational changes induced by ligand binding to the hTS active site.  We found that upon binding of the antifolate agents raltitrexed and nolatrexed, the two insert regions in hTS, the functions of which are unclear, undergo positional shifts toward the catalytic center.  We investigated the inactive conformation of hTS and found that the two insert regions are also involved in the conformational transition between the active and inactive state of hTS.  Moreover, we identified a ligand-binding site in the dimer interface, suggesting that the cavity in the dimer interface could serve as an allosteric site of hTS to regulate the conformational switching between the active and inactive states.  On the basis of these findings, we propose a regulatory mechanism of hTS activity that involves allosteric regulation of interactions of hTS with its own mRNA depending on cellular demands for TMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCnnQ5-JBnyrVg90H21EOLACvtfcHk0lhMUddYIRw9AA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlWhurzO&md5=64ac57f382a4d48721ac76bb91ead06e</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.787267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.787267%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DJansson%26aufirst%3DA.%26aulast%3DSim%26aufirst%3DD.%26aulast%3DLarsson%26aufirst%3DA.%26aulast%3DNordlund%26aufirst%3DP.%26atitle%3DStructural%2520analyses%2520of%2520human%2520thymidylate%2520synthase%2520reveal%2520a%2520site%2520that%2520may%2520control%2520conformational%2520switching%2520between%2520active%2520and%2520inactive%2520states%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D13449%26epage%3D13458%26doi%3D10.1074%2Fjbc.M117.787267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Durham, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, M. J.</span></span> <span> </span><span class="NLM_article-title">Target engagement in lead generation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">998</span>â <span class="NLM_lpage">1008</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.12.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.bmcl.2014.12.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25630223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC2MrgsFejug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=998-1008&author=T.+B.+Durhamauthor=M.+J.+Blanco&title=Target+engagement+in+lead+generation&doi=10.1016%2Fj.bmcl.2014.12.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Target engagement in lead generation</span></div><div class="casAuthors">Durham Timothy B; Blanco Maria-Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">998-1008</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pharmaceutical industry is currently facing multiple challenges, in particular the low number of new drug approvals in spite of the high level of R&D investment.  In order to improve target selection and assess properly the clinical hypothesis, it is important to start building an integrated drug discovery approach during Lead Generation.  This should include special emphasis on evaluating target engagement in the target tissue and linking preclinical to clinical readouts.  In this review, we would like to illustrate several strategies and technologies for assessing target engagement and the value of its application to medicinal chemistry efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTY-Uy19yFbSukdrW1FkXG-fW6udTcc2eYJ4E-wJl3oabntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MrgsFejug%253D%253D&md5=ecafc397f5418f21d83f7881548ae490</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.076%26sid%3Dliteratum%253Aachs%26aulast%3DDurham%26aufirst%3DT.%2BB.%26aulast%3DBlanco%26aufirst%3DM.%2BJ.%26atitle%3DTarget%2520engagement%2520in%2520lead%2520generation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D998%26epage%3D1008%26doi%3D10.1016%2Fj.bmcl.2014.12.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">SchÃ¼rmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janning, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Small-molecule target engagement in cells</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">435</span>â <span class="NLM_lpage">441</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2016.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.chembiol.2016.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27049669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlSqtb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=435-441&author=M.+Sch%C3%BCrmannauthor=P.+Janningauthor=S.+Zieglerauthor=H.+Waldmann&title=Small-molecule+target+engagement+in+cells&doi=10.1016%2Fj.chembiol.2016.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Target Engagement in Cells</span></div><div class="casAuthors">Schuermann, Marc; Janning, Petra; Ziegler, Slava; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">435-441</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Monitoring how, when, and where small mols. engage their targets inside living cells is a crit. step in chem. biol. and pharmacol. research, because it enables compd. efficacy and confirmation of mode of action to be assessed.  In this mini-review we summarize the currently available methodologies to detect and prove direct target engagement in cells and offer a crit. view of their key advantages and disadvantages.  As the interest of the field shifts toward discovery and validation of high-quality agents, we expect that efforts to develop and refine these types of methodologies will also intensify in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFG52Nxfgik7Vg90H21EOLACvtfcHk0lhBhce627CbCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlSqtb4%253D&md5=b81e50faa188d916de61b5dc01294ea8</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2016.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2016.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25BCrmann%26aufirst%3DM.%26aulast%3DJanning%26aufirst%3DP.%26aulast%3DZiegler%26aufirst%3DS.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DSmall-molecule%2520target%2520engagement%2520in%2520cells%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D435%26epage%3D441%26doi%3D10.1016%2Fj.chembiol.2016.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudkouskaya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinsuebphon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubbesing, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Intes, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, M.</span></span> <span> </span><span class="NLM_article-title">Quantitative imaging of receptor-ligand engagement in intact live animals</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">451</span>â <span class="NLM_lpage">459</span>, <span class="refDoi">Â DOI: 10.1016/j.jconrel.2018.07.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.jconrel.2018.07.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30036545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFCrt7%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2018&pages=451-459&author=A.+Rudkouskayaauthor=N.+Sinsuebphonauthor=J.+Wardauthor=K.+Tubbesingauthor=X.+Intesauthor=M.+Barroso&title=Quantitative+imaging+of+receptor-ligand+engagement+in+intact+live+animals&doi=10.1016%2Fj.jconrel.2018.07.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative imaging of receptor-ligand engagement in intact live animals</span></div><div class="casAuthors">Rudkouskaya, Alena; Sinsuebphon, Nattawut; Ward, Jamie; Tubbesing, Kate; Intes, Xavier; Barroso, Margarida</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">451-459</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Maintaining an intact tumor environment is crit. for quantitation of receptor-ligand engagement in a targeted drug development pipeline.  However, measuring receptor-ligand engagement in vivo and non-invasively in preclin. settings is extremely challenging.  We found that quantitation of intracellular receptor-ligand binding can be achieved using whole-body macroscopic lifetime-based Forster Resonance Energy Transfer (FRET) imaging in intact, live animals bearing tumor xenografts.  We detd. that FRET levels report on ligand binding to transferrin receptors conversely to raw fluorescence intensity.  FRET levels in heterogeneous tumors correlate with intracellular ligand binding but strikingly, not with ubiquitously used ex vivo receptor expression assessment.  Hence, MFLI-FRET provides a direct measurement of systemic delivery, target availability and intracellular drug delivery in preclin. studies.  Here, we have used MFLI to measure FRET longitudinally in intact and live animals.  MFLI-FRET is well-suited for guiding the development of targeted drug therapy in heterogeneous tumors in intact, live small animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmDJu1-V1P17Vg90H21EOLACvtfcHk0lhBhce627CbCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFCrt7%252FM&md5=8858fa552ec89ae64e00414596a656b1</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2018.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2018.07.032%26sid%3Dliteratum%253Aachs%26aulast%3DRudkouskaya%26aufirst%3DA.%26aulast%3DSinsuebphon%26aufirst%3DN.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DTubbesing%26aufirst%3DK.%26aulast%3DIntes%26aufirst%3DX.%26aulast%3DBarroso%26aufirst%3DM.%26atitle%3DQuantitative%2520imaging%2520of%2520receptor-ligand%2520engagement%2520in%2520intact%2520live%2520animals%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2018%26volume%3D286%26spage%3D451%26epage%3D459%26doi%3D10.1016%2Fj.jconrel.2018.07.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dart, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodroofe, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimprich, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkland, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machleidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupcho, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartnett, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niles, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohana, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. V.</span></span> <span> </span><span class="NLM_article-title">Target engagement and drug residence time can be observed in living cells with BRET</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">10091</span>, <span class="refDoi">Â DOI: 10.1038/ncomms10091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fncomms10091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=26631872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGmtrnO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=10091&author=M.+B.+Robersauthor=M.+L.+Dartauthor=C.+C.+Woodroofeauthor=C.+A.+Zimprichauthor=T.+A.+Kirklandauthor=T.+Machleidtauthor=K.+R.+Kupchoauthor=S.+Levinauthor=J.+R.+Hartnettauthor=K.+Zimmermanauthor=A.+L.+Nilesauthor=R.+F.+Ohanaauthor=D.+L.+Danielsauthor=M.+Slaterauthor=M.+G.+Woodauthor=M.+Congauthor=Y.+Q.+Chengauthor=K.+V.+Wood&title=Target+engagement+and+drug+residence+time+can+be+observed+in+living+cells+with+BRET&doi=10.1038%2Fncomms10091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Target engagement and drug residence time can be observed in living cells with BRET</span></div><div class="casAuthors">Robers, Matthew B.; Dart, Melanie L.; Woodroofe, Carolyn C.; Zimprich, Chad A.; Kirkland, Thomas A.; Machleidt, Thomas; Kupcho, Kevin R.; Levin, Sergiy; Hartnett, James R.; Zimmerman, Kristopher; Niles, Andrew L.; Ohana, Rachel Friedman; Daniels, Danette L.; Slater, Michael; Wood, Monika G.; Cong, Mei; Cheng, Yi-Qiang; Wood, Keith V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10091</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The therapeutic action of drugs is predicated on their phys. engagement with cellular targets.  Here we describe a broadly applicable method using bioluminescence resonance energy transfer (BRET) to reveal the binding characteristics of a drug with selected targets within intact cells.  Cell-permeable fluorescent tracers are used in a competitive binding format to quantify drug engagement with the target proteins fused to Nanoluc luciferase.  The approach enabled us to profile isoenzyme-specific engagement and binding kinetics for a panel of histone deacetylase (HDAC) inhibitors.  Our anal. was directed particularly to the clin. approved prodrug FK228 (Istodax/Romidepsin) because of its unique and largely unexplained mechanism of sustained intracellular action.  Anal. of the binding kinetics by BRET revealed remarkably long intracellular residence times for FK228 at HDAC1, explaining the protracted intracellular behavior of this prodrug.  Our results demonstrate a novel application of BRET for assessing target engagement within the complex milieu of the intracellular environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRFFk0LNiL_LVg90H21EOLACvtfcHk0lgUoyEXFoHNIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGmtrnO&md5=723cc5dd7d229b1115da4c2c9d75c913</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1038%2Fncomms10091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10091%26sid%3Dliteratum%253Aachs%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DDart%26aufirst%3DM.%2BL.%26aulast%3DWoodroofe%26aufirst%3DC.%2BC.%26aulast%3DZimprich%26aufirst%3DC.%2BA.%26aulast%3DKirkland%26aufirst%3DT.%2BA.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DKupcho%26aufirst%3DK.%2BR.%26aulast%3DLevin%26aufirst%3DS.%26aulast%3DHartnett%26aufirst%3DJ.%2BR.%26aulast%3DZimmerman%26aufirst%3DK.%26aulast%3DNiles%26aufirst%3DA.%2BL.%26aulast%3DOhana%26aufirst%3DR.%2BF.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DM.%2BG.%26aulast%3DCong%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DY.%2BQ.%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DTarget%2520engagement%2520and%2520drug%2520residence%2520time%2520can%2520be%2520observed%2520in%2520living%2520cells%2520with%2520BRET%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D10091%26doi%3D10.1038%2Fncomms10091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, E. K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheal, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machleidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfleger, K. D. G.</span></span> <span> </span><span class="NLM_article-title">Application of BRET to monitor ligand binding to GPCRs</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">661</span>â <span class="NLM_lpage">663</span>, <span class="refDoi">Â DOI: 10.1038/nmeth.3398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnmeth.3398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=26030448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtbbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=661-663&author=L.+A.+Stoddartauthor=E.+K.+M.+Johnstoneauthor=A.+J.+Whealauthor=J.+Gouldingauthor=M.+B.+Robersauthor=T.+Machleidtauthor=K.+V.+Woodauthor=S.+J.+Hillauthor=K.+D.+G.+Pfleger&title=Application+of+BRET+to+monitor+ligand+binding+to+GPCRs&doi=10.1038%2Fnmeth.3398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Application of BRET to monitor ligand binding to GPCRs</span></div><div class="casAuthors">Stoddart, Leigh A.; Johnstone, Elizabeth K. M.; Wheal, Amanda J.; Goulding, Joelle; Robers, Matthew B.; Machleidt, Thomas; Wood, Keith V.; Hill, Stephen J.; Pfleger, Kevin D. G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">661-663</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bioluminescence resonance energy transfer (BRET) is a well-established method for investigating protein-protein interactions.  Here we present a BRET approach to monitor ligand binding to G protein-coupled receptors (GPCRs) on the surface of living cells made possible by the use of fluorescent ligands in combination with a bioluminescent protein (NanoLuc) that can be readily expressed on the N terminus of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKCGBtnUo25LVg90H21EOLACvtfcHk0lgUoyEXFoHNIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtbbI&md5=b829c12d21f0079ceb4222be2ebf6f32</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.3398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.3398%26sid%3Dliteratum%253Aachs%26aulast%3DStoddart%26aufirst%3DL.%2BA.%26aulast%3DJohnstone%26aufirst%3DE.%2BK.%2BM.%26aulast%3DWheal%26aufirst%3DA.%2BJ.%26aulast%3DGoulding%26aufirst%3DJ.%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DK.%2BV.%26aulast%3DHill%26aufirst%3DS.%2BJ.%26aulast%3DPfleger%26aufirst%3DK.%2BD.%2BG.%26atitle%3DApplication%2520of%2520BRET%2520to%2520monitor%2520ligand%2520binding%2520to%2520GPCRs%26jtitle%3DNat.%2520Methods%26date%3D2015%26volume%3D12%26spage%3D661%26epage%3D663%26doi%3D10.1038%2Fnmeth.3398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simon, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niphakis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Determining target engagement in living systems</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">200</span>â <span class="NLM_lpage">205</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.1211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnchembio.1211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23508173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFWku7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=200-205&author=G.+M.+Simonauthor=M.+J.+Niphakisauthor=B.+F.+Cravatt&title=Determining+target+engagement+in+living+systems&doi=10.1038%2Fnchembio.1211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Determining target engagement in living systems</span></div><div class="casAuthors">Simon, Gabriel M.; Niphakis, Micah J.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">200-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chem. probes are crit. tools for elucidating the biol. functions of proteins and can lead to new medicines for treating disease.  The pharmacol. validation of protein function requires verification that chem. probes engage their intended targets in vivo.  Here we discuss technologies, both established and emergent, for measuring target engagement in living systems and propose that detg. this parameter should become std. practice for chem. probe and drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5eudh3YJSOLVg90H21EOLACvtfcHk0lgUoyEXFoHNIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFWku7g%253D&md5=48a97d0d8ff7a7de4f9de0e9c54a1c5c</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1211%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDetermining%2520target%2520engagement%2520in%2520living%2520systems%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D200%26epage%3D205%26doi%3D10.1038%2Fnchembio.1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompliano, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">Drug-target residence time and its implications for lead optimization</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">730</span>â <span class="NLM_lpage">739</span>, <span class="refDoi">Â DOI: 10.1038/nrd2082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnrd2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=16888652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug-target+residence+time+and+its+implications+for+lead+optimization&doi=10.1038%2Fnrd2082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time and its implications for lead optimization</span></div><div class="casAuthors">Copeland, Robert A.; Pompliano, David L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">730-739</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromols. by low-mol.-mass drugs.  The binding of drugs to their macromol. targets is therefore seen as paramount for pharmacol. activity.  In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC50 or Kd.  This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex.  We describe the potential advantages of long residence time in terms of duration of pharmacol. effect and target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6SJrMlrrTbVg90H21EOLACvtfcHk0lig8uzx7XQyFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D&md5=60ede2301584b10ac4e8fa18e1e6d107</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1038%2Fnrd2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2082%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug-target%2520residence%2520time%2520and%2520its%2520implications%2520for%2520lead%2520optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739%26doi%3D10.1038%2Fnrd2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tummino, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Residence time of receptor-ligand complexes and its effect on biological function</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5481</span>â <span class="NLM_lpage">5492</span>, <span class="refDoi">Â DOI: 10.1021/bi8002023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi8002023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1Ont7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=5481-5492&author=P.+J.+Tumminoauthor=R.+A.+Copeland&title=Residence+time+of+receptor-ligand+complexes+and+its+effect+on+biological+function&doi=10.1021%2Fbi8002023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Residence Time of Receptor-Ligand Complexes and Its Effect on Biological Function</span></div><div class="casAuthors">Tummino, Peter J.; Copeland, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5481-5492</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The formation and duration of binary receptor-ligand complexes are fundamental to many physiol. processes.  Most often, the effectiveness of interaction between a receptor and its ligand is quantified in terms of closed system, equil. affinity measurements, such as IC50 and Kd.  In the context of in vivo biol., however, the extent and duration of responses to receptor-ligand interactions depend greatly on the time period over which the ligand is in residence on its receptor.  Here we define receptor-ligand complex residence time in quant. terms and describe its significance to biol. function.  Examples of the importance of residence time are presented for natural ligands of different receptor types.  The impact of residence time on the optimization of potential ligands as drugs for human medicine is also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHshN2Bt_r9LVg90H21EOLACvtfcHk0lig8uzx7XQyFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1Ont7s%253D&md5=57f79f69f12c6ed14e3347638381d943</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fbi8002023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi8002023%26sid%3Dliteratum%253Aachs%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DResidence%2520time%2520of%2520receptor-ligand%2520complexes%2520and%2520its%2520effect%2520on%2520biological%2520function%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D5481%26epage%3D5492%26doi%3D10.1021%2Fbi8002023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vauquelin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span> <span> </span><span class="NLM_article-title">Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">1771</span>â <span class="NLM_lpage">1785</span>, <span class="refDoi">Â DOI: 10.1111/bph.12106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1111%2Fbph.12106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23330947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsVylur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=1771-1785&author=G.+Vauquelinauthor=S.+J.+Charlton&title=Exploring+avidity%3A+understanding+the+potential+gains+in+functional+affinity+and+target+residence+time+of+bivalent+and+heterobivalent+ligands&doi=10.1111%2Fbph.12106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands</span></div><div class="casAuthors">Vauquelin, Georges; Charlton, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1771-1785</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Bivalent ligands are increasingly important therapeutic agents.  Although the naturally occurring antibodies are predominant, it is becoming more common to combine different antibody fragments or even low mol. wt. compds. to generate heterobivalent ligands.  Such ligands exhibit markedly increased affinity (i.e. avidity) and target residence time when both pharmacophores can bind simultaneously to their target sites.  This is because binding of one pharmacophore forces the second tethered one to stay close to its corresponding site.  This "forced proximity" favors its binding and rebinding (once dissocd.) to that site.  However, rebinding will also take place when the diffusion of freshly dissocd. ligands is merely slowed down.  The present differential equation-based simulations explore the way both situations affect ligand binding.  Both delay the attainment of binding equil. (resulting in steep satn. curves) and also increase the target residence time.  Competitive ligands are able to interfere in a concn.-dependent manner, although much higher concns. are required in the "forced proximity" situation.  Also, it is only in that situation that the ligand shows increased affinity.  These simulations shed light on two practical consequences.  Depending on the pharmacokinetic half-life of the bivalent ligand in the body, it may not have sufficient time to achieve equil. with the target.  This will result in lower potency than expected, although it would have significant advantages in terms of residence time.  In in vitro expts., the manifestation of steep satn. curves and of accelerated dissocn. in the presence of competitive ligands could mistakenly be interpreted as evidence for non-competitive, allosteric interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbgxbt6V_uc7Vg90H21EOLACvtfcHk0lig8uzx7XQyFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsVylur4%253D&md5=d0868461b986affb15003dccaa8f7c99</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1111%2Fbph.12106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12106%26sid%3Dliteratum%253Aachs%26aulast%3DVauquelin%26aufirst%3DG.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26atitle%3DExploring%2520avidity%253A%2520understanding%2520the%2520potential%2520gains%2520in%2520functional%2520affinity%2520and%2520target%2520residence%2520time%2520of%2520bivalent%2520and%2520heterobivalent%2520ligands%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D168%26spage%3D1771%26epage%3D1785%26doi%3D10.1111%2Fbph.12106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebru, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. G.</span></span> <span> </span><span class="NLM_article-title">Time-resolved FRET and NMR analyses reveal selective binding of peptides containing the LC3-interacting region to ATG8 family proteins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">14033</span>â <span class="NLM_lpage">14042</span>, <span class="refDoi">Â DOI: 10.1074/jbc.RA119.008723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1074%2Fjbc.RA119.008723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=31362979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1Omt7fN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=14033-14042&issue=38&author=J.+M.+Atkinsonauthor=Y.+Yeauthor=M.+T.+Gebruauthor=Q.+Liuauthor=S.+Zhouauthor=M.+M.+Youngauthor=Y.+Takahashiauthor=Q.+Linauthor=F.+Tianauthor=H.+G.+Wang&title=Time-resolved+FRET+and+NMR+analyses+reveal+selective+binding+of+peptides+containing+the+LC3-interacting+region+to+ATG8+family+proteins&doi=10.1074%2Fjbc.RA119.008723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Time-resolved FRET and NMR analyses reveal selective binding of peptides containing the LC3-interacting region to ATG8 family proteins</span></div><div class="casAuthors">Atkinson, Jennifer M.; Ye, Yansheng; Gebru, Melat T.; Liu, Qiang; Zhou, Shouhao; Young, Megan M.; Takahashi, Yoshinori; Lin, Qing; Tian, Fang; Wang, Hong-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">14033-14042</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Selective autophagy sequesters cytoplasmic cargo for lysosomal degrdn. via the binding of autophagy receptors to Atg8 (autophagy-related 8) family proteins on the autophagic membrane.  The sole yeast Atg8 gene has six mAtg8 (mammalian Atg8) homologs, including the MAP1LC3 (microtubule-assocd. protein-1 light chain 3) family and the GABA receptor-assocd. proteins.  Selective autophagy receptors interact with two conserved hydrophobic pockets (termed the W-site and L-site) of mATG8 proteins through a linear motif called the LC3-interacting region (LIR) with the general compn. (W/F/Y)XX(I/L/V).  To address a lack in our knowledge regarding LIR peptide specificity toward each mATG8 homolog, here we used competitive time-resolved FRET to sensitively and quant. characterize the interactions between LIRs and mAtg8.  We report that 14 representative LIR-contg. peptides display differential binding affinities toward the mAtg8 proteins and identified the LIR domain peptide of TP53INP1 as exhibiting high affinity for all six mATG8 proteins.  Using peptide truncation studies, we found that both N- and C-terminal acidic residues, as well as the C-terminal Cys residue of the TP53INP1 LIR peptide, are required for its high-affinity binding to LC3A and LC3B, whereas binding to the GABARAP subfamily proteins was facilitated by residues either N-terminal or C-terminal to the core motif.  Finally, we used NMR chem. shift perturbation anal. to gain mol. insights into these findings.  Collectively, our results may aid in the development of mols. that selectively disrupt specific mATG8-LIR interactions to dissect the biol. roles of the six mATG8 homologs for potential therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOcEE61TwCcLVg90H21EOLACvtfcHk0liNgGpULPNJhg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1Omt7fN&md5=872143cc537a6849662a475558894201</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.008723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.008723%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DJ.%2BM.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DGebru%26aufirst%3DM.%2BT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DM.%2BM.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DQ.%26aulast%3DTian%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%2BG.%26atitle%3DTime-resolved%2520FRET%2520and%2520NMR%2520analyses%2520reveal%2520selective%2520binding%2520of%2520peptides%2520containing%2520the%2520LC3-interacting%2520region%2520to%2520ATG8%2520family%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26issue%3D38%26spage%3D14033%26epage%3D14042%26doi%3D10.1074%2Fjbc.RA119.008723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amason, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcin, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dranchak, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macarthur, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braisted, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span> <span> </span><span class="NLM_article-title">Quantitative high-throughput screening assays for the discovery and development of SIRPÎ±-CD47 interaction inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e0218897</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0218897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1371%2Fjournal.pone.0218897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=31276567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslWksrjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&issue=7&author=T.+W.+Millerauthor=J.+D.+Amasonauthor=E.+D.+Garcinauthor=L.+Lamyauthor=P.+K.+Dranchakauthor=R.+Macarthurauthor=J.+Braistedauthor=J.+S.+Rubinauthor=T.+L.+Burgessauthor=C.+L.+Farrellauthor=D.+D.+Robertsauthor=J.+Inglese&title=Quantitative+high-throughput+screening+assays+for+the+discovery+and+development+of+SIRP%CE%B1-CD47+interaction+inhibitors&doi=10.1371%2Fjournal.pone.0218897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative high-throughput screening assays for the discovery and development of SIRPÎ±-CD47 interaction inhibitors</span></div><div class="casAuthors">Miller, Thomas W.; Amason, Joshua D.; Garcin, Elsa D.; Lamy, Laurence; Dranchak, Patricia K.; Macarthur, Ryan; Braisted, John; Rubin, Jeffrey S.; Burgess, Teresa L.; Farrell, Catherine L.; Roberts, David D.; Inglese, James</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e0218897</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">CD47 is an immune checkpoint mol. that downregulates key aspects of both the innate and adaptive anti-tumor immune response via its counter receptor SIRPÎ±, and it is expressed at high levels in a wide variety of tumor types.  This has led to the development of biologics that inhibit SIRPÎ± engagement including humanized CD47 antibodies and a sol. SIRPÎ± decoy receptor that are currently undergoing clin. trials.  Unfortunately, toxicol. issues, including anemia related to on-target mechanisms, are barriers to their clin. advancement.  Another potential issue with large biologics that bind CD47 is perturbation of CD47 signaling through its high-affinity interaction with the matricellular protein thrombospondin-1 (TSP1).  One approach to avoid these shortcomings is to identify and develop small mol. mol. probes and pretherapeutic agents that would (1) selectively target SIRPÎ± or TSP1 interactions with CD47, (2) provide a route to optimize pharmacokinetics, reduce on-target toxicity and maximize tissue penetration, and (3) allow more flexible routes of administration.  As the first step toward this goal, we report the development of an automated quant. high-throughput screening (qHTS) assay platform capable of screening large diverse drug-like chem. libraries to discover novel small mols. that inhibit CD47-SIRPÎ± interaction.  Using time-resolved Forster resonance energy transfer (TR-FRET) and bead-based luminescent oxygen channeling assay formats (AlphaScreen), we developed biochem. assays, optimized their performance, and individually tested them in small-mol. library screening.  Based on performance and low false pos. rate, the LANCE TR-FRET assay was employed in a ~ 90,000 compd. library qHTS, while the AlphaScreen oxygen channeling assay served as a cross-validation orthogonal assay for follow-up characterization.  With this multi-assay strategy, we successfully eliminated compds. that interfered with the assays and identified five compds. that inhibit the CD47-SIRPÎ± interaction; these compds. will be further characterized and later disclosed.  Importantly, our results validate the large library qHTS for antagonists of CD47-SIRPÎ± interaction and suggest broad applicability of this approach to screen chem. libraries for other protein-protein interaction modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiuhG9zdKtzrVg90H21EOLACvtfcHk0liNgGpULPNJhg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslWksrjJ&md5=d21c80c6b39439cb1584e9f9de90c963</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0218897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0218897%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DT.%2BW.%26aulast%3DAmason%26aufirst%3DJ.%2BD.%26aulast%3DGarcin%26aufirst%3DE.%2BD.%26aulast%3DLamy%26aufirst%3DL.%26aulast%3DDranchak%26aufirst%3DP.%2BK.%26aulast%3DMacarthur%26aufirst%3DR.%26aulast%3DBraisted%26aufirst%3DJ.%26aulast%3DRubin%26aufirst%3DJ.%2BS.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26aulast%3DFarrell%26aufirst%3DC.%2BL.%26aulast%3DRoberts%26aufirst%3DD.%2BD.%26aulast%3DInglese%26aufirst%3DJ.%26atitle%3DQuantitative%2520high-throughput%2520screening%2520assays%2520for%2520the%2520discovery%2520and%2520development%2520of%2520SIRP%25CE%25B1-CD47%2520interaction%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2019%26volume%3D14%26issue%3D7%26doi%3D10.1371%2Fjournal.pone.0218897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, P. M.</span></span> <span> </span><span class="NLM_article-title">Quantitative determination of protein stability and ligand binding using a green fluorescent protein reporter system</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1285</span>â <span class="NLM_lpage">1292</span>, <span class="refDoi">Â DOI: 10.1039/c002001j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2Fc002001j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=20454718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsVOns7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=1285-1292&author=M.+J.+Moreauauthor=I.+Morinauthor=P.+M.+Schaeffer&title=Quantitative+determination+of+protein+stability+and+ligand+binding+using+a+green+fluorescent+protein+reporter+system&doi=10.1039%2Fc002001j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative determination of protein stability and ligand binding using a green fluorescent protein reporter system</span></div><div class="casAuthors">Moreau, Morgane J. J.; Morin, Isabelle; Schaeffer, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1285-1292</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Information about the stability of proteins is paramount to det. their optimal storage or reaction conditions.  It is also essential to det. protein stability in high-throughput when screening for new or improved functions of proteins obtained from large mutant libraries.  In drug discovery programs, monitoring of ligand-induced stabilization effects can be used to identify lead compds. in high-throughput.  These studies require expensive biophys. instrumentation and large quantities of purified proteins.  To address these issues, we developed a new method, using GFP as a reporter system to quantify the stability of a protein and its ligand-assocd. stabilization effects that requires neither special equipment nor extensive purifn. steps.  Here, GFP is fused to a protein of interest (POI) through a linker and is used as a reporter system for protein unfolding and aggregation.  The three POIs used in this study include the Ter-binding protein Tus, glycerol kinase and chloramphenicol acetyl transferase.  The fluorescent fusion protein is subjected to irreversible thermal denaturation leading to formation of aggregates, which are eliminated by a centrifugation step.  The residual fluorescence of the sol. fraction can be directly related to the stability of the POI and can be quant. monitored using a fluorescence plate reader.  The GFP-based stability assay (GFP-Basta) was able to identify stabilizing compds. and afforded a new quant. method for the screening and ranking of ligands for three different proteins.  These applications are particularly useful for drug discovery, directed evolution, structural and functional genomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Z1DX66ltIbVg90H21EOLACvtfcHk0lgyRRn6MYLJtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsVOns7s%253D&md5=95dd1d32e17d80f4bc1806951aa46c9b</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1039%2Fc002001j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc002001j%26sid%3Dliteratum%253Aachs%26aulast%3DMoreau%26aufirst%3DM.%2BJ.%26aulast%3DMorin%26aufirst%3DI.%26aulast%3DSchaeffer%26aufirst%3DP.%2BM.%26atitle%3DQuantitative%2520determination%2520of%2520protein%2520stability%2520and%2520ligand%2520binding%2520using%2520a%2520green%2520fluorescent%2520protein%2520reporter%2520system%26jtitle%3DMol.%2520BioSyst.%26date%3D2010%26volume%3D6%26spage%3D1285%26epage%3D1292%26doi%3D10.1039%2Fc002001j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¼cherl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borst, J. W.</span></span> <span> </span><span class="NLM_article-title">Probing protein-protein Interactions with FRET-FLIM</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>655</i></span>,  <span class="NLM_fpage">389</span>â <span class="NLM_lpage">399</span>, <span class="refDoi">Â DOI: 10.1007/978-1-60761-765-5_26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-60761-765-5_26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=20734275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKrurjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=655&publication_year=2010&pages=389-399&author=C.+B%C3%BCcherlauthor=J.+Akerauthor=S.+de+Vriesauthor=J.+W.+Borst&title=Probing+protein-protein+Interactions+with+FRET-FLIM&doi=10.1007%2F978-1-60761-765-5_26"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Probing protein-protein interactions with FRET-FLIM</span></div><div class="casAuthors">Buecherl, Christoph; Aker, Jose; de Vries, Sacco; Borst, Jan Willem</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">655</span>
        (<span class="NLM_cas:issue">Plant Developmental Biology</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The quantification of mol. interactions or conformational changes can conveniently be studied by using Foerster Resonance Energy Transfer (FRET) as a spectroscopic ruler.  The FRET phenomenon describes the transfer of energy from a donor to an acceptor mol., if they are in close proximity (<10 nm).  The most straightforward method to measure FRET is Fluorescence Lifetime Imaging Microscopy (FLIM).  In this chapter, we will describe an application of FRET using FLIM to monitor the hexamer formation of CrFP/eYFP-labeled Arabidopsis thaliana cell division cycle protein (AtCDC48) expressed in plant protoplasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK5Nv9VbZdp7Vg90H21EOLACvtfcHk0lgyRRn6MYLJtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKrurjI&md5=d95f3f78937e9b4b58e10853fbb65ff0</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1007%2F978-1-60761-765-5_26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-60761-765-5_26%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25BCcherl%26aufirst%3DC.%26aulast%3DAker%26aufirst%3DJ.%26aulast%3Dde%2BVries%26aufirst%3DS.%26aulast%3DBorst%26aufirst%3DJ.%2BW.%26atitle%3DProbing%2520protein-protein%2520Interactions%2520with%2520FRET-FLIM%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2010%26volume%3D655%26spage%3D389%26epage%3D399%26doi%3D10.1007%2F978-1-60761-765-5_26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liclican, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JÃ¼rgensmeier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagratis, N.</span></span> <span> </span><span class="NLM_article-title">Homogeneous BTK occupancy assay for pharmacodynamic assessment of tirabrutinib (GS-4059/ONO-4059) target engagement</span>. <i>SLAS Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">919</span>â <span class="NLM_lpage">929</span>, <span class="refDoi">Â DOI: 10.1177/2472555218786165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1177%2F2472555218786165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30011241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOgsrrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=919-929&author=H.+Yuauthor=H.+Truongauthor=S.+A.+Mitchellauthor=A.+Liclicanauthor=J.+J.+Gosinkauthor=W.+Liauthor=J.+Linauthor=J.+Y.+Fengauthor=J.+M.+J%C3%BCrgensmeierauthor=A.+Billinauthor=R.+Xuauthor=S.+Pattersonauthor=N.+Pagratis&title=Homogeneous+BTK+occupancy+assay+for+pharmacodynamic+assessment+of+tirabrutinib+%28GS-4059%2FONO-4059%29+target+engagement&doi=10.1177%2F2472555218786165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement</span></div><div class="casAuthors">Yu, Helen; Truong, Hoa; Mitchell, Scott A.; Liclican, Albert; Gosink, John J.; Li, Wanying; Lin, Julie; Feng, Joy Y.; Jurgensmeier, Juliane M.; Billin, Andrew; Xu, Ren; Patterson, Scott; Pagratis, Nikos</div><div class="citationInfo"><span class="NLM_cas:title">SLAS Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">919-929</span>CODEN:
                <span class="NLM_cas:coden">SDLIBT</span>;
        ISSN:<span class="NLM_cas:issn">2472-5560</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Bruton's tyrosine kinase (BTK) is a clin. validated target for B-cell leukemias and lymphomas with FDA-approved small-mol. inhibitors ibrutinib and acalabrutinib.  Tirabrutinib (GS-4059/ONO-4059, Gilead Sciences, Inc., Foster City, CA) is a second-generation, potent, selective, irreversible BTK inhibitor in clin. development for lymphoid malignancies, including chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL).  An accurate pharmacodynamic assay to assess tirabrutinib target coverage in phase 1/2 clin. studies will inform dose and schedule selection for advanced clin. evaluation.  We developed a novel duplex homogeneous BTK occupancy assay based on time-resolved fluorescence resonance energy transfer (TR-FRET) to measure free and total BTK levels in a multiplexed format.  The dual-wavelength emission property of terbium-conjugated anti-BTK antibody served as the energy donor for two fluorescent energy acceptors with distinct excitation and emission spectra.  The assay was characterized and qualified using full-length purified recombinant human BTK protein and peripheral blood mononuclear cells derived from healthy volunteers and patients with CLL.  We demonstrated assay utility using cells derived from lymph node and bone marrow samples from patients with CLL and DLBCL.  Our TR-FRET-based BTK occupancy assay provides accurate, quant. assessment of BTK occupancy in the clin. trial program for tirabrutinib and is in use in ongoing clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw4B-ns8y3L7Vg90H21EOLACvtfcHk0lhOxTdcq8TfFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOgsrrM&md5=d78702b99f5ab7e72a7f549a49e1ca3c</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1177%2F2472555218786165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2472555218786165%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DTruong%26aufirst%3DH.%26aulast%3DMitchell%26aufirst%3DS.%2BA.%26aulast%3DLiclican%26aufirst%3DA.%26aulast%3DGosink%26aufirst%3DJ.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DJ%25C3%25BCrgensmeier%26aufirst%3DJ.%2BM.%26aulast%3DBillin%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DPagratis%26aufirst%3DN.%26atitle%3DHomogeneous%2520BTK%2520occupancy%2520assay%2520for%2520pharmacodynamic%2520assessment%2520of%2520tirabrutinib%2520%2528GS-4059%252FONO-4059%2529%2520target%2520engagement%26jtitle%3DSLAS%2520Discovery%26date%3D2018%26volume%3D23%26spage%3D919%26epage%3D929%26doi%3D10.1177%2F2472555218786165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stockmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todorovic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerstein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lake, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadhukhan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, A.</span></span> <span> </span><span class="NLM_article-title">Cell-surface receptor-ligand interaction analysis with homogeneous time-resolved FRET and metabolic glycan engineering: application to transmembrane and GPI-anchored receptors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">16822</span>â <span class="NLM_lpage">16829</span>, <span class="refDoi">Â DOI: 10.1021/jacs.7b09359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b09359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7jP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=16822-16829&author=H.+Stockmannauthor=V.+Todorovicauthor=P.+L.+Richardsonauthor=V.+Marinauthor=V.+Scottauthor=C.+Gersteinauthor=M.+Lakeauthor=L.+Wangauthor=R.+Sadhukhanauthor=A.+Vasudevan&title=Cell-surface+receptor-ligand+interaction+analysis+with+homogeneous+time-resolved+FRET+and+metabolic+glycan+engineering%3A+application+to+transmembrane+and+GPI-anchored+receptors&doi=10.1021%2Fjacs.7b09359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-Surface Receptor-Ligand Interaction Analysis with Homogeneous Time-Resolved FRET and Metabolic Glycan Engineering: Application to Transmembrane and GPI-Anchored Receptors</span></div><div class="casAuthors">Stockmann, Henning; Todorovic, Viktor; Richardson, Paul L.; Marin, Violeta; Scott, Victoria; Gerstein, Clare; Lake, Marc; Wang, Leyu; Sadhukhan, Ramkrishna; Vasudevan, Anil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16822-16829</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand-binding assays are the linchpin of drug discovery and medicinal chem.  Cell-surface receptors and their ligands have traditionally been characterized by radioligand-binding assays, which have low temporal and spatial resoln. and entail safety risks.  Here, the authors report a powerful alternative (GlycoFRET), where terbium-labeled fluorescent reporters are irreversibly attached to receptors by metabolic glycan engineering.  For the first time, the authors show time-resolved fluorescence resonance energy transfer between receptor glycans and fluorescently labeled ligands.  The authors describe GlycoFRET for a GPI-anchored receptor, a G-protein-coupled receptor, and a heterodimeric cytokine receptor in living cells with excellent sensitivity and high signal-to-background ratios.  In contrast to previously described methods, GlycoFRET does not require genetic engineering or antibodies to label receptors.  Given that all cell-surface receptors are glycosylated, the authors expect that GlycoFRET can be generalized with applications in chem. biol. and biotechnol., such as target engagement, receptor pharmacol., and high-throughput screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6a1kXDrYJFLVg90H21EOLACvtfcHk0lhOxTdcq8TfFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7jP&md5=08081ff21f9bf9ea6a35d6dda988128d</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b09359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b09359%26sid%3Dliteratum%253Aachs%26aulast%3DStockmann%26aufirst%3DH.%26aulast%3DTodorovic%26aufirst%3DV.%26aulast%3DRichardson%26aufirst%3DP.%2BL.%26aulast%3DMarin%26aufirst%3DV.%26aulast%3DScott%26aufirst%3DV.%26aulast%3DGerstein%26aufirst%3DC.%26aulast%3DLake%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSadhukhan%26aufirst%3DR.%26aulast%3DVasudevan%26aufirst%3DA.%26atitle%3DCell-surface%2520receptor-ligand%2520interaction%2520analysis%2520with%2520homogeneous%2520time-resolved%2520FRET%2520and%2520metabolic%2520glycan%2520engineering%253A%2520application%2520to%2520transmembrane%2520and%2520GPI-anchored%2520receptors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D16822%26epage%3D16829%26doi%3D10.1021%2Fjacs.7b09359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaitoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponterini, G.</span></span> <span> </span><span class="NLM_article-title">Dimerâmonomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1023</span>â <span class="NLM_lpage">1030</span>, <span class="refDoi">Â DOI: 10.1002/pro.379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fpro.379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=20306493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFSgtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=1023-1030&author=F.+Genoveseauthor=S.+Ferrariauthor=G.+Guaitoliauthor=M.+Caselliauthor=M.+P.+Costiauthor=G.+Ponterini&title=Dimer%E2%80%93monomer+equilibrium+of+human+thymidylate+synthase+monitored+by+fluorescence+resonance+energy+transfer&doi=10.1002%2Fpro.379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer</span></div><div class="casAuthors">Genovese, Filippo; Ferrari, Stefania; Guaitoli, Giambattista; Caselli, Monica; Costi, M. Paola; Ponterini, Glauco</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1023-1030</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">An ad hoc bioconjugation/FRET assay was designed to spectroscopically monitor the quaternary state of human thymidylate synthase (hTS) dimeric protein.  The approach enabled the chemoselective engineering of allosteric residues while preserving the native protein functions through reversible masking of residues within the catalytic site, and was therefore suitable for activity/oligomerization dual assay screenings.  It was applied to tag the 2 subunits of hTS at Cys-43 and Cys-43' residues with an excitation energy donor/acceptor pair.  The dimer-monomer equil. of the enzyme was then characterized through steady-state fluorescence detn. of the intersubunit resonance energy transfer efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL_9goPgkDSbVg90H21EOLACvtfcHk0ljBiYQkT7vGKQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFSgtr4%253D&md5=0d70cf35f1bef5cc2e6170de9aa641e4</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1002%2Fpro.379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.379%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DF.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DGuaitoli%26aufirst%3DG.%26aulast%3DCaselli%26aufirst%3DM.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DPonterini%26aufirst%3DG.%26atitle%3DDimer%25E2%2580%2593monomer%2520equilibrium%2520of%2520human%2520thymidylate%2520synthase%2520monitored%2520by%2520fluorescence%2520resonance%2520energy%2520transfer%26jtitle%3DProtein%2520Sci.%26date%3D2010%26volume%3D19%26spage%3D1023%26epage%3D1030%26doi%3D10.1002%2Fpro.379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ponterini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavesi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauriola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PelÃ , M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gozzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacifico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marverti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâArca, D.</span></span> <span> </span><span class="NLM_article-title">Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">27198</span>, <span class="refDoi">Â DOI: 10.1038/srep27198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fsrep27198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27250901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFChu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=27198&author=G.+Ponteriniauthor=A.+Martelloauthor=G.+Pavesiauthor=A.+Lauriolaauthor=R.+Lucianiauthor=M.+Santucciauthor=M.+Pel%C3%A0author=G.+Gozziauthor=S.+Pacificoauthor=R.+Guerriniauthor=G.+Marvertiauthor=M.+P.+Costiauthor=D.+D%E2%80%99Arca&title=Intracellular+quantitative+detection+of+human+thymidylate+synthase+engagement+with+an+unconventional+inhibitor+using+tetracysteine-diarsenical-probe+technology&doi=10.1038%2Fsrep27198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology</span></div><div class="casAuthors">Ponterini, Glauco; Martello, Andrea; Pavesi, Giorgia; Lauriola, Angela; Luciani, Rosaria; Santucci, Matteo; Pela, Michela; Gozzi, Gaia; Pacifico, Salvatore; Guerrini, Remo; Marverti, Gaetano; Costi, Maria Paola; D'Arca, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27198</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Demonstrating a candidate drug's interaction with its target protein in live cells is of pivotal relevance to the successful outcome of the drug discovery process.  Although thymidylate synthase (hTS) is an important anticancer target protein, the efficacy of the few anti-hTS drugs currently used in clin. practice is limited by the development of resistance.  Hence, there is an intense search for new, unconventional anti-hTS drugs; there are approx. 1600 ongoing clin. trials involving hTS-targeting drugs, both alone and in combination protocols.  We recently discovered new, unconventional peptidic inhibitors of hTS that are active against cancer cells and do not result in the overexpression of hTS, which is a known mol. source of resistance.  Here, we propose an adaptation of the recently proposed tetracysteine-arsenic-binding-motif technol. to detect and quant. characterize the engagement of hTS with one such peptidic inhibitor in cell lysates.  This new model can be developed into a test for high-throughput screening studies of intracellular target-protein/small-mol. binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3QbclCRG7s7Vg90H21EOLACvtfcHk0ljBiYQkT7vGKQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFChu7o%253D&md5=7e5485349dba3e5073dc712e77c811d4</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1038%2Fsrep27198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep27198%26sid%3Dliteratum%253Aachs%26aulast%3DPonterini%26aufirst%3DG.%26aulast%3DMartello%26aufirst%3DA.%26aulast%3DPavesi%26aufirst%3DG.%26aulast%3DLauriola%26aufirst%3DA.%26aulast%3DLuciani%26aufirst%3DR.%26aulast%3DSantucci%26aufirst%3DM.%26aulast%3DPel%25C3%25A0%26aufirst%3DM.%26aulast%3DGozzi%26aufirst%3DG.%26aulast%3DPacifico%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DMarverti%26aufirst%3DG.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DD%25E2%2580%2599Arca%26aufirst%3DD.%26atitle%3DIntracellular%2520quantitative%2520detection%2520of%2520human%2520thymidylate%2520synthase%2520engagement%2520with%2520an%2520unconventional%2520inhibitor%2520using%2520tetracysteine-diarsenical-probe%2520technology%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D27198%26doi%3D10.1038%2Fsrep27198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di Rocco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacifico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cichero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fossa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franchini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardarelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponterini, G.</span></span> <span> </span><span class="NLM_article-title">Fluorometric detection of protein-ligand engagement: the case of phosphodiesterase 5</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">335</span>â <span class="NLM_lpage">342</span>, <span class="refDoi">Â DOI: 10.1016/j.jpba.2017.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.jpba.2017.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29132113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2ksrvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2018&pages=335-342&author=G.+Di+Roccoauthor=I.+Martinelliauthor=S.+Pacificoauthor=R.+Guerriniauthor=E.+Cicheroauthor=P.+Fossaauthor=S.+Franchiniauthor=S.+Cardarelliauthor=M.+Giorgiauthor=M.+Solaauthor=G.+Ponterini&title=Fluorometric+detection+of+protein-ligand+engagement%3A+the+case+of+phosphodiesterase+5&doi=10.1016%2Fj.jpba.2017.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorometric detection of protein-ligand engagement: The case of phosphodiesterase5</span></div><div class="casAuthors">Di Rocco, Giulia; Martinelli, Ilaria; Pacifico, Salvatore; Guerrini, Remo; Cichero, Elena; Fossa, Paola; Franchini, Silvia; Cardarelli, Silvia; Giorgi, Mauro; Sola, Marco; Ponterini, Glauco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">335-342</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) regulate the intracellular levels of cAMP and cGMP.  The great clin. success of the PDE5 inhibitors, Sildenafil (Viagra), Vardenafil (Levitra) and Tadalafil (Cialis) has led to an increasing interest for this class of enzymes.  Recent studies have shown a correlation between tumor growth and PDE5 overexpression, making PDE5-selective inhibitors promising candidates for cancer treatment.  The search for such inhibitors rests today on radioactive assays.  In this work, we exploit the conserved catalytic domain of the enzyme and propose a faster and safer method for detecting the binding of ligands and evaluate their affinities.  The new approach takes advantage of Forster Resonance Energy Transfer (FRET) between, as the donor, a fluorescein-like diarsenical probe able to covalently bind a tetracysteine motif fused to the recombinant PDE5 catalytic domain and, as the acceptor, a rhodamine probe covalently bound to the pseudosubstrate cGMPS.  The FRET efficiency decreases when a competitive ligand binds the PDE5 catalytic site and displaces the cGMPS-rhodamine conjugate.  We have structurally investigated the PDE5/cGMPS-rhodamine complex by mol. modeling and have used the FRET signal to quant. characterize its binding equil.  Competitive displacement expts. were carried out with tadalafil and cGMPS.  An adaptation of the competitive-displacement equil. model yielded the affinities for PDE5 of the incoming ligands, nano- and micromolar, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryhhrfmgbYmLVg90H21EOLACvtfcHk0lhNGqDIKIHJpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2ksrvM&md5=9bb3aed24d4ce27b6e09fa962b05fbcb</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2017.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2017.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BRocco%26aufirst%3DG.%26aulast%3DMartinelli%26aufirst%3DI.%26aulast%3DPacifico%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCichero%26aufirst%3DE.%26aulast%3DFossa%26aufirst%3DP.%26aulast%3DFranchini%26aufirst%3DS.%26aulast%3DCardarelli%26aufirst%3DS.%26aulast%3DGiorgi%26aufirst%3DM.%26aulast%3DSola%26aufirst%3DM.%26aulast%3DPonterini%26aufirst%3DG.%26atitle%3DFluorometric%2520detection%2520of%2520protein-ligand%2520engagement%253A%2520the%2520case%2520of%2520phosphodiesterase%25205%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2018%26volume%3D149%26spage%3D335%26epage%3D342%26doi%3D10.1016%2Fj.jpba.2017.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumer, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepler, J. R.</span></span> <span> </span><span class="NLM_article-title">Bioluminescence resonance energy transfer to detect protein-protein interactions in live cells</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1278</i></span>,  <span class="NLM_fpage">457</span>â <span class="NLM_lpage">465</span>, <span class="refDoi">Â DOI: 10.1007/978-1-4939-2425-7_30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-4939-2425-7_30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25859969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Ortbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1278&publication_year=2015&pages=457-465&author=N.+E.+Brownauthor=J.+B.+Blumerauthor=J.+R.+Hepler&title=Bioluminescence+resonance+energy+transfer+to+detect+protein-protein+interactions+in+live+cells&doi=10.1007%2F978-1-4939-2425-7_30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Bioluminescence Resonance Energy Transfer to Detect Protein-Protein Interactions in Live Cells</span></div><div class="casAuthors">Brown, Nicole E.; Blumer, Joe B.; Hepler, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1278</span>
        (<span class="NLM_cas:issue">Protein-Protein Interactions</span>),
    <span class="NLM_cas:pages">457-465</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Bioluminescence resonance energy transfer (BRET) is a valuable tool to detect protein-protein interactions.  BRET utilizes bioluminescent and fluorescent protein tags with compatible emission and excitation properties, making it possible to examine resonance energy transfer when the tags are in close proximity (<10 nm) as a typical result of protein-protein interactions.  Here we describe a protocol for detecting BRET from two known protein binding partners (GÎ±i1 and RGS14) in HEK 293 cells using Renilla luciferase and yellow fluorescent protein tags.  We discuss the calcn. of the acceptor/donor ratio as well as net BRET and demonstrate that BRET can be used as a platform to investigate the regulation of protein-protein interactions in live cells in real time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCQsE9_cnyF7Vg90H21EOLACvtfcHk0lhNGqDIKIHJpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Ortbg%253D&md5=b77525f8a71faedbfe0366b89e1fdebe</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-2425-7_30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-2425-7_30%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%2BE.%26aulast%3DBlumer%26aufirst%3DJ.%2BB.%26aulast%3DHepler%26aufirst%3DJ.%2BR.%26atitle%3DBioluminescence%2520resonance%2520energy%2520transfer%2520to%2520detect%2520protein-protein%2520interactions%2520in%2520live%2520cells%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2015%26volume%3D1278%26spage%3D457%26epage%3D465%26doi%3D10.1007%2F978-1-4939-2425-7_30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koblan, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ember, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remillard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vittori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schonbrunn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span> <span> </span><span class="NLM_article-title">Assessment of bromodomain target engagement by a series of BI2536 analogues with miniaturized BET-BRET</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">2575</span>â <span class="NLM_lpage">2581</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201600502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fcmdc.201600502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27862999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVChsbfK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2575-2581&issue=23&author=L.+W.+Koblanauthor=D.+L.+Buckleyauthor=C.+J.+Ottauthor=M.+E.+Fitzgeraldauthor=S.+W.+Emberauthor=J.+Y.+Zhuauthor=S.+Liuauthor=J.+M.+Robertsauthor=D.+Remillardauthor=S.+Vittoriauthor=W.+Zhangauthor=E.+Schonbrunnauthor=J.+E.+Bradner&title=Assessment+of+bromodomain+target+engagement+by+a+series+of+BI2536+analogues+with+miniaturized+BET-BRET&doi=10.1002%2Fcmdc.201600502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of Bromodomain Target Engagement by a Series of BI2536 Analogues with Miniaturized BET-BRET</span></div><div class="casAuthors">Koblan, Luke W.; Buckley, Dennis L.; Ott, Christopher J.; Fitzgerald, Mark E.; Ember, Stuart W. J.; Zhu, Jin-Yi; Liu, Shuai; Roberts, Justin M.; Remillard, David; Vittori, Sarah; Zhang, Wei; Schonbrunn, Ernst; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2575-2581</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Evaluating the engagement of a small mol. ligand with a protein target in cells provides useful information for chem. probe optimization and pharmaceutical development.  While several techniques exist that can be performed in a low-throughput manner, systematic evaluation of large compd. libraries remains a challenge.  In-cell engagement measurements are esp. useful when evaluating compd. classes suspected to target multiple cellular factors.  In this study we used a bioluminescent resonant energy transfer assay to assess bromodomain engagement by a compd. series contg. bromodomain- and kinase-biasing polypharmacophores based on the known dual BRD4 bromodomain/PLK1 kinase inhibitor BI2536.  With this assay, we discovered several novel agents with bromodomain-selective specificity profiles and cellular activity.  Thus, this platform aids in distinguishing mols. whose cellular activity is difficult to assess due to polypharmacol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiVVtnPQvEQrVg90H21EOLACvtfcHk0ljGiYdGKok9SA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVChsbfK&md5=a6d7c6a58870eb6208e18eb32068d821</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600502%26sid%3Dliteratum%253Aachs%26aulast%3DKoblan%26aufirst%3DL.%2BW.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DOtt%26aufirst%3DC.%2BJ.%26aulast%3DFitzgerald%26aufirst%3DM.%2BE.%26aulast%3DEmber%26aufirst%3DS.%2BW.%26aulast%3DZhu%26aufirst%3DJ.%2BY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DRemillard%26aufirst%3DD.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DAssessment%2520of%2520bromodomain%2520target%2520engagement%2520by%2520a%2520series%2520of%2520BI2536%2520analogues%2520with%2520miniaturized%2520BET-BRET%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26issue%3D23%26spage%3D2575%26epage%3D2581%26doi%3D10.1002%2Fcmdc.201600502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casarini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limoncella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaretti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbagallo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacifico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliavini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenti, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Rocco, G.</span></span> <span> </span><span class="NLM_article-title">Probing the effect of sildenafil on progesterone and testosterone production by an intracellular FRET/BRET combined approach</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">799</span>â <span class="NLM_lpage">808</span>, <span class="refDoi">Â DOI: 10.1021/acs.biochem.8b01073</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.8b01073" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKrsbnI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=799-808&author=L.+Casariniauthor=L.+Riccettiauthor=S.+Limoncellaauthor=C.+Lazzarettiauthor=F.+Barbagalloauthor=S.+Pacificoauthor=R.+Guerriniauthor=S.+Tagliaviniauthor=T.+Trentiauthor=M.+Simoniauthor=M.+Solaauthor=G.+Di+Rocco&title=Probing+the+effect+of+sildenafil+on+progesterone+and+testosterone+production+by+an+intracellular+FRET%2FBRET+combined+approach&doi=10.1021%2Facs.biochem.8b01073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the effect of sildenafil on progesterone and testosterone production by an intracellular FRET/BRET combined approach</span></div><div class="casAuthors">Casarini, Livio; Riccetti, Laura; Limoncella, Silvia; Lazzaretti, Clara; Barbagallo, Federica; Pacifico, Salvatore; Guerrini, Remo; Tagliavini, Simonetta; Trenti, Tommaso; Simoni, Manuela; Sola, Marco; Di Rocco, Giulia</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">799-808</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Forster resonance energy transfer (FRET)-based biosensors have been recently applied to the study of biol. pathways.  In this study, a new biosensor was validated for the first time in live HEK293 and steroidogenic MLTC-1 cell lines for studying the effect of the PDE5 inhibitor on the hCG/LH-induced steroidogenic pathway.  The sensor improves FRET between a donor (D), the fluorescein-like diarsenical probe that can covalently bind a tetracysteine motif fused to the PDE5 catalytic domain, and an acceptor (A), the rhodamine probe conjugated to the pseudosubstrate cGMPS.  Affinity const. (Kd) values of 5.6 Â± 3.2 and 13.7 Â± 0.8 Î¼M were obtained with HEK293 and MLTC-1 cells, resp.  The detection was based on the competitive displacement of the cGMPS-rhodamine conjugate by sildenafil; the Ki values were 3.6 Â± 0.3 nM (IC50 = 2.3 nM) in HEK293 cells and 10 Â± 1.0 nM (IC50 = 3.9 nM) in MLTC-1 cells.  The monitoring of both cAMP and cGMP by bioluminescence resonance energy transfer allowed the exploitation of the effects of PDE5i on steroidogenesis, indicating that sildenafil enhanced the gonadotropin-induced progesterone-to-testosterone conversion in a cAMP-independent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUvXyvJB7u07Vg90H21EOLACvtfcHk0ljGiYdGKok9SA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKrsbnI&md5=955f61b190ba915ccd4f820149db57c4</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.8b01073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.8b01073%26sid%3Dliteratum%253Aachs%26aulast%3DCasarini%26aufirst%3DL.%26aulast%3DRiccetti%26aufirst%3DL.%26aulast%3DLimoncella%26aufirst%3DS.%26aulast%3DLazzaretti%26aufirst%3DC.%26aulast%3DBarbagallo%26aufirst%3DF.%26aulast%3DPacifico%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DTagliavini%26aufirst%3DS.%26aulast%3DTrenti%26aufirst%3DT.%26aulast%3DSimoni%26aufirst%3DM.%26aulast%3DSola%26aufirst%3DM.%26aulast%3DDi%2BRocco%26aufirst%3DG.%26atitle%3DProbing%2520the%2520effect%2520of%2520sildenafil%2520on%2520progesterone%2520and%2520testosterone%2520production%2520by%2520an%2520intracellular%2520FRET%252FBRET%2520combined%2520approach%26jtitle%3DBiochemistry%26date%3D2019%26volume%3D58%26spage%3D799%26epage%3D808%26doi%3D10.1021%2Facs.biochem.8b01073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasta, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corona, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohana, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhala, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comess, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. V.</span></span> <span> </span><span class="NLM_article-title">Quantitative, real-time measurements of intracellular target engagement using energy transfer</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1888</i></span>,  <span class="NLM_fpage">45</span>â <span class="NLM_lpage">71</span>, <span class="refDoi">Â DOI: 10.1007/978-1-4939-8891-4_3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-4939-8891-4_3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30519940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFWhur%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1888&publication_year=2019&pages=45-71&author=M.+B.+Robersauthor=J.+D.+Vastaauthor=C.+R.+Coronaauthor=R.+F.+Ohanaauthor=R.+Hurstauthor=M.+A.+Jhalaauthor=K.+M.+Comessauthor=K.+V.+Wood&title=Quantitative%2C+real-time+measurements+of+intracellular+target+engagement+using+energy+transfer&doi=10.1007%2F978-1-4939-8891-4_3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative, real-time measurements of intracellular target engagement using energy transfer</span></div><div class="casAuthors">Robers, Matthew B.; Vasta, James D.; Corona, Cesear R.; Ohana, Rachel Friedman; Hurst, Robin; Jhala, Manisha A.; Comess, Kenneth M.; Wood, Keith V.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1888</span>
        (<span class="NLM_cas:issue">Systems Chemical Biology</span>),
    <span class="NLM_cas:pages">45-71</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Intracellular target affinity and residence time are fundamental aspects of pharmacol. mechanism.  Although various robust biochem. approaches exist to measure these binding characteristics, anal. of compd. binding with isolated targets may not accurately reflect engagement in the milieu of living cells.  To realize the influence of cellular context, methods are needed that are capable of quantifying affinity and residence time in the presence of the intracellular factors that may impact target engagement.  Bioluminescence resonance energy transfer (BRET) offers a soln. for intracellular target engagement when quant. metrics or kinetic analyses are required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTHXIcIw2B3rVg90H21EOLACvtfcHk0lgzmQyE_76qrA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFWhur%252FL&md5=ed9c50b4453b1bc61d7b037bb1c938a8</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-8891-4_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-8891-4_3%26sid%3Dliteratum%253Aachs%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DVasta%26aufirst%3DJ.%2BD.%26aulast%3DCorona%26aufirst%3DC.%2BR.%26aulast%3DOhana%26aufirst%3DR.%2BF.%26aulast%3DHurst%26aufirst%3DR.%26aulast%3DJhala%26aufirst%3DM.%2BA.%26aulast%3DComess%26aufirst%3DK.%2BM.%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DQuantitative%252C%2520real-time%2520measurements%2520of%2520intracellular%2520target%2520engagement%2520using%2520energy%2520transfer%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2019%26volume%3D1888%26spage%3D45%26epage%3D71%26doi%3D10.1007%2F978-1-4939-8891-4_3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levati, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benincasa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scocchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottonello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanini, B.</span></span> <span> </span><span class="NLM_article-title">New antimicrobials targeting bacterial RNA polymerase holoenzyme assembly identified with an <i>in vivo</i> BRET-based discovery platform</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1727</span>â <span class="NLM_lpage">1736</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.9b00178</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.9b00178" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2jtLnJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1727-1736&issue=8&author=S.+Sartiniauthor=E.+Levatiauthor=M.+Maccesiauthor=M.+Guerraauthor=G.+Spadoniauthor=S.+Bachauthor=M.+Benincasaauthor=M.+Scocchiauthor=S.+Ottonelloauthor=S.+Rivaraauthor=B.+Montanini&title=New+antimicrobials+targeting+bacterial+RNA+polymerase+holoenzyme+assembly+identified+with+an+in+vivo+BRET-based+discovery+platform&doi=10.1021%2Facschembio.9b00178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">New Antimicrobials Targeting Bacterial RNA Polymerase Holoenzyme Assembly Identified with an in Vivo BRET-Based Discovery Platform</span></div><div class="casAuthors">Sartini, Sara; Levati, Elisabetta; Maccesi, Martina; Guerra, Matteo; Spadoni, Gilberto; Bach, Stephane; Benincasa, Monica; Scocchi, Marco; Ottonello, Simone; Rivara, Silvia; Montanini, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1727-1736</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bacterial resistance represents a major health threat worldwide, and the development of new therapeutics, including innovative antibiotics, is urgently needed.  We describe a discovery platform, centered on in silico screening and in vivo bioluminescence resonance energy transfer in yeast cells, for the identification of new antimicrobials that, by targeting the protein-protein interaction between the Î²'-subunit and the initiation factor Ï70 of bacterial RNA polymerase, inhibit holoenzyme assembly and promoter-specific transcription.  Out of 34 000 candidate compds., we identified seven hits capable of interfering with this interaction.  Two derivs. of one of these hits proved to be effective in inhibiting transcription in vitro and growth of the Gram-pos. pathogens Staphylococcus aureus and Listeria monocytogenes.  Upon supplementation of a permeability adjuvant, one deriv. also effectively inhibited Escherichia coli growth.  On the basis of the chem. structures of these inhibitors, we generated a ligand-based pharmacophore model that will guide the rational discovery of increasingly effective antibacterial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplZ9dhJFCDn7Vg90H21EOLACvtfcHk0lgzmQyE_76qrA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2jtLnJ&md5=23fbe8dab2242079a02b24990fbbb075</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Facschembio.9b00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.9b00178%26sid%3Dliteratum%253Aachs%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DLevati%26aufirst%3DE.%26aulast%3DMaccesi%26aufirst%3DM.%26aulast%3DGuerra%26aufirst%3DM.%26aulast%3DSpadoni%26aufirst%3DG.%26aulast%3DBach%26aufirst%3DS.%26aulast%3DBenincasa%26aufirst%3DM.%26aulast%3DScocchi%26aufirst%3DM.%26aulast%3DOttonello%26aufirst%3DS.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMontanini%26aufirst%3DB.%26atitle%3DNew%2520antimicrobials%2520targeting%2520bacterial%2520RNA%2520polymerase%2520holoenzyme%2520assembly%2520identified%2520with%2520an%2520in%2520vivo%2520BRET-based%2520discovery%2520platform%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2019%26volume%3D14%26issue%3D8%26spage%3D1727%26epage%3D1736%26doi%3D10.1021%2Facschembio.9b00178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McClure, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. D.</span></span> <span> </span><span class="NLM_article-title">Impact of mass spectrometry-based technologies and strategies on chemoproteomics as a tool for drug discovery</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">785</span>â <span class="NLM_lpage">791</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.8b00181</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00181" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Kns7fO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=785-791&author=R.+A.+McClureauthor=J.+D.+Williams&title=Impact+of+mass+spectrometry-based+technologies+and+strategies+on+chemoproteomics+as+a+tool+for+drug+discovery&doi=10.1021%2Facsmedchemlett.8b00181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Mass Spectrometry-Based Technologies and Strategies on Chemoproteomics as a Tool for Drug Discovery</span></div><div class="casAuthors">McClure, Ryan A.; Williams, Jon D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">785-791</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chemoproteomics is an invaluable tool to discover protein targets from phenotypic assays and to understand on- and off-target engagement of potential therapeutic compds.  Highlighted in this technol. perspective is our view on how improvements in mass spectrometry (MS)-based proteomics technol. have dramatically impacted chemoproteomics.  Improvements in sample prepn., MS instrumentation, data acquisition, and quantification strategies have enabled medicinal chemists, chem. biologists, and mass spectrometrists to develop new chemoproteomic expts. and improve existing methods.  As a result of improvements in MS, we will detail how bead-based affinity capture and activity-based proteome profiling methods have been reduced from multiple LC-MS runs for samples and controls down to a single LC-MS run each for sample and control.  With improvements in scan duty cycle and sensitivity, sufficient depth of proteome coverage can be obtained for capture-free methods, which do not utilize an enrichment step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq83OUXdyesT7Vg90H21EOLACvtfcHk0li6NnKRGbmgUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Kns7fO&md5=2db5a5a100646e41ac01bef8318bc7e4</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00181%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26atitle%3DImpact%2520of%2520mass%2520spectrometry-based%2520technologies%2520and%2520strategies%2520on%2520chemoproteomics%2520as%2520a%2520tool%2520for%2520drug%2520discovery%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D785%26epage%3D791%26doi%3D10.1021%2Facsmedchemlett.8b00181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liew, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S. Q.</span></span> <span> </span><span class="NLM_article-title">A suite of âminimalistâ photo-crosslinkers for live-cell imaging and chemical proteomics: case study with BRD4 inhibitors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">11816</span>â <span class="NLM_lpage">11821</span>, <span class="refDoi">Â DOI: 10.1002/anie.201706076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.201706076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlOrt7rM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=11816-11821&author=S.+Panauthor=S.+Y.+Jangauthor=D.+Wangauthor=S.+S.+Liewauthor=Z.+Liauthor=J.+S.+Leeauthor=S.+Q.+Yao&title=A+suite+of+%E2%80%9Cminimalist%E2%80%9D+photo-crosslinkers+for+live-cell+imaging+and+chemical+proteomics%3A+case+study+with+BRD4+inhibitors&doi=10.1002%2Fanie.201706076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">A Suite of "Minimalist" Photo-Crosslinkers for Live-Cell Imaging and Chemical Proteomics: Case Study with BRD4 Inhibitors</span></div><div class="casAuthors">Pan, Sijun; Jang, Se-Young; Wang, Danyang; Liew, Si Si; Li, Zhengqiu; Lee, Jun-Seok; Yao, Shao Q.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">11816-11821</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Affinity-based probes (AfBPs) provide a powerful tool for large-scale chemoproteomic studies of drug-target interactions.  The development of high-quality probes capable of recapitulating genuine drug-target engagement, however, could be challenging.  "Minimalist" photo-crosslinkers, which contain an alkyl diazirine group and a chem. tractable tag, could alleviate such challenges, but few are currently available.  Herein, the authors have developed new alkyl diazirine-contg. photo-crosslinkers with different bioorthogonal tags.  They were subsequently used to create a suite of AfBPs based on GW841819X (a small mol. inhibitor of BRD4).  Through in vitro and in situ studies under conditions that emulated native drug-target interactions, the authors have obtained better insights into how a tag might affect the probe's performance.  Finally, SILAC-based chemoproteomic studies have led to the discovery of a novel off-target, APEX1.  Further studies showed GW841819X binds to APEX1 and caused up-regulation of endogenous DNMT1 expression under normoxia conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoG1Ettvbr27Vg90H21EOLACvtfcHk0lhPMjY3P2YBFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlOrt7rM&md5=7f9d0d80f4e802359803ae5c37548337</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706076%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DJang%26aufirst%3DS.%2BY.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLiew%26aufirst%3DS.%2BS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DYao%26aufirst%3DS.%2BQ.%26atitle%3DA%2520suite%2520of%2520%25E2%2580%259Cminimalist%25E2%2580%259D%2520photo-crosslinkers%2520for%2520live-cell%2520imaging%2520and%2520chemical%2520proteomics%253A%2520case%2520study%2520with%2520BRD4%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D11816%26epage%3D11821%26doi%3D10.1002%2Fanie.201706076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galmozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joslyn, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallaro, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narvaiza, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Ligand and target discovery by fragment-based screening in human cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">527</span>â <span class="NLM_lpage">541</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2016.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.cell.2016.12.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28111073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVeiu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=527-541&author=C.+G.+Parkerauthor=A.+Galmozziauthor=Y.+Wangauthor=B.+E.+Correiaauthor=K.+Sasakiauthor=C.+M.+Joslynauthor=A.+S.+Kimauthor=C.+L.+Cavallaroauthor=R.+M.+Lawrenceauthor=S.+R.+Johnsonauthor=I.+Narvaizaauthor=E.+Saezauthor=B.+F.+Cravatt&title=Ligand+and+target+discovery+by+fragment-based+screening+in+human+cells&doi=10.1016%2Fj.cell.2016.12.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand and Target Discovery by Fragment-Based Screening in Human Cells</span></div><div class="casAuthors">Parker, Christopher G.; Galmozzi, Andrea; Wang, Yujia; Correia, Bruno E.; Sasaki, Kenji; Joslyn, Christopher M.; Kim, Arthur S.; Cavallaro, Cullen L.; Lawrence, R. Michael; Johnson, Stephen R.; Narvaiza, Inigo; Saez, Enrique; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">527-541.e29</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Advances in the synthesis and screening of small-mol. libraries have accelerated the discovery of chem. probes for studying biol. processes.  Still, only a small fraction of the human proteome has chem. ligands.  Here, we describe a platform that marries fragment-based ligand discovery with quant. chem. proteomics to map thousands of reversible small mol.-protein interactions directly in human cells, many of which can be site-specifically detd.  We show that fragment hits can be advanced to furnish selective ligands that affect the activity of proteins heretofore lacking chem. probes.  We further combine fragment-based chem. proteomics with phenotypic screening to identify small mols. that promote adipocyte differentiation by engaging the poorly characterized membrane protein PGRMC2.  Fragment-based screening in human cells thus provides an extensive proteome-wide map of protein ligandability and facilitates the coordinated discovery of bioactive small mols. and their mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPk-YJwFlDwbVg90H21EOLACvtfcHk0lggJxiXIFBsRA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVeiu7Y%253D&md5=835264291015037ab9b7e446992caba3</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DC.%2BG.%26aulast%3DGalmozzi%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCorreia%26aufirst%3DB.%2BE.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DJoslyn%26aufirst%3DC.%2BM.%26aulast%3DKim%26aufirst%3DA.%2BS.%26aulast%3DCavallaro%26aufirst%3DC.%2BL.%26aulast%3DLawrence%26aufirst%3DR.%2BM.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DNarvaiza%26aufirst%3DI.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DLigand%2520and%2520target%2520discovery%2520by%2520fragment-based%2520screening%2520in%2520human%2520cells%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D527%26epage%3D541%26doi%3D10.1016%2Fj.cell.2016.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Proteome-wide identification of on- and off-targets of Bcl-2 inhibitors in native biological systems by using affinity-based probes (AfBPs)</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2312</span>â <span class="NLM_lpage">2320</span>, <span class="refDoi">Â DOI: 10.1002/cbic.201800380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fcbic.201800380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30133085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFequr%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=2312-2320&author=Z.+Wangauthor=Z.+Guoauthor=T.+Songauthor=X.+Zhangauthor=N.+Heauthor=P.+Liuauthor=P.+Wangauthor=Z.+Zhang&title=Proteome-wide+identification+of+on-+and+off-targets+of+Bcl-2+inhibitors+in+native+biological+systems+by+using+affinity-based+probes+%28AfBPs%29&doi=10.1002%2Fcbic.201800380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome-Wide Identification of On- and Off-Targets of Bcl-2 Inhibitors in Native Biological Systems by Using Affinity-Based Probes (AfBPs)</span></div><div class="casAuthors">Wang, Ziqian; Guo, Zongwei; Song, Ting; Zhang, Xiaodong; He, Nianzhe; Liu, Peng; Wang, Peiran; Zhang, Zhichao</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2312-2320</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Selective inhibition of proteins of the Bcl-2 family by small-mol. inhibitors is a promising new approach in drug discovery.  However, information about how these mols. interact with their cellular targets (on- and off-) is highly limited.  We have designed and synthesized photoreactive and "clickable" affinity-based probes (AfBPs)-Nap-2 and Nap-5-by introducing photo-crosslinkers onto Nap-1, a fluorescent deriv. of small-mol. Bcl-2 inhibitor S1-6.  The resulting trifunctional probes Nap-2 and Nap-5 can enrich, visualize, and enable the identification of cellular on- and off-targets of Bcl-2 inhibitors both in vitro and in situ.  Tubulin was validated as an off-target of Bcl-2 inhibitors (Nap-1 and S1-6) by large-scale cell-based proteome profiling and pull-down/western blotting (PD/WB) with Nap-2 and Nap-5.  It was preliminarily illustrated to be a BH3-contg. protein because some well-known Bcl-2 inhibitors can block the labeling of tubulin by Nap-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO-aBFZ-ybLLVg90H21EOLACvtfcHk0lggJxiXIFBsRA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFequr%252FI&md5=8ca5bbf1ae20f5ce024f72f431dd9166</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201800380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201800380%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DProteome-wide%2520identification%2520of%2520on-%2520and%2520off-targets%2520of%2520Bcl-2%2520inhibitors%2520in%2520native%2520biological%2520systems%2520by%2520using%2520affinity-based%2520probes%2520%2528AfBPs%2529%26jtitle%3DChemBioChem%26date%3D2018%26volume%3D19%26spage%3D2312%26epage%3D2320%26doi%3D10.1002%2Fcbic.201800380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gower, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. R.</span></span> <span> </span><span class="NLM_article-title">Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors</span>. <i>Proteome Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">17</span>, <span class="refDoi">Â DOI: 10.1186/s12953-017-0125-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1186%2Fs12953-017-0125-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28725163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC1cjpt1yqtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=17&author=M.+L.+Wongauthor=J.+Murphyauthor=E.+Harringtonauthor=C.+M.+Gowerauthor=R.+K.+Jainauthor=M.+Schirleauthor=J.+R.+Thomas&title=Examining+the+influence+of+specificity+ligands+and+ATP-competitive+ligands+on+the+overall+effectiveness+of+bivalent+kinase+inhibitors&doi=10.1186%2Fs12953-017-0125-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors</span></div><div class="casAuthors">Wong Margaret L; Murphy Jason; Harrington Edmund; Jain Rishi K; Schirle Markus; Thomas Jason R; Gower Carrie M</div><div class="citationInfo"><span class="NLM_cas:title">Proteome science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17</span>
        ISSN:<span class="NLM_cas:issn">1477-5956</span>.
    </div><div class="casAbstract">BACKGROUND:  Identifying selective kinase inhibitors remains a major challenge.  The design of bivalent inhibitors provides a rational strategy for accessing potent and selective inhibitors.  While bivalent kinase inhibitors have been successfully designed, no comprehensive assessment of affinity and selectivity for a series of bivalent inhibitors has been performed.  Here, we present an evaluation of the structure activity relationship for bivalent kinase inhibitors targeting ABL1.  METHODS:  Various SNAPtag constructs bearing different specificity ligands were expressed in vitro.  Bivalent inhibitor formation was accomplished by synthesizing individual ATP-competitive kinase inhibitors containing a SNAPtag targeting moiety, enabling the spontaneous self-assembly of the bivalent inhibitor.  Assembled bivalent inhibitors were incubated with K562 lysates, and then subjected to affinity enrichment using various ATP-competitive inhibitors immobilized to sepharose beads.  Resulting eluents were analyzed using Tandem Mass Tag (TMT) labeling and two-dimensional liquid chromatography-tandem mass spectrometry (2D-LC-MS/MS).  Relative binding affinity of the bivalent inhibitor was determined by calculating the concentration at which 50% of a given kinase remained bound to the affinity matrix.  RESULTS:  The profiling of three parental ATP-competitive inhibitors and nine SNAPtag conjugates led to the identification of 349 kinase proteins.  In all cases, the bivalent inhibitors exhibited enhanced binding affinity and selectivity for ABL1 when compared to the parental compound conjugated to SNAPtag alone.  While the rank order of binding affinity could be predicted by considering the binding affinities of the individual specificity ligands, the resulting affinity of the assembled bivalent inhibitor was not predictable.  The results from this study suggest that as the potency of the ATP-competitive ligand increases, the contribution of the specificity ligand towards the overall binding affinity of the bivalent inhibitor decreases.  However, the affinity of the specificity components in its interaction with the target is essential for achieving selectivity.  CONCLUSION:  Through comprehensive chemical proteomic profiling, this work provides the first insight into the influence of ATP-competitive and specificity ligands binding to their intended target on a proteome-wide scale.  The resulting data suggest a subtle interplay between the ATP-competitive and specificity ligands that cannot be accounted for by considering the specificity or affinity of the individual components alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpqnwfDgZWMRBrI9DTGjC0fW6udTcc2eZQ9hauDIW8ZLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjpt1yqtA%253D%253D&md5=168a38f44be508ae38a1f11acbe370bb</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1186%2Fs12953-017-0125-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12953-017-0125-1%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DM.%2BL.%26aulast%3DMurphy%26aufirst%3DJ.%26aulast%3DHarrington%26aufirst%3DE.%26aulast%3DGower%26aufirst%3DC.%2BM.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DJ.%2BR.%26atitle%3DExamining%2520the%2520influence%2520of%2520specificity%2520ligands%2520and%2520ATP-competitive%2520ligands%2520on%2520the%2520overall%2520effectiveness%2520of%2520bivalent%2520kinase%2520inhibitors%26jtitle%3DProteome%2520Sci.%26date%3D2016%26volume%3D15%26spage%3D17%26doi%3D10.1186%2Fs12953-017-0125-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veldhoven, J. P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offringa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenselink, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Es, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">Development of covalent ligands for G protein-coupled receptors: a case for the human adenosine A(3) receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3539</span>â <span class="NLM_lpage">3552</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b02026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b02026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvF2gsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3539-3552&issue=7&author=X.+Yangauthor=J.+P.+D.+van+Veldhovenauthor=J.+Offringaauthor=B.+J.+Kuiperauthor=E.+B.+Lenselinkauthor=L.+H.+Heitmanauthor=D.+van+der+Esauthor=A.+P.+Ijzerman&title=Development+of+covalent+ligands+for+G+protein-coupled+receptors%3A+a+case+for+the+human+adenosine+A%283%29+receptor&doi=10.1021%2Facs.jmedchem.8b02026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A3 Receptor</span></div><div class="casAuthors">Yang, Xue; van Veldhoven, Jacobus P. D.; Offringa, Jelle; Kuiper, Boaz J.; Lenselink, Eelke B.; Heitman, Laura H.; van der Es, Daan; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3539-3552</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of covalent ligands for G protein-coupled receptors (GPCRs) is not a trivial process.  Here, we report a streamlined workflow thereto from synthesis to validation, exemplified by the discovery of a covalent antagonist for the human adenosine A3 receptor (hA3AR).  Based on the 1H,3H-pyrido[2,1-f]purine-2,4-dione scaffold, a series of ligands bearing a fluorosulfonyl warhead and a varying linker was synthesized.  This series was subjected to an affinity screen, revealing compd. I as the most potent antagonist.  In addn., a nonreactive methylsulfonyl deriv. was developed as a reversible control compd.  A series of assays, comprising time-dependent affinity detn., washout expts., and [35S]GTPÎ³S binding assays, then validated I as the covalent antagonist.  A combined in silico hA3AR-homol. model and site-directed mutagenesis study was performed to demonstrate that amino acid residue Y2657.36 was the unique anchor point of the covalent interaction.  This workflow might be applied to other GPCRs to guide the discovery of covalent ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnbDNSsfDVVrVg90H21EOLACvtfcHk0liSgicrUK2QCw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvF2gsr0%253D&md5=47d46258dd0c33b21b5cc2e140684a40</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b02026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b02026%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3Dvan%2BVeldhoven%26aufirst%3DJ.%2BP.%2BD.%26aulast%3DOffringa%26aufirst%3DJ.%26aulast%3DKuiper%26aufirst%3DB.%2BJ.%26aulast%3DLenselink%26aufirst%3DE.%2BB.%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3Dvan%2Bder%2BEs%26aufirst%3DD.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DDevelopment%2520of%2520covalent%2520ligands%2520for%2520G%2520protein-coupled%2520receptors%253A%2520a%2520case%2520for%2520the%2520human%2520adenosine%2520A%25283%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D7%26spage%3D3539%26epage%3D3552%26doi%3D10.1021%2Facs.jmedchem.8b02026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murale, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span> <span> </span><span class="NLM_article-title">Photo-affinity labeling (PAL) in chemical proteomics: a handy tool to investigate protein-protein interactions (PPIs)</span>. <i>Proteome Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">14</span>, <span class="refDoi">Â DOI: 10.1186/s12953-017-0123-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1186%2Fs12953-017-0123-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28652856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC1cjitV2ksA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=14&author=D.+P.+Muraleauthor=S.+C.+Hongauthor=M.+M.+Haqueauthor=J.+S.+Lee&title=Photo-affinity+labeling+%28PAL%29+in+chemical+proteomics%3A+a+handy+tool+to+investigate+protein-protein+interactions+%28PPIs%29&doi=10.1186%2Fs12953-017-0123-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Photo-affinity labeling (PAL) in chemical proteomics: a handy tool to investigate protein-protein interactions (PPIs)</span></div><div class="casAuthors">Murale Dhiraj P; Hong Seong Cheol; Haque Md Mamunul; Lee Jun-Seok; Hong Seong Cheol; Lee Jun-Seok</div><div class="citationInfo"><span class="NLM_cas:title">Proteome science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn">1477-5956</span>.
    </div><div class="casAbstract">Protein-protein interactions (PPIs) trigger a wide range of biological signaling pathways that are crucial for biomedical research and drug discovery.  Various techniques have been used to study specific proteins, including affinity chromatography, activity-based probes, affinity-based probes and photo-affinity labeling (PAL).  PAL has become one of the most powerful strategies to study PPIs.  Traditional photocrosslinkers are used in PAL, including benzophenone, aryl azide, and diazirine.  Upon photoirradiation, these photocrosslinkers (Pls) generate highly reactive species that react with adjacent molecules, resulting in a direct covalent modification.  This review introduces recent examples of chemical proteomics study using PAL for PPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaiDChB3xtDcjl5L8hwNX0fW6udTcc2eY92NXqXIdRebntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjitV2ksA%253D%253D&md5=d6ef0d08db66c5d4b74caa24e5b97a94</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1186%2Fs12953-017-0123-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12953-017-0123-3%26sid%3Dliteratum%253Aachs%26aulast%3DMurale%26aufirst%3DD.%2BP.%26aulast%3DHong%26aufirst%3DS.%2BC.%26aulast%3DHaque%26aufirst%3DM.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26atitle%3DPhoto-affinity%2520labeling%2520%2528PAL%2529%2520in%2520chemical%2520proteomics%253A%2520a%2520handy%2520tool%2520to%2520investigate%2520protein-protein%2520interactions%2520%2528PPIs%2529%26jtitle%3DProteome%2520Sci.%26date%3D2016%26volume%3D15%26spage%3D14%26doi%3D10.1186%2Fs12953-017-0123-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Photoaffinity labeling in target- and binding-site identification</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">159</span>â <span class="NLM_lpage">183</span>, <span class="refDoi">Â DOI: 10.4155/fmc.14.152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.4155%2Ffmc.14.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25686004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVegu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=159-183&issue=2&author=E.+Smithauthor=I.+Collins&title=Photoaffinity+labeling+in+target-+and+binding-site+identification&doi=10.4155%2Ffmc.14.152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Photoaffinity labeling in target- and binding-site identification</span></div><div class="casAuthors">Smith, Ewan; Collins, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-183</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Photoaffinity labeling (PAL) using a chem. probe to covalently bind its target in response to activation by light has become a frequently used tool in drug discovery for identifying new drug targets and mol. interactions, and for probing the location and structure of binding sites.  Methods to identify the specific target proteins of hit mols. from phenotypic screens are highly valuable in early drug discovery.  In this review, we summarize the principles of PAL including probe design and exptl. techniques for in vitro and live cell investigations.  We emphasize the need to optimize and validate probes and highlight examples of the successful application of PAL across multiple disease areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpIXjEh35goLVg90H21EOLACvtfcHk0ljTSBlTDWcoCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVegu7c%253D&md5=ca00880405324587a542f19f8bd10d6c</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.152%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DPhotoaffinity%2520labeling%2520in%2520target-%2520and%2520binding-site%2520identification%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26issue%3D2%26spage%3D159%26epage%3D183%26doi%3D10.4155%2Ffmc.14.152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. A. B.</span></span> <span> </span><span class="NLM_article-title">Fishing for Drug Targets: A focus on diazirine photoaffinity probe synthesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">6945</span>â <span class="NLM_lpage">6963</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b01561</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01561" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFart7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6945-6963&issue=16&author=J.+R.+Hillauthor=A.+A.+B.+Robertson&title=Fishing+for+Drug+Targets%3A+A+focus+on+diazirine+photoaffinity+probe+synthesis&doi=10.1021%2Facs.jmedchem.7b01561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Fishing for Drug Targets: A Focus on Diazirine Photoaffinity Probe Synthesis</span></div><div class="casAuthors">Hill, James R.; Robertson, Avril A. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6945-6963</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Target identification is a high-priority, albeit challenging, aspect of drug discovery.  Diazirine-based photoaffinity probes (PAPs) can facilitate the process by covalently capturing transient mol. interactions.  This can help identify target proteins and map the ligand's interactome.  Diazirine probes have even been incorporated by cellular machinery into proteins.  Embarking on the synthesis of customized PAPs, contg. either an aliph. or trifluoromethyl Ph diazirine, can be a considerable endeavor, particularly for medicinal chemists and chem. biologists new to the field.  This review takes a synthetic focus, aiming to summarize available routes, propose new avenues, and illuminate recent advances in diazirine synthesis.  Select examples of diazirine photoaffinity labeling applications have been included throughout to provide instructive definition of the advantages and limitations of the technol. while simultaneously highlighting how these reagents can be applied in a practical sense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFaJOZyNuB67Vg90H21EOLACvtfcHk0ljTSBlTDWcoCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFart7g%253D&md5=37266e26bdd6a2028dddffc3ead4390d</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01561%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BR.%26aulast%3DRobertson%26aufirst%3DA.%2BA.%2BB.%26atitle%3DFishing%2520for%2520Drug%2520Targets%253A%2520A%2520focus%2520on%2520diazirine%2520photoaffinity%2520probe%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D16%26spage%3D6945%26epage%3D6963%26doi%3D10.1021%2Facs.jmedchem.7b01561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funabashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, Y.</span></span> <span> </span><span class="NLM_article-title">Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1867</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">22</span>â <span class="NLM_lpage">27</span>, <span class="refDoi">Â DOI: 10.1016/j.bbapap.2018.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.bbapap.2018.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFGlt77O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1867&publication_year=2019&pages=22-27&issue=1&author=K.+Kubotaauthor=M.+Funabashiauthor=Y.+Ogura&title=Target+deconvolution+from+phenotype-based+drug+discovery+by+using+chemical+proteomics+approaches&doi=10.1016%2Fj.bbapap.2018.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches</span></div><div class="casAuthors">Kubota, Kazuishi; Funabashi, Masanori; Ogura, Yuji</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1867</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-27</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Phenotype-based drug discovery is a key strategy for small mol. drug screening, and the mol. target identification of small mols., termed "target deconvolution," is crit. albeit challenging.  In this review, we classify approaches for target deconvolution, including both direct and indirect approaches, summarize their underlying principles, and provide examples of current chem. proteomics strategies including affinity purifn. using compd.-immobilized beads, photoaffinity labeling (PAL), cellular thermal shift assay (CETSA), and activity-based protein profiling (ABPP).  Because there is no single best target deconvolution strategy, it is important to carefully select a strategy on the basis of the test compd. characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopCpuzLRkmcbVg90H21EOLACvtfcHk0ljTSBlTDWcoCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFGlt77O&md5=1eceeee183cfa690ede7d464130884d8</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2018.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2018.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DKubota%26aufirst%3DK.%26aulast%3DFunabashi%26aufirst%3DM.%26aulast%3DOgura%26aufirst%3DY.%26atitle%3DTarget%2520deconvolution%2520from%2520phenotype-based%2520drug%2520discovery%2520by%2520using%2520chemical%2520proteomics%2520approaches%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2019%26volume%3D1867%26issue%3D1%26spage%3D22%26epage%3D27%26doi%3D10.1016%2Fj.bbapap.2018.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomohiro, T.</span></span> <span> </span><span class="NLM_article-title">Tag-Creation Approaches for Highly Efficient Profiling of Interacting Proteins and Domains</span>. In  <i>Photoaffinity Labeling for Structural Probing Within Protein</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatanaka, Y.</span>, <span class="NLM_string-name">Hashimoto, M.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Tokyo</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">13</span>â <span class="NLM_lpage">43</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-4-431-56569-7_2" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=13-43&author=T.+Tomohiroauthor=Y.+Hatanaka&author=M.+Hashimoto&title=Photoaffinity+Labeling+for+Structural+Probing+Within+Protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1007%2F978-4-431-56569-7_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-4-431-56569-7_2%26sid%3Dliteratum%253Aachs%26aulast%3DTomohiro%26aufirst%3DT.%26atitle%3DTag-Creation%2520Approaches%2520for%2520Highly%2520Efficient%2520Profiling%2520of%2520Interacting%2520Proteins%2520and%2520Domains%26btitle%3DPhotoaffinity%2520Labeling%2520for%2520Structural%2520Probing%2520Within%2520Protein%26aulast%3DHatanaka%26aufirst%3DY.%26pub%3DSpringer%26date%3D2017%26spage%3D13%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inahara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span> <span> </span><span class="NLM_article-title">Active/inactive dual-probe system for selective photo-affinity labeling of smallmolecule-binding proteins</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1567</span>â <span class="NLM_lpage">1571</span>, <span class="refDoi">Â DOI: 10.1002/asia.201200085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fasia.201200085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22514195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlslykurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1567-1571&author=K.+Sakuraiauthor=M.+Tawaauthor=A.+Okadaauthor=R.+Yamadaauthor=N.+Satoauthor=M.+Inaharaauthor=M.+Inoue&title=Active%2Finactive+dual-probe+system+for+selective+photo-affinity+labeling+of+smallmolecule-binding+proteins&doi=10.1002%2Fasia.201200085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Active/Inactive Dual-Probe System for Selective Photoaffinity Labeling of Small Molecule-Binding Proteins</span></div><div class="casAuthors">Sakurai, Kaori; Tawa, Masaki; Okada, Ayumi; Yamada, Rika; Sato, Noriyuki; Inahara, Masahiro; Inoue, Maia</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1567-1571</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors describe an active/inactive dual-probe approach to control the selectivity of photoaffinity labeling (PAL) reactions toward detecting specific small mol.-binding proteins.  The authors demonstrate that their new PAL system is applicable to levels of a binding protein in the cell lysate as low as 1% (wt./wt.).  In addn., a simple inactive analog representing the scaffold moiety of the PAL probe can also improve the labeling selectivity, which should be useful in cases where inactive analog is not easily obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrScjXZ1lusH7Vg90H21EOLACvtfcHk0lhFQTZPcPxKxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlslykurc%253D&md5=c505ed996528d8d94c1a6298850362fe</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1002%2Fasia.201200085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201200085%26sid%3Dliteratum%253Aachs%26aulast%3DSakurai%26aufirst%3DK.%26aulast%3DTawa%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DA.%26aulast%3DYamada%26aufirst%3DR.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DInahara%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DM.%26atitle%3DActive%252Finactive%2520dual-probe%2520system%2520for%2520selective%2520photo-affinity%2520labeling%2520of%2520smallmolecule-binding%2520proteins%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2012%26volume%3D7%26spage%3D1567%26epage%3D1571%26doi%3D10.1002%2Fasia.201200085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel photoaffinity probes for study of the target proteins of oleanolic acid</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1036</span>â <span class="NLM_lpage">1039</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.11.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.bmcl.2011.11.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22204907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFansg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1036-1039&issue=2&author=L.+Zhangauthor=Y.+Zhangauthor=J.+Dongauthor=J.+Liuauthor=L.+Zhangauthor=H.+Sun&title=Design+and+synthesis+of+novel+photoaffinity+probes+for+study+of+the+target+proteins+of+oleanolic+acid&doi=10.1016%2Fj.bmcl.2011.11.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of novel photoaffinity probes for study of the target proteins of oleanolic acid</span></div><div class="casAuthors">Zhang, Liying; Zhang, Yingxia; Dong, Jizhe; Liu, Jun; Zhang, Luyong; Sun, Hongbin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1036-1039</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To explore the mol. mechanisms of oleanolic acid, two novel photoaffinity probes were synthesized based on the structure-activity relationship reported previously.  Their potency were evaluated in an enzyme inhibition assay against rabbit muscle glycogen phosphorylase a (RMGPa), a known target protein of oleanolic acid.  The inhibitory activity of probe 2 was only about two-fold less potent than the mother compd. oleanolic acid.  The photoaffinity labeling expts. were also performed and two proteins were specifically tagged by probe 2.  The results suggest that the synthesized probes could be used as powerful tools to isolate and identify the target proteins of oleanolic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVo3sAcfs3RbVg90H21EOLACvtfcHk0lg9CON0ZfjgMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFansg%253D%253D&md5=93e99664d7398145d7f2b8cd6cac059f</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.11.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.11.123%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520photoaffinity%2520probes%2520for%2520study%2520of%2520the%2520target%2520proteins%2520of%2520oleanolic%2520acid%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D2%26spage%3D1036%26epage%3D1039%26doi%3D10.1016%2Fj.bmcl.2011.11.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio-Mower, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lellis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neduvelil, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Register, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardana, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardell, S. J.</span></span> <span> </span><span class="NLM_article-title">Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>405</i></span> (<span class="NLM_issue">6787</span>),  <span class="NLM_fpage">689</span>â <span class="NLM_lpage">694</span>, <span class="refDoi">Â DOI: 10.1038/35015085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2F35015085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10864326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlGgur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=689-694&issue=6787&author=Y.+M.+Liauthor=M.+Xuauthor=M.+T.+Laiauthor=Q.+Huangauthor=J.+L.+Castroauthor=J.+DiMuzio-Mowerauthor=T.+Harrisonauthor=C.+Lellisauthor=A.+Nadinauthor=J.+G.+Neduvelilauthor=R.+B.+Registerauthor=M.+K.+Sardanaauthor=M.+S.+Shearmanauthor=A.+L.+Smithauthor=X.+P.+Shiauthor=K.+C.+Yinauthor=J.+A.+Shaferauthor=S.+J.+Gardell&title=Photoactivated+gamma-secretase+inhibitors+directed+to+the+active+site+covalently+label+presenilin+1&doi=10.1038%2F35015085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Photoactivated Î³-secretase inhibitors directed to the active site covalently label presenilin 1</span></div><div class="casAuthors">Li, Yue-Ming; Xu, Min; Lai, Ming-Tain; Huang, Qlan; Castro, Jose L.; Dimuzio-Mower, Jillian; Harrison, Timothy; Lellis, Colin; Nadin, Alan; Neduvelil, Joseph G.; Register, R. Bruce; Sardana, Mohinder K.; Shearman, Mark S.; Smith, Adrian L.; Shi, Xiao-Ping; Yin, Kuo-Chang; Shafer, Jules A.; Gardell, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">6787</span>),
    <span class="NLM_cas:pages">689-694</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cleavage of the amyloid precursor protein (APP) by Î²- and Î³- secretases generates the N- and C-termini, resp., of AÎ² amyloidogenic peptides AÎ²40 and AÎ²42, the major constituents of the amyloid plaques in the brain parenchyma of Alzheimer's disease patients.  There is evidence that the polytopic membrane-spanning proteins, presenilin 1 and 2 (PS1 and PS2), are important determinants of Î³-secretase activity: (1) mutations in PS1 and PS2 that are assocd. with early-onset familial Alzheimer's disease increase the prodn. of AÎ²42, the more amyloidogenic peptide; (2) Î³-secretase activity is reduced in neuronal cultures derived from PS1-deficient mouse embryos; and (3) directed mutagenesis of 2 conserved Asp residues in transmembrane segments of PS1 inactivates the ability of Î³-secretase to catalyze processing of APP within its transmembrane domains.  It is unknown, however, whether PS1 (which has little or no homol. to any known aspartyl protease) is itself a transmembrane aspartic protease or a Î³-secretase cofactor, or helps to colocalize Î³-secretase and APP.  Here, the authors report photoaffinity labeling of PS1 (and PS2) by potent Î³-secretase inhibitors that were designed to function as transition state analog inhibitors directed to the active site of an aspartic protease.  This observation indicates that PS1 (and PS2) may contain the active site of Î³-secretase.  Interestingly, the intact, single-chain form of wild-type PS1 was not labeled by an active site-directed photoaffinity probe, suggesting that intact wild-type PS1 may be an aspartic protease zymogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbje-NpsbWSbVg90H21EOLACvtfcHk0lg9CON0ZfjgMA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlGgur4%253D&md5=233f579ccc85c0ba071d151f857100a4</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1038%2F35015085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35015085%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DCastro%26aufirst%3DJ.%2BL.%26aulast%3DDiMuzio-Mower%26aufirst%3DJ.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DLellis%26aufirst%3DC.%26aulast%3DNadin%26aufirst%3DA.%26aulast%3DNeduvelil%26aufirst%3DJ.%2BG.%26aulast%3DRegister%26aufirst%3DR.%2BB.%26aulast%3DSardana%26aufirst%3DM.%2BK.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26aulast%3DSmith%26aufirst%3DA.%2BL.%26aulast%3DShi%26aufirst%3DX.%2BP.%26aulast%3DYin%26aufirst%3DK.%2BC.%26aulast%3DShafer%26aufirst%3DJ.%2BA.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26atitle%3DPhotoactivated%2520gamma-secretase%2520inhibitors%2520directed%2520to%2520the%2520active%2520site%2520covalently%2520label%2520presenilin%25201%26jtitle%3DNature%26date%3D2000%26volume%3D405%26issue%3D6787%26spage%3D689%26epage%3D694%26doi%3D10.1038%2F35015085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colca, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavey, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holewa, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brightwell-Conrad, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulter, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilkuskie, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracheva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korshunova, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trusgnich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divakaruni, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigueira, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finck, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kletzien, R. F.</span></span> <span> </span><span class="NLM_article-title">Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteins</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e61551</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0061551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1371%2Fjournal.pone.0061551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23690925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVKhsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&issue=5&author=J.+R.+Colcaauthor=W.+G.+McDonaldauthor=G.+S.+Caveyauthor=S.+L.+Coleauthor=D.+D.+Holewaauthor=A.+S.+Brightwell-Conradauthor=C.+L.+Wolfeauthor=J.+S.+Wheelerauthor=K.+R.+Coulterauthor=P.+M.+Kilkuskieauthor=E.+Grachevaauthor=Y.+Korshunovaauthor=M.+Trusgnichauthor=R.+Karrauthor=S.+E.+Wileyauthor=A.+S.+Divakaruniauthor=A.+N.+Murphyauthor=P.+A.+Vigueiraauthor=B.+N.+Finckauthor=R.+F.+Kletzien&title=Identification+of+a+mitochondrial+target+of+thiazolidinedione+insulin+sensitizers+%28mTOT%29%2D%2Drelationship+to+newly+identified+mitochondrial+pyruvate+carrier+proteins&doi=10.1371%2Fjournal.pone.0061551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT) - relationship to newly identified mitochondrial pyruvate carrier proteins</span></div><div class="casAuthors">Colca, Jerry R.; McDonald, William G.; Cavey, Gregory S.; Cole, Serena L.; Holewa, Danielle D.; Brightwell-Conrad, Angela S.; Wolfe, Cindy L.; Wheeler, Jean S.; Coulter, Kristin R.; Kilkuskie, Peter M.; Gracheva, Elena; Korshunova, Yulia; Trusgnich, Michelle; Karr, Robert; Wiley, Sandra E.; Divakaruni, Ajit S.; Murphy, Anne N.; Vigueira, Patrick A.; Finck, Brian N.; Kletzien, Rolf F.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e61551</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Thiazolidinedione (TZD) insulin sensitizers have the potential to effectively treat a no. of human diseases, however the currently available agents have dose-limiting side effects that are mediated via activation of the transcription factor PPARÎ³.  We have recently shown PPARÎ³-independent actions of TZD insulin sensitizers, but the mol. target of these mols. remained to be identified.  Here we use a photo-catalyzable drug analog probe and mass spectrometry-based proteomics to identify a previously uncharacterized mitochondrial complex that specifically recognizes TZDs.  These studies identify two well-conserved proteins previously known as brain protein 44 (BRP44) and BRP44 Like (BRP44L), which recently have been renamed Mpc2 and Mpc1 to signify their function as a mitochondrial pyruvate carrier complex.  Knockdown of Mpc1 or Mpc2 in Drosophila melanogaster or pre-incubation with UK5099, an inhibitor of pyruvate transport, blocks the crosslinking of mitochondrial membranes by the TZD probe.  Knockdown of these proteins in Drosophila also led to increased hemolymph glucose and blocked drug action.  In isolated brown adipose tissue (BAT) cells, MSDC-0602, a PPARÎ³-sparing TZD, altered the incorporation of 13C-labeled carbon from glucose into acetyl CoA.  These results identify Mpc1 and Mpc2 as components of the mitochondrial target of TZDs (mTOT) and suggest that understanding the modulation of this complex, which appears to regulate pyruvate entry into the mitochondria, may provide a viable target for insulin sensitizing pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGcztjyI6bprVg90H21EOLACvtfcHk0liMRCfdk6v4hw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVKhsbw%253D&md5=ecc3245b69aa87e5d49312fe9741baef</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0061551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0061551%26sid%3Dliteratum%253Aachs%26aulast%3DColca%26aufirst%3DJ.%2BR.%26aulast%3DMcDonald%26aufirst%3DW.%2BG.%26aulast%3DCavey%26aufirst%3DG.%2BS.%26aulast%3DCole%26aufirst%3DS.%2BL.%26aulast%3DHolewa%26aufirst%3DD.%2BD.%26aulast%3DBrightwell-Conrad%26aufirst%3DA.%2BS.%26aulast%3DWolfe%26aufirst%3DC.%2BL.%26aulast%3DWheeler%26aufirst%3DJ.%2BS.%26aulast%3DCoulter%26aufirst%3DK.%2BR.%26aulast%3DKilkuskie%26aufirst%3DP.%2BM.%26aulast%3DGracheva%26aufirst%3DE.%26aulast%3DKorshunova%26aufirst%3DY.%26aulast%3DTrusgnich%26aufirst%3DM.%26aulast%3DKarr%26aufirst%3DR.%26aulast%3DWiley%26aufirst%3DS.%2BE.%26aulast%3DDivakaruni%26aufirst%3DA.%2BS.%26aulast%3DMurphy%26aufirst%3DA.%2BN.%26aulast%3DVigueira%26aufirst%3DP.%2BA.%26aulast%3DFinck%26aufirst%3DB.%2BN.%26aulast%3DKletzien%26aufirst%3DR.%2BF.%26atitle%3DIdentification%2520of%2520a%2520mitochondrial%2520target%2520of%2520thiazolidinedione%2520insulin%2520sensitizers%2520%2528mTOT%2529--relationship%2520to%2520newly%2520identified%2520mitochondrial%2520pyruvate%2520carrier%2520proteins%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D5%26doi%3D10.1371%2Fjournal.pone.0061551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrow, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layfield, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldham, N. J.</span></span> <span> </span><span class="NLM_article-title">Carbene footprinting accurately maps binding sites in proteinâligand and proteinâprotein interactions</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13288</span>â <span class="NLM_lpage">13297</span>, <span class="refDoi">Â DOI: 10.1038/ncomms13288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fncomms13288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27848959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVygu7%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13288-13297&author=L.+Manziauthor=A.+S.+Barrowauthor=D.+Scottauthor=R.+Layfieldauthor=T.+G.+Wrightauthor=J.+E.+Mosesauthor=N.+J.+Oldham&title=Carbene+footprinting+accurately+maps+binding+sites+in+protein%E2%80%93ligand+and+protein%E2%80%93protein+interactions&doi=10.1038%2Fncomms13288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Carbene footprinting accurately maps binding sites in protein-ligand and protein-protein interactions</span></div><div class="casAuthors">Manzi, Lucio; Barrow, Andrew S.; Scott, Daniel; Layfield, Robert; Wright, Timothy G.; Moses, John E.; Oldham, Neil J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13288</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Specific interactions between proteins and their binding partners are fundamental to life processes.  The ability to detect protein complexes, and map their sites of binding, is crucial to understanding basic biol. at the mol. level.  Methods that employ sensitive anal. techniques such as mass spectrometry have the potential to provide valuable insights with very little material and on short time scales.  Here we present a differential protein footprinting technique employing an efficient photo-activated probe for use with mass spectrometry.  Using this methodol. the location of a carbohydrate substrate was accurately mapped to the binding cleft of lysozyme, and in a more complex example, the interactions between a 100 kDa, multi-domain deubiquitinating enzyme, USP5 and a diubiquitin substrate were located to different functional domains.  The much improved properties of this probe make carbene footprinting a viable method for rapid and accurate identification of protein binding sites utilizing benign, near-UV photoactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFaUtr2rZhjbVg90H21EOLACvtfcHk0lgtB49MMfGoLQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVygu7%252FF&md5=edff12d1f12e5e6214093e2a535330a4</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1038%2Fncomms13288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13288%26sid%3Dliteratum%253Aachs%26aulast%3DManzi%26aufirst%3DL.%26aulast%3DBarrow%26aufirst%3DA.%2BS.%26aulast%3DScott%26aufirst%3DD.%26aulast%3DLayfield%26aufirst%3DR.%26aulast%3DWright%26aufirst%3DT.%2BG.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26aulast%3DOldham%26aufirst%3DN.%2BJ.%26atitle%3DCarbene%2520footprinting%2520accurately%2520maps%2520binding%2520sites%2520in%2520protein%25E2%2580%2593ligand%2520and%2520protein%25E2%2580%2593protein%2520interactions%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13288%26epage%3D13297%26doi%3D10.1038%2Fncomms13288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horne, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levenstein, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brockwell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radford, S. E.</span></span> <span> </span><span class="NLM_article-title">Rapid mapping of protein interactions using tag-transfer photocrosslinkers</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">16688</span>â <span class="NLM_lpage">16692</span>, <span class="refDoi">Â DOI: 10.1002/anie.201809149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.201809149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Oqu7fJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=16688-16692&issue=51&author=J.+E.+Horneauthor=M.+Walkoauthor=A.+N.+Calabreseauthor=M.+A.+Levensteinauthor=D.+J.+Brockwellauthor=N.+Kapurauthor=A.+J.+Wilsonauthor=S.+E.+Radford&title=Rapid+mapping+of+protein+interactions+using+tag-transfer+photocrosslinkers&doi=10.1002%2Fanie.201809149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Mapping of Protein Interactions Using Tag-Transfer Photocrosslinkers</span></div><div class="casAuthors">Horne, Jim E.; Walko, Martin; Calabrese, Antonio N.; Levenstein, Mark A.; Brockwell, David J.; Kapur, Nikil; Wilson, Andrew J.; Radford, Sheena E.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">16688-16692</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Analyzing protein complexes by chem. crosslinking-mass spectrometry (XL-MS) is limited by the side-chain reactivities and sizes of available crosslinkers, their slow reaction rates, and difficulties in crosslink enrichment, esp. for rare, transient or dynamic complexes.  Here the authors describe two new XL reagents that incorporate a methanethiosulfonate (MTS) group to label a reactive cysteine introduced into the bait protein, and a residue-unbiased diazirine-based photoactivatable XL group to trap its interacting partner(s).  Reductive removal of the bait transfers a thiol-contg. fragment of the crosslinking reagent onto the target that can be alkylated and located by MS sequencing and exploited for enrichment, enabling the detection of low abundance crosslinks.  Using these reagents and a bespoke UV LED irradn. platform, max. crosslinking yield is achieved within 10 s.  The utility of this "tag and transfer" approach is demonstrated using a well-defined peptide/protein regulatory interaction (BID80-102/MCL-1), and the dynamic interaction interface of a chaperone/substrate complex (Skp/OmpA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-T-qLsl_p9bVg90H21EOLACvtfcHk0lgtB49MMfGoLQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Oqu7fJ&md5=e6f285596ed0944a54a36ac51010b324</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1002%2Fanie.201809149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201809149%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DJ.%2BE.%26aulast%3DWalko%26aufirst%3DM.%26aulast%3DCalabrese%26aufirst%3DA.%2BN.%26aulast%3DLevenstein%26aufirst%3DM.%2BA.%26aulast%3DBrockwell%26aufirst%3DD.%2BJ.%26aulast%3DKapur%26aufirst%3DN.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DRadford%26aufirst%3DS.%2BE.%26atitle%3DRapid%2520mapping%2520of%2520protein%2520interactions%2520using%2520tag-transfer%2520photocrosslinkers%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26issue%3D51%26spage%3D16688%26epage%3D16692%26doi%3D10.1002%2Fanie.201809149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88a','cit88b'],'ref89':['cit89a','cit89b'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hendrik  Schneider</span>, <span class="hlFld-ContribAuthor ">Simon  Englert</span>, <span class="hlFld-ContribAuthor ">Arturo  MacarrÃ³n Palacios</span>, <span class="hlFld-ContribAuthor ">Jorge Alberto  Lerma Romero</span>, <span class="hlFld-ContribAuthor ">Ataurehman  Ali</span>, <span class="hlFld-ContribAuthor ">Olga  Avrutina</span>, <span class="hlFld-ContribAuthor ">Harald  Kolmar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation In Vitro. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fchem.2021.693097" title="DOI URL">https://doi.org/10.3389/fchem.2021.693097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2021.693097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2021.693097%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DSynthetic%252BIntegrin-Targeting%252BDextran-Fc%252BHybrids%252BEfficiently%252BInhibit%252BTumor%252BProliferation%252BIn%252BVitro%26aulast%3DSchneider%26aufirst%3DHendrik%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Consuelo  Ripoll</span>, <span class="hlFld-ContribAuthor ">Pilar  Herrero-Foncubierta</span>, <span class="hlFld-ContribAuthor ">Virginia  Puente-MuÃ±oz</span>, <span class="hlFld-ContribAuthor ">M. Carmen  Gonzalez-Garcia</span>, <span class="hlFld-ContribAuthor ">Delia  Miguel</span>, <span class="hlFld-ContribAuthor ">Sandra  Resa</span>, <span class="hlFld-ContribAuthor ">Jose M.  Paredes</span>, <span class="hlFld-ContribAuthor ">Maria J.  Ruedas-Rama</span>, <span class="hlFld-ContribAuthor ">Emilio  Garcia-Fernandez</span>, <span class="hlFld-ContribAuthor ">Mar  Roldan</span>, <span class="hlFld-ContribAuthor ">Susana  Rocha</span>, <span class="hlFld-ContribAuthor ">Herlinde  De Keersmaecker</span>, <span class="hlFld-ContribAuthor ">Johan  Hofkens</span>, <span class="hlFld-ContribAuthor ">Miguel  Martin</span>, <span class="hlFld-ContribAuthor ">Juan M.  Cuerva</span>, <span class="hlFld-ContribAuthor ">Angel  Orte</span>. </span><span class="cited-content_cbyCitation_article-title">Chimeric Drug Design with a Noncharged Carrier for Mitochondrial Delivery. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 254. <a href="https://doi.org/10.3390/pharmaceutics13020254" title="DOI URL">https://doi.org/10.3390/pharmaceutics13020254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13020254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13020254%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DChimeric%252BDrug%252BDesign%252Bwith%252Ba%252BNoncharged%252BCarrier%252Bfor%252BMitochondrial%252BDelivery%26aulast%3DRipoll%26aufirst%3DConsuelo%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Run-Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong-Yan  Guo</span>, <span class="hlFld-ContribAuthor ">Hao  Deng</span>, <span class="hlFld-ContribAuthor ">Jinzi  Li</span>, <span class="hlFld-ContribAuthor ">Zhe-Shan  Quan</span>. </span><span class="cited-content_cbyCitation_article-title">Piperazine skeleton in the structural modification of natural products: a review. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 1165-1197. <a href="https://doi.org/10.1080/14756366.2021.1931861" title="DOI URL">https://doi.org/10.1080/14756366.2021.1931861</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1931861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1931861%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DPiperazine%252Bskeleton%252Bin%252Bthe%252Bstructural%252Bmodification%252Bof%252Bnatural%252Bproducts%25253A%252Ba%252Breview%26aulast%3DZhang%26aufirst%3DRun-Hui%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D1165%26epage%3D1197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nakka  Niveditha</span>, <span class="hlFld-ContribAuthor ">Munnisa  Begum</span>, <span class="hlFld-ContribAuthor ">Duvvala  Prathibha</span>, <span class="hlFld-ContribAuthor ">Kalam  Sirisha</span>, <span class="hlFld-ContribAuthor ">Porika  Mahender</span>, <span class="hlFld-ContribAuthor ">Chandrashekar  Chitra</span>, <span class="hlFld-ContribAuthor ">Vedula Rajeswar  Rao</span>, <span class="hlFld-ContribAuthor ">Vanga Malla  Reddy</span>, <span class="hlFld-ContribAuthor ">Garlapati  Achaiah</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Pharmacological Evaluation of Some C3 Heterocyclic-Substituted Ciprofloxacin Derivatives as Chimeric Antitubercular Agents. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2020,</strong> <em>68 </em>
                                    (12)
                                     , 1170-1177. <a href="https://doi.org/10.1248/cpb.c20-00525" title="DOI URL">https://doi.org/10.1248/cpb.c20-00525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c20-00525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c20-00525%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BPharmacological%252BEvaluation%252Bof%252BSome%252BC3%252BHeterocyclic-Substituted%252BCiprofloxacin%252BDerivatives%252Bas%252BChimeric%252BAntitubercular%252BAgents%26aulast%3DNiveditha%26aufirst%3DNakka%26date%3D2020%26volume%3D68%26issue%3D12%26spage%3D1170%26epage%3D1177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jifa  Zhang</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Proteolysis-targeting chimeras in breast cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (24)
                                     , 2175-2177. <a href="https://doi.org/10.4155/fmc-2020-0279" title="DOI URL">https://doi.org/10.4155/fmc-2020-0279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0279%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DProteolysis-targeting%252Bchimeras%252Bin%252Bbreast%252Bcancer%252Btherapy%26aulast%3DZhang%26aufirst%3DJifa%26date%3D2020%26volume%3D12%26issue%3D24%26spage%3D2175%26epage%3D2177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert I.  Troup</span>, <span class="hlFld-ContribAuthor ">Charlene  Fallan</span>, <span class="hlFld-ContribAuthor ">Matthias G. J.  Baud</span>. </span><span class="cited-content_cbyCitation_article-title">Current strategies for the design of PROTAC linkers: a critical review. </span><span class="cited-content_cbyCitation_journal-name">Exploration of Targeted Anti-tumor Therapy</span><span> <strong>2020,</strong> <em>1 </em>
                                    (5)
                                     <a href="https://doi.org/10.37349/etat.2020.00018" title="DOI URL">https://doi.org/10.37349/etat.2020.00018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.37349/etat.2020.00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.37349%2Fetat.2020.00018%26sid%3Dliteratum%253Aachs%26jtitle%3DExploration%2520of%2520Targeted%2520Anti-tumor%2520Therapy%26atitle%3DCurrent%252Bstrategies%252Bfor%252Bthe%252Bdesign%252Bof%252BPROTAC%252Blinkers%25253A%252Ba%252Bcritical%252Breview%26aulast%3DTroup%26aufirst%3DRobert%2BI.%26date%3D2020%26date%3D2020%26volume%3D1%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas G.  Fischer</span>, <span class="hlFld-ContribAuthor ">Eliseu A.  MÃ¼nchow</span>, <span class="hlFld-ContribAuthor ">Candan  Tamerler</span>, <span class="hlFld-ContribAuthor ">Marco C.  Bottino</span>, <span class="hlFld-ContribAuthor ">Conrado  Aparicio</span>. </span><span class="cited-content_cbyCitation_article-title">Harnessing biomolecules for bioinspired dental biomaterials. </span><span class="cited-content_cbyCitation_journal-name">Journal of Materials Chemistry B</span><span> <strong>2020,</strong> <em>8 </em>
                                    (38)
                                     , 8713-8747. <a href="https://doi.org/10.1039/D0TB01456G" title="DOI URL">https://doi.org/10.1039/D0TB01456G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0TB01456G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0TB01456G%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Materials%2520Chemistry%2520B%26atitle%3DHarnessing%252Bbiomolecules%252Bfor%252Bbioinspired%252Bdental%252Bbiomaterials%26aulast%3DFischer%26aufirst%3DNicholas%2BG.%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D38%26spage%3D8713%26epage%3D8747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krzesimir  Ciura</span>, <span class="hlFld-ContribAuthor ">Joanna  Fedorowicz</span>, <span class="hlFld-ContribAuthor ">Hanna  Kapica</span>, <span class="hlFld-ContribAuthor ">Alicja  Adamkowska</span>, <span class="hlFld-ContribAuthor ">WiesÅaw  Sawicki</span>, <span class="hlFld-ContribAuthor ">JarosÅaw  SÄczewski</span>. </span><span class="cited-content_cbyCitation_article-title">Affinity of FluoroquinoloneâSafirinium Dye Hybrids to Phospholipids Estimated by IAM-HPLC. </span><span class="cited-content_cbyCitation_journal-name">Processes</span><span> <strong>2020,</strong> <em>8 </em>
                                    (9)
                                     , 1148. <a href="https://doi.org/10.3390/pr8091148" title="DOI URL">https://doi.org/10.3390/pr8091148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pr8091148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpr8091148%26sid%3Dliteratum%253Aachs%26jtitle%3DProcesses%26atitle%3DAffinity%252Bof%252BFluoroquinolone%2525E2%252580%252593Safirinium%252BDye%252BHybrids%252Bto%252BPhospholipids%252BEstimated%252Bby%252BIAM-HPLC%26aulast%3DCiura%26aufirst%3DKrzesimir%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D9%26spage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rohit  Bhadoria</span>, <span class="hlFld-ContribAuthor ">Kefeng  Ping</span>, <span class="hlFld-ContribAuthor ">Christer  Lohk</span>, <span class="hlFld-ContribAuthor ">Ivar  JÃ¤rving</span>, <span class="hlFld-ContribAuthor ">Pavel  Starkov</span>. </span><span class="cited-content_cbyCitation_article-title">A phenotypic approach to probing cellular outcomes using heterobivalent constructs. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (30)
                                     , 4216-4219. <a href="https://doi.org/10.1039/C9CC09595K" title="DOI URL">https://doi.org/10.1039/C9CC09595K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC09595K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC09595K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bphenotypic%252Bapproach%252Bto%252Bprobing%252Bcellular%252Boutcomes%252Busing%252Bheterobivalent%252Bconstructs%26aulast%3DBhadoria%26aufirst%3DRohit%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D30%26spage%3D4216%26epage%3D4219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overview of chimeric compounds with a diversity of structures: (a) examples of chimeras discussed in the Perspective, where linker moiety is highlighted in blue; (b) general structures of chimeric compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Examples of linkers and cleavage conditions: (a) hydrazone; (b) disulfide linker; (c) traditional click chemistry reaction used to easily link moieties together. The inverse DielsâAlder reaction has been used to link molecules to a solid surface for screening or for the release of a cytotoxic moiety. Linkers are highlighted in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of the well-known, potent PROTACs including JQ1 and a CDK9 inhibitor, presenting the best linker length. Linkers are highlighted in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Linkers for the physical capture of natural products. Resins utilize a linker (colored in blue) with a silicon atom to capture (a) hydroxyl- or (b) carboxylic acid-containing molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Two probes to observe (a) tubulin dynamics and (b) proteasome activity with the linker portion colored in blue. A variety of linker lengths between the small molecule binder/inhibitor and the fluorophore were evaluated to ensure that the fluorophore did not interfere with the binding to the protein of interest.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Schematic strategy of the selective delivery of biological cargos into cells exploiting receptor-mediated endocytosis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) LHRH-PEG-PHIS-<b>1</b>. (b) <b>1</b>-TAT conjugate. (c) Cleavable probe of octa-arginine peptide. Linker is colored in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structure of a monomer NGR-hTNF [<a href="https://www.molmed.com/node/33" class="extLink">https://www.molmed.com/node/33</a>].</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structure of <b>3</b> and <b>4</b>. Linker is colored in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Chemical structure of <b>5</b> and <b>7</b>. (b) Chemical structure of <b>6</b>. Linkers are colored in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (a) Anti-inflammatory human Î±CD11a antibody conjugated to a PDE4 inhibitor. (b<sub>1</sub>, b<sub>2</sub>) HLCX, immunosuppressive humanized antibody that binds selectively to CXCR4, conjugated to <b>8</b> with a noncleavable linker (b<sub>1</sub>) and a disulfide-cleavable linker (b<sub>2</sub>). Linkers are colored in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Description of FRET experiments for target engagement with no interaction (left) and interaction (right): FP, fluorescent protein; green dot line = donor excitation spectrum; green line = donor emission spectrum; violet dot line = acceptor excitation spectrum; violet line = acceptor emission spectrum.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. FRET experiment with TS dimer. The N-terminus is modified by inserting the sequence CCGPCC-tetracysteine (TC). Probe excitation at the proper wavelength causes the energy transfer and FRET signal increases upon binding of the LR-hilyte-405 ligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Description of BRET experiments for target engagement with no interaction (left) and interaction (right): Luc, luciferase; green line = donor emission spectrum; violet dot line = acceptor excitation spectrum; violet line = acceptor emission spectrum.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. (a) Chemical structure of NanoBRET ester activated dyes; (b) example of linker building blocks. Dyes directly bound to the building block are known; however sometimes a linker (colored in blue) between the head tag and the fluorescent probe is necessary.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Example of ABCP process for covalently binding ligands. (a) Different targets available in the cells for binding the covalent ligand (orange) with the alkyne reactive functionality. (b) Covalent ligand binds the target and forms a covalent or noncovalent complex. The reactive group is exposed outside the binding site. (c) The functional tag (green) is added. It reacts with the reacting group of the covalent ligand (alkyne) with a click chemistry reaction, thus forming a covalent complex with the target. The green tag has a high affinity for the resin that should sequester the chimeraâtarget complex from the sample matrix. (d) The affinity resin is added. The complex, once detached from the resin, is analyzed through mass spectrometry and the biomolecular target identified.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Chemical structures of the hA<sub>2A</sub>R antagonists investigated by Yang et al. The selective hA<sub>2A</sub>R antagonist (ZM241385) guided the design of the covalent antagonist <b>10</b>. The authors assessed the importance of the linker length (colored in blue) between the scaffold and the head on affinity and synthesized the optimized compounds <b>11</b> and <b>12</b>. Starting from compound <b>12</b>, the affinity-based probe <b>13</b> with an alkyne ligation-group and a fluorosulfonyl electrophilic was synthesized.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. (a) Most relevant photoaffinity compounds used to tag protein ligands aiming to study target engagement, protein functions, and their photoreaction: benzofenone, aryl azide, and diazirine (trifluoromethylphenyl diazirine, trifluoromethylethyl diazirine). (b) General structures of scaffolds for photoaffinity tagging.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Efficient PAL method for protein identification using a bead-based multivalent probe.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/medium/jm9b01456_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. (a) Chimeric molecule designed to identify the target of oleanolic acid; (b) photoactivated-Î³-secretase inhibitor in which the tag covalently label presenilin 1; (c) photoaffinity labeled palmytoil derivative directed to the peroxisomal Î²-oxidation enzyme. Shown in green are the photoreactive groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01456/20210322/images/large/jm9b01456_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01456&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 180 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergamini, F. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weil, T.</span></span> <span> </span><span class="NLM_article-title">Functional protein nanostructures: a chemical toolbox</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">9069</span>â <span class="NLM_lpage">9105</span>, <span class="refDoi">Â DOI: 10.1039/C8CS00590G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC8CS00590G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30452046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aqt7%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=9069-9105&author=S.+L.+Kuanauthor=F.+R.+G.+Bergaminiauthor=T.+Weil&title=Functional+protein+nanostructures%3A+a+chemical+toolbox&doi=10.1039%2FC8CS00590G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Functional protein nanostructures: a chemical toolbox</span></div><div class="casAuthors">Kuan, Seah Ling; Bergamini, Fernando R. G.; Weil, Tanja</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9069-9105</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Nature has evolved an optimal synthetic factory in the form of translational and posttranslational processes by which millions of proteins with defined primary sequences and 3D structures can be built.  Nature's toolkit gives rise to protein building blocks, which dictates their spatial arrangement to form functional protein nanostructures that serve a myriad of functions in cells, ranging from biocatalysis, formation of structural networks, and regulation of biochem. processes, to sensing.  With the advent of chem. tools for site-selective protein modifications and recombinant engineering, there is a rapid development to develop and apply synthetic methods for creating structurally defined, functional protein nanostructures for a broad range of applications in the fields of catalysis, materials and biomedical sciences.  In this review, design principles and structural features for achieving and characterizing functional protein nanostructures by synthetic approaches are summarized.  The synthetic customization of protein building blocks, the design and introduction of recognition units and linkers and subsequent assembly into structurally defined protein architectures are discussed herein.  Key examples of these supramol. protein nanostructures, their unique functions and resultant impact for biomedical applications are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEJPACRafpH7Vg90H21EOLACvtfcHk0lgQeVuUhAgYEg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aqt7%252FI&md5=01035c8507ab259bfcb90e9148e116a0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1039%2FC8CS00590G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CS00590G%26sid%3Dliteratum%253Aachs%26aulast%3DKuan%26aufirst%3DS.%2BL.%26aulast%3DBergamini%26aufirst%3DF.%2BR.%2BG.%26aulast%3DWeil%26aufirst%3DT.%26atitle%3DFunctional%2520protein%2520nanostructures%253A%2520a%2520chemical%2520toolbox%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2018%26volume%3D47%26spage%3D9069%26epage%3D9105%26doi%3D10.1039%2FC8CS00590G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Corson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberle, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Design and applications of bifunctional small molecules: why two heads are better than one</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">677</span>â <span class="NLM_lpage">692</span>, <span class="refDoi">Â DOI: 10.1021/cb8001792</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb8001792" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yiurzF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=677-692&author=T.+W.+Corsonauthor=N.+Aberleauthor=C.+M.+Crews&title=Design+and+applications+of+bifunctional+small+molecules%3A+why+two+heads+are+better+than+one&doi=10.1021%2Fcb8001792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than One</span></div><div class="casAuthors">Corson, Timothy W.; Aberle, Nicholas; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">677-692</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Induction of protein-protein interactions is a daunting challenge, but recent studies show promise for small mols. that specifically bring two or more protein mols. together for enhanced or novel biol. effect.  The first such bifunctional mols. were the rapamycin- and FK506-based "chem. inducers of dimerization", but the field has since expanded with new mols. and new applications in chem. genetics and cell biol.  Examples include coumermycin-mediated gyrase B dimerization, proteolysis targeting chimeric mols. (PROTACs), drug hybrids, and strategies for exploiting multivalency in toxin binding and antibody recruitment.  This Review discusses these and other advances in the design and use of bifunctional small mols. and potential strategies for future systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-ZyBtc3QT9rVg90H21EOLACvtfcHk0lgQeVuUhAgYEg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yiurzF&md5=2edac15286d3a739dd66214a332a545b</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1021%2Fcb8001792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb8001792%26sid%3Dliteratum%253Aachs%26aulast%3DCorson%26aufirst%3DT.%2BW.%26aulast%3DAberle%26aufirst%3DN.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DDesign%2520and%2520applications%2520of%2520bifunctional%2520small%2520molecules%253A%2520why%2520two%2520heads%2520are%2520better%2520than%2520one%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2008%26volume%3D3%26spage%3D677%26epage%3D692%26doi%3D10.1021%2Fcb8001792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lautenslager, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, L. L.</span></span> <span> </span><span class="NLM_article-title">Chimeric molecules constructed with endogenous substances</span>. <i>Adv. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">233</span>â <span class="NLM_lpage">262</span>, <span class="refDoi">Â DOI: 10.1016/S1569-2558(08)60387-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2FS1569-2558%2808%2960387-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADyaK28XmtlaqsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1994&pages=233-262&author=G.+T.+Lautenslagerauthor=L.+L.+Simpson&title=Chimeric+molecules+constructed+with+endogenous+substances&doi=10.1016%2FS1569-2558%2808%2960387-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Chimeric molecules constructed with endogenous substances</span></div><div class="casAuthors">Lautenslager, Gregory T.; Simpson, Lance L.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Molecular and Cell Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">Homing Mechanisms and Cellular Targeting</span>),
    <span class="NLM_cas:pages">233-262</span>CODEN:
                <span class="NLM_cas:coden">AMCBEZ</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">JAI Press</span>)
        </div><div class="casAbstract">A review, with 86 refs.  The authors provide here representative examples of the kinds of data that are emerging from the field of chimeric drug research.  Topics discussed include: prepn. of chimeric mols., demonstration of target delivery in vivo and in vitro, potentially therapeutic chimeric mols., chimeric mols. as tools in cell biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYo6EI8Z40w7Vg90H21EOLACvtfcHk0lja22aCJy-1xA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmtlaqsLY%253D&md5=7d9f1cd52dde17677f9d7defb1b84882</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2FS1569-2558%2808%2960387-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1569-2558%252808%252960387-2%26sid%3Dliteratum%253Aachs%26aulast%3DLautenslager%26aufirst%3DG.%2BT.%26aulast%3DSimpson%26aufirst%3DL.%2BL.%26atitle%3DChimeric%2520molecules%2520constructed%2520with%2520endogenous%2520substances%26jtitle%3DAdv.%2520Mol.%2520Cell%2520Biol.%26date%3D1994%26volume%3D9%26spage%3D233%26epage%3D262%26doi%3D10.1016%2FS1569-2558%2808%2960387-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maniaci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Bifunctional chemical probes inducing protein-protein interactions</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">145</span>â <span class="NLM_lpage">156</span>, <span class="refDoi">Â DOI: 10.1016/j.cbpa.2019.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.cbpa.2019.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=31419624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyltbjF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2019&pages=145-156&author=C.+Maniaciauthor=A.+Ciulli&title=Bifunctional+chemical+probes+inducing+protein-protein+interactions&doi=10.1016%2Fj.cbpa.2019.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Bifunctional chemical probes inducing protein-protein interactions</span></div><div class="casAuthors">Maniaci, Chiara; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-156</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Inducing biomol. interactions with synthetic mols. to impact biol. function is a concept of enormous appeal.  Recent years have seen a resurgence of interest in designing bispecific mols. that serve as bridging agents to bring proteins together.  Pioneering structural and biophys. investigation of ternary complexes formed by mono-functional and bifunctional ligands highlights that proximity-induced stabilization or de novo formation of protein-protein interactions is a common feature of their mol. recognition.  In this review, we illustrate these concepts and advances with representative case studies, and highlight progress over the past three years, with particular focus on recruitment to E3 ubiquitin ligases by 'mol. glues' and chimeric dimerizers (PROTACs) for targeted protein degrdn.  This approach promises to significantly expand the range of tractable targets for chem. biol. and therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobXJM1PThHPbVg90H21EOLACvtfcHk0lja22aCJy-1xA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyltbjF&md5=4302bb010003177f4f5e5c3d4a401dc9</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2019.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2019.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DManiaci%26aufirst%3DC.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DBifunctional%2520chemical%2520probes%2520inducing%2520protein-protein%2520interactions%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D52%26spage%3D145%26epage%3D156%26doi%3D10.1016%2Fj.cbpa.2019.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gilad, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuchinsky, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-David, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minnes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gancz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senderowitz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luboshits, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firer, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellerman, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent molecular chimera (CM358) to treat human metastatic melanoma</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">602</span>â <span class="NLM_lpage">615</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2017.06.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.ejmech.2017.06.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28710962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKrs7%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=602-615&author=Y.+Giladauthor=H.+Tuchinskyauthor=G.+Ben-Davidauthor=R.+Minnesauthor=A.+Ganczauthor=H.+Senderowitzauthor=G.+Luboshitsauthor=M.+A.+Firerauthor=G.+Gellerman&title=Discovery+of+potent+molecular+chimera+%28CM358%29+to+treat+human+metastatic+melanoma&doi=10.1016%2Fj.ejmech.2017.06.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent molecular chimera (CM358) to treat human metastatic melanoma</span></div><div class="casAuthors">Gilad, Y.; Tuchinsky, H.; Ben-David, G.; Minnes, R.; Gancz, A.; Senderowitz, H.; Luboshits, G.; Firer, M. A.; Gellerman, G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">602-615</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The resistance of cancer cells to chemotherapeutic agents, whether through intrinsic mechanisms or developed resistance, motivates the search for new chemotherapeutic strategies.  In the present report, the authors demonstrate a facile synthetic strategy towards the discovery of new anti-cancer substances.  This strategy is based on simple covalent coupling between known anti-cancer drugs, which results in novel 'chimeric' small mols.  One of these novel compds., CM358, is the product of an amide bond formation between the known Topoisomerase II (Topo II) inhibitor amonafide (AM) and the known DNA mustard alkylator chlorambucil (CLB).  It demonstrates significant enhanced cytotoxicity over an equimolar mixt. of AM and CLB in various cancer cell lines and in a xenograft model of human metastatic melanoma.  Topo II inhibition as well as in silico docking studies suggest that CM358 is a stronger Topo II binder than AM.  This may be attributed, at least partially, to the placement of the CLB moiety in a favorable orientation with respect to DNA crosslinking with nearby guanines.  In a human metastatic melanoma (WM 266-4) xenograft model, this compd. was profoundly superior to a mixt. of AM and CLB in redn. of tumor growth, maintenance of body wt. and extension of overall survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqEtOV5jXdSrVg90H21EOLACvtfcHk0lja22aCJy-1xA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKrs7%252FM&md5=c734f4cf1302f1b5bfc7c07de256b2c6</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.06.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.06.066%26sid%3Dliteratum%253Aachs%26aulast%3DGilad%26aufirst%3DY.%26aulast%3DTuchinsky%26aufirst%3DH.%26aulast%3DBen-David%26aufirst%3DG.%26aulast%3DMinnes%26aufirst%3DR.%26aulast%3DGancz%26aufirst%3DA.%26aulast%3DSenderowitz%26aufirst%3DH.%26aulast%3DLuboshits%26aufirst%3DG.%26aulast%3DFirer%26aufirst%3DM.%2BA.%26aulast%3DGellerman%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520potent%2520molecular%2520chimera%2520%2528CM358%2529%2520to%2520treat%2520human%2520metastatic%2520melanoma%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D602%26epage%3D615%26doi%3D10.1016%2Fj.ejmech.2017.06.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tashima, T.</span></span> <span> </span><span class="NLM_article-title">Effective cancer therapy based on selective drug delivery into cells across their membrane using receptor-mediated endocytosis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3015</span>â <span class="NLM_lpage">3024</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2018.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.bmcl.2018.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30031619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlGht7jJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3015-3024&author=T.+Tashima&title=Effective+cancer+therapy+based+on+selective+drug+delivery+into+cells+across+their+membrane+using+receptor-mediated+endocytosis&doi=10.1016%2Fj.bmcl.2018.07.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Effective cancer therapy based on selective drug delivery into cells across their membrane using receptor-mediated endocytosis</span></div><div class="casAuthors">Tashima, Toshihiko</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3015-3024</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cancer is one of the major causes of death globally.  The current treatment options are insufficient, leading to unmet medical needs in cancer treatment.  Off-target side effects, multidrug resistance, selective distribution to cancerous tissues, and cell membrane permeation of anti-cancer agents are crit. problems to overcome.  There is a method to solve these problems by using receptor-mediated endocytosis (RME).  It is well known that proteins such as integrin, HER2, EGFR, or other cancer biomarkers are specifically overexpressed on the surface of target cancer cells.  By taking advantage of such specific receptors, payloads can be transported into cells through endocytosis using a conjugate composed of the corresponding ligands connected to the payloads by an appropriate linker.  After RME, the payloads released by endosomal escape into the cytoplasm can exhibit the cytotoxic activity against cancer cells.  Cell-penetrating peptides (CPPs), tumor-homing peptides (THPs), and monoclonal antibodies (mAbs) are utilized as ligands in this system.  Antibody drug conjugates (ADCs) based on RME have already been used to cure cancer.  In addn. to the canonical conjugate method, nanocarriers for spontaneous accumulation in cancer tissue due to enhanced permeability and retention (EPR) effect are extensively used.  In this review, I introduce the possibilities and advantages of drug design and development based on RME for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGochutAByX4_bVg90H21EOLACvtfcHk0ljwiiV3_cnhWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlGht7jJ&md5=14af0e12d630a91dc941f8dc9431b893</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DTashima%26aufirst%3DT.%26atitle%3DEffective%2520cancer%2520therapy%2520based%2520on%2520selective%2520drug%2520delivery%2520into%2520cells%2520across%2520their%2520membrane%2520using%2520receptor-mediated%2520endocytosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3015%26epage%3D3024%26doi%3D10.1016%2Fj.bmcl.2018.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lazny, R.</span></span> <span> </span><span class="NLM_article-title">Hydrazone linker units</span>. In  <i>Linker Strategies in Solid-Phase Organic Synthesis</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, P. J. H.</span></span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons, Ltd.</span>: <span class="NLM_publisher-loc">Chichester, U.K.</span>, <span class="NLM_year">2009</span>; pp  <span class="NLM_fpage">303</span>â <span class="NLM_lpage">315</span>, <span class="refDoi">Â DOI: 10.1002/9780470749043.ch10</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2F9780470749043.ch10" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=303-315&author=R.+Laznyauthor=P.+J.+H.+Scott&title=Linker+Strategies+in+Solid-Phase+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2F9780470749043.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9780470749043.ch10%26sid%3Dliteratum%253Aachs%26aulast%3DLazny%26aufirst%3DR.%26atitle%3DHydrazone%2520linker%2520units%26btitle%3DLinker%2520Strategies%2520in%2520Solid-Phase%2520Organic%2520Synthesis%26aulast%3DScott%26aufirst%3DP.%2BJ.%2BH.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26date%3D2009%26spage%3D303%26epage%3D315%26doi%3D10.1002%2F9780470749043.ch10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enders, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wortmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, R.</span></span> <span> </span><span class="NLM_article-title">Recovery of carbonyl compounds from <i>N,N</i>-dialkylhydrazones</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">157</span>â <span class="NLM_lpage">169</span>, <span class="refDoi">Â DOI: 10.1021/ar990062y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar990062y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotlyisg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=157-169&issue=3&author=D.+Endersauthor=L.+Wortmannauthor=R.+Peters&title=Recovery+of+carbonyl+compounds+from+N%2CN-dialkylhydrazones&doi=10.1021%2Far990062y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recovery of Carbonyl Compounds from N,N-Dialkylhydrazones</span></div><div class="casAuthors">Enders, Dieter; Wortmann, Lars; Peters, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-169</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deprotonation of enantiomerically pure hydrazones and subsequent trapping with suitable electrophiles generates new stereogenic centers with excellent stereoselectivity.  To liberate the original carbonyl functionality in the final products, it is necessary to cleave the hydrazone moiety.  In recent years, many reagents have been developed to regenerate carbonyl compds. from the corresponding dialkylhydrazones which are compatible with a wide range of functionalities.  This has allowed the use of hydrazones in the total synthesis of complex natural products.  This Account is meant to be an overview of methods which are classified as oxidative, hydrolytic, and reductive cleavage procedures; 67 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWS8reJIc5UbVg90H21EOLACvtfcHk0ljwiiV3_cnhWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotlyisg%253D%253D&md5=ce11524b0ba2d6fd0c98f19a145944d1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Far990062y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far990062y%26sid%3Dliteratum%253Aachs%26aulast%3DEnders%26aufirst%3DD.%26aulast%3DWortmann%26aufirst%3DL.%26aulast%3DPeters%26aufirst%3DR.%26atitle%3DRecovery%2520of%2520carbonyl%2520compounds%2520from%2520N%252CN-dialkylhydrazones%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2000%26volume%3D33%26issue%3D3%26spage%3D157%26epage%3D169%26doi%3D10.1021%2Far990062y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclaire, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vial, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wietor, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, J. K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, S.</span></span> <span> </span><span class="NLM_article-title">Dynamic combinatorial chemistry</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3652</span>â <span class="NLM_lpage">3711</span>, <span class="refDoi">Â DOI: 10.1021/cr020452p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr020452p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVKhsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2006&pages=3652-3711&issue=9&author=P.+T.+Corbettauthor=J.+Leclaireauthor=L.+Vialauthor=K.+R.+Westauthor=J.-L.+Wietorauthor=J.+K.+M.+Sandersauthor=S.+Otto&title=Dynamic+combinatorial+chemistry&doi=10.1021%2Fcr020452p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic Combinatorial Chemistry</span></div><div class="casAuthors">Corbett, Peter T.; Leclaire, Julien; Vial, Laurent; West, Kevin R.; Wietor, Jean-Luc; Sanders, Jeremy K. M.; Otto, Sijbren</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3652-3711</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review comprehensively discusses all the major aspects of the dynamic combinatorial chem. which is the combinatorial chem. under thermodn. control.  The brief history of its development is followed by the discussion of the various reversible reactions, including the exchange reactions (acyl, imine, acetal or disulfide exchange), Diels-Alder reactions, metathesis, or metal-ligand coordination, with the emphasis on the conditions and functional group tolerance.  The exptl. issues of the synthesis of dynamic combinatorial libraries are also discussed.  This is followed by the section on the application of this approach for the synthesis of various receptors, ligands for biomols., and dynamic combinatorial studies on folding of peptides, nucleotides and synthetic polymers.  The review is concluded by the theor. studies of the dynamic combinatorial chem. and discussion of the related approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-I-tfzACnLVg90H21EOLACvtfcHk0ljwiiV3_cnhWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVKhsbo%253D&md5=6cc165c2f6d788f43a24493350143f0f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fcr020452p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr020452p%26sid%3Dliteratum%253Aachs%26aulast%3DCorbett%26aufirst%3DP.%2BT.%26aulast%3DLeclaire%26aufirst%3DJ.%26aulast%3DVial%26aufirst%3DL.%26aulast%3DWest%26aufirst%3DK.%2BR.%26aulast%3DWietor%26aufirst%3DJ.-L.%26aulast%3DSanders%26aufirst%3DJ.%2BK.%2BM.%26aulast%3DOtto%26aufirst%3DS.%26atitle%3DDynamic%2520combinatorial%2520chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2006%26volume%3D106%26issue%3D9%26spage%3D3652%26epage%3D3711%26doi%3D10.1021%2Fcr020452p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dyniewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LipiÅski, P. F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeÅniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BochyÅska-CzyÅ¼, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muchowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">TourwÃ©, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misicka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipkowski, A. W.</span></span> <span> </span><span class="NLM_article-title">Hydrazone linker as a useful tool for preparing chimeric peptide/nonpeptide bifunctional compounds</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">73</span>â <span class="NLM_lpage">77</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.6b00381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKgtrfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=73-77&issue=1&author=J.+Dyniewiczauthor=P.+F.+J.+Lipi%C5%84skiauthor=P.+Kossonauthor=A.+Le%C5%9Bniakauthor=M.+Bochy%C5%84ska-Czy%C5%BCauthor=A.+Muchowskaauthor=D.+Tourw%C3%A9author=S.+Balletauthor=A.+Misickaauthor=A.+W.+Lipkowski&title=Hydrazone+linker+as+a+useful+tool+for+preparing+chimeric+peptide%2Fnonpeptide+bifunctional+compounds&doi=10.1021%2Facsmedchemlett.6b00381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrazone linker as a useful tool for preparing chimeric peptide/nonpeptide bifunctional compounds</span></div><div class="casAuthors">Dyniewicz, Jolanta; Lipinski, Piotr F. J.; Kosson, Piotr; Lesniak, Anna; Bochynska-Czyz, Marta; Muchowska, Adriana; Tourwe, Dirk; Ballet, Steven; Misicka, Aleksandra; Lipkowski, Andrzej W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-77</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The area of multitarget compds., joining two pharmacophores within one mol., is a vivid field of research in medicinal chem.  Not only pharmacophoric elements are essential for the design and activity of such compds., but the type and length of linkers used to connect them are also crucial.  In the present contribution, we describe compd. (I) (as TFA salt) in which a typical opioid peptide sequence is combined with a fragment characteristic for neurokinin-1 receptor (NK1R) antagonists through a hydrazone bridge.  The compd. has a high affinity for Î¼- and Î´-opioid receptors (IC50= 12.7 and 74.0 nM, resp.) and a weak affinity for the NK1R.  Mol. modeling and structural considerations explain the obsd. activities.  In in vivo test, intrathecal and i.v. administrations of I exhibited a strong analgesic effect, which indicates potential BBB penetration.  This letter brings an exemplary application of the hydrazone linker for fast, facile, and successful prepn. of chimeric compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcYsdWkRkoCbVg90H21EOLACvtfcHk0litT77L0xUpSw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKgtrfI&md5=18b4e0c673d79a861b38446b4354c59b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00381%26sid%3Dliteratum%253Aachs%26aulast%3DDyniewicz%26aufirst%3DJ.%26aulast%3DLipi%25C5%2584ski%26aufirst%3DP.%2BF.%2BJ.%26aulast%3DKosson%26aufirst%3DP.%26aulast%3DLe%25C5%259Bniak%26aufirst%3DA.%26aulast%3DBochy%25C5%2584ska-Czy%25C5%25BC%26aufirst%3DM.%26aulast%3DMuchowska%26aufirst%3DA.%26aulast%3DTourw%25C3%25A9%26aufirst%3DD.%26aulast%3DBallet%26aufirst%3DS.%26aulast%3DMisicka%26aufirst%3DA.%26aulast%3DLipkowski%26aufirst%3DA.%2BW.%26atitle%3DHydrazone%2520linker%2520as%2520a%2520useful%2520tool%2520for%2520preparing%2520chimeric%2520peptide%252Fnonpeptide%2520bifunctional%2520compounds%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D73%26epage%3D77%26doi%3D10.1021%2Facsmedchemlett.6b00381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FonoviÄ, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelst, S. H. L.</span></span> <span> </span><span class="NLM_article-title">Cleavable linkers in chemical proteomics applications</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1491</i></span>,  <span class="NLM_fpage">185</span>â <span class="NLM_lpage">203</span>, <span class="refDoi">Â DOI: 10.1007/978-1-4939-6439-0_14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-4939-6439-0_14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27778290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCkt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1491&publication_year=2017&pages=185-203&author=Y.+Yangauthor=M.+Fonovi%C4%87author=S.+H.+L.+Verhelst&title=Cleavable+linkers+in+chemical+proteomics+applications&doi=10.1007%2F978-1-4939-6439-0_14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cleavable linkers in chemical proteomics applications</span></div><div class="casAuthors">Yang, Yinliang; Fonovic, Marko; Verhelst, Steven H. L.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1491</span>
        (<span class="NLM_cas:issue">Activity-Based Proteomics</span>),
    <span class="NLM_cas:pages">185-203</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The discovery of the protein targets of small mol. probes is a crucial aspect of activity-based protein profiling and chem. biol.  Mass spectrometry is the primary method for target identification, and in the last decade, cleavable linkers have become a popular strategy to facilitate protein enrichment and identification.  In this chapter, we provide an overview of cleavable linkers used in chem. proteomics approaches, discuss their different chemistries, and describe how they aid in protein identification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE55qAFBd5ZrVg90H21EOLACvtfcHk0litT77L0xUpSw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCkt7k%253D&md5=6dee0fec091866f2a29bc333a6da635a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-6439-0_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-6439-0_14%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DFonovi%25C4%2587%26aufirst%3DM.%26aulast%3DVerhelst%26aufirst%3DS.%2BH.%2BL.%26atitle%3DCleavable%2520linkers%2520in%2520chemical%2520proteomics%2520applications%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2017%26volume%3D1491%26spage%3D185%26epage%3D203%26doi%3D10.1007%2F978-1-4939-6439-0_14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, H.</span></span> <span> </span><span class="NLM_article-title">Useful tools for biomolecule isolation, detection, and identification: acylhydrazone-based cleavable linkers</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">763</span>â <span class="NLM_lpage">772</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2009.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.chembiol.2009.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=19635413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVCjsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=763-772&issue=7&author=K.+D.+Parkauthor=R.+Liuauthor=H.+Kohn&title=Useful+tools+for+biomolecule+isolation%2C+detection%2C+and+identification%3A+acylhydrazone-based+cleavable+linkers&doi=10.1016%2Fj.chembiol.2009.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Useful Tools for Biomolecule Isolation, Detection, and Identification: Acylhydrazone-Based Cleavable Linkers</span></div><div class="casAuthors">Park, Ki Duk; Liu, Rihe; Kohn, Harold</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">763-772</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Proteomic searches using affinity-based chromatog. (e.g., biotin-[strept]avidin) have been severely hampered by low protein recovery yields, protein destruction and denaturation, and the release of background proteins from the support.  These limitations confound protein identification.  A new acylhydrazone-based cleavable linker was developed to permit the efficient isolation of proteins with a traceable tag allowing detection and identification under mild conditions.  The utility of the acylhydrazone linker was validated in a proteomic search wherein aldehyde dehydrogenase-1 was selectively captured and isolated from the mouse sol. liver proteome without interfering background proteins.  The use of acylhydrazone linkers is expected to be generalized, allowing for the selective release of tagged mols. from noncovalent and covalently tagged supports.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ewRLvYfaFbVg90H21EOLACvtfcHk0litT77L0xUpSw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVCjsb4%253D&md5=5a876b2ace7fc36fd058457f70875bf8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.%2BD.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DKohn%26aufirst%3DH.%26atitle%3DUseful%2520tools%2520for%2520biomolecule%2520isolation%252C%2520detection%252C%2520and%2520identification%253A%2520acylhydrazone-based%2520cleavable%2520linkers%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26issue%3D7%26spage%3D763%26epage%3D772%26doi%3D10.1016%2Fj.chembiol.2009.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dirksen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yegneswaran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, P. E.</span></span> <span> </span><span class="NLM_article-title">Bisaryl hydrazones as exchangeable biocompatible linkers</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2023</span>â <span class="NLM_lpage">2027</span>, <span class="refDoi">Â DOI: 10.1002/anie.200906756</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.200906756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFSnsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=2023-2027&issue=11&author=A.+Dirksenauthor=S.+Yegneswaranauthor=P.+E.+Dawson&title=Bisaryl+hydrazones+as+exchangeable+biocompatible+linkers&doi=10.1002%2Fanie.200906756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Bisaryl Hydrazones as Exchangeable Biocompatible Linkers</span></div><div class="casAuthors">Dirksen, Anouk; Yegneswaran, Subramanian; Dawson, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2023-2027, S2023/1-S2023/32</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Stable, yet exchangeable, bisaryl hydrazones undergo rapid exchange (cleavage) under mild conditions by catalytic transimination.  This highly efficient hydrazone exchange is useful for the affinity purifn. of biotinylated proteins on (strept)avidin beads.  The authors studied the biotinylation agent CLB354 which is com. available.  The reversibility and stability of CLB354 were first validated in soln. at pH 6.0 to facilitate both reequilibration kinetics and protein stability.  The CLB354 hydrazone was fully stable overnight; however, upon treatment with 100 mM aniline, approx. 25% of the hydrazone was hydrolyzed rapidly, and a new equil. was attained.  Further, the hydrazone can be cleaved by transimination with any aminooxy compd.  Thus, CLB354-modified serum albumin can be refunctionalized by exchanging the CLB354 biotin tag with a new label or affinity tag, e.g., by using aminooxyacetyl-Alexa Fluor 488 or aminooxyacetyl-modified FLAG peptide and 100 mM aniline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOj6SRJFrSQbVg90H21EOLACvtfcHk0litT77L0xUpSw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFSnsb4%253D&md5=f9789e287885d2150b3847e65a6febd9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fanie.200906756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200906756%26sid%3Dliteratum%253Aachs%26aulast%3DDirksen%26aufirst%3DA.%26aulast%3DYegneswaran%26aufirst%3DS.%26aulast%3DDawson%26aufirst%3DP.%2BE.%26atitle%3DBisaryl%2520hydrazones%2520as%2520exchangeable%2520biocompatible%2520linkers%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26issue%3D11%26spage%3D2023%26epage%3D2027%26doi%3D10.1002%2Fanie.200906756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">GÃ³ngora-BenÃ­tez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulla-Puche, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albericio, F.</span></span> <span> </span><span class="NLM_article-title">Multifaceted roles of disulfide bonds. Peptides as therapeutics</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">901</span>â <span class="NLM_lpage">926</span>, <span class="refDoi">Â DOI: 10.1021/cr400031z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr400031z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7nJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=901-926&issue=2&author=M.+G%C3%B3ngora-Ben%C3%ADtezauthor=J.+Tulla-Pucheauthor=F.+Albericio&title=Multifaceted+roles+of+disulfide+bonds.+Peptides+as+therapeutics&doi=10.1021%2Fcr400031z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Multifaceted Roles of Disulfide Bonds. Peptides as Therapeutics</span></div><div class="casAuthors">Gongora-Benitez, Miriam; Tulla-Puche, Judit; Albericio, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">901-926</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present review, we have focused our attention on disulfide bonds as constrained elements and their further implications in the development of peptide-based therapeutics.  Thus, the versatile roles of the disulfide bonds formed between Cys residues in therapeutic peptides have been covered.  First, the biol. relevance of these covalent linkages in the oxidative folding process and the contribution of these structural elements to the 3D conformational stability of polypeptides have been discussed.  In addn., the capacity of these linkages to modulate the pharmacodynamic and pharmacokinetic properties of the peptide has been fully disclosed.  Overall, peptide cyclization through the incorporation of disulfide bridges not only may allow the improvement of diverse pharmacol. features, but may also provide valuable information about biol. processes and that is relevant for the further design of peptide analogs and peptidomimetics.  Here we have referred to several studies in which the insertion of a disulfide bond has endowed peptides enhanced pharmacol. properties, including bioactivity, selectivity and resistance to proteases. ,many other studies have demonstrated that these constrained elements are potentially capable of stabilizing secondary structure elements involved in widespread mol. surface recognition processes.  Moreover, disulfide bonds are being applied as reversible covalent bonds for the construction of peptide conjugates that comprise a drug delivery carrier for enhancing cell permeability.  In this regard, the early development of bioactive peptides linked to drug delivery systems is gaining relevance, and this tendency has been progressively implemented in many pharmaceutical companies.  In particular, CPPs may allow a large no. of peptide drugs to enter the market, and they are expected to contribute to accelerating the research performed in both the industrial sector and in the academic world.  The next generation of CPPs is expected to combine both targeting and internalization advantages.  On the other hand, of special interest are small disulfide-rich peptides,which have also been discussed as valuable therapeutic agents.  In general, these privileged mols. show extraordinary chem. and biol. stability and, given their highly constrained architecture, many of them and analogs thereof are currently undergoing preclin. studies or are in clin. trials.  Together with the increasing significance of these constrained peptides as drugs themselves, some of these rigid structures have been used as scaffolds for peptide engineering.  Thus, by taking advantages of the privileged pharmacokinetic properties of some of these extremely rigid architectures, this novel approach is emerging as an extremely valuable tool for peptide drug discovery.  Furthermore, of relevance, owing to their special topol. and cyclic backbone, some small cyclicdisulfide-rich peptides have the capacity to cross the cell membrane.  These peptides constitute a new family of CPPs that are referred to as cyclic cell-penetrating peptides(CCPPs).  These mols. ofer several advantages over linear CPPs, including greater stability and bioavailability, and therefore, they are promising mols. for drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBYp3zST79N7Vg90H21EOLACvtfcHk0liHQ4sY-AnoFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yls7nJ&md5=903478ec86d15479bf1987d142cccf58</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcr400031z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400031z%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B3ngora-Ben%25C3%25ADtez%26aufirst%3DM.%26aulast%3DTulla-Puche%26aufirst%3DJ.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DMultifaceted%2520roles%2520of%2520disulfide%2520bonds.%2520Peptides%2520as%2520therapeutics%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26issue%3D2%26spage%3D901%26epage%3D926%26doi%3D10.1021%2Fcr400031z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kourra, C. M. B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cramer, N.</span></span> <span> </span><span class="NLM_article-title">Converting disulfide bridges in native peptides to stable methylene thioacetals</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">7007</span>â <span class="NLM_lpage">7012</span>, <span class="refDoi">Â DOI: 10.1039/C6SC02285E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC6SC02285E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28451136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Crt7bO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=7007-7012&issue=12&author=C.+M.+B.+K.+Kourraauthor=N.+Cramer&title=Converting+disulfide+bridges+in+native+peptides+to+stable+methylene+thioacetals&doi=10.1039%2FC6SC02285E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Converting disulfide bridges in native peptides to stable methylene thioacetals</span></div><div class="casAuthors">Kourra, C. M. B. K.; Cramer, N.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7007-7012</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Disulfide bridges play a crucial role in defining and rigidifying the three-dimensional structure of peptides.  However, disulfides are inherently unstable in reducing environments.  Consequently, the development of strategies aiming to circumvent these deficiencies - ideally with little structural disturbance - are highly sought after.  Herein, we report a simple protocol converting the disulfide bond of peptides into highly stable methylene thioacetal.  The transformation occurs under mild, biocompatible conditions, enabling the conversion of unprotected native peptides into analogs with enhanced stability.  The developed protocol is applicable to a range of peptides and selective in the presence of a multitude of potentially reactive functional groups.  The thioacetal modification annihilates the reductive lability and increases the serum, pH and temp. stability of the important peptide hormone oxytocin.  Moreover, it is shown that the biol. activities for oxytocin are retained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNUJLTzqWREbVg90H21EOLACvtfcHk0liHQ4sY-AnoFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Crt7bO&md5=a91a7082858d171b9f5c3e07e30f7c61</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1039%2FC6SC02285E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6SC02285E%26sid%3Dliteratum%253Aachs%26aulast%3DKourra%26aufirst%3DC.%2BM.%2BB.%2BK.%26aulast%3DCramer%26aufirst%3DN.%26atitle%3DConverting%2520disulfide%2520bridges%2520in%2520native%2520peptides%2520to%2520stable%2520methylene%2520thioacetals%26jtitle%3DChem.%2520Sci.%26date%3D2016%26volume%3D7%26issue%3D12%26spage%3D7007%26epage%3D7012%26doi%3D10.1039%2FC6SC02285E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vinther, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huus, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steensgaard, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SÃ¸rensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kjeldsen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubalek, F.</span></span> <span> </span><span class="NLM_article-title">Additional disulfide bonds in insulin: prediction, recombinant expression, receptor binding affinity, and stability</span>. <i>Protein Sci. Publ. Protein Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">779</span>â <span class="NLM_lpage">788</span>, <span class="refDoi">Â DOI: 10.1002/pro.2649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fpro.2649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25627966" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2015&pages=779-788&issue=5&author=T.+N.+Vintherauthor=I.+Petterssonauthor=K.+Huusauthor=M.+Schleinauthor=D.+B.+Steensgaardauthor=A.+S%C3%B8rensenauthor=K.+J.+Jensenauthor=T.+Kjeldsenauthor=F.+Hubalek&title=Additional+disulfide+bonds+in+insulin%3A+prediction%2C+recombinant+expression%2C+receptor+binding+affinity%2C+and+stability&doi=10.1002%2Fpro.2649"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fpro.2649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.2649%26sid%3Dliteratum%253Aachs%26aulast%3DVinther%26aufirst%3DT.%2BN.%26aulast%3DPettersson%26aufirst%3DI.%26aulast%3DHuus%26aufirst%3DK.%26aulast%3DSchlein%26aufirst%3DM.%26aulast%3DSteensgaard%26aufirst%3DD.%2BB.%26aulast%3DS%25C3%25B8rensen%26aufirst%3DA.%26aulast%3DJensen%26aufirst%3DK.%2BJ.%26aulast%3DKjeldsen%26aufirst%3DT.%26aulast%3DHubalek%26aufirst%3DF.%26atitle%3DAdditional%2520disulfide%2520bonds%2520in%2520insulin%253A%2520prediction%252C%2520recombinant%2520expression%252C%2520receptor%2520binding%2520affinity%252C%2520and%2520stability%26jtitle%3DProtein%2520Sci.%2520Publ.%2520Protein%2520Soc.%26date%3D2015%26volume%3D24%26issue%3D5%26spage%3D779%26epage%3D788%26doi%3D10.1002%2Fpro.2649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaro, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, W.-C.</span></span> <span> </span><span class="NLM_article-title">Design of an in vivo cleavable disulfide linker in recombinant fusion proteins</span>. <i>BioTechniques</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">513</span>â <span class="NLM_lpage">518</span>, <span class="refDoi">Â DOI: 10.2144/000113450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.2144%2F000113450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=20615204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1ynu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=513-518&issue=1&author=X.+Chenauthor=Y.+Baiauthor=J.+L.+Zaroauthor=W.-C.+Shen&title=Design+of+an+in+vivo+cleavable+disulfide+linker+in+recombinant+fusion+proteins&doi=10.2144%2F000113450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Design of an in vivo cleavable disulfide linker in recombinant fusion proteins</span></div><div class="casAuthors">Chen, Xiaoying; Bai, Yun; Zaro, Jannica L.; Shen, Wei-Chiang</div><div class="citationInfo"><span class="NLM_cas:title">BioTechniques</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">513-518</span>CODEN:
                <span class="NLM_cas:coden">BTNQDO</span>;
        ISSN:<span class="NLM_cas:issn">0736-6205</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">In order to achieve optimal biol. activity and desired pharmacokinetic profiles, a dithiocyclopeptide linker was designed for in vivo release of protein domains from a recombinant fusion protein.  This novel in vivo cleavable disulfide linker, based on a dithiocyclopeptide contg. a thrombin-sensitive sequence and an intramol. disulfide bond, was inserted between transferrin and granulocyte colony-stimulating factor (G-CSF) recombinant fusion protein domains.  After expression of the fusion protein, G-C-T, from HEK293 cells, thrombin treatment in vitro generated a fusion protein linked via a reversible disulfide bond that was quickly cleaved in vivo, sepg. the protein domains.  After release from the fusion protein, free G-CSF exhibited an improved biol. activity in a cell proliferation assay.  Although reversible disulfide bonds are commonly used in protein chem. conjugation methods, to our knowledge this report is the first example of the construction of a recombinant fusion protein with a disulfide linkage for the release of the functional domain.  This linker design can be adapted to diverse recombinant fusion proteins in which in vivo sepn. of protein domains is required to achieve an improved therapeutic effect and a desirable pharmacokinetic profile and biodistribution of the functional domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJe1VaOAvimLVg90H21EOLACvtfcHk0liHQ4sY-AnoFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1ynu7o%253D&md5=1bdf286914280510536ef1bc415198d3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2144%2F000113450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2144%252F000113450%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DZaro%26aufirst%3DJ.%2BL.%26aulast%3DShen%26aufirst%3DW.-C.%26atitle%3DDesign%2520of%2520an%2520in%2520vivo%2520cleavable%2520disulfide%2520linker%2520in%2520recombinant%2520fusion%2520proteins%26jtitle%3DBioTechniques%26date%3D2010%26volume%3D49%26issue%3D1%26spage%3D513%26epage%3D518%26doi%3D10.2144%2F000113450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Sanfrutos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutting, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinis, C.</span></span> <span> </span><span class="NLM_article-title">Structurally diverse cyclisation linkers impose different backbone conformations in bicyclic peptides</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1032</span>â <span class="NLM_lpage">1038</span>, <span class="refDoi">Â DOI: 10.1002/cbic.201200049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fcbic.201200049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22492661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Kltb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1032-1038&issue=7&author=S.+Chenauthor=J.+Morales-Sanfrutosauthor=A.+Angeliniauthor=B.+Cuttingauthor=C.+Heinis&title=Structurally+diverse+cyclisation+linkers+impose+different+backbone+conformations+in+bicyclic+peptides&doi=10.1002%2Fcbic.201200049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structurally Diverse Cyclisation Linkers Impose Different Backbone Conformations in Bicyclic Peptides</span></div><div class="casAuthors">Chen, Shiyu; Morales-Sanfrutos, Julia; Angelini, Alessandro; Cutting, Brian; Heinis, Christian</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1032-1038</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Combinatorial libraries of structurally diverse peptide macrocycles offer a rich source for the development of high-affinity ligands to targets of interest.  In this work we have developed linkers for the generation of genetically encoded bicyclic peptides and tested whether the peptides cyclised by them have significant variations in their backbone conformations.  Two new cyclisation reagents, each contg. three thiol-reactive groups, efficiently and selectively cyclised linear peptides contg. three cysteine moieties.  When the mesitylene linker of the bicyclic peptide PK15, a potent inhibitor of plasma kallikrein (Ki=2 nM), was replaced by the new linkers, its inhibitory activity dropped by a factor of more than 1000, suggesting that the linkers impose different conformations on the peptide.  Indeed, structural anal. by soln.-state NMR revealed different NOE constraints in the three bicyclic peptides, indicating that these relatively small linkers at the centers of bicyclic peptide structures significantly influence the conformations of the peptides.  These results demonstrate the prominent structural role of linkers in peptide macrocycles and suggest that application of different cyclisation linkers in a combinatorial fashion could be an attractive means to generate topol. diverse macrocycle libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphdCp8KV5HeLVg90H21EOLACvtfcHk0lhdvBlGxP22fg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Kltb4%253D&md5=ddb3f7e338a22ea1a1e3ced71624781d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201200049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201200049%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DMorales-Sanfrutos%26aufirst%3DJ.%26aulast%3DAngelini%26aufirst%3DA.%26aulast%3DCutting%26aufirst%3DB.%26aulast%3DHeinis%26aufirst%3DC.%26atitle%3DStructurally%2520diverse%2520cyclisation%2520linkers%2520impose%2520different%2520backbone%2520conformations%2520in%2520bicyclic%2520peptides%26jtitle%3DChemBioChem%26date%3D2012%26volume%3D13%26issue%3D7%26spage%3D1032%26epage%3D1038%26doi%3D10.1002%2Fcbic.201200049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tegge, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bautsch, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of cyclic peptides and peptide libraries on a new disulfide linker</span>. <i>J. Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">693</span>â <span class="NLM_lpage">699</span>, <span class="refDoi">Â DOI: 10.1002/psc.879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fpsc.879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=17668890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1aju7vN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=693-699&issue=10&author=W.+Teggeauthor=W.+Bautschauthor=R.+Frank&title=Synthesis+of+cyclic+peptides+and+peptide+libraries+on+a+new+disulfide+linker&doi=10.1002%2Fpsc.879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of cyclic peptides and peptide libraries on a new disulfide linker</span></div><div class="casAuthors">Tegge, Werner; Bautsch, Wilfried; Frank, Ronald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">693-699</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A new cysteine-based disulfide linker I for Fmoc solid-phase peptide synthesis was developed, and it allowed the on-resin assembly and side chain deprotection of cyclic peptides.  Cyclic peptides of the structure [cyclo(a-a-x-x-a-a-c); a = D-Ala, c = D-Cys, x = D-amino acid] composed of D-amino acids were assembled and the synthesis and cleavage conditions studied.  The best cyclization results were obtained with PyBOP/HOAt/diisopropylethyl amine.  Racemization rates of the cysteine in the analyzed model sequences were between 5.2 and 12.3%.  Cleavage of the disulfide bond was best carried out with DTT in 50% 2-propanol/100 mM ammonium bicarbonate.  The cleaved peptides can be used directly in biol. assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0YzKe6x4FyrVg90H21EOLACvtfcHk0lhdvBlGxP22fg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1aju7vN&md5=4a29ed9136b622bae76366c2aac7625a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fpsc.879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.879%26sid%3Dliteratum%253Aachs%26aulast%3DTegge%26aufirst%3DW.%26aulast%3DBautsch%26aufirst%3DW.%26aulast%3DFrank%26aufirst%3DR.%26atitle%3DSynthesis%2520of%2520cyclic%2520peptides%2520and%2520peptide%2520libraries%2520on%2520a%2520new%2520disulfide%2520linker%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2007%26volume%3D13%26issue%3D10%26spage%3D693%26epage%3D699%26doi%3D10.1002%2Fpsc.879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ArnÃ©r, E. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmgren, A.</span></span> <span> </span><span class="NLM_article-title">Physiological functions of thioredoxin and thioredoxin reductase: thioredoxin and thioredoxin reductase</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>267</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">6102</span>â <span class="NLM_lpage">6109</span>, <span class="refDoi">Â DOI: 10.1046/j.1432-1327.2000.01701.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1046%2Fj.1432-1327.2000.01701.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11012661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVygsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=6102-6109&issue=20&author=E.+S.+J.+Arn%C3%A9rauthor=A.+Holmgren&title=Physiological+functions+of+thioredoxin+and+thioredoxin+reductase%3A+thioredoxin+and+thioredoxin+reductase&doi=10.1046%2Fj.1432-1327.2000.01701.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological functions of thioredoxin and thioredoxin reductase</span></div><div class="casAuthors">Arner, Elias S. J.; Holmgren, Arne</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6102-6109</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review with 85 refs.  The thioredoxin system (thioredoxin, thioredoxin reductase, and NADPH) is ubiquitous from archea to man.  Thioredoxins, with a dithiol/disulfide active site (CGPC) are the major cellular protein disulfide reductases; they therefore also serve as electron donors for enzymes such as ribonucleotide reductases, thioredoxin peroxidases (peroxiredoxins), and methionine sulfoxide reductases.  Glutaredoxins catalyze glutathione-disulfide oxido-redns. overlapping the functions of thioredoxins and using electrons from NADPH via glutathione reductase.  Thioredoxin isoforms are present in most organisms and mitochondria have a sep. thioredoxin system.  Plants have chloroplast thioredoxins, which via ferredoxin-thioredoxin reductase regulates photosynthetic enzymes by light.  Thioredoxins are crit. for redox regulation of protein function and signaling via thiol redox control.  A growing no. of transcription factors including NF-ÎºB or the Ref-1-dependent AP1 require thioredoxin redn. for DNA binding.  The cytosolic mammalian thioredoxin, lack of which is embryonically lethal, has numerous functions in defense against oxidative stress, control of growth and apoptosis, but is also secreted and has co-cytokine and chemokine activities.  Thioredoxin reductase is a specific dimeric 70-kDa flavoprotein in bacteria, fungi, and plants with a redox active site disulfide/dithiol.  In contrast, thioredoxin reductases of higher eukaryotes are larger (112-130 kDa), Se-dependent dimeric flavoproteins with a broad substrate specificity that also reduce non-disulfide substrates such as hydroperoxides, vitamin C, or selenite.  All mammalian thioredoxin reductase isoenzymes are homologous to glutathione reductase and contain a conserved C-terminal elongation with a cysteine-selenocysteine sequence forming a redox-active selenenylsulfide/selenolthiol active site and are inhibited by Au-thioglucose (aurothioglucose) and other clin. used drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpFnizkYrcdLVg90H21EOLACvtfcHk0lhdvBlGxP22fg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVygsLw%253D&md5=d9813ca6b77dd9cae997e6f78a8c2272</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01701.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01701.x%26sid%3Dliteratum%253Aachs%26aulast%3DArn%25C3%25A9r%26aufirst%3DE.%2BS.%2BJ.%26aulast%3DHolmgren%26aufirst%3DA.%26atitle%3DPhysiological%2520functions%2520of%2520thioredoxin%2520and%2520thioredoxin%2520reductase%253A%2520thioredoxin%2520and%2520thioredoxin%2520reductase%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26issue%3D20%26spage%3D6102%26epage%3D6109%26doi%3D10.1046%2Fj.1432-1327.2000.01701.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garnett, M. C.</span></span> <span> </span><span class="NLM_article-title">Targeted drug conjugates: principles and progress</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">171</span>â <span class="NLM_lpage">216</span>, <span class="refDoi">Â DOI: 10.1016/S0169-409X(01)00227-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2FS0169-409X%2801%2900227-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11731026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1ahsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=171-216&issue=2&author=M.+C.+Garnett&title=Targeted+drug+conjugates%3A+principles+and+progress&doi=10.1016%2FS0169-409X%2801%2900227-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted drug conjugates: principles and progress</span></div><div class="casAuthors">Garnett, Martin C.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-216</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Reports of targeting drugs using antibodies have appeared in the literature since 1958, but exciting clin. results in this field have only been reported in the last few years.  Progress in this field has occurred largely through an understanding how drug-immunoconjugates work.  The objective of this review is to draw together the fundamental principles on which this field of work is based, to examine the evidence supporting those principles, and the effectiveness and selectivity of targeted drug conjugates.  The activity of many drug-immunoconjugates can now largely be accounted for by the underlying principles.  Excellent development work, both with conventional anti-cancer agents and very potent drugs have led to a no. of interesting clin. trials.  In the best Phase I and II trials, good evidence of effectiveness have been reported, which suggest that drug-immunoconjugates may now be heralding a new era for chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzGpSvXcXgr7Vg90H21EOLACvtfcHk0ljORQl1U8wQGg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1ahsbY%253D&md5=31e7f00b7fd6e839cc09b783132697fa</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2801%2900227-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252801%252900227-7%26sid%3Dliteratum%253Aachs%26aulast%3DGarnett%26aufirst%3DM.%2BC.%26atitle%3DTargeted%2520drug%2520conjugates%253A%2520principles%2520and%2520progress%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D53%26issue%3D2%26spage%3D171%26epage%3D216%26doi%3D10.1016%2FS0169-409X%2801%2900227-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hein, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span> <span> </span><span class="NLM_article-title">Click chemistry, a powerful tool for pharmaceutical sciences</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2216</span>â <span class="NLM_lpage">2230</span>, <span class="refDoi">Â DOI: 10.1007/s11095-008-9616-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs11095-008-9616-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=18509602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOru7%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=2216-2230&issue=10&author=C.+D.+Heinauthor=X.-M.+Liuauthor=D.+Wang&title=Click+chemistry%2C+a+powerful+tool+for+pharmaceutical+sciences&doi=10.1007%2Fs11095-008-9616-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Click chemistry, a powerful tool for pharmaceutical sciences</span></div><div class="casAuthors">Hein, Christopher D.; Liu, Xin-Ming; Wang, Dong</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2216-2230</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Click chem. refers to a group of reactions that are fast, simple to use, easy to purify, versatile, regiospecific, and give high product yields.  While there are a no. of reactions that fulfill the criteria, the Huisgen 1,3-dipolar cycloaddn. of azides and terminal alkynes has emerged as the frontrunner.  It has found applications in a wide variety of research areas, including materials sciences, polymer chem., and pharmaceutical sciences.  In this manuscript, important aspects of the Huisgen cycloaddn. will be reviewed, along with some of its many pharmaceutical applications.  Bioconjugation, nanoparticle surface modification, and pharmaceutical-related polymer chem. will all be covered.  Limitations of the reaction will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtfV89MGuuCrVg90H21EOLACvtfcHk0ljORQl1U8wQGg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOru7%252FI&md5=7e0c89178299b2eb8a5b0099ac661a34</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs11095-008-9616-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-008-9616-1%26sid%3Dliteratum%253Aachs%26aulast%3DHein%26aufirst%3DC.%2BD.%26aulast%3DLiu%26aufirst%3DX.-M.%26aulast%3DWang%26aufirst%3DD.%26atitle%3DClick%2520chemistry%252C%2520a%2520powerful%2520tool%2520for%2520pharmaceutical%2520sciences%26jtitle%3DPharm.%2520Res.%26date%3D2008%26volume%3D25%26issue%3D10%26spage%3D2216%26epage%3D2230%26doi%3D10.1007%2Fs11095-008-9616-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hems, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagstaff, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saalbach, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Field, R. A.</span></span> <span> </span><span class="NLM_article-title">CuAAC click chemistry for the enhanced detection of novel alkyne-based natural product toxins</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">86</span>),  <span class="NLM_fpage">12234</span>â <span class="NLM_lpage">12237</span>, <span class="refDoi">Â DOI: 10.1039/C8CC05113E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC8CC05113E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30311608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFWktLfK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2018&pages=12234-12237&issue=86&author=E.+S.+Hemsauthor=B.+A.+Wagstaffauthor=G.+Saalbachauthor=R.+A.+Field&title=CuAAC+click+chemistry+for+the+enhanced+detection+of+novel+alkyne-based+natural+product+toxins&doi=10.1039%2FC8CC05113E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">CuAAC click chemistry for the enhanced detection of novel alkyne-based natural product toxins</span></div><div class="casAuthors">Hems, Edward S.; Wagstaff, Ben A.; Saalbach, Gerhard; Field, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">86</span>),
    <span class="NLM_cas:pages">12234-12237</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In the context of discovering and quantifying terminal alkyne-based natural products, here the authors report the combination of CuAAC click chem. with LC-MS for the detection of polyether toxins (prymnesins) assocd. with harmful algal blooms.  The added-value of the CuAAC-based approach is evident from the authors' ability to detect novel prymnesin-like compds. in algal species with previously uncharacterized toxins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWd-cevavKZLVg90H21EOLACvtfcHk0ljORQl1U8wQGg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFWktLfK&md5=d2d25d8284f45e8c631845b1c28f4e13</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2FC8CC05113E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CC05113E%26sid%3Dliteratum%253Aachs%26aulast%3DHems%26aufirst%3DE.%2BS.%26aulast%3DWagstaff%26aufirst%3DB.%2BA.%26aulast%3DSaalbach%26aufirst%3DG.%26aulast%3DField%26aufirst%3DR.%2BA.%26atitle%3DCuAAC%2520click%2520chemistry%2520for%2520the%2520enhanced%2520detection%2520of%2520novel%2520alkyne-based%2520natural%2520product%2520toxins%26jtitle%3DChem.%2520Commun.%26date%3D2018%26volume%3D54%26issue%3D86%26spage%3D12234%26epage%3D12237%26doi%3D10.1039%2FC8CC05113E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span> <span> </span><span class="NLM_article-title">Chemical assay-guided natural product isolation <i>via</i> solid-supported chemodosimetric fluorescent probe</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2806</span>â <span class="NLM_lpage">2811</span>, <span class="refDoi">Â DOI: 10.1039/C5SC00360A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC5SC00360A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28706669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFWqtr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=2806-2811&issue=5&author=H.+Jeonauthor=C.+Limauthor=J.+M.+Leeauthor=S.+Kim&title=Chemical+assay-guided+natural+product+isolation+via+solid-supported+chemodosimetric+fluorescent+probe&doi=10.1039%2FC5SC00360A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical assay-guided natural product isolation via solid-supported chemodosimetric fluorescent probe</span></div><div class="casAuthors">Jeon, Hongjun; Lim, Chaemin; Lee, Ji Min; Kim, Sanghee</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2806-2811</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">As a new model of chem. assay-guided natural product isolation, an effective chemodosimetric assay system was devised.  Our chem. assay system features a fluorogenic chemodosimeter immobilized on a solid support, which offers advantages in identifying the desired compds. in complex natural product mixts.  To isolate only compds. with the target functional groups, the click chem. concept was adopted.  The model system presented here was developed for natural products with a terminal alkyne.  Using our newly designed alkyne sensing beads with the aforementioned features, we have readily identified, quantified, and isolated compds. with a terminal alkyne group from plant exts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofs5p9BeLMpbVg90H21EOLACvtfcHk0lgbaaN9Q6KtlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFWqtr0%253D&md5=da31fcf576ffbfc28c7ad57d84cd4c97</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC5SC00360A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC00360A%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DS.%26atitle%3DChemical%2520assay-guided%2520natural%2520product%2520isolation%2520via%2520solid-supported%2520chemodosimetric%2520fluorescent%2520probe%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3D2806%26epage%3D2811%26doi%3D10.1039%2FC5SC00360A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mfuh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amako, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, C. M.</span></span> <span> </span><span class="NLM_article-title">Small molecule interactome mapping by photoaffinity labeling reveals binding site hotspots for the NSAIDs</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4259</span>â <span class="NLM_lpage">4268</span>, <span class="refDoi">Â DOI: 10.1021/jacs.7b11639</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b11639" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksFemu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=4259-4268&issue=12&author=J.+Gaoauthor=A.+Mfuhauthor=Y.+Amakoauthor=C.+M.+Woo&title=Small+molecule+interactome+mapping+by+photoaffinity+labeling+reveals+binding+site+hotspots+for+the+NSAIDs&doi=10.1021%2Fjacs.7b11639"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Interactome Mapping by Photoaffinity Labeling Reveals Binding Site Hotspots for the NSAIDs</span></div><div class="casAuthors">Gao, Jinxu; Mfuh, Adelphe; Amako, Yuka; Woo, Christina M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4259-4268</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Many therapeutics elicit cell-type specific polypharmacol. that is executed by a network of mol. recognition events between a small mol. and the whole proteome.  However, measurement of the structures that underpin the mol. assocns. between the proteome and even common therapeutics, such as the nonsteroidal anti-inflammatory drugs (NSAIDs), is limited by the inability to map the small mol. interactome.  To address this gap, the authors developed a platform termed small mol. interactome mapping by photoaffinity labeling (SIM-PAL) and applied it to the in cellulo direct characterization of specific NSAID binding sites.  SIM-PAL uses photochem. conjugation of NSAID derivs. in the whole proteome and enrichment and isotope-recoding of the conjugated peptides for targeted mass spectrometry-based assignment.  Using SIM-PAL, the authors identified the NSAID interactome consisting of over 1000 significantly enriched proteins and directly characterized nearly 200 conjugated peptides representing direct binding sites of the photo-NSAIDs with proteins from Jurkat and K562 cells.  The enriched proteins were often identified as parts of complexes, including known targets of NSAID activity (e.g., NF-ÎºB) and novel interactions (e.g., AP-2, proteasome).  The conjugated peptides revealed direct NSAID binding sites from the cell surface to the nucleus and a specific binding site hotspot for the three photo-NSAIDs on histones H2A and H2B.  NSAID binding stabilized COX-2 and histone H2A by cellular thermal shift assay.  Since small mol. stabilization of protein complexes is a gain of function regulatory mechanism, it is conceivable that NSAIDs affect biol. processes through these broader proteomic interactions.  SIM-PAL enabled characterization of NSAID binding site hotspots and is amenable to map global binding sites for virtually any mol. of interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRBw8rIiOnebVg90H21EOLACvtfcHk0lgbaaN9Q6KtlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksFemu7Y%253D&md5=76e1aaaf371bdee85352c048938fd556</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b11639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b11639%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DMfuh%26aufirst%3DA.%26aulast%3DAmako%26aufirst%3DY.%26aulast%3DWoo%26aufirst%3DC.%2BM.%26atitle%3DSmall%2520molecule%2520interactome%2520mapping%2520by%2520photoaffinity%2520labeling%2520reveals%2520binding%2520site%2520hotspots%2520for%2520the%2520NSAIDs%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26issue%3D12%26spage%3D4259%26epage%3D4268%26doi%3D10.1021%2Fjacs.7b11639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agnew, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweredoski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwieniec, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshaies, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, J. L.</span></span> <span> </span><span class="NLM_article-title">Designer reagents for mass spectrometry-based proteomics: clickable cross-linkers for elucidation of protein structures and interactions</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2662</span>â <span class="NLM_lpage">2669</span>, <span class="refDoi">Â DOI: 10.1021/ac202637n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac202637n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFSiurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=2662-2669&issue=6&author=C.+H.+Sohnauthor=H.+D.+Agnewauthor=J.+E.+Leeauthor=M.+J.+Sweredoskiauthor=R.+L.+J.+Grahamauthor=G.+T.+Smithauthor=S.+Hessauthor=G.+Czerwieniecauthor=J.+A.+Looauthor=J.+R.+Heathauthor=R.+J.+Deshaiesauthor=J.+L.+Beauchamp&title=Designer+reagents+for+mass+spectrometry-based+proteomics%3A+clickable+cross-linkers+for+elucidation+of+protein+structures+and+interactions&doi=10.1021%2Fac202637n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Designer Reagents for Mass Spectrometry-Based Proteomics: Clickable Cross-Linkers for Elucidation of Protein Structures and Interactions</span></div><div class="casAuthors">Sohn, Chang Ho; Agnew, Heather D.; Lee, J. Eugene; Sweredoski, Michael J.; Graham, Robert L. J.; Smith, Geoffrey T.; Hess, Sonja; Czerwieniec, Gregg; Loo, Joseph A.; Heath, James R.; Deshaies, Raymond J.; Beauchamp, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2662-2669</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors present novel homobifunctional amine-reactive clickable cross-linkers (CXLs) for investigation of three-dimensional protein structures and protein-protein interactions (PPIs).  CXLs afford consolidated advantages not previously available in a simple cross-linker, including (1) their small size and cationic nature at physiol. pH, resulting in good water soly. and cell-permeability, (2) an alkyne group for bio-orthogonal conjugation to affinity tags via the click reaction for enrichment of cross-linked peptides, (3) a nucleophilic displacement reaction involving the 1,2,3-triazole ring formed in the click reaction, yielding a lock-mass reporter ion for only clicked peptides, and (4) higher charge states of cross-linked peptides in the gas-phase for augmented electron transfer dissocn. (ETD) yields.  Ubiquitin, a lysine-abundant protein, is used as a model system to demonstrate structural studies using CXLs.  To validate the sensitivity of the authors' approach, biotin-azide labeling and subsequent enrichment of cross-linked peptides are performed for cross-linked ubiquitin digests mixed with yeast cell lysates.  Cross-linked peptides are detected and identified by collision induced dissocn. (CID) and ETD with linear quadrupole ion trap (LTQ)-Fourier transform ion cyclotron resonance (FTICR) and LTQ-Orbitrap mass spectrometers.  The application of CXLs to more complex systems (e.g., in vivo crosslinking) is illustrated by Western blot detection of Cul1 complexes including known binders, Cand1 and Skp2, in HEK 293 cells, confirming good water soly. and cell-permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhUvKb5u9bdbVg90H21EOLACvtfcHk0lgbaaN9Q6KtlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFSiurc%253D&md5=9db7fedc435cc06c74be7dca907c3a14</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fac202637n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac202637n%26sid%3Dliteratum%253Aachs%26aulast%3DSohn%26aufirst%3DC.%2BH.%26aulast%3DAgnew%26aufirst%3DH.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DSweredoski%26aufirst%3DM.%2BJ.%26aulast%3DGraham%26aufirst%3DR.%2BL.%2BJ.%26aulast%3DSmith%26aufirst%3DG.%2BT.%26aulast%3DHess%26aufirst%3DS.%26aulast%3DCzerwieniec%26aufirst%3DG.%26aulast%3DLoo%26aufirst%3DJ.%2BA.%26aulast%3DHeath%26aufirst%3DJ.%2BR.%26aulast%3DDeshaies%26aufirst%3DR.%2BJ.%26aulast%3DBeauchamp%26aufirst%3DJ.%2BL.%26atitle%3DDesigner%2520reagents%2520for%2520mass%2520spectrometry-based%2520proteomics%253A%2520clickable%2520cross-linkers%2520for%2520elucidation%2520of%2520protein%2520structures%2520and%2520interactions%26jtitle%3DAnal.%2520Chem.%26date%3D2012%26volume%3D84%26issue%3D6%26spage%3D2662%26epage%3D2669%26doi%3D10.1021%2Fac202637n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiapparelli, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClatchy, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cline, H. T.</span></span> <span> </span><span class="NLM_article-title">Direct detection of biotinylated proteins by mass spectrometry</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3966</span>â <span class="NLM_lpage">3978</span>, <span class="refDoi">Â DOI: 10.1021/pr5002862</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr5002862" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlalu7fP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=3966-3978&issue=9&author=L.+M.+Schiapparelliauthor=D.+B.+McClatchyauthor=H.-H.+Liuauthor=P.+Sharmaauthor=J.+R.+Yatesauthor=H.+T.+Cline&title=Direct+detection+of+biotinylated+proteins+by+mass+spectrometry&doi=10.1021%2Fpr5002862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Detection of Biotinylated Proteins by Mass Spectrometry</span></div><div class="casAuthors">Schiapparelli, Lucio Matias; McClatchy, Daniel B.; Liu, Han-Hsuan; Sharma, Pranav; Yates, John R.; Cline, Hollis T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3966-3978</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mass spectrometric strategies to identify protein subpopulations involved in specific biol. functions rely on covalently tagging biotin to proteins using various chem. modification methods.  The biotin tag is primarily used for enrichment of the targeted subpopulation for subsequent mass spectrometry (MS) anal.  A limitation of these strategies is that MS anal. does not easily discriminate unlabeled contaminants from the labeled protein subpopulation under study.  To solve this problem, the authors developed a flexible method that only relies on direct MS detection of biotin-tagged proteins called "Direct Detection of Biotin-contg. Tags" (DiDBiT).  Compared with conventional targeted proteomic strategies, DiDBiT improves direct detection of biotinylated proteins â¼200 fold.  DiDBiT is applicable to several protein labeling protocols in cell culture and in vivo using cell permeable NHS-biotin and incorporation of the noncanonical amino acid, azidohomoalanine (AHA), into newly synthesized proteins, followed by click chem. tagging with biotin.  DiDBiT improves the direct detection of biotin-tagged newly synthesized peptides >20-fold compared to conventional methods.  With the increased sensitivity afforded by DiDBiT, the authors demonstrate the MS detection of newly synthesized proteins labeled in vivo in the rodent nervous system with unprecedented temporal resoln. as short as 3 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9UP2KaZC2YrVg90H21EOLACvtfcHk0lh_84S1fE7_VQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlalu7fP&md5=453780d5e1b813625d87f8317725c9e1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fpr5002862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr5002862%26sid%3Dliteratum%253Aachs%26aulast%3DSchiapparelli%26aufirst%3DL.%2BM.%26aulast%3DMcClatchy%26aufirst%3DD.%2BB.%26aulast%3DLiu%26aufirst%3DH.-H.%26aulast%3DSharma%26aufirst%3DP.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26aulast%3DCline%26aufirst%3DH.%2BT.%26atitle%3DDirect%2520detection%2520of%2520biotinylated%2520proteins%2520by%2520mass%2520spectrometry%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2014%26volume%3D13%26issue%3D9%26spage%3D3966%26epage%3D3978%26doi%3D10.1021%2Fpr5002862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span> <span> </span><span class="NLM_article-title">Chemical proteomics approaches for identifying the cellular targets of natural products</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">681</span>â <span class="NLM_lpage">708</span>, <span class="refDoi">Â DOI: 10.1039/C6NP00001K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC6NP00001K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27098809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsF2gsbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2016&pages=681-708&issue=5&author=M.+H.+Wrightauthor=S.+A.+Sieber&title=Chemical+proteomics+approaches+for+identifying+the+cellular+targets+of+natural+products&doi=10.1039%2FC6NP00001K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical proteomics approaches for identifying the cellular targets of natural products</span></div><div class="casAuthors">Wright, M. H.; Sieber, S. A.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">681-708</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Covering: 2010 up to 2016: Deconvoluting the mode of action of natural products and drugs remains one of the biggest challenges in chem. and biol. today.  Chem. proteomics is a growing area of chem. biol. that seeks to design small mol. probes to understand protein function.  In the context of natural products, chem. proteomics can be used to identify the protein binding partners or targets of small mols. in live cells.  Here, the authors highlight recent examples of chem. probes based on natural products and their application for target identification.  The review focuses on probes that can be covalently linked to their target proteins (either via intrinsic chem. reactivity or via the introduction of photocrosslinkers), and can be applied "in situ" - in living systems rather than cell lysates.  The authors also focus here on strategies that employ a click reaction, the copper-catalyzed azide-alkyne cycloaddn. reaction (CuAAC), to allow minimal functionalization of natural product scaffolds with an alkyne or azide tag.  The authors also discuss 'competitive mode' approaches that screen for natural products that compete with a well-characterized chem. probe for binding to a particular set of protein targets.  Fueled by advances in mass spectrometry instrumentation and bioinformatics, many modern strategies are now embracing quant. proteomics to help define the true interacting partners of probes, and the authors highlight the opportunities this rapidly evolving technol. provides in chem. proteomics.  Finally, some of the limitations and challenges of chem. proteomics approaches are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkznMeYsfcMLVg90H21EOLACvtfcHk0lh_84S1fE7_VQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsF2gsbc%253D&md5=0732834925092e013d9545f46ce4fd2f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2FC6NP00001K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6NP00001K%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DM.%2BH.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26atitle%3DChemical%2520proteomics%2520approaches%2520for%2520identifying%2520the%2520cellular%2520targets%2520of%2520natural%2520products%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2016%26volume%3D33%26issue%3D5%26spage%3D681%26epage%3D708%26doi%3D10.1039%2FC6NP00001K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harju, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vahermo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutikainen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yli-Kauhaluoma, J.</span></span> <span> </span><span class="NLM_article-title">Solid-phase synthesis of 1,2,3-triazoles via 1,3-dipolar cycloaddition</span>. <i>J. Comb. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">826</span>â <span class="NLM_lpage">833</span>, <span class="refDoi">Â DOI: 10.1021/cc030110c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc030110c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1aqtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=826-833&issue=6&author=K.+Harjuauthor=M.+Vahermoauthor=I.+Mutikainenauthor=J.+Yli-Kauhaluoma&title=Solid-phase+synthesis+of+1%2C2%2C3-triazoles+via+1%2C3-dipolar+cycloaddition&doi=10.1021%2Fcc030110c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-Phase Synthesis of 1,2,3-Triazoles via 1,3-Dipolar Cycloaddition</span></div><div class="casAuthors">Harju, Kirsi; Vahermo, Mikko; Mutikainen, Ilpo; Yli-Kauhaluoma, Jari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">826-833</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The solid-phase synthesis of 1,2,3-triazoles via 1,3-dipolar cycloaddn. of polymer-bound azides to various alkynes is reported.  Polymer-bound azides were synthesized from polymer-bound halides and sodium azide and reacted with alkynes to produce polymer-bound 1,2,3-triazoles.  Cleavage of the triazoles was performed with trifluoroacetic acid.  A traceless synthesis of 1,2,3-triazoles was developed using 2-methoxy-substituted resin (polymer-bound 4-hydroxy-2-methoxybenzyl alc.).  In addn., a synthesis of 4-hydroxybenzyl-substituted 1,2,3-triazoles from the bromo-Wang resin (4-(bromomethyl)phenoxymethyl polystyrene) was achieved.  Crystal structure of some of these compds. were also reported in details.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxFbM111d_-rVg90H21EOLACvtfcHk0lh_84S1fE7_VQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1aqtrY%253D&md5=9038258f59e7fc8a0d180ccc01b76eb6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fcc030110c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc030110c%26sid%3Dliteratum%253Aachs%26aulast%3DHarju%26aufirst%3DK.%26aulast%3DVahermo%26aufirst%3DM.%26aulast%3DMutikainen%26aufirst%3DI.%26aulast%3DYli-Kauhaluoma%26aufirst%3DJ.%26atitle%3DSolid-phase%2520synthesis%2520of%25201%252C2%252C3-triazoles%2520via%25201%252C3-dipolar%2520cycloaddition%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2003%26volume%3D5%26issue%3D6%26spage%3D826%26epage%3D833%26doi%3D10.1021%2Fcc030110c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blass, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulkner, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunn, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natchus, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portlock, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tullis, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, R.</span></span> <span> </span><span class="NLM_article-title">Solid-phase synthesis of functionalized 1,2,3-triazoles</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">4059</span>â <span class="NLM_lpage">4061</span>, <span class="refDoi">Â DOI: 10.1016/S0040-4039(02)00742-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2FS0040-4039%2802%2900742-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjsl2iurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=4059-4061&issue=22&author=B.+E.+Blassauthor=K.+R.+Coburnauthor=A.+L.+Faulknerauthor=C.+L.+Hunnauthor=M.+G.+Natchusauthor=M.+S.+Parkerauthor=D.+E.+Portlockauthor=J.+S.+Tullisauthor=R.+Wood&title=Solid-phase+synthesis+of+functionalized+1%2C2%2C3-triazoles&doi=10.1016%2FS0040-4039%2802%2900742-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-phase synthesis of functionalized 1,2,3-triazoles</span></div><div class="casAuthors">Blass, Benjamin E.; Coburn, Keith R.; Faulkner, Amy L.; Hunn, Cheryl L.; Natchus, Michael G.; Parker, M. Sharon; Portlock, David E.; Tullis, Joshua S.; Wood, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4059-4061</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Functionalized 1,2,3-triazoles are prepd. by 2 + 3 cycloaddn. of resin bound Î±-azido esters with substituted alkynes.  The reaction is regioselective when the electron-deficient alkyne Me propiolate is used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6SbfVVfh2_bVg90H21EOLACvtfcHk0liN6Uh9uf9Xyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjsl2iurs%253D&md5=33205d48ac04c22beb32664a0dfc4c31</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2802%2900742-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252802%252900742-6%26sid%3Dliteratum%253Aachs%26aulast%3DBlass%26aufirst%3DB.%2BE.%26aulast%3DCoburn%26aufirst%3DK.%2BR.%26aulast%3DFaulkner%26aufirst%3DA.%2BL.%26aulast%3DHunn%26aufirst%3DC.%2BL.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DParker%26aufirst%3DM.%2BS.%26aulast%3DPortlock%26aufirst%3DD.%2BE.%26aulast%3DTullis%26aufirst%3DJ.%2BS.%26aulast%3DWood%26aufirst%3DR.%26atitle%3DSolid-phase%2520synthesis%2520of%2520functionalized%25201%252C2%252C3-triazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26issue%3D22%26spage%3D4059%26epage%3D4061%26doi%3D10.1016%2FS0040-4039%2802%2900742-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angelo, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, P. S.</span></span> <span> </span><span class="NLM_article-title">Solution- and solid-phase synthesis of triazole oligomers that display protein-like functionality</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7963</span>â <span class="NLM_lpage">7967</span>, <span class="refDoi">Â DOI: 10.1021/jo701292h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo701292h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGmurzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=7963-7967&issue=21&author=N.+G.+Angeloauthor=P.+S.+Arora&title=Solution-+and+solid-phase+synthesis+of+triazole+oligomers+that+display+protein-like+functionality&doi=10.1021%2Fjo701292h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Solution- and solid-phase synthesis of triazole oligomers that display protein-like functionality</span></div><div class="casAuthors">Angelo, Nicholas G.; Arora, Paramjit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7963-7967</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We recently developed a new class of oligomers that contain Î±-amino acid residues linked by 1,2,3-triazole groups (Angelo, N. G. at al., 2005).  Synthesis of these oligomers involves an iterative sequence consisting of diazotransfer and Huisgen 1,3-dipolar cycloaddn. steps.  In this contribution, we describe an efficient one-pot, two-step sequence for the prepn. of triazoles from the corresponding amino acid-derived amines and alkynes in soln.  The one-pot sequence affords the desired products in significantly higher yields than our original method.  We also outline a highly effective protocol for the synthesis of these triazole-based biomimetic oligomers on the solid phase.  We find that amino acid derivs. and iterative formation of triazole rings require nontraditional reaction conditions for high yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdq71A6hgSsLVg90H21EOLACvtfcHk0liN6Uh9uf9Xyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGmurzO&md5=67e5dbe97b10b50228cfd0967cd6ce0f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo701292h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo701292h%26sid%3Dliteratum%253Aachs%26aulast%3DAngelo%26aufirst%3DN.%2BG.%26aulast%3DArora%26aufirst%3DP.%2BS.%26atitle%3DSolution-%2520and%2520solid-phase%2520synthesis%2520of%2520triazole%2520oligomers%2520that%2520display%2520protein-like%2520functionality%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26issue%3D21%26spage%3D7963%26epage%3D7967%26doi%3D10.1021%2Fjo701292h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galibert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piller, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piller, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aucagne, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmas, A. F.</span></span> <span> </span><span class="NLM_article-title">Combining triazole ligation and enzymatic glycosylation on solid phase simplifies the synthesis of very long glycoprotein analogues</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3617</span>â <span class="NLM_lpage">3623</span>, <span class="refDoi">Â DOI: 10.1039/C5SC00773A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC5SC00773A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30155000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsVCgt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=3617-3623&issue=6&author=M.+Galibertauthor=V.+Pillerauthor=F.+Pillerauthor=V.+Aucagneauthor=A.+F.+Delmas&title=Combining+triazole+ligation+and+enzymatic+glycosylation+on+solid+phase+simplifies+the+synthesis+of+very+long+glycoprotein+analogues&doi=10.1039%2FC5SC00773A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Combining triazole ligation and enzymatic glycosylation on solid phase simplifies the synthesis of very long glycoprotein analogues</span></div><div class="casAuthors">Galibert, Mathieu; Piller, Veronique; Piller, Friedrich; Aucagne, Vincent; Delmas, Agnes F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3617-3623</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The solid-phase chem. assembly of a protein through iterative chemoselective ligation of unprotected peptide segments can be followed with chem. and/or enzymic transformations of the resulting immobilized protein, the latter steps thus benefitting from the advantages provided by the solid support.  We demonstrate here the usefulness of this strategy for the chemo-enzymic synthesis of glycoprotein analogs.  A linker was specifically designed for application to the synthesis of O-glycoproteins: this new linker is readily cleaved under mild aq. conditions compatible with very sensitive glycosidic bonds, but is remarkably stable under a wide range of chem. and biochem. conditions.  It was utilized for solid-supported N-to-C peptidomimetic triazole ligation followed by enzymic glycosylation, ultimately leading to a very large MUC1-derived glycoprotein contg. 160 amino acid residues, 24 Î±-GalNAc moieties linked to Ser and Thr, and 3 triazoles as peptide bond mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoThcaaBgGp-bVg90H21EOLACvtfcHk0li4zJgpMOR1kA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsVCgt7Y%253D&md5=2a70b397de1e8d632c9f74e02fb7f5d1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1039%2FC5SC00773A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC00773A%26sid%3Dliteratum%253Aachs%26aulast%3DGalibert%26aufirst%3DM.%26aulast%3DPiller%26aufirst%3DV.%26aulast%3DPiller%26aufirst%3DF.%26aulast%3DAucagne%26aufirst%3DV.%26aulast%3DDelmas%26aufirst%3DA.%2BF.%26atitle%3DCombining%2520triazole%2520ligation%2520and%2520enzymatic%2520glycosylation%2520on%2520solid%2520phase%2520simplifies%2520the%2520synthesis%2520of%2520very%2520long%2520glycoprotein%2520analogues%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26issue%3D6%26spage%3D3617%26epage%3D3623%26doi%3D10.1039%2FC5SC00773A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rossin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Duijnhoven, S. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ten Hoeve, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijn, L. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeben, F. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Versteegen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robillard, M. S.</span></span> <span> </span><span class="NLM_article-title">Triggered drug release from an antibodyâdrug conjugate using fast âclick-to-releaseâ chemistry in mice</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1697</span>â <span class="NLM_lpage">1706</span>, <span class="refDoi">Â DOI: 10.1021/acs.bioconjchem.6b00231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.6b00231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslOqs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1697-1706&issue=7&author=R.+Rossinauthor=S.+M.+J.+van+Duijnhovenauthor=W.+ten+Hoeveauthor=H.+M.+Janssenauthor=L.+H.+J.+Kleijnauthor=F.+J.+M.+Hoebenauthor=R.+M.+Versteegenauthor=M.+S.+Robillard&title=Triggered+drug+release+from+an+antibody%E2%80%93drug+conjugate+using+fast+%E2%80%9Cclick-to-release%E2%80%9D+chemistry+in+mice&doi=10.1021%2Facs.bioconjchem.6b00231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Triggered Drug Release from an Antibody-Drug Conjugate Using Fast "Click-to-Release" Chemistry in Mice</span></div><div class="casAuthors">Rossin, Raffaella; van Duijnhoven, Sander M. J.; ten Hoeve, Wolter; Janssen, Henk M.; Hoeben, Freek J. M.; Versteegen, Ron M.; Robillard, Marc S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1697-1706</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of a bioorthogonal reaction for the selective cleavage of tumor-bound antibody-drug conjugates (ADCs) would represent a powerful new tool for ADC therapy, as it would not rely on the currently used intracellular biol. activation mechanisms, thereby expanding the scope to noninternalizing cancer targets.  Here we report that the recently developed inverse-electron-demand Diels-Alder pyridazine elimination reaction can provoke rapid and self-immolative release of doxorubicin from an ADC in vitro and in tumor-bearing mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_mlmSXQbE_rVg90H21EOLACvtfcHk0li4zJgpMOR1kA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslOqs7c%253D&md5=9f3a1807dac9f4e032f951c2b7ea253d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.6b00231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.6b00231%26sid%3Dliteratum%253Aachs%26aulast%3DRossin%26aufirst%3DR.%26aulast%3Dvan%2BDuijnhoven%26aufirst%3DS.%2BM.%2BJ.%26aulast%3Dten%2BHoeve%26aufirst%3DW.%26aulast%3DJanssen%26aufirst%3DH.%2BM.%26aulast%3DKleijn%26aufirst%3DL.%2BH.%2BJ.%26aulast%3DHoeben%26aufirst%3DF.%2BJ.%2BM.%26aulast%3DVersteegen%26aufirst%3DR.%2BM.%26aulast%3DRobillard%26aufirst%3DM.%2BS.%26atitle%3DTriggered%2520drug%2520release%2520from%2520an%2520antibody%25E2%2580%2593drug%2520conjugate%2520using%2520fast%2520%25E2%2580%259Cclick-to-release%25E2%2580%259D%2520chemistry%2520in%2520mice%26jtitle%3DBioconjugate%2520Chem.%26date%3D2016%26volume%3D27%26issue%3D7%26spage%3D1697%26epage%3D1706%26doi%3D10.1021%2Facs.bioconjchem.6b00231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Versteegen, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">tenHoeve, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robillard, M. S.</span></span> <span> </span><span class="NLM_article-title">Click to release: instantaneous doxorubicin elimination upon tetrazine ligation</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">52</span>),  <span class="NLM_fpage">14112</span>â <span class="NLM_lpage">14116</span>, <span class="refDoi">Â DOI: 10.1002/anie.201305969</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.201305969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVClsb%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=14112-14116&issue=52&author=R.+M.+Versteegenauthor=R.+Rossinauthor=W.+tenHoeveauthor=H.+M.+Janssenauthor=M.+S.+Robillard&title=Click+to+release%3A+instantaneous+doxorubicin+elimination+upon+tetrazine+ligation&doi=10.1002%2Fanie.201305969"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Click to Release: Instantaneous Doxorubicin Elimination upon Tetrazine Ligation</span></div><div class="casAuthors">Versteegen, Ron M.; Rossin, Raffaella; ten Hoeve, Wolter; Janssen, Henk M.; Robillard, Marc S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">14112-14116</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have developed a new bioorthogonal elimination reaction that enables instantaneous, self-immolative, and traceless release of doxorubicin from trans-cyclooctene following tetrazine ligation.  In this proof-of-principle study, the inverse-electron-demand Diels-Alder (inv-DA) pyridazine elimination reached 79 % yield within minutes under ambient conditions at micromolar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3HeqXm0w1MrVg90H21EOLACvtfcHk0li4zJgpMOR1kA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVClsb%252FM&md5=c926aeb4b257768962ca1b3d6285a0aa</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fanie.201305969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201305969%26sid%3Dliteratum%253Aachs%26aulast%3DVersteegen%26aufirst%3DR.%2BM.%26aulast%3DRossin%26aufirst%3DR.%26aulast%3DtenHoeve%26aufirst%3DW.%26aulast%3DJanssen%26aufirst%3DH.%2BM.%26aulast%3DRobillard%26aufirst%3DM.%2BS.%26atitle%3DClick%2520to%2520release%253A%2520instantaneous%2520doxorubicin%2520elimination%2520upon%2520tetrazine%2520ligation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26issue%3D52%26spage%3D14112%26epage%3D14116%26doi%3D10.1002%2Fanie.201305969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, A. L.</span></span> <span> </span><span class="NLM_article-title">Click chemistry-mediated complementation assay for RNAâprotein interactions</span>. <i>ACS Comb. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">522</span>â <span class="NLM_lpage">527</span>, <span class="refDoi">Â DOI: 10.1021/acscombsci.9b00071</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscombsci.9b00071" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVyku7bM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=522-527&issue=7&author=E.+J.+Shermanauthor=D.+A.+Lorenzauthor=A.+L.+Garner&title=Click+chemistry-mediated+complementation+assay+for+RNA%E2%80%93protein+interactions&doi=10.1021%2Facscombsci.9b00071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Click Chemistry-Mediated Complementation Assay for RNA-Protein Interactions</span></div><div class="casAuthors">Sherman, Emily J.; Lorenz, Daniel A.; Garner, Amanda L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Combinatorial Science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">522-527</span>CODEN:
                <span class="NLM_cas:coden">ACSCCC</span>;
        ISSN:<span class="NLM_cas:issn">2156-8944</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Click chem.-based assays are a growing class of biochem. assay for facilitating the discovery of modulators of important biol. processes.  To date, most have relied on the use of immobilized biomols., which increases the cost of the assay and decreases throughput because of the necessary washing steps.  To overcome these challenges, we have developed a click chem.-mediated complementation assay that retains many of the advantages of the previous technol., including catalytic signal amplification for assay robustness and applicability to full-length biomols., but that can be performed in a homogeneous format.  As demonstration of this methodol., we have developed a new high-throughput screening method for RNA-protein interactions using the interaction of Lin28 with the pre-microRNA, prelet-7, as a model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJQ1dvOtKrn7Vg90H21EOLACvtfcHk0lht3PSF4p6zLw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVyku7bM&md5=5d6cc0f309b80fbd3dd99ee2540485ee</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facscombsci.9b00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscombsci.9b00071%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DE.%2BJ.%26aulast%3DLorenz%26aufirst%3DD.%2BA.%26aulast%3DGarner%26aufirst%3DA.%2BL.%26atitle%3DClick%2520chemistry-mediated%2520complementation%2520assay%2520for%2520RNA%25E2%2580%2593protein%2520interactions%26jtitle%3DACS%2520Comb.%2520Sci.%26date%3D2019%26volume%3D21%26issue%3D7%26spage%3D522%26epage%3D527%26doi%3D10.1021%2Facscombsci.9b00071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garner, A. L.</span></span> <span> </span><span class="NLM_article-title">A click chemistry-based microRNA maturation assay optimized for high-throughput screening</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">53</span>),  <span class="NLM_fpage">8267</span>â <span class="NLM_lpage">8270</span>, <span class="refDoi">Â DOI: 10.1039/C6CC02894B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC6CC02894B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27284591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVyku7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=8267-8270&issue=53&author=D.+A.+Lorenzauthor=A.+L.+Garner&title=A+click+chemistry-based+microRNA+maturation+assay+optimized+for+high-throughput+screening&doi=10.1039%2FC6CC02894B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A click chemistry-based microRNA maturation assay optimized for high-throughput screening</span></div><div class="casAuthors">Lorenz, Daniel A.; Garner, Amanda L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">8267-8270</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Catalytic enzyme-linked click-chem. assays (cat-ELCCA) are an emerging class of biochem. assay.  Herein we report on expanding the toolkit of cat-ELCCA to include the kinetically superior inverse-electron demand Diels-Alder (IEDDA) reaction.  The result is a technol. with improved sensitivity and reproducibility, enabling automated high-throughput screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSCdT1hlZPvLVg90H21EOLACvtfcHk0liYIYIXCEJh4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVyku7k%253D&md5=53bf017ea3d054a4b31486358929f3c8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2FC6CC02894B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CC02894B%26sid%3Dliteratum%253Aachs%26aulast%3DLorenz%26aufirst%3DD.%2BA.%26aulast%3DGarner%26aufirst%3DA.%2BL.%26atitle%3DA%2520click%2520chemistry-based%2520microRNA%2520maturation%2520assay%2520optimized%2520for%2520high-throughput%2520screening%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26issue%3D53%26spage%3D8267%26epage%3D8270%26doi%3D10.1039%2FC6CC02894B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">Proteolysis targeting chimeras (PROTACs) of anaplastic lymphoma kinase (ALK)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">304</span>â <span class="NLM_lpage">314</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2018.03.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.ejmech.2018.03.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29627725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1ejs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2018&pages=304-314&author=C.+Zhangauthor=X.-R.+Hanauthor=X.+Yangauthor=B.+Jiangauthor=J.+Liuauthor=Y.+Xiongauthor=J.+Jin&title=Proteolysis+targeting+chimeras+%28PROTACs%29+of+anaplastic+lymphoma+kinase+%28ALK%29&doi=10.1016%2Fj.ejmech.2018.03.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK)</span></div><div class="casAuthors">Zhang, Chengwei; Han, Xiao-Ran; Yang, Xiaobao; Jiang, Biao; Liu, Jing; Xiong, Yue; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">304-314</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) activation has been assocd. with many types of human cancer.  Significant efforts have been devoted to the development of ALK inhibitors to antagonize the kinase activity of ALK.  Four ALK inhibitors have been approved by the FDA to date for treating patients with ALK-pos. nonsmall cell lung cancers (NSCLC).  However, drug resistance has been obsd. in the majority of patients treated with these inhibitors.  New therapeutic strategies (e.g., compds. with novel mechanisms of action) are needed to overcome the drug resistance issue.  The emerging PROTAC (Proteolysis Targeting Chimera) technol. has been successfully applied to selective degrdn. of multiple protein targets, but not ALK.  Since ALK protein levels are not important for viability in mammals, ALK PROTACs could lead to novel therapeutics with minimal toxicity.  Here the authors report the design, synthesis and biol. evaluation of novel PROTACs (degraders) of ALK.  MS4077 (I) and MS4078 (II) potently decreased cellular levels of oncogenic active ALK fusion proteins in a concn.- and time-dependent manner in SU-DHL-1 lymphoma and NCI-H2228 lung cancer cells.  The ALK protein degrdn. induced by compds. I and II was cereblon and proteasome dependent.  In addn., compds. I and II potently inhibited proliferation of SU-DHL-1 cells.  Furthermore, compd. II displayed good plasma exposure in a mouse pharmacokinetic study, thus is suitable for in vivo efficacy studies.  The authors also developed MS4748 and MS4740 , very close analogs of I and II resp., which are incapable to degrade the ALK fusion proteins, as neg. controls.  All 4 compds. are valuable chem. tools for investigating effects of ALK pharmacol. degrdn.  The study paved the way for developing the next generation of ALK PROTACs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPGM3aAZZ6h7Vg90H21EOLACvtfcHk0liYIYIXCEJh4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1ejs7Y%253D&md5=804324b95034f38b46e45f89e18e55be</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.071%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DX.-R.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DProteolysis%2520targeting%2520chimeras%2520%2528PROTACs%2529%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D151%26spage%3D304%26epage%3D314%26doi%3D10.1016%2Fj.ejmech.2018.03.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillen, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flessa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toy, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braqi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandarlapaty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span> <span> </span><span class="NLM_article-title">new class of selective estrogen receptor degraders (SERDs): expanding the toolbox of PROTAC degrons</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">803</span>â <span class="NLM_lpage">808</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.8b00106</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00106" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1KnsrjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=803-808&issue=8&author=L.+Wangauthor=V.+S.+Guillenauthor=N.+Sharmaauthor=K.+Flessaauthor=J.+Minauthor=K.+E.+Carlsonauthor=W.+Toyauthor=S.+Braqiauthor=B.+S.+Katzenellenbogenauthor=J.+A.+Katzenellenbogenauthor=S.+Chandarlapatyauthor=A.+Sharma&title=new+class+of+selective+estrogen+receptor+degraders+%28SERDs%29%3A+expanding+the+toolbox+of+PROTAC+degrons&doi=10.1021%2Facsmedchemlett.8b00106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New Class of Selective Estrogen Receptor Degraders (SERDs): Expanding the Toolbox of PROTAC Degrons</span></div><div class="casAuthors">Wang, Lucia; Guillen, Valeria S.; Sharma, Naina; Flessa, Kevin; Min, Jian; Carlson, Kathryn E.; Toy, Weiyi; Braqi, Sara; Katzenellenbogen, Benita S.; Katzenellenbogen, John A.; Chandarlapaty, Sarat; Sharma, Abhishek</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">803-808</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An effective endocrine therapy for breast cancer is to selectively and effectively degrade the estrogen receptor (ER).  Up until now, there have been largely only two mol. scaffolds capable of doing this.  In this study, the authors have developed new classes of scaffolds that possess selective estrogen receptor degrader (SERD) and ER antagonistic properties.  These novel SERDs potently inhibit MCF-7 breast cancer cell proliferation and the expression of ER target genes, and their efficacy is comparable to Fulvestrant.  Unlike Fulvestrant, the modular protein-targeted chimera (PROTAC)-type design of these novel SERDs should allow easy diversification into a library of analogs to further fine-tune their pharmacokinetic properties including oral availability.  This work also expands the pool of currently available PROTAC-type scaffolds that could be beneficial for targeted degrdn. of various other therapeutically important proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUcvpKaxYxg7Vg90H21EOLACvtfcHk0ljCDOZ2SEjB2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1KnsrjM&md5=b432fad9bae5cb37e79c34c985475845</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00106%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGuillen%26aufirst%3DV.%2BS.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DFlessa%26aufirst%3DK.%26aulast%3DMin%26aufirst%3DJ.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DToy%26aufirst%3DW.%26aulast%3DBraqi%26aufirst%3DS.%26aulast%3DKatzenellenbogen%26aufirst%3DB.%2BS.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26aulast%3DChandarlapaty%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DA.%26atitle%3Dnew%2520class%2520of%2520selective%2520estrogen%2520receptor%2520degraders%2520%2528SERDs%2529%253A%2520expanding%2520the%2520toolbox%2520of%2520PROTAC%2520degrons%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26issue%3D8%26spage%3D803%26epage%3D808%26doi%3D10.1021%2Facsmedchemlett.8b00106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hines, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lartigue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">MDM2-recruiting PROTAC offers superior, synergistic antiproliferative activity via simultaneous degradation of BRD4 and stabilization of p53</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">251</span>â <span class="NLM_lpage">262</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-18-2918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1158%2F0008-5472.CAN-18-2918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30385614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotFGnsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=251-262&issue=1&author=J.+Hinesauthor=S.+Lartigueauthor=H.+Dongauthor=Y.+Qianauthor=C.+M.+Crews&title=MDM2-recruiting+PROTAC+offers+superior%2C+synergistic+antiproliferative+activity+via+simultaneous+degradation+of+BRD4+and+stabilization+of+p53&doi=10.1158%2F0008-5472.CAN-18-2918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">MDM2-recruiting PROTAC offers superior, synergistic antiproliferative activity via simultaneous degradation of BRD4 and stabilization of p53</span></div><div class="casAuthors">Hines, John; Lartigue, Schan; Dong, Hanqing; Qian, Yimin; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">251-262</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Although the no. of proteins effectively targeted for posttranslational degrdn. by PROTAC has grown steadily, the no. of E3 ligases successfully exploited to accomplish this has been limited to the few for which small-mol. ligands have been discovered.  Although the E3 ligase MDM2 is bound by the nutlin class of small-mol. ligands, there are few nutlin-based PROTAC.  Because a nutlin-based PROTAC should both knockdown its target protein and upregulate the tumor suppressor p53, we examd. the ability of such a PROTAC to decrease cancer cell viability.  A nutlin-based, BRD4-degrading PROTAC, A1874, was able to degrade its target protein by 98% with nanomolar potency.  Given the complementary ability of A1874 to stabilize p53, we discovered that the nutlin-based PROTAC was more effective in inhibiting proliferation of many cancer cell lines with wild-type p53 than was a corresponding VHL-utilizing PROTAC with similar potency and efficacy to degrade BRD4.  This is the first report of a PROTAC in which the E3 ligase ligand and targeting warhead combine to exert a synergistic antiproliferative effect.  Our study highlights the untapped potential that may be unlocked by expanding the repertoire of E3 ligases that can be recruited by PROTAC.  Significance: These findings present the first BRD4-targeting MDM2-based PROTAC that possesses potent, distinct, and synergistic biol. activities assocd. with both ends of this heterobifunctional mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4UdOVtfCjPLVg90H21EOLACvtfcHk0ljMYE58lW-x5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotFGnsr0%253D&md5=e5dbf80505bb32c232bce66b0445a1a9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-18-2918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-18-2918%26sid%3Dliteratum%253Aachs%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DLartigue%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DMDM2-recruiting%2520PROTAC%2520offers%2520superior%252C%2520synergistic%2520antiproliferative%2520activity%2520via%2520simultaneous%2520degradation%2520of%2520BRD4%2520and%2520stabilization%2520of%2520p53%26jtitle%3DCancer%2520Res.%26date%3D2019%26volume%3D79%26issue%3D1%26spage%3D251%26epage%3D262%26doi%3D10.1158%2F0008-5472.CAN-18-2918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wurz, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cee, V. J.</span></span> <span> </span><span class="NLM_article-title">Targeted degradation of MDM2 as a new approach to improve the efficacy of MDM2-p53 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">445</span>â <span class="NLM_lpage">447</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01945</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01945" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKqsbfI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=445-447&issue=2&author=R.+P.+Wurzauthor=V.+J.+Cee&title=Targeted+degradation+of+MDM2+as+a+new+approach+to+improve+the+efficacy+of+MDM2-p53+inhibitors&doi=10.1021%2Facs.jmedchem.8b01945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Degradation of MDM2 as a New Approach to Improve the Efficacy of MDM2-p53 Inhibitors</span></div><div class="casAuthors">Wurz, Ryan P.; Cee, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">445-447</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  MDM2 is a key oncogenic protein that serves as a neg. regulator of the tumor suppressor p53.  While a no. of inhibitors of the MDM2-p53 interaction have progressed to clin. testing as treatments for a variety of hematol. and solid tumor cancers, the results thus far have been mixed, with perhaps the strongest responses obsd. in relapsed/refractory acute myeloid leukemia (AML).  In an effort to improve the efficacy for this class of compds., researchers have turned to targeted degrdn. of MDM2.  IMiD-based MDM2 PROTAC 8, which potently reduces MDM2 protein levels through targeted degrdn., exhibits enhanced efficacy in the RS4;11 xenograft model relative to a nondegrading MDM2-p53 inhibitor MI-1061.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJX1faKXhdSbVg90H21EOLACvtfcHk0ljMYE58lW-x5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKqsbfI&md5=bcfd2c618a1fb00d4fc4885fdb4fc3c6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01945%26sid%3Dliteratum%253Aachs%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26atitle%3DTargeted%2520degradation%2520of%2520MDM2%2520as%2520a%2520new%2520approach%2520to%2520improve%2520the%2520efficacy%2520of%2520MDM2-p53%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D2%26spage%3D445%26epage%3D447%26doi%3D10.1021%2Facs.jmedchem.8b01945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silva, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donovan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucente, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickerson, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggarty, S. J.</span></span> <span> </span><span class="NLM_article-title">Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e45457</span> <span class="refDoi">Â DOI: 10.7554/eLife.45457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.7554%2FeLife.45457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30907729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVegtb%252FK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=M.+C.+Silvaauthor=F.+M.+Fergusonauthor=Q.+Caiauthor=K.+A.+Donovanauthor=G.+Nandiauthor=D.+Patnaikauthor=T.+Zhangauthor=H.-T.+Huangauthor=D.+E.+Lucenteauthor=B.+C.+Dickersonauthor=T.+J.+Mitchisonauthor=E.+S.+Fischerauthor=N.+S.+Grayauthor=S.+J.+Haggarty&title=Targeted+degradation+of+aberrant+tau+in+frontotemporal+dementia+patient-derived+neuronal+cell+models&doi=10.7554%2FeLife.45457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models</span></div><div class="casAuthors">Silva, M. Catarina; Ferguson, Fleur M.; Cai, Quan; Donovan, Katherine A.; Nandi, Ghata; Patnaik, Debasis; Zhang, Tinghu; Huang, Hai-Tsang; Lucente, Diane E.; Dickerson, Bradford C.; Mitchison, Timothy J.; Fischer, Eric S.; Gray, Nathanael S.; Haggarty, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45457</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Tauopathies are neurodegenerative diseases characterized by aberrant forms of tau protein accumulation leading to neuronal death in focal brain areas.  Positron emission tomog. (PET) tracers that bind to pathol. tau are used in diagnosis, but there are no current therapies to eliminate these tau species.  We employed targeted protein degrdn. technol. to convert a tau PET-probe into a functional degrader of pathogenic tau.  The hetero-bifunctional mol. QC-01-175 was designed to engage both tau and Cereblon (CRBN), a substrate-receptor for the E3-ubiquitin ligase CRL4CRBN, to trigger tau ubiquitination and proteasomal degrdn.  QC-01-175 effected clearance of tau in frontotemporal dementia (FTD) patient-derived neuronal cell models, with minimal effect on tau from neurons of healthy controls, indicating specificity for disease-relevant forms.  QC-01-175 also rescued stress vulnerability in FTD neurons, phenocopying CRISPR-mediated MAPT-knockout.  This work demonstrates that aberrant tau in FTD patient-derived neurons is amenable to targeted degrdn., representing an important advance for therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2f2OKye5kv7Vg90H21EOLACvtfcHk0ljZH1iTtDovIA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVegtb%252FK&md5=63ea1b63444b4ec41839300ce90c6dea</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.7554%2FeLife.45457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.45457%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DM.%2BC.%26aulast%3DFerguson%26aufirst%3DF.%2BM.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DDonovan%26aufirst%3DK.%2BA.%26aulast%3DNandi%26aufirst%3DG.%26aulast%3DPatnaik%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DH.-T.%26aulast%3DLucente%26aufirst%3DD.%2BE.%26aulast%3DDickerson%26aufirst%3DB.%2BC.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26aulast%3DFischer%26aufirst%3DE.%2BS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26atitle%3DTargeted%2520degradation%2520of%2520aberrant%2520tau%2520in%2520frontotemporal%2520dementia%2520patient-derived%2520neuronal%2520cell%2520models%26jtitle%3DeLife%26date%3D2019%26volume%3D8%26doi%3D10.7554%2FeLife.45457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cyrus, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehenkel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-B.</span></span> <span> </span><span class="NLM_article-title">Impact of linker length on the activity of PROTACs</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">359</span>â <span class="NLM_lpage">364</span>, <span class="refDoi">Â DOI: 10.1039/C0MB00074D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC0MB00074D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=20922213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslGhsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=359-364&issue=2&author=K.+Cyrusauthor=M.+Wehenkelauthor=E.-Y.+Choiauthor=H.-J.+Hanauthor=H.+Leeauthor=H.+Swansonauthor=K.-B.+Kim&title=Impact+of+linker+length+on+the+activity+of+PROTACs&doi=10.1039%2FC0MB00074D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of linker length on the activity of PROTACs</span></div><div class="casAuthors">Cyrus, Kedra; Wehenkel, Marie; Choi, Eun-Young; Han, Hyeong-Jun; Lee, Hyosung; Swanson, Hollie; Kim, Kyung-Bo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">359-364</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Conventional genetic approaches have provided a powerful tool in the study of proteins.  However, these techniques often preclude selective manipulation of temporal and spatial protein functions, which is crucial for the investigation of dynamic cellular processes.  To overcome these limitations, a small mol.-based novel technol. termed "PROteolysis TArgeting ChimeraS (PROTACs)" has been developed, targeting proteins for degrdn. at the post-translational level.  Despite the promising potential of PROTACs to serve as mol. probes of complex signaling pathways, their design has not been generalized for broad application.  Here, we present the first generalized approach for PROTAC design by fine-tuning the distance between the two participating partner proteins, the E3 ubiquitin ligase and the target protein.  As such, we took a chem. approach to create estrogen receptor (ER)-Î± targeting PROTACs with varying linker lengths and the loss of the ER in cultured cells was monitored via western blot and fluorometric analyses.  We found a significant effect of chain length on PROTAC efficacy, and, in this case, the optimum distance between the E3 recognition motif and the ligand was a 16 atom chain length.  The information gathered from this expt. may offer a generalizable PROTAC design strategy to further the expansion of the PROTAC toolbox, opening new possibilities for the broad application of the PROTAC strategy in the study of multiple signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP7hxQSvFw57Vg90H21EOLACvtfcHk0ljZH1iTtDovIA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslGhsw%253D%253D&md5=56dc56cb3a73d17bc8903c4962d7648c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1039%2FC0MB00074D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0MB00074D%26sid%3Dliteratum%253Aachs%26aulast%3DCyrus%26aufirst%3DK.%26aulast%3DWehenkel%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DE.-Y.%26aulast%3DHan%26aufirst%3DH.-J.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DSwanson%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK.-B.%26atitle%3DImpact%2520of%2520linker%2520length%2520on%2520the%2520activity%2520of%2520PROTACs%26jtitle%3DMol.%2520BioSyst.%26date%3D2011%26volume%3D7%26issue%3D2%26spage%3D359%26epage%3D364%26doi%3D10.1039%2FC0MB00074D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinebach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udeshi, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehm, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KÃ¶pff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GÃ¼tschow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KrÃ¶nke, J.</span></span> <span> </span><span class="NLM_article-title">Homo-PROTACs for the chemical knockdown of cereblon</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2771</span>â <span class="NLM_lpage">2782</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.8b00693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.8b00693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFejsLrO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2771-2782&issue=9&author=C.+Steinebachauthor=S.+Lindnerauthor=N.+D.+Udeshiauthor=D.+C.+Maniauthor=H.+Kehmauthor=S.+K%C3%B6pffauthor=S.+A.+Carrauthor=M.+G%C3%BCtschowauthor=J.+Kr%C3%B6nke&title=Homo-PROTACs+for+the+chemical+knockdown+of+cereblon&doi=10.1021%2Facschembio.8b00693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Homo-PROTACs for the Chemical Knockdown of Cereblon</span></div><div class="casAuthors">Steinebach, Christian; Lindner, Stefanie; Udeshi, Namrata D.; Mani, Deepak C.; Kehm, Hannes; Koepff, Simon; Carr, Steven A.; Guetschow, Michael; Kroenke, Jan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2771-2782</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The immunomodulatory drugs (IMiDs) thalidomide, lenalidomide, and pomalidomide, all approved for the treatment of multiple myeloma, induce targeted ubiquitination and degrdn. of Ikaros (IKZF1) and Aiolos (IKZF3) via the cereblon (CRBN) E3 ubiquitin ligase.  IMiD-based proteolysis-targeting chimeras (PROTACs) can efficiently recruit CRBN to a protein of interest, leading to its ubiquitination and proteasomal degrdn.  By linking two pomalidomide mols., we designed homobifunctional, so-called homo-PROTACs and investigated their ability to induce self-directed ubiquitination and degrdn.  The homodimerized compd. I was characterized as a highly potent and efficient CRBN degrader with only minimal effects on IKZF1 and IKZF3.  The cellular selectivity of I for CRBN degrdn. was confirmed at the proteome level by quant. mass spectrometry.  Inactivation by compd. I did not affect proliferation of different cell lines, prevented pomalidomide-induced degrdn. of IKZF1 and IKZF3, and antagonized the effects of pomalidomide on multiple myeloma cells.  Homobifunctional CRBN degraders will be useful tools for future biomedical investigations of CRBN-related signaling and may help to further elucidate the mol. mechanism of thalidomide analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosUoD-BkTUibVg90H21EOLACvtfcHk0ljrp7iLH9J2ng"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFejsLrO&md5=71bf2d53ad23c2b873f754de5144883c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facschembio.8b00693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.8b00693%26sid%3Dliteratum%253Aachs%26aulast%3DSteinebach%26aufirst%3DC.%26aulast%3DLindner%26aufirst%3DS.%26aulast%3DUdeshi%26aufirst%3DN.%2BD.%26aulast%3DMani%26aufirst%3DD.%2BC.%26aulast%3DKehm%26aufirst%3DH.%26aulast%3DK%25C3%25B6pff%26aufirst%3DS.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26aulast%3DKr%25C3%25B6nke%26aufirst%3DJ.%26atitle%3DHomo-PROTACs%2520for%2520the%2520chemical%2520knockdown%2520of%2520cereblon%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26issue%3D9%26spage%3D2771%26epage%3D2782%26doi%3D10.1021%2Facschembio.8b00693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toure, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellerschmied, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salami, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaime-Figueroa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Modular PROTAC design for the degradation of oncogenic BCR-ABL</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">807</span>â <span class="NLM_lpage">810</span>, <span class="refDoi">Â DOI: 10.1002/anie.201507634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.201507634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOlt7rN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=807-810&issue=2&author=A.+C.+Laiauthor=M.+Toureauthor=D.+Hellerschmiedauthor=J.+Salamiauthor=S.+Jaime-Figueroaauthor=E.+Koauthor=J.+Hinesauthor=C.+M.+Crews&title=Modular+PROTAC+design+for+the+degradation+of+oncogenic+BCR-ABL&doi=10.1002%2Fanie.201507634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL</span></div><div class="casAuthors">Lai, Ashton C.; Toure, Momar; Hellerschmied, Doris; Salami, Jemilat; Jaime-Figueroa, Saul; Ko, Eunhwa; Hines, John; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">807-810</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Proteolysis Targeting Chimera (PROTAC) technol. is a rapidly emerging alternative therapeutic strategy with the potential to address many of the challenges currently faced in modern drug development programs.  PROTAC technol. employs small mols. that recruit target proteins for ubiquitination and removal by the proteasome.  The synthesis of PROTAC compds. that mediate the degrdn. of c-ABL and BCR-ABL by recruiting either Cereblon or Von Hippel Lindau E3 ligases is reported.  During the course of their development, the authors discovered that the capacity of a PROTAC to induce degrdn. involves more than just target binding: the identity of the inhibitor warhead and the recruited E3 ligase largely det. the degrdn. profiles of the compds.; thus, as a starting point for PROTAC development, both the target ligand and the recruited E3 ligase should be varied to rapidly generate a PROTAC with the desired degrdn. profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdcSTHt5WfILVg90H21EOLACvtfcHk0liiam4OnBqkwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOlt7rN&md5=58a5d78f32bc8a21fd1a6e0c38b8979c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fanie.201507634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201507634%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DA.%2BC.%26aulast%3DToure%26aufirst%3DM.%26aulast%3DHellerschmied%26aufirst%3DD.%26aulast%3DSalami%26aufirst%3DJ.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DKo%26aufirst%3DE.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DModular%2520PROTAC%2520design%2520for%2520the%2520degradation%2520of%2520oncogenic%2520BCR-ABL%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D2%26spage%3D807%26epage%3D810%26doi%3D10.1002%2Fanie.201507634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zorba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starr, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiemer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uccello, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Irrizary, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czabaniuk, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuff, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niosi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luthra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmugasundaram, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M. F.</span></span> <span> </span><span class="NLM_article-title">Delineating the role of cooperativity in the design of potent PROTACs for BTK</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span> (<span class="NLM_issue">31</span>),  <span class="NLM_fpage">E7285</span>â <span class="NLM_lpage">E7292</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1803662115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1073%2Fpnas.1803662115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30012605" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E7285-E7292&issue=31&author=A.+Zorbaauthor=C.+Nguyenauthor=Y.+Xuauthor=J.+Starrauthor=K.+Borzilleriauthor=J.+Smithauthor=H.+Zhuauthor=K.+A.+Farleyauthor=W.+Dingauthor=J.+Schiemerauthor=X.+Fengauthor=J.+S.+Changauthor=D.+P.+Uccelloauthor=J.+A.+Youngauthor=C.+N.+Garcia-Irrizaryauthor=L.+Czabaniukauthor=B.+Schuffauthor=R.+Oliverauthor=J.+Montgomeryauthor=M.+M.+Haywardauthor=J.+Coeauthor=J.+Chenauthor=M.+Niosiauthor=S.+Luthraauthor=J.+C.+Shahauthor=A.+El-Kattanauthor=X.+Qiuauthor=G.+M.+Westauthor=M.+C.+Noeauthor=V.+Shanmugasundaramauthor=A.+M.+Gilbertauthor=M.+F.+Brownauthor=M.+F.+Calabrese&title=Delineating+the+role+of+cooperativity+in+the+design+of+potent+PROTACs+for+BTK&doi=10.1073%2Fpnas.1803662115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1803662115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1803662115%26sid%3Dliteratum%253Aachs%26aulast%3DZorba%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DStarr%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DFarley%26aufirst%3DK.%2BA.%26aulast%3DDing%26aufirst%3DW.%26aulast%3DSchiemer%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DJ.%2BS.%26aulast%3DUccello%26aufirst%3DD.%2BP.%26aulast%3DYoung%26aufirst%3DJ.%2BA.%26aulast%3DGarcia-Irrizary%26aufirst%3DC.%2BN.%26aulast%3DCzabaniuk%26aufirst%3DL.%26aulast%3DSchuff%26aufirst%3DB.%26aulast%3DOliver%26aufirst%3DR.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DNiosi%26aufirst%3DM.%26aulast%3DLuthra%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DJ.%2BC.%26aulast%3DEl-Kattan%26aufirst%3DA.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DWest%26aufirst%3DG.%2BM.%26aulast%3DNoe%26aufirst%3DM.%2BC.%26aulast%3DShanmugasundaram%26aufirst%3DV.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCalabrese%26aufirst%3DM.%2BF.%26atitle%3DDelineating%2520the%2520role%2520of%2520cooperativity%2520in%2520the%2520design%2520of%2520potent%2520PROTACs%2520for%2520BTK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2018%26volume%3D115%26issue%3D31%26spage%3DE7285%26epage%3DE7292%26doi%3D10.1073%2Fpnas.1803662115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HaliloÇ§lu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussinov, R.</span></span> <span> </span><span class="NLM_article-title">Dynamic allostery: linkers are not merely flexible</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">907</span>â <span class="NLM_lpage">917</span>, <span class="refDoi">Â DOI: 10.1016/j.str.2011.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.str.2011.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=21742258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslWhs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=907-917&issue=7&author=B.+Maauthor=C.-J.+Tsaiauthor=T.+Halilo%C7%A7luauthor=R.+Nussinov&title=Dynamic+allostery%3A+linkers+are+not+merely+flexible&doi=10.1016%2Fj.str.2011.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic Allostery: Linkers Are Not Merely Flexible</span></div><div class="casAuthors">Ma, Buyong; Tsai, Chung-Jung; Haliloglu, Tuerkan; Nussinov, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">907-917</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Most proteins consist of multiple domains.  How do linkers efficiently transfer information between sites that are on different domains to activate the protein.  Mere flexibility only implies that the conformations would be sampled.  For fast timescales between triggering events and cellular response, which often involves large conformational change, flexibility on its own may not constitute a good soln.  We posit that successive conformational states along major allosteric propagation pathways are pre-encoded in linker sequences where each state is encoded by the previous one.  The barriers between these states that are hierarchically populated are lower, achieving faster timescales even for large conformational changes.  We further propose that evolution has optimized the linker sequences and lengths for efficiency, which explains why mutations in linkers may affect protein function and review the literature in this light.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowoC_Noh0o87Vg90H21EOLACvtfcHk0lgQ79JceZA0oQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslWhs7c%253D&md5=06fde055f3fbee945de9acefb36eff96</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2011.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2011.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DB.%26aulast%3DTsai%26aufirst%3DC.-J.%26aulast%3DHalilo%25C7%25A7lu%26aufirst%3DT.%26aulast%3DNussinov%26aufirst%3DR.%26atitle%3DDynamic%2520allostery%253A%2520linkers%2520are%2520not%2520merely%2520flexible%26jtitle%3DStructure%26date%3D2011%26volume%3D19%26issue%3D7%26spage%3D907%26epage%3D917%26doi%3D10.1016%2Fj.str.2011.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Odendaal, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trader, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. E.</span></span> <span> </span><span class="NLM_article-title">Chemoselective enrichment for natural products discovery</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">760</span>â <span class="NLM_lpage">764</span>, <span class="refDoi">Â DOI: 10.1039/c0sc00620c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2Fc0sc00620c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=24926410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFGlu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=760-764&issue=4&author=A.+Y.+Odendaalauthor=D.+J.+Traderauthor=E.+E.+Carlson&title=Chemoselective+enrichment+for+natural+products+discovery&doi=10.1039%2Fc0sc00620c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective enrichment for natural products discovery</span></div><div class="casAuthors">Odendaal, Antoinette Y.; Trader, Darci J.; Carlson, Erin E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">760-764</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Natural products account for a significant proportion of modern day therapeutic agents.  However, the discovery of novel compds. is hindered by the isolation process, which often relies upon extn. and chromatog. sepn. techniques.  These methods, which are dependent upon the physicochem. properties of the compds., have a limited ability to both purify and conc. the minor components of a biol. ext.  We have devised an isolation strategy based upon an orthogonal chem. feature, namely, functional group compn.  Development of a functional group-targeted method is expected to achieve exceptional resoln. given the large no. of distinct moieties present in natural product exts.  Here, the authors describe the generation of controllably reversible covalent enrichment tags for the chemoselective isolation of alc.-contg. natural products from complex mixts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiRYVde2bZIrVg90H21EOLACvtfcHk0lisfARl_Pg7Cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFGlu74%253D&md5=1f82d819b8146ac319307f981ca95029</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fc0sc00620c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0sc00620c%26sid%3Dliteratum%253Aachs%26aulast%3DOdendaal%26aufirst%3DA.%2BY.%26aulast%3DTrader%26aufirst%3DD.%2BJ.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26atitle%3DChemoselective%2520enrichment%2520for%2520natural%2520products%2520discovery%26jtitle%3DChem.%2520Sci.%26date%3D2011%26volume%3D2%26issue%3D4%26spage%3D760%26epage%3D764%26doi%3D10.1039%2Fc0sc00620c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trader, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. E.</span></span> <span> </span><span class="NLM_article-title">Siloxyl ether functionalized resins for chemoselective enrichment of carboxylic acids</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">5652</span>â <span class="NLM_lpage">5655</span>, <span class="refDoi">Â DOI: 10.1021/ol202376m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol202376m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Clsb3F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=5652-5655&issue=20&author=D.+J.+Traderauthor=E.+E.+Carlson&title=Siloxyl+ether+functionalized+resins+for+chemoselective+enrichment+of+carboxylic+acids&doi=10.1021%2Fol202376m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Siloxyl Ether Functionalized Resins for Chemoselective Enrichment of Carboxylic Acids</span></div><div class="casAuthors">Trader, Darci J.; Carlson, Erin E.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5652-5655</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although the carboxylic acid moiety is prevalent in many biol. produced mols., including natural products and proteins, methods to chemoselectively target this functional group have remained elusive.  Generally, strategies that utilize carboxylate nucleophilicity also promote reactions with other nucleophiles such as amines and hydroxyls.  A reagent was sought to facilitate the selective isolation of carboxylic acid contg. compds. from complex mixts.  Here, the development of siloxyl ether functionalized solid supports is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQD8dn1Sp1vbVg90H21EOLACvtfcHk0lisfARl_Pg7Cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Clsb3F&md5=2b39fdf1ea6087efd95bf5a7832342bf</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fol202376m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol202376m%26sid%3Dliteratum%253Aachs%26aulast%3DTrader%26aufirst%3DD.%2BJ.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26atitle%3DSiloxyl%2520ether%2520functionalized%2520resins%2520for%2520chemoselective%2520enrichment%2520of%2520carboxylic%2520acids%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26issue%3D20%26spage%3D5652%26epage%3D5655%26doi%3D10.1021%2Fol202376m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trader, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. E.</span></span> <span> </span><span class="NLM_article-title">Taming of a superbase for selective phenol desilylation and natural product isolation</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">7349</span>â <span class="NLM_lpage">7355</span>, <span class="refDoi">Â DOI: 10.1021/jo4010298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo4010298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslCju7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=7349-7355&issue=14&author=D.+J.+Traderauthor=E.+E.+Carlson&title=Taming+of+a+superbase+for+selective+phenol+desilylation+and+natural+product+isolation&doi=10.1021%2Fjo4010298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Taming of a Superbase for Selective Phenol Desilylation and Natural Product Isolation</span></div><div class="casAuthors">Trader, Darci J.; Carlson, Erin E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7349-7355</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hydroxyl moieties are highly prevalent in natural products.  We previously reported a chemoselective strategy for enrichment of hydroxyl-functionalized mols. by formation of a silyl ether bond to a resin.  To generate smaller pools of mols. for anal., we developed cleavage conditions to promote stepwise release of phenolic silyl ethers followed by aliph. silyl ethers with a "tamed" version of the superbase 1,1,3,3-tetramethylguanidine.  We demonstrate this as a general strategy for selective deprotection of phenolic silyl ethers under neutral conditions at room temp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW_Cpc_bn3VbVg90H21EOLACvtfcHk0lisfARl_Pg7Cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslCju7k%253D&md5=9b803667733f0ad8be6cf0370513346f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo4010298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo4010298%26sid%3Dliteratum%253Aachs%26aulast%3DTrader%26aufirst%3DD.%2BJ.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26atitle%3DTaming%2520of%2520a%2520superbase%2520for%2520selective%2520phenol%2520desilylation%2520and%2520natural%2520product%2520isolation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2013%26volume%3D78%26issue%3D14%26spage%3D7349%26epage%3D7355%26doi%3D10.1021%2Fjo4010298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trader, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. E.</span></span> <span> </span><span class="NLM_article-title">Toward the development of solid-supported reagents for separation of alcohol-containing compounds by steric environment</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">27â28</span>),  <span class="NLM_fpage">4191</span>â <span class="NLM_lpage">4196</span>, <span class="refDoi">Â DOI: 10.1016/j.tet.2014.03.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.tet.2014.03.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1WlsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=4191-4196&issue=27%E2%80%9328&author=D.+J.+Traderauthor=E.+E.+Carlson&title=Toward+the+development+of+solid-supported+reagents+for+separation+of+alcohol-containing+compounds+by+steric+environment&doi=10.1016%2Fj.tet.2014.03.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Toward the development of solid-supported reagents for separation of alcohol-containing compounds by steric environment</span></div><div class="casAuthors">Trader, Darci J.; Carlson, Erin E.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">27-28</span>),
    <span class="NLM_cas:pages">4191-4196</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The affinity of silicon for oxygen has long been exploited to preferentially react hydroxyl moieties in the presence of others.  Here, the authors explore the ability of a variety of dialkylsiloxane-functionalized resins to selectively capture and subsequently, release alc.-contg. compds. based on the steric environment about the silicon and hydroxyl moiety.  The devised reagents will be applicable to the sepn. of compd. mixts., esp. for the selective enrichment of low abundant mols. such as bioactive natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUDWRH8S6lMLVg90H21EOLACvtfcHk0lgrqlXyoX69lw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1WlsLk%253D&md5=81ff67283413b5656369d2000a2870b1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2014.03.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2014.03.040%26sid%3Dliteratum%253Aachs%26aulast%3DTrader%26aufirst%3DD.%2BJ.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26atitle%3DToward%2520the%2520development%2520of%2520solid-supported%2520reagents%2520for%2520separation%2520of%2520alcohol-containing%2520compounds%2520by%2520steric%2520environment%26jtitle%3DTetrahedron%26date%3D2014%26volume%3D70%26issue%3D27%25E2%2580%259328%26spage%3D4191%26epage%3D4196%26doi%3D10.1016%2Fj.tet.2014.03.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Capehart, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E. E.</span></span> <span> </span><span class="NLM_article-title">Mass spectrometry-based assay for the rapid detection of thiol-containing natural products</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">90</span>),  <span class="NLM_fpage">13229</span>â <span class="NLM_lpage">13232</span>, <span class="refDoi">Â DOI: 10.1039/C6CC07111B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC6CC07111B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27722280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1SisLzK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2016&pages=13229-13232&issue=90&author=S.+L.+Capehartauthor=E.+E.+Carlson&title=Mass+spectrometry-based+assay+for+the+rapid+detection+of+thiol-containing+natural+products&doi=10.1039%2FC6CC07111B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Mass spectrometry-based assay for the rapid detection of thiol-containing natural products</span></div><div class="casAuthors">Capehart, Stacy L.; Carlson, Erin E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">90</span>),
    <span class="NLM_cas:pages">13229-13232</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Natural products are privileged scaffolds due to their high propensity to possess bioactivity.  To expedite discovery of thiol-contg. compds., we devised a selective solid-supported reagent for their immobilization, followed by cleavage of a photocleavable linker to yield stable natural product conjugates for direct detection by mass spectrometry.  Importantly, the natural products can also be tracelessly released to yield the native structures for chem. and biol. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2V-WLNy0IQLVg90H21EOLACvtfcHk0lgrqlXyoX69lw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1SisLzK&md5=735fd48eb84f27aeadd726e0fd04969d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1039%2FC6CC07111B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6CC07111B%26sid%3Dliteratum%253Aachs%26aulast%3DCapehart%26aufirst%3DS.%2BL.%26aulast%3DCarlson%26aufirst%3DE.%2BE.%26atitle%3DMass%2520spectrometry-based%2520assay%2520for%2520the%2520rapid%2520detection%2520of%2520thiol-containing%2520natural%2520products%26jtitle%3DChem.%2520Commun.%26date%3D2016%26volume%3D52%26issue%3D90%26spage%3D13229%26epage%3D13232%26doi%3D10.1039%2FC6CC07111B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tietz, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sokolowski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melby, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doroghazi, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, D. A.</span></span> <span> </span><span class="NLM_article-title">Nucleophilic 1,4-additions for natural product discovery</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2014</span>â <span class="NLM_lpage">2022</span>, <span class="refDoi">Â DOI: 10.1021/cb500324n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500324n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVWmsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2014-2022&issue=9&author=C.+L.+Coxauthor=J.+I.+Tietzauthor=K.+Sokolowskiauthor=J.+O.+Melbyauthor=J.+R.+Doroghaziauthor=D.+A.+Mitchell&title=Nucleophilic+1%2C4-additions+for+natural+product+discovery&doi=10.1021%2Fcb500324n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleophilic 1,4-Additions for Natural Product Discovery</span></div><div class="casAuthors">Cox, Courtney L.; Tietz, Jonathan I.; Sokolowski, Karol; Melby, Joel O.; Doroghazi, James R.; Mitchell, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2014-2022</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Natural products remain an important source of drug candidates, but the difficulties inherent to traditional isolation, coupled with unacceptably high rates of compd. rediscovery, limit the pace of natural product detection.  Here we describe a reactivity-based screening method to rapidly identify exported bacterial metabolites that contain dehydrated amino acids (i.e., carbonyl- or imine-activated alkenes), a common motif in several classes of natural products.  Our strategy entails the use of a com. available thiol, dithiothreitol, for the covalent labeling of activated alkenes by nucleophilic 1,4-addn.  Modification is easily discerned by comparing mass spectra of reacted and unreacted cell surface exts.  When combined with bioinformatic anal. of putative natural product gene clusters, targeted screening and isolation can be performed on a prioritized list of strains.  Moreover, known compds. are easily dereplicated, effectively eliminating superfluous isolation and characterization.  As a proof of principle, this labeling method was used to identify known natural products belonging to the thiopeptide, lanthipeptide, and linaridin classes.  Further, upon screening a panel of only 23 actinomycetes, we discovered and characterized a novel thiopeptide antibiotic, cyclothiazomycin C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6dV1rGigxarVg90H21EOLACvtfcHk0lgE4gOatYh9Eg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVWmsr8%253D&md5=913792736c31c9515f1dd7f4e1df07bf</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fcb500324n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500324n%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BL.%26aulast%3DTietz%26aufirst%3DJ.%2BI.%26aulast%3DSokolowski%26aufirst%3DK.%26aulast%3DMelby%26aufirst%3DJ.%2BO.%26aulast%3DDoroghazi%26aufirst%3DJ.%2BR.%26aulast%3DMitchell%26aufirst%3DD.%2BA.%26atitle%3DNucleophilic%25201%252C4-additions%2520for%2520natural%2520product%2520discovery%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26issue%3D9%26spage%3D2014%26epage%3D2022%26doi%3D10.1021%2Fcb500324n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro-FalcÃ³n, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, C. C.</span></span> <span> </span><span class="NLM_article-title">Thiol probes to detect electrophilic natural products based on their mechanism of action</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2328</span>â <span class="NLM_lpage">2336</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.5b00924</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00924" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2mt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2328-2336&issue=8&author=G.+Castro-Falc%C3%B3nauthor=D.+Hahnauthor=D.+Reimerauthor=C.+C.+Hughes&title=Thiol+probes+to+detect+electrophilic+natural+products+based+on+their+mechanism+of+action&doi=10.1021%2Facschembio.5b00924"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Thiol Probes To Detect Electrophilic Natural Products Based on Their Mechanism of Action</span></div><div class="casAuthors">Castro-Falcon, Gabriel; Hahn, Dongyup; Reimer, Daniela; Hughes, Chambers C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2328-2336</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New methods are urgently needed to find novel natural products as structural leads for the development of new drugs against emerging diseases such as cancer and multiresistant bacterial infections.  Here we introduce a reactivity-guided drug discovery approach for electrophilic natural products, a therapeutically relevant class of natural products that covalently modify their cellular targets, in crude exts.  Using carefully designed halogenated arom. reagents, the process furnishes derivs. that are UV-active and highly conspicuous via mass spectrometry by virtue of an isotopically unique bromine or chlorine tag.  In addn. to the identification of high-value metabolites, the process facilitates the difficult task of structure elucidation by providing derivs. that are primed for X-ray crystallog. anal.  We show that a cysteine probe efficiently and chemoselectively labels enone-, Î²-lactam-, and Î²-lactone-based electrophilic natural products (parthenolide, andrographolide, wortmannin, penicillin G, salinosporamide), while a thiophenol probe preferentially labels epoxide-based electrophilic natural products (triptolide, epoxomicin, eponemycin, cyclomarin, salinamide).  Using the optimized method, we were able to detect and isolate the epoxide-bearing natural product tirandalydigin from Salinispora and thereby link an orphan gene cluster to its gene product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_VJhjyqvV2LVg90H21EOLACvtfcHk0lgE4gOatYh9Eg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2mt7k%253D&md5=106b4dc36df6e75d3ef52ae3c8314d5e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00924%26sid%3Dliteratum%253Aachs%26aulast%3DCastro-Falc%25C3%25B3n%26aufirst%3DG.%26aulast%3DHahn%26aufirst%3DD.%26aulast%3DReimer%26aufirst%3DD.%26aulast%3DHughes%26aufirst%3DC.%2BC.%26atitle%3DThiol%2520probes%2520to%2520detect%2520electrophilic%2520natural%2520products%2520based%2520on%2520their%2520mechanism%2520of%2520action%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26issue%3D8%26spage%3D2328%26epage%3D2336%26doi%3D10.1021%2Facschembio.5b00924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudolf, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandl, F. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span> <span> </span><span class="NLM_article-title">Subclass-specific labeling of protein-reactive natural products with customized nucleophilic probes</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3701</span>â <span class="NLM_lpage">3707</span>, <span class="refDoi">Â DOI: 10.1002/chem.201405009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fchem.201405009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25605563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlWit70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=3701-3707&issue=9&author=G.+C.+Rudolfauthor=M.+F.+Kochauthor=F.+A.+M.+Mandlauthor=S.+A.+Sieber&title=Subclass-specific+labeling+of+protein-reactive+natural+products+with+customized+nucleophilic+probes&doi=10.1002%2Fchem.201405009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Subclass-Specific Labeling of Protein-Reactive Natural Products with Customized Nucleophilic Probes</span></div><div class="casAuthors">Rudolf, Georg C.; Koch, Maximilian F.; Mandl, Franziska A. M.; Sieber, Stephan A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3701-3707</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Natural products represent a rich source of bioactive compds. that constitute a large fraction of approved drugs.  Among those are mols. with electrophilic scaffolds, such as Michael acceptors, Î²-lactams, and epoxides that irreversibly inhibit essential enzymes based on their catalytic mechanism.  In the search for novel bioactive mols., current methods are challenged by the frequent rediscovery of known chem. entities.  Herein small nucleophilic probes that attack electrophilic natural products and enhance their detection by HPLC-UV and HPLC-MS are introduced.  A screen of diverse probe designs revealed one compd. with a desired selectivity for epoxide- and maleimide-based antibiotics.  Correspondingly, the natural products showdomycin and phosphomycin could be selectively targeted in exts. of their natural producing organism, in which the probe-modified mols. exhibited superior retention and MS detection relative to their unmodified counterparts.  This method may thus help to discover small, electrophilic mols. that might otherwise easily elude detection in complex samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM01h3ok-8ErVg90H21EOLACvtfcHk0lgE4gOatYh9Eg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlWit70%253D&md5=ea664fb3ba17ec1a4b60c396e2e10fa3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fchem.201405009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201405009%26sid%3Dliteratum%253Aachs%26aulast%3DRudolf%26aufirst%3DG.%2BC.%26aulast%3DKoch%26aufirst%3DM.%2BF.%26aulast%3DMandl%26aufirst%3DF.%2BA.%2BM.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26atitle%3DSubclass-specific%2520labeling%2520of%2520protein-reactive%2520natural%2520products%2520with%2520customized%2520nucleophilic%2520probes%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2015%26volume%3D21%26issue%3D9%26spage%3D3701%26epage%3D3707%26doi%3D10.1002%2Fchem.201405009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rohena, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mooberry, S. L.</span></span> <span> </span><span class="NLM_article-title">Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">335</span>â <span class="NLM_lpage">355</span>, <span class="refDoi">Â DOI: 10.1039/C3NP70092E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC3NP70092E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=24481420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVagsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=335-355&issue=3&author=C.+C.+Rohenaauthor=S.+L.+Mooberry&title=Recent+progress+with+microtubule+stabilizers%3A+new+compounds%2C+binding+modes+and+cellular+activities&doi=10.1039%2FC3NP70092E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities</span></div><div class="casAuthors">Rohena, Cristina C.; Mooberry, Susan L.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">335-355</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Covering: late 2008 to August 2013Nature has yielded numerous classes of chem. distinct microtubule stabilizers.  Several of these, including paclitaxel (Taxol) and docetaxel (Taxotere), are important drugs used in the treatment of cancer.  New microtubule stabilizers and novel formulations of these agents continue to provide advances in cancer therapy.  In this review we cover recent progress in the chem. and biol. of these diverse microtubule stabilizers focusing on the wide range of organisms that produce these compds., their mechanisms of inhibiting microtubule-dependent processes, mechanisms of drug resistance, and their interactions with tubulin including their distinct binding sites and modes.  A new potential role for microtubule stabilizers in neurodegenerative diseases is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGbuNICZ6-bLVg90H21EOLACvtfcHk0ljdD_wicxWj9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVagsro%253D&md5=50febeef8c139e67374a92250e7e2a7a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1039%2FC3NP70092E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3NP70092E%26sid%3Dliteratum%253Aachs%26aulast%3DRohena%26aufirst%3DC.%2BC.%26aulast%3DMooberry%26aufirst%3DS.%2BL.%26atitle%3DRecent%2520progress%2520with%2520microtubule%2520stabilizers%253A%2520new%2520compounds%252C%2520binding%2520modes%2520and%2520cellular%2520activities%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2014%26volume%3D31%26issue%3D3%26spage%3D335%26epage%3D355%26doi%3D10.1039%2FC3NP70092E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komlodi-Pasztor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sackett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkerson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fojo, T.</span></span> <span> </span><span class="NLM_article-title">Mitosis is not a key target of microtubule agents in patient tumors</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">244</span>â <span class="NLM_lpage">250</span>, <span class="refDoi">Â DOI: 10.1038/nrclinonc.2010.228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnrclinonc.2010.228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=21283127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFKlsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=244-250&issue=4&author=E.+Komlodi-Pasztorauthor=D.+Sackettauthor=J.+Wilkersonauthor=T.+Fojo&title=Mitosis+is+not+a+key+target+of+microtubule+agents+in+patient+tumors&doi=10.1038%2Fnrclinonc.2010.228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Mitosis is not a key target of microtubule agents in patient tumors</span></div><div class="casAuthors">Komlodi-Pasztor, Edina; Sackett, Dan; Wilkerson, Julia; Fojo, Tito</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">244-250</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Perspective, the clin. disappointment of mitosis-specific agents is explained in the context of the mechanism of action of microtubule-targeting agents.  The authors propose a new paradigm for the anticancer activity of microtubule-targeting agents and suggest that mitosis-specific inhibitors will not result in significant clin. impact.  Mitosis-specific agents have, to date, not been clin. successful.  By contrast, microtubule-targeting agents (MTAs) have a long record of success, usually attributed to the induction of mitotic arrest.  Indeed, it was this success that led to the search for mitosis-specific inhibitors.  We believe the clin. disappointment of mitosis-specific inhibitors stands as evidence that MTAs have been successful not only by interfering with mitosis but, more importantly, by disrupting essential interphase cellular mechanisms.  In this Perspective we will review literature that supports a paradigm shift in how we think about one of our most widely used classes of chemotherapeutics-MTAs.  We believe that the steady presence and const. physiol. role of microtubules are responsible for the overall success of MTAs.  While mitosis-specific inhibitors are effective on only a small fraction of the tumor mass (dividing cells), MTAs target tubulin, a protein that has crucial roles in both mitotic and non-mitotic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYOmCILGEs2LVg90H21EOLACvtfcHk0ljdD_wicxWj9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFKlsLY%253D&md5=2a72541e9b990534b74e88c18265e4c8</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2010.228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2010.228%26sid%3Dliteratum%253Aachs%26aulast%3DKomlodi-Pasztor%26aufirst%3DE.%26aulast%3DSackett%26aufirst%3DD.%26aulast%3DWilkerson%26aufirst%3DJ.%26aulast%3DFojo%26aufirst%3DT.%26atitle%3DMitosis%2520is%2520not%2520a%2520key%2520target%2520of%2520microtubule%2520agents%2520in%2520patient%2520tumors%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D8%26issue%3D4%26spage%3D244%26epage%3D250%26doi%3D10.1038%2Fnrclinonc.2010.228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, B. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a fluorescent analogue of paclitaxel that selectively binds microtubules and sensitively detects efflux by P-glycoprotein</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">6927</span>â <span class="NLM_lpage">6931</span>, <span class="refDoi">Â DOI: 10.1002/anie.201703298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.201703298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsVait7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=6927-6931&issue=24&author=M.+M.+Leeauthor=Z.+Gaoauthor=B.+R.+Peterson&title=Synthesis+of+a+fluorescent+analogue+of+paclitaxel+that+selectively+binds+microtubules+and+sensitively+detects+efflux+by+P-glycoprotein&doi=10.1002%2Fanie.201703298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a Fluorescent Analogue of Paclitaxel that Selectively Binds Microtubules and Sensitively Detects Efflux by P-Glycoprotein</span></div><div class="casAuthors">Lee, Molly M.; Gao, Zhe; Peterson, Blake R.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6927-6931</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The anticancer drug paclitaxel (Taxol) exhibits paradoxical and poorly understood effects against slow-growing tumors.  To investigate its biol. activity, fluorophores such as Oregon Green have been linked to this drug.  However, this modification increases its polarity by approx. 1000-fold and reduces the toxicity of Taxol towards cancer cell lines by over 200-fold.  To construct more drug-like fluorescent probes suitable for imaging by confocal microscopy and anal. by flow cytometry, we synthesized derivs. of Taxol linked to the drug-like fluorophore Pacific Blue (PB).  We found that PB-Gly-Taxol bound the target protein Î²-tubulin with both high affinity in vitro and high specificity in living cells, exhibited substantial cytotoxicity towards HeLa cells, and was a highly sensitive substrate of the multidrug resistance transporter P-glycoprotein (P-gp).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1uJC2tWeaq7Vg90H21EOLACvtfcHk0ljI89n_EzBDBw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsVait7s%253D&md5=df79696b677a7d539b11e9dd25cad86b</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fanie.201703298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201703298%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BM.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DPeterson%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%2520of%2520a%2520fluorescent%2520analogue%2520of%2520paclitaxel%2520that%2520selectively%2520binds%2520microtubules%2520and%2520sensitively%2520detects%2520efflux%2520by%2520P-glycoprotein%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26issue%3D24%26spage%3D6927%26epage%3D6931%26doi%3D10.1002%2Fanie.201703298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obeng, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boise, L. H.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>107</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4907</span>â <span class="NLM_lpage">4916</span>, <span class="refDoi">Â DOI: 10.1182/blood-2005-08-3531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1182%2Fblood-2005-08-3531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=16507771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFCgtL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=4907-4916&issue=12&author=E.+A.+Obengauthor=L.+M.+Carlsonauthor=D.+M.+Gutmanauthor=W.+J.+Harringtonauthor=K.+P.+Leeauthor=L.+H.+Boise&title=Proteasome+inhibitors+induce+a+terminal+unfolded+protein+response+in+multiple+myeloma+cells&doi=10.1182%2Fblood-2005-08-3531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells</span></div><div class="casAuthors">Obeng, Esther A.; Carlson, Louise M.; Gutman, Delia M.; Harrington, William J., Jr.; Lee, Kelvin P.; Boise, Lawrence H.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4907-4916</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Multiple myeloma (MM) is an incurable plasma cell malignancy.  The 26S proteasome inhibitor, bortezomib, selectively induces apoptosis in MM cells; however, the nature of its selectivity remains unknown.  Here we demonstrate that 5 different MM cell lines display similar patterns of sensitivity to 3 proteasome inhibitors (PIs) but respond differently to specific NF-ÎºB inhibition.  We further show that PIs initiate the unfolded protein response (UPR), a signaling pathway activated by the accumulation of misfolded proteins within the endoplasmic reticulum (ER).  Consistent with reports that prosurvival/physiol. UPR components are required for B-cell differentiation into antibody-secreting cells, we found that MM cells inherently expressed the ER chaperones GRP78/Bip and GRP94/gp96.  However, bortezomib rapidly induced components of the proapoptotic/terminal UPR, including PERK, the ER stress-specific eIF-2Î± kinase; ATF4, an ER stress-induced transcription factor; and its proapoptotic target, CHOP/GADD153.  Consistent with our hypothesis that PIs induce the accumulation of misfolded ER-processed proteins, we found that the amt. of Ig subunits retained within MM cells correlated with their sensitivity to PIs.  These findings suggest that MM cells have a lower threshold for PI-induced UPR induction and ER stress-induced apoptosis because they constitutively express ER stress survival factors to function as secretory cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9ai4oVJk_fbVg90H21EOLACvtfcHk0ljI89n_EzBDBw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFCgtL8%253D&md5=b5567cce878c528c30a55fc8079b19b4</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-08-3531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-08-3531%26sid%3Dliteratum%253Aachs%26aulast%3DObeng%26aufirst%3DE.%2BA.%26aulast%3DCarlson%26aufirst%3DL.%2BM.%26aulast%3DGutman%26aufirst%3DD.%2BM.%26aulast%3DHarrington%26aufirst%3DW.%2BJ.%26aulast%3DLee%26aufirst%3DK.%2BP.%26aulast%3DBoise%26aufirst%3DL.%2BH.%26atitle%3DProteasome%2520inhibitors%2520induce%2520a%2520terminal%2520unfolded%2520protein%2520response%2520in%2520multiple%2520myeloma%2520cells%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26issue%3D12%26spage%3D4907%26epage%3D4916%26doi%3D10.1182%2Fblood-2005-08-3531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orlowski, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, D. J.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibitors in cancer therapy: lessons from the first decade</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1649</span>â <span class="NLM_lpage">1657</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-07-2218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1158%2F1078-0432.CCR-07-2218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=18347166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlejt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1649-1657&issue=6&author=R.+Z.+Orlowskiauthor=D.+J.+Kuhn&title=Proteasome+inhibitors+in+cancer+therapy%3A+lessons+from+the+first+decade&doi=10.1158%2F1078-0432.CCR-07-2218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibitors in cancer therapy: lessons from the first decade</span></div><div class="casAuthors">Orlowski, Robert Z.; Kuhn, Deborah J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1649-1657</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The ubiquitin-proteasome pathway is involved in intracellular protein turnover, and its function is crucial to cellular homeostasis.  First synthesized as probes of proteolytic processes, proteasome inhibitors began to be thought of as potential drug candidates when they were found to induce programmed cell death preferentially in transformed cells.  They made their first leap into the clinic to be tested as therapeutic agents 10 years ago, and since then, great strides have been made in defining their mechanisms of action, their clin. efficacy and toxicity, and some of their limitations in the form of resistance pathways.  Validation of the ubiquitin-proteasome pathway as a target for cancer therapy has come in the form of approvals of the first such inhibitor, bortezomib, for relapsed/refractory multiple myeloma and mantle cell lymphoma, for which this agent has become a std. of care.  Lessons learned from this first-in-class agent are now being applied to the development of a new generation of proteasome inhibitors that hold the promise of efficacy in bortezomib-resistant disease and possibly in a broader spectrum of diseases.  This saga provides a salient example of the promise of translational medicine and a paradigm by which other agents may be successfully brought from the bench to the bedside.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCNIRIVHoPx7Vg90H21EOLACvtfcHk0ljI89n_EzBDBw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlejt74%253D&md5=f1639611d273422351658c10b4d8e9ad</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-2218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-2218%26sid%3Dliteratum%253Aachs%26aulast%3DOrlowski%26aufirst%3DR.%2BZ.%26aulast%3DKuhn%26aufirst%3DD.%2BJ.%26atitle%3DProteasome%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520lessons%2520from%2520the%2520first%2520decade%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26issue%3D6%26spage%3D1649%26epage%3D1657%26doi%3D10.1158%2F1078-0432.CCR-07-2218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oerlemans, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assaraf, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Zantwijk, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkers, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheffer, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debipersad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vojtekova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Heijden, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ylstra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaspers, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dijkmans, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheper, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, G.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of bortezomib resistance: proteasome subunit 5 (PSMB5) gene mutation and overexpression of PSMB5 protein</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2489</span>â <span class="NLM_lpage">2499</span>, <span class="refDoi">Â DOI: 10.1182/blood-2007-08-104950</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1182%2Fblood-2007-08-104950" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=18565852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCru7zO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=2489-2499&issue=6&author=R.+Oerlemansauthor=N.+E.+Frankeauthor=Y.+G.+Assarafauthor=J.+Cloosauthor=I.+van+Zantwijkauthor=C.+R.+Berkersauthor=G.+L.+Schefferauthor=K.+Debipersadauthor=K.+Vojtekovaauthor=C.+Lemosauthor=J.+W.+van+der+Heijdenauthor=B.+Ylstraauthor=G.+J.+Petersauthor=G.+L.+Kaspersauthor=B.+A.+Dijkmansauthor=R.+J.+Scheperauthor=G.+Jansen&title=Molecular+basis+of+bortezomib+resistance%3A+proteasome+subunit+5+%28PSMB5%29+gene+mutation+and+overexpression+of+PSMB5+protein&doi=10.1182%2Fblood-2007-08-104950"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of bortezomib resistance: proteasome subunit Î²5 (PSMB5) gene mutation and overexpression of PSMB5 protein</span></div><div class="casAuthors">Oerlemans, Ruud; Franke, Niels E.; Assaraf, Yehuda G.; Cloos, Jacqueline; van Zantwijk, Ina; Berkers, Celia R.; Scheffer, George L.; Debipersad, Kabir; Vojtekova, Katharina; Lemos, Clara; van der Heijden, Joost W.; Ylstra, Bauke; Peters, Godefridus J.; Kaspers, Gertjan L.; Dijkmans, Ben A. C.; Scheper, Rik J.; Jansen, Gerrit</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2489-2499</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The proteasome inhibitor bortezomib is a novel anticancer drug that has shown promise in the treatment of refractory multiple myeloma.  However, its clin. efficacy has been hampered by the emergence of drug-resistance phenomena, the mol. basis of which remains elusive.  Toward this end, we here developed high levels (45- to 129-fold) of acquired resistance to bortezomib in human myelomonocytic THP1 cells by exposure to stepwise increasing (2.5-200 nM) concns. of bortezomib.  Study of the mol. mechanism of bortezomib resistance in these cells revealed (1) an Ala49Thr mutation residing in a highly conserved bortezomib-binding pocket in the proteasome Î²5-subunit (PSMB5) protein, (2) a dramatic overexpression (up to 60-fold) of PSMB5 protein but not of other proteasome subunits including PSMB6, PSMB7, and PSMA7, (3) high levels of cross-resistance to Î²5 subunit-targeted cytotoxic peptides 4A6, MG132, MG262, and ALLN, but not to a broad spectrum of chemotherapeutic drugs, (4) no marked changes in chymotrypsin-like proteasome activity, and (5) restoration of bortezomib sensitivity in bortezomib-resistant cells by siRNA-mediated silencing of PSMB5 gene expression.  Collectively, these findings establish a novel mechanism of bortezomib resistance assocd. with the selective overexpression of a mutant PSMB5 protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtSyGb53RI9rVg90H21EOLACvtfcHk0lirZdOW3etjHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCru7zO&md5=48981ee986f506ff7c36107cfd606d43</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-08-104950&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-08-104950%26sid%3Dliteratum%253Aachs%26aulast%3DOerlemans%26aufirst%3DR.%26aulast%3DFranke%26aufirst%3DN.%2BE.%26aulast%3DAssaraf%26aufirst%3DY.%2BG.%26aulast%3DCloos%26aufirst%3DJ.%26aulast%3Dvan%2BZantwijk%26aufirst%3DI.%26aulast%3DBerkers%26aufirst%3DC.%2BR.%26aulast%3DScheffer%26aufirst%3DG.%2BL.%26aulast%3DDebipersad%26aufirst%3DK.%26aulast%3DVojtekova%26aufirst%3DK.%26aulast%3DLemos%26aufirst%3DC.%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DJ.%2BW.%26aulast%3DYlstra%26aufirst%3DB.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26aulast%3DKaspers%26aufirst%3DG.%2BL.%26aulast%3DDijkmans%26aufirst%3DB.%2BA.%26aulast%3DScheper%26aufirst%3DR.%2BJ.%26aulast%3DJansen%26aufirst%3DG.%26atitle%3DMolecular%2520basis%2520of%2520bortezomib%2520resistance%253A%2520proteasome%2520subunit%25205%2520%2528PSMB5%2529%2520gene%2520mutation%2520and%2520overexpression%2520of%2520PSMB5%2520protein%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26issue%3D6%26spage%3D2489%26epage%3D2499%26doi%3D10.1182%2Fblood-2007-08-104950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmony, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span> <span> </span><span class="NLM_article-title">Activity-based imaging probes of the proteasome</span>. <i>Cell Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">101</span>, <span class="refDoi">Â DOI: 10.1007/s12013-013-9626-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs12013-013-9626-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23700161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGlt7vL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=91-101&issue=1&author=K.+C.+Carmonyauthor=K.+B.+Kim&title=Activity-based+imaging+probes+of+the+proteasome&doi=10.1007%2Fs12013-013-9626-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-Based Imaging Probes of the Proteasome</span></div><div class="casAuthors">Carmony, Kimberly Cornish; Kim, Kyung Bo</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-101</span>CODEN:
                <span class="NLM_cas:coden">CBBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1085-9195</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Over the years, the proteasome has been extensively investigated due to its crucial roles in many important signaling pathways and its implications in diseases.  Two proteasome inhibitors-bortezomib and carfilzomib-have received FDA approval for the treatment of multiple myeloma, thereby validating the proteasome as a chemotherapeutic target.  As a result, further research efforts have been focused on dissecting the complex biol. of the proteasome to gain the insight required for developing next-generation proteasome inhibitors.  It is clear that chem. probes have made significant contributions to these efforts, mostly by functioning as inhibitors that selectively block the catalytic activity of proteasomes.  Analogs of these inhibitors are now providing addnl. tools for visualization of catalytically active proteasome subunits, several of which allow real-time monitoring of proteasome activity in living cells as well as in in vivo settings.  These imaging probes will provide powerful tools for assessing the efficacy of proteasome inhibitors in clin. settings.  In this review, we will focus on the recent efforts towards developing imaging probes of proteasomes, including the latest developments in immunoproteasome-selective imaging probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomIIGjZYtqkbVg90H21EOLACvtfcHk0lirZdOW3etjHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGlt7vL&md5=ab86e23696ee5f95d51d391abace9038</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs12013-013-9626-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12013-013-9626-4%26sid%3Dliteratum%253Aachs%26aulast%3DCarmony%26aufirst%3DK.%2BC.%26aulast%3DKim%26aufirst%3DK.%2BB.%26atitle%3DActivity-based%2520imaging%2520probes%2520of%2520the%2520proteasome%26jtitle%3DCell%2520Biochem.%2520Biophys.%26date%3D2013%26volume%3D67%26issue%3D1%26spage%3D91%26epage%3D101%26doi%3D10.1007%2Fs12013-013-9626-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Jong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuurman, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodenko, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovaa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkers, C. R.</span></span> <span> </span><span class="NLM_article-title">Fluorescence-based proteasome activity profiling</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>803</i></span>,  <span class="NLM_fpage">183</span>â <span class="NLM_lpage">204</span>, <span class="refDoi">Â DOI: 10.1007/978-1-61779-364-6_13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-61779-364-6_13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22065226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlersLnO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=803&publication_year=2012&pages=183-204&author=A.+de%0AJongauthor=K.+G.+Schuurmanauthor=B.+Rodenkoauthor=H.+Ovaaauthor=C.+R.+Berkers&title=Fluorescence-based+proteasome+activity+profiling&doi=10.1007%2F978-1-61779-364-6_13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence-based proteasome activity profiling</span></div><div class="casAuthors">de Jong, Annemieke; Schuurman, Karianne G.; Rodenko, Boris; Ovaa, Huib; Berkers, Celia R.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">803</span>
        (<span class="NLM_cas:issue">Chemical Proteomics</span>),
    <span class="NLM_cas:pages">183-204</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">With the proteasome emerging as a therapeutic target for cancer treatment, accurate tools for monitoring proteasome (inhibitor) activity are in demand.  In this chapter, we describe the synthesis and use of a fluorescent proteasome activity probe that allows for accurate profiling of proteasomal activity in cell lysates, intact cells, and murine and human patient-derived material, with high sensitivity using SDS-PAGE.  The probe allows for direct scanning of the gel for fluorescent emission of the distinct proteasomal subunits and circumvents the use of Western blot anal.  Due to its suitable biochem. and biophys. properties, the fluorescent probe can also be used for confocal laser scanning microscopy and flow cytometry-based expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGKphTXhYIbVg90H21EOLACvtfcHk0liJhaSC4W5mgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlersLnO&md5=3c45141e01daf097484509bb1b3efa21</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-364-6_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-61779-364-6_13%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BJong%26aufirst%3DA.%26aulast%3DSchuurman%26aufirst%3DK.%2BG.%26aulast%3DRodenko%26aufirst%3DB.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DBerkers%26aufirst%3DC.%2BR.%26atitle%3DFluorescence-based%2520proteasome%2520activity%2520profiling%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2012%26volume%3D803%26spage%3D183%26epage%3D204%26doi%3D10.1007%2F978-1-61779-364-6_13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geurink, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Elst, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Ru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veelen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Dulk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ossendorp, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit Î²5t</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">795</span>â <span class="NLM_lpage">801</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2010.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.chembiol.2010.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=20797608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2iu7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=795-801&issue=8&author=B.+I.+Floreaauthor=M.+Verdoesauthor=N.+Liauthor=W.+A.+van+der+Lindenauthor=P.+P.+Geurinkauthor=H.+van+den+Elstauthor=T.+Hofmannauthor=A.+de+Ruauthor=P.+A.+van+Veelenauthor=K.+Tanakaauthor=K.+Sasakiauthor=S.+Murataauthor=H.+den+Dulkauthor=J.+Brouwerauthor=F.+A.+Ossendorpauthor=A.+F.+Kisselevauthor=H.+S.+Overkleeft&title=Activity-based+profiling+reveals+reactivity+of+the+murine+thymoproteasome-specific+subunit+%CE%B25t&doi=10.1016%2Fj.chembiol.2010.05.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-based profiling reveals reactivity of the murine thymoproteasome-specific subunit Î²5t</span></div><div class="casAuthors">Florea, Bogdan I.; Verdoes, Martijn; Li, Nan; van der Linden, Wouter A.; Geurink, Paul P.; van den Elst, Hans; Hofmann, Tanja; de Ru, Arnoud; van Veelen, Peter A.; Tanaka, Keiji; Sasaki, Katsuhiro; Murata, Shigeo; den Dulk, Hans; Brouwer, Jaap; Ossendorp, Ferry A.; Kisselev, Alexei F.; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">795-801</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Epithelial cells of the thymus cortex express a unique proteasome particle involved in pos. T cell selection.  This thymoproteasome contains the recently discovered Î²5t subunit that has an uncharted activity, if any.  We synthesized fluorescent epoxomicin probes that were used in a chem. proteomics approach, entailing activity-based profiling, affinity purifn., and LC-MS identification, to demonstrate that the Î²5t subunit is catalytically active in the murine thymus.  A panel of established proteasome inhibitors showed that the broad-spectrum inhibitor epoxomicin blocks the Î²5t activity and that the subunit-specific antagonists bortezomib and NC005 do not inhibit Î²5t.  We show that Î²5t has a substrate preference distinct from Î²5/Î²5i that might explain how the thymoproteasome generates the MHC class I peptide repertoire needed for pos. T cell selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvUV4I2cVH_LVg90H21EOLACvtfcHk0liJhaSC4W5mgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2iu7nK&md5=7a7c58efdb059452ad0b6579e5677bfa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3DGeurink%26aufirst%3DP.%2BP.%26aulast%3Dvan%2Bden%2BElst%26aufirst%3DH.%26aulast%3DHofmann%26aufirst%3DT.%26aulast%3Dde%2BRu%26aufirst%3DA.%26aulast%3Dvan%2BVeelen%26aufirst%3DP.%2BA.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DMurata%26aufirst%3DS.%26aulast%3Dden%2BDulk%26aufirst%3DH.%26aulast%3DBrouwer%26aufirst%3DJ.%26aulast%3DOssendorp%26aufirst%3DF.%2BA.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DActivity-based%2520profiling%2520reveals%2520reactivity%2520of%2520the%2520murine%2520thymoproteasome-specific%2520subunit%2520%25CE%25B25t%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26issue%3D8%26spage%3D795%26epage%3D801%26doi%3D10.1016%2Fj.chembiol.2010.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ovaa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Swieten, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeuwenburgh, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiebiger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den
Nieuwendijk, A. M. C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galardy, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploegh, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">Chemistry in living cells: detection of active proteasomes by a two-step labeling strategy</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">31</span>),  <span class="NLM_fpage">3626</span>â <span class="NLM_lpage">3629</span>, <span class="refDoi">Â DOI: 10.1002/anie.200351314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.200351314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFWksbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=3626-3629&issue=31&author=H.+Ovaaauthor=P.+F.+van+Swietenauthor=B.+M.+Kesslerauthor=M.+A.+Leeuwenburghauthor=E.+Fiebigerauthor=A.+M.+C.+H.+van+den%0ANieuwendijkauthor=P.+J.+Galardyauthor=G.+A.+van+der+Marelauthor=H.+L.+Ploeghauthor=H.+S.+Overkleeft&title=Chemistry+in+living+cells%3A+detection+of+active+proteasomes+by+a+two-step+labeling+strategy&doi=10.1002%2Fanie.200351314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry in living cells: Detection of active proteasomes by a two-step labeling strategy</span></div><div class="casAuthors">Ovaa, Huib; van Swieten, Paul F.; Kessler, Benedikt M.; Leeuwenburgh, Michiel A.; Fiebiger, Edda; van den Nieuwendijk, Adrianus M. C. H.; Galardy, Paul J.; van der Marel, Gijsbert A.; Ploegh, Hidde L.; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">3626-3629</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors describe new functional proteomics strategy that allows two step labeling for the catalytically active subunits of the proteasome in living cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOOcjHX7i-a7Vg90H21EOLACvtfcHk0lhfSqTw-tEyDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFWksbg%253D&md5=a439beadb0efa7c681108cb3ce8a50c1</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351314%26sid%3Dliteratum%253Aachs%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3Dvan%2BSwieten%26aufirst%3DP.%2BF.%26aulast%3DKessler%26aufirst%3DB.%2BM.%26aulast%3DLeeuwenburgh%26aufirst%3DM.%2BA.%26aulast%3DFiebiger%26aufirst%3DE.%26aulast%3Dvan%2Bden%2BNieuwendijk%26aufirst%3DA.%2BM.%2BC.%2BH.%26aulast%3DGalardy%26aufirst%3DP.%2BJ.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DPloegh%26aufirst%3DH.%2BL.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DChemistry%2520in%2520living%2520cells%253A%2520detection%2520of%2520active%2520proteasomes%2520by%2520a%2520two-step%2520labeling%2520strategy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26issue%3D31%26spage%3D3626%26epage%3D3629%26doi%3D10.1002%2Fanie.200351314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillaert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sae-Heng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risseeuw, M. D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippov, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">Acetylene functionalized BODIPY dyes and their application in the synthesis of activity based proteasome probes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">6169</span>â <span class="NLM_lpage">6171</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2007.09.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.bmcl.2007.09.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=17888658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt7%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6169-6171&issue=22&author=M.+Verdoesauthor=U.+Hillaertauthor=B.+I.+Floreaauthor=M.+Sae-Hengauthor=M.+D.+P.+Risseeuwauthor=D.+V.+Filippovauthor=G.+A.+van+der+Marelauthor=H.+S.+Overkleeft&title=Acetylene+functionalized+BODIPY+dyes+and+their+application+in+the+synthesis+of+activity+based+proteasome+probes&doi=10.1016%2Fj.bmcl.2007.09.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylene functionalized BODIPY dyes and their application in the synthesis of activity based proteasome probes</span></div><div class="casAuthors">Verdoes, Martijn; Hillaert, Ulrik; Florea, Bogdan I.; Sae-Heng, Myra; Risseeuw, Martijn D. P.; Filippov, Dmitri V.; Van der Marel, Gijsbert A.; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6169-6171</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The synthesis of three acetylene functionalized BODIPY dyes is described.  These dyes are used to fluorescently modify an azido functionalized epoxomicin analog employing the Huisgen 1,3-dipolar cycloaddn., resulting in a panel of fluorescent epoxomicin derived proteasome probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjRloqekg7s7Vg90H21EOLACvtfcHk0lhfSqTw-tEyDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt7%252FL&md5=cd747cd1e5d341f9a077eb1b661d8d55</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.025%26sid%3Dliteratum%253Aachs%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DHillaert%26aufirst%3DU.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DSae-Heng%26aufirst%3DM.%26aulast%3DRisseeuw%26aufirst%3DM.%2BD.%2BP.%26aulast%3DFilippov%26aufirst%3DD.%2BV.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DAcetylene%2520functionalized%2520BODIPY%2520dyes%2520and%2520their%2520application%2520in%2520the%2520synthesis%2520of%2520activity%2520based%2520proteasome%2520probes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D22%26spage%3D6169%26epage%3D6171%26doi%3D10.1016%2Fj.bmcl.2007.09.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">A set of activity-based probes to visualize human (immuno)proteasome activities</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4199</span>â <span class="NLM_lpage">4203</span>, <span class="refDoi">Â DOI: 10.1002/anie.201509092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.201509092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslCntLbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=4199-4203&issue=13&author=G.+de%0ABruinauthor=B.+T.+Xinauthor=M.+Krausauthor=M.+van+der%0ASteltauthor=G.+A.+van+der+Marelauthor=A.+F.+Kisselevauthor=C.+Driessenauthor=B.+I.+Floreaauthor=H.+S.+Overkleeft&title=A+set+of+activity-based+probes+to+visualize+human+%28immuno%29proteasome+activities&doi=10.1002%2Fanie.201509092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A set of activity-based probes to visualize human (immuno)proteasome activities</span></div><div class="casAuthors">de Bruin, Gerjan; Xin, Bo Tao; Kraus, Marianne; van der Stelt, Mario; van der Marel, Gijsbert A.; Kisselev, Alexei F.; Driessen, Christoph; Florea, Bogdan I.; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4199-4203</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Proteasomes are therapeutic targets for various cancers and autoimmune diseases.  Constitutively expressed proteasomes have three active sites, Î²1c, Î²2c, and Î²5c.  Lymphoid tissues also express the immunoproteasome subunits Î²1i, Î²2i, and Î²5i.  Rapid and simultaneous measurement of the activity of these catalytic subunits would assist in the discovery of new inhibitors, improve anal. of proteasome inhibitors in clin. trials, and simplify anal. of subunit expression.  In this work, we present a cocktail of activity-based probes that enables simultaneous gel-based detection of all six catalytic human proteasome subunits.  We used this cocktail to develop specific inhibitors for Î²1c, Î²2c, Î²5c, and Î²2i, to compare the active-site specificity of clin. proteasome inhibitors, and to demonstrate that many hematol. malignancies predominantly express immunoproteasomes.  Furthermore, we show that selective and complete inhibition of Î²5i and Î²1i is cytotoxic to primary cells from acute lymphocytic leukemia (ALL) patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrebn-jSmyOmLVg90H21EOLACvtfcHk0lgVjempKVQJZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslCntLbJ&md5=b04c6ea92827f327395fc313444e5126</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fanie.201509092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201509092%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BBruin%26aufirst%3DG.%26aulast%3DXin%26aufirst%3DB.%2BT.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DDriessen%26aufirst%3DC.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DA%2520set%2520of%2520activity-based%2520probes%2520to%2520visualize%2520human%2520%2528immuno%2529proteasome%2520activities%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26issue%3D13%26spage%3D4199%26epage%3D4203%26doi%3D10.1002%2Fanie.201509092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jen, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Valle, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aydanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jewell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norsworthy, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przepiorka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdur, R.</span></span> <span> </span><span class="NLM_article-title">FDA approval: gemtuzumab ozogamicin for the treatment of adults with newly diagnosed CD33-positive acute myeloid leukemia</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3242</span>â <span class="NLM_lpage">3246</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-17-3179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1158%2F1078-0432.CCR-17-3179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29476018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlantb%252FO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=3242-3246&author=E.+Y.+Jenauthor=C.+W.+Koauthor=J.+E.+Leeauthor=P.+L.+Del+Valleauthor=A.+Aydanianauthor=C.+Jewellauthor=K.+J.+Norsworthyauthor=D.+Przepiorkaauthor=L.+Nieauthor=J.+Liuauthor=C.+M.+Shethauthor=M.+Shapiroauthor=A.+T.+Farrellauthor=R.+Pazdur&title=FDA+approval%3A+gemtuzumab+ozogamicin+for+the+treatment+of+adults+with+newly+diagnosed+CD33-positive+acute+myeloid+leukemia&doi=10.1158%2F1078-0432.CCR-17-3179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia</span></div><div class="casAuthors">Jen, Emily Y.; Ko, Chia-Wen; Lee, Jee Eun; Del Valle, Pedro L.; Aydanian, Antonina; Jewell, Charles; Norsworthy, Kelly J.; Przepiorka, Donna; Nie, Lei; Liu, Jiang; Sheth, Christopher M.; Shapiro, Marjorie; Farrell, Ann T.; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3242-3246</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">On Sept. 1, 2017, the FDA granted approval for gemtuzumab ozogamicin (Mylotarg; Pfizer Inc.) in combination with daunorubicin and cytarabine and as a monotherapy for the treatment of adult patients with newly diagnosed CD33-pos. acute myeloid leukemia (AML).  Gemtuzumab ozogamicin is a CD33-targeted antibody-drug conjugate joined to calicheamicin.  Approval of gemtuzumab ozogamicin combination treatment was based on a randomized trial of 271 patients with newly diagnosed AML treated with daunorubicin and cytarabine with or without 3 mg/m2 fractionated gemtuzumab ozogamicin, which resulted in an event-free survival (EFS) of 13.6 mo for gemtuzumab ozogamicin + daunorubicin and cytarabine and 8.8 mo for daunorubicin and cytarabine alone [HR = 0.68 (95% confidence interval (CI), 0.51-0.91)].  Hemorrhage, prolonged thrombocytopenia, and veno-occlusive disease were serious toxicities that were more common in patients treated with gemtuzumab ozogamicin + daunorubicin and cytarabine.  Approval of gemtuzumab ozogamicin monotherapy was based on a randomized trial of 237 patients with newly diagnosed AML treated without curative intent.  Median overall survival (OS) was 4.9 mo with gemtuzumab ozogamicin vs. 3.6 mo on best supportive care [HR = 0.69 (95% CI, 0.53-0.90)].  Adverse events were similar on both arms.  Postapproval, several studies are required including evaluation of fractionated gemtuzumab ozogamicin pharmacokinetics, safety of combination gemtuzumab ozogamicin in the pediatric population, immunogenicity, and the effects of gemtuzumab ozogamicin on platelet function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4Pd2W8O-Rs7Vg90H21EOLACvtfcHk0lgVjempKVQJZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlantb%252FO&md5=00a69bf2b71711a4567d30035ef9797d</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-17-3179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-17-3179%26sid%3Dliteratum%253Aachs%26aulast%3DJen%26aufirst%3DE.%2BY.%26aulast%3DKo%26aufirst%3DC.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DDel%2BValle%26aufirst%3DP.%2BL.%26aulast%3DAydanian%26aufirst%3DA.%26aulast%3DJewell%26aufirst%3DC.%26aulast%3DNorsworthy%26aufirst%3DK.%2BJ.%26aulast%3DPrzepiorka%26aufirst%3DD.%26aulast%3DNie%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DSheth%26aufirst%3DC.%2BM.%26aulast%3DShapiro%26aufirst%3DM.%26aulast%3DFarrell%26aufirst%3DA.%2BT.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DFDA%2520approval%253A%2520gemtuzumab%2520ozogamicin%2520for%2520the%2520treatment%2520of%2520adults%2520with%2520newly%2520diagnosed%2520CD33-positive%2520acute%2520myeloid%2520leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2018%26volume%3D24%26spage%3D3242%26epage%3D3246%26doi%3D10.1158%2F1078-0432.CCR-17-3179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norsworthy, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przepiorka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdur, R.</span></span> <span> </span><span class="NLM_article-title">FDA approval summary: mylotarg for treatment of patients with relapsed or refractory CD33-positive acute myeloid leukemia</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1103</span>â <span class="NLM_lpage">1108</span>, <span class="refDoi">Â DOI: 10.1634/theoncologist.2017-0604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1634%2Ftheoncologist.2017-0604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29650683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1yntr3O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=1103-1108&author=K.+J.+Norsworthyauthor=C.+W.+Koauthor=J.+E.+Leeauthor=J.+Liuauthor=C.+S.+Johnauthor=D.+Przepiorkaauthor=A.+T.+Farrellauthor=R.+Pazdur&title=FDA+approval+summary%3A+mylotarg+for+treatment+of+patients+with+relapsed+or+refractory+CD33-positive+acute+myeloid+leukemia&doi=10.1634%2Ftheoncologist.2017-0604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia</span></div><div class="casAuthors">Norsworthy, Kelly J.; Ko, Chia-Wen; Lee, Jee Eun; Liu, Jiang; John, Christy S.; Przepiorka, Donna; Farrell, Ann T.; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1103-1108</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1549-490X</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">GO is a CD33-directed antibody drug conjugate linked to the cytotoxic antibiotic calicheamicin.  It originally received accelerated approval for treatment of older patients with relapsed CD33-pos. AML in 2000, but it was withdrawn from the market in 2010 when the confirmatory trial failed to demonstrate clin. benefit among safety concerns, such as a higher rate of induction fatalities on the GO combination arm compared with chemotherapy alone.  In addn., GO was assocd. with hepatic veno-occlusive disease (VOD), which has substantial morbidity and mortality.  Pharmacokinetic analyses suggested a lower max. concn. of GO would result in less VOD without affecting target satn. or efficacy.  A meta-anal. across dose schedules of GO in patients with R/R AML showed that a lower-dose "fractionated" schedule of 3 mg/m2 days 1, 4, and 7 was assocd. with less early mortality, hemorrhage, and VOD, without an apparent decrease in complete remission (CR) rate.  MyloFrance 1 was a single-arm study evaluating response rates in patients with relapsed CD33-pos. AML treated with the lower-dose fractionated GO regimen.  The CR rate was 26% (95% confidence interval 16%-40%).  Common adverse reactions were fever, infections, nausea, vomiting, constipation, bleeding, increased liver enzymes, and mucositis.  There were no cases of VOD.  These results supported the approval of GO as monotherapy for R/R CD33-pos. AML using the lower-dose fractionated regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ5hq8ChgdU7Vg90H21EOLACvtfcHk0liNx_SpqZlA0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1yntr3O&md5=9b54edbd41525fca590ee14bfa2434ce</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2017-0604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2017-0604%26sid%3Dliteratum%253Aachs%26aulast%3DNorsworthy%26aufirst%3DK.%2BJ.%26aulast%3DKo%26aufirst%3DC.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DJohn%26aufirst%3DC.%2BS.%26aulast%3DPrzepiorka%26aufirst%3DD.%26aulast%3DFarrell%26aufirst%3DA.%2BT.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DFDA%2520approval%2520summary%253A%2520mylotarg%2520for%2520treatment%2520of%2520patients%2520with%2520relapsed%2520or%2520refractory%2520CD33-positive%2520acute%2520myeloid%2520leukemia%26jtitle%3DOncologist%26date%3D2018%26volume%3D23%26spage%3D1103%26epage%3D1108%26doi%3D10.1634%2Ftheoncologist.2017-0604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, Y. N.</span></span> <span> </span><span class="NLM_article-title">Inotuzumab ozogamicin: first global approval</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">1603</span>â <span class="NLM_lpage">1610</span>, <span class="refDoi">Â DOI: 10.1007/s40265-017-0802-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs40265-017-0802-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28819740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlGktL3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2017&pages=1603-1610&author=Y.+N.+Lamb&title=Inotuzumab+ozogamicin%3A+first+global+approval&doi=10.1007%2Fs40265-017-0802-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Inotuzumab Ozogamicin: First Global Approval</span></div><div class="casAuthors">Lamb, Yvette N.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1603-1610</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">I.v. inotuzumab ozogamicin (Besponsa; Pfizer) is an anti-CD22 monoclonal antibody-calicheamicin conjugate that binds to CD22-expressing tumor cells.  Upon binding, the complex is internalized and the cytotoxic calicheamicin deriv. is released inside the cell, inducing double-strand DNA breakage and subsequent cell death.  In June 2017, the EMA granted inotuzumab ozogamicin approval as monotherapy for the treatment of adults with relapsed or refractory CD22-pos. B-cell precursor acute lymphoblastic leukemia (ALL).  The use of inotuzumab ozogamicin in adult patients with Philadelphia chromosome-pos., relapsed or refractory CD22-pos. B-cell precursor ALL is restricted to those who have failed treatment with at least one tyrosine kinase inhibitor.  Inotuzumab ozogamicin was granted priority review for the treatment of relapsed or refractory B-cell precursor ALL by the US FDA in Feb. 2017.  In the USA, a phase III trial evaluating inotuzumab ozogamicin in combination with frontline chemotherapy in adults with newly diagnosed B-cell ALL has recently been initiated and inotuzumab ozogamicin is under phase II evaluation in childhood CD22-pos. B-cell ALL.  Inotuzumab ozogamicin combination therapies are also being evaluated in the phase I/II or II setting in ALL and chronic myeloid leukemia and in the phase I setting in Burkitt's lymphoma.  This article summarizes the milestones in the development of inotuzumab ozogamicin leading to this first approval for ALL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSHnoFMpPaqbVg90H21EOLACvtfcHk0liNx_SpqZlA0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlGktL3P&md5=76c6dbf41181e769901bbc313aabdb20</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1007%2Fs40265-017-0802-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-017-0802-5%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DY.%2BN.%26atitle%3DInotuzumab%2520ozogamicin%253A%2520first%2520global%2520approval%26jtitle%3DDrugs%26date%3D2017%26volume%3D77%26spage%3D1603%26epage%3D1610%26doi%3D10.1007%2Fs40265-017-0802-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donato, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FernÃ¡ndez-Zarzoso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hueso, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la
Rubia, J.</span></span> <span> </span><span class="NLM_article-title">Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: an evidence-based review</span>. <i>OncoTargets Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">4583</span>â <span class="NLM_lpage">4590</span>, <span class="refDoi">Â DOI: 10.2147/OTT.S141053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.2147%2FOTT.S141053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30122950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BB3c7ps1ajuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=4583-4590&author=E.+M.+Donatoauthor=M.+Fern%C3%A1ndez-Zarzosoauthor=J.+A.+Huesoauthor=J.+de+la%0ARubia&title=Brentuximab+vedotin+in+Hodgkin+lymphoma+and+anaplastic+large-cell+lymphoma%3A+an+evidence-based+review&doi=10.2147%2FOTT.S141053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: an evidence-based review</span></div><div class="casAuthors">Donato Eva M; Fernandez-Zarzoso Miguel; Hueso Jose Antonio; de la Rubia Javier; de la Rubia Javier</div><div class="citationInfo"><span class="NLM_cas:title">OncoTargets and therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4583-4590</span>
        ISSN:<span class="NLM_cas:issn">1178-6930</span>.
    </div><div class="casAbstract">Hodgkin lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) account for ~10% and 2%-3% of all cases of lymphoid neoplasms, respectively.  Up to 30% of patients with HL are refractory or relapse after first-line therapy, and elderly patients with HL represent a subgroup of patients with suboptimal responses to the currently available treatments.  Five-year overall survival for ALCL patients is 50%-80% with conventional chemotherapy.  Therefore, new therapeutic approaches are needed for these groups of patients.  Brentuximab vedotin is a chimeric IgG1 anti-CD30 antibody-drug conjugate that has all the features that are necessary to make a substantive difference with the standard therapies in patients with HL and ALCL: a novel mechanism of action, single-agent activity, non-cross-resistance, and safety both in the relapsed-refractory and in the front-line setting.  This review provides an update of the results of the most relevant clinical trials including brentuximab vedotin for patients with HL and ALCL conducted to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQOH2aP9Lst_yEJCPKhJPuqfW6udTcc2ebmc9ISLPcP_7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c7ps1ajuw%253D%253D&md5=08cf83d2027f2c9e7b7dc132a4551818</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.2147%2FOTT.S141053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FOTT.S141053%26sid%3Dliteratum%253Aachs%26aulast%3DDonato%26aufirst%3DE.%2BM.%26aulast%3DFern%25C3%25A1ndez-Zarzoso%26aufirst%3DM.%26aulast%3DHueso%26aufirst%3DJ.%2BA.%26aulast%3Dde%2Bla%2BRubia%26aufirst%3DJ.%26atitle%3DBrentuximab%2520vedotin%2520in%2520Hodgkin%2520lymphoma%2520and%2520anaplastic%2520large-cell%2520lymphoma%253A%2520an%2520evidence-based%2520review%26jtitle%3DOncoTargets%2520Ther.%26date%3D2018%26volume%3D11%26spage%3D4583%26epage%3D4590%26doi%3D10.2147%2FOTT.S141053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasamon, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Claro, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenthal, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazdur, R.</span></span> <span> </span><span class="NLM_article-title">FDA approval summary: brentuximab vedotin in first-line treatment of peripheral T-cell lymphoma</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">e180</span>â <span class="NLM_lpage">e187</span>, <span class="refDoi">Â DOI: 10.1634/theoncologist.2019-0098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1634%2Ftheoncologist.2019-0098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30914464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFKhs7fF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=e180-e187&author=N.+C.+Richardsonauthor=Y.+L.+Kasamonauthor=H.+Chenauthor=R.+A.+de+Claroauthor=J.+Yeauthor=G.+M.+Blumenthalauthor=A.+T.+Farrellauthor=R.+Pazdur&title=FDA+approval+summary%3A+brentuximab+vedotin+in+first-line+treatment+of+peripheral+T-cell+lymphoma&doi=10.1634%2Ftheoncologist.2019-0098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma</span></div><div class="casAuthors">Richardson, Nicholas C.; Kasamon, Yvette L.; Chen, Haiyan; de Claro, R. Angelo; Ye, Jingjing; Blumenthal, Gideon M.; Farrell, Ann T.; Pazdur, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e180-e187</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1549-490X</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">Approval was based on ECHELON-2, a randomized, double-blind, actively controlled trial that compared BV+CHP with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in 452 patients with newly diagnosed, CD30-expressing PTCL.  Efficacy was based on independent review facility-assessed progression-free survival (PFS).  The median PFS was 48.2 mo with BV+CHP vs. 20.8 mo with CHOP, resulting in a hazard ratio (HR) of 0.71 (95% confidence interval).  The trial also demonstrated improvement in overall survival (HR 0.66; 95% CI: 0.46-0.95), complete response rate (68% vs. 56%), and overall response rate (83% vs. 72%) with BV+CHP.  The most common adverse reactions (incidence â¥20%) obsd. â¥2% more with BV+CHP were nausea, diarrhea, fatigue or asthenia, mucositis, pyrexia, vomiting, and anemia.  Peripheral neuropathy rates were similar (52% with BV+CHP, 55% with CHOP).  Through the Real-Time Oncol. Review pilot program, which allows FDA early access to key data, FDA granted this approval less than 2 wk after official submission of the application.  Implications for Practice : This is the first U.S. Food and Drug Administration approval for treatment of patients with newly diagnosed peripheral T-cell lymphomas (PTCL).  Improvement in progression-free and overall survival over cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy, which has been the std. of care for decades, is unprecedented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEhAAcx2pjcbVg90H21EOLACvtfcHk0lhpE7qh4yjuAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFKhs7fF&md5=1508f5760132350665aaa03a10ed0623</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2019-0098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2019-0098%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DN.%2BC.%26aulast%3DKasamon%26aufirst%3DY.%2BL.%26aulast%3DChen%26aufirst%3DH.%26aulast%3Dde%2BClaro%26aufirst%3DR.%2BA.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DBlumenthal%26aufirst%3DG.%2BM.%26aulast%3DFarrell%26aufirst%3DA.%2BT.%26aulast%3DPazdur%26aufirst%3DR.%26atitle%3DFDA%2520approval%2520summary%253A%2520brentuximab%2520vedotin%2520in%2520first-line%2520treatment%2520of%2520peripheral%2520T-cell%2520lymphoma%26jtitle%3DOncologist%26date%3D2019%26volume%3D24%26spage%3De180%26epage%3De187%26doi%3D10.1634%2Ftheoncologist.2019-0098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von
Minckwitz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mano, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loibl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamounas, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Untch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolmark, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastogi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneeweiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redondo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacot, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conlin, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arce-Salinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wapnir, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackisch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiGiovanna, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasching, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crown, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">WÃ¼lfing, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rota Caremoli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesarowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smitt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douthwaite, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singel, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, C. E.,  Jr.</span></span> <span> </span><span class="NLM_article-title">KATHERINE Investigators. Trastuzumab emtansine for residual invasive HER2-positive breast cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>380</i></span>,  <span class="NLM_fpage">617</span>â <span class="NLM_lpage">628</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa1814017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1056%2FNEJMoa1814017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30516102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvVSjsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2019&pages=617-628&author=G.+von%0AMinckwitzauthor=C.+S.+Huangauthor=M.+S.+Manoauthor=S.+Loiblauthor=E.+P.+Mamounasauthor=M.+Untchauthor=N.+Wolmarkauthor=P.+Rastogiauthor=A.+Schneeweissauthor=A.+Redondoauthor=H.+H.+Fischerauthor=W.+Jacotauthor=A.+K.+Conlinauthor=C.+Arce-Salinasauthor=I.+L.+Wapnirauthor=C.+Jackischauthor=M.+P.+DiGiovannaauthor=P.+A.+Faschingauthor=J.+P.+Crownauthor=P.+W%C3%BClfingauthor=Z.+Shaoauthor=E.+Rota+Caremoliauthor=H.+Wuauthor=L.+H.+Lamauthor=D.+Tesarowskiauthor=M.+Smittauthor=H.+Douthwaiteauthor=S.+M.+Singelauthor=C.+E.+Geyer&title=KATHERINE+Investigators.+Trastuzumab+emtansine+for+residual+invasive+HER2-positive+breast+cancer&doi=10.1056%2FNEJMoa1814017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Trastuzumab emtansine for residual invasive HER2-positive breast cancer</span></div><div class="casAuthors">von Minckwitz, G.; Huang, C.-S.; Mano, M. S.; Loibl, S.; Mamounas, E. P.; Untch, M.; Wolmark, N.; Rastogi, P.; Schneeweiss, A.; Redondo, A.; Fischer, H. H.; Jacot, W.; Conlin, A. K.; Arce-Salinas, C.; Wapnir, I. L.; Jackisch, C.; DiGiovanna, M. P.; Fasching, P. A.; Crown, J. P.; Wuelfing, P.; Shao, Z.; Caremoli, E. Rota; Wu, H.; Lam, L. H.; Tesarowski, D.; Smitt, M.; Douthwaite, H.; Singel, S. M.; Geyer, C. E., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">617-628</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background Patients who have residual invasive breast cancer after receiving neoadjuvant chemotherapy plus human epidermal growth factor receptor 2 (HER2)-targeted therapy have a worse prognosis than those who have no residual cancer.  Trastuzumab emtansine (T-DM1), an antibody-drug conjugate of trastuzumab and the cytotoxic agent emtansine (DM1), a maytansine deriv. and microtubule inhibitor, provides benefit in patients with metastatic breast cancer that was previously treated with chemotherapy plus HER2-targeted therapy.  Methods We conducted a phase 3, open-label trial involving patients with HER2-pos. early breast cancer who were found to have residual invasive disease in the breast or axilla at surgery after receiving neoadjuvant therapy contg. a taxane (with or without anthracycline) and trastuzumab.  Patients were randomly assigned to receive adjuvant T-DM1 or trastuzumab for 14 cycles.  The primary end point was invasive disease-free survival (defined as freedom from ipsilateral invasive breast tumor recurrence, ipsilateral locoregional invasive breast cancer recurrence, contralateral invasive breast cancer, distant recurrence, or death from any cause).  Results At the interim anal., among 1486 randomly assigned patients (743 in the T-DM1 group and 743 in the trastuzumab group), invasive disease or death had occurred in 91 patients in the T-DM1 group (12.2%) and 165 patients in the trastuzumab group (22.2%).  The estd. percentage of patients who were free of invasive disease at 3 years was 88.3% in the T-DM1 group and 77.0% in the trastuzumab group.  Invasive disease-free survival was significantly higher in the T-DM1 group than in the trastuzumab group (hazard ratio for invasive disease or death, 0.50; 95% confidence interval, 0.39 to 0.64; P<0.001).  Distant recurrence as the first invasive-disease event occurred in 10.5% of patients in the T-DM1 group and 15.9% of those in the trastuzumab group.  The safety data were consistent with the known safety profile of T-DM1, with more adverse events assocd. with T-DM1 than with trastuzumab alone.  Conclusions Among patients with HER2-pos. early breast cancer who had residual invasive disease after completion of neoadjuvant therapy, the risk of recurrence of invasive breast cancer or death was 50% lower with adjuvant T-DM1 than with trastuzumab alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_AnDXLpkvDLVg90H21EOLACvtfcHk0lhpE7qh4yjuAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvVSjsrc%253D&md5=cf91a52e85e92514122bace6236f69fb</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1814017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1814017%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BMinckwitz%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DC.%2BS.%26aulast%3DMano%26aufirst%3DM.%2BS.%26aulast%3DLoibl%26aufirst%3DS.%26aulast%3DMamounas%26aufirst%3DE.%2BP.%26aulast%3DUntch%26aufirst%3DM.%26aulast%3DWolmark%26aufirst%3DN.%26aulast%3DRastogi%26aufirst%3DP.%26aulast%3DSchneeweiss%26aufirst%3DA.%26aulast%3DRedondo%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DH.%2BH.%26aulast%3DJacot%26aufirst%3DW.%26aulast%3DConlin%26aufirst%3DA.%2BK.%26aulast%3DArce-Salinas%26aufirst%3DC.%26aulast%3DWapnir%26aufirst%3DI.%2BL.%26aulast%3DJackisch%26aufirst%3DC.%26aulast%3DDiGiovanna%26aufirst%3DM.%2BP.%26aulast%3DFasching%26aufirst%3DP.%2BA.%26aulast%3DCrown%26aufirst%3DJ.%2BP.%26aulast%3DW%25C3%25BClfing%26aufirst%3DP.%26aulast%3DShao%26aufirst%3DZ.%26aulast%3DRota%2BCaremoli%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DL.%2BH.%26aulast%3DTesarowski%26aufirst%3DD.%26aulast%3DSmitt%26aufirst%3DM.%26aulast%3DDouthwaite%26aufirst%3DH.%26aulast%3DSingel%26aufirst%3DS.%2BM.%26aulast%3DGeyer%26aufirst%3DC.%2BE.%26atitle%3DKATHERINE%2520Investigators.%2520Trastuzumab%2520emtansine%2520for%2520residual%2520invasive%2520HER2-positive%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2019%26volume%3D380%26spage%3D617%26epage%3D628%26doi%3D10.1056%2FNEJMoa1814017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krop, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welslau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baselga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiÃ©ras, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guardino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwell, K.</span></span> <span> </span><span class="NLM_article-title">EMILIA Study Group. Trastuzumab emtansine for HER2-positive advanced breast cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>367</i></span>,  <span class="NLM_fpage">1783</span>â <span class="NLM_lpage">1791</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa1209124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1056%2FNEJMoa1209124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23020162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt73M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=1783-1791&author=S.+Vermaauthor=D.+Milesauthor=L.+Gianniauthor=I.+E.+Kropauthor=M.+Welslauauthor=J.+Baselgaauthor=M.+Pegramauthor=D.+Y.+Ohauthor=V.+Di%C3%A9rasauthor=E.+Guardinoauthor=L.+Fangauthor=M.+W.+Luauthor=S.+Olsenauthor=K.+Blackwell&title=EMILIA+Study+Group.+Trastuzumab+emtansine+for+HER2-positive+advanced+breast+cancer&doi=10.1056%2FNEJMoa1209124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Trastuzumab emtansine for HER2-positive advanced breast cancer</span></div><div class="casAuthors">Verma, Sunil; Miles, David; Gianni, Luca; Krop, Ian E.; Welslau, Manfred; Baselga, Jose; Pegram, Mark; Oh, Do-Youn; Dieras, Veronique; Guardino, Ellie; Fang, Liang; Lu, Michael W.; Olsen, Steven; Blackwell, Kim</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1783-1791</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate incorporating the human epidermal growth factor receptor 2 (HER2)-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.  The antibody and the cytotoxic agent are conjugated by means of a stable linker.  METHODS: We randomly assigned patients with HER2-pos. advanced breast cancer, who had previously been treated with trastuzumab and a taxane, to T-DM1 or lapatinib plus capecitabine.  The primary end points were progression-free survival (as assessed by independent review), overall survival, and safety.  Secondary end points included progression-free survival (investigator-assessed), the objective response rate, and the time to symptom progression.  Two interim analyses of overall survival were conducted.  RESULTS: Among 991 randomly assigned patients, median progression-free survival as assessed by independent review was 9.6 mo with T-DM1 vs. 6.4 mo with lapatinib plus capecitabine (hazard ratio for progression or death from any cause, 0.65; 95% confidence interval [CI], 0.55 to 0.77; P<0.001), and median overall survival at the second interim anal. crossed the stopping boundary for efficacy (30.9 mo vs. 25.1 mo; hazard ratio for death from any cause, 0.68; 95% CI, 0.55 to 0.85; P<0.001).  The objective response rate was higher with T-DM1 (43.6%, vs. 30.8% with lapatinib plus capecitabine; P<0.001); results for all addnl. secondary end points favored T-DM1.  Rates of grade 3 or above were higher with lapatinib plus capecitabine than with T-DM1 (57% vs. 41%).  The incidences of thrombocytopenia and increased serum aminotransferase levels were higher with T-DM1, whereas the incidences of diarrhea, nausea, vomiting, and palmar-plantar erythrodysesthesia were higher with lapatinib plus capecitabine.  CONCLUSIONS: T-DM1 significantly prolonged progression-free and overall survival with less toxicity than lapatinib plus capecitabine in patients with HER2-pos. advanced breast cancer previously treated with trastuzumab and a taxane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGRhxRQ7JSJrVg90H21EOLACvtfcHk0ljUeVdoA1j05g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1ekt73M&md5=3be5bac27a81b530442dc8a6b4a1f82e</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1209124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1209124%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DS.%26aulast%3DMiles%26aufirst%3DD.%26aulast%3DGianni%26aufirst%3DL.%26aulast%3DKrop%26aufirst%3DI.%2BE.%26aulast%3DWelslau%26aufirst%3DM.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DPegram%26aufirst%3DM.%26aulast%3DOh%26aufirst%3DD.%2BY.%26aulast%3DDi%25C3%25A9ras%26aufirst%3DV.%26aulast%3DGuardino%26aufirst%3DE.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DS.%26aulast%3DBlackwell%26aufirst%3DK.%26atitle%3DEMILIA%2520Study%2520Group.%2520Trastuzumab%2520emtansine%2520for%2520HER2-positive%2520advanced%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D367%26spage%3D1783%26epage%3D1791%26doi%3D10.1056%2FNEJMoa1209124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deeks, E. D.</span></span> <span> </span><span class="NLM_article-title">Polatuzumab vedotin: first global approval</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1467</span>â <span class="NLM_lpage">1475</span>, <span class="refDoi">Â DOI: 10.1007/s40265-019-01175-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs40265-019-01175-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=31352604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BB3MvitVSmsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2019&pages=1467-1475&issue=13&author=E.+D.+Deeks&title=Polatuzumab+vedotin%3A+first+global+approval&doi=10.1007%2Fs40265-019-01175-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Polatuzumab Vedotin: First Global Approval</span></div><div class="casAuthors">Deeks Emma D</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1467-1475</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Polatuzumab vedotin (polatuzumab vedotin-piiq; PolivyÂ®) is an antibody-drug conjugate comprising a monoclonal antibody against CD79b (a B cell receptor component) covalently conjugated to the anti-mitotic cytotoxic agent monomethyl auristatin (MMAE) via a cleavable linker.  After binding to CD79b on the B-cell surface, polatuzumab vedotin is internalized and the linker is cleaved, releasing MMAE into the cell, where it inhibits division and induces apoptosis.  Polatuzumab vedotin is being developed by Genentech (a subsidiary of Roche) for the treatment of haematological malignancies.  In June 2019, the US FDA granted accelerated approval to polatuzumab vedotin, in combination with bendamustine plus rituximab, for the treatment of adults with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who have received at least two prior therapies.  Use of the compound in combination with bendamustine plus rituximab is also under regulatory review for relapsed/refractory DLBCL in the EU and is in ongoing phase 1b/2 development in this setting or relapsed/refractory follicular lymphoma (FL) in several countries.  Various other polatuzumab vedotin combination therapy regimens are also in phase 1b/2 development for relapsed/refractory non-Hodgkin lymphoma (NHL) [including DLBCL and FL] or in phase 2 or 3 development for previously untreated DLBCL, while polatuzumab vedotin monotherapy has been in phase 1 development for relapsed/refractory B-cell NHL in Japan.  This article summarizes the milestones in the development of polatuzumab vedotin leading to this first approval for its use in combination with bendamustine plus rituximab for relapsed/refractory DLBCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWjRJKq7mXFhjv2lLSLOxFfW6udTcc2eYO-zo54BAQhLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvitVSmsA%253D%253D&md5=2aed4fe7658078144e9a1169ecf60e37</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1007%2Fs40265-019-01175-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-019-01175-0%26sid%3Dliteratum%253Aachs%26aulast%3DDeeks%26aufirst%3DE.%2BD.%26atitle%3DPolatuzumab%2520vedotin%253A%2520first%2520global%2520approval%26jtitle%3DDrugs%26date%3D2019%26volume%3D79%26issue%3D13%26spage%3D1467%26epage%3D1475%26doi%3D10.1007%2Fs40265-019-01175-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sacchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curnis, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corti, A.</span></span> <span> </span><span class="NLM_article-title">Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">7150</span>â <span class="NLM_lpage">7155</span>, <span class="refDoi">Â DOI: 10.1158/0008-5472.CAN-04-1445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1158%2F0008-5472.CAN-04-1445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=15466213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFaltro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7150-7155&author=A.+Sacchiauthor=A.+Gasparriauthor=F.+Curnisauthor=M.+Belloneauthor=A.+Corti&title=Crucial+role+for+interferon+gamma+in+the+synergism+between+tumor+vasculature-targeted+tumor+necrosis+factor+alpha+%28NGR-TNF%29+and+doxorubicin&doi=10.1158%2F0008-5472.CAN-04-1445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Crucial role for interferon Î³ in the synergism between tumor vasculature-targeted tumor necrosis factor Î± (NGR,TNF) and doxorubicin</span></div><div class="casAuthors">Sacchi, Angelina; Gasparri, Anna; Curnis, Flavio; Bellone, Matteo; Corti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7150-7155</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">NGR-TNF is a deriv. of TNF-Î±, consisting of TNF fused to CNGRCG, a tumor vasculature-targeting peptide.  Previous studies showed that NGR-TNF can exert synergistic antitumor effects with doxorubicin and with other chemotherapeutic drugs in murine models.  In this study, the authors have investigated the role of endogenous IFN-Î³ on the antitumor activity of NGR-TNF in combination with doxorubicin.  The study was carried out using murine B16F1 melanoma and TS/A mammary adenocarcinoma implanted s.c. in (a) immunocompetent mice, (b) athymic nude mice, and (c) IFN-Î³-knockout mice.  Synergism between NGR-TNF and doxorubicin was obsd. in immunocompetent mice but not in nude or IFN-Î³-knockout mice.  Preadministration of a neutralizing anti-IFN-Î³ antibody to immunocompetent mice inhibited the NGR-TNF/doxorubicin synergism, whereas administration of IFN-Î³ to nude and to IFN-Î³-knockout mice restored the synergistic activity.  The synergism in nude mice was restored also by transfecting tumor cells with the IFN-Î³ cDNA.  Administration of NGR-TNF in combination with IFN-Î³ to nude mice, but not of NGR-TNF alone, doubled the penetration of doxorubicin in TS/A tumors.  These findings point to a crucial role for locally produced IFN-Î³ in tumor vascular targeting with NGR-TNF and doxorubicin.  Finally, addn. of IFN-Î³ to the treatment of immunocompetent mice with NGR-TNF/doxorubicin induced only modest improvement in response, suggesting that exogenous IFN-Î³ can improve the therapeutic activity of these drugs only in case of suboptimal prodn. of endogenous IFN-Î³.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC_DWQbtJ-erVg90H21EOLACvtfcHk0ljUeVdoA1j05g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFaltro%253D&md5=64a30f33d0c908bfeecbe05149ab5976</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1445%26sid%3Dliteratum%253Aachs%26aulast%3DSacchi%26aufirst%3DA.%26aulast%3DGasparri%26aufirst%3DA.%26aulast%3DCurnis%26aufirst%3DF.%26aulast%3DBellone%26aufirst%3DM.%26aulast%3DCorti%26aufirst%3DA.%26atitle%3DCrucial%2520role%2520for%2520interferon%2520gamma%2520in%2520the%2520synergism%2520between%2520tumor%2520vasculature-targeted%2520tumor%2520necrosis%2520factor%2520alpha%2520%2528NGR-TNF%2529%2520and%2520doxorubicin%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7150%26epage%3D7155%26doi%3D10.1158%2F0008-5472.CAN-04-1445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregorc, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capelletto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genova, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambiase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoro, A.</span></span> <span> </span><span class="NLM_article-title">NGR-hTNF and doxorubicin as second-line treatment of patients with small cell lung cancer</span>. <i>Oncologist</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1133</span>â <span class="NLM_lpage">e112</span>, <span class="refDoi">Â DOI: 10.1634/theoncologist.2018-0292</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1634%2Ftheoncologist.2018-0292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30076277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1yntr3L" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=1133-e112&author=V.+Gregorcauthor=R.+Cavinaauthor=S.+Novelloauthor=F.+Grossiauthor=C.+Lazzariauthor=E.+Capellettoauthor=C.+Genovaauthor=G.+Saliniauthor=A.+Lambiaseauthor=A.+Santoro&title=NGR-hTNF+and+doxorubicin+as+second-line+treatment+of+patients+with+small+cell+lung+cancer&doi=10.1634%2Ftheoncologist.2018-0292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">NGR-hTNF and Doxorubicin as Second-Line Treatment of Patients with Small Cell Lung Cancer</span></div><div class="casAuthors">Gregorc, Vanesa; Cavina, Raffaele; Novello, Sivia; Grossi, Francesco; Lazzari, Chiara; Capelletto, Enrica; Genova, Carlo; Salini, Giulia; Lambiase, Antonio; Santoro, Armando</div><div class="citationInfo"><span class="NLM_cas:title">Oncologist</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1133-e112</span>CODEN:
                <span class="NLM_cas:coden">OCOLF6</span>;
        ISSN:<span class="NLM_cas:issn">1549-490X</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">Lessons Learned : NGR-hTNF was safely combined with doxorubicin, showing a promising antitumor activity in unselected patients with relapsed small cell lung cancer.  Similar antitumor activity was obsd. in platinum-sensitive and platinum-resistant patient cohorts.  Relapsed small cell lung cancer (SCLC) patients have limited treatment options and poor outcomes.  NGR-hTNF is a vascular-targeting agent, which increases intratumoral chemotherapy penetration and T-lymphocyte infiltration.  The primary endpoint of this single-arm phase II trial was progression-free survival (PFS), and safety, response rate, and survival were secondary endpoints.  The most common grade 3-4 toxicities were neutropenia (53%) and anemia (21%).  Median PFS was 3.2 mo for all patients, 2.7 mo for platinum-resistant patients, and 4.1 mo for platinum-sensitive patients.  Seven patients had partial responses (25%), including four (25%) with platinum-resistant and three (25%) with platinum-sensitive relapse.  Mean changes from baseline in tumor burden (after two, four, and six cycles) did not differ between platinum-resistant (-9%, -29%, and -32%) and platinum-sensitive (-11%, -20%, and -43%) cohorts.  Overall survival was assocd. only with baseline lymphocyte counts, with median survival times of 13.1 and 5.2 mo for lymphocyte counts above or below the median, resp.  NGR-hTNF plus doxorubicin showed manageable toxicity and promising activity in patients with relapsed SCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4JWmw-WDN-7Vg90H21EOLACvtfcHk0lggFS-_wp1kkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1yntr3L&md5=27b5dc0eef3e76ba871f0572063b6443</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1634%2Ftheoncologist.2018-0292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Ftheoncologist.2018-0292%26sid%3Dliteratum%253Aachs%26aulast%3DGregorc%26aufirst%3DV.%26aulast%3DCavina%26aufirst%3DR.%26aulast%3DNovello%26aufirst%3DS.%26aulast%3DGrossi%26aufirst%3DF.%26aulast%3DLazzari%26aufirst%3DC.%26aulast%3DCapelletto%26aufirst%3DE.%26aulast%3DGenova%26aufirst%3DC.%26aulast%3DSalini%26aufirst%3DG.%26aulast%3DLambiase%26aufirst%3DA.%26aulast%3DSantoro%26aufirst%3DA.%26atitle%3DNGR-hTNF%2520and%2520doxorubicin%2520as%2520second-line%2520treatment%2520of%2520patients%2520with%2520small%2520cell%2520lung%2520cancer%26jtitle%3DOncologist%26date%3D2018%26volume%3D23%26spage%3D1133%26epage%3De112%26doi%3D10.1634%2Ftheoncologist.2018-0292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span> <span> </span><span class="NLM_article-title">Clinical application of radiolabeled RGD peptides for PET imaging of integrin Î±vÎ²3</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">78</span>â <span class="NLM_lpage">92</span>, <span class="refDoi">Â DOI: 10.7150/thno.13242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.7150%2Fthno.13242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=26722375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XntF2nt7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=78-92&author=H.+Chenauthor=G.+Niuauthor=H.+Wuauthor=X.+Chen&title=Clinical+application+of+radiolabeled+RGD+peptides+for+PET+imaging+of+integrin+%CE%B1v%CE%B23&doi=10.7150%2Fthno.13242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical application of radiolabeled RGD peptides for PET imaging of integrin Î±vÎ²3</span></div><div class="casAuthors">Chen, Haojun; Niu, Gang; Wu, Hua; Chen, Xiaoyuan</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-92</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Mol. imaging for non-invasive assessment of angiogenesisis is of great interest for clinicians because of the wide-spread application of anti-angiogenic cancer therapeutics.  Besides, many other interventions that involve the change of blood vessel/tumor microenvironment would also benefit from such imaging strategies.  Of the imaging techniques that target angiogenesis, radiolabeled Arg-Gly-Asp (RGD) peptides have been a major focus because of their high affinity and selectivity for integrin Î±vÎ²3--one of the most extensively examd. target of angiogenesis.  Since the level of integrin Î±vÎ²3 expression has been established as a surrogate marker of angiogenic activity, imaging Î±vÎ²3 expression can potentially be used as an early indicator of effectiveness of antiangiogenic therapy at the mol. level.  In this review, we summarize RGD-based PET tracers that have already been used in clin. trials and intercompared them in terms of radiosynthesis, dosimetry, pharmacokinetics and clin. applications.  A perspective of their future use in the clinic is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMF5yFaBW4RLVg90H21EOLACvtfcHk0lggFS-_wp1kkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntF2nt7c%253D&md5=7124509bee7f3bb9b90a3a8d0ae0f82c</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.7150%2Fthno.13242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.13242%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DNiu%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DClinical%2520application%2520of%2520radiolabeled%2520RGD%2520peptides%2520for%2520PET%2520imaging%2520of%2520integrin%2520%25CE%25B1v%25CE%25B23%26jtitle%3DTheranostics%26date%3D2016%26volume%3D6%26spage%3D78%26epage%3D92%26doi%3D10.7150%2Fthno.13242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sehnert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhardt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DÃ¼bel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voll, R. E.</span></span> <span> </span><span class="NLM_article-title">The âsneaking-ligandâ approach: cell-type specific inhibition of the classical NF-ÎºB pathway</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1280</i></span>,  <span class="NLM_fpage">559</span>â <span class="NLM_lpage">578</span>, <span class="refDoi">Â DOI: 10.1007/978-1-4939-2422-6_33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-4939-2422-6_33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25736772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1yqsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1280&publication_year=2015&pages=559-578&author=B.+Sehnertauthor=H.+Burkhardtauthor=S.+D%C3%BCbelauthor=R.+E.+Voll&title=The+%E2%80%9Csneaking-ligand%E2%80%9D+approach%3A+cell-type+specific+inhibition+of+the+classical+NF-%CE%BAB+pathway&doi=10.1007%2F978-1-4939-2422-6_33"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The "Sneaking-Ligand" Approach: Cell-Type Specific Inhibition of the Classical NF-ÎºB Pathway</span></div><div class="casAuthors">Sehnert, Bettina; Burkhardt, Harald; Duebel, Stefan; Voll, Reinhard E.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1280</span>
        (<span class="NLM_cas:issue">NF-kappa B</span>),
    <span class="NLM_cas:pages">559-578</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The intracellular delivery of mols. across the plasma membrane represents a major obstacle.  The conjugation of cell-permeable peptides (CPPs) to proteins promotes the uptake and internalization.  However, uptake of CPPs is receptor independent and not cell-type specific.  Recently, we established the "sneaking-ligand" approach which is based on multimodular recombinant fusion proteins that consist of three modules connected with serine-glycine linkers.  Module one is responsible for receptor-mediated endocytosis; module two supports translocation into the cytoplasm so that the effector module three can interact with its binding partner in the cytoplasm.  For NF-ÎºB inhibition, we described an NF-ÎºB inhibitor that targets selectively the activated endothelium via an oligopeptide motif.  Upon E-selectin-mediated endocytosis, the Pseudomonas exotoxin A domain II (ETAII) translocates the NEMO-binding peptide to the cytoplasm interfering with IÎºB kinase complex assembly.  Inflammatory autoimmune diseases are triggered, but also resolved by a variety of cell types.  Therefore, the inhibition of NF-ÎºB should be restricted to those cells that are crucially involved in the pathogenesis of inflammatory diseases.  A general blockade of NF-ÎºB may result in severe immunosuppression and possibly in organ dysfunction or damage.  The "sneaking-ligand" approach could minimize the risks of therapeutic interventions and identify disease-relevant cell types.  Here we describe the recombinant expression and purifn. of the E-selectin-specific "sneaking-ligand construct" (SLC1) and its ability to inhibit cytokine-induced NF-ÎºB activation in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIYbdxKarRm7Vg90H21EOLACvtfcHk0lggFS-_wp1kkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1yqsb8%253D&md5=875051a6f3aee09a809a6848860b217d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-2422-6_33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-2422-6_33%26sid%3Dliteratum%253Aachs%26aulast%3DSehnert%26aufirst%3DB.%26aulast%3DBurkhardt%26aufirst%3DH.%26aulast%3DD%25C3%25BCbel%26aufirst%3DS.%26aulast%3DVoll%26aufirst%3DR.%2BE.%26atitle%3DThe%2520%25E2%2580%259Csneaking-ligand%25E2%2580%259D%2520approach%253A%2520cell-type%2520specific%2520inhibition%2520of%2520the%2520classical%2520NF-%25CE%25BAB%2520pathway%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2015%26volume%3D1280%26spage%3D559%26epage%3D578%26doi%3D10.1007%2F978-1-4939-2422-6_33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakase, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futaki, S.</span></span> <span> </span><span class="NLM_article-title">Syndecan-4 is a receptor for clathrin-mediated endocytosis of arginine-rich cell-penetrating peptides</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1119</span>â <span class="NLM_lpage">1130</span>, <span class="refDoi">Â DOI: 10.1021/acs.bioconjchem.6b00082</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.6b00082" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVOqtLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1119-1130&author=Y.+Kawaguchiauthor=T.+Takeuchiauthor=K.+Kuwataauthor=J.+Chibaauthor=Y.+Hatanakaauthor=I.+Nakaseauthor=S.+Futaki&title=Syndecan-4+is+a+receptor+for+clathrin-mediated+endocytosis+of+arginine-rich+cell-penetrating+peptides&doi=10.1021%2Facs.bioconjchem.6b00082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Syndecan-4 Is a Receptor for Clathrin-Mediated Endocytosis of Arginine-Rich Cell-Penetrating Peptides</span></div><div class="casAuthors">Kawaguchi, Yoshimasa; Takeuchi, Toshihide; Kuwata, Keiko; Chiba, Junya; Hatanaka, Yasumaru; Nakase, Ikuhiko; Futaki, Shiroh</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1119-1130</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Arginine-rich cell-penetrating peptides (CPPs) such as Tat and oligoarginine peptides have been widely used as carriers for intracellular delivery of bioactive mols.  Despite accumulating evidence for involvement of endocytosis in the cellular uptake of arginine-rich CPPs, the primary cell-surface receptors for these peptide carriers that would initiate endocytic processes leading to intracellular delivery of bioactive cargoes have remained poorly understood.  Our previous attempt to identify membrane receptors for octa-arginine (R8) peptide, one of the representative arginine-rich CPPs, using the photo-crosslinking probe bearing a photoreactive diazirine was not successful due to considerable amts. of cellular proteins nonspecifically bound to the affinity beads.  To address this issue, here we developed a photo-crosslinking probe in which a cleavable linker of a diazobenzene moiety was employed to allow selective elution of cross-linked proteins by reducing agent-mediated cleavage.  We demonstrated that introduction of the diazobenzene moiety into the photoaffinity probe enables efficient purifn. of cross-linked proteins with significant redn. of nonspecific binding proteins, leading to successful identification of 17 membrane-assocd. proteins that would interact with R8 peptide.  RNAi-mediated knockdown expts. in combination with the pharmacol. inhibitors revealed that, among the proteins identified, syndecan-4, one of the heparan sulfate proteoglycans, is an endogenous membrane-assocd. receptor for the cellular uptake of R8 peptide via clathrin-mediated endocytosis.  This syndecan-4-dependent pathway was also involved in the intracellular delivery of bioactive proteins mediated by R8 peptide.  These results reveal that syndecan-4 is a primary cell-surface target for R8 peptide that allows intracellular delivery of bioactive cargo mols. via clathrin-mediated endocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0PfX3BhtTMbVg90H21EOLACvtfcHk0ljsQgr-91t7WA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVOqtLc%253D&md5=88e30a7cc5c1b295e1ec4f60f14d2777</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.6b00082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.6b00082%26sid%3Dliteratum%253Aachs%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DKuwata%26aufirst%3DK.%26aulast%3DChiba%26aufirst%3DJ.%26aulast%3DHatanaka%26aufirst%3DY.%26aulast%3DNakase%26aufirst%3DI.%26aulast%3DFutaki%26aufirst%3DS.%26atitle%3DSyndecan-4%2520is%2520a%2520receptor%2520for%2520clathrin-mediated%2520endocytosis%2520of%2520arginine-rich%2520cell-penetrating%2520peptides%26jtitle%3DBioconjugate%2520Chem.%26date%3D2016%26volume%3D27%26spage%3D1119%26epage%3D1130%26doi%3D10.1021%2Facs.bioconjchem.6b00082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milletti, F.</span></span> <span> </span><span class="NLM_article-title">Cell-penetrating peptides: classes, origin, and current landscape</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">850</span>â <span class="NLM_lpage">860</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2012.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.drudis.2012.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22465171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xltl2qsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=850-860&author=F.+Milletti&title=Cell-penetrating+peptides%3A+classes%2C+origin%2C+and+current+landscape&doi=10.1016%2Fj.drudis.2012.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-penetrating peptides: classes, origin, and current landscape</span></div><div class="casAuthors">Milletti, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">850-860</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  With more than ten new FDA approvals since 2001, peptides are emerging as an important therapeutic alternative to small mols.  However, unlike small mols., peptides on the market today are limited to extracellular targets.  By contrast, cell-penetrating peptides (CPPs) can target intracellular proteins and also carry other cargoes (e.g. other peptides, small mols. or proteins) into the cell, thus offering great potential as future therapeutics.  In this review I present a classification scheme for CPPs based on their phys.-chem. properties and origin, and I provide a general framework for understanding and discovering new CPPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokvlaYLzhGQrVg90H21EOLACvtfcHk0ljsQgr-91t7WA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xltl2qsrc%253D&md5=b3a88bd00e9aa633937eedb488d24552</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26atitle%3DCell-penetrating%2520peptides%253A%2520classes%252C%2520origin%252C%2520and%2520current%2520landscape%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D850%26epage%3D860%26doi%3D10.1016%2Fj.drudis.2012.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pooga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">Classes of cell-penetrating peptides</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1324</i></span>,  <span class="NLM_fpage">3</span>â <span class="NLM_lpage">28</span>, <span class="refDoi">Â DOI: 10.1007/978-1-4939-2806-4_1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-4939-2806-4_1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=26202259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FlvVamsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1324&publication_year=2015&pages=3-28&author=M.+Poogaauthor=U.+Langel&title=Classes+of+cell-penetrating+peptides&doi=10.1007%2F978-1-4939-2806-4_1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Classes of Cell-Penetrating Peptides</span></div><div class="casAuthors">Pooga Margus; Langel Ulo</div><div class="citationInfo"><span class="NLM_cas:title">Methods in molecular biology (Clifton, N.J.)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1324</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3-28</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During the three decades of cell-penetrating peptides era the superfamily of CPPs has rapidly expanded, and the quest for new sequences continues.  CPPs have been well recognized by scientific community and they have been used for transduction of a wide variety of molecules and particles into cultured cells and in vivo.  In parallel with application of CPPs for delivering of active payloads, the mechanisms that such peptides take advantage of for gaining access to cells' insides have been in the focus of intense studies.  Although the common denominator "cell penetration" unites all CPPs, the interaction partners on the cell surface, evoked cellular responses and even the uptake mechanisms might greatly vary between different peptide types.  Here we present some possibilities for classification of CPPs based on their type of origin, physical-chemical properties, and the extent of modifications and design efforts.  We also briefly analyze the internalization mechanisms with regard to their classification into groups based on physical-chemical characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTODotqZ4D8gYJKJbLTgsvCfW6udTcc2eZFrFUqEgK7mbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FlvVamsQ%253D%253D&md5=04bf0a57fe57eae76555477a73ebc580</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-2806-4_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-2806-4_1%26sid%3Dliteratum%253Aachs%26aulast%3DPooga%26aufirst%3DM.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DClasses%2520of%2520cell-penetrating%2520peptides%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2015%26volume%3D1324%26spage%3D3%26epage%3D28%26doi%3D10.1007%2F978-1-4939-2806-4_1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LÃ¶nn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, S. F.</span></span> <span> </span><span class="NLM_article-title">Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell</span>. <i>Expert Opin. Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1627</span>â <span class="NLM_lpage">1636</span>, <span class="refDoi">Â DOI: 10.1517/17425247.2015.1046431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1517%2F17425247.2015.1046431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25994800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC2MfmtVOktA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=1627-1636&author=P.+L%C3%B6nnauthor=S.+F.+Dowdy&title=Cationic+PTD%2FCPP-mediated+macromolecular+delivery%3A+charging+into+the+cell&doi=10.1517%2F17425247.2015.1046431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell</span></div><div class="casAuthors">Lonn Peter; Dowdy Steven F; Lonn Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on drug delivery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1627-36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Macromolecular therapeutics, including enzymes, transcription factors, siRNAs, peptides and large synthetic molecules, can potentially be used to treat human diseases by targeting intracellular molecular pathways and modulating biological responses.  However, large macromolecules have no ability to enter cells and require delivery vehicles.  Protein transduction domains (PTDs), also known as cell-penetrating peptides (CPPs), are a diverse class of peptides that can deliver macromolecules into cells.  AREAS COVERED:  In this review, we cover the uptake and usage of arginine-rich PTDs/CPPs (TAT-PTD, Penetratin/Antp and 8R).  We review the endocytosis-mediated uptake of these peptides and highlight three important steps: i) cell association; ii) internalization and iii) endosomal escape.  We also discuss the array of different cargos that have been delivered by cationic PTDs/CPPs as well as cellular processes and biological responses that have been modulated.  EXPERT OPINION:  PTDs/CPPs have shown great potential to deliver otherwise undeliverable macromolecular therapeutics into cells for experimentation in cell culture and in animal disease models in vivo.  Moreover, over 25 clinical trials have been performed predominantly using the TAT-PTD.  However, more work is still needed.  Endosomal escape and target-cell specificity remain two of the major future challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHkdvjMpsQUAqdek-gHSrIfW6udTcc2eaEO1lWibmOH7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfmtVOktA%253D%253D&md5=23f45daeb40a68d82b7b33aebe41c097</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1517%2F17425247.2015.1046431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2015.1046431%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6nn%26aufirst%3DP.%26aulast%3DDowdy%26aufirst%3DS.%2BF.%26atitle%3DCationic%2520PTD%252FCPP-mediated%2520macromolecular%2520delivery%253A%2520charging%2520into%2520the%2520cell%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2015%26volume%3D12%26spage%3D1627%26epage%3D1636%26doi%3D10.1517%2F17425247.2015.1046431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker-Hapak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, S. F.</span></span> <span> </span><span class="NLM_article-title">TAT-mediated protein transduction into mammalian cells</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">247</span>â <span class="NLM_lpage">256</span>, <span class="refDoi">Â DOI: 10.1006/meth.2001.1186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1006%2Fmeth.2001.1186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11403574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkt1Kjsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=247-256&author=M.+Becker-Hapakauthor=S.+S.+McAllisterauthor=S.+F.+Dowdy&title=TAT-mediated+protein+transduction+into+mammalian+cells&doi=10.1006%2Fmeth.2001.1186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">TAT-mediated protein transduction into mammalian cells</span></div><div class="casAuthors">Becker-Hapak, Michelle; McAllister, Sandra S.; Dowdy, Steven F.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-256</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Manipulation of mammalian cells has been achieved by the transfection of expression vectors, microinjection, or diffusion of peptidyl mimetics.  While these approaches have been somewhat successful, the classic manipulation methods are not easily regulated and can be laborious.  One approach to circumvent these problems is the use of HIV TAT-mediated protein transduction.  Although this technol. was originally described in 1988, few improvements were reported in the subsequent 10 yr.  In the last few years, significant steps have been taken to advance this technol. into a broadly applicable method that allows for the rapid introduction of full-length proteins into primary and transformed cells.  The technol. requires the synthesis of a fusion protein, linking the TAT transduction domain to the mol. of interest using a bacterial expression vector, followed by the purifn. of this fusion protein under either sol. or denaturing conditions.  The purified fusion protein can be directly added to mammalian cell culture or injected in vivo into mice.  Protein transduction occurs in a concn.-dependent manner, achieving max. intracellular concns. in less than 5 min, with nearly equal intracellular concns. between all cells in the transduced population.  Full-length TAT fusion proteins have been used to address a no. of biol. questions, relating to cell cycle progression, apoptosis, and cellular architecture.  Described here are the fundamental requirements for the creation, isolation, and utilization of TAT-fusion proteins to affect mammalian cells.  A detailed protocol for prodn. and transduction of TAT-Cdc42 into primary cells is given to illustrate the technique.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobW7K39xtvULVg90H21EOLACvtfcHk0lgI0JNdVEEEyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkt1Kjsrk%253D&md5=8cf037588673b4d2930326b1a5f49954</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1006%2Fmeth.2001.1186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmeth.2001.1186%26sid%3Dliteratum%253Aachs%26aulast%3DBecker-Hapak%26aufirst%3DM.%26aulast%3DMcAllister%26aufirst%3DS.%2BS.%26aulast%3DDowdy%26aufirst%3DS.%2BF.%26atitle%3DTAT-mediated%2520protein%2520transduction%2520into%2520mammalian%2520cells%26jtitle%3DMethods%26date%3D2001%26volume%3D24%26spage%3D247%26epage%3D256%26doi%3D10.1006%2Fmeth.2001.1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadhwani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¼rck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berditsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schober, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brock, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich, A. S.</span></span> <span> </span><span class="NLM_article-title">Lactam-stapled cell-penetrating peptides: cell uptake and membrane binding properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8071</span>â <span class="NLM_lpage">8082</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00813</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00813" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFWjt7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8071-8082&author=M.+J.+Kleinauthor=S.+Schmidtauthor=P.+Wadhwaniauthor=J.+B%C3%BCrckauthor=J.+Reichertauthor=S.+Afoninauthor=M.+Berditschauthor=T.+Schoberauthor=R.+Brockauthor=M.+Kansyauthor=A.+S.+Ulrich&title=Lactam-stapled+cell-penetrating+peptides%3A+cell+uptake+and+membrane+binding+properties&doi=10.1021%2Facs.jmedchem.7b00813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties</span></div><div class="casAuthors">Klein, Marco J.; Schmidt, Samuel; Wadhwani, Parvesh; Buerck, Jochen; Reichert, Johannes; Afonin, Sergii; Berditsch, Marina; Schober, Tim; Brock, Roland; Kansy, Manfred; Ulrich, Anne S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8071-8082</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stapling of side chains to stabilize an Î±-helical structure has been generally assocd. with an increased uptake of CPPs.  Here, we compare four amphiphilic stapled peptides with their linear counterparts in terms of their membrane binding and conformational features in order to correlate these with uptake efficiency and toxicol. effects.  The impact of lactam stapling was found to vary strongly with regard to the different aspects of peptide-membrane interactions.  Nearly all stapled peptides caused less membrane perturbation (vesicle leakage, hemolysis, bacterial lysis) than their linear counterparts.  In one case (MAP-1) where stapling enhanced Î±-helicity in aq. and lipid environments, leakage was eliminated while cell uptake in HEK293 and HeLa cells remained high, which improved the overall characteristics.  The other systems (DRIM, WWSP, KFGF) did not improve, however.  The data suggest that cell uptake of amphipathic CPPs correlates with their adopted Î±-helix content in membranes rather than their helicity in soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxrP7UiuD6-LVg90H21EOLACvtfcHk0lgI0JNdVEEEyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFWjt7jK&md5=9cd212ed0548dd17f54e0def8b20bd39</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00813%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DM.%2BJ.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DWadhwani%26aufirst%3DP.%26aulast%3DB%25C3%25BCrck%26aufirst%3DJ.%26aulast%3DReichert%26aufirst%3DJ.%26aulast%3DAfonin%26aufirst%3DS.%26aulast%3DBerditsch%26aufirst%3DM.%26aulast%3DSchober%26aufirst%3DT.%26aulast%3DBrock%26aufirst%3DR.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DUlrich%26aufirst%3DA.%2BS.%26atitle%3DLactam-stapled%2520cell-penetrating%2520peptides%253A%2520cell%2520uptake%2520and%2520membrane%2520binding%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8071%26epage%3D8082%26doi%3D10.1021%2Facs.jmedchem.7b00813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathman, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothbard, J. B.</span></span> <span> </span><span class="NLM_article-title">Polyarginine enters cells more efficiently than other polycationic homopolymers</span>. <i>J. Pept. Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">318</span>â <span class="NLM_lpage">325</span>, <span class="refDoi">Â DOI: 10.1034/j.1399-3011.2000.00723.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1034%2Fj.1399-3011.2000.00723.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11095185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVGltbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2000&pages=318-325&author=D.+J.+Mitchellauthor=D.+T.+Kimauthor=L.+Steinmanauthor=C.+G.+Fathmanauthor=J.+B.+Rothbard&title=Polyarginine+enters+cells+more+efficiently+than+other+polycationic+homopolymers&doi=10.1034%2Fj.1399-3011.2000.00723.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Polyarginine enters cells more efficiently than other polycationic homopolymers</span></div><div class="casAuthors">Mitchell, D. J.; Kim, D. T.; Steinman, L.; Fathman, C. G.; Rothbard, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">318-325</span>CODEN:
                <span class="NLM_cas:coden">JPERFA</span>;
        ISSN:<span class="NLM_cas:issn">1397-002X</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">Homopolymers or peptides contg. a high percentage of cationic amino acids have been shown to have a unique ability to cross the plasma membrane of cells, and consequently have been used to facilitate the uptake of a variety of biopolymers and small mols.  To investigate whether the polycationic character of these mols., or some other structural feature, was the mol. basis for the effect, the ability of a variety of homopolymers to enter cells was assayed by confocal microscopy and flow cytometry.  Polymers of L- or D-arginine contg. six or more amino acids entered cells far more effectively than polymers of equal length composed of lysine, ornithine and histidine.  Peptides of fewer than six amino acids were ineffective.  The length of the arginine side-chain could be varied without significant loss of activity.  These data combined with the inability of polymers of citrulline to enter cells demonstrated that the guanidine headgroup of arginine was the crit. structural component responsible for the biol. activity.  Cellular uptake could be inhibited by pre-incubation of the cells with sodium azide, but not by low temp. (3Â°C), indicating that the process was energy dependent, but did not involve endocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDvbyXtDgX0rVg90H21EOLACvtfcHk0lj0wv8_pQyl1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVGltbY%253D&md5=f17351640273d66473f3a2f5e70e2f09</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1034%2Fj.1399-3011.2000.00723.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1399-3011.2000.00723.x%26sid%3Dliteratum%253Aachs%26aulast%3DMitchell%26aufirst%3DD.%2BJ.%26aulast%3DKim%26aufirst%3DD.%2BT.%26aulast%3DSteinman%26aufirst%3DL.%26aulast%3DFathman%26aufirst%3DC.%2BG.%26aulast%3DRothbard%26aufirst%3DJ.%2BB.%26atitle%3DPolyarginine%2520enters%2520cells%2520more%2520efficiently%2520than%2520other%2520polycationic%2520homopolymers%26jtitle%3DJ.%2520Pept.%2520Res.%26date%3D2000%26volume%3D56%26spage%3D318%26epage%3D325%26doi%3D10.1034%2Fj.1399-3011.2000.00723.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalafatovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giralt, E.</span></span> <span> </span><span class="NLM_article-title">Cell-penetrating peptides: design strategies beyond primary structure and amphipathicity</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1929</span>, <span class="refDoi">Â DOI: 10.3390/molecules22111929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.3390%2Fmolecules22111929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVGjtrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1929&issue=11&author=D.+Kalafatovicauthor=E.+Giralt&title=Cell-penetrating+peptides%3A+design+strategies+beyond+primary+structure+and+amphipathicity&doi=10.3390%2Fmolecules22111929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-penetrating peptides: design strategies beyond primary structure and amphipathicity</span></div><div class="casAuthors">Kalafatovic, Daniela; Giralt, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1929/1-1929/38</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Efficient intracellular drug delivery and target specificity are often hampered by the presence of biol. barriers.  Thus, compds. that efficiently cross cell membranes are the key to improving the therapeutic value and on-target specificity of non-permeable drugs.  The discovery of cell-penetrating peptides (CPPs) and the early design approaches through mimicking the natural penetration domains used by viruses have led to greater efficiency of intracellular delivery.  Following these nature-inspired examples, a no. of rationally designed CPPs has been developed.  In this review, a variety of CPP designs will be described, including linear and flexible, pos. charged and often amphipathic CPPs, and more rigid versions comprising cyclic, stapled, or dimeric and/or multivalent, self-assembled peptides or peptido-mimetics.  The application of distinct design strategies to known physico-chem. properties of CPPs offers the opportunity to improve their penetration efficiency and/or internalization kinetics.  This led to increased design complexity of new CPPs that does not always result in greater CPP activity.  Therefore, the transition of CPPs to a clin. setting remains a challenge also due to the concomitant involvement of various internalization routes and heterogeneity of cells used in the in vitro studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXVMiu0WvRi7Vg90H21EOLACvtfcHk0lj0wv8_pQyl1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVGjtrY%253D&md5=cde796080669da1abb1bd06fd1ed57a5</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22111929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22111929%26sid%3Dliteratum%253Aachs%26aulast%3DKalafatovic%26aufirst%3DD.%26aulast%3DGiralt%26aufirst%3DE.%26atitle%3DCell-penetrating%2520peptides%253A%2520design%2520strategies%2520beyond%2520primary%2520structure%2520and%2520amphipathicity%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26issue%3D11%26spage%3D1929%26doi%3D10.3390%2Fmolecules22111929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Multifunctional pH-sensitive micelles for tumor-specific uptake and cellular delivery</span>. <i>Polym. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1373</span>â <span class="NLM_lpage">1382</span>, <span class="refDoi">Â DOI: 10.1039/C4PY01403K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2FC4PY01403K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSitr7N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1373-1382&author=T.+Yangauthor=F.+Liauthor=H.+Zhangauthor=L.+Fanauthor=Y.+Qiaoauthor=G.+Tanauthor=H.+Zhangauthor=H.+Wu&title=Multifunctional+pH-sensitive+micelles+for+tumor-specific+uptake+and+cellular+delivery&doi=10.1039%2FC4PY01403K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional pH-sensitive micelles for tumor-specific uptake and cellular delivery</span></div><div class="casAuthors">Yang, Tiehong; Li, Fei; Zhang, Haitao; Fan, Li; Qiao, Youbei; Tan, Guangguo; Zhang, Haifei; Wu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Polymer Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1373-1382</span>CODEN:
                <span class="NLM_cas:coden">PCOHC2</span>;
        ISSN:<span class="NLM_cas:issn">1759-9962</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The distinct ability of cell-penetrating peptides (CPPs) has led to the development of novel drug delivery methods in human cells for therapeutic purposes.  The lack of specific selectivity is a main obstacle to the widespread use of CPPs.  A novel delivery method based on acid-sensitive micelles used for the introduction and protection of TAT was developed.  Doxorubicin-TAT conjugate (Dox-TAT) was loaded in the LH-releasing hormone modified poly (ethylene glycol)-poly (L-histidine)-doxorubicin (LHRH-PEG-PHIS-Dox) micelle.  Dox was chem. conjugated to the polymer backbone not only to improve the stability of micelles, but also to increase the drug loading efficiency of the micelle.  These micelles could dissoc. the responding tumor extracellular pHe and release Dox-TAT to pass directly through the cell membrane to the cytosol of the multidrug resistant cancer cells.  The undissociated micelles could also be actively internalized into the cells by receptor-mediated endocytosis, resulting in high cytotoxicity.  LHRH-PEG-PHIS-Dox/Dox-TAT showed the highest antitumor effects among the 4 treatment groups in vitro and vivo and showed no remarkable effect on the body wt. compared to the control.  This skillfully designed system combined the double functions of targeted delivery and TAT-mediated efficient entry, which could increase the antitumor activity, even in drug resistant tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopRWvv29el1rVg90H21EOLACvtfcHk0lj0wv8_pQyl1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSitr7N&md5=d91fafa26fb6aadc18237183d3cea230</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1039%2FC4PY01403K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4PY01403K%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DMultifunctional%2520pH-sensitive%2520micelles%2520for%2520tumor-specific%2520uptake%2520and%2520cellular%2520delivery%26jtitle%3DPolym.%2520Chem.%26date%3D2015%26volume%3D6%26spage%3D1373%26epage%3D1382%26doi%3D10.1039%2FC4PY01403K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhunia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohapatra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span> <span> </span><span class="NLM_article-title">Spatial position regulates power of tryptophan: discovery of a major-groove-specific nuclear-localizing, cell-penetrating tetrapeptide</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">1697</span>â <span class="NLM_lpage">1714</span>, <span class="refDoi">Â DOI: 10.1021/jacs.7b10254</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b10254" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVCms73M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=1697-1714&author=D.+Bhuniaauthor=P.+Mondalauthor=G.+Dasauthor=A.+Sahaauthor=P.+Senguptaauthor=J.+Janaauthor=S.+Mohapatraauthor=S.+Chatterjeeauthor=S.+Ghosh&title=Spatial+position+regulates+power+of+tryptophan%3A+discovery+of+a+major-groove-specific+nuclear-localizing%2C+cell-penetrating+tetrapeptide&doi=10.1021%2Fjacs.7b10254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Spatial Position Regulates Power of Tryptophan: Discovery of a Major-Groove-Specific Nuclear-Localizing, Cell-Penetrating Tetrapeptide</span></div><div class="casAuthors">Bhunia, Debmalya; Mondal, Prasenjit; Das, Gaurav; Saha, Abhijit; Sengupta, Pallabi; Jana, Jagannath; Mohapatra, Saswat; Chatterjee, Subhrangsu; Ghosh, Surajit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1697-1714</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Identification of key amino acids is required for development of efficient cell-penetrating peptides (CPPs) and has tremendous implications in medicine.  Extensive research work has enlightened us about the importance of two amino acids, arginine and tryptophan, in cell penetration.  Here, we present a top-down approach to show how spatial positions of two tryptophan regulate the cellular entry and nuclear localization.  This enables us to develop short, non-toxic tetrapeptides with excellent potential for cell penetration and nuclear localization.  Among them, Glu-Thr-Trp-Trp (ETWW) emerges as the most promising.  Results suggest that it enters into cancer cells following an endocytic pathway and binds at the major groove of nuclear DNA, where successive tryptophan plays major role.  We subsequently show that it is not a P-glycoprotein substrate and is non-toxic to PC12-derived neurons, suggesting its excellent potential as a CPP.  Furthermore, its potential as a CPP is validated in multi-cellular 3D cell culture (spheroid) and in in vivo mice model.  This study provides major fundamental insights about the positional importance of tryptophan and opens new avenues toward the development of next-generation CPPs and major-groove-specific anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNpbOr7U6DZrVg90H21EOLACvtfcHk0lhNQMDP2Nb4gQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVCms73M&md5=6bf318f4ce47228b74c9325820424673</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b10254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b10254%26sid%3Dliteratum%253Aachs%26aulast%3DBhunia%26aufirst%3DD.%26aulast%3DMondal%26aufirst%3DP.%26aulast%3DDas%26aufirst%3DG.%26aulast%3DSaha%26aufirst%3DA.%26aulast%3DSengupta%26aufirst%3DP.%26aulast%3DJana%26aufirst%3DJ.%26aulast%3DMohapatra%26aufirst%3DS.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DS.%26atitle%3DSpatial%2520position%2520regulates%2520power%2520of%2520tryptophan%253A%2520discovery%2520of%2520a%2520major-groove-specific%2520nuclear-localizing%252C%2520cell-penetrating%2520tetrapeptide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26spage%3D1697%26epage%3D1714%26doi%3D10.1021%2Fjacs.7b10254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez-Berrocal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebel-Binay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebollo, A.</span></span> <span> </span><span class="NLM_article-title">New therapeutic approach for targeting Hippo signaling pathway</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">4771</span>, <span class="refDoi">Â DOI: 10.1038/s41598-019-41404-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fs41598-019-41404-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30886324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BB3cbls1aisg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=4771&issue=1&author=L.+Dominguez-Berrocalauthor=E.+Cirriauthor=X.+Zhangauthor=L.+Andriniauthor=G.+H.+Marinauthor=S.+Lebel-Binayauthor=A.+Rebollo&title=New+therapeutic+approach+for+targeting+Hippo+signaling+pathway&doi=10.1038%2Fs41598-019-41404-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">New Therapeutic Approach for Targeting Hippo Signalling Pathway</span></div><div class="casAuthors">Dominguez-Berrocal Leticia; Cirri Erica; Lebel-Binay Sophie; Zhang Xiguang; Rebollo Angelita; Andrini Laura; Marin Gustavo H</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4771</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nuclear localization signals are short amino acid sequences that target proteins for nuclear import.  In this manuscript, we have generated a chimeric tri-functional peptide composed of a cell penetrating peptide (CPP), a nuclear localization sequence and an interfering peptide blocking the interaction between TEAD and YAP, two transcription factors involved in the Hippo signalling pathway, whose deregulation is related to several types of cancer.  We have validated the cell penetration and nuclear localization by flow cytometry and fluorescence microscopy and shown that the new generated peptide displays an apoptotic effect in tumor cell lines thanks to the specific nuclear delivery of the cargo, which targets a protein/protein interaction in the nucleus.  In addition, the peptide has an anti-tumoral effect in vivo in xenograft models of breast cancer.  The chimeric peptide designed in the current study shows encouraging prospects for developing nuclear anti- neoplastic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0QQqyEO8ni6__Jf7-eMvJfW6udTcc2eZ9t19isv_2Dbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbls1aisg%253D%253D&md5=e5e3fe64f71051dcfa5607a2426f65fb</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-41404-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-41404-w%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez-Berrocal%26aufirst%3DL.%26aulast%3DCirri%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAndrini%26aufirst%3DL.%26aulast%3DMarin%26aufirst%3DG.%2BH.%26aulast%3DLebel-Binay%26aufirst%3DS.%26aulast%3DRebollo%26aufirst%3DA.%26atitle%3DNew%2520therapeutic%2520approach%2520for%2520targeting%2520Hippo%2520signaling%2520pathway%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D4771%26doi%3D10.1038%2Fs41598-019-41404-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Veiman, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mager, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurrikoff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arukuusk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhorutsenko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pooga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, Ã.</span></span> <span> </span><span class="NLM_article-title">PepFect14 peptide vector for efficient gene delivery in cell cultures</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">199</span>â <span class="NLM_lpage">210</span>, <span class="refDoi">Â DOI: 10.1021/mp3003557</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp3003557" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslemu7bP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=199-210&author=K.+L.+Veimanauthor=I.+Magerauthor=K.+Ezzatauthor=H.+Margusauthor=T.+Lehtoauthor=K.+Langelauthor=K.+Kurrikoffauthor=P.+Arukuuskauthor=J.+Suhorutsenkoauthor=K.+Padariauthor=M.+Poogaauthor=T.+Lehtoauthor=%C3%9C.+Langel&title=PepFect14+peptide+vector+for+efficient+gene+delivery+in+cell+cultures&doi=10.1021%2Fmp3003557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88aR"><div class="casContent"><span class="casTitleNuber">88a</span><div class="casTitle"><span class="NLM_cas:atitle">PepFect14 Peptide Vector for Efficient Gene Delivery in Cell Cultures</span></div><div class="casAuthors">Veiman, Kadi-Liis; Mager, Imre; Ezzat, Kariem; Margus, Helerin; Lehto, Tonis; Langel, Kent; Kurrikoff, Kaido; Arukuusk, Piret; Suhorutsenko, Julia; Padari, Kart; Pooga, Margus; Lehto, Taavi; Langel, Ulo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-210</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The successful applicability of gene therapy approaches will heavily rely on the development of efficient and safe nonviral gene delivery vectors, for example, cell-penetrating peptides (CPPs).  CPPs can condense oligonucleotides and plasmid DNA (pDNA) into nanoparticles, thus allowing the transfection of genetic material into cells.  However, despite few promising attempts, CPP-mediated pDNA delivery has been relatively inefficient due to the unfavorable nanoparticle characteristics or the nanoparticle entrapment to endocytic compartments.  In many cases, both of these drawbacks could be alleviated by modifying CPPs with a stearic acid residue, as demonstrated in the delivery of both the pDNA and the short oligonucleotides.  In this study, PepFect14 (PF14) peptide, previously used for the transport of shorter oligonucleotides, is demonstrated to be suited also for the delivery of pDNA.  It is shown that PF14 forms stable nanoparticles with pDNA with a neg. surface charge and size of around 130-170 nm.  These nanoparticles facilitate efficient gene delivery and expression in a variety of regular adherent cell lines and also in difficult-to-transfect primary cells.  Uptake studies indicate that PF14/pDNA nanoparticles are utilizing class A scavenger receptors (SCARA) and caveolae-mediated endocytosis as the main route for cellular internalization.  Conclusively, PF14 is an efficient nonviral vector for gene delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVJFF3VBLZIrVg90H21EOLACvtfcHk0lhNQMDP2Nb4gQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslemu7bP&md5=76ca152e87152d037613e228df76d4ba</span></div><a href="/servlet/linkout?suffix=cit88a&amp;dbid=16384&amp;doi=10.1021%2Fmp3003557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp3003557%26sid%3Dliteratum%253Aachs%26aulast%3DVeiman%26aufirst%3DK.%2BL.%26aulast%3DMager%26aufirst%3DI.%26aulast%3DEzzat%26aufirst%3DK.%26aulast%3DMargus%26aufirst%3DH.%26aulast%3DLehto%26aufirst%3DT.%26aulast%3DLangel%26aufirst%3DK.%26aulast%3DKurrikoff%26aufirst%3DK.%26aulast%3DArukuusk%26aufirst%3DP.%26aulast%3DSuhorutsenko%26aufirst%3DJ.%26aulast%3DPadari%26aufirst%3DK.%26aulast%3DPooga%26aufirst%3DM.%26aulast%3DLehto%26aufirst%3DT.%26aulast%3DLangel%26aufirst%3D%25C3%259C.%26atitle%3DPepFect14%2520peptide%2520vector%2520for%2520efficient%2520gene%2520delivery%2520in%2520cell%2520cultures%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D199%26epage%3D210%26doi%3D10.1021%2Fmp3003557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit88b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Andaloussi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaghloul, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magdy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guterstam, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sillard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arzumanov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gait, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">HÃ¤llbrink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, Ã.</span></span> <span> </span><span class="NLM_article-title">PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5284</span>â <span class="NLM_lpage">5298</span>, <span class="refDoi">Â DOI: 10.1093/nar/gkr072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1093%2Fnar%2Fgkr072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=21345932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslOgtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=5284-5298&issue=12&author=K.+Ezzatauthor=S.+El+Andaloussiauthor=E.+M.+Zaghloulauthor=T.+Lehtoauthor=S.+Lindbergauthor=P.+M.+Morenoauthor=J.+R.+Violaauthor=T.+Magdyauthor=R.+Abdoauthor=P.+Guterstamauthor=R.+Sillardauthor=S.+M.+Hammondauthor=M.+J.+Woodauthor=A.+A.+Arzumanovauthor=M.+J.+Gaitauthor=C.+I.+Smithauthor=M.+H%C3%A4llbrinkauthor=%C3%9C.+Langel&title=PepFect+14%2C+a+novel+cell-penetrating+peptide+for+oligonucleotide+delivery+in+solution+and+as+solid+formulation&doi=10.1093%2Fnar%2Fgkr072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88bR"><div class="casContent"><span class="casTitleNuber">88b</span><div class="casTitle"><span class="NLM_cas:atitle">PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation</span></div><div class="casAuthors">Ezzat, Kariem; El Andaloussi, Samir; Zaghloul, Eman M.; Lehto, Taavi; Lindberg, Staffan; Moreno, Pedro M. D.; Viola, Joana R.; Magdy, Tarek; Abdo, Rania; Guterstam, Peter; Sillard, Rannar; Hammond, Suzan M.; Wood, Matthew J. A.; Arzumanov, Andrey A.; Gait, Michael J.; Smith, C. I. Edvard; Haellbrink, Mattias; Langel, Uelo</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5284-5298</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Numerous human genetic diseases are caused by mutations that give rise to aberrant alternative splicing.  Recently, several of these debilitating disorders have been shown to be amenable for splice-correcting oligonucleotides (SCOs) that modify splicing patterns and restore the phenotype in exptl. models.  However, translational approaches are required to transform SCOs into usable drug products.  In this study, we present a new cell-penetrating peptide, PepFect14 (PF14), which efficiently delivers SCOs to different cell models including HeLa pLuc705 and mdx mouse myotubes; a cell culture model of Duchenne's muscular dystrophy (DMD).  Non-covalent PF14-SCO nanocomplexes induce splice-correction at rates higher than the com. available lipid-based vector Lipofectamine 2000 (LF2000) and remain active in the presence of serum.  Furthermore, we demonstrate the feasibility of incorporating this delivery system into solid formulations that could be suitable for several therapeutic applications.  Solid dispersion technique is utilized and the formed solid formulations are as active as the freshly prepd. nanocomplexes in soln. even when stored at an elevated temps. for several weeks.  In contrast, LF2000 drastically loses activity after being subjected to same procedure.  This shows that using PF14 is a very promising translational approach for the delivery of SCOs in different pharmaceutical forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoamzA5Sq7uFrVg90H21EOLACvtfcHk0lig5WJIejHfQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslOgtbw%253D&md5=64e66305efb772c25386977d53802340</span></div><a href="/servlet/linkout?suffix=cit88b&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkr072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkr072%26sid%3Dliteratum%253Aachs%26aulast%3DEzzat%26aufirst%3DK.%26aulast%3DEl%2BAndaloussi%26aufirst%3DS.%26aulast%3DZaghloul%26aufirst%3DE.%2BM.%26aulast%3DLehto%26aufirst%3DT.%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DMoreno%26aufirst%3DP.%2BM.%26aulast%3DViola%26aufirst%3DJ.%2BR.%26aulast%3DMagdy%26aufirst%3DT.%26aulast%3DAbdo%26aufirst%3DR.%26aulast%3DGuterstam%26aufirst%3DP.%26aulast%3DSillard%26aufirst%3DR.%26aulast%3DHammond%26aufirst%3DS.%2BM.%26aulast%3DWood%26aufirst%3DM.%2BJ.%26aulast%3DArzumanov%26aufirst%3DA.%2BA.%26aulast%3DGait%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BI.%26aulast%3DH%25C3%25A4llbrink%26aufirst%3DM.%26aulast%3DLangel%26aufirst%3D%25C3%259C.%26atitle%3DPepFect%252014%252C%2520a%2520novel%2520cell-penetrating%2520peptide%2520for%2520oligonucleotide%2520delivery%2520in%2520solution%2520and%2520as%2520solid%2520formulation%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26issue%3D12%26spage%3D5284%26epage%3D5298%26doi%3D10.1093%2Fnar%2Fgkr072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmfors, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudoran, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juks, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Andaloussi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pooga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1172</span>â <span class="NLM_lpage">1180</span>, <span class="refDoi">Â DOI: 10.1096/fj.11-191536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1096%2Ffj.11-191536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22138034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt12ntLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1172-1180&author=K.+Ezzatauthor=H.+Helmforsauthor=O.+Tudoranauthor=C.+Juksauthor=S.+Lindbergauthor=K.+Padariauthor=S.+El-Andaloussiauthor=M.+Poogaauthor=U.+Langel&title=Scavenger+receptor-mediated+uptake+of+cell-penetrating+peptide+nanocomplexes+with+oligonucleotides&doi=10.1096%2Ffj.11-191536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89aR"><div class="casContent"><span class="casTitleNuber">89a</span><div class="casTitle"><span class="NLM_cas:atitle">Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides</span></div><div class="casAuthors">Ezzat, Kariem; Helmfors, Henrik; Tudoran, Oana; Juks, Carmen; Lindberg, Staffan; Padari, Kaert; El-Andaloussi, Samir; Pooga, Margus; Langel, Ulo</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1172-1180, 10.1096/fj.11-191536</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Cell-penetrating peptides (CPPs) are short cationic peptides that penetrate cells by interacting with the neg. charged plasma membrane; however, the detailed uptake mechanism is not clear.  In contrary to the conventional mode of action of CPPs, we show here that a CPP, PepFect14 (PF14), forms neg. charged nanocomplexes with oligonucleotides and their uptake is mediated by class-A scavenger receptors (SCARAs).  Specific inhibitory ligands of SCARAs, such as fucoidin, polyinosinic acid, and dextran sulfate, totally inhibit the activity of PF14-oligonucleotide nanocomplexes in the HeLa pLuc705 splice-correction cell model, while nonspecific, chem. related mols. do not.  Furthermore, RNA interference (RNAi) knockdown of SCARA subtypes (SCARA3 and SCARA5) that are expressed in this cell line led to a significant redn. of the activity to <50%.  In line with this, immunostaining shows prevalent colocalization of the nanocomplexes with the receptors, and electron microscopy images show no binding or internalization of the nanocomplexes in the presence of the inhibitory ligands.  Interestingly, naked oligonucleotides also colocalize with SCARAs when used at high concns.  These results demonstrate the involvement of SCARA3 and SCARA5 in the uptake of PF14-oligonucleotide nanocomplexes and suggest for the first time that some CPP-based systems function through scavenger receptors, which could yield novel possibilities to understand and improve the transfection by CPPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8-lZu5xJLF7Vg90H21EOLACvtfcHk0lig5WJIejHfQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt12ntLg%253D&md5=552bb91ce3e35694a212893d5d12ea34</span></div><a href="/servlet/linkout?suffix=cit89a&amp;dbid=16384&amp;doi=10.1096%2Ffj.11-191536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.11-191536%26sid%3Dliteratum%253Aachs%26aulast%3DEzzat%26aufirst%3DK.%26aulast%3DHelmfors%26aufirst%3DH.%26aulast%3DTudoran%26aufirst%3DO.%26aulast%3DJuks%26aufirst%3DC.%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DPadari%26aufirst%3DK.%26aulast%3DEl-Andaloussi%26aufirst%3DS.%26aulast%3DPooga%26aufirst%3DM.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DScavenger%2520receptor-mediated%2520uptake%2520of%2520cell-penetrating%2520peptide%2520nanocomplexes%2520with%2520oligonucleotides%26jtitle%3DFASEB%2520J.%26date%3D2012%26volume%3D26%26spage%3D1172%26epage%3D1180%26doi%3D10.1096%2Ffj.11-191536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit89b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MuÃ±oz-AlarcÃ³n, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmfors, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosqueira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyllborg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tudoran, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>441</i></span>,  <span class="NLM_fpage">242</span>â <span class="NLM_lpage">247</span>, <span class="refDoi">Â DOI: 10.1016/j.ijpharm.2012.11.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.ijpharm.2012.11.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23200958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVWju7zO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2013&pages=242-247&author=S.+Lindbergauthor=A.+Mu%C3%B1oz-Alarc%C3%B3nauthor=H.+Helmforsauthor=D.+Mosqueiraauthor=D.+Gyllborgauthor=O.+Tudoranauthor=U.+Langel&title=PepFect15%2C+a+novel+endosomolytic+cell-penetrating+peptide+for+oligonucleotide+delivery+via+scavenger+receptors&doi=10.1016%2Fj.ijpharm.2012.11.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89bR"><div class="casContent"><span class="casTitleNuber">89b</span><div class="casTitle"><span class="NLM_cas:atitle">PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors</span></div><div class="casAuthors">Lindberg, Staffan; Munoz-Alarcon, Andres; Helmfors, Henrik; Mosqueira, Diogo; Gyllborg, Daniel; Tudoran, Oana; Langel, Ulo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">441</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">242-247</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Gene-regulatory biomols. such as splice-correcting oligonucleotides and anti-microRNA oligonucleotides are important tools in the struggle to understand and treat genetic disorders caused by defective gene expression or aberrant splicing.  However, oligonucleotides generally suffer from low bioavailability, hence requiring efficient and non-toxic delivery vectors to reach their targets.  Cell-penetrating peptides constitute a promising category of carrier mols. for intracellular delivery of bioactive cargo.  In this study we present a novel cell-penetrating peptide, PepFect15, comprising the previously reported PepFect14 peptide modified with endosomolytic trifluoromethylquinoline moieties to facilitate endosomal escape.  Pepfect15 efficiently delivers both splice-correcting oligonucleotides and anti-microRNA oligonucleotides into cells through a non-covalent complexation strategy.  To our knowledge this is the first work that describes peptide-mediated anti-microRNA delivery.  The peptide and its cargo form stable, neg. charged nanoparticles that are taken up by cells largely through scavenger receptor type A mediated endocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdGDuD_mlcKLVg90H21EOLACvtfcHk0lig5WJIejHfQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVWju7zO&md5=e6a081f1ee6e2d46c0f15027c8c62cf1</span></div><a href="/servlet/linkout?suffix=cit89b&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2012.11.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2012.11.037%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DMu%25C3%25B1oz-Alarc%25C3%25B3n%26aufirst%3DA.%26aulast%3DHelmfors%26aufirst%3DH.%26aulast%3DMosqueira%26aufirst%3DD.%26aulast%3DGyllborg%26aufirst%3DD.%26aulast%3DTudoran%26aufirst%3DO.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DPepFect15%252C%2520a%2520novel%2520endosomolytic%2520cell-penetrating%2520peptide%2520for%2520oligonucleotide%2520delivery%2520via%2520scavenger%2520receptors%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2013%26volume%3D441%26spage%3D242%26epage%3D247%26doi%3D10.1016%2Fj.ijpharm.2012.11.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helmfors, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Alarcon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srimanee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langel, U.</span></span> <span> </span><span class="NLM_article-title">A convergent uptake route for peptide- and polymer-based nucleotide delivery systems</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>206</i></span>,  <span class="NLM_fpage">58</span>â <span class="NLM_lpage">66</span>, <span class="refDoi">Â DOI: 10.1016/j.jconrel.2015.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.jconrel.2015.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25769688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVahu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2015&pages=58-66&author=S.+Lindbergauthor=J.+Regbergauthor=J.+Erikssonauthor=H.+Helmforsauthor=A.+Munoz-Alarconauthor=A.+Srimaneeauthor=R.+A.+Figueroaauthor=E.+Hallbergauthor=K.+Ezzatauthor=U.+Langel&title=A+convergent+uptake+route+for+peptide-+and+polymer-based+nucleotide+delivery+systems&doi=10.1016%2Fj.jconrel.2015.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">A convergent uptake route for peptide- and polymer-based nucleotide delivery systems</span></div><div class="casAuthors">Lindberg, Staffan; Regberg, Jakob; Eriksson, Jonas; Helmfors, Henrik; Munoz-Alarcon, Andres; Srimanee, Artita; Figueroa, Ricardo A.; Hallberg, Einar; Ezzat, Kariem; Langel, Ulo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">58-66</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cell-penetrating peptides (CPPs) have been used as vehicles to deliver various cargos into cells and are promising as tools to deliver therapeutic biomols. such as oligonucleotides both in vitro and in vivo.  CPPs are pos. charged and it is believed that CPPs deliver their cargo in a receptor-independent manner by interacting with the neg. charged plasma membrane and thereby inducing endocytosis.  In this study we examine the mechanism of uptake of several different, well known, CPPs that form complexes with oligonucleotides.  We show that these CPP:oligonucleotide complexes are neg. charged in transfection-media and their uptake is mediated by class A scavenger receptors (SCARA).  These receptors are known to promiscuously bind to, and mediate uptake of poly-anionic macromols.  Uptake of CPP:oligonucleotide complexes was abolished using pharmacol. SCARA inhibitors as well as siRNA-mediated knockdown of SCARA.  Addnl., uptake of CPP:oligonucleotide was significantly increased by transiently overexpressing SCARA.  Furthermore, SCARA inhibitors also blocked internalization of cationic polymer:oligonucleotide complexes.  Our results demonstrate that the previous held belief that CPPs act receptor independently does not hold true for CPP:oligonucleotide complexes, as scavenger receptor class A (SCARA) mediates the uptake of all the examd. CPP:oligonucleotide complexes in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI3Fl4rEfn7rVg90H21EOLACvtfcHk0lhW9wlO_UiQ6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVahu7o%253D&md5=1c1a1e52b01f8a47087b18518e5e7654</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2015.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2015.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DRegberg%26aufirst%3DJ.%26aulast%3DEriksson%26aufirst%3DJ.%26aulast%3DHelmfors%26aufirst%3DH.%26aulast%3DMunoz-Alarcon%26aufirst%3DA.%26aulast%3DSrimanee%26aufirst%3DA.%26aulast%3DFigueroa%26aufirst%3DR.%2BA.%26aulast%3DHallberg%26aufirst%3DE.%26aulast%3DEzzat%26aufirst%3DK.%26aulast%3DLangel%26aufirst%3DU.%26atitle%3DA%2520convergent%2520uptake%2520route%2520for%2520peptide-%2520and%2520polymer-based%2520nucleotide%2520delivery%2520systems%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2015%26volume%3D206%26spage%3D58%26epage%3D66%26doi%3D10.1016%2Fj.jconrel.2015.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Craig, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuckey, N. W.</span></span> <span> </span><span class="NLM_article-title">Attenuation of neuronal death by peptide inhibitors of AP-1 activation in acute and delayed in vitro ischaemia (oxygen/glucose deprivation) models</span>. <i>Int. J. Pept. Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">6</span>, <span class="refDoi">Â DOI: 10.1007/s10989-010-9234-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs10989-010-9234-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKltbzE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1-6&author=A.+J.+Craigauthor=B.+P.+Meloniauthor=P.+M.+Wattauthor=N.+W.+Knuckey&title=Attenuation+of+neuronal+death+by+peptide+inhibitors+of+AP-1+activation+in+acute+and+delayed+in+vitro+ischaemia+%28oxygen%2Fglucose+deprivation%29+models&doi=10.1007%2Fs10989-010-9234-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of Neuronal Death by Peptide Inhibitors of AP-1 Activation in Acute and Delayed In Vitro Ischaemia (Oxygen/Glucose Deprivation) Models</span></div><div class="casAuthors">Craig, Amanda J.; Meloni, Bruno P.; Watt, Paul; Knuckey, Neville W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Peptide Research and Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">IJPRFC</span>;
        ISSN:<span class="NLM_cas:issn">1573-3149</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Using acute and delayed in vitro ischemia models we evaluated the neuroprotective efficacy of five peptides (PYC19D-TAT, PYC35D-TAT, PYC36D-TAT, PYC38D-TAT, PYC41D-TAT) previously demonstrated to down-regulate AP-1 activation (e.g. c-Jun/c-Fos activation), and inhibit neuronal death in vitro following glutamate and kainic acid excitotoxicity.  The JNK inhibitor peptide (JNKI-1D-TAT) and the TAT cell-penetrating-carrier peptide (D-TAT) were used as controls.  In the acute model, all five AP-1 inhibitory peptides, JNKI-1D-TAT, and D-TAT provided neuroprotection by increasing neuronal viability from â5 to 23-53%.  In the delayed model, three of the five AP-1 inhibitory peptides (PYC35D-TAT, PYC36D-TAT, PYC38D-TAT) and JNKI-1D-TAT provided neuroprotection by increasing neuronal viability from â10 to 35-80%.  This study not only highlights a group of peptides with therapeutic potential, but also the need to assess putative therapeutics in multiple in vitro models to achieve a comprehensive representation of their neuroprotective capacity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXA0B2gepsjrVg90H21EOLACvtfcHk0lhW9wlO_UiQ6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKltbzE&md5=b311025351457862bdd1f74a3336ff58</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1007%2Fs10989-010-9234-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10989-010-9234-8%26sid%3Dliteratum%253Aachs%26aulast%3DCraig%26aufirst%3DA.%2BJ.%26aulast%3DMeloni%26aufirst%3DB.%2BP.%26aulast%3DWatt%26aufirst%3DP.%2BM.%26aulast%3DKnuckey%26aufirst%3DN.%2BW.%26atitle%3DAttenuation%2520of%2520neuronal%2520death%2520by%2520peptide%2520inhibitors%2520of%2520AP-1%2520activation%2520in%2520acute%2520and%2520delayed%2520in%2520vitro%2520ischaemia%2520%2528oxygen%252Fglucose%2520deprivation%2529%2520models%26jtitle%3DInt.%2520J.%2520Pept.%2520Res.%2520Ther.%26date%3D2011%26volume%3D17%26spage%3D1%26epage%3D6%26doi%3D10.1007%2Fs10989-010-9234-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaslin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puyal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P. G.</span></span> <span> </span><span class="NLM_article-title">Excitotoxicity-induced endocytosis confers drug targeting in cerebral ischemia</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">337</span>â <span class="NLM_lpage">347</span>, <span class="refDoi">Â DOI: 10.1002/ana.21584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fana.21584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=19334077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BD1M3lvVCjtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=337-347&author=A.+Vaslinauthor=J.+Puyalauthor=P.+G.+Clarke&title=Excitotoxicity-induced+endocytosis+confers+drug+targeting+in+cerebral+ischemia&doi=10.1002%2Fana.21584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Excitotoxicity-induced endocytosis confers drug targeting in cerebral ischemia</span></div><div class="casAuthors">Vaslin Anne; Puyal Julien; Clarke Peter G H</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">337-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Targeting neuroprotectants specifically to the cells that need them is a major goal in biomedical research.  Many peptidic protectants contain an active sequence linked to a carrier such as the transactivator of transcription (TAT) transduction sequence, and here we test the hypothesis that TAT-linked peptides are selectively endocytosed into neurons stressed by excitotoxicity and focal cerebral ischemia.  METHODS:  In vivo experiments involved intracerebroventricular injection of TAT peptides or conventional tracers (peroxidase, fluorescein isothiocyanate-dextran) in young rats exposed to occlusion of the middle cerebral artery at postnatal day 12.  Cellular mechanisms of uptake were analyzed in dissociated cortical neuronal cultures.  RESULTS:  In both models, all tracers were taken up selectively into stressed neurons by endocytosis.  In the in vivo model, this was neuron specific and limited to the ischemic area, where the neurons displayed enhanced immunolabeling for early endosomal antigen-1 and clathrin.  The highly efficient uptake of TAT peptides occurred by the same selective mechanism as for conventional tracers.  All tracers were targeted to the nucleus and cytoplasm of neurons that appeared viable, although ultimately destined to die.  In dissociated cortical neuronal cultures, an excitotoxic dose of N-methyl-D-aspartate induced a similar endocytosis.  It was 100 times more efficient with TAT peptides than with dextran, because the former bound to heparan sulfate proteoglycans at the cell surface, but it depended on dynamin and clathrin in both cases.  INTERPRETATION:  Excitotoxicity-induced endocytosis is the main entry route for protective TAT peptides and targets selectively the neurons that need to be protected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBbvFEgSBPZbqxQ2mb9Pu8fW6udTcc2eYkgtQMU1MQ2Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3lvVCjtQ%253D%253D&md5=2e3666075098f275fcd6d2c35f42ba80</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2Fana.21584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21584%26sid%3Dliteratum%253Aachs%26aulast%3DVaslin%26aufirst%3DA.%26aulast%3DPuyal%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DP.%2BG.%26atitle%3DExcitotoxicity-induced%2520endocytosis%2520confers%2520drug%2520targeting%2520in%2520cerebral%2520ischemia%26jtitle%3DAnn.%2520Neurol.%26date%3D2009%26volume%3D65%26spage%3D337%26epage%3D347%26doi%3D10.1002%2Fana.21584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meloni, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookes, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knuckey, N. W.</span></span> <span> </span><span class="NLM_article-title">Poly-arginine and arginine-rich peptides are neuroprotective in stroke models</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">993</span>â <span class="NLM_lpage">1004</span>, <span class="refDoi">Â DOI: 10.1038/jcbfm.2015.11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fjcbfm.2015.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25669902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisVyjt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=993-1004&author=B.+P.+Meloniauthor=L.+M.+Brookesauthor=V.+W.+Clarkauthor=J.+L.+Crossauthor=A.+B.+Edwardsauthor=R.+S.+Andertonauthor=R.+M.+Hopkinsauthor=K.+Hoffmannauthor=N.+W.+Knuckey&title=Poly-arginine+and+arginine-rich+peptides+are+neuroprotective+in+stroke+models&doi=10.1038%2Fjcbfm.2015.11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Poly-arginine and arginine-rich peptides are neuroprotective in stroke models</span></div><div class="casAuthors">Meloni, Bruno P.; Brookes, Laura M.; Clark, Vince W.; Cross, Jane L.; Edwards, Adam B.; Anderton, Ryan S.; Hopkins, Richard M.; Hoffmann, Katrin; Knuckey, Neville W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">993-1004</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Using cortical neuron18al cultures and glutamic acid excitotoxicity and oxygen-glucose deprivation (OGD) stroke models, we demonstrated that poly-arginine and arginine-rich cell-penetrating peptides (CPPs), are highly neuroprotective, with efficacy increasing with increasing arginine content, have the capacity to reduce glutamic acid-induced neuronal calcium influx and require heparan sulfate preotoglycan-mediated endocytosis to induce a neuroprotective effect.  Furthermore, neuroprotection could be induced with immediate peptide treatment or treatment up to 2 to 4 h before glutamic acid excitotoxicity or OGD, and with poly-arginine-9 (R9) when administered i.v. after stroke onset in a rat model.  In contrast, the JNKI-1 peptide when fused to the (non-arginine) kFGF CPP, which does not rely on endocytosis for uptake, was not neuroprotective in the glutamic acid model; the kFGF peptide was also ineffective.  Similarly, pos. charged poly-lysine-10 (K10) and R9 fused to the neg. charged poly-glutamic acid-9 (E9) peptide (R9/E9) displayed minimal neuroprotection after excitotoxicity.  These results indicate that peptide pos. charge and arginine residues are crit. for neuroprotection, and have led us to hypothesize that peptide-induced endocytic internalization of ion channels is a potential mechanism of action.  The findings also question the mode of action of different neuroprotective peptides fused to arginine-rich CPPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVDmEy49zKrVg90H21EOLACvtfcHk0lhW9wlO_UiQ6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisVyjt7g%253D&md5=bc6817a13ec5b3982e609ec93bcc924c</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2015.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2015.11%26sid%3Dliteratum%253Aachs%26aulast%3DMeloni%26aufirst%3DB.%2BP.%26aulast%3DBrookes%26aufirst%3DL.%2BM.%26aulast%3DClark%26aufirst%3DV.%2BW.%26aulast%3DCross%26aufirst%3DJ.%2BL.%26aulast%3DEdwards%26aufirst%3DA.%2BB.%26aulast%3DAnderton%26aufirst%3DR.%2BS.%26aulast%3DHopkins%26aufirst%3DR.%2BM.%26aulast%3DHoffmann%26aufirst%3DK.%26aulast%3DKnuckey%26aufirst%3DN.%2BW.%26atitle%3DPoly-arginine%2520and%2520arginine-rich%2520peptides%2520are%2520neuroprotective%2520in%2520stroke%2520models%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2015%26volume%3D35%26spage%3D993%26epage%3D1004%26doi%3D10.1038%2Fjcbfm.2015.11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cregg, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DePaul, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyck, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madalena, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimi-Abdolrezaee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busch, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silver, J.</span></span> <span> </span><span class="NLM_article-title">Modulation of the proteoglycan receptor PTPÏ promotes recovery after spinal cord injury</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>518</i></span>,  <span class="NLM_fpage">404</span>â <span class="NLM_lpage">408</span>, <span class="refDoi">Â DOI: 10.1038/nature13974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnature13974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25470046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFamsrfM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=518&publication_year=2015&pages=404-408&author=B.+T.+Langauthor=J.+M.+Creggauthor=M.+A.+DePaulauthor=A.+P.+Tranauthor=K.+Xuauthor=S.+M.+Dyckauthor=K.+M.+Madalenaauthor=B.+P.+Brownauthor=Y.+L.+Wengauthor=S.+Liauthor=S.+Karimi-Abdolrezaeeauthor=S.+A.+Buschauthor=Y.+Shenauthor=J.+Silver&title=Modulation+of+the+proteoglycan+receptor+PTP%CF%83+promotes+recovery+after+spinal+cord+injury&doi=10.1038%2Fnature13974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the proteoglycan receptor PTPÏ promotes recovery after spinal cord injury</span></div><div class="casAuthors">Lang, Bradley T.; Cregg, Jared M.; DePaul, Marc A.; Tran, Amanda P.; Xu, Kui; Dyck, Scott M.; Madalena, Kathryn M.; Brown, Benjamin P.; Weng, Yi-Lan; Li, Shuxin; Karimi-Abdolrezaee, Soheila; Busch, Sarah A.; Shen, Yingjie; Silver, Jerry</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">518</span>
        (<span class="NLM_cas:issue">7539</span>),
    <span class="NLM_cas:pages">404-408</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Contusive spinal cord injury leads to a variety of disabilities owing to limited neuronal regeneration and functional plasticity.  It is well established that an upregulation of glial-derived chondroitin sulfate proteoglycans (CSPGs) within the glial scar and perineuronal net creates a barrier to axonal regrowth and sprouting.  Protein tyrosine phosphatase Ï (PTPÏ), along with its sister phosphatase leukocyte common antigen-related (LAR) and the nogo receptors 1 and 3 (NgR), have recently been identified as receptors for the inhibitory glycosylated side chains of CSPGs.  Here we find in rats that PTPÏ has a crit. role in converting growth cones into a dystrophic state by tightly stabilizing them within CSPG-rich substrates.  We generated a membrane-permeable peptide mimetic of the PTPÏ wedge domain that binds to PTPÏ and relieves CSPG-mediated inhibition.  Systemic delivery of this peptide over weeks restored substantial serotonergic innervation to the spinal cord below the level of injury and facilitated functional recovery of both locomotor and urinary systems.  Our results add a new layer of understanding to the crit. role of PTPÏ in mediating the growth-inhibited state of neurons due to CSPGs within the injured adult spinal cord.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRJw9YvZignrVg90H21EOLACvtfcHk0lj8n3bee0gjgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFamsrfM&md5=b1576e037194831e9d65889f31b85808</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fnature13974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13974%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DB.%2BT.%26aulast%3DCregg%26aufirst%3DJ.%2BM.%26aulast%3DDePaul%26aufirst%3DM.%2BA.%26aulast%3DTran%26aufirst%3DA.%2BP.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DDyck%26aufirst%3DS.%2BM.%26aulast%3DMadalena%26aufirst%3DK.%2BM.%26aulast%3DBrown%26aufirst%3DB.%2BP.%26aulast%3DWeng%26aufirst%3DY.%2BL.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DKarimi-Abdolrezaee%26aufirst%3DS.%26aulast%3DBusch%26aufirst%3DS.%2BA.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSilver%26aufirst%3DJ.%26atitle%3DModulation%2520of%2520the%2520proteoglycan%2520receptor%2520PTP%25CF%2583%2520promotes%2520recovery%2520after%2520spinal%2520cord%2520injury%26jtitle%3DNature%26date%3D2015%26volume%3D518%26spage%3D404%26epage%3D408%26doi%3D10.1038%2Fnature13974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wadia, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stan, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, S. F.</span></span> <span> </span><span class="NLM_article-title">Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">310</span>â <span class="NLM_lpage">315</span>, <span class="refDoi">Â DOI: 10.1038/nm996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnm996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=14770178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1Wnurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=310-315&author=J.+S.+Wadiaauthor=R.+V.+Stanauthor=S.+F.+Dowdy&title=Transducible+TAT-HA+fusogenic+peptide+enhances+escape+of+TAT-fusion+proteins+after+lipid+raft+macropinocytosis&doi=10.1038%2Fnm996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis</span></div><div class="casAuthors">Wadia, Jehangir S.; Stan, Radu V.; Dowdy, Steven F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">310-315</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The TAT protein transduction domain (PTD) has been used to deliver a wide variety of biol. active cargo for the treatment of multiple preclin. disease models, including cancer and stroke.  However, the mechanism of transduction remains unknown.  Because of the TAT PTD's strong cell-surface binding, early assumptions regarding cellular uptake suggested a direct penetration mechanism across the lipid bilayer by a temp.- and energy-independent process.  Here we show, using a transducible TAT-Cre recombinase reporter assay on live cells, that after an initial ionic cell-surface interaction, TAT-fusion proteins are rapidly internalized by lipid raft-dependent macropinocytosis.  Transduction was independent of interleukin-2 receptor/raft-, caveolar- and clathrin-mediated endocytosis and phagocytosis.  Using this information, we developed a transducible, pH-sensitive, fusogenic dTAT-HA2 peptide that markedly enhanced TAT-Cre escape from macropinosomes.  Taken together, these observations provide a scientific basis for the development of new, biol. active, transducible therapeutic mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaAe03bmoBfLVg90H21EOLACvtfcHk0lj8n3bee0gjgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1Wnurg%253D&md5=e0ec3c1addca9481feb438cf564045cc</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1038%2Fnm996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm996%26sid%3Dliteratum%253Aachs%26aulast%3DWadia%26aufirst%3DJ.%2BS.%26aulast%3DStan%26aufirst%3DR.%2BV.%26aulast%3DDowdy%26aufirst%3DS.%2BF.%26atitle%3DTransducible%2520TAT-HA%2520fusogenic%2520peptide%2520enhances%2520escape%2520of%2520TAT-fusion%2520proteins%2520after%2520lipid%2520raft%2520macropinocytosis%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D310%26epage%3D315%26doi%3D10.1038%2Fnm996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richard, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melikov, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prevot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebleu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernomordik, L. V.</span></span> <span> </span><span class="NLM_article-title">Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">15300</span>â <span class="NLM_lpage">15306</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M401604200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1074%2Fjbc.M401604200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=15687490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFSltL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=15300-15306&author=J.+P.+Richardauthor=K.+Melikovauthor=H.+Brooksauthor=P.+Prevotauthor=B.+Lebleuauthor=L.+V.+Chernomordik&title=Cellular+uptake+of+unconjugated+TAT+peptide+involves+clathrin-dependent+endocytosis+and+heparan+sulfate+receptors&doi=10.1074%2Fjbc.M401604200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors</span></div><div class="casAuthors">Richard, Jean Philippe; Melikov, Kamran; Brooks, Hilary; Prevot, Paul; Lebleu, Bernard; Chernomordik, Leonid V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">15300-15306</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Delivery of macromols. mediated by protein transduction domains (PTDs) attracts a lot of interest due to its therapeutic and biotechnol. potential.  A major reevaluation of the mechanism of PTD-mediated internalization and the role of endocytosis in this mechanism has been recently initiated.  Here, we demonstrated that the entry of TAT peptide (one of the most widely used PTDs) into different primary cells is ATP and temp.-dependent, indicating the involvement of endocytosis.  Specific inhibitors of clathrin-dependent endocytosis partially inhibited TAT peptide uptake, implicating this pathway in TAT peptide entry.  In contrast, the caveolin-dependent pathway is not essential for the uptake of unconjugated TAT peptide as evidenced by the efficient internalization of TAT in the presence of the known inhibitors of raft/caveolin-dependent pathway and for cells lacking or deficient in caveolin-1 expression.  Whereas a significant part of TAT peptide uptake involved heparan sulfate receptors, efficient internalization of peptide was obsd. even in their absence, indicating the involvement of other receptors.  Our results suggested that unconjugated peptide might follow endocytic pathways different from those utilized by TAT peptide conjugated to different proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0jQflp6Sa2LVg90H21EOLACvtfcHk0lj8n3bee0gjgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFSltL4%253D&md5=1d8de5308857569b689db4f3383f2572</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M401604200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M401604200%26sid%3Dliteratum%253Aachs%26aulast%3DRichard%26aufirst%3DJ.%2BP.%26aulast%3DMelikov%26aufirst%3DK.%26aulast%3DBrooks%26aufirst%3DH.%26aulast%3DPrevot%26aufirst%3DP.%26aulast%3DLebleu%26aufirst%3DB.%26aulast%3DChernomordik%26aufirst%3DL.%2BV.%26atitle%3DCellular%2520uptake%2520of%2520unconjugated%2520TAT%2520peptide%2520involves%2520clathrin-dependent%2520endocytosis%2520and%2520heparan%2520sulfate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D15300%26epage%3D15306%26doi%3D10.1074%2Fjbc.M401604200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellegrini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcangeli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fittipaldi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltram, F.</span></span> <span> </span><span class="NLM_article-title">Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time</span>. <i>Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">284</span>â <span class="NLM_lpage">294</span>, <span class="refDoi">Â DOI: 10.1016/S1525-0016(03)00122-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2FS1525-0016%2803%2900122-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=12907151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFOktr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=284-294&author=A.+Ferrariauthor=V.+Pellegriniauthor=C.+Arcangeliauthor=A.+Fittipaldiauthor=M.+Giaccaauthor=F.+Beltram&title=Caveolae-mediated+internalization+of+extracellular+HIV-1+tat+fusion+proteins+visualized+in+real+time&doi=10.1016%2FS1525-0016%2803%2900122-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Caveolae-Mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time</span></div><div class="casAuthors">Ferrari, Aldo; Pellegrini, Vittorio; Arcangeli, Caterina; Fittipaldi, Antonio; Giacca, Mauro; Beltram, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">284-294</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The Tat protein from HIV-1, when fused with heterologous proteins or peptides, can traverse cell membranes.  This ability has generated great interest due to potential therapeutic applications.  However, the relevant cellular pathway and its dynamics have not been elucidated yet.  Here we unravel the intracellular fate of exogenously added Tat fused with green fluorescent protein (GFP) in live HeLa and CHO cells, from the early interaction with the plasma membrane up to the long-term accumulation in the perinuclear region.  We demonstrate that the internalization process of full-length Tat and of heterologous proteins fused to the transduction domain of Tat exploits a caveolar-mediated pathway and is inhibited at 4Â°.  Remarkably, a slow linear movement toward the nucleus of individual GFP-tagged Tat-filled caveolae with an av. velocity of 3 Î¼m/h was obsd.  No fluorescence was obsd. in the nucleus, possibly suggesting that Tat fusion protein unfolding is required for nuclear translocation.  In addn., early sensitivity to cytochalasin-D treatment indicates the essential role of the actin cytoskeleton in the displacement of Tat vesicles toward the nucleus.  Our results imply that HIV-1 Tat mediates the internalization of protein cargos in a slow and temp.-dependent manner by exploiting the caveolar pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC_IT5g1y8KbVg90H21EOLACvtfcHk0lgSqG8b1dgEgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFOktr8%253D&md5=e5f60c42ccba353cf96503a2a453d3a7</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2FS1525-0016%2803%2900122-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1525-0016%252803%252900122-9%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DA.%26aulast%3DPellegrini%26aufirst%3DV.%26aulast%3DArcangeli%26aufirst%3DC.%26aulast%3DFittipaldi%26aufirst%3DA.%26aulast%3DGiacca%26aufirst%3DM.%26aulast%3DBeltram%26aufirst%3DF.%26atitle%3DCaveolae-mediated%2520internalization%2520of%2520extracellular%2520HIV-1%2520tat%2520fusion%2520proteins%2520visualized%2520in%2520real%2520time%26jtitle%3DMol.%2520Ther.%26date%3D2003%26volume%3D8%26spage%3D284%26epage%3D294%26doi%3D10.1016%2FS1525-0016%2803%2900122-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kosuge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakase, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futaki, S.</span></span> <span> </span><span class="NLM_article-title">Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">656</span>â <span class="NLM_lpage">664</span>, <span class="refDoi">Â DOI: 10.1021/bc700289w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc700289w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVGgu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=656-664&author=M.+Kosugeauthor=T.+Takeuchiauthor=I.+Nakaseauthor=A.+T.+Jonesauthor=S.+Futaki&title=Cellular+internalization+and+distribution+of+arginine-rich+peptides+as+a+function+of+extracellular+peptide+concentration%2C+serum%2C+and+plasma+membrane+associated+proteoglycans&doi=10.1021%2Fbc700289w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular Internalization and Distribution of Arginine-Rich Peptides as a Function of Extracellular Peptide Concentration, Serum, and Plasma Membrane Associated Proteoglycans</span></div><div class="casAuthors">Kosuge, Michie; Takeuchi, Toshihide; Nakase, Ikuhiko; Jones, Arwyn Tomos; Futaki, Shiroh</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">656-664</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The exact mechanisms by which Arg-rich cell-penetrating peptides enter cells are still the subject of debate.  Here, we have analyzed in detail the effects of serum and extracellular concn. on the internalization of oligoarginines (Rn; n = 4, 8, 12, 16).  The presence of serum in the incubation medium had a major influence on the uptake of R12 and R16 peptides but did not affect the uptake of R4 and R8 significantly.  Incubation of cells at 37 Â°C with R12 and R16 peptides in serum-contg. medium showed that the majority of labeling was confined to punctate endocytic structures.  Performing the same expts. in serum-free media led to a dramatic increase in cytosolic labeling, and similarly diffuse R12 and R16 labeling was obsd. in cells treated with peptides at 4 Â°C.  This suggests, in both cases, that the peptides were entering via a nonendocytic mechanism.  Further studies on R12 peptide suggest that the initiation of nonendocytic uptake and cytosolic labeling is also dependent on serum concn. and extracellular peptide concn.  At relatively low concns., the peptide labels endocytic structures, but upon raising the peptide concn., the fraction labeling the cytosol increases dramatically and this accompanies a nonlinear increase in total cellular fluorescence.  Membrane-assocd. proteoglycans also contribute to increasing the peptide concn. at the cell surface by enhancing their recruitment via electrostatic interactions.  These results demonstrate that uptake mechanisms of these compds. are highly dependent on both the presence of serum and the effective extracellular peptide concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE7X585THn2rVg90H21EOLACvtfcHk0lgSqG8b1dgEgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVGgu78%253D&md5=437124544cad7ac13a1300f39e8f3218</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fbc700289w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc700289w%26sid%3Dliteratum%253Aachs%26aulast%3DKosuge%26aufirst%3DM.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DNakase%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DA.%2BT.%26aulast%3DFutaki%26aufirst%3DS.%26atitle%3DCellular%2520internalization%2520and%2520distribution%2520of%2520arginine-rich%2520peptides%2520as%2520a%2520function%2520of%2520extracellular%2520peptide%2520concentration%252C%2520serum%252C%2520and%2520plasma%2520membrane%2520associated%2520proteoglycans%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D656%26epage%3D664%26doi%3D10.1021%2Fbc700289w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Labropoulou, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skandalis, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravazoula, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perimenis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karamanos, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalofonos, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theocharis, A. D.</span></span> <span> </span><span class="NLM_article-title">Expression of syndecan-4 and correlation with metastatic potential in testicular germ cell tumours</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">214864</span>, <span class="refDoi">Â DOI: 10.1155/2013/214864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1155%2F2013%2F214864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23844358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC3sjpvFehsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=214864&author=V.+T.+Labropoulouauthor=S.+S.+Skandalisauthor=P.+Ravazoulaauthor=P.+Perimenisauthor=N.+K.+Karamanosauthor=H.+P.+Kalofonosauthor=A.+D.+Theocharis&title=Expression+of+syndecan-4+and+correlation+with+metastatic+potential+in+testicular+germ+cell+tumours&doi=10.1155%2F2013%2F214864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of syndecan-4 and correlation with metastatic potential in testicular germ cell tumours</span></div><div class="casAuthors">Labropoulou Vassiliki T; Skandalis Spyros S; Ravazoula Panagiota; Perimenis Petros; Karamanos Nikos K; Kalofonos Haralabos P; Theocharis Achilleas D</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2013</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">214864</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although syndecan-4 is implicated in cancer progression, there is no information for its role in testicular germ cell tumours (TGCTs).  Thus, we examined the expression of syndecan-4 in patients with TGCTs and its correlation with the clinicopathological findings.  Immunohistochemical staining in 71 tissue specimens and mRNA analysis revealed significant overexpression of syndecan-4 in TGCTs.  In seminomas, high percentage of tumour cells exhibited membranous and/or cytoplasmic staining for syndecan-4 in all cases.  Stromal staining for syndecan-4 was found in seminomas and it was associated with nodal metastasis (P = 0.04), vascular/lymphatic invasion (P = 0.01), and disease stage (P = 0.04).  Reduced tumour cell associated staining for syndecan-4 was observed in nonseminomatous germ cell tumours (NSGCTs) compared to seminomas.  This loss of syndecan-4 was associated with nodal metastasis (P = 0.01), vascular/lymphatic invasion (P = 0.01), and disease stage (P = 0.01).  Stromal staining for syndecan-4 in NSGCTs did not correlate with any of the clinicopathological variables.  The stromal expression of syndecan-4 in TGCTs was correlated with microvessel density (P = 0.03).  Our results indicate that syndecan-4 is differentially expressed in seminomas and NSGCTs and might be a useful marker.  Stromal staining in seminomas and reduced levels of syndecan-4 in tumour cells in NSGCTs are related to metastatic potential, whereas stromal staining in TGCTs is associated with neovascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4lnANo20pTlVwdslNBF-tfW6udTcc2eZIKZ81fEpQUbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjpvFehsA%253D%253D&md5=8b2b678a183cf03b40145f4c340612aa</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1155%2F2013%2F214864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F214864%26sid%3Dliteratum%253Aachs%26aulast%3DLabropoulou%26aufirst%3DV.%2BT.%26aulast%3DSkandalis%26aufirst%3DS.%2BS.%26aulast%3DRavazoula%26aufirst%3DP.%26aulast%3DPerimenis%26aufirst%3DP.%26aulast%3DKaramanos%26aufirst%3DN.%2BK.%26aulast%3DKalofonos%26aufirst%3DH.%2BP.%26aulast%3DTheocharis%26aufirst%3DA.%2BD.%26atitle%3DExpression%2520of%2520syndecan-4%2520and%2520correlation%2520with%2520metastatic%2520potential%2520in%2520testicular%2520germ%2520cell%2520tumours%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2013%26volume%3D2013%26spage%3D214864%26doi%3D10.1155%2F2013%2F214864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baba, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swartz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Buren, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eickhoff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolberg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedl, A.</span></span> <span> </span><span class="NLM_article-title">Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">98</span>, <span class="refDoi">Â DOI: 10.1007/s10549-005-9135-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs10549-005-9135-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=16636895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVaqsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=91-98&author=F.+Babaauthor=K.+Swartzauthor=R.+van+Burenauthor=J.+Eickhoffauthor=Y.+Zhangauthor=W.+Wolbergauthor=A.+Friedl&title=Syndecan-1+and+syndecan-4+are+overexpressed+in+an+estrogen+receptor-negative%2C+highly+proliferative+breast+carcinoma+subtype&doi=10.1007%2Fs10549-005-9135-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype</span></div><div class="casAuthors">Baba, Fuesun; Swartz, Kathryn; Buren, Regina; Eickhoff, Jens; Zhang, Yong; Wolberg, William; Friedl, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Members of the syndecan and glypican families of cell surface heparan sulfate proteoglycans (HSPGs) are modulators of growth factor signaling and cell adhesion.  Both loss and gain in expression of syndecans and glypicans has been assocd. with malignant progression.  The goal of this project was to investigate a possible relationship between expression of cell surface HSPGs (syndecan-1, syndecan-4 and glypican-1) and established prognostic factors or clin. outcome in breast carcinomas.  Tissue arrays contg. 207 human breast carcinoma samples in duplicate were immuno-labeled with antibodies to syndecan-1, syndecan-4, glypican-1, Ki67, E-cadherin, estrogen receptor (ER) and progesterone receptor (PR).  Clin. follow-up information was available for up to 18.6 years (median follow-up 6.2 years).  Syndecan-1 and syndecan-4 expression in carcinoma cells ranged from complete loss to high expression, but glypican-1 was detected only in a small subset of breast carcinomas.  Expression of all three HSPGs was significantly assocd. with the Ki67 proliferation index (syndecan-1: p=0.0025; syndecan-4: p<0.0001; glypican-1 p=0.01).  Syndecan-1 and syndecan-4 expression correlated with ER negativity, grade, and size of the primary tumors.  Syndecan-1 expression (but not syndecan-4 nor glypican-1) predicted patient outcome (DFS: p=0.0054; OS: p=0.0086).  However, multivariate anal. failed to identify syndecan-1 as an independent prognostic marker, which was due to its significant assocn. with established prognostic factors.  The strong assocn. between cell surface HSPGs and the Ki67 proliferation marker would support a biol. role in carcinoma growth regulation.  Furthermore, the close correlation between syndecan expression and neg. ER status raises the possibility of hormonal regulation or more likely an assocn. with an aggressive, ER-neg. carcinoma phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-sbDg04DpCbVg90H21EOLACvtfcHk0lihIV3Xmyl-ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVaqsb0%253D&md5=0360ceb3457f64ec8db596ec5f18c81e</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1007%2Fs10549-005-9135-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-005-9135-2%26sid%3Dliteratum%253Aachs%26aulast%3DBaba%26aufirst%3DF.%26aulast%3DSwartz%26aufirst%3DK.%26aulast%3Dvan%2BBuren%26aufirst%3DR.%26aulast%3DEickhoff%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWolberg%26aufirst%3DW.%26aulast%3DFriedl%26aufirst%3DA.%26atitle%3DSyndecan-1%2520and%2520syndecan-4%2520are%2520overexpressed%2520in%2520an%2520estrogen%2520receptor-negative%252C%2520highly%2520proliferative%2520breast%2520carcinoma%2520subtype%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2006%26volume%3D98%26spage%3D91%26epage%3D98%26doi%3D10.1007%2Fs10549-005-9135-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couchman, J. R.</span></span> <span> </span><span class="NLM_article-title">Syndecan-4 up-regulation in proliferative renal disease is related to microfilament organization</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1631</span>â <span class="NLM_lpage">1633</span>, <span class="refDoi">Â DOI: 10.1096/fj.00-0794fje</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1096%2Ffj.00-0794fje" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11427509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFaktLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=1631-1633&author=S.+Yungauthor=A.+Woodsauthor=T.+M.+Chanauthor=M.+Daviesauthor=J.+D.+Williamsauthor=J.+R.+Couchman&title=Syndecan-4+up-regulation+in+proliferative+renal+disease+is+related+to+microfilament+organization&doi=10.1096%2Ffj.00-0794fje"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Syndecan-4 up-regulation in proliferative renal disease is related to microfilament organization</span></div><div class="casAuthors">Yung, Susan; Woods, Anne; Chan, Tak Mao; Davies, Malcolm; Williams, John D.; Couchman, John R.</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1631-1633, 10.1096/fj.00-0794fje</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Syndecan-4 is a transmembrane heparan sulfate proteoglycan (HSPG) expressed widely in mammalian cells.  It has been implicated in growth-factor binding, cell-extracellular matrix adhesion, and tissue damage responses.  Although several HSPGs are present within kidney mesangium and glomerular basement membranes, no data are available on the synthesis of syndecan-4 by mesangial cells or its expression in human renal disease.  We examd. renal biopsy specimens from normal controls, nonproliferative disease (thin-membrane disease), and progressive proliferative disease (IgA nephropathy).  By using RT-PCR and immunohistochem. staining, we identified an increase in both gene expression (IgA nephropathy vs. thin membrane disease, P = 0.0004) and synthesis of syndecan-4 in progressive proliferative disease.  Syndecan-4 increased within both mesangium and tubulo-interstitium, as did Î±-actinin, a microfilament cytoskeletal component.  Syndecan-4 was a focal adhesion component in human mesangial cells, colocalizing with vinculin and Î±-actinin, and was. present in the cortical, submembraneous myosin sheath as seen for Î±-actinin.  Both syndecan-4 and Î±-actinin were retained selectively in detergent-resistant cytoskeleton-matrix prepns., emphasizing their close assocn. in cell-matrix adhesion.  Syndecan-4 may be important in the adhesion, migration, and proliferation of HMC, and its up-regulation could indicate proliferative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZWlp1tS35VrVg90H21EOLACvtfcHk0lihIV3Xmyl-ig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFaktLc%253D&md5=ebd4f8a2e4e5c14f674cfff5e6bcf72e</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1096%2Ffj.00-0794fje&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.00-0794fje%26sid%3Dliteratum%253Aachs%26aulast%3DYung%26aufirst%3DS.%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DT.%2BM.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DCouchman%26aufirst%3DJ.%2BR.%26atitle%3DSyndecan-4%2520up-regulation%2520in%2520proliferative%2520renal%2520disease%2520is%2520related%2520to%2520microfilament%2520organization%26jtitle%3DFASEB%2520J.%26date%3D2001%26volume%3D15%26spage%3D1631%26epage%3D1633%26doi%3D10.1096%2Ffj.00-0794fje" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez Plaza, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Nava, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diener, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, M. T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, I. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantoja, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volkmer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klipp, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rio, G.</span></span> <span> </span><span class="NLM_article-title">Cell penetrating peptides and cationic antibacterial peptides: two sides of the same coin</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">14448</span>â <span class="NLM_lpage">14457</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M113.515023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1074%2Fjbc.M113.515023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=24706763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1artbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=14448-14457&author=J.+G.+Rodriguez+Plazaauthor=R.+Morales-Navaauthor=C.+Dienerauthor=G.+Schreiberauthor=Z.+D.+Gonzalezauthor=M.+T.+L.+Ortizauthor=I.+O.+Blakeauthor=O.+Pantojaauthor=R.+Volkmerauthor=E.+Klippauthor=A.+Herrmannauthor=G.+Del+Rio&title=Cell+penetrating+peptides+and+cationic+antibacterial+peptides%3A+two+sides+of+the+same+coin&doi=10.1074%2Fjbc.M113.515023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Cell Penetrating Peptides and Cationic Antibacterial Peptides</span></div><div class="casAuthors">Rodriguez Plaza, Jonathan G.; Morales-Nava, Rosmarbel; Diener, Christian; Schreiber, Gabriele; Gonzalez, Zyanya D.; Ortiz, Maria Teresa Lara; Blake, Ivan Ortega; Pantoja, Omar; Volkmer, Rudolf; Klipp, Edda; Herrmann, Andreas; Del Rio, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">14448-14457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cell penetrating peptides (CPP) and cationic antibacterial peptides (CAP) have similar physicochem. properties and yet it is not understood how such similar peptides display different activities.  To address this question, we used Iztli peptide 1 (IP-1) because it has both CPP and CAP activities.  Combining exptl. and computational modeling of the internalization of IP-1, we show it is not internalized by receptor-mediated endocytosis, yet it permeates into many different cell types, including fungi and human cells.  We also show that IP-1 makes pores in the presence of high elec. potential at the membrane, such as those found in bacteria and mitochondria.  These results provide the basis to understand the functional redundancy of CPPs and CAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvXU3959As-bVg90H21EOLACvtfcHk0lgoCgloQJEK9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1artbc%253D&md5=9e84d680274a096b1ae254e23d354de9</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.515023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.515023%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%2BPlaza%26aufirst%3DJ.%2BG.%26aulast%3DMorales-Nava%26aufirst%3DR.%26aulast%3DDiener%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DG.%26aulast%3DGonzalez%26aufirst%3DZ.%2BD.%26aulast%3DOrtiz%26aufirst%3DM.%2BT.%2BL.%26aulast%3DBlake%26aufirst%3DI.%2BO.%26aulast%3DPantoja%26aufirst%3DO.%26aulast%3DVolkmer%26aufirst%3DR.%26aulast%3DKlipp%26aufirst%3DE.%26aulast%3DHerrmann%26aufirst%3DA.%26aulast%3DDel%2BRio%26aufirst%3DG.%26atitle%3DCell%2520penetrating%2520peptides%2520and%2520cationic%2520antibacterial%2520peptides%253A%2520two%2520sides%2520of%2520the%2520same%2520coin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D14448%26epage%3D14457%26doi%3D10.1074%2Fjbc.M113.515023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, G.</span></span> <span> </span><span class="NLM_article-title">Selectivity for and destruction of Salmonella typhimurium via a membrane damage mechanism of a cell penetrating peptide ppTG20 analogue</span>. <i>Int. J. Antimicrob. Agents</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">337</span>â <span class="NLM_lpage">343</span>, <span class="refDoi">Â DOI: 10.1016/j.ijantimicag.2012.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.ijantimicag.2012.05.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22819152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVymsLbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=337-343&author=L.+Liauthor=Y.+Shiauthor=G.+Suauthor=G.+Le&title=Selectivity+for+and+destruction+of+Salmonella+typhimurium+via+a+membrane+damage+mechanism+of+a+cell+penetrating+peptide+ppTG20+analogue&doi=10.1016%2Fj.ijantimicag.2012.05.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity for and destruction of Salmonella typhimurium via a membrane damage mechanism of a cell-penetrating peptide ppTG20 analog</span></div><div class="casAuthors">Li, LiRong; Shi, YongHui; Su, GuanFang; Le, GuoWei</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-343</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">P7, an analog of the cell-penetrating peptide (CPP) ppTG20, was derived by replacing Phe and Trp with Arg based on the structure-activity relationships of CPPs and antimicrobial peptides (AMPs).  P7 showed antimicrobial activity against Salmonella typhimurium at 4 Î¼M and possessed broad antimicrobial activity greater than its parent peptide.  P7 displayed good selectivity, with low hemolysis below its min. inhibitory concn. range, but displayed cytotoxic activity against the HT29 and MDA-MB231 mammalian cell lines.  Studies of calcein leakage from egg yolk L-Î±-phosphatidylcholine/egg yolk L-Î±-phosphatidyl-DL-glycerol (EYPC/EYPG) (bacterial membrane mimic) and EYPC/cholesterol (eukaryotic membrane mimic) vesicles also demonstrated that P7 exhibited high selectivity and caused pore formation in the bacterial membrane.  CD expts. suggested that the conformation of P7 underwent transitions from a random coil in sodium phosphate buffer to an Î±-helical conformation in bacterial model membranes.  P7 induced influx of the membrane fluorescent probe 1-N-phenylnaphthylamine (NPN) and the nucleic acid fluorescent probe SYTOX Green by increasing live S. typhimurium cell outer membrane and plasma membrane permeability, resp.  P7 also induced ion channel formation in the cell plasma membrane causing leakage of potassium ions.  Flow cytometric anal. demonstrated that S. typhimurium cell membrane integrity was destroyed following incubation with P7.  These results indicated that P7 exhibited good bacterial selectivity and exerted its antibacterial activity by a membrane damage mechanism.  Furthermore, these results suggested that CPPs may represent a source of templates for AMP design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP6YHjUBhdPrVg90H21EOLACvtfcHk0lgoCgloQJEK9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVymsLbJ&md5=39420120bb4d50ddd1882a35a6e73a6f</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.ijantimicag.2012.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijantimicag.2012.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DG.%26aulast%3DLe%26aufirst%3DG.%26atitle%3DSelectivity%2520for%2520and%2520destruction%2520of%2520Salmonella%2520typhimurium%2520via%2520a%2520membrane%2520damage%2520mechanism%2520of%2520a%2520cell%2520penetrating%2520peptide%2520ppTG20%2520analogue%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2012%26volume%3D40%26spage%3D337%26epage%3D343%26doi%3D10.1016%2Fj.ijantimicag.2012.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gautam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group">Open Source Drug Discovery Consortium</span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghava, G. P. S.</span></span> <span> </span><span class="NLM_article-title">Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2367</span>â <span class="NLM_lpage">2391</span>, <span class="refDoi">Â DOI: 10.2174/0929867321666140217122100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.2174%2F0929867321666140217122100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=24533809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1Wgu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=2367-2391&author=A.+Gautamauthor=P.+Kapoorauthor=K.+Chaudharyauthor=R.+Kumarauthor=Open+Source+Drug+Discovery+Consortiumauthor=G.+P.+S.+Raghava&title=Tumor+homing+peptides+as+molecular+probes+for+cancer+therapeutics%2C+diagnostics+and+theranostics&doi=10.2174%2F0929867321666140217122100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Homing Peptides as Molecular Probes for Cancer Therapeutics, Diagnostics and Theranostics</span></div><div class="casAuthors">Gautam, A.; Kapoor, P.; Chaudhary, K.; Kumar, R.; Raghava, G. P. S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2367-2391</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer is one of the leading causes of mortality worldwide, with more than 10 million new cases each year.  Despite the presence of several anticancer agents, cancer treatment is still not very effective.  Main reasons behind this high mortality rate are the lack of screening tests for early diagnosis, and non-availability of tumor specific drug delivery system.  Most of the current anticancer drugs are unable to differentiate between cancerous and normal cells, leading to systemic toxicity, and adverse side effects.  In order to tackle this problem, a considerable progress has been made over the years to identify peptides, which specifically bind to the tumor cells, and tumor vasculature (tumor homing peptides).  With the advances in phage display technol., and combinatorial libraries like one-bead one-compd. library, several hundreds of tumor homing peptides, and their derivs., which have potential to detect tumor in vivo, and deliver anticancer agents specifically to the tumor site, have been discovered.  Currently, many tumor homing peptide-based therapies for cancer treatment and diagnosis are being tested in various phases of clin. trials.  In this review, we have discussed the progress made so far in the identification of tumor homing peptides, and their applications in cancer therapeutics, diagnosis, and theranostics.  In addn., a brief discussion on tumor homing peptide resource, and in silico designing of tumor homing peptides has also been provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZnw78DFn6PLVg90H21EOLACvtfcHk0lgoCgloQJEK9A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpt1Wgu7o%253D&md5=0708beeac08584ead97e1ac9666621e8</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.2174%2F0929867321666140217122100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666140217122100%26sid%3Dliteratum%253Aachs%26aulast%3DGautam%26aufirst%3DA.%26aulast%3DKapoor%26aufirst%3DP.%26aulast%3DChaudhary%26aufirst%3DK.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3D%26aulast%3DRaghava%26aufirst%3DG.%2BP.%2BS.%26atitle%3DTumor%2520homing%2520peptides%2520as%2520molecular%2520probes%2520for%2520cancer%2520therapeutics%252C%2520diagnostics%2520and%2520theranostics%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D2367%26epage%3D2391%26doi%3D10.2174%2F0929867321666140217122100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, G. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. M.</span></span> <span> </span><span class="NLM_article-title">Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">1783</span>â <span class="NLM_lpage">1791</span>, <span class="refDoi">Â DOI: 10.1016/j.biopha.2016.10.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.biopha.2016.10.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27899251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGjtr7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2016&pages=1783-1791&author=L.+Q.+Fanauthor=G.+X.+Duauthor=P.+F.+Liauthor=M.+W.+Liauthor=Y.+Sunauthor=L.+M.+Zhao&title=Improved+breast+cancer+cell-specific+intracellular+drug+delivery+and+therapeutic+efficacy+by+coupling+decoration+with+cell+penetrating+peptide+and+SP90+peptide&doi=10.1016%2Fj.biopha.2016.10.102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide</span></div><div class="casAuthors">Fan, Li-Qiang; Du, Guo-Xiu; Li, Peng-Fei; Li, Ming-Wei; Sun, Yao; Zhao, Li-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1783-1791</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Lack of satisfactory specificity towards tumor cells and poor intracellular delivery efficacy are the major drawbacks with conventional cancer chemotherapy.  Conjugated anticancer drugs to targeting moieties e.g. to peptides with the ability to recognize cancer cells and to cell penetrating peptide can improve these characteristics, resp.  Combining a tumor homing peptide with an appropriate cell-penetrating peptide can enhance the tumor-selective internalization efficacy of the carrying cargo mols.  In the present study, the breast cancer homing ability of SP90 peptide and the synergistic effect of SP90 with a cell-penetrating peptide(C peptide) were evaluated.  SP90 and chimeric peptide SP90-C specifically targeted cargo mol. into breast cancer cells, esp. triple neg. MDA-MB-231 cell, in a dose- and time-dependent manner, but not normal breast cells and other cancer cells, while C peptide alone had no cell-selectivity.  SP90-C increased the intracellular delivery efficiency by 12-fold or 10-fold compared to SP90 or C peptide alone, resp.  SP90 and SP90-C conjugation increased the anti-proliferative and apoptosis-inducing activity of HIV-1 Vpr, a potential novel anticancer protein drug, to breast cancer cell but not normal breast cell by arresting cells in G2/M phase.  With excellent breast cancer cell-selective penetrating efficacy, SP90-C appears as a promising candidate vector for targeted anti-cancer drug delivery.  SP90-VPR-C is a potential novel breast cancer-targeted anticancer agent for its high anti-tumor activity and low toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq24qwlXCMTZbVg90H21EOLACvtfcHk0liUoTYxDwe_Ww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGjtr7J&md5=a8705ffd636328de359610245c9be9d0</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2016.10.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2016.10.102%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DL.%2BQ.%26aulast%3DDu%26aufirst%3DG.%2BX.%26aulast%3DLi%26aufirst%3DP.%2BF.%26aulast%3DLi%26aufirst%3DM.%2BW.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DL.%2BM.%26atitle%3DImproved%2520breast%2520cancer%2520cell-specific%2520intracellular%2520drug%2520delivery%2520and%2520therapeutic%2520efficacy%2520by%2520coupling%2520decoration%2520with%2520cell%2520penetrating%2520peptide%2520and%2520SP90%2520peptide%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2016%26volume%3D84%26spage%3D1783%26epage%3D1791%26doi%3D10.1016%2Fj.biopha.2016.10.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Q.</span></span> <span> </span><span class="NLM_article-title">Vascular-homing peptides for cancer therapy</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">187</span>â <span class="NLM_lpage">195</span>, <span class="refDoi">Â DOI: 10.1016/j.biopha.2017.05.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.biopha.2017.05.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28544932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotlWmu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2017&pages=187-195&author=L.+Luauthor=H.+Qiauthor=J.+Zhuauthor=W.+X.+Sunauthor=B.+Zhangauthor=C.+Y.+Tangauthor=Q.+Cheng&title=Vascular-homing+peptides+for+cancer+therapy&doi=10.1016%2Fj.biopha.2017.05.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular-homing peptides for cancer therapy</span></div><div class="casAuthors">Lu, Lan; Qi, Huan; Zhu, Jie; Sun, Wen Xia; Zhang, Bin; Tang, Chun Yan; Cheng, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">187-195</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In the past 30 years, a variety of phage libraries have been extensively utilized to identify and develop tumor homing peptides (THPs).  THPs specifically bind to tumor cells or elements of the tumor microenvironment while no or low affinity to normal cells.  In this regard, the efficacy of therapeutic agents in cancer therapy can be enhanced by targeting strategies based on coupling with THPs that recognize receptors expressed by tumor cells or tumor vasculature.  Esp., vascular-homing peptides, targeting tumor vasculature, have their receptors expressed on or around the blood vessel including pro-angiogenic factors, metalloproteinase, integrins, fibrin-fibronectin complexes, etc.  This review briefly summarizes recent studies on identification and therapeutic applications of vascular-homing peptides targeting common angiogenic markers or with unknown vascular targets in some certain types of cancers.  These newly discovered vascular-homing peptides are promising candidates which could provide novel strategies for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk1emmqQIRebVg90H21EOLACvtfcHk0liUoTYxDwe_Ww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotlWmu7Y%253D&md5=b631bcb2a5a38a173ac8da55466e3559</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2017.05.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2017.05.054%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DL.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DW.%2BX.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DC.%2BY.%26aulast%3DCheng%26aufirst%3DQ.%26atitle%3DVascular-homing%2520peptides%2520for%2520cancer%2520therapy%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2017%26volume%3D92%26spage%3D187%26epage%3D195%26doi%3D10.1016%2Fj.biopha.2017.05.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregorc, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennicelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Punt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citterio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmer-Bonte, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caligaris Cappio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambiase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordignon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Herpen, C. M.</span></span> <span> </span><span class="NLM_article-title">Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">219</span>â <span class="NLM_lpage">224</span>, <span class="refDoi">Â DOI: 10.1038/sj.bjc.6605162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fsj.bjc.6605162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=19568235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1MXoslOmur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2009&pages=219-224&author=V.+Gregorcauthor=A.+Santoroauthor=E.+Bennicelliauthor=C.+J.+Puntauthor=G.+Citterioauthor=J.+N.+Timmer-Bonteauthor=F.+Caligaris+Cappioauthor=A.+Lambiaseauthor=C.+Bordignonauthor=C.+M.+van+Herpen&title=Phase+Ib+study+of+NGR-hTNF%2C+a+selective+vascular+targeting+agent%2C+administered+at+low+doses+in+combination+with+doxorubicin+to+patients+with+advanced+solid+tumours&doi=10.1038%2Fsj.bjc.6605162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumors</span></div><div class="casAuthors">Gregorc, V.; Santoro, A.; Bennicelli, E.; Punt, C. J. A.; Citterio, G.; Timmer-Bonte, J. N. H.; Caligaris Cappio, F.; Lambiase, A.; Bordignon, C.; van Herpen, C. M. L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">219-224</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Asparagine-glycine-arginine-human tumor necrosis factor (NGR-hTNF) is a vascular targeting agent exploiting a tumor-homing peptide (NGR) that selectively binds to aminopeptidase N/CD13, overexpressed on tumor blood vessels.  Significant preclin. synergy was shown between low doses of NGR-TNF and doxorubicin.  The primary aim of this phase I trial was to verify the safety of low-dose NGR-hTNF combined with doxorubicin in treating refractory/resistant solid tumors.  Secondary objectives included pharmacokinetics (PKs), pharmacodynamics, and clin. activity.  In all 15 patients received NGR-hTNF (0.2-0.4-0.8-1.6 Î¼g/m-2) and doxorubicin (60-75 mg/m-2), both given i.v. every 3 wk.  No dose-limiting toxicity occurred and the combination was well tolerated.  Around two cases of neutropenic fevers, lasting 2 days, and two cases of cardiac ejection-fraction drops, one asymptomatic and the other symptomatic, were registered.  Only 11% of the adverse events were related to NGR-hTNF and were short-lasting and mild-to-moderate in severity.  There was no apparent PK interaction and the shedding of sol. TNF-receptors did not increase to 0.8 Î¼g/m-2.  One partial response (7%), at dose level 0.8 Î¼g/m-2, and 10 stable diseases (66%), lasting for a median duration of 5.6 mo, were obsd.  NGR-hTNF plus doxorubicin was administered safely and showed promising activity in patients pre-treated with anthracyclines.  The dose level of 0.8 Î¼g/m-2 NGR-hTNF plus doxorubicin 75 mg/m-2 was selected for phase II development.  British Journal of Cancer (2009) 101, 219-224; doi:10.1038/sj.bjc.6605162 www.bjcancer.com Published online 30 June 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmvMk75_JYVLVg90H21EOLACvtfcHk0liUoTYxDwe_Ww"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXoslOmur0%253D&md5=12ade314d9e9d352fa27250cfc56fdee</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605162%26sid%3Dliteratum%253Aachs%26aulast%3DGregorc%26aufirst%3DV.%26aulast%3DSantoro%26aufirst%3DA.%26aulast%3DBennicelli%26aufirst%3DE.%26aulast%3DPunt%26aufirst%3DC.%2BJ.%26aulast%3DCitterio%26aufirst%3DG.%26aulast%3DTimmer-Bonte%26aufirst%3DJ.%2BN.%26aulast%3DCaligaris%2BCappio%26aufirst%3DF.%26aulast%3DLambiase%26aufirst%3DA.%26aulast%3DBordignon%26aufirst%3DC.%26aulast%3Dvan%2BHerpen%26aufirst%3DC.%2BM.%26atitle%3DPhase%2520Ib%2520study%2520of%2520NGR-hTNF%252C%2520a%2520selective%2520vascular%2520targeting%2520agent%252C%2520administered%2520at%2520low%2520doses%2520in%2520combination%2520with%2520doxorubicin%2520to%2520patients%2520with%2520advanced%2520solid%2520tumours%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2009%26volume%3D101%26spage%3D219%26epage%3D224%26doi%3D10.1038%2Fsj.bjc.6605162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorusso, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scambia, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amadio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">di Legge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietragalla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vincenzo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masciullo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Stefano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangili, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citterio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambiase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordignon, C.</span></span> <span> </span><span class="NLM_article-title">Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">37</span>â <span class="NLM_lpage">42</span>, <span class="refDoi">Â DOI: 10.1038/bjc.2012.233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fbjc.2012.233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22644293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xptl2itrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=37-42&author=D.+Lorussoauthor=G.+Scambiaauthor=G.+Amadioauthor=A.+di+Leggeauthor=A.+Pietragallaauthor=R.+De+Vincenzoauthor=V.+Masciulloauthor=M.+Di+Stefanoauthor=G.+Mangiliauthor=G.+Citterioauthor=M.+Mantoriauthor=A.+Lambiaseauthor=C.+Bordignon&title=Phase+II+study+of+NGR-hTNF+in+combination+with+doxorubicin+in+relapsed+ovarian+cancer+patients&doi=10.1038%2Fbjc.2012.233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients</span></div><div class="casAuthors">Lorusso, D.; Scambia, G.; Amadio, G.; di Legge, A.; Pietragalla, A.; De Vincenzo, R.; Masciullo, V.; Di Stefano, M.; Mangili, G.; Citterio, G.; Mantori, M.; Lambiase, A.; Bordignon, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-42</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: The NGR-hTNF (asparagine-glycine-arginine-human tumor necrosis factor) is able to promote antitumor immune responses and to improve the intratumoral doxorubicin uptake by selectively damaging tumor blood vessels.  Methods: Patients progressing after â¥1 platinum/taxane-based regimen received NGR-hTNF 0.8 Î¼g m-2 and doxorubicin 60 mg m-2 every 3 wk.  Primary endpoint was a Response Evaluation Criteria in Solid Tumors-defined response rate with a target of more than 6 out of 37 responding patients.  Results: A total of 37 patients with platinum-free interval lower than 6 mo (PFI<6; n=25), or between 6 and 12 mo (PFI=6-12; n=12) were enrolled.  Median baseline peripheral blood lymphocyte count (PBLC) was 1.6 per mL (interquartile range, 1.2-2.1).  In all, 18 patients (49%) received more than 6 cycles.  Febrile neutropenia was registered in one patient (3%).  Among 35 assessable patients, 8 (23%; 95% CI 12-39%) had partial response (2 with PFI<6; 6 with PFI=6-12) and 15 (43%) had stable disease (10 with PFI<6; 5 with PFI=6-12).  Median progression-free survival (PFS) was 5.0 mo for all patients, 3.8 mo for patients with PFI<6, and 7.8 mo for patients with PFI=6-12.  Median overall survival (OS) was 17.0 mo.  Patients with baseline PBLC higher than the first quartile had improved PFS (P=0.01) and OS (P=0.001).  Conclusion: Tolerability and activity of this combination warrant further randomized testing in patients with PFI<6.  The role of PBLC as a blood-based biomarker deserves further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoONjEpS26OS7Vg90H21EOLACvtfcHk0lgs1jKGP0lkWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xptl2itrw%253D&md5=6bd86917b1f896d085371ca682a9a040</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2012.233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2012.233%26sid%3Dliteratum%253Aachs%26aulast%3DLorusso%26aufirst%3DD.%26aulast%3DScambia%26aufirst%3DG.%26aulast%3DAmadio%26aufirst%3DG.%26aulast%3Ddi%2BLegge%26aufirst%3DA.%26aulast%3DPietragalla%26aufirst%3DA.%26aulast%3DDe%2BVincenzo%26aufirst%3DR.%26aulast%3DMasciullo%26aufirst%3DV.%26aulast%3DDi%2BStefano%26aufirst%3DM.%26aulast%3DMangili%26aufirst%3DG.%26aulast%3DCitterio%26aufirst%3DG.%26aulast%3DMantori%26aufirst%3DM.%26aulast%3DLambiase%26aufirst%3DA.%26aulast%3DBordignon%26aufirst%3DC.%26atitle%3DPhase%2520II%2520study%2520of%2520NGR-hTNF%2520in%2520combination%2520with%2520doxorubicin%2520in%2520relapsed%2520ovarian%2520cancer%2520patients%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2012%26volume%3D107%26spage%3D37%26epage%3D42%26doi%3D10.1038%2Fbjc.2012.233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gregorc, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaafar, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favaretto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jassem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polychronis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidoli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiseo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bearz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greillier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontana, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambiase, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâBrien, M.</span></span> <span> </span><span class="NLM_article-title">NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">799</span>â <span class="NLM_lpage">811</span>, <span class="refDoi">Â DOI: 10.1016/S1470-2045(18)30193-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2FS1470-2045%2818%2930193-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29753703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptlejsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=799-811&author=V.+Gregorcauthor=R.+M.+Gaafarauthor=A.+Favarettoauthor=F.+Grossiauthor=J.+Jassemauthor=A.+Polychronisauthor=P.+Bidoliauthor=M.+Tiseoauthor=R.+Shahauthor=P.+Taylorauthor=S.+Novelloauthor=A.+Muzioauthor=A.+Bearzauthor=L.+Greillierauthor=F.+Fontanaauthor=G.+Saliniauthor=A.+Lambiaseauthor=M.+O%E2%80%99Brien&title=NGR-hTNF+in+combination+with+best+investigator+choice+in+previously+treated+malignant+pleural+mesothelioma+%28NGR015%29%3A+a+randomised%2C+double-blind%2C+placebo-controlled+phase+3+trial&doi=10.1016%2FS1470-2045%2818%2930193-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial</span></div><div class="casAuthors">Gregorc, Vanesa; Gaafar, Rabab M.; Favaretto, Adolfo; Grossi, Francesco; Jassem, Jacek; Polychronis, Andreas; Bidoli, Paolo; Tiseo, Marcello; Shah, Riyaz; Taylor, Paul; Novello, Silvia; Muzio, Alberto; Bearz, Alessandra; Greillier, Laurent; Fontana, Floriana; Salini, Giulia; Lambiase, Antonio; O'Brien, Mary</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">799-811</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Malignant pleural mesothelioma is an aggressive cancer with highly vascularised tumors.  It has poor prognosis and few treatment options after failure of first-line chemotherapy.  NGR-hTNF is a vascular-targeting drug that increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumor microenvironment.  In this trial, we aimed to investigate the efficacy and safety of NGR-hTNF in patients with malignant pleural mesothelioma who had progressed during or after a first-line treatment.  NGR015 was a randomised, double-blind, placebo-controlled phase 3 trial done in 41 centers in 12 countries.  Eligible participants had malignant pleural mesothelioma of any histol. subtype (epithelial, sarcomatoid, or mixed), were aged 18 years or older, and had an Eastern Cooperative Oncol. Group performance status of 0-2 and radiol. documented progressive disease after one pemetrexed-based chemotherapy regimen.  Participants were randomly assigned to receive weekly NGR-hTNF 0Â·8 Î¼g/m2 i.v. plus best investigator choice (n=200), or placebo plus best investigator choice (n=200).  Best investigator choice was decided before random assignment and could be single-agent gemcitabine (1000-1250 mg/m2 i.v.), vinorelbine (25 mg/m2 i.v. or 60 mg/m2 orally), doxorubicin (60-75 mg/m2 i.v.), or best supportive care only.  Patients were randomised (1:1) with a block size of four after stratification for performance status and best investigator choice.  The primary study endpoint was overall survival in the intention-to-treat population.  The trial is closed to new participants and is registered with ClinicalTrials.gov (NCT01098266).  Between Apr. 12, 2010 and Jan 21, 2013, we enrolled 400 eligible participants. 381 (95%) of 400 patients were selected to receive chemotherapy before all participants were randomly assigned to receive NGF-hTNF plus best investigator choice (n=200) or placebo plus best investigator choice (n=200).  At the cutoff date (Apr. 29, 2014), the median follow-up was 18Â·7 mo (IQR 15Â·1-24Â·4), and overall survival did not differ between the two treatment groups (median 8Â·5 mo [95% CI 7Â·2-9Â·9] in the NGR-hTNF group vs 8Â·0 mo [6Â·6-8Â·9] in the placebo group; hazard ratio 0Â·94, 95% CI 0Â·75-1Â·18; p=0Â·58).  Grade 3 or worse study-emergent adverse events occurred in 136 (70%) of patients receiving NGR-hTNF vs. 118 (61%) of patients receiving placebo, with the most common being neutropenia (35 [18%] of 193 patients vs 36 [19%] of 193 patients), pain (11 [6%] vs 16 [8%]), dyspnoea (nine [5%] vs seven [4%]), and chills (nine [5%] vs none). 50 (26%) patients in the NGR-hTNF group had a serious adverse event, compared with 47 (24%) in the placebo group.  Treatment-related serious adverse events occurred in 17 (9%) patients in the NGR-hTNF group and 20 patients (10%) in the placebo group.  There were 12 deaths in the NGR-hTNF group and 13 deaths in the placebo group, but none were treatment related.  The study did not meet its primary endpoint.  The hypothesis-generating findings from the subgroup analyses deserve a confirmatory randomised trial because patients who rapidly progress after first-line treatment have a poor prognosis.MolMed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMlaVH76-vRLVg90H21EOLACvtfcHk0lgs1jKGP0lkWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptlejsL8%253D&md5=e4eb787a369c92e712b827322f623b43</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2818%2930193-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252818%252930193-1%26sid%3Dliteratum%253Aachs%26aulast%3DGregorc%26aufirst%3DV.%26aulast%3DGaafar%26aufirst%3DR.%2BM.%26aulast%3DFavaretto%26aufirst%3DA.%26aulast%3DGrossi%26aufirst%3DF.%26aulast%3DJassem%26aufirst%3DJ.%26aulast%3DPolychronis%26aufirst%3DA.%26aulast%3DBidoli%26aufirst%3DP.%26aulast%3DTiseo%26aufirst%3DM.%26aulast%3DShah%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DNovello%26aufirst%3DS.%26aulast%3DMuzio%26aufirst%3DA.%26aulast%3DBearz%26aufirst%3DA.%26aulast%3DGreillier%26aufirst%3DL.%26aulast%3DFontana%26aufirst%3DF.%26aulast%3DSalini%26aufirst%3DG.%26aulast%3DLambiase%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%26atitle%3DNGR-hTNF%2520in%2520combination%2520with%2520best%2520investigator%2520choice%2520in%2520previously%2520treated%2520malignant%2520pleural%2520mesothelioma%2520%2528NGR015%2529%253A%2520a%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520phase%25203%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2018%26volume%3D19%26spage%3D799%26epage%3D811%26doi%3D10.1016%2FS1470-2045%2818%2930193-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zarovni, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corti, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor alpha coupled to NGR and RGD tumor-homing peptides</span>. <i>Hum. Gene Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">373</span>â <span class="NLM_lpage">382</span>, <span class="refDoi">Â DOI: 10.1089/104303404322959524</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1089%2F104303404322959524" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=15053862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisF2ksb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=373-382&author=N.+Zarovniauthor=L.+Monacoauthor=A.+Corti&title=Inhibition+of+tumor+growth+by+intramuscular+injection+of+cDNA+encoding+tumor+necrosis+factor+alpha+coupled+to+NGR+and+RGD+tumor-homing+peptides&doi=10.1089%2F104303404322959524"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor Î± coupled to NGR and RGD tumor-homing peptides</span></div><div class="casAuthors">Zarovni, Natasa; Monaco, Lucia; Corti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Human Gene Therapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">373-382</span>CODEN:
                <span class="NLM_cas:coden">HGTHE3</span>;
        ISSN:<span class="NLM_cas:issn">1043-0342</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">The antitumor properties of tumor necrosis factor Î± (TNF) and its efficacy in selective destruction of tumor-assocd. vessels are well known.  Besides the TNF protein, the TNF gene has been used for gene therapy of cancer and shown to induce antitumor responses both in animal models and in patients.  We show here that the therapeutic properties of the TNF gene are improved by fusing the TNF sequence with those of peptides able to target tumor vessels, such as CNGRCG or ACDCRGDCFCG.  I.m. administration of plasmid DNA encoding CNGRCG-TNF and ACDCRGDCFCG-TNF (pNGR-TNF and pRGD-TNF, resp.), but not plasmids encoding TNF (pTNF) or empty vector (pMock), inhibited the growth of s.c. murine B16F1 melanomas and RMA-T lymphomas implanted at sites distant from the site of plasmid injection.  The combination of pNGR-TNF or pRGD-TNF with doxorubicin or melphalan induced stronger effects than single agents.  These treatments induced antitumor effects without activating toxic or neg. feedback mechanisms.  In addn., pRGD-TNF increased the uptake of an antibody directed to a tumor-assocd. antigen.  These results suggest that the therapeutic properties of NGR-TNF and RGD-TNF cDNAs are greater than those of TNF cDNA and provide the rationale for developing new gene therapy approaches based on vascular targeting with TNF coupled to tumor-homing peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7XOSfbgn9DrVg90H21EOLACvtfcHk0lgs1jKGP0lkWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisF2ksb4%253D&md5=ab5d29e64a8d4f33bd570677c2cf3854</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1089%2F104303404322959524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F104303404322959524%26sid%3Dliteratum%253Aachs%26aulast%3DZarovni%26aufirst%3DN.%26aulast%3DMonaco%26aufirst%3DL.%26aulast%3DCorti%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520tumor%2520growth%2520by%2520intramuscular%2520injection%2520of%2520cDNA%2520encoding%2520tumor%2520necrosis%2520factor%2520alpha%2520coupled%2520to%2520NGR%2520and%2520RGD%2520tumor-homing%2520peptides%26jtitle%3DHum.%2520Gene%2520Ther.%26date%3D2004%26volume%3D15%26spage%3D373%26epage%3D382%26doi%3D10.1089%2F104303404322959524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seidi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahanban-Esfahlan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monhemi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zare, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minofar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daei Farshchi Adli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farajzadeh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behzadi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesgari Abbasi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubauer, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriggl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarghami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javaheri, T.</span></span> <span> </span><span class="NLM_article-title">NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">3967</span>â <span class="NLM_lpage">3980</span>, <span class="refDoi">Â DOI: 10.1038/s41388-018-0213-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fs41388-018-0213-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29662195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXns1Ortb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&pages=3967-3980&author=K.+Seidiauthor=R.+Jahanban-Esfahlanauthor=H.+Monhemiauthor=P.+Zareauthor=B.+Minofarauthor=A.+Daei+Farshchi+Adliauthor=D.+Farajzadehauthor=R.+Behzadiauthor=M.+Mesgari+Abbasiauthor=H.+A.+Neubauerauthor=R.+Morigglauthor=N.+Zarghamiauthor=T.+Javaheri&title=NGR+%28Asn-Gly-Arg%29-targeted+delivery+of+coagulase+to+tumor+vasculature+arrests+cancer+cell+growth&doi=10.1038%2Fs41388-018-0213-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth</span></div><div class="casAuthors">Seidi, Khaled; Jahanban-Esfahlan, Rana; Monhemi, Hassan; Zare, Peyman; Minofar, Babak; Daei Farshchi Adli, Amir; Farajzadeh, Davoud; Behzadi, Ramezan; Mesgari Abbasi, Mehran; Neubauer, Heidi A.; Moriggl, Richard; Zarghami, Nosratollah; Javaheri, Tahereh</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">3967-3980</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Induction of selective thrombosis and infarction in tumor-feeding vessels represents an attractive strategy to combat cancer.  Here we took advantage of the unique coagulation properties of staphylocoagulase and genetically engineered it to generate a new fusion protein with novel anti-cancer properties.  This novel bi-functional protein consists of truncated coagulase (tCoa) and an NGR (GNGRAHA) motif that recognizes CD13 and Î±vÎ²3 integrin receptors, targeting it to tumor endothelial cells.  Herein, we report that tCoa coupled by its C-terminus to an NGR sequence retained its normal binding activity with prothrombin and avÎ²3 integrins, as confirmed in silico and in vitro.  Moreover, in vivo biodistribution studies demonstrated selective accumulation of FITC-labeled tCoa-NGR fusion proteins at the site of s.c. implanted PC3 tumor xenografts in nude mice.  Notably, systemic administration of tCoa-NGR to mice bearing 4T1 mouse mammary xenografts or PC3 human prostate tumors resulted in a significant redn. in tumor growth.  These anti-tumor effects were accompanied by massive thrombotic occlusion of small and large tumor vessels, tumor infarction and tumor cell death.  From these findings, we propose tCoa-NGR mediated tumor infarction as a novel and promising anti-cancer strategy targeting both CD13 and integrin Î±vÎ²3 pos. tumor neovasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8xflAWfaBbrVg90H21EOLACvtfcHk0lj4yM7aZQmJqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXns1Ortb8%253D&md5=8299f8a01f2f50e5a7b6a08b4a8d424d</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1038%2Fs41388-018-0213-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41388-018-0213-4%26sid%3Dliteratum%253Aachs%26aulast%3DSeidi%26aufirst%3DK.%26aulast%3DJahanban-Esfahlan%26aufirst%3DR.%26aulast%3DMonhemi%26aufirst%3DH.%26aulast%3DZare%26aufirst%3DP.%26aulast%3DMinofar%26aufirst%3DB.%26aulast%3DDaei%2BFarshchi%2BAdli%26aufirst%3DA.%26aulast%3DFarajzadeh%26aufirst%3DD.%26aulast%3DBehzadi%26aufirst%3DR.%26aulast%3DMesgari%2BAbbasi%26aufirst%3DM.%26aulast%3DNeubauer%26aufirst%3DH.%2BA.%26aulast%3DMoriggl%26aufirst%3DR.%26aulast%3DZarghami%26aufirst%3DN.%26aulast%3DJavaheri%26aufirst%3DT.%26atitle%3DNGR%2520%2528Asn-Gly-Arg%2529-targeted%2520delivery%2520of%2520coagulase%2520to%2520tumor%2520vasculature%2520arrests%2520cancer%2520cell%2520growth%26jtitle%3DOncogene%26date%3D2018%26volume%3D37%26spage%3D3967%26epage%3D3980%26doi%3D10.1038%2Fs41388-018-0213-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosseini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseini, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashempour, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattahi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeghizadeh, M.</span></span> <span> </span><span class="NLM_article-title">Effect of RGD coupled MDA-7/IL-24 on apoptosis induction in a hepatocellular carcinoma cell line</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">495</span>â <span class="NLM_lpage">501</span>, <span class="refDoi">Â DOI: 10.3892/mmr.2016.6009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.3892%2Fmmr.2016.6009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27959433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptVymt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=495-501&author=E.+Hosseiniauthor=S.+Y.+Hosseiniauthor=T.+Hashempourauthor=M.+R.+Fattahiauthor=M.+Sadeghizadeh&title=Effect+of+RGD+coupled+MDA-7%2FIL-24+on+apoptosis+induction+in+a+hepatocellular+carcinoma+cell+line&doi=10.3892%2Fmmr.2016.6009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of RGD coupled MDA-7/IL-24 on apoptosis induction in a hepatocellular carcinoma cell line</span></div><div class="casAuthors">Hosseini, Ebrahim; Hosseini, Seyed Younes; Hashempour, Tayebeh; Fattahi, Mohammad Reza; Sadeghizadeh, Majid</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">495-501</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The melanoma differentiation assocd. gene 7 (MDA 7) gene, also termed interleukin 24 (IL 24), is a tumor suppressor gene that induces apoptosis in a broad scope of malignant neoplastic cells.  The apoptosis induction capacity of the MDA 7/IL 24 gene is partially assocd. with adhering to cognate receptors.  The current study aimed to enhance the antitumor effect of IL 24.  The intrinsic signal sequence of IL 24 replaced with a fused artificial signal (secrecon) RGD4C sequence and its impact was evaluated in HepG2 cells.  The modified SP.RGD.IL 24 and native IL 24 cDNA sequences were cloned into the pcDNA3.1 expression vector.  Subsequently, the expression level, secretion efficacy and targeting propensity of the modified SP.RGD.IL 24 product compared with normal IL 24 by were detd. by enzyme linked immunosorbent assay.  The constructs were then transfected into HepG2 and LX 2 cells as tumor and normal hepatic cell lines, resp.  The expression level of the pro apoptotic DNA damage inducible transcript 3 (Gadd153) and BCL2 assocd. X apoptosis regulator (Bax) genes in the different groups were compared by reverse transcription quant. polymerase chain reaction.  Addnl., the rate of apoptosis induction of modified and intact IL 24 sequences was compared by flow cytometry anal. of cells following their propidium iodide/annexin V staining.  SP.RGD IL 24 protein was expressed and secreted in a similar manner to native IL 24, however, the modified SP.RGD.IL 24 adhered to tumor cells more efficiently than IL 24 (P<0.05).  SP.RGD.IL 24 significantly induced upregulation of Gadd153 and Bax in HepG2 cells compared with native IL 24 (P<0.05).  However, neither had a significant impact on the expression level of pro apoptotic genes in LX 2 cells.  Flow cytometry anal. also indicated that modified SP.RGD.IL 24 induced apoptosis more than native IL 24 in HepG2 cells (P<0.05).  In conclusion, the novel generated RGD coupled IL 24 construct exhibited sufficient anticancer activity compared with the native IL 24.  The results of the current study provide novel insights for the future of cytokine targeting and indicates its potential capacity as a valuable candidate for gene therapy methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFk5dU-cAWjrVg90H21EOLACvtfcHk0lj4yM7aZQmJqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptVymt7Y%253D&md5=ea330c953d3c5f0473996e0420b72054</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2016.6009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2016.6009%26sid%3Dliteratum%253Aachs%26aulast%3DHosseini%26aufirst%3DE.%26aulast%3DHosseini%26aufirst%3DS.%2BY.%26aulast%3DHashempour%26aufirst%3DT.%26aulast%3DFattahi%26aufirst%3DM.%2BR.%26aulast%3DSadeghizadeh%26aufirst%3DM.%26atitle%3DEffect%2520of%2520RGD%2520coupled%2520MDA-7%252FIL-24%2520on%2520apoptosis%2520induction%2520in%2520a%2520hepatocellular%2520carcinoma%2520cell%2520line%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2017%26volume%3D15%26spage%3D495%26epage%3D501%26doi%3D10.3892%2Fmmr.2016.6009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. N.</span></span> <span> </span><span class="NLM_article-title">Potent antitumor effect elicited by RGD-mda-7, an mda-7/IL-24 mutant, via targeting the integrin receptor of tumor cells</span>. <i>Cancer Biother.Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">647</span>â <span class="NLM_lpage">655</span>, <span class="refDoi">Â DOI: 10.1089/cbr.2011.0984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1089%2Fcbr.2011.0984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=21902545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlWrsbrI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=647-655&author=B.+F.+Zhangauthor=J.+J.+Liuauthor=D.+S.+Peiauthor=Z.+X.+Yangauthor=J.+H.+Diauthor=F.+F.+Chenauthor=H.+Z.+Liauthor=W.+Xuauthor=Y.+P.+Wuauthor=J.+N.+Zheng&title=Potent+antitumor+effect+elicited+by+RGD-mda-7%2C+an+mda-7%2FIL-24+mutant%2C+via+targeting+the+integrin+receptor+of+tumor+cells&doi=10.1089%2Fcbr.2011.0984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Antitumor Effect Elicited by RGD-mda-7, an mda-7/IL-24 Mutant, via Targeting the Integrin Receptor of Tumor Cells</span></div><div class="casAuthors">Zhang, Bao-Fu; Liu, Jun-Jie; Pei, Dong-Sheng; Yang, Zhi-Xia; Di, Jie-Hui; Chen, Fei-Fei; Li, Hui-Zhong; Xu, Wei; Wu, Yong-Ping; Zheng, Jun-Nian</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">647-655</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">The melanoma differentiation-assocd. gene-7/interleukin-24 gene (mda-7/IL-24) is a novel tumor-suppressor/cytokine gene that exhibits potent tumor-suppressive activity without damaging normal cells.  To enhance the antitumor effect, an mda-7/IL-24 mutant, RGD-mda-7, which includes the cell adhesive sequence 164Arg-165Gly-166Asp (RGD motif), was constructed and evaluated for bioactivity.  RGD peptide binds to integrins Î±VÎ²3 and Î±VÎ²5, which are selectively expressed in tumor neovasculature and in the surface of some tumor cells.  The wtmda-7/IL-24 and RGD-mda-7 were expressed in Escherichia coli and then purified and renatured.  The immunostimulatory activity of RGD-mda-7 was assayed by stimulating peripheral blood mononuclear cells.  The results suggested that the abilities of RGD-mda-7 to induce IL-6, TNF-Î±, and IFN-Î³ prodn. were higher than wtmda-7/IL-24.  Tumor targeting of RGD-mda-7 was assayed using cell adhesion expts.  The antitumor effect of the purified RGD-mda-7 on cell proliferation in vitro was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) uptake, cell apoptosis by staining with fluorescent probes of FITC-annexin V and DAPI, and caspase-3 expression and activity.  The in vitro results showed that RGD-mda-7 inhibited the proliferation of multiple tumor cell lines (Hela, ACHN, HepG2, and A549).  Staining with fluorescent probes of FITC-annexin V and DAPI indicated that RGD-mda-7 could induce apoptosis more effectively in four tumor cell lines than wtmda-7/IL-24, but has no effect on normal cell line NHLF.  Western blotting showed that treatment of tumor cells with RGD-mda-7 could activate apoptotic pathway by cleavage of caspase-3 as same as wtmda-7/IL-24.  Further, RGD-mda-7 group showed a higher cleaved level of caspase-3, but not in NHLF cells.  These results demonstrate that RGD-MDA-7 possesses more potent antitumor effects than wtmda-7/IL-24 and therefore merits further investigation in preclin. and clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3JNaAmoTztLVg90H21EOLACvtfcHk0lj4yM7aZQmJqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlWrsbrI&md5=d2756e2822bced4bbf5eddcc831d1cfd</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2011.0984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2011.0984%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DB.%2BF.%26aulast%3DLiu%26aufirst%3DJ.%2BJ.%26aulast%3DPei%26aufirst%3DD.%2BS.%26aulast%3DYang%26aufirst%3DZ.%2BX.%26aulast%3DDi%26aufirst%3DJ.%2BH.%26aulast%3DChen%26aufirst%3DF.%2BF.%26aulast%3DLi%26aufirst%3DH.%2BZ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%2BP.%26aulast%3DZheng%26aufirst%3DJ.%2BN.%26atitle%3DPotent%2520antitumor%2520effect%2520elicited%2520by%2520RGD-mda-7%252C%2520an%2520mda-7%252FIL-24%2520mutant%252C%2520via%2520targeting%2520the%2520integrin%2520receptor%2520of%2520tumor%2520cells%26jtitle%3DCancer%2520Biother.Radiopharm.%26date%3D2011%26volume%3D26%26spage%3D647%26epage%3D655%26doi%3D10.1089%2Fcbr.2011.0984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseini, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenavar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortazavi, M.</span></span> <span> </span><span class="NLM_article-title">The effect of RGD/NGR peptide modification of melanoma differentiation-associated gene-7/interleukin-24 on its receptor attachment, an in silico analysis</span>. <i>Cancer Biother.Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">205</span>â <span class="NLM_lpage">214</span>, <span class="refDoi">Â DOI: 10.1089/cbr.2017.2195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1089%2Fcbr.2017.2195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28792792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKjtLrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=205-214&author=S.+Binaauthor=S.+Y.+Hosseiniauthor=F.+Shenavarauthor=E.+Hosseiniauthor=M.+Mortazavi&title=The+effect+of+RGD%2FNGR+peptide+modification+of+melanoma+differentiation-associated+gene-7%2Finterleukin-24+on+its+receptor+attachment%2C+an+in+silico+analysis&doi=10.1089%2Fcbr.2017.2195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">The Effect of RGD/NGR Peptide Modification of Melanoma Differentiation-Associated Gene-7/Interleukin-24 on Its Receptor Attachment, an In Silico Analysis</span></div><div class="casAuthors">Bina, Samaneh; Hosseini, Seyed Younes; Shenavar, Fatemeh; Hosseini, Ebrahim; Mortazavi, Mojtaba</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">205-214</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Melanoma differentiation-assocd. gene-7 (mda-7/interleukin [IL]-24), a unique tumor suppressor gene, induces selective apoptosis in tumor cells.  Secreted IL-24 binds to heterodimeric receptor complexes of IL-20R1/IL-20R2, IL-22R1/IL-20R2, or sigma-1 receptor (Sig1R) that consequently enhances apoptosis.  However, this mechanism is not well understood and most likely involves different pathways.  Targeting of cytokine by tumor homing peptides (THPs) to the tumor cell surface mol.-like integrin shows to be beneficial in gene immunotherapy approaches.  In this study, the in silico targeting of RGD/NGR-modified IL-24 to tumor cells was conducted.  In this regard, the sequences of six new synthetic IL-24s that have been modified by RGD (Arg-Gly-Asp) or NGR (CRNGRGPDC) were aligned and their structures were modeled through homol. modeling to evaluate their attachment potential to cognate receptor complexes such as IL-20R1/IL-20R2, IL-22R1/IL-20R2, or Sig1R.  The results of homol. modeling showed that modification of IL-24 with RGD motif in N-terminal and middle of this protein exhibited stronger interaction with cognate receptors.  These results also demonstrated that modified IL-24 with RGD motif in the C-terminal has lost native activity.  However, the interaction of THP-modified IL-24 with Sig1R would not be affected to that extent, interestingly.  Conclusively, in silico anal. showed that modification of IL-24 with THPs needs a more detailed study as these modifications may disrupt native interaction with receptors and reduce apoptosis induction property.  This structural anal. gives us a better understanding of mda-7/IL-24 interaction with cognate receptors and helps a more rational design for further cytokine modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVoSjS1yD987Vg90H21EOLACvtfcHk0liqLQmWe8qVgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKjtLrM&md5=fda11918ca6ee51f24a2c8cfee50faab</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2017.2195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2017.2195%26sid%3Dliteratum%253Aachs%26aulast%3DBina%26aufirst%3DS.%26aulast%3DHosseini%26aufirst%3DS.%2BY.%26aulast%3DShenavar%26aufirst%3DF.%26aulast%3DHosseini%26aufirst%3DE.%26aulast%3DMortazavi%26aufirst%3DM.%26atitle%3DThe%2520effect%2520of%2520RGD%252FNGR%2520peptide%2520modification%2520of%2520melanoma%2520differentiation-associated%2520gene-7%252Finterleukin-24%2520on%2520its%2520receptor%2520attachment%252C%2520an%2520in%2520silico%2520analysis%26jtitle%3DCancer%2520Biother.Radiopharm.%26date%3D2017%26volume%3D32%26spage%3D205%26epage%3D214%26doi%3D10.1089%2Fcbr.2017.2195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Numata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reagan, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblatt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, D. L.</span></span> <span> </span><span class="NLM_article-title">Spider silk-based gene carriers for tumor cell-specific delivery</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1605</span>â <span class="NLM_lpage">1610</span>, <span class="refDoi">Â DOI: 10.1021/bc200170u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc200170u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1yhsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1605-1610&author=K.+Numataauthor=M.+R.+Reaganauthor=R.+H.+Goldsteinauthor=M.+Rosenblattauthor=D.+L.+Kaplan&title=Spider+silk-based+gene+carriers+for+tumor+cell-specific+delivery&doi=10.1021%2Fbc200170u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Spider Silk-Based Gene Carriers for Tumor Cell-Specific Delivery</span></div><div class="casAuthors">Numata, Keiji; Reagan, Michaela R.; Goldstein, Robert H.; Rosenblatt, Michael; Kaplan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1605-1610</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The present study demonstrates pDNA complexes of recombinant silk proteins contg. poly(L-lysine) and tumor-homing peptides (THPs), which are globular and approx. 150-250 nm in diam., show significant enhancement of target specificity to tumor cells by addns. of F3 and CGKRK THPs.  We report herein the prepn. and study of novel nanoscale silk-based ionic complexes contg. pDNA able to home specifically to tumor cells.  Particular focus was on how the THP, F3 (KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK), and CGKRK, enhanced transfection specificity to tumor cells.  Genetically engineered silk proteins contg. both poly(L-lysine) domains to interact with pDNA and the THP to bind to specific tumor cells for target-specific pDNA delivery were prepd. using Escherichia coli, followed by in vitro and in vivo transfection expts. into MDA-MB-435 melanoma cells and highly metastatic human breast tumor MDA-MB-231 cells.  Non-tumorigenic MCF-10A breast epithelial cells were used as a control cell line for in vitro tumor-specific delivery studies.  These results demonstrate that combination of the bioengineered silk delivery systems and THP can serve as a versatile and useful new platform for nonviral gene delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5KI76DmrK-LVg90H21EOLACvtfcHk0liqLQmWe8qVgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1yhsbg%253D&md5=84da58032d1c002b3dcbaebaea340ee8</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fbc200170u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200170u%26sid%3Dliteratum%253Aachs%26aulast%3DNumata%26aufirst%3DK.%26aulast%3DReagan%26aufirst%3DM.%2BR.%26aulast%3DGoldstein%26aufirst%3DR.%2BH.%26aulast%3DRosenblatt%26aufirst%3DM.%26aulast%3DKaplan%26aufirst%3DD.%2BL.%26atitle%3DSpider%2520silk-based%2520gene%2520carriers%2520for%2520tumor%2520cell-specific%2520delivery%26jtitle%3DBioconjugate%2520Chem.%26date%3D2011%26volume%3D22%26spage%3D1605%26epage%3D1610%26doi%3D10.1021%2Fbc200170u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foo, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karageorgiou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitchel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, D. L.</span></span> <span> </span><span class="NLM_article-title">RGD-functionalized bioengineered spider dragline silk biomaterial</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3139</span>â <span class="NLM_lpage">3145</span>, <span class="refDoi">Â DOI: 10.1021/bm0607877</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bm0607877" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWkurbJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=3139-3145&author=E.+Biniauthor=C.+W.+Fooauthor=J.+Huangauthor=V.+Karageorgiouauthor=B.+Kitchelauthor=D.+L.+Kaplan&title=RGD-functionalized+bioengineered+spider+dragline+silk+biomaterial&doi=10.1021%2Fbm0607877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">RGD-Functionalized Bioengineered Spider Dragline Silk Biomaterial</span></div><div class="casAuthors">Bini, Elisabetta; Foo, Cheryl Wong Po; Huang, Jia; Karageorgiou, Vassilis; Kitchel, Brandon; Kaplan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3139-3145</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spider silk fibers have remarkable mech. properties that suggest the component proteins could be useful biopolymers for fabricating biomaterial scaffolds for tissue formation.  Two bioengineered protein variants from the consensus sequence of the major component of dragline silk from Nephila clavipes were cloned and expressed to include RGD cell-binding domains.  The engineered silks were characterized by CD and FTIR and showed structural transitions from random coil to insol. Î²-sheet upon treatment with methanol.  The recombinant proteins were processed into films and fibers and successfully used as biomaterial matrixes to culture human bone marrow stromal cells induced to differentiate into bone-like tissue upon addn. of osteogenic stimulants.  The recombinant spider silk and the recombinant spider silk with RGD encoded into the protein both supported enhanced the differentiation of human bone marrow derived mesenchymal stem cells (hMSCs) to osteogenic outcomes when compared to tissue culture plastic.  The recombinant spider silk protein without the RGD displayed enhanced bone related outcomes, measured by calcium deposition, when compared to the same protein with RGD.  Based on comparisons to our prior studies with silkworm silks and RGD modifications, the current results illustrate the potential to bioengineer spider silk proteins into new biomaterial matrixes, while also highlighting the importance of subtle differences in silk sources and modes of presentation of RGD to cells in terms of tissue-specific outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvK5XgFzps6LVg90H21EOLACvtfcHk0liqLQmWe8qVgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWkurbJ&md5=8477bf8542dd6539fa980764bc9b3acf</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1021%2Fbm0607877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbm0607877%26sid%3Dliteratum%253Aachs%26aulast%3DBini%26aufirst%3DE.%26aulast%3DFoo%26aufirst%3DC.%2BW.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DKarageorgiou%26aufirst%3DV.%26aulast%3DKitchel%26aufirst%3DB.%26aulast%3DKaplan%26aufirst%3DD.%2BL.%26atitle%3DRGD-functionalized%2520bioengineered%2520spider%2520dragline%2520silk%2520biomaterial%26jtitle%3DBiomacromolecules%26date%3D2006%26volume%3D7%26spage%3D3139%26epage%3D3145%26doi%3D10.1021%2Fbm0607877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valluzzi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernaglia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, D. L.</span></span> <span> </span><span class="NLM_article-title">Cloning, expression, and assembly of sericin-like protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">46117</span>â <span class="NLM_lpage">46123</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M307792200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1074%2Fjbc.M307792200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=12963711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosl2iurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=46117-46123&author=J.+Huangauthor=R.+Valluzziauthor=E.+Biniauthor=B.+Vernagliaauthor=D.+L.+Kaplan&title=Cloning%2C+expression%2C+and+assembly+of+sericin-like+protein&doi=10.1074%2Fjbc.M307792200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, Expression, and Assembly of Sericin-like Protein</span></div><div class="casAuthors">Huang, Jia; Valluzzi, Regina; Bini, Elisabetta; Vernaglia, Brian; Kaplan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">46117-46123</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Recombinant sericin proteins of different mol. masses (17.4, 31.9, and 46.5 kDa), based on the 38-amino acid repetitive motif of native sericin, were cloned, expressed, and purified.  The recombinant sericin self-assembled during dialysis (starting concn. of 2.5 mg/mL) forming twisted fibers.  CD and Fourier transform IR spectroscopy studies demonstrated protein conformational transitions occurred from random coil to Î²-sheets during the dialysis.  Congo red-stained recombinant sericin fibrils exhibited apple-green birefringence, indicating long-range order in the array of Î²-sheets.  Biosynthetic sericin has a high content of polar amino acids (e.g. >40 mol % serine), leading to a Î²-sheet conformation formed by hydrogen bonding via polar zipper interactions.  Anal. of recombinant sericin sequence using Mandel-Gutfreund's definition of polar and non-polar amino acids showed that the hydrophobicity pattern resembles the most frequent pattern of amyloidogenic proteins, polar amino acid aggregates (PPPPP).  Many Î²-proteins and peptides are designed to study amyloidogenesis using a polar/non-polar alternating pattern (PNPNPN).  Sericin-like proteins or peptides provide an alternative model in terms of hydrophobicity pattern with which to explore questions related to Î²-sheet formation and amyloidogenesis.  The glue-like property of sericin is attributed to the hydrogen bonding between serine residues of sericin with serine residues in the fibroin structural components of silk fiber.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJY5taYG6ayrVg90H21EOLACvtfcHk0ljaRRHvKPT-Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosl2iurs%253D&md5=67d0129e750dc8a3bbe83c43538791b3</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M307792200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M307792200%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DValluzzi%26aufirst%3DR.%26aulast%3DBini%26aufirst%3DE.%26aulast%3DVernaglia%26aufirst%3DB.%26aulast%3DKaplan%26aufirst%3DD.%2BL.%26atitle%3DCloning%252C%2520expression%252C%2520and%2520assembly%2520of%2520sericin-like%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D46117%26epage%3D46123%26doi%3D10.1074%2Fjbc.M307792200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiGirolamo, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, D. L.</span></span> <span> </span><span class="NLM_article-title">Construction, cloning, and expression of synthetic genes encoding spider dragline silk</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">10879</span>â <span class="NLM_lpage">10885</span>, <span class="refDoi">Â DOI: 10.1021/bi00034a022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00034a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADyaK2MXnsVymu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=10879-10885&author=J.+T.+Princeauthor=K.+P.+McGrathauthor=C.+M.+DiGirolamoauthor=D.+L.+Kaplan&title=Construction%2C+cloning%2C+and+expression+of+synthetic+genes+encoding+spider+dragline+silk&doi=10.1021%2Fbi00034a022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Construction, Cloning, and Expression of Synthetic Genes Encoding Spider Dragline Silk</span></div><div class="casAuthors">Prince, John T.; McGrath, Kevin P.; DiGirolamo, Carla M.; Kaplan, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">10879-85</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Synthetic genes encoding recombinant spider silk proteins have been constructed, cloned, and expressed.  Protein sequences were derived from Nephila clavipes dragline silk proteins and reverse-translated to the corresponding DNA sequences.  Codon selection was chosen to maximize expression levels in Escherichia coli.  DNA "monomer" sequences were multimerized to encode high mol. wt. synthetic spider silks using a "head-to-tail" construction strategy.  Multimers were cloned into a prokaryotic expression vector and the encoded silk proteins were expressed in E. coli upon induction with IPTG.1.  Four multimers, ranging in size from 14.7 to 41.3 kDa, were chosen for detailed anal.  These proteins were isolated by immobilized metal affinity chromatog. and purified using reverse-phase HPLC.  The compn. and identity of the purified proteins were confirmed by amino acid compn. anal., N-terminal sequencing, laser desorption mass spectroscopy, and Western anal. using antibodies reactive to native spider dragline silk.  CD measurements indicate that the synthetic spider silks have substantial Î²-sheet structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzJnLQNu110bVg90H21EOLACvtfcHk0ljaRRHvKPT-Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsVymu74%253D&md5=9af2b96394613f96dd80b085af242a67</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fbi00034a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00034a022%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DJ.%2BT.%26aulast%3DMcGrath%26aufirst%3DK.%2BP.%26aulast%3DDiGirolamo%26aufirst%3DC.%2BM.%26aulast%3DKaplan%26aufirst%3DD.%2BL.%26atitle%3DConstruction%252C%2520cloning%252C%2520and%2520expression%2520of%2520synthetic%2520genes%2520encoding%2520spider%2520dragline%2520silk%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D10879%26epage%3D10885%26doi%3D10.1021%2Fbi00034a022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeler, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W. J.</span></span> <span> </span><span class="NLM_article-title">The regulation of type 7 adenylyl cyclase by its C1b region and <i>Escherichia coli</i> peptidylprolyl isomerase, SlyD</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">8500</span>â <span class="NLM_lpage">8506</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M010361200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1074%2Fjbc.M010361200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11113152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFKgtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=8500-8506&author=S.+Z.+Yanauthor=J.+A.+Beelerauthor=Y.+B.+Chenauthor=R.+K.+Sheltonauthor=W.+J.+Tang&title=The+regulation+of+type+7+adenylyl+cyclase+by+its+C1b+region+and+Escherichia+coli+peptidylprolyl+isomerase%2C+SlyD&doi=10.1074%2Fjbc.M010361200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">The regulation of type 7 adenylyl cyclase by its C1b region and Escherichia coli peptidylprolyl isomerase, SlyD</span></div><div class="casAuthors">Yan, Shui-Zhong; Beeler, Jeff A.; Chen, Yibang; Shelton, Robyn K.; Tang, Wei-Jen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">8500-8506</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mammalian membrane-bound adenylyl cyclase consists of two highly conserved cytoplasmic domains (C1a and C2a) sepd. by a less conserved connecting region, C1b, and one of two transmembrane domains, M2.  The C1a and C2a domains form a catalytic core that can be stimulated by forskolin and the stimulatory G protein subunit Î± (GÎ±s).  In this study, we analyzed the regulation of type 7 adenylyl cyclase (AC7) by C1b.  The C1a, C1b, and C2a domains of AC7 were purified sep.  Escherichia coli SlyD protein, a cis-trans peptidylprolyl isomerase (PPIase), copurifies with AC7 C1b (7C1b).  SlyD protein can inhibit the GÎ±s- and/or forskolin-activated activity of both sol. and membrane-bound AC7.  Mutant forms of SlyD with reduced PPIase activity are less potent in the inhibition of AC7 activity.  Interestingly, different isoforms of mammalian membrane-bound adenylyl cyclase can be either inhibited or stimulated by SlyD protein, raising the possibility that mammalian PPIase may regulate enzymic activity of mammalian adenylyl cyclase.  Purified 7C1b-SlyD complex has a greater inhibitory effect on AC7 activity than SlyD alone.  This inhibition by 7C1b is abolished in a 7C1b mutant in which a conserved glutamic acid (amino acid residue 582) is changed to alanine.  Inhibition of adenylyl cyclase activity by 7C1b is further confirmed by using 7C1b purified from an E. coli slyD-deficient strain.  This inhibitory activity of AC7 is also obsd. with the 28-mer peptides derived from a region of C1b conserved in AC7 and AC2 but is not obsd. with a peptide derived from the corresponding region of AC6.  This inhibitory activity exhibited by the C1b domain may result from the interaction of 7C1b with 7C1a and 7C2a and may serve to hold AC7 in the basal nonstimulated state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph9J9YcVgkp7Vg90H21EOLACvtfcHk0ljaRRHvKPT-Fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFKgtLs%253D&md5=27290875d988e901e5df4bb39d6d32dd</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M010361200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M010361200%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BZ.%26aulast%3DBeeler%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DY.%2BB.%26aulast%3DShelton%26aufirst%3DR.%2BK.%26aulast%3DTang%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520regulation%2520of%2520type%25207%2520adenylyl%2520cyclase%2520by%2520its%2520C1b%2520region%2520and%2520Escherichia%2520coli%2520peptidylprolyl%2520isomerase%252C%2520SlyD%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D8500%26epage%3D8506%26doi%3D10.1074%2Fjbc.M010361200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galbiati, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civitarese, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allevi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avvakumova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosperi, D.</span></span> <span> </span><span class="NLM_article-title">âBlindâ targeting in action: from phage display to breast cancer cell targeting with peptide-gold nanoconjugates</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">155</span>â <span class="NLM_lpage">162</span>, <span class="refDoi">Â DOI: 10.1016/j.phrs.2016.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.phrs.2016.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27293049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtV2gtLbO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=155-162&author=E.+Galbiatiauthor=L.+Gambiniauthor=V.+Civitareseauthor=M.+Belliniauthor=D.+Ambrosiniauthor=R.+Alleviauthor=S.+Avvakumovaauthor=S.+Romeoauthor=D.+Prosperi&title=%E2%80%9CBlind%E2%80%9D+targeting+in+action%3A+from+phage+display+to+breast+cancer+cell+targeting+with+peptide-gold+nanoconjugates&doi=10.1016%2Fj.phrs.2016.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">"Blind" targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates</span></div><div class="casAuthors">Galbiati, Elisabetta; Gambini, Luca; Civitarese, Viola; Bellini, Michela; Ambrosini, Dario; Allevi, Raffaele; Avvakumova, Svetlana; Romeo, Sergio; Prosperi, Davide</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">155-162</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tumor homing peptides (THPs) specific for a representative breast cancer cell line (MCF-7) were carefully selected basing on a phage-displayed peptide library freely available on the web, namely the "TumorHoPe: A Database of Tumor Homing Peptides".  The selected THPs were synthesized and evaluated in terms of their affinity toward MCF-7 cells.  Out of 5 tested THPs, 3 best-performing peptide sequences and 1 scrambled sequence were sep. conjugated to spherical gold nanoparticles yielding stable nanoconjugates.  THP nanoconjugates were examd. for their ability to actively target MCF-7 cells in comparison to noncancerous 3T3-L1 fibroblast cells.  These THP-gold nanoconjugates exhibited good selectivity and binding affinity by flow cytometry, and low cytotoxicity as assayed by cell death expts.  The uptake of targeted nanoconjugates by the breast cancer cells was confirmed by transmission electron microscopy anal.  This work demonstrates that it is possible to exploit the conjugation of short peptides selected from phage-displayed libraries to develop nanomaterials reliably endowed with tumor targeting potential irresp. of a specific knowledge of the target cell biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz990-b0NgJbVg90H21EOLACvtfcHk0lg7lAk8FMrOvQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtV2gtLbO&md5=2270ce0006b9fb97e5b3fc15769c508c</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2016.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2016.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DGalbiati%26aufirst%3DE.%26aulast%3DGambini%26aufirst%3DL.%26aulast%3DCivitarese%26aufirst%3DV.%26aulast%3DBellini%26aufirst%3DM.%26aulast%3DAmbrosini%26aufirst%3DD.%26aulast%3DAllevi%26aufirst%3DR.%26aulast%3DAvvakumova%26aufirst%3DS.%26aulast%3DRomeo%26aufirst%3DS.%26aulast%3DProsperi%26aufirst%3DD.%26atitle%3D%25E2%2580%259CBlind%25E2%2580%259D%2520targeting%2520in%2520action%253A%2520from%2520phage%2520display%2520to%2520breast%2520cancer%2520cell%2520targeting%2520with%2520peptide-gold%2520nanoconjugates%26jtitle%3DPharmacol.%2520Res.%26date%3D2016%26volume%3D111%26spage%3D155%26epage%3D162%26doi%3D10.1016%2Fj.phrs.2016.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S.</span></span> <span> </span><span class="NLM_article-title">Antibody-drug conjugates as novel anti-cancer chemotherapeutics</span>. <i>Biosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span>, <span class="NLM_elocation-id">e00225</span> <span class="refDoi">Â DOI: 10.1042/BSR20150089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1042%2FBSR20150089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=26182432" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&author=C.+Petersauthor=S.+Brown&title=Antibody-drug+conjugates+as+novel+anti-cancer+chemotherapeutics&doi=10.1042%2FBSR20150089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1042%2FBSR20150089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBSR20150089%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DS.%26atitle%3DAntibody-drug%2520conjugates%2520as%2520novel%2520anti-cancer%2520chemotherapeutics%26jtitle%3DBiosci.%2520Rep.%26date%3D2015%26volume%3D35%26doi%3D10.1042%2FBSR20150089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, C. K.</span></span> <span> </span><span class="NLM_article-title">Therapeutic drug monitoring of monoclonal antibodies: applicability based on their pharmacokinetic properties</span>. <i>Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">14</span>â <span class="NLM_lpage">18</span>, <span class="refDoi">Â DOI: 10.1016/j.dmpk.2018.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.dmpk.2018.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30606646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFSmsbfO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2019&pages=14-18&author=C.+K.+Imamura&title=Therapeutic+drug+monitoring+of+monoclonal+antibodies%3A+applicability+based+on+their+pharmacokinetic+properties&doi=10.1016%2Fj.dmpk.2018.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic drug monitoring of monoclonal antibodies: Applicability based on their pharmacokinetic properties</span></div><div class="casAuthors">Imamura, Chiyo K.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-18</span>CODEN:
                <span class="NLM_cas:coden">DMPRB8</span>;
        ISSN:<span class="NLM_cas:issn">1347-4367</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Monoclonal antibodies (mAbs) have dramatically improved clin. outcomes for inflammatory and malignant diseases.  The elimination route of mAbs is cellular uptake by nonspecific pinocytosis or receptor-mediated endocytosis followed by proteolytic degrdn. which is protected by neonatal Fc-receptor or mediated by antigenic target.  There is a wide-interindividual variability in mAbs exposure due to target burden and other factors affecting unique their pharmacokinetics.  It has been reported that higher exposures are correlated with better clin. outcomes of various therapeutic mAbs.  On the other hand, flat exposure-efficacy relationships of anti-PD-1 antibodies nivolmab and pembrolizumab mean ensuring abs. max. efficacy in each patient by the approved dose regardless of their large interpatient variability in pharmacokinetics.  Administration of mAbs can induce prodn. of anti-drug antibodies (ADAs), which impact on their pharmacokinetics and pharmacodynamics.  In therapeutic drug monitoring (TDM) of mAbs, when total (free, sol. target bound and ADAs bound) mAbs concn. is measured, ADAs content (concn./titer) should be also monitored because mAbs exists in inactive complex with ADAs.  Along with detn. of appropriated therapeutic windows taking into account ADAs content, treatment algorithms for TDM-guided clin. decision-making must be developed and prospectively shown to be superior to traditional clin. care for each mAb in each indication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfQ0LoTNuGGbVg90H21EOLACvtfcHk0lg7lAk8FMrOvQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFSmsbfO&md5=15e3cc37e07716639286fb3c9ac2fbcd</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.dmpk.2018.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dmpk.2018.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DImamura%26aufirst%3DC.%2BK.%26atitle%3DTherapeutic%2520drug%2520monitoring%2520of%2520monoclonal%2520antibodies%253A%2520applicability%2520based%2520on%2520their%2520pharmacokinetic%2520properties%26jtitle%3DDrug%2520Metab.%2520Pharmacokinet.%26date%3D2019%26volume%3D34%26spage%3D14%26epage%3D18%26doi%3D10.1016%2Fj.dmpk.2018.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Antibody engineering for pursuing a healthier future</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">495</span>, <span class="refDoi">Â DOI: 10.3389/fmicb.2017.00495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.3389%2Ffmicb.2017.00495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28400756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC1cvmvFGjuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=495&author=A.+F.+Saeedauthor=R.+Wangauthor=S.+Lingauthor=S.+Wang&title=Antibody+engineering+for+pursuing+a+healthier+future&doi=10.3389%2Ffmicb.2017.00495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody Engineering for Pursuing a Healthier Future</span></div><div class="casAuthors">Saeed Abdullah F U H; Wang Rongzhi; Ling Sumei; Wang Shihua</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">495</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Since the development of antibody-production techniques, a number of immunoglobulins have been developed on a large scale using conventional methods.  Hybridoma technology opened a new horizon in the production of antibodies against target antigens of infectious pathogens, malignant diseases including autoimmune disorders, and numerous potent toxins.  However, these clinical humanized or chimeric murine antibodies have several limitations and complexities.  Therefore, to overcome these difficulties, recent advances in genetic engineering techniques and phage display technique have allowed the production of highly specific recombinant antibodies.  These engineered antibodies have been constructed in the hunt for novel therapeutic drugs equipped with enhanced immunoprotective abilities, such as engaging immune effector functions, effective development of fusion proteins, efficient tumor and tissue penetration, and high-affinity antibodies directed against conserved targets.  Advanced antibody engineering techniques have extensive applications in the fields of immunology, biotechnology, diagnostics, and therapeutic medicines.  However, there is limited knowledge regarding dynamic antibody development approaches.  Therefore, this review extends beyond our understanding of conventional polyclonal and monoclonal antibodies.  Furthermore, recent advances in antibody engineering techniques together with antibody fragments, display technologies, immunomodulation, and broad applications of antibodies are discussed to enhance innovative antibody production in pursuit of a healthier future for humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQW4iF9XXfGFtHxxy173TfNfW6udTcc2eaqzEBYWYpqrbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cvmvFGjuw%253D%253D&md5=671371258655d9b244e8878b0fb0c509</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2017.00495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2017.00495%26sid%3Dliteratum%253Aachs%26aulast%3DSaeed%26aufirst%3DA.%2BF.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLing%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DAntibody%2520engineering%2520for%2520pursuing%2520a%2520healthier%2520future%26jtitle%3DFront.%2520Microbiol.%26date%3D2017%26volume%3D8%26spage%3D495%26doi%3D10.3389%2Ffmicb.2017.00495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhimolea, E.</span></span> <span> </span><span class="NLM_article-title">The future of antibodies as cancer drugs</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">954</span>â <span class="NLM_lpage">963</span>, <span class="refDoi">Â DOI: 10.1016/j.drudis.2012.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.drudis.2012.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22561895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVWhtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=954-963&author=J.+M.+Reichertauthor=E.+Dhimolea&title=The+future+of+antibodies+as+cancer+drugs&doi=10.1016%2Fj.drudis.2012.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">The future of antibodies as cancer drugs</span></div><div class="casAuthors">Reichert, Janice M.; Dhimolea, Eugen</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">17-18</span>),
    <span class="NLM_cas:pages">954-963</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Targeted therapeutics such as monoclonal antibodies (mAbs) have proven successful as cancer drugs.  To profile products that could be marketed in the future, we examd. the current com. clin. pipeline of mAb candidates for cancer.  Our anal. revealed trends toward development of a variety of noncanonical mAbs, including antibody-drug conjugates (ADCs), bispecific antibodies, engineered antibodies and antibody fragments and/or domains.  We found substantial diversity in the antibody sequence source, isotype, carbohydrate residues, targets and mechanisms of action (MOA).  Although well-validated targets, such as epidermal growth factor receptor (EGFR) and CD20, continue to provide opportunities for companies, we found notable trends toward targeting less-well-validated antigens and exploration of innovative MOA such as the generation of anticancer immune responses or recruitment of cytotoxic T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9CNrebCmHvLVg90H21EOLACvtfcHk0lg5q3to4e88YQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVWhtLs%253D&md5=76a93479c0bcb8d2773134cdb21f465b</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2012.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2012.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DReichert%26aufirst%3DJ.%2BM.%26aulast%3DDhimolea%26aufirst%3DE.%26atitle%3DThe%2520future%2520of%2520antibodies%2520as%2520cancer%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D954%26epage%3D963%26doi%3D10.1016%2Fj.drudis.2012.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerbing, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimondi, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirsch, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aplenc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamis, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonzo, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meshinchi, S.</span></span> <span> </span><span class="NLM_article-title">CD33 expression and its association with gemtuzumab ozogamicin response: results from the randomized phase III Childrenâs Oncology Group Trial AAML0531</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">747</span>â <span class="NLM_lpage">755</span>, <span class="refDoi">Â DOI: 10.1200/JCO.2015.62.6846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1200%2FJCO.2015.62.6846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=26786921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Ciu7vJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=747-755&author=J.+A.+Pollardauthor=M.+Lokenauthor=R.+B.+Gerbingauthor=S.+C.+Raimondiauthor=B.+A.+Hirschauthor=R.+Aplencauthor=I.+D.+Bernsteinauthor=A.+S.+Gamisauthor=T.+A.+Alonzoauthor=S.+Meshinchi&title=CD33+expression+and+its+association+with+gemtuzumab+ozogamicin+response%3A+results+from+the+randomized+phase+III+Children%E2%80%99s+Oncology+Group+Trial+AAML0531&doi=10.1200%2FJCO.2015.62.6846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">CD33 expression and its association with gemtuzumab ozogamicin response: results from the randomized phase III children's oncology group trial AAML0531</span></div><div class="casAuthors">Pollard, Jessica A.; Loken, Michael; Gerbing, Robert B.; Raimondi, Susana C.; Hirsch, Betsy A.; Aplenc, Richard; Bernstein, Irwin D.; Gamis, Alan S.; Alonzo, Todd A.; Meshinchi, Soheil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">747-755</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: CD33 is variably expressed on acute myeloid leukemia (AML) blasts and is targeted by gemtuzumab ozogamicin (GO).  GO has shown benefit in both adult and pediatric AML trials, yet limited data exist about whether GO response correlates with CD33 expression level.  Patients and Methods: CD33 expression levels were prospectively quantified by multidimensional flow cytometry in 825 patients enrolled in Children's Oncol. Group AAML0531 and correlated with response to GO.  Results: Patients with low CD33 expression (lowest quartile of expression [Q1]) had no benefit with the addn. of GO to conventional chemotherapy (relapse risk [RR]: GO 36% v No-GO 34%, P =.731; event-free survival [EFS]: GO 53% v No-GO 58%,P =.456).  However, patients with higher CD33 expression (Q2 to Q4) had significantly reduced RR (GO 32% v No-GO 49%, P <.001) and improved EFS (GO 53% v No-GO 41%, P =.005).  This differential effect was obsd. in all risk groups.  Specifically, low-risk (LR), intermediate-risk (IR), and high-risk (HR) patients with low CD33 expression had similar outcomes regardless of GO exposure, whereas the addn. of GO to conventional chemotherapy resulted in a significant decrease in RR and disease-free survival (DFS) for patients with higher CD33 expression (LR RR, GO 13% v No-GO 35%, P =.001; LR DFS, GO 79% v No-GO 59%, P =.007; IR RR, GO 44% v No-GO 57%, P =.044; IR DFS, GO 51% v No-GO 40%, P =.078; HR RR, GO 40% v No-GO 73%, P =.016; HR DFS, GO 47% v No-GO 28%, P =.135).  Conclusion: We demonstrate that GO lacks clin. benefit in patients with low CD33 expression but significantly reduces RR and improves EFS in patients with high CD33 expression, which suggests a role for CD33-targeted therapeutics in subsets of pediatric AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh3RhS-uyQSbVg90H21EOLACvtfcHk0lg5q3to4e88YQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Ciu7vJ&md5=49165c37020863b29b547bb83bca7eef</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1200%2FJCO.2015.62.6846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2015.62.6846%26sid%3Dliteratum%253Aachs%26aulast%3DPollard%26aufirst%3DJ.%2BA.%26aulast%3DLoken%26aufirst%3DM.%26aulast%3DGerbing%26aufirst%3DR.%2BB.%26aulast%3DRaimondi%26aufirst%3DS.%2BC.%26aulast%3DHirsch%26aufirst%3DB.%2BA.%26aulast%3DAplenc%26aufirst%3DR.%26aulast%3DBernstein%26aufirst%3DI.%2BD.%26aulast%3DGamis%26aufirst%3DA.%2BS.%26aulast%3DAlonzo%26aufirst%3DT.%2BA.%26aulast%3DMeshinchi%26aufirst%3DS.%26atitle%3DCD33%2520expression%2520and%2520its%2520association%2520with%2520gemtuzumab%2520ozogamicin%2520response%253A%2520results%2520from%2520the%2520randomized%2520phase%2520III%2520Children%25E2%2580%2599s%2520Oncology%2520Group%2520Trial%2520AAML0531%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D34%26spage%3D747%26epage%3D755%26doi%3D10.1200%2FJCO.2015.62.6846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sievers, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadtmauer, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LÃ¶wenberg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dombret, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theobald, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eten, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loken, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dongen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appelbaum, F. R.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3244</span>â <span class="NLM_lpage">3254</span>, <span class="refDoi">Â DOI: 10.1200/JCO.2001.19.13.3244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1200%2FJCO.2001.19.13.3244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=11432892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlShtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=3244-3254&issue=13&author=E.+L.+Sieversauthor=R.+A.+Larsonauthor=E.+A.+Stadtmauerauthor=E.+Esteyauthor=B.+L%C3%B6wenbergauthor=H.+Dombretauthor=C.+Karanesauthor=M.+Theobaldauthor=J.+M.+Bennettauthor=M.+L.+Shermanauthor=M.+S.+Bergerauthor=C.+B.+Etenauthor=M.+R.+Lokenauthor=J.+J.+van+Dongenauthor=I.+D.+Bernsteinauthor=F.+R.+Appelbaum&title=Efficacy+and+safety+of+gemtuzumab+ozogamicin+in+patients+with+CD33-positive+acute+myeloid+leukemia+in+first+relapse&doi=10.1200%2FJCO.2001.19.13.3244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse</span></div><div class="casAuthors">Sievers, Eric L.; Larson, Richard A.; Stadtmauer, Edward A.; Estey, Elihu; Lowenberg, Bob; Dombret, Herve; Karanes, Chatchada; Theobald, Matthias; Bennett, John M.; Sherman, Matthew L.; Berger, Mark S.; Elen, Catharine B.; Loken, Michael R.; Van Dongen, Jacques J. M.; Bernstein, Irwin D.; Appelbaum, Frederick R.; Boogaerts, M.; Erba, H.; Huijgens, P.; Spielberger, R.; Tarantolo, S.; Castaigne, S.; Mignot, A.; Gramatski, M.; Harousseau, J.-L.; Mineur, P.; Roy, D.; Tallman, M.; Voliotis, D.; Ehninger, G.; Goldstone, A.; Juliusson, G.; List, A.; Aglietta, M.; Burnett, A.; Cambier, N.; Cassileth, P.; Fernandez, M.-N.; Fiere, D.; Gobbi, M.; Heil, G.; Hess, U.; Horst, A.; Karp, J.; Minden, M.; Paul, C.; Rai, K.; Schenkein, D.; Schuster, M.; Sierra, J.; Stenke, L.; Wahlin, A.; Wernli, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3244-3254</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose: Three open-label, multicenter trials were conducted to evaluate the efficacy and safety of single-agent Mylotarg (gemtuzumab ozogamicin; CMA-676; Wyeth Labs., Philadelphia, PA), an antibody-targeted chemotherapy agent, in patients with CD33-pos. acute myeloid leukemia (AML) in untreated first relapse.  Patients and Methods: The study population comprised 142 patients with AML in first relapse with no history of an antecedent hematol. disorder and a median age of 61 yr.  All patients received Mylotarg as a 2-h i.v. infusion, at a dose of 9 mg/m2, at 2-wk intervals for two doses.  Patients were evaluated for remission, survival, and treatment-emergent adverse events.  Results: Thirty percent of patients treated with Mylotarg obtained remission as characterized by 5% or less blasts in the marrow, recovery of neutrophils to at least 1,500/Î¼L, and RBC and platelet transfusion independence.  Although patients treated with Mylotarg had relatively high incidences of myelosuppression, grade 3 or 4 hyperbilirubinemia (23%), and elevated hepatic transaminase levels (17%), the incidences of grade 3 or 4 mucositis (4%) and infections (28%) were relatively low.  There was a low incidence of severe nausea and vomiting (11%) and no treatment-related cardiotoxicity, cerebellar toxicity, or alopecia.  Many patients received Mylotarg on an outpatient basis (38% and 41% of patients for the first and second doses, resp.).  Among the 142 patients, the median total duration of hospitalization was 24 days; 16% of patients required 7 days of hospitalization or less.  Conclusion: Administration of the antibody-targeted chemotherapy agent Mylotarg to patients with CD33-pos. AML in first relapse induces complete remissions with what appears to be a favorable safety profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1QUS965AwaLVg90H21EOLACvtfcHk0lg5q3to4e88YQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlShtbw%253D&md5=2edabaf5f61f4d4e63853851f6a8dd00</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1200%2FJCO.2001.19.13.3244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2001.19.13.3244%26sid%3Dliteratum%253Aachs%26aulast%3DSievers%26aufirst%3DE.%2BL.%26aulast%3DLarson%26aufirst%3DR.%2BA.%26aulast%3DStadtmauer%26aufirst%3DE.%2BA.%26aulast%3DEstey%26aufirst%3DE.%26aulast%3DL%25C3%25B6wenberg%26aufirst%3DB.%26aulast%3DDombret%26aufirst%3DH.%26aulast%3DKaranes%26aufirst%3DC.%26aulast%3DTheobald%26aufirst%3DM.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DSherman%26aufirst%3DM.%2BL.%26aulast%3DBerger%26aufirst%3DM.%2BS.%26aulast%3DEten%26aufirst%3DC.%2BB.%26aulast%3DLoken%26aufirst%3DM.%2BR.%26aulast%3Dvan%2BDongen%26aufirst%3DJ.%2BJ.%26aulast%3DBernstein%26aufirst%3DI.%2BD.%26aulast%3DAppelbaum%26aufirst%3DF.%2BR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520gemtuzumab%2520ozogamicin%2520in%2520patients%2520with%2520CD33-positive%2520acute%2520myeloid%2520leukemia%2520in%2520first%2520relapse%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2001%26volume%3D19%26issue%3D13%26spage%3D3244%26epage%3D3254%26doi%3D10.1200%2FJCO.2001.19.13.3244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ricart, A. D.</span></span> <span> </span><span class="NLM_article-title">Antibody-drug conjugates of calicheamicin derivative: gemtuzumab ozogamicin and inotuzumab ozogamicin</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6417</span>â <span class="NLM_lpage">6427</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-11-0486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1158%2F1078-0432.CCR-11-0486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22003069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSksrzF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6417-6427&author=A.+D.+Ricart&title=Antibody-drug+conjugates+of+calicheamicin+derivative%3A+gemtuzumab+ozogamicin+and+inotuzumab+ozogamicin&doi=10.1158%2F1078-0432.CCR-11-0486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin</span></div><div class="casAuthors">Ricart, Alejandro D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6417-6427</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Antibody-drug conjugates (ADC) are an attractive approach for the treatment of acute myeloid leukemia and non-Hodgkin lymphomas, which in most cases, are inherently sensitive to cytotoxic agents.  CD33 and CD22 are specific markers of myeloid leukemias and B-cell malignancies, resp.  These endocytic receptors are ideal for an ADC strategy because they can effectively carry the cytotoxic payload into the cell.  Gemtuzumab ozogamicin (GO, Mylotarg) and inotuzumab ozogamicin consist of a deriv. of calicheamicin (a potent DNA-binding cytotoxic antibiotic) linked to a humanized monoclonal IgG4 antibody directed against CD33 or CD22, resp.  Both of these ADCs have a target-mediated pharmacokinetic disposition.  GO was the first drug to prove the ADC concept in the clinic, specifically in phase II studies that included substantial proportions of older patients with relapsed acute myeloid leukemia.  In contrast, in phase III studies, it has thus far failed to show clin. benefit in first-line treatment in combination with std. chemotherapy.  Inotuzumab ozogamicin has shown remarkable clin. activity in relapsed/refractory B-cell non-Hodgkin lymphoma, and it has started phase III evaluation.  The safety profile of these ADCs includes reversible myelosuppression (esp. neutropenia and thrombocytopenia), elevated hepatic transaminases, and hyperbilirubinemia.  There have been postmarketing reports of hepatotoxicity, esp. veno-occlusive disease, assocd. with GO.  The incidence is â¼2%, but patients who undergo hematopoietic stem cell transplantation have an increased risk.  As we steadily move toward the goal of personalized medicine, these kinds of agents will provide a unique opportunity to treat selected patient subpopulations based on the expression of their specific tumor targets.  Clin Cancer Res; 17(20); 6417-27.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXhh65029iwbVg90H21EOLACvtfcHk0lhTWCkHKTD59g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSksrzF&md5=103b40cfe49632a86367414e0e97c011</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-0486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-0486%26sid%3Dliteratum%253Aachs%26aulast%3DRicart%26aufirst%3DA.%2BD.%26atitle%3DAntibody-drug%2520conjugates%2520of%2520calicheamicin%2520derivative%253A%2520gemtuzumab%2520ozogamicin%2520and%2520inotuzumab%2520ozogamicin%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D6417%26epage%3D6427%26doi%3D10.1158%2F1078-0432.CCR-11-0486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadeau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeidan, A. M.</span></span> <span> </span><span class="NLM_article-title">Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia</span>. <i>J. Blood Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">67</span>â <span class="NLM_lpage">74</span>, <span class="refDoi">Â DOI: 10.2147/JBM.S136575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.2147%2FJBM.S136575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29713210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVKlsbvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=67-74&author=N.+Uyauthor=M.+Nadeauauthor=M.+Stahlauthor=A.+M.+Zeidan&title=Inotuzumab+ozogamicin+in+the+treatment+of+relapsed%2Frefractory+acute+B+cell+lymphoblastic+leukemia&doi=10.2147%2FJBM.S136575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia</span></div><div class="casAuthors">Uy, Natalie; Nadeau, Michelle; Stahl, Maximilian; Zeidan, Amer M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Blood Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">67-74</span>CODEN:
                <span class="NLM_cas:coden">JBMOB7</span>;
        ISSN:<span class="NLM_cas:issn">1179-2736</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">The improvement in outcomes of adult patients with acute lymphoblastic leukemia (ALL) has been modest, with the exception of Philadelphia chromosome-pos. disease, despite advances in supportive care and stem cell transplantation.  The recent approvals of novel agents, including the bispecific T-cell engager blinatumomab, the antibody-drug conjugate inotuzumab ozogamicin, and chimeric antigen receptor T-cell products are changing the management of B-ALL, which traditionally relied on chemotherapy-based approaches.  Inotuzumab ozogamicin is a humanized CD22 monoclonal antibody linked to the cytotoxic agent calicheamicin.  CD22 is expressed on leukemic blasts in >90% of ALL patients, and inotuzumab ozogamicin has shown excellent clin. activity even among heavily pretreated relapsed/refractory (R/R) B-ALL patients and elderly B-ALL patients.  Clin. trials have shown superior survival with the drug over chemotherapy-based approaches in the first- or second-line salvage therapy for relapsed B-ALL as monotherapy.  Currently, new trials are evaluating inotuzumab ozogamicin in the frontline setting in combination-based approaches.  In this review, we summarize the preclin. and clin. data of inotuzumab ozogamicin in R/R B-ALL and foresee the future use of this drug in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXQ-gzUimZrbVg90H21EOLACvtfcHk0lhTWCkHKTD59g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVKlsbvE&md5=d2a0bf30dbbbbc5a21d2bccb4bd7890f</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.2147%2FJBM.S136575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FJBM.S136575%26sid%3Dliteratum%253Aachs%26aulast%3DUy%26aufirst%3DN.%26aulast%3DNadeau%26aufirst%3DM.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DZeidan%26aufirst%3DA.%2BM.%26atitle%3DInotuzumab%2520ozogamicin%2520in%2520the%2520treatment%2520of%2520relapsed%252Frefractory%2520acute%2520B%2520cell%2520lymphoblastic%2520leukemia%26jtitle%3DJ.%2520Blood%2520Med.%26date%3D2018%26volume%3D9%26spage%3D67%26epage%3D74%26doi%3D10.2147%2FJBM.S136575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doronina, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toki, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torgov, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendelsohn, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerveny, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chace, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBlanc, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gearing, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovee, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegall, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francisco, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senter, P. D.</span></span> <span> </span><span class="NLM_article-title">Development of potent monoclonal antibody auristatin conjugates for cancer therapy</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">778</span>â <span class="NLM_lpage">784</span>, <span class="refDoi">Â DOI: 10.1038/nbt832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnbt832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=12778055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFertLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=778-784&author=S.+O.+Doroninaauthor=B.+E.+Tokiauthor=M.+Y.+Torgovauthor=B.+A.+Mendelsohnauthor=C.+G.+Cervenyauthor=D.+F.+Chaceauthor=R.+L.+DeBlancauthor=R.+P.+Gearingauthor=T.+D.+Boveeauthor=C.+B.+Siegallauthor=J.+A.+Franciscoauthor=A.+F.+Wahlauthor=D.+L.+Meyerauthor=P.+D.+Senter&title=Development+of+potent+monoclonal+antibody+auristatin+conjugates+for+cancer+therapy&doi=10.1038%2Fnbt832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Development of potent monoclonal antibody auristatin conjugates for cancer therapy</span></div><div class="casAuthors">Doronina, Svetlana O.; Toki, Brian E.; Torgov, Michael Y.; Mendelsohn, Brian A.; Cerveny, Charles G.; Chace, Dana F.; DeBlanc, Ron L.; Gearing, R. Patrick; Bovee, Tim D.; Siegall, Clay B.; Francisco, Joseph A.; Wahl, Alan F.; Meyer, Damon L.; Senter, Peter D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">778-784</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We describe the in vitro and in vivo properties of monoclonal antibody (mAb)-drug conjugates consisting of the potent synthetic dolastatin 10 analogs auristatin E (AE) and monomethylauristatin E (MMAE), linked to the chimeric mAbs cBR96 (specific to Lewis Y on carcinomas) and cAC10 (specific to CD30 on hematol. malignancies).  The linkers used for conjugate formation included an acid-labile hydrazone and protease-sensitive dipeptides, leading to uniformly substituted conjugates that efficiently released active drug in the lysosomes of antigen-pos. (Ag+) tumor cells.  The peptide-linked mAb-valine-citrulline-MMAE and mAb-phenylalanine-lysine-MMAE conjugates were much more stable in buffers and plasma than the conjugates of mAb and the hydrazone of 5-benzoylvaleric acid-AE ester (AEVB).  As a result, the mAb-Val-Cit-MMAE conjugates exhibited greater in vitro specificity and lower in vivo toxicity than corresponding hydrazone conjugates.  In vivo studies demonstrated that the peptide-linked conjugates induced regressions and cures of established tumor xenografts with therapeutic indexes as high as 60-fold.  These conjugates illustrate the importance of linker technol., drug potency and conjugation methodol. in developing safe and efficacious mAb-drug conjugates for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro97SFKtdQ7rVg90H21EOLACvtfcHk0lhTWCkHKTD59g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFertLc%253D&md5=d77716ec93de5ac7473c18a597339086</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1038%2Fnbt832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt832%26sid%3Dliteratum%253Aachs%26aulast%3DDoronina%26aufirst%3DS.%2BO.%26aulast%3DToki%26aufirst%3DB.%2BE.%26aulast%3DTorgov%26aufirst%3DM.%2BY.%26aulast%3DMendelsohn%26aufirst%3DB.%2BA.%26aulast%3DCerveny%26aufirst%3DC.%2BG.%26aulast%3DChace%26aufirst%3DD.%2BF.%26aulast%3DDeBlanc%26aufirst%3DR.%2BL.%26aulast%3DGearing%26aufirst%3DR.%2BP.%26aulast%3DBovee%26aufirst%3DT.%2BD.%26aulast%3DSiegall%26aufirst%3DC.%2BB.%26aulast%3DFrancisco%26aufirst%3DJ.%2BA.%26aulast%3DWahl%26aufirst%3DA.%2BF.%26aulast%3DMeyer%26aufirst%3DD.%2BL.%26aulast%3DSenter%26aufirst%3DP.%2BD.%26atitle%3DDevelopment%2520of%2520potent%2520monoclonal%2520antibody%2520auristatin%2520conjugates%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Biotechnol.%26date%3D2003%26volume%3D21%26spage%3D778%26epage%3D784%26doi%3D10.1038%2Fnbt832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamblett, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senter, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chace, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerveny, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissler, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopcha, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabinski, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francisco, J. A.</span></span> <span> </span><span class="NLM_article-title">Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">7063</span>â <span class="NLM_lpage">7070</span>, <span class="refDoi">Â DOI: 10.1158/1078-0432.CCR-04-0789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1158%2F1078-0432.CCR-04-0789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=15501986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslGlu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=7063-7070&author=K.+J.+Hamblettauthor=P.+D.+Senterauthor=D.+F.+Chaceauthor=M.+M.+Sunauthor=J.+Lenoxauthor=C.+G.+Cervenyauthor=K.+M.+Kisslerauthor=S.+X.+Bernhardtauthor=A.+K.+Kopchaauthor=R.+F.+Zabinskiauthor=D.+L.+Meyerauthor=J.+A.+Francisco&title=Effects+of+drug+loading+on+the+antitumor+activity+of+a+monoclonal+antibody+drug+conjugate&doi=10.1158%2F1078-0432.CCR-04-0789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate</span></div><div class="casAuthors">Hamblett, Kevin J.; Senter, Peter D.; Chace, Dana F.; Sun, Michael M. C.; Lenox, Joel; Cerveny, Charles G.; Kissler, Kim M.; Bernhardt, Starr X.; Kopcha, Anastasia K.; Zabinski, Roger F.; Meyer, Damon L.; Francisco, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7063-7070</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">An antibody-drug conjugate consisting of monomethyl auristatin E (MMAE) conjugated to the anti-CD30 monoclonal antibody (mAb) cAC10, with eight drug moieties per mAb, was previously shown to have potent cytotoxic activity against CD30+ malignant cells.  To det. the effect of drug loading on antibody-drug conjugate therapeutic potential, we assessed cAC10 antibody-drug conjugates contg. different drug-mAb ratios in vitro and in vivo.  Coupling MMAE to the cysteines that comprise the interchain disulfides of cAC10 created an antibody-drug conjugate population, which was purified using hydrophobic interaction chromatog. to yield antibody-drug conjugates with two, four, and eight drugs per antibody (E2, E4, and E8, resp.).  Antibody-drug conjugate potency was tested in vitro against CD30+ lines followed by in vivo xenograft models.  The max.-tolerated dose and pharmacokinetic profiles of the antibody-drug conjugates were investigated in mice.  Although antibody-drug conjugate potency in vitro was directly dependent on drug loading (IC50 values E8<E4<E2), the in vivo antitumor activity of E4 was comparable with E8 at equal mAb doses, although the E4 contained half the amt. of MMAE per mAb.  E2 was also an active antitumor agent but required higher doses.  The max.-tolerated dose of E2 in mice was at least double that of E4, which in turn was twice that of E8.  MMAE loading affected plasma clearance, as E8 cleared 3-fold faster than E4 and 5-fold faster than E2.  By decreasing drug loading per antibody, the therapeutic index was increased demonstrating that drug loading is a key design parameter for antibody-drug conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCAEfk7W0KNbVg90H21EOLACvtfcHk0liM4jmALHswOQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslGlu78%253D&md5=2d2dd7a498d1181a57dcd3ab8b931e65</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-0789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-0789%26sid%3Dliteratum%253Aachs%26aulast%3DHamblett%26aufirst%3DK.%2BJ.%26aulast%3DSenter%26aufirst%3DP.%2BD.%26aulast%3DChace%26aufirst%3DD.%2BF.%26aulast%3DSun%26aufirst%3DM.%2BM.%26aulast%3DLenox%26aufirst%3DJ.%26aulast%3DCerveny%26aufirst%3DC.%2BG.%26aulast%3DKissler%26aufirst%3DK.%2BM.%26aulast%3DBernhardt%26aufirst%3DS.%2BX.%26aulast%3DKopcha%26aufirst%3DA.%2BK.%26aulast%3DZabinski%26aufirst%3DR.%2BF.%26aulast%3DMeyer%26aufirst%3DD.%2BL.%26aulast%3DFrancisco%26aufirst%3DJ.%2BA.%26atitle%3DEffects%2520of%2520drug%2520loading%2520on%2520the%2520antitumor%2520activity%2520of%2520a%2520monoclonal%2520antibody%2520drug%2520conjugate%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D7063%26epage%3D7070%26doi%3D10.1158%2F1078-0432.CCR-04-0789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tankersley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundblad, J. L.</span></span> <span> </span><span class="NLM_article-title">A new preparation of modified immune serum globulin (human) suitable for intravenous administration. I. Standardization of the reduction and alkylation reaction</span>. <i>Vox Sang.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">373</span>â <span class="NLM_lpage">382</span>, <span class="refDoi">Â DOI: 10.1111/j.1423-0410.1981.tb00725.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1111%2Fj.1423-0410.1981.tb00725.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=7293114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADyaL3MXlsFKnsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1981&pages=373-382&author=D.+D.+Schroederauthor=D.+L.+Tankersleyauthor=J.+L.+Lundblad&title=A+new+preparation+of+modified+immune+serum+globulin+%28human%29+suitable+for+intravenous+administration.+I.+Standardization+of+the+reduction+and+alkylation+reaction&doi=10.1111%2Fj.1423-0410.1981.tb00725.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">A new preparation of modified immune serum globulin (human) suitable for intravenous administration.  I.  Standardization of the reduction and alkylation reaction</span></div><div class="casAuthors">Schroeder, Duane D.; Tankersley, Donald L.; Lundblad, John L.</div><div class="citationInfo"><span class="NLM_cas:title">Vox Sanguinis</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">373-82</span>CODEN:
                <span class="NLM_cas:coden">VOSAAD</span>;
        ISSN:<span class="NLM_cas:issn">0042-9007</span>.
    </div><div class="casAbstract">Immune serum globulin (ISG) prepd. by Cohn cold alc. fractionation of pooled human plasma was reduced with dithiothreitol (DTT)  [3483-12-3] and alkylated with iodoacetamide  [144-48-9] and other alkylating agents.  There are a few labile interheavy chain disulfide bonds in ISG which react under mild, nondissociating conditions.  The extent of disulfide cleavage is controlled primarily by the ratio of DTT to ISG until 4-5 disulfide bonds have been reduced.  Detailed studies were reported on the variables of ISG concn., DTT to ISG ratio, pH, and time, leading to a chem. modified ISG that has a controlled and limited no. of reduced and alkylated disulfide bonds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOh3_8MIJz_7Vg90H21EOLACvtfcHk0liM4jmALHswOQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXlsFKnsL4%253D&md5=ec50baf4cc3d54ec3671fc927b8732e5</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1111%2Fj.1423-0410.1981.tb00725.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1423-0410.1981.tb00725.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DD.%2BD.%26aulast%3DTankersley%26aufirst%3DD.%2BL.%26aulast%3DLundblad%26aufirst%3DJ.%2BL.%26atitle%3DA%2520new%2520preparation%2520of%2520modified%2520immune%2520serum%2520globulin%2520%2528human%2529%2520suitable%2520for%2520intravenous%2520administration.%2520I.%2520Standardization%2520of%2520the%2520reduction%2520and%2520alkylation%2520reaction%26jtitle%3DVox%2520Sang.%26date%3D1981%26volume%3D40%26spage%3D373%26epage%3D382%26doi%3D10.1111%2Fj.1423-0410.1981.tb00725.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheler, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einhorn, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowlati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiting, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalal, S. I.</span></span> <span> </span><span class="NLM_article-title">A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">738</span>â <span class="NLM_lpage">747</span>, <span class="refDoi">Â DOI: 10.1007/s10637-019-00768-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2Fs10637-019-00768-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30993587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFersLbL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2019&pages=738-747&author=J.+P.+Sharmanauthor=J.+J.+Whelerauthor=L.+Einhornauthor=A.+Dowlatiauthor=G.+I.+Shapiroauthor=J.+Hiltonauthor=J.+M.+Burkeauthor=T.+Siddiqiauthor=N.+Whitingauthor=S.+I.+Jalal&title=A+phase+2%2C+open-label+study+of+brentuximab+vedotin+in+patients+with+CD30-expressing+solid+tumors&doi=10.1007%2Fs10637-019-00768-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors</span></div><div class="casAuthors">Sharman, Jeffrey P.; Wheler, Jennifer J.; Einhorn, Lawrence; Dowlati, Afshin; Shapiro, Geoffrey I.; Hilton, John; Burke, John M.; Siddiqi, Tanya; Whiting, Nancy; Jalal, Shadia I.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">738-747</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Brentuximab vedotin (BV) is an anti-CD30 antibody-drug conjugate used in the treatment of several types of lymphomas.  Expression of the target antigen has also been reported on a variety of malignant tumors of nonlymphoid origin.  This phase 2, open-label study evaluated the safety and antitumor activity of BV in patients with CD30-expressing nonlymphomatous malignancies.  Methods: Patients were dosed with 1.8 or 2.4 mg/kg BV once every three weeks.  Antitumor activity was assessed at Cycles 2, 4, and every 4 cycles thereafter.  Patients with stable disease or better were eligible to continue treatment until disease progression, unacceptable toxicity, or study closure.  Results: Of the 2693 patients screened, 3.8% had solid tumors with CD30 expression and 63 eligible patients with solid tumors enrolled in this study.  The most common CD30 pos. solid tumors were testicular cancer and mesothelioma.  Both subtypes had more than one patient with an objective response.  The median duration of BV exposure was 6.1 wk.  The disease control rate, defined as achieving stable disease or better at any point during the study, was 55%.  The objective response rate was 11%, with a median duration of response of 2.92 mo.  The most common adverse events reported were fatigue (57%), nausea (33%), and decreased appetite (32%).  Conclusion: The safety profile of BV in patients with solid tumors was similar to the known safety profile of BV.  In solid tumors, BV had modest activity as a single agent, which was similar to other second-line treatments already available to patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq27DoX7tPvgLVg90H21EOLACvtfcHk0liXa5Lg1U2yjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFersLbL&md5=e416b5ef07c0ac20471a7f93bf0ed7b3</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1007%2Fs10637-019-00768-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-019-00768-6%26sid%3Dliteratum%253Aachs%26aulast%3DSharman%26aufirst%3DJ.%2BP.%26aulast%3DWheler%26aufirst%3DJ.%2BJ.%26aulast%3DEinhorn%26aufirst%3DL.%26aulast%3DDowlati%26aufirst%3DA.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DHilton%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DJ.%2BM.%26aulast%3DSiddiqi%26aufirst%3DT.%26aulast%3DWhiting%26aufirst%3DN.%26aulast%3DJalal%26aufirst%3DS.%2BI.%26atitle%3DA%2520phase%25202%252C%2520open-label%2520study%2520of%2520brentuximab%2520vedotin%2520in%2520patients%2520with%2520CD30-expressing%2520solid%2520tumors%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2019%26volume%3D37%26spage%3D738%26epage%3D747%26doi%3D10.1007%2Fs10637-019-00768-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sehn, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamdar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrera, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMillan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flowers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ãzcan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">TrnÄnÃ½, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salles, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matasar, M. J.</span></span> <span> </span><span class="NLM_article-title">Randomized phase 2 trial of polatuzumab vedotin (pola) with bendamustine and rituximab (BR) in relapsed/refractory (r/r) FL and DLBCL</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">7507</span>, <span class="refDoi">Â DOI: 10.1200/JCO.2018.36.15_suppl.7507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1200%2FJCO.2018.36.15_suppl.7507" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2018&pages=7507&issue=15&author=L.+H.+Sehnauthor=M.+Kamdarauthor=A.+F.+Herreraauthor=A.+McMillanauthor=C.+Flowersauthor=W.+S.+Kimauthor=T.+M.+Kimauthor=M.+%C3%96zcanauthor=J.+Demeterauthor=M.+Hertzbergauthor=M.+Trn%C4%9Bn%C3%BDauthor=G.+A.+Sallesauthor=A.+Daviesauthor=J.+H.+Hirataauthor=J.+Chengauthor=G.+Kuauthor=M.+J.+Matasar&title=Randomized+phase+2+trial+of+polatuzumab+vedotin+%28pola%29+with+bendamustine+and+rituximab+%28BR%29+in+relapsed%2Frefractory+%28r%2Fr%29+FL+and+DLBCL&doi=10.1200%2FJCO.2018.36.15_suppl.7507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1200%2FJCO.2018.36.15_suppl.7507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2018.36.15_suppl.7507%26sid%3Dliteratum%253Aachs%26aulast%3DSehn%26aufirst%3DL.%2BH.%26aulast%3DKamdar%26aufirst%3DM.%26aulast%3DHerrera%26aufirst%3DA.%2BF.%26aulast%3DMcMillan%26aufirst%3DA.%26aulast%3DFlowers%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DW.%2BS.%26aulast%3DKim%26aufirst%3DT.%2BM.%26aulast%3D%25C3%2596zcan%26aufirst%3DM.%26aulast%3DDemeter%26aufirst%3DJ.%26aulast%3DHertzberg%26aufirst%3DM.%26aulast%3DTrn%25C4%259Bn%25C3%25BD%26aufirst%3DM.%26aulast%3DSalles%26aufirst%3DG.%2BA.%26aulast%3DDavies%26aufirst%3DA.%26aulast%3DHirata%26aufirst%3DJ.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DKu%26aufirst%3DG.%26aulast%3DMatasar%26aufirst%3DM.%2BJ.%26atitle%3DRandomized%2520phase%25202%2520trial%2520of%2520polatuzumab%2520vedotin%2520%2528pola%2529%2520with%2520bendamustine%2520and%2520rituximab%2520%2528BR%2529%2520in%2520relapsed%252Frefractory%2520%2528r%252Fr%2529%2520FL%2520and%2520DLBCL%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2018%26volume%3D36%26issue%3D15%26spage%3D7507%26doi%3D10.1200%2FJCO.2018.36.15_suppl.7507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weglarz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampton, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollong, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazane, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. S.</span></span> <span> </span><span class="NLM_article-title">Targeted delivery of an anti-inflammatory PDE4 inhibitor to immune cells via an antibody-drug conjugate</span>. <i>Mol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2078</span>â <span class="NLM_lpage">2089</span>, <span class="refDoi">Â DOI: 10.1038/mt.2016.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fmt.2016.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27731313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKgtL7I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2078-2089&author=S.+Yuauthor=A.+D.+Pearsonauthor=R.+K.+Limauthor=D.+T.+Rodgersauthor=S.+Liauthor=H.+B.+Parkerauthor=M.+Weglarzauthor=E.+N.+Hamptonauthor=M.+J.+Bollongauthor=J.+Shenauthor=C.+Zambaldoauthor=D.+Wangauthor=A.+K.+Woodsauthor=T.+M.+Wrightauthor=P.+G.+Schultzauthor=S.+A.+Kazaneauthor=T.+S.+Youngauthor=M.+S.+Tremblay&title=Targeted+delivery+of+an+anti-inflammatory+PDE4+inhibitor+to+immune+cells+via+an+antibody-drug+conjugate&doi=10.1038%2Fmt.2016.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-drug Conjugate</span></div><div class="casAuthors">Yu, Shan; Pearson, Aaron D.; Lim, Reyna K. V.; Rodgers, David T.; Li, Sijia; Parker, Holly B.; Weglarz, Meredith; Hampton, Eric N.; Bollong, Michael J.; Shen, Jiayin; Zambaldo, Claudio; Wang, Danling; Woods, Ashley K.; Wright, Timothy M.; Schultz, Peter G.; Kazane, Stephanie A.; Young, Travis S.; Tremblay, Matthew S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2078-2089</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphodiesterase 4 (PDE4) inhibitors are approved for the treatment of some moderate to severe inflammatory conditions.  However, dose-limiting side effects in the central nervous system and gastrointestinal tract, including nausea, emesis, headache, and diarrhea, have impeded the broader therapeutic application of PDE4 inhibitors.  We sought to exploit the wealth of validation surrounding PDE4 inhibition by improving the therapeutic index through generation of an antibody-drug conjugate (ADC) that selectively targets immune cells through the CD11a antigen.  The resulting ADC consisted of a human Î±CD11a antibody (based on efalizumab clone hu1124) conjugated to an analog of the highly potent PDE4 inhibitor GSK256066.  Both the human Î±CD11a ADC and a mouse surrogate Î±CD11a ADC (based on the M17 clone) rapidly internalized into immune cells and suppressed lipopolysaccharide (LPS)-induced TNFÎ± secretion in primary human monocytes and mouse peritoneal cells, resp.  In a carrageenan-induced air pouch inflammation mouse model, treatment with the ADC significantly reduced inflammatory cytokine prodn. in the air pouch exudate.  Overall, these results provide compelling evidence for the feasibility of delivering drugs with anti-inflammatory activity selectively to the immune compartment via CD11a and the development of tissue-targeted PDE4 inhibitors as a promising therapeutic modality for treating inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTURNcWDw-37Vg90H21EOLACvtfcHk0liXa5Lg1U2yjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKgtL7I&md5=82964396c796f6cfda7cf938e55bcc72</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1038%2Fmt.2016.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmt.2016.175%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DS.%26aulast%3DPearson%26aufirst%3DA.%2BD.%26aulast%3DLim%26aufirst%3DR.%2BK.%26aulast%3DRodgers%26aufirst%3DD.%2BT.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DH.%2BB.%26aulast%3DWeglarz%26aufirst%3DM.%26aulast%3DHampton%26aufirst%3DE.%2BN.%26aulast%3DBollong%26aufirst%3DM.%2BJ.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DZambaldo%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWoods%26aufirst%3DA.%2BK.%26aulast%3DWright%26aufirst%3DT.%2BM.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DKazane%26aufirst%3DS.%2BA.%26aulast%3DYoung%26aufirst%3DT.%2BS.%26aulast%3DTremblay%26aufirst%3DM.%2BS.%26atitle%3DTargeted%2520delivery%2520of%2520an%2520anti-inflammatory%2520PDE4%2520inhibitor%2520to%2520immune%2520cells%2520via%2520an%2520antibody-drug%2520conjugate%26jtitle%3DMol.%2520Ther.%26date%3D2016%26volume%3D24%26spage%3D2078%26epage%3D2089%26doi%3D10.1038%2Fmt.2016.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weglarz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zumbaldo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazane, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M.</span></span> <span> </span><span class="NLM_article-title">P-262 A PDE4 inhibitor-antibody conjugate for treating ulcerative colitis</span>. <i>Inflammatory Bowel Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">262</span>, <span class="refDoi">Â DOI: 10.1097/01.MIB.0000512805.98510.c0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1097%2F01.MIB.0000512805.98510.c0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=262&issue=1&author=S.+Yuauthor=A.+Pearsonauthor=R.+Limauthor=D.+Rodgersauthor=S.+Liauthor=H.+Parkerauthor=M.+Weglarzauthor=E.+Hamptonauthor=M.+Bollongauthor=J.+Shenauthor=C.+Zumbaldoauthor=D.+Wangauthor=A.+Woodsauthor=T.+Wrightauthor=P.+Schultzauthor=S.+Kazaneauthor=T.+Youngauthor=M.+Tremblay&title=P-262+A+PDE4+inhibitor-antibody+conjugate+for+treating+ulcerative+colitis&doi=10.1097%2F01.MIB.0000512805.98510.c0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1097%2F01.MIB.0000512805.98510.c0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.MIB.0000512805.98510.c0%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DS.%26aulast%3DPearson%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DR.%26aulast%3DRodgers%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DH.%26aulast%3DWeglarz%26aufirst%3DM.%26aulast%3DHampton%26aufirst%3DE.%26aulast%3DBollong%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DZumbaldo%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DT.%26aulast%3DSchultz%26aufirst%3DP.%26aulast%3DKazane%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DTremblay%26aufirst%3DM.%26atitle%3DP-262%2520A%2520PDE4%2520inhibitor-antibody%2520conjugate%2520for%2520treating%2520ulcerative%2520colitis%26jtitle%3DInflammatory%2520Bowel%2520Dis.%26date%3D2017%26volume%3D23%26issue%3D1%26spage%3D262%26doi%3D10.1097%2F01.MIB.0000512805.98510.c0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazane, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span> <span> </span><span class="NLM_article-title">An immunosuppressive antibody-drug conjugate</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">3229</span>â <span class="NLM_lpage">3232</span>, <span class="refDoi">Â DOI: 10.1021/jacs.5b00620</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b00620" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtV2ms78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=3229-3232&author=R.+E.+Wangauthor=T.+Liuauthor=Y.+Wangauthor=Y.+Caoauthor=J.+Duauthor=X.+Luoauthor=V.+Deshmukhauthor=C.+H.+Kimauthor=B.+R.+Lawsonauthor=M.+S.+Tremblayauthor=T.+S.+Youngauthor=S.+A.+Kazaneauthor=F.+Wangauthor=P.+G.+Schultz&title=An+immunosuppressive+antibody-drug+conjugate&doi=10.1021%2Fjacs.5b00620"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">An Immunosuppressive Antibody-dasatinib conjugate and its Lck inhibitory activity</span></div><div class="casAuthors">Wang, Rongsheng E.; Liu, Tao; Wang, Ying; Cao, Yu; Du, Jintang; Luo, Xiaozhou; Deshmukh, Vishal; Kim, Chan Hyuk; Lawson, Brian R.; Tremblay, Matthew S.; Young, Travis S.; Kazane, Stephanie A.; Wang, Feng; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3229-3232</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors have developed a novel antibody-drug conjugate (ADC) that can selectively deliver the Lck inhibitor dasatinib to human T lymphocytes.  This ADC is based on a humanized antibody that selectively binds with high affinity to CXCR4, an antigen that is selectively expressed on hematopoietic cells.  The resulting dasatinib-antibody conjugate suppresses T-cell-receptor (TCR)-mediated T-cell activation and cytokine expression with low nM EC50 and has minimal effects on cell viability.  This ADC may lead to a new class of selective immunosuppressive drugs with improved safety and extend the ADC strategy to the targeted delivery of kinase inhibitors for indications beyond oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5o7sm-GjByLVg90H21EOLACvtfcHk0liD0_pqmU8JTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtV2ms78%253D&md5=13c29dbff95aee1e20e256351beb4dcb</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b00620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b00620%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%2BE.%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DDeshmukh%26aufirst%3DV.%26aulast%3DKim%26aufirst%3DC.%2BH.%26aulast%3DLawson%26aufirst%3DB.%2BR.%26aulast%3DTremblay%26aufirst%3DM.%2BS.%26aulast%3DYoung%26aufirst%3DT.%2BS.%26aulast%3DKazane%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DAn%2520immunosuppressive%2520antibody-drug%2520conjugate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D3229%26epage%3D3232%26doi%3D10.1021%2Fjacs.5b00620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span> <i>Chemical Biology: From Small Molecules to Systems
Biology and Drug
Design</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, L. S.</span>, <span class="NLM_string-name">Kapoor, T.</span>, <span class="NLM_string-name">Wess, G.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2007</span>; Vol.  <span class="NLM_volume">1-3</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2F9783527619375" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=L.+S.+Schreiber&author=T.+Kapoor&author=G.+Wess&title=Chemical+Biology%3A+From+Small+Molecules+to+Systems%0ABiology+and+Drug%0ADesign"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1002%2F9783527619375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527619375%26sid%3Dliteratum%253Aachs%26btitle%3DChemical%2520Biology%253A%2520From%2520Small%2520Molecules%2520to%2520Systems%250ABiology%2520and%2520Drug%250ADesign%26aulast%3DSchreiber%26aufirst%3DL.%2BS.%26pub%3DWiley-VCH%26date%3D2007%26volume%3D1-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span> <span> </span><span class="NLM_article-title">Applications of chemogenomic library screening in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">285</span>â <span class="NLM_lpage">296</span>, <span class="refDoi">Â DOI: 10.1038/nrd.2016.244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnrd.2016.244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28104905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ort7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=285-296&issue=4&author=L.+H.+Jonesauthor=M.+E.+Bunnage&title=Applications+of+chemogenomic+library+screening+in+drug+discovery&doi=10.1038%2Fnrd.2016.244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of chemogenomic library screening in drug discovery</span></div><div class="casAuthors">Jones, Lyn H.; Bunnage, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">285-296</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The allure of phenotypic screening, combined with the industry preference for target-based approaches, has prompted the development of innovative chem. biol. technologies that facilitate the identification of new therapeutic targets for accelerated drug discovery.  A chemogenomic library is a collection of selective small-mol. pharmacol. agents, and a hit from such a set in a phenotypic screen suggests that the annotated target or targets of that pharmacol. agent may be involved in perturbing the observable phenotype.  In this Review, we describe opportunities for chemogenomic screening to considerably expedite the conversion of phenotypic screening projects into target-based drug discovery approaches.  Other applications are explored, including drug repositioning, predictive toxicol. and the discovery of novel pharmacol. modalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruetMviqci8rVg90H21EOLACvtfcHk0liD0_pqmU8JTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ort7c%253D&md5=a51a882947528be18392170cfa48c554</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.244%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26atitle%3DApplications%2520of%2520chemogenomic%2520library%2520screening%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26issue%3D4%26spage%3D285%26epage%3D296%26doi%3D10.1038%2Fnrd.2016.244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hermansonn, G. T.</span></span> <i>Bioconjugate Techniques</i>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA, U.S.</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=G.+T.+Hermansonn&title=Bioconjugate+Techniques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHermansonn%26aufirst%3DG.%2BT.%26btitle%3DBioconjugate%2520Techniques%26pub%3DAcademic%2520Press%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlund, P.</span></span> <span> </span><span class="NLM_article-title">Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">13449</span>â <span class="NLM_lpage">13458</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M117.787267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1074%2Fjbc.M117.787267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28634233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlWhurzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=13449-13458&author=D.+Chenauthor=A.+Janssonauthor=D.+Simauthor=A.+Larssonauthor=P.+Nordlund&title=Structural+analyses+of+human+thymidylate+synthase+reveal+a+site+that+may+control+conformational+switching+between+active+and+inactive+states&doi=10.1074%2Fjbc.M117.787267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states</span></div><div class="casAuthors">Chen, Dan; Jansson, Anna; Sim, Daniel; Larsson, Andreas; Nordlund, Par</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">13449-13458</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Thymidylate synthase (TS) is the sole enzyme responsible for de novo biosynthesis of thymidylate (TMP) and is essential for cell proliferation and survival.  Inhibition of human TS (hTS) has been extensively investigated for cancer chemotherapy, but several aspects of its activity and regulation are still uncertain.  In this study, we performed comprehensive structural and biophys. studies of hTS using crystallog. and thermal shift assay and provided the first detailed structural information on the conformational changes induced by ligand binding to the hTS active site.  We found that upon binding of the antifolate agents raltitrexed and nolatrexed, the two insert regions in hTS, the functions of which are unclear, undergo positional shifts toward the catalytic center.  We investigated the inactive conformation of hTS and found that the two insert regions are also involved in the conformational transition between the active and inactive state of hTS.  Moreover, we identified a ligand-binding site in the dimer interface, suggesting that the cavity in the dimer interface could serve as an allosteric site of hTS to regulate the conformational switching between the active and inactive states.  On the basis of these findings, we propose a regulatory mechanism of hTS activity that involves allosteric regulation of interactions of hTS with its own mRNA depending on cellular demands for TMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCnnQ5-JBnyrVg90H21EOLACvtfcHk0ljgnYHM8EM4Yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlWhurzO&md5=64ac57f382a4d48721ac76bb91ead06e</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.787267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.787267%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DD.%26aulast%3DJansson%26aufirst%3DA.%26aulast%3DSim%26aufirst%3DD.%26aulast%3DLarsson%26aufirst%3DA.%26aulast%3DNordlund%26aufirst%3DP.%26atitle%3DStructural%2520analyses%2520of%2520human%2520thymidylate%2520synthase%2520reveal%2520a%2520site%2520that%2520may%2520control%2520conformational%2520switching%2520between%2520active%2520and%2520inactive%2520states%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D13449%26epage%3D13458%26doi%3D10.1074%2Fjbc.M117.787267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Durham, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, M. J.</span></span> <span> </span><span class="NLM_article-title">Target engagement in lead generation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">998</span>â <span class="NLM_lpage">1008</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.12.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.bmcl.2014.12.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25630223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC2MrgsFejug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=998-1008&author=T.+B.+Durhamauthor=M.+J.+Blanco&title=Target+engagement+in+lead+generation&doi=10.1016%2Fj.bmcl.2014.12.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Target engagement in lead generation</span></div><div class="casAuthors">Durham Timothy B; Blanco Maria-Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & medicinal chemistry letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">998-1008</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pharmaceutical industry is currently facing multiple challenges, in particular the low number of new drug approvals in spite of the high level of R&D investment.  In order to improve target selection and assess properly the clinical hypothesis, it is important to start building an integrated drug discovery approach during Lead Generation.  This should include special emphasis on evaluating target engagement in the target tissue and linking preclinical to clinical readouts.  In this review, we would like to illustrate several strategies and technologies for assessing target engagement and the value of its application to medicinal chemistry efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTY-Uy19yFbSukdrW1FkXG-fW6udTcc2eZcSxYGzxa86rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MrgsFejug%253D%253D&md5=ecafc397f5418f21d83f7881548ae490</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.076%26sid%3Dliteratum%253Aachs%26aulast%3DDurham%26aufirst%3DT.%2BB.%26aulast%3DBlanco%26aufirst%3DM.%2BJ.%26atitle%3DTarget%2520engagement%2520in%2520lead%2520generation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D998%26epage%3D1008%26doi%3D10.1016%2Fj.bmcl.2014.12.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">SchÃ¼rmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janning, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Small-molecule target engagement in cells</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">435</span>â <span class="NLM_lpage">441</span>, <span class="refDoi">Â DOI: 10.1016/j.chembiol.2016.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.chembiol.2016.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27049669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlSqtb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=435-441&author=M.+Sch%C3%BCrmannauthor=P.+Janningauthor=S.+Zieglerauthor=H.+Waldmann&title=Small-molecule+target+engagement+in+cells&doi=10.1016%2Fj.chembiol.2016.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Target Engagement in Cells</span></div><div class="casAuthors">Schuermann, Marc; Janning, Petra; Ziegler, Slava; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">435-441</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Monitoring how, when, and where small mols. engage their targets inside living cells is a crit. step in chem. biol. and pharmacol. research, because it enables compd. efficacy and confirmation of mode of action to be assessed.  In this mini-review we summarize the currently available methodologies to detect and prove direct target engagement in cells and offer a crit. view of their key advantages and disadvantages.  As the interest of the field shifts toward discovery and validation of high-quality agents, we expect that efforts to develop and refine these types of methodologies will also intensify in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFG52Nxfgik7Vg90H21EOLACvtfcHk0ljgnYHM8EM4Yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlSqtb4%253D&md5=b81e50faa188d916de61b5dc01294ea8</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2016.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2016.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25BCrmann%26aufirst%3DM.%26aulast%3DJanning%26aufirst%3DP.%26aulast%3DZiegler%26aufirst%3DS.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DSmall-molecule%2520target%2520engagement%2520in%2520cells%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D435%26epage%3D441%26doi%3D10.1016%2Fj.chembiol.2016.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudkouskaya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinsuebphon, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubbesing, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Intes, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barroso, M.</span></span> <span> </span><span class="NLM_article-title">Quantitative imaging of receptor-ligand engagement in intact live animals</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">451</span>â <span class="NLM_lpage">459</span>, <span class="refDoi">Â DOI: 10.1016/j.jconrel.2018.07.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.jconrel.2018.07.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30036545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFCrt7%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2018&pages=451-459&author=A.+Rudkouskayaauthor=N.+Sinsuebphonauthor=J.+Wardauthor=K.+Tubbesingauthor=X.+Intesauthor=M.+Barroso&title=Quantitative+imaging+of+receptor-ligand+engagement+in+intact+live+animals&doi=10.1016%2Fj.jconrel.2018.07.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative imaging of receptor-ligand engagement in intact live animals</span></div><div class="casAuthors">Rudkouskaya, Alena; Sinsuebphon, Nattawut; Ward, Jamie; Tubbesing, Kate; Intes, Xavier; Barroso, Margarida</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">451-459</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Maintaining an intact tumor environment is crit. for quantitation of receptor-ligand engagement in a targeted drug development pipeline.  However, measuring receptor-ligand engagement in vivo and non-invasively in preclin. settings is extremely challenging.  We found that quantitation of intracellular receptor-ligand binding can be achieved using whole-body macroscopic lifetime-based Forster Resonance Energy Transfer (FRET) imaging in intact, live animals bearing tumor xenografts.  We detd. that FRET levels report on ligand binding to transferrin receptors conversely to raw fluorescence intensity.  FRET levels in heterogeneous tumors correlate with intracellular ligand binding but strikingly, not with ubiquitously used ex vivo receptor expression assessment.  Hence, MFLI-FRET provides a direct measurement of systemic delivery, target availability and intracellular drug delivery in preclin. studies.  Here, we have used MFLI to measure FRET longitudinally in intact and live animals.  MFLI-FRET is well-suited for guiding the development of targeted drug therapy in heterogeneous tumors in intact, live small animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmDJu1-V1P17Vg90H21EOLACvtfcHk0ljTHNMG6clfnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFCrt7%252FM&md5=8858fa552ec89ae64e00414596a656b1</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2018.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2018.07.032%26sid%3Dliteratum%253Aachs%26aulast%3DRudkouskaya%26aufirst%3DA.%26aulast%3DSinsuebphon%26aufirst%3DN.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DTubbesing%26aufirst%3DK.%26aulast%3DIntes%26aufirst%3DX.%26aulast%3DBarroso%26aufirst%3DM.%26atitle%3DQuantitative%2520imaging%2520of%2520receptor-ligand%2520engagement%2520in%2520intact%2520live%2520animals%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2018%26volume%3D286%26spage%3D451%26epage%3D459%26doi%3D10.1016%2Fj.jconrel.2018.07.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dart, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodroofe, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimprich, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkland, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machleidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupcho, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartnett, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niles, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohana, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. V.</span></span> <span> </span><span class="NLM_article-title">Target engagement and drug residence time can be observed in living cells with BRET</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">10091</span>, <span class="refDoi">Â DOI: 10.1038/ncomms10091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fncomms10091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=26631872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFGmtrnO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=10091&author=M.+B.+Robersauthor=M.+L.+Dartauthor=C.+C.+Woodroofeauthor=C.+A.+Zimprichauthor=T.+A.+Kirklandauthor=T.+Machleidtauthor=K.+R.+Kupchoauthor=S.+Levinauthor=J.+R.+Hartnettauthor=K.+Zimmermanauthor=A.+L.+Nilesauthor=R.+F.+Ohanaauthor=D.+L.+Danielsauthor=M.+Slaterauthor=M.+G.+Woodauthor=M.+Congauthor=Y.+Q.+Chengauthor=K.+V.+Wood&title=Target+engagement+and+drug+residence+time+can+be+observed+in+living+cells+with+BRET&doi=10.1038%2Fncomms10091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Target engagement and drug residence time can be observed in living cells with BRET</span></div><div class="casAuthors">Robers, Matthew B.; Dart, Melanie L.; Woodroofe, Carolyn C.; Zimprich, Chad A.; Kirkland, Thomas A.; Machleidt, Thomas; Kupcho, Kevin R.; Levin, Sergiy; Hartnett, James R.; Zimmerman, Kristopher; Niles, Andrew L.; Ohana, Rachel Friedman; Daniels, Danette L.; Slater, Michael; Wood, Monika G.; Cong, Mei; Cheng, Yi-Qiang; Wood, Keith V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10091</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The therapeutic action of drugs is predicated on their phys. engagement with cellular targets.  Here we describe a broadly applicable method using bioluminescence resonance energy transfer (BRET) to reveal the binding characteristics of a drug with selected targets within intact cells.  Cell-permeable fluorescent tracers are used in a competitive binding format to quantify drug engagement with the target proteins fused to Nanoluc luciferase.  The approach enabled us to profile isoenzyme-specific engagement and binding kinetics for a panel of histone deacetylase (HDAC) inhibitors.  Our anal. was directed particularly to the clin. approved prodrug FK228 (Istodax/Romidepsin) because of its unique and largely unexplained mechanism of sustained intracellular action.  Anal. of the binding kinetics by BRET revealed remarkably long intracellular residence times for FK228 at HDAC1, explaining the protracted intracellular behavior of this prodrug.  Our results demonstrate a novel application of BRET for assessing target engagement within the complex milieu of the intracellular environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRFFk0LNiL_LVg90H21EOLACvtfcHk0ljTHNMG6clfnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFGmtrnO&md5=723cc5dd7d229b1115da4c2c9d75c913</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1038%2Fncomms10091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10091%26sid%3Dliteratum%253Aachs%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DDart%26aufirst%3DM.%2BL.%26aulast%3DWoodroofe%26aufirst%3DC.%2BC.%26aulast%3DZimprich%26aufirst%3DC.%2BA.%26aulast%3DKirkland%26aufirst%3DT.%2BA.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DKupcho%26aufirst%3DK.%2BR.%26aulast%3DLevin%26aufirst%3DS.%26aulast%3DHartnett%26aufirst%3DJ.%2BR.%26aulast%3DZimmerman%26aufirst%3DK.%26aulast%3DNiles%26aufirst%3DA.%2BL.%26aulast%3DOhana%26aufirst%3DR.%2BF.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DWood%26aufirst%3DM.%2BG.%26aulast%3DCong%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DY.%2BQ.%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DTarget%2520engagement%2520and%2520drug%2520residence%2520time%2520can%2520be%2520observed%2520in%2520living%2520cells%2520with%2520BRET%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D10091%26doi%3D10.1038%2Fncomms10091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoddart, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, E. K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheal, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machleidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfleger, K. D. G.</span></span> <span> </span><span class="NLM_article-title">Application of BRET to monitor ligand binding to GPCRs</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">661</span>â <span class="NLM_lpage">663</span>, <span class="refDoi">Â DOI: 10.1038/nmeth.3398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnmeth.3398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=26030448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtbbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=661-663&author=L.+A.+Stoddartauthor=E.+K.+M.+Johnstoneauthor=A.+J.+Whealauthor=J.+Gouldingauthor=M.+B.+Robersauthor=T.+Machleidtauthor=K.+V.+Woodauthor=S.+J.+Hillauthor=K.+D.+G.+Pfleger&title=Application+of+BRET+to+monitor+ligand+binding+to+GPCRs&doi=10.1038%2Fnmeth.3398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Application of BRET to monitor ligand binding to GPCRs</span></div><div class="casAuthors">Stoddart, Leigh A.; Johnstone, Elizabeth K. M.; Wheal, Amanda J.; Goulding, Joelle; Robers, Matthew B.; Machleidt, Thomas; Wood, Keith V.; Hill, Stephen J.; Pfleger, Kevin D. G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">661-663</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bioluminescence resonance energy transfer (BRET) is a well-established method for investigating protein-protein interactions.  Here we present a BRET approach to monitor ligand binding to G protein-coupled receptors (GPCRs) on the surface of living cells made possible by the use of fluorescent ligands in combination with a bioluminescent protein (NanoLuc) that can be readily expressed on the N terminus of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKCGBtnUo25LVg90H21EOLACvtfcHk0ljTHNMG6clfnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtbbI&md5=b829c12d21f0079ceb4222be2ebf6f32</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.3398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.3398%26sid%3Dliteratum%253Aachs%26aulast%3DStoddart%26aufirst%3DL.%2BA.%26aulast%3DJohnstone%26aufirst%3DE.%2BK.%2BM.%26aulast%3DWheal%26aufirst%3DA.%2BJ.%26aulast%3DGoulding%26aufirst%3DJ.%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DK.%2BV.%26aulast%3DHill%26aufirst%3DS.%2BJ.%26aulast%3DPfleger%26aufirst%3DK.%2BD.%2BG.%26atitle%3DApplication%2520of%2520BRET%2520to%2520monitor%2520ligand%2520binding%2520to%2520GPCRs%26jtitle%3DNat.%2520Methods%26date%3D2015%26volume%3D12%26spage%3D661%26epage%3D663%26doi%3D10.1038%2Fnmeth.3398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simon, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niphakis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Determining target engagement in living systems</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">200</span>â <span class="NLM_lpage">205</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.1211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnchembio.1211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23508173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFWku7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=200-205&author=G.+M.+Simonauthor=M.+J.+Niphakisauthor=B.+F.+Cravatt&title=Determining+target+engagement+in+living+systems&doi=10.1038%2Fnchembio.1211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Determining target engagement in living systems</span></div><div class="casAuthors">Simon, Gabriel M.; Niphakis, Micah J.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">200-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chem. probes are crit. tools for elucidating the biol. functions of proteins and can lead to new medicines for treating disease.  The pharmacol. validation of protein function requires verification that chem. probes engage their intended targets in vivo.  Here we discuss technologies, both established and emergent, for measuring target engagement in living systems and propose that detg. this parameter should become std. practice for chem. probe and drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5eudh3YJSOLVg90H21EOLACvtfcHk0lhqwI-kiugBZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFWku7g%253D&md5=48a97d0d8ff7a7de4f9de0e9c54a1c5c</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1211%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDetermining%2520target%2520engagement%2520in%2520living%2520systems%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D200%26epage%3D205%26doi%3D10.1038%2Fnchembio.1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompliano, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">Drug-target residence time and its implications for lead optimization</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">730</span>â <span class="NLM_lpage">739</span>, <span class="refDoi">Â DOI: 10.1038/nrd2082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fnrd2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=16888652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug-target+residence+time+and+its+implications+for+lead+optimization&doi=10.1038%2Fnrd2082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time and its implications for lead optimization</span></div><div class="casAuthors">Copeland, Robert A.; Pompliano, David L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">730-739</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromols. by low-mol.-mass drugs.  The binding of drugs to their macromol. targets is therefore seen as paramount for pharmacol. activity.  In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC50 or Kd.  This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex.  We describe the potential advantages of long residence time in terms of duration of pharmacol. effect and target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6SJrMlrrTbVg90H21EOLACvtfcHk0lhqwI-kiugBZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D&md5=60ede2301584b10ac4e8fa18e1e6d107</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1038%2Fnrd2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2082%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug-target%2520residence%2520time%2520and%2520its%2520implications%2520for%2520lead%2520optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739%26doi%3D10.1038%2Fnrd2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tummino, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <span> </span><span class="NLM_article-title">Residence time of receptor-ligand complexes and its effect on biological function</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5481</span>â <span class="NLM_lpage">5492</span>, <span class="refDoi">Â DOI: 10.1021/bi8002023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi8002023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1Ont7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=5481-5492&author=P.+J.+Tumminoauthor=R.+A.+Copeland&title=Residence+time+of+receptor-ligand+complexes+and+its+effect+on+biological+function&doi=10.1021%2Fbi8002023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Residence Time of Receptor-Ligand Complexes and Its Effect on Biological Function</span></div><div class="casAuthors">Tummino, Peter J.; Copeland, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5481-5492</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The formation and duration of binary receptor-ligand complexes are fundamental to many physiol. processes.  Most often, the effectiveness of interaction between a receptor and its ligand is quantified in terms of closed system, equil. affinity measurements, such as IC50 and Kd.  In the context of in vivo biol., however, the extent and duration of responses to receptor-ligand interactions depend greatly on the time period over which the ligand is in residence on its receptor.  Here we define receptor-ligand complex residence time in quant. terms and describe its significance to biol. function.  Examples of the importance of residence time are presented for natural ligands of different receptor types.  The impact of residence time on the optimization of potential ligands as drugs for human medicine is also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHshN2Bt_r9LVg90H21EOLACvtfcHk0lhqwI-kiugBZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1Ont7s%253D&md5=57f79f69f12c6ed14e3347638381d943</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fbi8002023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi8002023%26sid%3Dliteratum%253Aachs%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DResidence%2520time%2520of%2520receptor-ligand%2520complexes%2520and%2520its%2520effect%2520on%2520biological%2520function%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D5481%26epage%3D5492%26doi%3D10.1021%2Fbi8002023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vauquelin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span> <span> </span><span class="NLM_article-title">Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">1771</span>â <span class="NLM_lpage">1785</span>, <span class="refDoi">Â DOI: 10.1111/bph.12106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1111%2Fbph.12106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23330947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsVylur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=1771-1785&author=G.+Vauquelinauthor=S.+J.+Charlton&title=Exploring+avidity%3A+understanding+the+potential+gains+in+functional+affinity+and+target+residence+time+of+bivalent+and+heterobivalent+ligands&doi=10.1111%2Fbph.12106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands</span></div><div class="casAuthors">Vauquelin, Georges; Charlton, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1771-1785</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Bivalent ligands are increasingly important therapeutic agents.  Although the naturally occurring antibodies are predominant, it is becoming more common to combine different antibody fragments or even low mol. wt. compds. to generate heterobivalent ligands.  Such ligands exhibit markedly increased affinity (i.e. avidity) and target residence time when both pharmacophores can bind simultaneously to their target sites.  This is because binding of one pharmacophore forces the second tethered one to stay close to its corresponding site.  This "forced proximity" favors its binding and rebinding (once dissocd.) to that site.  However, rebinding will also take place when the diffusion of freshly dissocd. ligands is merely slowed down.  The present differential equation-based simulations explore the way both situations affect ligand binding.  Both delay the attainment of binding equil. (resulting in steep satn. curves) and also increase the target residence time.  Competitive ligands are able to interfere in a concn.-dependent manner, although much higher concns. are required in the "forced proximity" situation.  Also, it is only in that situation that the ligand shows increased affinity.  These simulations shed light on two practical consequences.  Depending on the pharmacokinetic half-life of the bivalent ligand in the body, it may not have sufficient time to achieve equil. with the target.  This will result in lower potency than expected, although it would have significant advantages in terms of residence time.  In in vitro expts., the manifestation of steep satn. curves and of accelerated dissocn. in the presence of competitive ligands could mistakenly be interpreted as evidence for non-competitive, allosteric interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbgxbt6V_uc7Vg90H21EOLACvtfcHk0li8Gv6jlnOZuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsVylur4%253D&md5=d0868461b986affb15003dccaa8f7c99</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1111%2Fbph.12106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12106%26sid%3Dliteratum%253Aachs%26aulast%3DVauquelin%26aufirst%3DG.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26atitle%3DExploring%2520avidity%253A%2520understanding%2520the%2520potential%2520gains%2520in%2520functional%2520affinity%2520and%2520target%2520residence%2520time%2520of%2520bivalent%2520and%2520heterobivalent%2520ligands%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D168%26spage%3D1771%26epage%3D1785%26doi%3D10.1111%2Fbph.12106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebru, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. G.</span></span> <span> </span><span class="NLM_article-title">Time-resolved FRET and NMR analyses reveal selective binding of peptides containing the LC3-interacting region to ATG8 family proteins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">14033</span>â <span class="NLM_lpage">14042</span>, <span class="refDoi">Â DOI: 10.1074/jbc.RA119.008723</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1074%2Fjbc.RA119.008723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=31362979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1Omt7fN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=14033-14042&issue=38&author=J.+M.+Atkinsonauthor=Y.+Yeauthor=M.+T.+Gebruauthor=Q.+Liuauthor=S.+Zhouauthor=M.+M.+Youngauthor=Y.+Takahashiauthor=Q.+Linauthor=F.+Tianauthor=H.+G.+Wang&title=Time-resolved+FRET+and+NMR+analyses+reveal+selective+binding+of+peptides+containing+the+LC3-interacting+region+to+ATG8+family+proteins&doi=10.1074%2Fjbc.RA119.008723"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Time-resolved FRET and NMR analyses reveal selective binding of peptides containing the LC3-interacting region to ATG8 family proteins</span></div><div class="casAuthors">Atkinson, Jennifer M.; Ye, Yansheng; Gebru, Melat T.; Liu, Qiang; Zhou, Shouhao; Young, Megan M.; Takahashi, Yoshinori; Lin, Qing; Tian, Fang; Wang, Hong-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">14033-14042</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Selective autophagy sequesters cytoplasmic cargo for lysosomal degrdn. via the binding of autophagy receptors to Atg8 (autophagy-related 8) family proteins on the autophagic membrane.  The sole yeast Atg8 gene has six mAtg8 (mammalian Atg8) homologs, including the MAP1LC3 (microtubule-assocd. protein-1 light chain 3) family and the GABA receptor-assocd. proteins.  Selective autophagy receptors interact with two conserved hydrophobic pockets (termed the W-site and L-site) of mATG8 proteins through a linear motif called the LC3-interacting region (LIR) with the general compn. (W/F/Y)XX(I/L/V).  To address a lack in our knowledge regarding LIR peptide specificity toward each mATG8 homolog, here we used competitive time-resolved FRET to sensitively and quant. characterize the interactions between LIRs and mAtg8.  We report that 14 representative LIR-contg. peptides display differential binding affinities toward the mAtg8 proteins and identified the LIR domain peptide of TP53INP1 as exhibiting high affinity for all six mATG8 proteins.  Using peptide truncation studies, we found that both N- and C-terminal acidic residues, as well as the C-terminal Cys residue of the TP53INP1 LIR peptide, are required for its high-affinity binding to LC3A and LC3B, whereas binding to the GABARAP subfamily proteins was facilitated by residues either N-terminal or C-terminal to the core motif.  Finally, we used NMR chem. shift perturbation anal. to gain mol. insights into these findings.  Collectively, our results may aid in the development of mols. that selectively disrupt specific mATG8-LIR interactions to dissect the biol. roles of the six mATG8 homologs for potential therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOcEE61TwCcLVg90H21EOLACvtfcHk0li8Gv6jlnOZuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1Omt7fN&md5=872143cc537a6849662a475558894201</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.008723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.008723%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DJ.%2BM.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DGebru%26aufirst%3DM.%2BT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DM.%2BM.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DQ.%26aulast%3DTian%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%2BG.%26atitle%3DTime-resolved%2520FRET%2520and%2520NMR%2520analyses%2520reveal%2520selective%2520binding%2520of%2520peptides%2520containing%2520the%2520LC3-interacting%2520region%2520to%2520ATG8%2520family%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26issue%3D38%26spage%3D14033%26epage%3D14042%26doi%3D10.1074%2Fjbc.RA119.008723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amason, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcin, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dranchak, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macarthur, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braisted, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inglese, J.</span></span> <span> </span><span class="NLM_article-title">Quantitative high-throughput screening assays for the discovery and development of SIRPÎ±-CD47 interaction inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e0218897</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0218897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1371%2Fjournal.pone.0218897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=31276567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslWksrjJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&issue=7&author=T.+W.+Millerauthor=J.+D.+Amasonauthor=E.+D.+Garcinauthor=L.+Lamyauthor=P.+K.+Dranchakauthor=R.+Macarthurauthor=J.+Braistedauthor=J.+S.+Rubinauthor=T.+L.+Burgessauthor=C.+L.+Farrellauthor=D.+D.+Robertsauthor=J.+Inglese&title=Quantitative+high-throughput+screening+assays+for+the+discovery+and+development+of+SIRP%CE%B1-CD47+interaction+inhibitors&doi=10.1371%2Fjournal.pone.0218897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative high-throughput screening assays for the discovery and development of SIRPÎ±-CD47 interaction inhibitors</span></div><div class="casAuthors">Miller, Thomas W.; Amason, Joshua D.; Garcin, Elsa D.; Lamy, Laurence; Dranchak, Patricia K.; Macarthur, Ryan; Braisted, John; Rubin, Jeffrey S.; Burgess, Teresa L.; Farrell, Catherine L.; Roberts, David D.; Inglese, James</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e0218897</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">CD47 is an immune checkpoint mol. that downregulates key aspects of both the innate and adaptive anti-tumor immune response via its counter receptor SIRPÎ±, and it is expressed at high levels in a wide variety of tumor types.  This has led to the development of biologics that inhibit SIRPÎ± engagement including humanized CD47 antibodies and a sol. SIRPÎ± decoy receptor that are currently undergoing clin. trials.  Unfortunately, toxicol. issues, including anemia related to on-target mechanisms, are barriers to their clin. advancement.  Another potential issue with large biologics that bind CD47 is perturbation of CD47 signaling through its high-affinity interaction with the matricellular protein thrombospondin-1 (TSP1).  One approach to avoid these shortcomings is to identify and develop small mol. mol. probes and pretherapeutic agents that would (1) selectively target SIRPÎ± or TSP1 interactions with CD47, (2) provide a route to optimize pharmacokinetics, reduce on-target toxicity and maximize tissue penetration, and (3) allow more flexible routes of administration.  As the first step toward this goal, we report the development of an automated quant. high-throughput screening (qHTS) assay platform capable of screening large diverse drug-like chem. libraries to discover novel small mols. that inhibit CD47-SIRPÎ± interaction.  Using time-resolved Forster resonance energy transfer (TR-FRET) and bead-based luminescent oxygen channeling assay formats (AlphaScreen), we developed biochem. assays, optimized their performance, and individually tested them in small-mol. library screening.  Based on performance and low false pos. rate, the LANCE TR-FRET assay was employed in a ~ 90,000 compd. library qHTS, while the AlphaScreen oxygen channeling assay served as a cross-validation orthogonal assay for follow-up characterization.  With this multi-assay strategy, we successfully eliminated compds. that interfered with the assays and identified five compds. that inhibit the CD47-SIRPÎ± interaction; these compds. will be further characterized and later disclosed.  Importantly, our results validate the large library qHTS for antagonists of CD47-SIRPÎ± interaction and suggest broad applicability of this approach to screen chem. libraries for other protein-protein interaction modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiuhG9zdKtzrVg90H21EOLACvtfcHk0li8Gv6jlnOZuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslWksrjJ&md5=d21c80c6b39439cb1584e9f9de90c963</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0218897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0218897%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DT.%2BW.%26aulast%3DAmason%26aufirst%3DJ.%2BD.%26aulast%3DGarcin%26aufirst%3DE.%2BD.%26aulast%3DLamy%26aufirst%3DL.%26aulast%3DDranchak%26aufirst%3DP.%2BK.%26aulast%3DMacarthur%26aufirst%3DR.%26aulast%3DBraisted%26aufirst%3DJ.%26aulast%3DRubin%26aufirst%3DJ.%2BS.%26aulast%3DBurgess%26aufirst%3DT.%2BL.%26aulast%3DFarrell%26aufirst%3DC.%2BL.%26aulast%3DRoberts%26aufirst%3DD.%2BD.%26aulast%3DInglese%26aufirst%3DJ.%26atitle%3DQuantitative%2520high-throughput%2520screening%2520assays%2520for%2520the%2520discovery%2520and%2520development%2520of%2520SIRP%25CE%25B1-CD47%2520interaction%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2019%26volume%3D14%26issue%3D7%26doi%3D10.1371%2Fjournal.pone.0218897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, P. M.</span></span> <span> </span><span class="NLM_article-title">Quantitative determination of protein stability and ligand binding using a green fluorescent protein reporter system</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1285</span>â <span class="NLM_lpage">1292</span>, <span class="refDoi">Â DOI: 10.1039/c002001j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1039%2Fc002001j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=20454718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsVOns7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=1285-1292&author=M.+J.+Moreauauthor=I.+Morinauthor=P.+M.+Schaeffer&title=Quantitative+determination+of+protein+stability+and+ligand+binding+using+a+green+fluorescent+protein+reporter+system&doi=10.1039%2Fc002001j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative determination of protein stability and ligand binding using a green fluorescent protein reporter system</span></div><div class="casAuthors">Moreau, Morgane J. J.; Morin, Isabelle; Schaeffer, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1285-1292</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-206X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Information about the stability of proteins is paramount to det. their optimal storage or reaction conditions.  It is also essential to det. protein stability in high-throughput when screening for new or improved functions of proteins obtained from large mutant libraries.  In drug discovery programs, monitoring of ligand-induced stabilization effects can be used to identify lead compds. in high-throughput.  These studies require expensive biophys. instrumentation and large quantities of purified proteins.  To address these issues, we developed a new method, using GFP as a reporter system to quantify the stability of a protein and its ligand-assocd. stabilization effects that requires neither special equipment nor extensive purifn. steps.  Here, GFP is fused to a protein of interest (POI) through a linker and is used as a reporter system for protein unfolding and aggregation.  The three POIs used in this study include the Ter-binding protein Tus, glycerol kinase and chloramphenicol acetyl transferase.  The fluorescent fusion protein is subjected to irreversible thermal denaturation leading to formation of aggregates, which are eliminated by a centrifugation step.  The residual fluorescence of the sol. fraction can be directly related to the stability of the POI and can be quant. monitored using a fluorescence plate reader.  The GFP-based stability assay (GFP-Basta) was able to identify stabilizing compds. and afforded a new quant. method for the screening and ranking of ligands for three different proteins.  These applications are particularly useful for drug discovery, directed evolution, structural and functional genomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Z1DX66ltIbVg90H21EOLACvtfcHk0lhGyRcCsDFThQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsVOns7s%253D&md5=95dd1d32e17d80f4bc1806951aa46c9b</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1039%2Fc002001j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc002001j%26sid%3Dliteratum%253Aachs%26aulast%3DMoreau%26aufirst%3DM.%2BJ.%26aulast%3DMorin%26aufirst%3DI.%26aulast%3DSchaeffer%26aufirst%3DP.%2BM.%26atitle%3DQuantitative%2520determination%2520of%2520protein%2520stability%2520and%2520ligand%2520binding%2520using%2520a%2520green%2520fluorescent%2520protein%2520reporter%2520system%26jtitle%3DMol.%2520BioSyst.%26date%3D2010%26volume%3D6%26spage%3D1285%26epage%3D1292%26doi%3D10.1039%2Fc002001j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¼cherl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borst, J. W.</span></span> <span> </span><span class="NLM_article-title">Probing protein-protein Interactions with FRET-FLIM</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>655</i></span>,  <span class="NLM_fpage">389</span>â <span class="NLM_lpage">399</span>, <span class="refDoi">Â DOI: 10.1007/978-1-60761-765-5_26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-60761-765-5_26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=20734275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKrurjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=655&publication_year=2010&pages=389-399&author=C.+B%C3%BCcherlauthor=J.+Akerauthor=S.+de+Vriesauthor=J.+W.+Borst&title=Probing+protein-protein+Interactions+with+FRET-FLIM&doi=10.1007%2F978-1-60761-765-5_26"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Probing protein-protein interactions with FRET-FLIM</span></div><div class="casAuthors">Buecherl, Christoph; Aker, Jose; de Vries, Sacco; Borst, Jan Willem</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">655</span>
        (<span class="NLM_cas:issue">Plant Developmental Biology</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The quantification of mol. interactions or conformational changes can conveniently be studied by using Foerster Resonance Energy Transfer (FRET) as a spectroscopic ruler.  The FRET phenomenon describes the transfer of energy from a donor to an acceptor mol., if they are in close proximity (<10 nm).  The most straightforward method to measure FRET is Fluorescence Lifetime Imaging Microscopy (FLIM).  In this chapter, we will describe an application of FRET using FLIM to monitor the hexamer formation of CrFP/eYFP-labeled Arabidopsis thaliana cell division cycle protein (AtCDC48) expressed in plant protoplasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK5Nv9VbZdp7Vg90H21EOLACvtfcHk0lhGyRcCsDFThQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKrurjI&md5=d95f3f78937e9b4b58e10853fbb65ff0</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1007%2F978-1-60761-765-5_26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-60761-765-5_26%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25BCcherl%26aufirst%3DC.%26aulast%3DAker%26aufirst%3DJ.%26aulast%3Dde%2BVries%26aufirst%3DS.%26aulast%3DBorst%26aufirst%3DJ.%2BW.%26atitle%3DProbing%2520protein-protein%2520Interactions%2520with%2520FRET-FLIM%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2010%26volume%3D655%26spage%3D389%26epage%3D399%26doi%3D10.1007%2F978-1-60761-765-5_26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liclican, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JÃ¼rgensmeier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagratis, N.</span></span> <span> </span><span class="NLM_article-title">Homogeneous BTK occupancy assay for pharmacodynamic assessment of tirabrutinib (GS-4059/ONO-4059) target engagement</span>. <i>SLAS Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">919</span>â <span class="NLM_lpage">929</span>, <span class="refDoi">Â DOI: 10.1177/2472555218786165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1177%2F2472555218786165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30011241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOgsrrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=919-929&author=H.+Yuauthor=H.+Truongauthor=S.+A.+Mitchellauthor=A.+Liclicanauthor=J.+J.+Gosinkauthor=W.+Liauthor=J.+Linauthor=J.+Y.+Fengauthor=J.+M.+J%C3%BCrgensmeierauthor=A.+Billinauthor=R.+Xuauthor=S.+Pattersonauthor=N.+Pagratis&title=Homogeneous+BTK+occupancy+assay+for+pharmacodynamic+assessment+of+tirabrutinib+%28GS-4059%2FONO-4059%29+target+engagement&doi=10.1177%2F2472555218786165"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement</span></div><div class="casAuthors">Yu, Helen; Truong, Hoa; Mitchell, Scott A.; Liclican, Albert; Gosink, John J.; Li, Wanying; Lin, Julie; Feng, Joy Y.; Jurgensmeier, Juliane M.; Billin, Andrew; Xu, Ren; Patterson, Scott; Pagratis, Nikos</div><div class="citationInfo"><span class="NLM_cas:title">SLAS Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">919-929</span>CODEN:
                <span class="NLM_cas:coden">SDLIBT</span>;
        ISSN:<span class="NLM_cas:issn">2472-5560</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Bruton's tyrosine kinase (BTK) is a clin. validated target for B-cell leukemias and lymphomas with FDA-approved small-mol. inhibitors ibrutinib and acalabrutinib.  Tirabrutinib (GS-4059/ONO-4059, Gilead Sciences, Inc., Foster City, CA) is a second-generation, potent, selective, irreversible BTK inhibitor in clin. development for lymphoid malignancies, including chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL).  An accurate pharmacodynamic assay to assess tirabrutinib target coverage in phase 1/2 clin. studies will inform dose and schedule selection for advanced clin. evaluation.  We developed a novel duplex homogeneous BTK occupancy assay based on time-resolved fluorescence resonance energy transfer (TR-FRET) to measure free and total BTK levels in a multiplexed format.  The dual-wavelength emission property of terbium-conjugated anti-BTK antibody served as the energy donor for two fluorescent energy acceptors with distinct excitation and emission spectra.  The assay was characterized and qualified using full-length purified recombinant human BTK protein and peripheral blood mononuclear cells derived from healthy volunteers and patients with CLL.  We demonstrated assay utility using cells derived from lymph node and bone marrow samples from patients with CLL and DLBCL.  Our TR-FRET-based BTK occupancy assay provides accurate, quant. assessment of BTK occupancy in the clin. trial program for tirabrutinib and is in use in ongoing clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw4B-ns8y3L7Vg90H21EOLACvtfcHk0lhGyRcCsDFThQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOgsrrM&md5=d78702b99f5ab7e72a7f549a49e1ca3c</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1177%2F2472555218786165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2472555218786165%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DTruong%26aufirst%3DH.%26aulast%3DMitchell%26aufirst%3DS.%2BA.%26aulast%3DLiclican%26aufirst%3DA.%26aulast%3DGosink%26aufirst%3DJ.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DJ%25C3%25BCrgensmeier%26aufirst%3DJ.%2BM.%26aulast%3DBillin%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DPagratis%26aufirst%3DN.%26atitle%3DHomogeneous%2520BTK%2520occupancy%2520assay%2520for%2520pharmacodynamic%2520assessment%2520of%2520tirabrutinib%2520%2528GS-4059%252FONO-4059%2529%2520target%2520engagement%26jtitle%3DSLAS%2520Discovery%26date%3D2018%26volume%3D23%26spage%3D919%26epage%3D929%26doi%3D10.1177%2F2472555218786165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stockmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todorovic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerstein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lake, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadhukhan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, A.</span></span> <span> </span><span class="NLM_article-title">Cell-surface receptor-ligand interaction analysis with homogeneous time-resolved FRET and metabolic glycan engineering: application to transmembrane and GPI-anchored receptors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">16822</span>â <span class="NLM_lpage">16829</span>, <span class="refDoi">Â DOI: 10.1021/jacs.7b09359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b09359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7jP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=16822-16829&author=H.+Stockmannauthor=V.+Todorovicauthor=P.+L.+Richardsonauthor=V.+Marinauthor=V.+Scottauthor=C.+Gersteinauthor=M.+Lakeauthor=L.+Wangauthor=R.+Sadhukhanauthor=A.+Vasudevan&title=Cell-surface+receptor-ligand+interaction+analysis+with+homogeneous+time-resolved+FRET+and+metabolic+glycan+engineering%3A+application+to+transmembrane+and+GPI-anchored+receptors&doi=10.1021%2Fjacs.7b09359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-Surface Receptor-Ligand Interaction Analysis with Homogeneous Time-Resolved FRET and Metabolic Glycan Engineering: Application to Transmembrane and GPI-Anchored Receptors</span></div><div class="casAuthors">Stockmann, Henning; Todorovic, Viktor; Richardson, Paul L.; Marin, Violeta; Scott, Victoria; Gerstein, Clare; Lake, Marc; Wang, Leyu; Sadhukhan, Ramkrishna; Vasudevan, Anil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16822-16829</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand-binding assays are the linchpin of drug discovery and medicinal chem.  Cell-surface receptors and their ligands have traditionally been characterized by radioligand-binding assays, which have low temporal and spatial resoln. and entail safety risks.  Here, the authors report a powerful alternative (GlycoFRET), where terbium-labeled fluorescent reporters are irreversibly attached to receptors by metabolic glycan engineering.  For the first time, the authors show time-resolved fluorescence resonance energy transfer between receptor glycans and fluorescently labeled ligands.  The authors describe GlycoFRET for a GPI-anchored receptor, a G-protein-coupled receptor, and a heterodimeric cytokine receptor in living cells with excellent sensitivity and high signal-to-background ratios.  In contrast to previously described methods, GlycoFRET does not require genetic engineering or antibodies to label receptors.  Given that all cell-surface receptors are glycosylated, the authors expect that GlycoFRET can be generalized with applications in chem. biol. and biotechnol., such as target engagement, receptor pharmacol., and high-throughput screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6a1kXDrYJFLVg90H21EOLACvtfcHk0ljH8Eb6i7vpkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7jP&md5=08081ff21f9bf9ea6a35d6dda988128d</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b09359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b09359%26sid%3Dliteratum%253Aachs%26aulast%3DStockmann%26aufirst%3DH.%26aulast%3DTodorovic%26aufirst%3DV.%26aulast%3DRichardson%26aufirst%3DP.%2BL.%26aulast%3DMarin%26aufirst%3DV.%26aulast%3DScott%26aufirst%3DV.%26aulast%3DGerstein%26aufirst%3DC.%26aulast%3DLake%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DSadhukhan%26aufirst%3DR.%26aulast%3DVasudevan%26aufirst%3DA.%26atitle%3DCell-surface%2520receptor-ligand%2520interaction%2520analysis%2520with%2520homogeneous%2520time-resolved%2520FRET%2520and%2520metabolic%2520glycan%2520engineering%253A%2520application%2520to%2520transmembrane%2520and%2520GPI-anchored%2520receptors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D16822%26epage%3D16829%26doi%3D10.1021%2Fjacs.7b09359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guaitoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponterini, G.</span></span> <span> </span><span class="NLM_article-title">Dimerâmonomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1023</span>â <span class="NLM_lpage">1030</span>, <span class="refDoi">Â DOI: 10.1002/pro.379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fpro.379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=20306493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFSgtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=1023-1030&author=F.+Genoveseauthor=S.+Ferrariauthor=G.+Guaitoliauthor=M.+Caselliauthor=M.+P.+Costiauthor=G.+Ponterini&title=Dimer%E2%80%93monomer+equilibrium+of+human+thymidylate+synthase+monitored+by+fluorescence+resonance+energy+transfer&doi=10.1002%2Fpro.379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer</span></div><div class="casAuthors">Genovese, Filippo; Ferrari, Stefania; Guaitoli, Giambattista; Caselli, Monica; Costi, M. Paola; Ponterini, Glauco</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1023-1030</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">An ad hoc bioconjugation/FRET assay was designed to spectroscopically monitor the quaternary state of human thymidylate synthase (hTS) dimeric protein.  The approach enabled the chemoselective engineering of allosteric residues while preserving the native protein functions through reversible masking of residues within the catalytic site, and was therefore suitable for activity/oligomerization dual assay screenings.  It was applied to tag the 2 subunits of hTS at Cys-43 and Cys-43' residues with an excitation energy donor/acceptor pair.  The dimer-monomer equil. of the enzyme was then characterized through steady-state fluorescence detn. of the intersubunit resonance energy transfer efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL_9goPgkDSbVg90H21EOLACvtfcHk0ljH8Eb6i7vpkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFSgtr4%253D&md5=0d70cf35f1bef5cc2e6170de9aa641e4</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1002%2Fpro.379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.379%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DF.%26aulast%3DFerrari%26aufirst%3DS.%26aulast%3DGuaitoli%26aufirst%3DG.%26aulast%3DCaselli%26aufirst%3DM.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DPonterini%26aufirst%3DG.%26atitle%3DDimer%25E2%2580%2593monomer%2520equilibrium%2520of%2520human%2520thymidylate%2520synthase%2520monitored%2520by%2520fluorescence%2520resonance%2520energy%2520transfer%26jtitle%3DProtein%2520Sci.%26date%3D2010%26volume%3D19%26spage%3D1023%26epage%3D1030%26doi%3D10.1002%2Fpro.379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ponterini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavesi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauriola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PelÃ , M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gozzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacifico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marverti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DâArca, D.</span></span> <span> </span><span class="NLM_article-title">Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">27198</span>, <span class="refDoi">Â DOI: 10.1038/srep27198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fsrep27198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27250901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFChu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=27198&author=G.+Ponteriniauthor=A.+Martelloauthor=G.+Pavesiauthor=A.+Lauriolaauthor=R.+Lucianiauthor=M.+Santucciauthor=M.+Pel%C3%A0author=G.+Gozziauthor=S.+Pacificoauthor=R.+Guerriniauthor=G.+Marvertiauthor=M.+P.+Costiauthor=D.+D%E2%80%99Arca&title=Intracellular+quantitative+detection+of+human+thymidylate+synthase+engagement+with+an+unconventional+inhibitor+using+tetracysteine-diarsenical-probe+technology&doi=10.1038%2Fsrep27198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology</span></div><div class="casAuthors">Ponterini, Glauco; Martello, Andrea; Pavesi, Giorgia; Lauriola, Angela; Luciani, Rosaria; Santucci, Matteo; Pela, Michela; Gozzi, Gaia; Pacifico, Salvatore; Guerrini, Remo; Marverti, Gaetano; Costi, Maria Paola; D'Arca, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27198</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Demonstrating a candidate drug's interaction with its target protein in live cells is of pivotal relevance to the successful outcome of the drug discovery process.  Although thymidylate synthase (hTS) is an important anticancer target protein, the efficacy of the few anti-hTS drugs currently used in clin. practice is limited by the development of resistance.  Hence, there is an intense search for new, unconventional anti-hTS drugs; there are approx. 1600 ongoing clin. trials involving hTS-targeting drugs, both alone and in combination protocols.  We recently discovered new, unconventional peptidic inhibitors of hTS that are active against cancer cells and do not result in the overexpression of hTS, which is a known mol. source of resistance.  Here, we propose an adaptation of the recently proposed tetracysteine-arsenic-binding-motif technol. to detect and quant. characterize the engagement of hTS with one such peptidic inhibitor in cell lysates.  This new model can be developed into a test for high-throughput screening studies of intracellular target-protein/small-mol. binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3QbclCRG7s7Vg90H21EOLACvtfcHk0ljWWmBa2d9C4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFChu7o%253D&md5=7e5485349dba3e5073dc712e77c811d4</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1038%2Fsrep27198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep27198%26sid%3Dliteratum%253Aachs%26aulast%3DPonterini%26aufirst%3DG.%26aulast%3DMartello%26aufirst%3DA.%26aulast%3DPavesi%26aufirst%3DG.%26aulast%3DLauriola%26aufirst%3DA.%26aulast%3DLuciani%26aufirst%3DR.%26aulast%3DSantucci%26aufirst%3DM.%26aulast%3DPel%25C3%25A0%26aufirst%3DM.%26aulast%3DGozzi%26aufirst%3DG.%26aulast%3DPacifico%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DMarverti%26aufirst%3DG.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DD%25E2%2580%2599Arca%26aufirst%3DD.%26atitle%3DIntracellular%2520quantitative%2520detection%2520of%2520human%2520thymidylate%2520synthase%2520engagement%2520with%2520an%2520unconventional%2520inhibitor%2520using%2520tetracysteine-diarsenical-probe%2520technology%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D27198%26doi%3D10.1038%2Fsrep27198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di Rocco, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacifico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cichero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fossa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franchini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardarelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponterini, G.</span></span> <span> </span><span class="NLM_article-title">Fluorometric detection of protein-ligand engagement: the case of phosphodiesterase 5</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">335</span>â <span class="NLM_lpage">342</span>, <span class="refDoi">Â DOI: 10.1016/j.jpba.2017.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.jpba.2017.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=29132113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2ksrvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2018&pages=335-342&author=G.+Di+Roccoauthor=I.+Martinelliauthor=S.+Pacificoauthor=R.+Guerriniauthor=E.+Cicheroauthor=P.+Fossaauthor=S.+Franchiniauthor=S.+Cardarelliauthor=M.+Giorgiauthor=M.+Solaauthor=G.+Ponterini&title=Fluorometric+detection+of+protein-ligand+engagement%3A+the+case+of+phosphodiesterase+5&doi=10.1016%2Fj.jpba.2017.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorometric detection of protein-ligand engagement: The case of phosphodiesterase5</span></div><div class="casAuthors">Di Rocco, Giulia; Martinelli, Ilaria; Pacifico, Salvatore; Guerrini, Remo; Cichero, Elena; Fossa, Paola; Franchini, Silvia; Cardarelli, Silvia; Giorgi, Mauro; Sola, Marco; Ponterini, Glauco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">335-342</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) regulate the intracellular levels of cAMP and cGMP.  The great clin. success of the PDE5 inhibitors, Sildenafil (Viagra), Vardenafil (Levitra) and Tadalafil (Cialis) has led to an increasing interest for this class of enzymes.  Recent studies have shown a correlation between tumor growth and PDE5 overexpression, making PDE5-selective inhibitors promising candidates for cancer treatment.  The search for such inhibitors rests today on radioactive assays.  In this work, we exploit the conserved catalytic domain of the enzyme and propose a faster and safer method for detecting the binding of ligands and evaluate their affinities.  The new approach takes advantage of Forster Resonance Energy Transfer (FRET) between, as the donor, a fluorescein-like diarsenical probe able to covalently bind a tetracysteine motif fused to the recombinant PDE5 catalytic domain and, as the acceptor, a rhodamine probe covalently bound to the pseudosubstrate cGMPS.  The FRET efficiency decreases when a competitive ligand binds the PDE5 catalytic site and displaces the cGMPS-rhodamine conjugate.  We have structurally investigated the PDE5/cGMPS-rhodamine complex by mol. modeling and have used the FRET signal to quant. characterize its binding equil.  Competitive displacement expts. were carried out with tadalafil and cGMPS.  An adaptation of the competitive-displacement equil. model yielded the affinities for PDE5 of the incoming ligands, nano- and micromolar, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryhhrfmgbYmLVg90H21EOLACvtfcHk0ljWWmBa2d9C4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2ksrvM&md5=9bb3aed24d4ce27b6e09fa962b05fbcb</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2017.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2017.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BRocco%26aufirst%3DG.%26aulast%3DMartinelli%26aufirst%3DI.%26aulast%3DPacifico%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCichero%26aufirst%3DE.%26aulast%3DFossa%26aufirst%3DP.%26aulast%3DFranchini%26aufirst%3DS.%26aulast%3DCardarelli%26aufirst%3DS.%26aulast%3DGiorgi%26aufirst%3DM.%26aulast%3DSola%26aufirst%3DM.%26aulast%3DPonterini%26aufirst%3DG.%26atitle%3DFluorometric%2520detection%2520of%2520protein-ligand%2520engagement%253A%2520the%2520case%2520of%2520phosphodiesterase%25205%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2018%26volume%3D149%26spage%3D335%26epage%3D342%26doi%3D10.1016%2Fj.jpba.2017.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumer, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepler, J. R.</span></span> <span> </span><span class="NLM_article-title">Bioluminescence resonance energy transfer to detect protein-protein interactions in live cells</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1278</i></span>,  <span class="NLM_fpage">457</span>â <span class="NLM_lpage">465</span>, <span class="refDoi">Â DOI: 10.1007/978-1-4939-2425-7_30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-4939-2425-7_30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25859969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Ortbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1278&publication_year=2015&pages=457-465&author=N.+E.+Brownauthor=J.+B.+Blumerauthor=J.+R.+Hepler&title=Bioluminescence+resonance+energy+transfer+to+detect+protein-protein+interactions+in+live+cells&doi=10.1007%2F978-1-4939-2425-7_30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Bioluminescence Resonance Energy Transfer to Detect Protein-Protein Interactions in Live Cells</span></div><div class="casAuthors">Brown, Nicole E.; Blumer, Joe B.; Hepler, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1278</span>
        (<span class="NLM_cas:issue">Protein-Protein Interactions</span>),
    <span class="NLM_cas:pages">457-465</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Bioluminescence resonance energy transfer (BRET) is a valuable tool to detect protein-protein interactions.  BRET utilizes bioluminescent and fluorescent protein tags with compatible emission and excitation properties, making it possible to examine resonance energy transfer when the tags are in close proximity (<10 nm) as a typical result of protein-protein interactions.  Here we describe a protocol for detecting BRET from two known protein binding partners (GÎ±i1 and RGS14) in HEK 293 cells using Renilla luciferase and yellow fluorescent protein tags.  We discuss the calcn. of the acceptor/donor ratio as well as net BRET and demonstrate that BRET can be used as a platform to investigate the regulation of protein-protein interactions in live cells in real time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCQsE9_cnyF7Vg90H21EOLACvtfcHk0ljWWmBa2d9C4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Ortbg%253D&md5=b77525f8a71faedbfe0366b89e1fdebe</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-2425-7_30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-2425-7_30%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%2BE.%26aulast%3DBlumer%26aufirst%3DJ.%2BB.%26aulast%3DHepler%26aufirst%3DJ.%2BR.%26atitle%3DBioluminescence%2520resonance%2520energy%2520transfer%2520to%2520detect%2520protein-protein%2520interactions%2520in%2520live%2520cells%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2015%26volume%3D1278%26spage%3D457%26epage%3D465%26doi%3D10.1007%2F978-1-4939-2425-7_30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koblan, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ember, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remillard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vittori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schonbrunn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span> <span> </span><span class="NLM_article-title">Assessment of bromodomain target engagement by a series of BI2536 analogues with miniaturized BET-BRET</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">2575</span>â <span class="NLM_lpage">2581</span>, <span class="refDoi">Â DOI: 10.1002/cmdc.201600502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fcmdc.201600502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27862999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVChsbfK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2575-2581&issue=23&author=L.+W.+Koblanauthor=D.+L.+Buckleyauthor=C.+J.+Ottauthor=M.+E.+Fitzgeraldauthor=S.+W.+Emberauthor=J.+Y.+Zhuauthor=S.+Liuauthor=J.+M.+Robertsauthor=D.+Remillardauthor=S.+Vittoriauthor=W.+Zhangauthor=E.+Schonbrunnauthor=J.+E.+Bradner&title=Assessment+of+bromodomain+target+engagement+by+a+series+of+BI2536+analogues+with+miniaturized+BET-BRET&doi=10.1002%2Fcmdc.201600502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of Bromodomain Target Engagement by a Series of BI2536 Analogues with Miniaturized BET-BRET</span></div><div class="casAuthors">Koblan, Luke W.; Buckley, Dennis L.; Ott, Christopher J.; Fitzgerald, Mark E.; Ember, Stuart W. J.; Zhu, Jin-Yi; Liu, Shuai; Roberts, Justin M.; Remillard, David; Vittori, Sarah; Zhang, Wei; Schonbrunn, Ernst; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2575-2581</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Evaluating the engagement of a small mol. ligand with a protein target in cells provides useful information for chem. probe optimization and pharmaceutical development.  While several techniques exist that can be performed in a low-throughput manner, systematic evaluation of large compd. libraries remains a challenge.  In-cell engagement measurements are esp. useful when evaluating compd. classes suspected to target multiple cellular factors.  In this study we used a bioluminescent resonant energy transfer assay to assess bromodomain engagement by a compd. series contg. bromodomain- and kinase-biasing polypharmacophores based on the known dual BRD4 bromodomain/PLK1 kinase inhibitor BI2536.  With this assay, we discovered several novel agents with bromodomain-selective specificity profiles and cellular activity.  Thus, this platform aids in distinguishing mols. whose cellular activity is difficult to assess due to polypharmacol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiVVtnPQvEQrVg90H21EOLACvtfcHk0liXdce-xpqecg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVChsbfK&md5=a6d7c6a58870eb6208e18eb32068d821</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600502%26sid%3Dliteratum%253Aachs%26aulast%3DKoblan%26aufirst%3DL.%2BW.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DOtt%26aufirst%3DC.%2BJ.%26aulast%3DFitzgerald%26aufirst%3DM.%2BE.%26aulast%3DEmber%26aufirst%3DS.%2BW.%26aulast%3DZhu%26aufirst%3DJ.%2BY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DRemillard%26aufirst%3DD.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSchonbrunn%26aufirst%3DE.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DAssessment%2520of%2520bromodomain%2520target%2520engagement%2520by%2520a%2520series%2520of%2520BI2536%2520analogues%2520with%2520miniaturized%2520BET-BRET%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26issue%3D23%26spage%3D2575%26epage%3D2581%26doi%3D10.1002%2Fcmdc.201600502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casarini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limoncella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaretti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbagallo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacifico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliavini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trenti, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Rocco, G.</span></span> <span> </span><span class="NLM_article-title">Probing the effect of sildenafil on progesterone and testosterone production by an intracellular FRET/BRET combined approach</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">799</span>â <span class="NLM_lpage">808</span>, <span class="refDoi">Â DOI: 10.1021/acs.biochem.8b01073</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.8b01073" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKrsbnI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=799-808&author=L.+Casariniauthor=L.+Riccettiauthor=S.+Limoncellaauthor=C.+Lazzarettiauthor=F.+Barbagalloauthor=S.+Pacificoauthor=R.+Guerriniauthor=S.+Tagliaviniauthor=T.+Trentiauthor=M.+Simoniauthor=M.+Solaauthor=G.+Di+Rocco&title=Probing+the+effect+of+sildenafil+on+progesterone+and+testosterone+production+by+an+intracellular+FRET%2FBRET+combined+approach&doi=10.1021%2Facs.biochem.8b01073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the effect of sildenafil on progesterone and testosterone production by an intracellular FRET/BRET combined approach</span></div><div class="casAuthors">Casarini, Livio; Riccetti, Laura; Limoncella, Silvia; Lazzaretti, Clara; Barbagallo, Federica; Pacifico, Salvatore; Guerrini, Remo; Tagliavini, Simonetta; Trenti, Tommaso; Simoni, Manuela; Sola, Marco; Di Rocco, Giulia</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">799-808</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Forster resonance energy transfer (FRET)-based biosensors have been recently applied to the study of biol. pathways.  In this study, a new biosensor was validated for the first time in live HEK293 and steroidogenic MLTC-1 cell lines for studying the effect of the PDE5 inhibitor on the hCG/LH-induced steroidogenic pathway.  The sensor improves FRET between a donor (D), the fluorescein-like diarsenical probe that can covalently bind a tetracysteine motif fused to the PDE5 catalytic domain, and an acceptor (A), the rhodamine probe conjugated to the pseudosubstrate cGMPS.  Affinity const. (Kd) values of 5.6 Â± 3.2 and 13.7 Â± 0.8 Î¼M were obtained with HEK293 and MLTC-1 cells, resp.  The detection was based on the competitive displacement of the cGMPS-rhodamine conjugate by sildenafil; the Ki values were 3.6 Â± 0.3 nM (IC50 = 2.3 nM) in HEK293 cells and 10 Â± 1.0 nM (IC50 = 3.9 nM) in MLTC-1 cells.  The monitoring of both cAMP and cGMP by bioluminescence resonance energy transfer allowed the exploitation of the effects of PDE5i on steroidogenesis, indicating that sildenafil enhanced the gonadotropin-induced progesterone-to-testosterone conversion in a cAMP-independent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUvXyvJB7u07Vg90H21EOLACvtfcHk0liXdce-xpqecg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKrsbnI&md5=955f61b190ba915ccd4f820149db57c4</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.8b01073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.8b01073%26sid%3Dliteratum%253Aachs%26aulast%3DCasarini%26aufirst%3DL.%26aulast%3DRiccetti%26aufirst%3DL.%26aulast%3DLimoncella%26aufirst%3DS.%26aulast%3DLazzaretti%26aufirst%3DC.%26aulast%3DBarbagallo%26aufirst%3DF.%26aulast%3DPacifico%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DTagliavini%26aufirst%3DS.%26aulast%3DTrenti%26aufirst%3DT.%26aulast%3DSimoni%26aufirst%3DM.%26aulast%3DSola%26aufirst%3DM.%26aulast%3DDi%2BRocco%26aufirst%3DG.%26atitle%3DProbing%2520the%2520effect%2520of%2520sildenafil%2520on%2520progesterone%2520and%2520testosterone%2520production%2520by%2520an%2520intracellular%2520FRET%252FBRET%2520combined%2520approach%26jtitle%3DBiochemistry%26date%3D2019%26volume%3D58%26spage%3D799%26epage%3D808%26doi%3D10.1021%2Facs.biochem.8b01073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robers, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasta, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corona, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohana, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhala, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comess, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. V.</span></span> <span> </span><span class="NLM_article-title">Quantitative, real-time measurements of intracellular target engagement using energy transfer</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1888</i></span>,  <span class="NLM_fpage">45</span>â <span class="NLM_lpage">71</span>, <span class="refDoi">Â DOI: 10.1007/978-1-4939-8891-4_3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-1-4939-8891-4_3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30519940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFWhur%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1888&publication_year=2019&pages=45-71&author=M.+B.+Robersauthor=J.+D.+Vastaauthor=C.+R.+Coronaauthor=R.+F.+Ohanaauthor=R.+Hurstauthor=M.+A.+Jhalaauthor=K.+M.+Comessauthor=K.+V.+Wood&title=Quantitative%2C+real-time+measurements+of+intracellular+target+engagement+using+energy+transfer&doi=10.1007%2F978-1-4939-8891-4_3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative, real-time measurements of intracellular target engagement using energy transfer</span></div><div class="casAuthors">Robers, Matthew B.; Vasta, James D.; Corona, Cesear R.; Ohana, Rachel Friedman; Hurst, Robin; Jhala, Manisha A.; Comess, Kenneth M.; Wood, Keith V.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1888</span>
        (<span class="NLM_cas:issue">Systems Chemical Biology</span>),
    <span class="NLM_cas:pages">45-71</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Intracellular target affinity and residence time are fundamental aspects of pharmacol. mechanism.  Although various robust biochem. approaches exist to measure these binding characteristics, anal. of compd. binding with isolated targets may not accurately reflect engagement in the milieu of living cells.  To realize the influence of cellular context, methods are needed that are capable of quantifying affinity and residence time in the presence of the intracellular factors that may impact target engagement.  Bioluminescence resonance energy transfer (BRET) offers a soln. for intracellular target engagement when quant. metrics or kinetic analyses are required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTHXIcIw2B3rVg90H21EOLACvtfcHk0liXdce-xpqecg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFWhur%252FL&md5=ed9c50b4453b1bc61d7b037bb1c938a8</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-8891-4_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-8891-4_3%26sid%3Dliteratum%253Aachs%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DVasta%26aufirst%3DJ.%2BD.%26aulast%3DCorona%26aufirst%3DC.%2BR.%26aulast%3DOhana%26aufirst%3DR.%2BF.%26aulast%3DHurst%26aufirst%3DR.%26aulast%3DJhala%26aufirst%3DM.%2BA.%26aulast%3DComess%26aufirst%3DK.%2BM.%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DQuantitative%252C%2520real-time%2520measurements%2520of%2520intracellular%2520target%2520engagement%2520using%2520energy%2520transfer%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2019%26volume%3D1888%26spage%3D45%26epage%3D71%26doi%3D10.1007%2F978-1-4939-8891-4_3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sartini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levati, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spadoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bach, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benincasa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scocchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottonello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanini, B.</span></span> <span> </span><span class="NLM_article-title">New antimicrobials targeting bacterial RNA polymerase holoenzyme assembly identified with an <i>in vivo</i> BRET-based discovery platform</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1727</span>â <span class="NLM_lpage">1736</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.9b00178</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.9b00178" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2jtLnJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1727-1736&issue=8&author=S.+Sartiniauthor=E.+Levatiauthor=M.+Maccesiauthor=M.+Guerraauthor=G.+Spadoniauthor=S.+Bachauthor=M.+Benincasaauthor=M.+Scocchiauthor=S.+Ottonelloauthor=S.+Rivaraauthor=B.+Montanini&title=New+antimicrobials+targeting+bacterial+RNA+polymerase+holoenzyme+assembly+identified+with+an+in+vivo+BRET-based+discovery+platform&doi=10.1021%2Facschembio.9b00178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">New Antimicrobials Targeting Bacterial RNA Polymerase Holoenzyme Assembly Identified with an in Vivo BRET-Based Discovery Platform</span></div><div class="casAuthors">Sartini, Sara; Levati, Elisabetta; Maccesi, Martina; Guerra, Matteo; Spadoni, Gilberto; Bach, Stephane; Benincasa, Monica; Scocchi, Marco; Ottonello, Simone; Rivara, Silvia; Montanini, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1727-1736</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bacterial resistance represents a major health threat worldwide, and the development of new therapeutics, including innovative antibiotics, is urgently needed.  We describe a discovery platform, centered on in silico screening and in vivo bioluminescence resonance energy transfer in yeast cells, for the identification of new antimicrobials that, by targeting the protein-protein interaction between the Î²'-subunit and the initiation factor Ï70 of bacterial RNA polymerase, inhibit holoenzyme assembly and promoter-specific transcription.  Out of 34 000 candidate compds., we identified seven hits capable of interfering with this interaction.  Two derivs. of one of these hits proved to be effective in inhibiting transcription in vitro and growth of the Gram-pos. pathogens Staphylococcus aureus and Listeria monocytogenes.  Upon supplementation of a permeability adjuvant, one deriv. also effectively inhibited Escherichia coli growth.  On the basis of the chem. structures of these inhibitors, we generated a ligand-based pharmacophore model that will guide the rational discovery of increasingly effective antibacterial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplZ9dhJFCDn7Vg90H21EOLACvtfcHk0lgS99Il5yilBw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2jtLnJ&md5=23fbe8dab2242079a02b24990fbbb075</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Facschembio.9b00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.9b00178%26sid%3Dliteratum%253Aachs%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DLevati%26aufirst%3DE.%26aulast%3DMaccesi%26aufirst%3DM.%26aulast%3DGuerra%26aufirst%3DM.%26aulast%3DSpadoni%26aufirst%3DG.%26aulast%3DBach%26aufirst%3DS.%26aulast%3DBenincasa%26aufirst%3DM.%26aulast%3DScocchi%26aufirst%3DM.%26aulast%3DOttonello%26aufirst%3DS.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DMontanini%26aufirst%3DB.%26atitle%3DNew%2520antimicrobials%2520targeting%2520bacterial%2520RNA%2520polymerase%2520holoenzyme%2520assembly%2520identified%2520with%2520an%2520in%2520vivo%2520BRET-based%2520discovery%2520platform%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2019%26volume%3D14%26issue%3D8%26spage%3D1727%26epage%3D1736%26doi%3D10.1021%2Facschembio.9b00178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McClure, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. D.</span></span> <span> </span><span class="NLM_article-title">Impact of mass spectrometry-based technologies and strategies on chemoproteomics as a tool for drug discovery</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">785</span>â <span class="NLM_lpage">791</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.8b00181</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00181" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Kns7fO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=785-791&author=R.+A.+McClureauthor=J.+D.+Williams&title=Impact+of+mass+spectrometry-based+technologies+and+strategies+on+chemoproteomics+as+a+tool+for+drug+discovery&doi=10.1021%2Facsmedchemlett.8b00181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Mass Spectrometry-Based Technologies and Strategies on Chemoproteomics as a Tool for Drug Discovery</span></div><div class="casAuthors">McClure, Ryan A.; Williams, Jon D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">785-791</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chemoproteomics is an invaluable tool to discover protein targets from phenotypic assays and to understand on- and off-target engagement of potential therapeutic compds.  Highlighted in this technol. perspective is our view on how improvements in mass spectrometry (MS)-based proteomics technol. have dramatically impacted chemoproteomics.  Improvements in sample prepn., MS instrumentation, data acquisition, and quantification strategies have enabled medicinal chemists, chem. biologists, and mass spectrometrists to develop new chemoproteomic expts. and improve existing methods.  As a result of improvements in MS, we will detail how bead-based affinity capture and activity-based proteome profiling methods have been reduced from multiple LC-MS runs for samples and controls down to a single LC-MS run each for sample and control.  With improvements in scan duty cycle and sensitivity, sufficient depth of proteome coverage can be obtained for capture-free methods, which do not utilize an enrichment step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq83OUXdyesT7Vg90H21EOLACvtfcHk0lgS99Il5yilBw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Kns7fO&md5=2db5a5a100646e41ac01bef8318bc7e4</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00181%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26atitle%3DImpact%2520of%2520mass%2520spectrometry-based%2520technologies%2520and%2520strategies%2520on%2520chemoproteomics%2520as%2520a%2520tool%2520for%2520drug%2520discovery%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D785%26epage%3D791%26doi%3D10.1021%2Facsmedchemlett.8b00181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liew, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, S. Q.</span></span> <span> </span><span class="NLM_article-title">A suite of âminimalistâ photo-crosslinkers for live-cell imaging and chemical proteomics: case study with BRD4 inhibitors</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">11816</span>â <span class="NLM_lpage">11821</span>, <span class="refDoi">Â DOI: 10.1002/anie.201706076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.201706076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlOrt7rM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=11816-11821&author=S.+Panauthor=S.+Y.+Jangauthor=D.+Wangauthor=S.+S.+Liewauthor=Z.+Liauthor=J.+S.+Leeauthor=S.+Q.+Yao&title=A+suite+of+%E2%80%9Cminimalist%E2%80%9D+photo-crosslinkers+for+live-cell+imaging+and+chemical+proteomics%3A+case+study+with+BRD4+inhibitors&doi=10.1002%2Fanie.201706076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">A Suite of "Minimalist" Photo-Crosslinkers for Live-Cell Imaging and Chemical Proteomics: Case Study with BRD4 Inhibitors</span></div><div class="casAuthors">Pan, Sijun; Jang, Se-Young; Wang, Danyang; Liew, Si Si; Li, Zhengqiu; Lee, Jun-Seok; Yao, Shao Q.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">11816-11821</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Affinity-based probes (AfBPs) provide a powerful tool for large-scale chemoproteomic studies of drug-target interactions.  The development of high-quality probes capable of recapitulating genuine drug-target engagement, however, could be challenging.  "Minimalist" photo-crosslinkers, which contain an alkyl diazirine group and a chem. tractable tag, could alleviate such challenges, but few are currently available.  Herein, the authors have developed new alkyl diazirine-contg. photo-crosslinkers with different bioorthogonal tags.  They were subsequently used to create a suite of AfBPs based on GW841819X (a small mol. inhibitor of BRD4).  Through in vitro and in situ studies under conditions that emulated native drug-target interactions, the authors have obtained better insights into how a tag might affect the probe's performance.  Finally, SILAC-based chemoproteomic studies have led to the discovery of a novel off-target, APEX1.  Further studies showed GW841819X binds to APEX1 and caused up-regulation of endogenous DNMT1 expression under normoxia conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoG1Ettvbr27Vg90H21EOLACvtfcHk0lgS99Il5yilBw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlOrt7rM&md5=7f9d0d80f4e802359803ae5c37548337</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706076%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DJang%26aufirst%3DS.%2BY.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLiew%26aufirst%3DS.%2BS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DYao%26aufirst%3DS.%2BQ.%26atitle%3DA%2520suite%2520of%2520%25E2%2580%259Cminimalist%25E2%2580%259D%2520photo-crosslinkers%2520for%2520live-cell%2520imaging%2520and%2520chemical%2520proteomics%253A%2520case%2520study%2520with%2520BRD4%2520inhibitors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D11816%26epage%3D11821%26doi%3D10.1002%2Fanie.201706076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parker, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galmozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joslyn, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallaro, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narvaiza, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Ligand and target discovery by fragment-based screening in human cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">527</span>â <span class="NLM_lpage">541</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2016.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.cell.2016.12.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28111073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVeiu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=527-541&author=C.+G.+Parkerauthor=A.+Galmozziauthor=Y.+Wangauthor=B.+E.+Correiaauthor=K.+Sasakiauthor=C.+M.+Joslynauthor=A.+S.+Kimauthor=C.+L.+Cavallaroauthor=R.+M.+Lawrenceauthor=S.+R.+Johnsonauthor=I.+Narvaizaauthor=E.+Saezauthor=B.+F.+Cravatt&title=Ligand+and+target+discovery+by+fragment-based+screening+in+human+cells&doi=10.1016%2Fj.cell.2016.12.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand and Target Discovery by Fragment-Based Screening in Human Cells</span></div><div class="casAuthors">Parker, Christopher G.; Galmozzi, Andrea; Wang, Yujia; Correia, Bruno E.; Sasaki, Kenji; Joslyn, Christopher M.; Kim, Arthur S.; Cavallaro, Cullen L.; Lawrence, R. Michael; Johnson, Stephen R.; Narvaiza, Inigo; Saez, Enrique; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">527-541.e29</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Advances in the synthesis and screening of small-mol. libraries have accelerated the discovery of chem. probes for studying biol. processes.  Still, only a small fraction of the human proteome has chem. ligands.  Here, we describe a platform that marries fragment-based ligand discovery with quant. chem. proteomics to map thousands of reversible small mol.-protein interactions directly in human cells, many of which can be site-specifically detd.  We show that fragment hits can be advanced to furnish selective ligands that affect the activity of proteins heretofore lacking chem. probes.  We further combine fragment-based chem. proteomics with phenotypic screening to identify small mols. that promote adipocyte differentiation by engaging the poorly characterized membrane protein PGRMC2.  Fragment-based screening in human cells thus provides an extensive proteome-wide map of protein ligandability and facilitates the coordinated discovery of bioactive small mols. and their mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPk-YJwFlDwbVg90H21EOLACvtfcHk0lgnnfS2H6VqGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVeiu7Y%253D&md5=835264291015037ab9b7e446992caba3</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DC.%2BG.%26aulast%3DGalmozzi%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCorreia%26aufirst%3DB.%2BE.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DJoslyn%26aufirst%3DC.%2BM.%26aulast%3DKim%26aufirst%3DA.%2BS.%26aulast%3DCavallaro%26aufirst%3DC.%2BL.%26aulast%3DLawrence%26aufirst%3DR.%2BM.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DNarvaiza%26aufirst%3DI.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DLigand%2520and%2520target%2520discovery%2520by%2520fragment-based%2520screening%2520in%2520human%2520cells%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D527%26epage%3D541%26doi%3D10.1016%2Fj.cell.2016.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span> <span> </span><span class="NLM_article-title">Proteome-wide identification of on- and off-targets of Bcl-2 inhibitors in native biological systems by using affinity-based probes (AfBPs)</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2312</span>â <span class="NLM_lpage">2320</span>, <span class="refDoi">Â DOI: 10.1002/cbic.201800380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fcbic.201800380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=30133085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFequr%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=2312-2320&author=Z.+Wangauthor=Z.+Guoauthor=T.+Songauthor=X.+Zhangauthor=N.+Heauthor=P.+Liuauthor=P.+Wangauthor=Z.+Zhang&title=Proteome-wide+identification+of+on-+and+off-targets+of+Bcl-2+inhibitors+in+native+biological+systems+by+using+affinity-based+probes+%28AfBPs%29&doi=10.1002%2Fcbic.201800380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Proteome-Wide Identification of On- and Off-Targets of Bcl-2 Inhibitors in Native Biological Systems by Using Affinity-Based Probes (AfBPs)</span></div><div class="casAuthors">Wang, Ziqian; Guo, Zongwei; Song, Ting; Zhang, Xiaodong; He, Nianzhe; Liu, Peng; Wang, Peiran; Zhang, Zhichao</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2312-2320</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Selective inhibition of proteins of the Bcl-2 family by small-mol. inhibitors is a promising new approach in drug discovery.  However, information about how these mols. interact with their cellular targets (on- and off-) is highly limited.  We have designed and synthesized photoreactive and "clickable" affinity-based probes (AfBPs)-Nap-2 and Nap-5-by introducing photo-crosslinkers onto Nap-1, a fluorescent deriv. of small-mol. Bcl-2 inhibitor S1-6.  The resulting trifunctional probes Nap-2 and Nap-5 can enrich, visualize, and enable the identification of cellular on- and off-targets of Bcl-2 inhibitors both in vitro and in situ.  Tubulin was validated as an off-target of Bcl-2 inhibitors (Nap-1 and S1-6) by large-scale cell-based proteome profiling and pull-down/western blotting (PD/WB) with Nap-2 and Nap-5.  It was preliminarily illustrated to be a BH3-contg. protein because some well-known Bcl-2 inhibitors can block the labeling of tubulin by Nap-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO-aBFZ-ybLLVg90H21EOLACvtfcHk0liWjlrqysC74g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFequr%252FI&md5=8ca5bbf1ae20f5ce024f72f431dd9166</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201800380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201800380%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DSong%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DZ.%26atitle%3DProteome-wide%2520identification%2520of%2520on-%2520and%2520off-targets%2520of%2520Bcl-2%2520inhibitors%2520in%2520native%2520biological%2520systems%2520by%2520using%2520affinity-based%2520probes%2520%2528AfBPs%2529%26jtitle%3DChemBioChem%26date%3D2018%26volume%3D19%26spage%3D2312%26epage%3D2320%26doi%3D10.1002%2Fcbic.201800380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gower, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. R.</span></span> <span> </span><span class="NLM_article-title">Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors</span>. <i>Proteome Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">17</span>, <span class="refDoi">Â DOI: 10.1186/s12953-017-0125-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1186%2Fs12953-017-0125-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28725163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC1cjpt1yqtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=17&author=M.+L.+Wongauthor=J.+Murphyauthor=E.+Harringtonauthor=C.+M.+Gowerauthor=R.+K.+Jainauthor=M.+Schirleauthor=J.+R.+Thomas&title=Examining+the+influence+of+specificity+ligands+and+ATP-competitive+ligands+on+the+overall+effectiveness+of+bivalent+kinase+inhibitors&doi=10.1186%2Fs12953-017-0125-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors</span></div><div class="casAuthors">Wong Margaret L; Murphy Jason; Harrington Edmund; Jain Rishi K; Schirle Markus; Thomas Jason R; Gower Carrie M</div><div class="citationInfo"><span class="NLM_cas:title">Proteome science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17</span>
        ISSN:<span class="NLM_cas:issn">1477-5956</span>.
    </div><div class="casAbstract">BACKGROUND:  Identifying selective kinase inhibitors remains a major challenge.  The design of bivalent inhibitors provides a rational strategy for accessing potent and selective inhibitors.  While bivalent kinase inhibitors have been successfully designed, no comprehensive assessment of affinity and selectivity for a series of bivalent inhibitors has been performed.  Here, we present an evaluation of the structure activity relationship for bivalent kinase inhibitors targeting ABL1.  METHODS:  Various SNAPtag constructs bearing different specificity ligands were expressed in vitro.  Bivalent inhibitor formation was accomplished by synthesizing individual ATP-competitive kinase inhibitors containing a SNAPtag targeting moiety, enabling the spontaneous self-assembly of the bivalent inhibitor.  Assembled bivalent inhibitors were incubated with K562 lysates, and then subjected to affinity enrichment using various ATP-competitive inhibitors immobilized to sepharose beads.  Resulting eluents were analyzed using Tandem Mass Tag (TMT) labeling and two-dimensional liquid chromatography-tandem mass spectrometry (2D-LC-MS/MS).  Relative binding affinity of the bivalent inhibitor was determined by calculating the concentration at which 50% of a given kinase remained bound to the affinity matrix.  RESULTS:  The profiling of three parental ATP-competitive inhibitors and nine SNAPtag conjugates led to the identification of 349 kinase proteins.  In all cases, the bivalent inhibitors exhibited enhanced binding affinity and selectivity for ABL1 when compared to the parental compound conjugated to SNAPtag alone.  While the rank order of binding affinity could be predicted by considering the binding affinities of the individual specificity ligands, the resulting affinity of the assembled bivalent inhibitor was not predictable.  The results from this study suggest that as the potency of the ATP-competitive ligand increases, the contribution of the specificity ligand towards the overall binding affinity of the bivalent inhibitor decreases.  However, the affinity of the specificity components in its interaction with the target is essential for achieving selectivity.  CONCLUSION:  Through comprehensive chemical proteomic profiling, this work provides the first insight into the influence of ATP-competitive and specificity ligands binding to their intended target on a proteome-wide scale.  The resulting data suggest a subtle interplay between the ATP-competitive and specificity ligands that cannot be accounted for by considering the specificity or affinity of the individual components alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpqnwfDgZWMRBrI9DTGjC0fW6udTcc2eZ1F2s5yne537ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjpt1yqtA%253D%253D&md5=168a38f44be508ae38a1f11acbe370bb</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1186%2Fs12953-017-0125-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12953-017-0125-1%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DM.%2BL.%26aulast%3DMurphy%26aufirst%3DJ.%26aulast%3DHarrington%26aufirst%3DE.%26aulast%3DGower%26aufirst%3DC.%2BM.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DJ.%2BR.%26atitle%3DExamining%2520the%2520influence%2520of%2520specificity%2520ligands%2520and%2520ATP-competitive%2520ligands%2520on%2520the%2520overall%2520effectiveness%2520of%2520bivalent%2520kinase%2520inhibitors%26jtitle%3DProteome%2520Sci.%26date%3D2016%26volume%3D15%26spage%3D17%26doi%3D10.1186%2Fs12953-017-0125-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Veldhoven, J. P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offringa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenselink, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Es, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">Development of covalent ligands for G protein-coupled receptors: a case for the human adenosine A(3) receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3539</span>â <span class="NLM_lpage">3552</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b02026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b02026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvF2gsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3539-3552&issue=7&author=X.+Yangauthor=J.+P.+D.+van+Veldhovenauthor=J.+Offringaauthor=B.+J.+Kuiperauthor=E.+B.+Lenselinkauthor=L.+H.+Heitmanauthor=D.+van+der+Esauthor=A.+P.+Ijzerman&title=Development+of+covalent+ligands+for+G+protein-coupled+receptors%3A+a+case+for+the+human+adenosine+A%283%29+receptor&doi=10.1021%2Facs.jmedchem.8b02026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A3 Receptor</span></div><div class="casAuthors">Yang, Xue; van Veldhoven, Jacobus P. D.; Offringa, Jelle; Kuiper, Boaz J.; Lenselink, Eelke B.; Heitman, Laura H.; van der Es, Daan; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3539-3552</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of covalent ligands for G protein-coupled receptors (GPCRs) is not a trivial process.  Here, we report a streamlined workflow thereto from synthesis to validation, exemplified by the discovery of a covalent antagonist for the human adenosine A3 receptor (hA3AR).  Based on the 1H,3H-pyrido[2,1-f]purine-2,4-dione scaffold, a series of ligands bearing a fluorosulfonyl warhead and a varying linker was synthesized.  This series was subjected to an affinity screen, revealing compd. I as the most potent antagonist.  In addn., a nonreactive methylsulfonyl deriv. was developed as a reversible control compd.  A series of assays, comprising time-dependent affinity detn., washout expts., and [35S]GTPÎ³S binding assays, then validated I as the covalent antagonist.  A combined in silico hA3AR-homol. model and site-directed mutagenesis study was performed to demonstrate that amino acid residue Y2657.36 was the unique anchor point of the covalent interaction.  This workflow might be applied to other GPCRs to guide the discovery of covalent ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnbDNSsfDVVrVg90H21EOLACvtfcHk0lgbdBZl_KYLMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvF2gsr0%253D&md5=47d46258dd0c33b21b5cc2e140684a40</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b02026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b02026%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%26aulast%3Dvan%2BVeldhoven%26aufirst%3DJ.%2BP.%2BD.%26aulast%3DOffringa%26aufirst%3DJ.%26aulast%3DKuiper%26aufirst%3DB.%2BJ.%26aulast%3DLenselink%26aufirst%3DE.%2BB.%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3Dvan%2Bder%2BEs%26aufirst%3DD.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DDevelopment%2520of%2520covalent%2520ligands%2520for%2520G%2520protein-coupled%2520receptors%253A%2520a%2520case%2520for%2520the%2520human%2520adenosine%2520A%25283%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D7%26spage%3D3539%26epage%3D3552%26doi%3D10.1021%2Facs.jmedchem.8b02026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murale, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span> <span> </span><span class="NLM_article-title">Photo-affinity labeling (PAL) in chemical proteomics: a handy tool to investigate protein-protein interactions (PPIs)</span>. <i>Proteome Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">14</span>, <span class="refDoi">Â DOI: 10.1186/s12953-017-0123-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1186%2Fs12953-017-0123-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=28652856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A280%3ADC%252BC1cjitV2ksA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=14&author=D.+P.+Muraleauthor=S.+C.+Hongauthor=M.+M.+Haqueauthor=J.+S.+Lee&title=Photo-affinity+labeling+%28PAL%29+in+chemical+proteomics%3A+a+handy+tool+to+investigate+protein-protein+interactions+%28PPIs%29&doi=10.1186%2Fs12953-017-0123-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Photo-affinity labeling (PAL) in chemical proteomics: a handy tool to investigate protein-protein interactions (PPIs)</span></div><div class="casAuthors">Murale Dhiraj P; Hong Seong Cheol; Haque Md Mamunul; Lee Jun-Seok; Hong Seong Cheol; Lee Jun-Seok</div><div class="citationInfo"><span class="NLM_cas:title">Proteome science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn">1477-5956</span>.
    </div><div class="casAbstract">Protein-protein interactions (PPIs) trigger a wide range of biological signaling pathways that are crucial for biomedical research and drug discovery.  Various techniques have been used to study specific proteins, including affinity chromatography, activity-based probes, affinity-based probes and photo-affinity labeling (PAL).  PAL has become one of the most powerful strategies to study PPIs.  Traditional photocrosslinkers are used in PAL, including benzophenone, aryl azide, and diazirine.  Upon photoirradiation, these photocrosslinkers (Pls) generate highly reactive species that react with adjacent molecules, resulting in a direct covalent modification.  This review introduces recent examples of chemical proteomics study using PAL for PPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaiDChB3xtDcjl5L8hwNX0fW6udTcc2eYeqdWenXNtTLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjitV2ksA%253D%253D&md5=d6ef0d08db66c5d4b74caa24e5b97a94</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1186%2Fs12953-017-0123-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12953-017-0123-3%26sid%3Dliteratum%253Aachs%26aulast%3DMurale%26aufirst%3DD.%2BP.%26aulast%3DHong%26aufirst%3DS.%2BC.%26aulast%3DHaque%26aufirst%3DM.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26atitle%3DPhoto-affinity%2520labeling%2520%2528PAL%2529%2520in%2520chemical%2520proteomics%253A%2520a%2520handy%2520tool%2520to%2520investigate%2520protein-protein%2520interactions%2520%2528PPIs%2529%26jtitle%3DProteome%2520Sci.%26date%3D2016%26volume%3D15%26spage%3D14%26doi%3D10.1186%2Fs12953-017-0123-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Photoaffinity labeling in target- and binding-site identification</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">159</span>â <span class="NLM_lpage">183</span>, <span class="refDoi">Â DOI: 10.4155/fmc.14.152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.4155%2Ffmc.14.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=25686004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVegu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=159-183&issue=2&author=E.+Smithauthor=I.+Collins&title=Photoaffinity+labeling+in+target-+and+binding-site+identification&doi=10.4155%2Ffmc.14.152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Photoaffinity labeling in target- and binding-site identification</span></div><div class="casAuthors">Smith, Ewan; Collins, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-183</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Photoaffinity labeling (PAL) using a chem. probe to covalently bind its target in response to activation by light has become a frequently used tool in drug discovery for identifying new drug targets and mol. interactions, and for probing the location and structure of binding sites.  Methods to identify the specific target proteins of hit mols. from phenotypic screens are highly valuable in early drug discovery.  In this review, we summarize the principles of PAL including probe design and exptl. techniques for in vitro and live cell investigations.  We emphasize the need to optimize and validate probes and highlight examples of the successful application of PAL across multiple disease areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpIXjEh35goLVg90H21EOLACvtfcHk0lgbdBZl_KYLMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVegu7c%253D&md5=ca00880405324587a542f19f8bd10d6c</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.152%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DPhotoaffinity%2520labeling%2520in%2520target-%2520and%2520binding-site%2520identification%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26issue%3D2%26spage%3D159%26epage%3D183%26doi%3D10.4155%2Ffmc.14.152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. A. B.</span></span> <span> </span><span class="NLM_article-title">Fishing for Drug Targets: A focus on diazirine photoaffinity probe synthesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">6945</span>â <span class="NLM_lpage">6963</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b01561</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01561" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFart7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6945-6963&issue=16&author=J.+R.+Hillauthor=A.+A.+B.+Robertson&title=Fishing+for+Drug+Targets%3A+A+focus+on+diazirine+photoaffinity+probe+synthesis&doi=10.1021%2Facs.jmedchem.7b01561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Fishing for Drug Targets: A Focus on Diazirine Photoaffinity Probe Synthesis</span></div><div class="casAuthors">Hill, James R.; Robertson, Avril A. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6945-6963</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Target identification is a high-priority, albeit challenging, aspect of drug discovery.  Diazirine-based photoaffinity probes (PAPs) can facilitate the process by covalently capturing transient mol. interactions.  This can help identify target proteins and map the ligand's interactome.  Diazirine probes have even been incorporated by cellular machinery into proteins.  Embarking on the synthesis of customized PAPs, contg. either an aliph. or trifluoromethyl Ph diazirine, can be a considerable endeavor, particularly for medicinal chemists and chem. biologists new to the field.  This review takes a synthetic focus, aiming to summarize available routes, propose new avenues, and illuminate recent advances in diazirine synthesis.  Select examples of diazirine photoaffinity labeling applications have been included throughout to provide instructive definition of the advantages and limitations of the technol. while simultaneously highlighting how these reagents can be applied in a practical sense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFaJOZyNuB67Vg90H21EOLACvtfcHk0lg98M1v_gpSow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFart7g%253D&md5=37266e26bdd6a2028dddffc3ead4390d</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01561%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BR.%26aulast%3DRobertson%26aufirst%3DA.%2BA.%2BB.%26atitle%3DFishing%2520for%2520Drug%2520Targets%253A%2520A%2520focus%2520on%2520diazirine%2520photoaffinity%2520probe%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D16%26spage%3D6945%26epage%3D6963%26doi%3D10.1021%2Facs.jmedchem.7b01561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funabashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, Y.</span></span> <span> </span><span class="NLM_article-title">Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1867</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">22</span>â <span class="NLM_lpage">27</span>, <span class="refDoi">Â DOI: 10.1016/j.bbapap.2018.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.bbapap.2018.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFGlt77O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1867&publication_year=2019&pages=22-27&issue=1&author=K.+Kubotaauthor=M.+Funabashiauthor=Y.+Ogura&title=Target+deconvolution+from+phenotype-based+drug+discovery+by+using+chemical+proteomics+approaches&doi=10.1016%2Fj.bbapap.2018.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches</span></div><div class="casAuthors">Kubota, Kazuishi; Funabashi, Masanori; Ogura, Yuji</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1867</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-27</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Phenotype-based drug discovery is a key strategy for small mol. drug screening, and the mol. target identification of small mols., termed "target deconvolution," is crit. albeit challenging.  In this review, we classify approaches for target deconvolution, including both direct and indirect approaches, summarize their underlying principles, and provide examples of current chem. proteomics strategies including affinity purifn. using compd.-immobilized beads, photoaffinity labeling (PAL), cellular thermal shift assay (CETSA), and activity-based protein profiling (ABPP).  Because there is no single best target deconvolution strategy, it is important to carefully select a strategy on the basis of the test compd. characteristics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopCpuzLRkmcbVg90H21EOLACvtfcHk0lg98M1v_gpSow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFGlt77O&md5=1eceeee183cfa690ede7d464130884d8</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2018.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2018.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DKubota%26aufirst%3DK.%26aulast%3DFunabashi%26aufirst%3DM.%26aulast%3DOgura%26aufirst%3DY.%26atitle%3DTarget%2520deconvolution%2520from%2520phenotype-based%2520drug%2520discovery%2520by%2520using%2520chemical%2520proteomics%2520approaches%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2019%26volume%3D1867%26issue%3D1%26spage%3D22%26epage%3D27%26doi%3D10.1016%2Fj.bbapap.2018.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomohiro, T.</span></span> <span> </span><span class="NLM_article-title">Tag-Creation Approaches for Highly Efficient Profiling of Interacting Proteins and Domains</span>. In  <i>Photoaffinity Labeling for Structural Probing Within Protein</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatanaka, Y.</span>, <span class="NLM_string-name">Hashimoto, M.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Tokyo</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">13</span>â <span class="NLM_lpage">43</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1007%2F978-4-431-56569-7_2" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=13-43&author=T.+Tomohiroauthor=Y.+Hatanaka&author=M.+Hashimoto&title=Photoaffinity+Labeling+for+Structural+Probing+Within+Protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1007%2F978-4-431-56569-7_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-4-431-56569-7_2%26sid%3Dliteratum%253Aachs%26aulast%3DTomohiro%26aufirst%3DT.%26atitle%3DTag-Creation%2520Approaches%2520for%2520Highly%2520Efficient%2520Profiling%2520of%2520Interacting%2520Proteins%2520and%2520Domains%26btitle%3DPhotoaffinity%2520Labeling%2520for%2520Structural%2520Probing%2520Within%2520Protein%26aulast%3DHatanaka%26aufirst%3DY.%26pub%3DSpringer%26date%3D2017%26spage%3D13%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inahara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span> <span> </span><span class="NLM_article-title">Active/inactive dual-probe system for selective photo-affinity labeling of smallmolecule-binding proteins</span>. <i>Chem. - Asian J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1567</span>â <span class="NLM_lpage">1571</span>, <span class="refDoi">Â DOI: 10.1002/asia.201200085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fasia.201200085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22514195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlslykurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1567-1571&author=K.+Sakuraiauthor=M.+Tawaauthor=A.+Okadaauthor=R.+Yamadaauthor=N.+Satoauthor=M.+Inaharaauthor=M.+Inoue&title=Active%2Finactive+dual-probe+system+for+selective+photo-affinity+labeling+of+smallmolecule-binding+proteins&doi=10.1002%2Fasia.201200085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Active/Inactive Dual-Probe System for Selective Photoaffinity Labeling of Small Molecule-Binding Proteins</span></div><div class="casAuthors">Sakurai, Kaori; Tawa, Masaki; Okada, Ayumi; Yamada, Rika; Sato, Noriyuki; Inahara, Masahiro; Inoue, Maia</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - An Asian Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1567-1571</span>CODEN:
                <span class="NLM_cas:coden">CAAJBI</span>;
        ISSN:<span class="NLM_cas:issn">1861-4728</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors describe an active/inactive dual-probe approach to control the selectivity of photoaffinity labeling (PAL) reactions toward detecting specific small mol.-binding proteins.  The authors demonstrate that their new PAL system is applicable to levels of a binding protein in the cell lysate as low as 1% (wt./wt.).  In addn., a simple inactive analog representing the scaffold moiety of the PAL probe can also improve the labeling selectivity, which should be useful in cases where inactive analog is not easily obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrScjXZ1lusH7Vg90H21EOLACvtfcHk0lg98M1v_gpSow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlslykurc%253D&md5=c505ed996528d8d94c1a6298850362fe</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1002%2Fasia.201200085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fasia.201200085%26sid%3Dliteratum%253Aachs%26aulast%3DSakurai%26aufirst%3DK.%26aulast%3DTawa%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DA.%26aulast%3DYamada%26aufirst%3DR.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DInahara%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DM.%26atitle%3DActive%252Finactive%2520dual-probe%2520system%2520for%2520selective%2520photo-affinity%2520labeling%2520of%2520smallmolecule-binding%2520proteins%26jtitle%3DChem.%2520-%2520Asian%2520J.%26date%3D2012%26volume%3D7%26spage%3D1567%26epage%3D1571%26doi%3D10.1002%2Fasia.201200085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel photoaffinity probes for study of the target proteins of oleanolic acid</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1036</span>â <span class="NLM_lpage">1039</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.11.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1016%2Fj.bmcl.2011.11.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=22204907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFansg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1036-1039&issue=2&author=L.+Zhangauthor=Y.+Zhangauthor=J.+Dongauthor=J.+Liuauthor=L.+Zhangauthor=H.+Sun&title=Design+and+synthesis+of+novel+photoaffinity+probes+for+study+of+the+target+proteins+of+oleanolic+acid&doi=10.1016%2Fj.bmcl.2011.11.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of novel photoaffinity probes for study of the target proteins of oleanolic acid</span></div><div class="casAuthors">Zhang, Liying; Zhang, Yingxia; Dong, Jizhe; Liu, Jun; Zhang, Luyong; Sun, Hongbin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1036-1039</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To explore the mol. mechanisms of oleanolic acid, two novel photoaffinity probes were synthesized based on the structure-activity relationship reported previously.  Their potency were evaluated in an enzyme inhibition assay against rabbit muscle glycogen phosphorylase a (RMGPa), a known target protein of oleanolic acid.  The inhibitory activity of probe 2 was only about two-fold less potent than the mother compd. oleanolic acid.  The photoaffinity labeling expts. were also performed and two proteins were specifically tagged by probe 2.  The results suggest that the synthesized probes could be used as powerful tools to isolate and identify the target proteins of oleanolic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVo3sAcfs3RbVg90H21EOLACvtfcHk0liqIzRXE1fejw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFansg%253D%253D&md5=93e99664d7398145d7f2b8cd6cac059f</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.11.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.11.123%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DH.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520photoaffinity%2520probes%2520for%2520study%2520of%2520the%2520target%2520proteins%2520of%2520oleanolic%2520acid%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D2%26spage%3D1036%26epage%3D1039%26doi%3D10.1016%2Fj.bmcl.2011.11.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio-Mower, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lellis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neduvelil, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Register, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardana, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardell, S. J.</span></span> <span> </span><span class="NLM_article-title">Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>405</i></span> (<span class="NLM_issue">6787</span>),  <span class="NLM_fpage">689</span>â <span class="NLM_lpage">694</span>, <span class="refDoi">Â DOI: 10.1038/35015085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2F35015085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10864326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlGgur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2000&pages=689-694&issue=6787&author=Y.+M.+Liauthor=M.+Xuauthor=M.+T.+Laiauthor=Q.+Huangauthor=J.+L.+Castroauthor=J.+DiMuzio-Mowerauthor=T.+Harrisonauthor=C.+Lellisauthor=A.+Nadinauthor=J.+G.+Neduvelilauthor=R.+B.+Registerauthor=M.+K.+Sardanaauthor=M.+S.+Shearmanauthor=A.+L.+Smithauthor=X.+P.+Shiauthor=K.+C.+Yinauthor=J.+A.+Shaferauthor=S.+J.+Gardell&title=Photoactivated+gamma-secretase+inhibitors+directed+to+the+active+site+covalently+label+presenilin+1&doi=10.1038%2F35015085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Photoactivated Î³-secretase inhibitors directed to the active site covalently label presenilin 1</span></div><div class="casAuthors">Li, Yue-Ming; Xu, Min; Lai, Ming-Tain; Huang, Qlan; Castro, Jose L.; Dimuzio-Mower, Jillian; Harrison, Timothy; Lellis, Colin; Nadin, Alan; Neduvelil, Joseph G.; Register, R. Bruce; Sardana, Mohinder K.; Shearman, Mark S.; Smith, Adrian L.; Shi, Xiao-Ping; Yin, Kuo-Chang; Shafer, Jules A.; Gardell, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">405</span>
        (<span class="NLM_cas:issue">6787</span>),
    <span class="NLM_cas:pages">689-694</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cleavage of the amyloid precursor protein (APP) by Î²- and Î³- secretases generates the N- and C-termini, resp., of AÎ² amyloidogenic peptides AÎ²40 and AÎ²42, the major constituents of the amyloid plaques in the brain parenchyma of Alzheimer's disease patients.  There is evidence that the polytopic membrane-spanning proteins, presenilin 1 and 2 (PS1 and PS2), are important determinants of Î³-secretase activity: (1) mutations in PS1 and PS2 that are assocd. with early-onset familial Alzheimer's disease increase the prodn. of AÎ²42, the more amyloidogenic peptide; (2) Î³-secretase activity is reduced in neuronal cultures derived from PS1-deficient mouse embryos; and (3) directed mutagenesis of 2 conserved Asp residues in transmembrane segments of PS1 inactivates the ability of Î³-secretase to catalyze processing of APP within its transmembrane domains.  It is unknown, however, whether PS1 (which has little or no homol. to any known aspartyl protease) is itself a transmembrane aspartic protease or a Î³-secretase cofactor, or helps to colocalize Î³-secretase and APP.  Here, the authors report photoaffinity labeling of PS1 (and PS2) by potent Î³-secretase inhibitors that were designed to function as transition state analog inhibitors directed to the active site of an aspartic protease.  This observation indicates that PS1 (and PS2) may contain the active site of Î³-secretase.  Interestingly, the intact, single-chain form of wild-type PS1 was not labeled by an active site-directed photoaffinity probe, suggesting that intact wild-type PS1 may be an aspartic protease zymogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbje-NpsbWSbVg90H21EOLACvtfcHk0liqIzRXE1fejw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlGgur4%253D&md5=233f579ccc85c0ba071d151f857100a4</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1038%2F35015085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35015085%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DCastro%26aufirst%3DJ.%2BL.%26aulast%3DDiMuzio-Mower%26aufirst%3DJ.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DLellis%26aufirst%3DC.%26aulast%3DNadin%26aufirst%3DA.%26aulast%3DNeduvelil%26aufirst%3DJ.%2BG.%26aulast%3DRegister%26aufirst%3DR.%2BB.%26aulast%3DSardana%26aufirst%3DM.%2BK.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26aulast%3DSmith%26aufirst%3DA.%2BL.%26aulast%3DShi%26aufirst%3DX.%2BP.%26aulast%3DYin%26aufirst%3DK.%2BC.%26aulast%3DShafer%26aufirst%3DJ.%2BA.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26atitle%3DPhotoactivated%2520gamma-secretase%2520inhibitors%2520directed%2520to%2520the%2520active%2520site%2520covalently%2520label%2520presenilin%25201%26jtitle%3DNature%26date%3D2000%26volume%3D405%26issue%3D6787%26spage%3D689%26epage%3D694%26doi%3D10.1038%2F35015085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colca, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavey, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holewa, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brightwell-Conrad, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulter, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilkuskie, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracheva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korshunova, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trusgnich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Divakaruni, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigueira, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finck, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kletzien, R. F.</span></span> <span> </span><span class="NLM_article-title">Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteins</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e61551</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0061551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1371%2Fjournal.pone.0061551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=23690925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVKhsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&issue=5&author=J.+R.+Colcaauthor=W.+G.+McDonaldauthor=G.+S.+Caveyauthor=S.+L.+Coleauthor=D.+D.+Holewaauthor=A.+S.+Brightwell-Conradauthor=C.+L.+Wolfeauthor=J.+S.+Wheelerauthor=K.+R.+Coulterauthor=P.+M.+Kilkuskieauthor=E.+Grachevaauthor=Y.+Korshunovaauthor=M.+Trusgnichauthor=R.+Karrauthor=S.+E.+Wileyauthor=A.+S.+Divakaruniauthor=A.+N.+Murphyauthor=P.+A.+Vigueiraauthor=B.+N.+Finckauthor=R.+F.+Kletzien&title=Identification+of+a+mitochondrial+target+of+thiazolidinedione+insulin+sensitizers+%28mTOT%29%2D%2Drelationship+to+newly+identified+mitochondrial+pyruvate+carrier+proteins&doi=10.1371%2Fjournal.pone.0061551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT) - relationship to newly identified mitochondrial pyruvate carrier proteins</span></div><div class="casAuthors">Colca, Jerry R.; McDonald, William G.; Cavey, Gregory S.; Cole, Serena L.; Holewa, Danielle D.; Brightwell-Conrad, Angela S.; Wolfe, Cindy L.; Wheeler, Jean S.; Coulter, Kristin R.; Kilkuskie, Peter M.; Gracheva, Elena; Korshunova, Yulia; Trusgnich, Michelle; Karr, Robert; Wiley, Sandra E.; Divakaruni, Ajit S.; Murphy, Anne N.; Vigueira, Patrick A.; Finck, Brian N.; Kletzien, Rolf F.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e61551</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Thiazolidinedione (TZD) insulin sensitizers have the potential to effectively treat a no. of human diseases, however the currently available agents have dose-limiting side effects that are mediated via activation of the transcription factor PPARÎ³.  We have recently shown PPARÎ³-independent actions of TZD insulin sensitizers, but the mol. target of these mols. remained to be identified.  Here we use a photo-catalyzable drug analog probe and mass spectrometry-based proteomics to identify a previously uncharacterized mitochondrial complex that specifically recognizes TZDs.  These studies identify two well-conserved proteins previously known as brain protein 44 (BRP44) and BRP44 Like (BRP44L), which recently have been renamed Mpc2 and Mpc1 to signify their function as a mitochondrial pyruvate carrier complex.  Knockdown of Mpc1 or Mpc2 in Drosophila melanogaster or pre-incubation with UK5099, an inhibitor of pyruvate transport, blocks the crosslinking of mitochondrial membranes by the TZD probe.  Knockdown of these proteins in Drosophila also led to increased hemolymph glucose and blocked drug action.  In isolated brown adipose tissue (BAT) cells, MSDC-0602, a PPARÎ³-sparing TZD, altered the incorporation of 13C-labeled carbon from glucose into acetyl CoA.  These results identify Mpc1 and Mpc2 as components of the mitochondrial target of TZDs (mTOT) and suggest that understanding the modulation of this complex, which appears to regulate pyruvate entry into the mitochondria, may provide a viable target for insulin sensitizing pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGcztjyI6bprVg90H21EOLACvtfcHk0liqIzRXE1fejw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVKhsbw%253D&md5=ecc3245b69aa87e5d49312fe9741baef</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0061551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0061551%26sid%3Dliteratum%253Aachs%26aulast%3DColca%26aufirst%3DJ.%2BR.%26aulast%3DMcDonald%26aufirst%3DW.%2BG.%26aulast%3DCavey%26aufirst%3DG.%2BS.%26aulast%3DCole%26aufirst%3DS.%2BL.%26aulast%3DHolewa%26aufirst%3DD.%2BD.%26aulast%3DBrightwell-Conrad%26aufirst%3DA.%2BS.%26aulast%3DWolfe%26aufirst%3DC.%2BL.%26aulast%3DWheeler%26aufirst%3DJ.%2BS.%26aulast%3DCoulter%26aufirst%3DK.%2BR.%26aulast%3DKilkuskie%26aufirst%3DP.%2BM.%26aulast%3DGracheva%26aufirst%3DE.%26aulast%3DKorshunova%26aufirst%3DY.%26aulast%3DTrusgnich%26aufirst%3DM.%26aulast%3DKarr%26aufirst%3DR.%26aulast%3DWiley%26aufirst%3DS.%2BE.%26aulast%3DDivakaruni%26aufirst%3DA.%2BS.%26aulast%3DMurphy%26aufirst%3DA.%2BN.%26aulast%3DVigueira%26aufirst%3DP.%2BA.%26aulast%3DFinck%26aufirst%3DB.%2BN.%26aulast%3DKletzien%26aufirst%3DR.%2BF.%26atitle%3DIdentification%2520of%2520a%2520mitochondrial%2520target%2520of%2520thiazolidinedione%2520insulin%2520sensitizers%2520%2528mTOT%2529--relationship%2520to%2520newly%2520identified%2520mitochondrial%2520pyruvate%2520carrier%2520proteins%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D5%26doi%3D10.1371%2Fjournal.pone.0061551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrow, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layfield, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moses, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldham, N. J.</span></span> <span> </span><span class="NLM_article-title">Carbene footprinting accurately maps binding sites in proteinâligand and proteinâprotein interactions</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13288</span>â <span class="NLM_lpage">13297</span>, <span class="refDoi">Â DOI: 10.1038/ncomms13288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1038%2Fncomms13288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=27848959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVygu7%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13288-13297&author=L.+Manziauthor=A.+S.+Barrowauthor=D.+Scottauthor=R.+Layfieldauthor=T.+G.+Wrightauthor=J.+E.+Mosesauthor=N.+J.+Oldham&title=Carbene+footprinting+accurately+maps+binding+sites+in+protein%E2%80%93ligand+and+protein%E2%80%93protein+interactions&doi=10.1038%2Fncomms13288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Carbene footprinting accurately maps binding sites in protein-ligand and protein-protein interactions</span></div><div class="casAuthors">Manzi, Lucio; Barrow, Andrew S.; Scott, Daniel; Layfield, Robert; Wright, Timothy G.; Moses, John E.; Oldham, Neil J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13288</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Specific interactions between proteins and their binding partners are fundamental to life processes.  The ability to detect protein complexes, and map their sites of binding, is crucial to understanding basic biol. at the mol. level.  Methods that employ sensitive anal. techniques such as mass spectrometry have the potential to provide valuable insights with very little material and on short time scales.  Here we present a differential protein footprinting technique employing an efficient photo-activated probe for use with mass spectrometry.  Using this methodol. the location of a carbohydrate substrate was accurately mapped to the binding cleft of lysozyme, and in a more complex example, the interactions between a 100 kDa, multi-domain deubiquitinating enzyme, USP5 and a diubiquitin substrate were located to different functional domains.  The much improved properties of this probe make carbene footprinting a viable method for rapid and accurate identification of protein binding sites utilizing benign, near-UV photoactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFaUtr2rZhjbVg90H21EOLACvtfcHk0lj62Sh4u0uvDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVygu7%252FF&md5=edff12d1f12e5e6214093e2a535330a4</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1038%2Fncomms13288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13288%26sid%3Dliteratum%253Aachs%26aulast%3DManzi%26aufirst%3DL.%26aulast%3DBarrow%26aufirst%3DA.%2BS.%26aulast%3DScott%26aufirst%3DD.%26aulast%3DLayfield%26aufirst%3DR.%26aulast%3DWright%26aufirst%3DT.%2BG.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26aulast%3DOldham%26aufirst%3DN.%2BJ.%26atitle%3DCarbene%2520footprinting%2520accurately%2520maps%2520binding%2520sites%2520in%2520protein%25E2%2580%2593ligand%2520and%2520protein%25E2%2580%2593protein%2520interactions%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13288%26epage%3D13297%26doi%3D10.1038%2Fncomms13288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horne, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levenstein, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brockwell, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radford, S. E.</span></span> <span> </span><span class="NLM_article-title">Rapid mapping of protein interactions using tag-transfer photocrosslinkers</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">16688</span>â <span class="NLM_lpage">16692</span>, <span class="refDoi">Â DOI: 10.1002/anie.201809149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=10.1002%2Fanie.201809149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Oqu7fJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=16688-16692&issue=51&author=J.+E.+Horneauthor=M.+Walkoauthor=A.+N.+Calabreseauthor=M.+A.+Levensteinauthor=D.+J.+Brockwellauthor=N.+Kapurauthor=A.+J.+Wilsonauthor=S.+E.+Radford&title=Rapid+mapping+of+protein+interactions+using+tag-transfer+photocrosslinkers&doi=10.1002%2Fanie.201809149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Mapping of Protein Interactions Using Tag-Transfer Photocrosslinkers</span></div><div class="casAuthors">Horne, Jim E.; Walko, Martin; Calabrese, Antonio N.; Levenstein, Mark A.; Brockwell, David J.; Kapur, Nikil; Wilson, Andrew J.; Radford, Sheena E.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">16688-16692</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Analyzing protein complexes by chem. crosslinking-mass spectrometry (XL-MS) is limited by the side-chain reactivities and sizes of available crosslinkers, their slow reaction rates, and difficulties in crosslink enrichment, esp. for rare, transient or dynamic complexes.  Here the authors describe two new XL reagents that incorporate a methanethiosulfonate (MTS) group to label a reactive cysteine introduced into the bait protein, and a residue-unbiased diazirine-based photoactivatable XL group to trap its interacting partner(s).  Reductive removal of the bait transfers a thiol-contg. fragment of the crosslinking reagent onto the target that can be alkylated and located by MS sequencing and exploited for enrichment, enabling the detection of low abundance crosslinks.  Using these reagents and a bespoke UV LED irradn. platform, max. crosslinking yield is achieved within 10 s.  The utility of this "tag and transfer" approach is demonstrated using a well-defined peptide/protein regulatory interaction (BID80-102/MCL-1), and the dynamic interaction interface of a chaperone/substrate complex (Skp/OmpA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-T-qLsl_p9bVg90H21EOLACvtfcHk0lj62Sh4u0uvDg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Oqu7fJ&md5=e6f285596ed0944a54a36ac51010b324</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1002%2Fanie.201809149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201809149%26sid%3Dliteratum%253Aachs%26aulast%3DHorne%26aufirst%3DJ.%2BE.%26aulast%3DWalko%26aufirst%3DM.%26aulast%3DCalabrese%26aufirst%3DA.%2BN.%26aulast%3DLevenstein%26aufirst%3DM.%2BA.%26aulast%3DBrockwell%26aufirst%3DD.%2BJ.%26aulast%3DKapur%26aufirst%3DN.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26aulast%3DRadford%26aufirst%3DS.%2BE.%26atitle%3DRapid%2520mapping%2520of%2520protein%2520interactions%2520using%2520tag-transfer%2520photocrosslinkers%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2018%26volume%3D57%26issue%3D51%26spage%3D16688%26epage%3D16692%26doi%3D10.1002%2Fanie.201809149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="NLM_notes" id="rightTab-contrib"><span class="title" id="d486379067e1411">Author Contributions</span><p class="last">The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></div><div class="NLM_notes" id="rightTab-notes1"><p class="first last">The authors declare no competing financial interest.</p></div><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01456/suppl_file/jm9b01456_liveslides.mp4">jm9b01456_liveslides.mp4 (5.72 MB)</a></li></ul></div></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01456&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01456%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01456" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679941625cd83cfa","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
